{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "id": "d27814c9-e062-4c48-a9de-725c5f6f418b",
   "metadata": {},
   "source": [
    "# 离群点分析\n",
    "本文件将分析HT29的features与smiles数据，使用以下6种离散点分析方法：  \n",
    "**基于统计**  \n",
    "**基于距离**  \n",
    "**基于密度**  \n",
    "**两阶段离群点挖掘方法TOD**  \n",
    "**基于聚类的离群挖掘方法CBOD**  \n",
    "**基于聚类的动态数据的离群点检测**  \n",
    "来分别对药品协同的化学性质离群点和结构性质离群点进行分析，对比两个特征空间的离群点差异"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "e420bec6-4d5f-4860-8fa3-efa5f2c3da5b",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import os\n",
    "import numpy as np\n",
    "from sklearn.preprocessing import StandardScaler, MinMaxScaler\n",
    "from sklearn.impute import SimpleImputer, KNNImputer\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "from sklearn.covariance import EllipticEnvelope\n",
    "from sklearn.neighbors import NearestNeighbors, LocalOutlierFactor\n",
    "from sklearn.cluster import KMeans\n",
    "from sklearn.decomposition import PCA\n",
    "from sklearn.metrics.pairwise import euclidean_distances\n",
    "from sklearn.model_selection import train_test_split\n",
    "from rdkit import Chem\n",
    "from rdkit.Chem import AllChem\n",
    "from rdkit import RDLogger\n",
    "from matplotlib_venn import venn2\n",
    "import plotly.express as px\n",
    "import plotly.graph_objects as go\n",
    "RDLogger.DisableLog('rdApp.*')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "86649a64-841f-4e8a-83cc-53f4a642919f",
   "metadata": {},
   "source": [
    "## 数据清洗\n",
    "### 文件读取、缺失值比例检测与记录、样本筛选(80%)、使用KNN进行缺失值填充、标准化"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "19483c6b-bfa1-44ce-a231-466e3d122a9d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "==================== 正在处理: CO_HCT-116 ====================\n",
      "原始数据读取成功: 5251 行, 416 特征列\n",
      "正在记录原始缺失值分布到 -> output\\missing_ratio_log_CO_HCT-116.txt\n",
      "-> 日志写入完毕。\n",
      "\n",
      "[数据清洗] 没有样本超过 80% 缺失阈值，无需删除。\n",
      "[填充缺失] 剩余缺失值总数: 3680，先对非缺失值做 Z-Score 标准化然后使用 KNN 填充...\n",
      "-> KNN 填充完成（结果为标准化后的特征）。\n",
      "处理结束! 最终数据维度: (5251, 418)\n",
      "--------------------------------------------------\n",
      "\n",
      "\n",
      "==================== 正在处理: CO_HT29 ====================\n",
      "原始数据读取成功: 5279 行, 416 特征列\n",
      "正在记录原始缺失值分布到 -> output\\missing_ratio_log_CO_HT29.txt\n",
      "-> 日志写入完毕。\n",
      "\n",
      "[数据清洗] 没有样本超过 80% 缺失阈值，无需删除。\n",
      "[填充缺失] 剩余缺失值总数: 3624，先对非缺失值做 Z-Score 标准化然后使用 KNN 填充...\n",
      "-> KNN 填充完成（结果为标准化后的特征）。\n",
      "处理结束! 最终数据维度: (5279, 418)\n",
      "--------------------------------------------------\n",
      "\n",
      "所有日志文件已生成至: E:\\file\\postgraduate\\机器学习\\期末\\ML期末作业\\output\n"
     ]
    }
   ],
   "source": [
    "def load_log_and_preprocess(folder_path):\n",
    "    \"\"\"\n",
    "    流程：\n",
    "    1. 读取数据\n",
    "    2. [关键步骤] 计算原始数据的每行缺失比例，并保存到 output/txt 文件\n",
    "    3. 过滤：删除缺失率 > 80% 的样本\n",
    "    4. 填充：对剩余样本进行均值填充\n",
    "    5. 标准化：Z-Score\n",
    "    \"\"\"\n",
    "    \n",
    "    # --- 0. 准备工作 ---\n",
    "    dataset_name = os.path.basename(folder_path) # 获取文件夹名，如 CO_HT29\n",
    "    \n",
    "    # 确保 output 文件夹存在\n",
    "    output_dir = 'output'\n",
    "    if not os.path.exists(output_dir):\n",
    "        os.makedirs(output_dir)\n",
    "    \n",
    "    feat_path = os.path.join(folder_path, 'dataset_features.csv')\n",
    "    smile_path = os.path.join(folder_path, 'dataset_smiles.csv')\n",
    "    \n",
    "    if not os.path.exists(folder_path):\n",
    "        print(f\"错误: 找不到文件夹 {folder_path}\")\n",
    "        return None, None\n",
    "\n",
    "    print(f\"\\n{'='*20} 正在处理: {dataset_name} {'='*20}\")\n",
    "\n",
    "    # --- 1. 读取原始数据 ---\n",
    "    try:\n",
    "        df_features = pd.read_csv(feat_path)\n",
    "        df_smiles = pd.read_csv(smile_path)\n",
    "    except Exception as e:\n",
    "        print(f\"读取失败: {e}\")\n",
    "        return None, None\n",
    "\n",
    "    # 切分特征(X) 和 标签(y)\n",
    "    # 前416列是特征 (0-415)，后面是标签\n",
    "    X_raw = df_features.iloc[:, :416]\n",
    "    y_raw = df_features.iloc[:, 416:]\n",
    "    \n",
    "    print(f\"原始数据读取成功: {X_raw.shape[0]} 行, {X_raw.shape[1]} 特征列\")\n",
    "\n",
    "    # --- 2. [核心步骤] 记录缺失值比例 (在填充之前!) ---\n",
    "    # 计算每一行的缺失比例\n",
    "    missing_ratios = X_raw.isnull().mean(axis=1)\n",
    "    \n",
    "    log_filename = f\"missing_ratio_log_{dataset_name}.txt\"\n",
    "    log_path = os.path.join(output_dir, log_filename)\n",
    "    \n",
    "    print(f\"正在记录原始缺失值分布到 -> {log_path}\")\n",
    "    \n",
    "    with open(log_path, 'w', encoding='utf-8') as f:\n",
    "        f.write(f\"Dataset: {dataset_name}\\n\")\n",
    "        f.write(f\"Raw_Total_Rows: {len(X_raw)}\\n\")\n",
    "        f.write(\"Description: 此文件记录了原始数据的缺失比例。比例 > 0.8 的行将在后续步骤中被删除。\\n\")\n",
    "        f.write(\"-\" * 40 + \"\\n\")\n",
    "        f.write(\"Row_Index\\tMissing_Ratio\\tStatus\\n\") # 表头\n",
    "        \n",
    "        for idx, ratio in missing_ratios.items():\n",
    "            # 标记一下该行稍后会被 Drop 还是 Keep\n",
    "            status = \"DROP\" if ratio > 0.8 else \"KEEP\"\n",
    "            f.write(f\"{idx}\\t{ratio:.6f}\\t{status}\\n\")\n",
    "            \n",
    "    print(\"-> 日志写入完毕。\")\n",
    "\n",
    "    # --- 3. 样本筛选 (删除缺失 > 80% 的行) ---\n",
    "    # 找出要删除的索引\n",
    "    drop_indices = missing_ratios[missing_ratios > 0.8].index.tolist()\n",
    "    \n",
    "    X_clean = X_raw\n",
    "    y_clean = y_raw\n",
    "    df_smiles_clean = df_smiles\n",
    "    \n",
    "    if len(drop_indices) > 0:\n",
    "        print(f\"\\n[数据清洗] 发现 {len(drop_indices)} 个样本缺失率 > 80%，正在删除...\")\n",
    "        # 同步删除特征、标签、SMILES\n",
    "        X_clean = X_raw.drop(drop_indices).reset_index(drop=True)\n",
    "        y_clean = y_raw.drop(drop_indices).reset_index(drop=True)\n",
    "        df_smiles_clean = df_smiles.drop(drop_indices).reset_index(drop=True)\n",
    "        print(f\"-> 删除完成。剩余样本数: {X_clean.shape[0]}\")\n",
    "    else:\n",
    "        print(\"\\n[数据清洗] 没有样本超过 80% 缺失阈值，无需删除。\")\n",
    "\n",
    "    # --- 4. 使用 KNN 填充缺失值 (先标准化再填充) ---\n",
    "    # 检查清洗后的数据里是否还有 NaN (比如缺失率 20% 的行)\n",
    "    remaining_nans = X_clean.isnull().sum().sum()\n",
    "\n",
    "    if remaining_nans > 0:\n",
    "        print(f\"[填充缺失] 剩余缺失值总数: {remaining_nans}，先对非缺失值做 Z-Score 标准化然后使用 KNN 填充...\")\n",
    "\n",
    "        # 计算列的均值和标准差，忽略 NaN\n",
    "        X_vals = X_clean.astype(float)\n",
    "        col_means = np.nanmean(X_vals.values, axis=0)\n",
    "        col_stds = np.nanstd(X_vals.values, axis=0)\n",
    "        # 避免标准差为0导致除以0\n",
    "        col_stds[col_stds == 0] = 1.0\n",
    "\n",
    "        # 对非 NaN 值进行标准化，NaN 会被保留\n",
    "        X_standardized = (X_vals - col_means) / col_stds\n",
    "\n",
    "        # KNN 填充在标准化空间进行\n",
    "        knn_imputer = KNNImputer(n_neighbors=5)\n",
    "        X_imputed_arr = knn_imputer.fit_transform(X_standardized)\n",
    "\n",
    "        # imputer 返回的是 numpy array（标准化后的值），保持为 DataFrame\n",
    "        X_clean = pd.DataFrame(X_imputed_arr, columns=X_clean.columns)\n",
    "        print(\"-> KNN 填充完成（结果为标准化后的特征）。\")\n",
    "    else:\n",
    "        # 如果没有缺失，按常规对整个数据做标准化\n",
    "        print(\"[填充缺失] 数据完整，无需 KNN 填充，接着进行 Z-Score 标准化...\")\n",
    "        scaler = StandardScaler()\n",
    "        X_scaled_arr = scaler.fit_transform(X_clean)\n",
    "        X_clean = pd.DataFrame(X_scaled_arr, columns=X_clean.columns)\n",
    "\n",
    "    # --- 5. （此时）数据已为标准化特征，拼接回完整表格 (特征 + 标签)\n",
    "    df_final = pd.concat([X_clean, y_clean], axis=1)\n",
    "    \n",
    "    print(f\"处理结束! 最终数据维度: {df_final.shape}\")\n",
    "    print(\"-\" * 50 + \"\\n\")\n",
    "    \n",
    "    return df_final, df_smiles_clean\n",
    "\n",
    "# ==========================================\n",
    "# 执行主程序\n",
    "# ==========================================\n",
    "\n",
    "dir_hct116 = 'CO_HCT-116'\n",
    "dir_ht29 = 'CO_HT29'\n",
    "\n",
    "# 1. 处理 HCT-116\n",
    "df_hct116_ready, df_hct116_smiles_ready = load_log_and_preprocess(dir_hct116)\n",
    "\n",
    "# 2. 处理 HT-29\n",
    "df_ht29_ready, df_ht29_smiles_ready = load_log_and_preprocess(dir_ht29)\n",
    "\n",
    "print(f\"所有日志文件已生成至: {os.path.abspath('output')}\")"
   ]
  },
  {
   "cell_type": "raw",
   "id": "bef0c094-3640-4786-9e83-9d77cad58b73",
   "metadata": {},
   "source": [
    "Dataset: CO_HT29\n",
    "Raw_Total_Rows: 5279\n",
    "Description: 此文件记录了原始数据的缺失比例。比例 > 0.8 的行将在后续步骤中被删除。\n",
    "----------------------------------------\n",
    "Row_Index\tMissing_Ratio\tStatus\n",
    "0\t0.000000\tKEEP\n",
    "1\t0.000000\tKEEP\n",
    "2\t0.000000\tKEEP\n",
    "3\t0.000000\tKEEP\n",
    "4\t0.000000\tKEEP\n",
    "5\t0.000000\tKEEP\n",
    "6\t0.000000\tKEEP\n",
    "7\t0.000000\tKEEP"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f127073b-ab68-4c30-9d22-2024aceff9fb",
   "metadata": {},
   "source": [
    "## 全局设置\n",
    "### 设置plt绘图参数、定义输出文件夹"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "5031c76b-8e0b-4ecf-9e78-f1ac365d5fd2",
   "metadata": {},
   "outputs": [],
   "source": [
    "sns.set(style=\"whitegrid\")\n",
    "plt.rcParams['font.sans-serif'] = ['SimHei']  # 正常显示中文\n",
    "plt.rcParams['axes.unicode_minus'] = False    # 正常显示负号\n",
    "\n",
    "# 定义输出文件夹\n",
    "OUTPUT_DIR = 'output'\n",
    "if not os.path.exists(OUTPUT_DIR):\n",
    "    os.makedirs(OUTPUT_DIR)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f71e4281-bb0f-456d-8b8f-ecccf0c7d37c",
   "metadata": {},
   "source": [
    "# 基于Feature的离群点检测\n",
    "## 数据预处理\n",
    "### 数据集选择、特征提取与降维（保留95%方差）"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "id": "c14c4738-e7ad-43c1-9412-77d5cce42261",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "当前分析对象: HT-29_FEATURE\n",
      "[PCA] 原始维度: 416 -> 降维后: 75 (保留 95% 方差)\n",
      "特征提取与 PCA 降维完成。\n"
     ]
    }
   ],
   "source": [
    "# --- 1. 选择要分析的数据集 ---\n",
    "current_dataset_name = \"HT-29_FEATURE\"\n",
    "df_current = df_ht29_ready           \n",
    "df_smiles_current = df_ht29_smiles_ready\n",
    "\n",
    "print(f\"当前分析对象: {current_dataset_name}\")\n",
    "\n",
    "# --- 2. 提取特征并先做 PCA(0.95) 降维，供后续离群点检测使用 ---\n",
    "# 提取前416列特征矩阵\n",
    "X = df_current.iloc[:, :416].values\n",
    "\n",
    "# 先用 PCA 保留 95% 方差，降维用于后续离群点检测\n",
    "# 使用 svd_solver='full' 以保证 n_components=0.95 时行为一致\n",
    "pca_reducer = PCA(n_components=0.95, svd_solver='full')\n",
    "X_reduced = pca_reducer.fit_transform(X)\n",
    "print(f\"[PCA] 原始维度: {X.shape[1]} -> 降维后: {X_reduced.shape[1]} (保留 95% 方差)\")\n",
    "\n",
    "# 为了绘图，再在降维后的数据上做一次 2D PCA，保证可视化和检测使用相同（或相似）的空间\n",
    "if X_reduced.shape[1] >= 2:\n",
    "    pca2 = PCA(n_components=2)\n",
    "    X_pca = pca2.fit_transform(X_reduced)\n",
    "else:\n",
    "    # 如果降维后只有 1 维，为了可视化构造第二列为 0\n",
    "    X_pca = np.hstack([X_reduced, np.zeros((X_reduced.shape[0], 1))])\n",
    "\n",
    "# 初始化一个 DataFrame 用来存结果\n",
    "outlier_flags = pd.DataFrame(index=df_current.index)\n",
    "\n",
    "print(\"特征提取与 PCA 降维完成。\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b722917e-2cff-4046-a912-7ce06104ce25",
   "metadata": {},
   "source": [
    "## 1.基于统计的离群点分析"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "78915cbe-bfa2-43c0-a145-6c359f44d2b2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "正在运行统计法检测...\n",
      "图片已保存: output\\HT-29_FEATURE_1_Statistical.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# --- 方法 1: 基于统计 (Statistical) ---\n",
    "print(f\"正在运行统计法检测...\")\n",
    "\n",
    "# 设定离群阈值\n",
    "contamination = 0.02\n",
    "\n",
    "# 1. 计算 (在降维后的空间上进行检测)\n",
    "# support_fraction=0.9 表示使用 90% 的数据来拟合椭圆，剩下的作为噪点参考\n",
    "ee = EllipticEnvelope(contamination=contamination, support_fraction=0.9, random_state=42)\n",
    "y_pred_stat = ee.fit_predict(X_reduced) # 1正常, -1异常\n",
    "\n",
    "# 记录结果 (True 为异常)\n",
    "outlier_flags['Stat'] = (y_pred_stat == -1)\n",
    "\n",
    "# 2. 绘图\n",
    "plt.figure(figsize=(10, 6))\n",
    "# 画正常点\n",
    "plt.scatter(X_pca[~outlier_flags['Stat'], 0], X_pca[~outlier_flags['Stat'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常样本')\n",
    "# 画异常点\n",
    "plt.scatter(X_pca[outlier_flags['Stat'], 0], X_pca[outlier_flags['Stat'], 1], \n",
    "            c='red', s=40, edgecolor='k', label='统计异常点')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 统计法 (Elliptic Envelope)\\n检出数量: {outlier_flags[\"Stat\"].sum()}')\n",
    "plt.xlabel('PCA Component 1')\n",
    "plt.ylabel('PCA Component 2')\n",
    "plt.legend()\n",
    "\n",
    "# 3. 保存\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_1_Statistical.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a38bf1b6-a07c-44d1-a492-f9d1b4217493",
   "metadata": {},
   "source": [
    "## 2.基于距离的离群点分析"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "e0ba1073-6131-4ee8-894c-ce628ad2bd04",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "正在运行距离法检测...\n",
      "图片已保存: output\\HT-29_FEATURE_2_Distance.png\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA1IAAAI4CAYAAABgPtiPAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjcsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvTLEjVAAAAAlwSFlzAAAPYQAAD2EBqD+naQABAABJREFUeJzsnQe4HGX1/9+bgAiB5AYEIQlSpQmICoiI0gTpRXoREKRI79JDEpSSSAcBQQTlSpF0IFJF/StWRKQICASSUPIDkkgAS3L/z+cN3/W9k5nZ2d3Z3dnd83mefbbNzk6fc95zzvd09fb29jrDMAzDMAzDMAwjM/2yT2oYhmEYhmEYhmGYI2UYhmEYhmEYhlEFFpEyDMMwDMMwDMOoEHOkDMMwDMMwDMMwKsQcKcMwDMMwDMMwjAoxR8owDMMwDMMwDKNCzJEyDMMwDMMwDMOoEHOkDMMwDMMwDMMwKsQcKcMwDMOoM++//76bO3eubWfDMIw2YpFmL4BhGIZh1MLMmTPde++91+ezpZde2s2fP9/NmjVroen5/N///rdbbbXV3CKLJN8G/9//+3/uiSeecEcffXSm5Xj++efdJz/5ydjvvvOd7/jv77jjDpcnL774oltxxRXdoosumut8jdqYOnWqW2GFFdxHPvIR25SG0caYI2UYhmG0NKNGjXKPPfaYGzRokH//xhtvuDPPPNPNmTPHXXXVVW7AgAF9pu/t7fURol/+8pdu8ODB3qnq37+/f4S888477sorr3S77LKLGzZsWJ/f/+c///GvZShPnz7d7b777m7LLbd0F154oVtyySX7zIvp8jaqX3vtNXfIIYe4Sy+91G244Ya5ztuojRtvvNEfY2PGjLFNaRhtjKX2GYbREvzud79za665pnvyySf7fM5nP/rRj/zrrbbayr+PPvg8K6RfnXXWWW6jjTZy6667rttvv/38qH9oRN98883uq1/9qltvvfXc/vvv76MWWZk2bVrsMvI444wz/DRf//rXY7+/9tpr+8zr7bffdmuttZa7+uqrY7dV3APHQtuKKEnIxRdfXNpWTKff8B9bbLGFd1hwTsJtH/f44x//6BoJDgrb7IEHHvCPT3/60z5Cw+c4GGyP8PH73//eH0c4UTB8+HD32c9+1j+YXo/zzz/fO0S77bZbn88/85nP+GnD7Td06FBvPP/hD39we++9t3v33Xe9IU30C/r169fHUcN5++CDD6peZ+Z7/PHHe0eKZdJx9eCDD5ammThxov9MUTBe77vvvn3mw3bjodcbbLBBn32s4yArOgY4dzhHLrvsMr8dkqZlf7QjZ599tnv55Zfdbbfd1uxFMQyjjlhEyjCMtuH73/++N1CfeuopbxwzGrzyyitXFAk477zz3K9//Wt32GGHeUObeX7rW99y9913nzeGMQx7enrct7/9bT9vDKWDDjrI3XnnnRUZnPweZy1Ehj1svPHG7vTTT+/z/cc//vE+74nC4Nj95je/cccee2zp80996lPuZz/7mX99zTXXuJdeeqk0Mr7ccstlXsaPfvSj7ic/+YmPvrBNr7jiCvfCCy+4W265pTTNN77xDbfjjjv2+d2qq67qGknc/iVlr6urK9PviSDhFGHwL7HEEn6dcVI322wz71iQkjd69Gi3yiqr+P2WlEa3ySabuNtvv9395S9/8dt8zz33XGia8BjBOb3++utdNdx1111+vQ899NDY74mQjRw50m2//fZun332KX3++OOPu6efftqts846sb9jG9x9991+v1YLv/3KV77inUrWj//kmInuD45Rtmk14Owxz4MPPtgNHDjQFQ3OHQYmcE7ZB6SaGobRfpgjZRhG2yAjVfUyq6++ult77bUz/57IEw4TI/hEm2DIkCHum9/8pvv73//ua1GIfuHg7LXXXv57IhPbbLONN76J2GTlE5/4ROk/4lhqqaVSv1cND0Y9ETEiIEon41m/7e7u9kZduXnFgeOo37GevMc4nzFjht8usPzyy1c17zwhOoPjoOgGRjYOZiXg+Oywww7eOf3yl7/st+13v/tdX+vCtiXySMQQB+2AAw7wKXwcF4IoHJEqnGseOPTaPzgQ3/ve9/zxhWMLOKdZHb04brrpJnfJJZfEfjdv3jx32mmn+VTHuGPyxz/+sXcek2CgAAeF/V0NHBOK3rEtTjzxRB8p4zwJqeW4YR8TiSWdsoiOFFCDh0OJw3jEEUc0e3EMw6gDltpnGIYRGIBjx47tY+DhiMg4fe6559y//vUvt+mmm5a+J11rpZVW8oZ8oyESdeCBB3pHohEpUtour7/+uisSOLgsE04e6W5E9rTffvvb38amH5J2FbLYYov5Zxwfaqceeugh9+abb7ojjzzSp3dyXBCZxKFmGpxTQU3W4Ycf7lP6NF+iRR/72Me8M4Ohz3uOFV7zWGaZZaqOUjz77LP+eCRaFsd1113n/vrXv/raKRzyaFTznnvu8fVfcfD9K6+84rdBHmy33XZu2WWXdQ8//LDrRHbaaSc3ZcqUZi+GYRh1whwpwzA6BozP//73v7EPnBHSuqgHCsGg5PM11lijVOMSKsExTyIN0bS7ekMEhcgQI95E3XCqGqGOB3mlKZXbH1k55phjfKSQdEy2Ba+JGClFkhQzPSZMmOA/T0r3lJOEwATOFA4SaaI///nPfe0VtVBR2Pek2pEW97Wvfc394x//8K9ZvyRYP2qkiFxVCs4c0a84iE5SS8e2YHmjEMEBljcOapt4EGHNA6JuOK5hnWG5Gikc2OOOO859/vOf9+mvJ598sps9e7b/DoeW32299db+Pc+8V52X+NWvfuX3BduAuj/VUYY1hBzPRx11lHdIiZaFziMRTdISN998c7+tGbD429/+1uc/qLUjMr3++uv79L3JkycvtC78ltRQwzDaE0vtMwyjpYirO8kKxlJS5IgaI4y3EIy3W2+91adyYXhjfBFNYKSfFC1S6C6//HIfDZFhlxcY8dGaK2q3GN0HHKfFF1/cG3E4C4888oirJzgHKNgh700ETpAiFqaJUfOSdQS+0v2RxD//+c8+EaIQRYGEhBSiaWtEGoHtKaI1aiCxjjAqqTRSUkJJYUuLFkX36bnnnuuN9ErAAdBxEJfyx/9T0xYH0TqiJNRy4WzFgVNCGmM0alctRAcridgi8kH0l9RFUiCpTyM1kogjDjKpcmwDIoTUMLItQmXGV1991UvWIxKCcAzzIsURBzFUN8RJ/sIXvuDTGIniUf9GOibHBuc4KZA4cewzrgNsL45ttiEDGdSn4axxnPC7U045xUcamWfomLNs1NxZnZRhtB/mSBmG0VIgmoDRKjCWsnLDDTeUZKujkIYVBcMNQwiDCzDWL7jgAm8wffGLX/TfUY+FNDbCAZVAFCUEIQfSoATOEUZgkhgFhhvGOg4eI/coCYa1S3nAuoWGP04UyxnW9mBMEr0RlQh7VLo/kth22229SIgcPqTPcYxCpyhLPQuRnhD2M0Ywx0EWSKMj4sM6Ed3g+KCmCiVBlg9xBCKbgLNDNCoqzZ4FDP2kGjCcRsQlcAwQeYiLXCGOgqBEkvNNrRjOC0IqedUfVVKzhgIhkSSiQYDjjrOsc4AH0wDbM5SmV7SP7c1xScomUWaidGyP0JHiNc4TsB+ILuGgMUBCBAtHjW0lARWcMSTn+X+OXY4ZHRtEzh599FE3fvz4Po6UlicqrW8YRntgjpRhGC0FxeuVCEiEhA5YOUjToZaE9B71JwIknTHAcGSoQ2HUmtHvtMaucWDs4wCJqDGIUZ60nqS+kZ6ECELo6LBMEsHIAxxHIheqFSJSgfEYTWtrxP5Ig8gcy0o6Hc4Jxi5pczhSOFQyusP6rjB1kMgLzkMUnB2cFikgRsGYRtkvhHqpH/zgByVhCiCdkH2dV68nIjDRNDOBsANRknHjxvkIIg52FBwLDH+O3ThwhnHGiMLkcTwR2VXNWhaQaMdpYVsyWMA2RhExKzhetDHA6UcEBJVC9mVUbp5Is1C0CCcYZ5zj6HOf+1yfbc72FDjd1KpFI4yqtRMcf/xveA0xDKN9MEfKMAwjAhLfpFwh46xR8RDSdxjtnjRpkh+priQqFjpO1TogOHA4UUixSz6a6FUljhTRkmgNDw5aKO2NE8Ey8iDqg4Owxx57VOw0NhLVSAHPf/7zn2PTLsPaJBwHtgU1VERg+I71JPUQ8QogVY6ogmroUPaLq+MiQvHWW2+VUgf/9Kc/+UgIkQpgH917770L9fCqBOTtiRgR5Ykq/xHJY31QicMZwZGIc+CItJA6iRw+gxNRENjAUWQwoVZwOtheWUEhEceT9FXqkH74wx/65VWftXKQXsl+Q5afeeFQU+cWp5xZSfSM8w6HS4Me1CeGbQcgmmLK8rO/DMNoT0xswjAMI4DUHoxQ+uyQ2pUEo9ykbzFNo9N2MDARwCA6JkeHEXsU6rKKNGAMRgUAGImPRsbCVEQiO3EF9UWGNCsM+egjdB7CeimM6BEjRnhniiicQHzh1FNPTUxFBOpnSO/CgWGeOGdIqJMipkgeaWE4J0nRoCzgvBPhQKo9CRQEiRYSlYkD5xLhDKKNcRCBIdWUqFAt4NTwHzjiWSCqiJNJRJYIKDVppNZGxTEU+YkT9CAah1w/ziaDHKxnXI1W0nnLvmJAIWwsTWSJCJbSIUlzJfKp848HTnvU8aQpcpiyaxhGe2GOlGEYRgCF4xSGY7w988wz7sknn/SPqFw0xeikRzEqXQ+oCdF/60GkTFENal9CQ5BlQU0QBy8L1PLgeJGuxKg5z8yXtLA4SGFiXUl1DJ01UuWiy4mB2QxYLvYdfZBwhqqBND4eSKojooETxLZC/AP1tVD9LQRnAZEEjH+MbNXzYeiHPYRw0Ike0qw1SRAiCyzXRRddlKgMqKgU+zbO4eLYIeqUhuqDKoVjgkgcES36WeHwx0V2k9I0cUapReT4RGCFAQv2R9TRox6Q9EMifjhPOj9wVnnNfO6//36/T3CkiLhmgRop1p0ILPNn+3Fd0OAFsG0RsSByTZotKbDs07DmjQgW3xHdNAyjPSlufoZhGEaDwRGRjHgYjQCMajkZGKcYeEkS0nnAf0QVCkkrQwAAAw1DOoR6DqIgOEOok5UD5TbWl/mh9IZRilFIOlQSRKUY4SfyopoianCidTgYoWeffbZrBCjl4eQiLsAzqY44czgsRI+oTyHSFoXvSIPjEaZy4TASjWBebBMiWkSvqLtBAh1jGkJnkugVtUlsf4mI0CyWlDTEEA455BDvGPOgdocH06IIh5x3NYITbH9+i7Id9XZJUSmcGaI6cTVGfK8GwXGQEkeN0l/+8peKlo3jgQge24ztwfpXAkp8rBfblG2L8ATHZhRSW3FeOQZIucPJhxNOOMFH0njGKeKYxfEiYpQVoo9ExXCmSKNlW+BEkwqpqBXfoSaIE8fnpEqSDgw49DiRpCOqUbZhGO1HV2+l7d8NwzCMWLicpvUOop7F1LvyBWcFuWuiZUTp5OjoO9Ta4vYT0QkcEIQNaEBLPRQ1Uhi9pJclOTc4z0T9iEDgMOCgIIWNEY0DiXMCONrURSGoQaNn0uxw2qivIy2POirq7IhsRqXUs4KUO1ElnMhQuMRoPjhQOG9p6cGGYbQ+5kgZhmHkBGk8aelQjHCHdRdGMSBiRYRHYhNp4DwRCUFAgGgP+1RS8QgNRPtTpUGESr+vFqKKlSjiGY0BJ5d9GxUDMQyjvTBHyjAMIydI2SK6kQRGdlQu2WgtiGQRVTQD2TAMwzBHyjAMwzAMwzAMo0JMtc8wDKNBWEmqYRiGYbQP5kgZhmE0AGSYUcoj/Q9Qk0ORrFLnCjU/ZK8RKwih4WiaAptROciox0mHo5pIU116C1XKUUcd5R544IFM02r+KNChrMjxghCGjhnk+dNSSQ3DMIz6YvLnhmEYDYCGnTNmzPCy2N/+9rd9nyqcojSQc95iiy36fDZp0iTvlNHHhnqdRRZZcBlHtj3s1YM8N4Y3AghGdfz0pz/1ynpR6fBbbrnF3XfffV5qXo1h40BY5BOf+ERJMhtoBjx79uw+06E6yH5C5U0gXrHrrrv65r70VkIO/MADD3TXXXedd6xwppHjRiiDvldpIAVPo2XmkwTNmUeOHOl7ZhmGYRjZsIiUYRhGA6Ch6De/+U3fqJQeRii+0e+I98hpP/HEE+6cc87x0Q6MbQzwqJGOY0Q0Y5999vGGNcpxiFfwIDLx4x//uPQexy1rE9RKQQKcJqdRcAj0/+Fj6tSpmedN/6aTTjrJ98WipxVKiFGVumOPPdZtvPHG/sFrmuHWA/pJRZ0PIoEPP/yw377lIoD0UFJfMoHjG1X2QyqbfReCjDu/R9pcwhYcN3feeaeXbIe//e1vpQaxaXAcffnLX/ZOUtIDhbk0p7BWnn32Wd+TKg6ifvR6+uxnP+uOP/74hRxNwXnBMU8fM8MwjCJgESnDMIw6g+NBU1NG/NWwFSMdaOiJM/Xd737XG+Y4B1L2ixrczAdHg0a99DuiaSjzwdDGaaIBqZoG43RVk3pWDqJorEecUfzUU0/5fklRB2OFFVbIPH/6MU2bNs1HXHDMSIWbOHGid0SBBqw0O73iiit8o9Qrr7zSNye+++67XV48//zzftuzDf/v//7Pv6fhKz2g6EtFM1Yc4e2339437N16661j5/ORj3wkU0SQfajjQXC8IKFNRAzHDSZMmOC++MUv+u9wfF544QXfO4vpFIVkueMk3Jl+8ODBictQiWx7pRBBY7+SlhiFbUvz6y233NIfzziUPNPsNoR0RtJXN9xwQ7fddtvVbVkNwzAqwRwpwzCMOkO/IFKwMCQxrnkIjHMiAWussYa75557fCPYuKa+GPU33nijb+pKtCqEFD9SwUgNK9cHqRYw6GkwSpPZOIisrbXWWm699darav40saWXEw7j+uuvX4pk0FgXI5ptQFojzXD1PdvrG9/4hnvttdcqctjSwHkjKoKjhjNHCt3JJ5/sPvnJT/q6KXpJ4VixTHw+YsQIH1GJUotEOlG8Rx991B8Lv/3tb/1nROdwlohyUWMHBxxwQJ/f4WR/5zvf6fMZ86CmK82pY13ZvnlDpPTggw/2x3kcpCpyPNOYGGfu05/+tI+eEZnVPoY77rjDR3BpcmwYhlEUzJEyDMOoM4o4YIQz0h6O/mO88vj85z9fek/6VhQiINRY4UiJE0880T300EM+DYymrESKeGBkM8J/+eWX57oeODnMEyM3rr6LiBSGcLXgMKy00kp9DOivfOUrPmoHRF5wCkKBDtLdIM+0NLYpUa9NN93UnXbaab42CYdqv/3285E/6o2ImrGcpNlR80btGhHBcNlrgfqobbfd1kdycLKfe+45n+648sor+2XAOSFaNXr0aD/9YYcd5jbaaCN36KGHlpxrjiVSE9lfWZEASl7bk+gZ24gIZlyzavY5aaI6J4iccS7wubYlUUGOAZxGnFnDMIyiYI6UYRhGnVFkAoEIHiFjx471jhNRFiJSjMZjTIagzqaReyJPgsgWxnQ0AnHxxRd7RyCOq666yoslIIRQKTgVGLxJhjmOFEbvbbfdVnIOqf/B+M+aAhZtWExK3/Tp070DhROJU0FaHzVi/Aepdl/60pd8hChPfvnLX5YcNqJipJ+RGkcqWpjKh3E/ZswY78COGzeujyOFk4dzFeXMM8/0j5CoA8Y2Pvvss32UjYgXThwphcyP9EYc2bAGjjoxoj6Kdj7++OM+UocDT9QuTWgCWFeiUhxfrKtSUBUJwwkiGkRtWCWgVMkxE611k7NHzVncPn/55Zf7HM840dTHcQziMBJ5q2c6omEYRhbMkTIMw2gQiAPssccern///t5wHTJkiDeKMYJxQEgTo76IKEwIKU04UThhikAAhiSKbXGqbUnqa3vvvfdC889KmuFKxIb6LWpYWA9k3nHaiJT8/Oc/L6kLpkFNV9SJJNqGQ4IhjSODE8U2pFYIVlllFR+tyxscXBn7pMThPFGLxfLhrOAc88CZw1lheUi7C8FBjn52yCGHuP33399Hm0Ki6/2rX/3KbbXVVl58gRoxIlTUz5ECR/QLxxEHW8ycOdNHygTOBscbzlE5VT9BNJGaqygIPDAPtnWex4zSE6PpqOxzjic5sawv5wwONemxbA+2D8eXYRhGM7HhHMMwjAZBVAAjkVoixBRwpIjWUN9D2hw1ThjPcc4PaYFxNS6MzKNmFj6U3hUHYhCVRhWywLJT24RxS6Rkhx12cN///ve98Ut0Jws4KBjMcdE8nCwcKiI51GERkULRDmP86KOPzrW+B+OdiB3rRF0aqXvnnnuur1tiH+D8XnjhhX5anCgcU5zFMO2SbaFUxfCBQ0nkKPwMB5EoIY5o6AhTd8V/8t9ImBNlJHqD44EsOtEcHA4+57dxaW84Hiwry4mjxYO6JZw8veeB1LtqsaIgbELdW95S+oqeRZ0t9rmcLLYjgw6IihDpxMFle1Arh/y8YRhGM7GIlGEYRpPAaSCNafnll/e1R6jAJY3gUwMVByICUQMYoYRtttmmLsucBEZ2ND0NJxGngchJnIMYhShLmNIFpHPJCX3kkUe840ANk1LViASh4vbggw965y0PiAqyvNSkIS9O76/LLrvM9/UivW3o0KFeXQ4HC6eLeqlo+uKf//xnn46IE1wOol6kbpK+J3C0EffAieBBJI4HjhGqdiwfESrk8IlW4pCFjpyQGiAOoaKCRKmIGJIyJ15//fVMUcO8HSkicfx3dJ9r/3I8sG3DKCrbFJVLBiQUmTQMw2gGFpEyDMNoEERVqEEhqnD66aeXPscoxmDEkaoUnAcM7vCRxXjPG9ITERYIIYJUiRockSZqgyQgAaSn4aQRhWEb4XiG9T4Y2WEqWK2glEe0g55fQFSKKAi9rVArpJYNiXlSMan7+cUvfuFT3pBBD8EhzlrDIwcmVHMkAsO6c6xQK0XNEyltTKveUdTHEUnic4Qx4pAEPscJog88cMBwuvSeB+9x6BoN+xynM1prpybG7OswZTHsxRWVjDcMw2g05kgZhmE0CNKzSL0jgkSq3s477+ydjHBEnpQyUrayQu1KtAEucuGNhigRzkboNNE4lRStrEp+KA0SKZFqIfPCccFJId2LFDhk5Jkm3F68J2UxD1DGQykv7JNFyhz/TyNkIoA4dexLIm04XfVyXImy4VQQ8UIanqgYTpR6auEcEaEirTCMZoWwrNRVsbxEPnkMGjTIO216z4MoV1I/rHrC+lADpXMAZxxnWo4hKYXs89C5xvHifS0KkYZhGHlgqX2GYRh1hpF+0rOoXcJIJIVNTg+Kb3yGGhsGPBCBSCKU/k7qG0TKVlhvE1XGo6Ym7zop0utIiaMHE5E1aqNw6HBIpC5HdOqll17yjklcvQ3bhXon0rZQpSMCRdPZCy64wH9PGhcGNBEU1A0RoMCxIXqh1K9y/1EO6oGOPfbY2O/4Dxw7atp4ZvlIt1MT5LT9VA1bbLGFjzjRNwr1QwQlcPR4j6PBuqLIRyocr+MgLRFHJZQzV2pfKI/PdiUqFSdMUes2TWOvvfbyjjPOKOtEqiLiFnLq+J7jCAETRDrYBjiUiJrECWMYhmE0EnOkDMMw6gyRFSIaGMMY/ap3IjqFeAK9pUhxIg2LKAeGJFGpaC8fjF3mRVoZdVAYw6Q4IUgQgoPBd4zk4xiE0RqM1mrlz9MgWsR6IIKAFDi1UURJcA4lIEF0pZyMNo4Ukt80YGWe1CKp9gpxDt4jNPGTn/zEOyvrrruu34asZ9b/qBSiaqRk8h84NhJDYBmIorEP2Cc4GVoO9hMODJLoWeTP4yCFDbl3asOYH04bxwyKdfwXUSQiNp/97Gd9KiJCH5tttlmfeaD0iJw5tUgS7kDAgXRF1kVQz6U0wCj12KaC9UBEAqeOSNOOO+7onSalO+JcE70lqkbfNJYTh4tmyIZhGM2mqzePYTPDMAwjEUbQMRJxAspB81eMZdLZiFaFdTN33323V4zDgMawxEFJqsPh0o7RSS+huF5G7QyS6zgV1E7VAqp5REEw5sO+SkkQyVJUkahf2PMrDSI+yJujQifBCI4XHB5SB4nE4XjhYDJfHMnJkyf7fUs6JfuZ/kqkUnJsqL6LHk445HLuBE5ZnNQ8kdN//vOfvvlt2KPKMAzDiMccKcMwjAJBpINIlKIHRuWiF/SVOuecc2redKQo0nCXVEIcU6IkSfsFJ4SeUaHjmxUiiPR9oiZK9U+sBxE+Ut5CWXOWA4U/0v6i0SHS8qg5ijpIhmEYRn0wR8owDMMwDMMwDKNCTLXPMAzDMAzDMAyjQsyRMgzDMAzDMAzDqBBzpAzDMAzDMAzDMCrEHCnDMAzDMAzDMIwKsT5SzrnHH3/cKyEtuuiilW4/wzAMwzAMwzDaCPo2otJarvG3RaQ+lJO1dlqGjgV6rNjxYDQCO96MRmHHmmHHmtGO9NbJbsvqG1hEyrlSJIoO8UZnQwPNZ555xq2++uo1N/M0DDvejKJg1zbDjjWjHXmvTnbbk08+mWk6i0gZhmEYhmEYhmFUiDlShmEYhmEYhmEYFWKOlGEYhmEYhmEYRoWYI2UYhmEYhmEYhlEh5kgZhmEYhmEYhmFUiKn2GYZhGIZhGB3FvHnzfK8go7X517/+VXru169fZrXu/v375/L/5kgZhmEYhmEYHQG9gV5//XU3a9asZi+KkQPz5893iyyyiJsxY0ZmRwq6u7vd8ssv75vu1oI5UoZhGIZhGEZHICdqueWW832HajWkjeZHFolGLbbYYpmiTDjS9J568803/fsVVlihpv83R8owDMMwDMPoCKNbTtQyyyzT7MUxctqn8NGPfjRzut7iiy/un3GmOBZqSfMzsQnDMAzDMAyj7VFNFJEoo7NZ4sNjoNY6OXOkDMMwDMMwjI7B0vmMrpxSOs2RMgzDMAzDMAyjJv7973+XUu3g7bffbvstao6UYRiGYRiGYbQYCCfgvPBcbjoEGZg25K677nKPPvpo6f2hhx7qrrvuutL7888/3z333HOx85w4caLbdttt+3x2+OGHu0mTJvnXf/nLX9wWW2zhXnvttbLr8ac//cmtueaaJSnzVsLEJgzDMAzDMAyjxZg+fbrbeuutM09/7LHHuuOOO670fsUVV3RHH320u/vuu90qq6ziPvKRj3j1O5gyZYr75S9/6U444YTYeSHusNiH04rdd9/dO1K77babu/XWW91ee+2VSRWPeUF0fq2AOVKGYRiGYRhtxiuvvOLGjh3r/u///s997GMfc1/72tfcJz7xiWYvlpEjOCm/+c1vfB+lsObn1FNPdWussYY74ogjSp+RckcjWrj33nu9kyRn6vrrr/evn332WX+8/P3vf3e//vWv/fwvvvhi/90BBxzg1ltvvdL86NnUL+jbdMEFF/ieTquvvrq78MILvSO2/fbbuxEjRngn7aCDDvLTzZw506vksczi/fff989z5szps37//e9//fPSSy9d2OPGHCnDMAzDMIw2ARWys88+2/X09LiuriXd/PnDXL9+09yYMWPc/vvv777zne+UDGqjtcEhiZNxx0khujNw4MDY35GuR/0S0aiQfffdN/Y1UantttvOvz755JPdww8/XEor/PSnP+3OOusst/7663tHCoeO9MA999zTfe5zn/PTDR48uDSv/fbbzztTOgZx8OjrBBtttJFbaqml+jhSG2+8sbvhhhtcUTFHyjAMwzAMo01Y4ETd6WbNGunee28/19u7uOvqes8tscRPXU/PKD/NJZdc0uzFbAuo6fnnP//pHQrS4nACmpGe9tZbb3k5b/VHyuJsE+WZNm1an5qoOL7//e/7dVN06Lvf/a6PRJEm+MYbb7g77rjDv2ca8bOf/cxtsMEGbtddd11ofg8++GCf9z/4wQ/cjTfe6Pt7ETn9yU9+4iNYrYI5UoZhGIZhGG3A1KlTfSQKJ2ru3ENLn/f2LuHmzj3Mv+7pGe6NYEvzq92JwpHAKcGRID2NyMrHP/7xhjtTOCzs0zCKFAVnj0gVy6q6p/Hjx3vn5aKLLor9DVEoIkoPPPBAn3qmd9991/3ud79zK6+8sl9XolCk5TH/sEeXolZ8Htf0lmjUT3/6U/f1r3/dXXXVVW6XXXbxAhinn366axVMtc8wDMMwDKMNGDdunE/nIxIVx3vv7e+/p3bKqA0iUThROBISaeA9nzca0uTCiBBcffXVXglPD+qbnnrqKf8d0/LAAWK5l19++dgH38f1W0Kx74MPPvBRJAQmqKsicrXpppu6DTfc0KvwURtFqt4mm2zia7LiuPPOO92AAQPcVltt5d8jTkE0i9S/VsEiUoZhGIZhGG0ABi01UaTzxcHnvb1D/XRGbRBpIbojR4Nn3kclxhtBnLMTKvQRGcLxiTpbfI7Tg/MDRNWIHGk6Xod9oYD1Ix1vyy239NLmRDbPOOMMn5737W9/209DhAkHC4GTJHCWLrvsMnfNNdeUln/VVVf1in/nnnuuu/baa/uIWRSV4i+hYRiGYRiGURbStBCW6OpaoIIWhVop56b56YzawNlAXEE9nHjmfdRZKQI4KtRPRdPr9t57b/fHP/6x9Nh88829mET4Gel7ITg+RLFwlFSTd9RRR5XtZRWCU4eTt+OOO/qoVcjxxx/vFSeJaFUyz2ZhjpRhGIZhGEYbgHHb2/uuF5aIY8Hnc1MjBUY2EJYgpU6Nbnnmfag6V2RGjhzp1l13XR+N0oPmvJdeemmfz9ZZZx132223lX73j3/8w0udyyn7+Mc/7p5//nm39tpru8985jN9Uvt4zWfMQymPRL1OPPFE74zhgFFbhWMFc+fO9REwluEXv/iFj6rNnj3bFRlL7TMMwzAMw2gDVlppJS9x3tMzkhiJr4kKVfu6u0f5701oonZwBHAiiqDaVw0sL1LkRJQEcujIjR9yyCGlz0jTC6NsODm8D9X39thjD5+Sx7qTjhem9hFVonaM37zwwgs+4oRkOzVV9JmizkopfJtttpmflmVADZBpOV6pm8qqSNhozJEyDMMwDKNjaPdGtfSJkjrf4MGjfU0U6XxEotRHysgHHIdmOU44b8iXS5r8nXfe8e+BCA+RHr0HIj1Mh7Q4jku5tDnmj1NDv6mw75icKr7/74eS6HHpjJo/aYX6HgEL0gk5DvnsV7/6lf/8r3/9qxea+MMf/tCnUS9S6NRhFdWJAnOkDMMwDMNoezqlUS3rQJ8o0qLkMC677LI+QtBODmOn8/rrr/soEPsbZ4UIDw+Bc4KKo6B+i/TD3//+914pD+ckdFp0jjANjBo1yqvqkf6HGl8cH0mpB4sT3VhyySX7RLui0/Lf4TIxf6KsRaartxUquerMk08+6Z+RhjQ6G3pAPPPMMz7XN+yFYBh2vBmtjF3bnO9Ns6BR7XkLNapdkPK2tzWqbfNjjUjNSy+95KMy9EMykqFXFM7XwIEDC72Z5s2b5/cr+zOuV1W1x0JW38DEJgzDMAzD6JBGtef5RrWSB1ej2lmzzvXfk/ZnGMaC6FHRnagiYI6UYRiGYRhtjTWqNQyjHpgjZRiGYRhGW2ONag3DqAfmSBmGYRiG0dZYo1rDMOqBOVKGYRiGYbQ11qjWMIx6YI6UYRiGYRgd0ai2u3ukGzDgJtfV9b7/HNU+3lujWsMwqsH6SBmGYRiG0fZYo1qjk6FXE/LgcRLhNNal79QnP/lJt9RSSzVl+VoVc6QMwzAMowVAmlsNVqn5+drXvmYNVivAGtUa7cRDDz3kTjjhBLf00kv792+//ba7/PLL3S9+8Qs3YcIEt9hiiy3kSF1zzTXuS1/60kLzol8UDZyPPvpod+CBB5b977333tu9/PLLXiI9jjlz5rgNN9zQXXfddQt999Zbb7kbbrjBnXzyyX4Z//znP7uDDjrI/e1vf/Pf/+Y3v/GfsTzluO222/w6PfDAA65ZmCNlGIZhGAXmP//5jzv77LN9n6OuriXd/PnDXL9+09yYMWN8uhqRFpwEIxuf+MQn3Iknnmiby2hpFllkEfeZz3zG/fjHP/bvv/71r/vrAJ8fccQR7rjjjov93QUXXOAeffRR95GPfMR1dXX1md+NN97obr/99j7Xnvfff9/Pa6+99ip9zm9xug455JDY/7jqqqsSe7LRm+qFF15wI0aMcN/97nf9vHioue7FF1/sdtttt0zbgEa6rDNNoPmtom0sN68bEV0zR8owDMMwCswCJ+pON2vWSPfee/v5ZrLU9iyxxE9dT88oP80ll1zS7MU0DKOB4PjEfdavX7r8wTnnnOMfYVTns5/9rFt77bVdb2+v+8EPfuAdneHDh7sBAwbEziN0wLJCROy8887zr3FyXn/9dXfGGWe4WbNm+e94TbT9xRdfdH//+9/9+49//OPupJNOSpwny/HGG2+47bbbrs8yMb8dd9zRXXjhha7emCNlGIZhGAVNzZs6daqPROFEzZ17aOnz3t4l3Ny5h/nXPT3DfRpMuXkZhtE+6bak482dO9c988wz/j2v+SwLpNH97Gc/85EmUvSIai2xxBI+gkOK4KmnnuoWX3xxn5pHih6PKNdee627+eabvfPF/+pZrzfbbLM+0+M80Rj76quvdssuu2yf74466qjSa6X0/frXv3aPPPJIqiMFK6ywgps8ebKPTsXVf9Ubc6QMwzAMo468++677qyzznJ33z3Wp+b19g51/fpNz5Sah+HBb4hExfHee/u7wYNHe2PO0tUMo3PSbQcNGuQdkvPPP9+99NJLPs2PtDmgBumWW27pM/23v/3tUnoe1yTqkJQeiCM4ffp0t/zyy/toEHVWq6yyivvDH/7ghg0bFvv/rOfxxx+fGAEj3e5b3/qWv/atuOKKfpsBka/TTz/d11ElQR3XWmut5UUwQli2XXbZZaHpiaiFnHvuuZlqvfLAHCnDMAzDSBhpxkAhBQUDA8MiacT5X//6l/vnP//pU0rI92dkl0JqPsdomDjxXjd7duWpeRg4GGn8Jg4+xzFjOsMwOifddv3113fXX3+9+93vfudFJngNCE1Ea6SonyJKJEiD0+Mvf/mL22+//dzGG29cEoP40Y9+VJo+Lo3vy1/+svvhD3/ofvKTnyQuHw4WDs7QoUP9eyJGOG9Evl599VVfq7Xmmmsu9DtqtHDqdt11V/8IkXOK0IYcPGqjPvjgg1JEit80smbUHCnDMAzDiBlpJn3uP/9Z3vXv/5o3krq6FnWjR492BxxwQJ8RZ5wl8vT5LcYDxdmMxpLfT9rNhAkTvRNVTWoe6UKMdNP3KM6ZYrmcm+anMwyj/hQl3RbBCByI7u5ufw2iril0lqKEDhHTvfPOO26nnXby76dMmeLnESr94ZBFfycOP/xw//j973/vo1phRIg0u1VXXdWts846C/1ONVfME7VBBqiiMAiVVIOV1UGKqx+rF+ZIGYZhGEaGkeaBA0e5f/97Q/99OOJMJAonCiMEAwAjRRGqSZMmua6uAVWn5u2+++4+XYj/D402wefOzfWRMsMw6k9R0m0ff/xxL9Sw/fbbu+eff94ddthhvl4ozoGJsskmm7hf/vKXpfdPP/20//0dd9zh55GE0vPk0IwbN85HgUJHisgYg00sB6l51ExJlU/w/hvf+EYposTAU6iwt+2228b+fzTVLwnm2SjMkTIMwzBainoVeGcZaR44cLibPftE19NzeWnEmXQ+IlEaReWZ93yOodPbW31q3korreRrEXp6RjK1N9JC5667e5T/3oQmDKMxFCXdFgdG9Unrrruu++lPGVRxbuTIkV7QgUcIynaA00WdUegwkUpHvRUOUJQZM2a4Bx980KfSjRo1yjtbUe66664+71H84wE0+SVKFcL8BFF7Ug//+Mc/ll1nrqmw9dZbZ5quEZgjZRiGYbQE9S7wzjLSvNRSox3+EtNpxJnRVdL5iEQpIqVR2CFDhriursk1peaxXkoXYqQbI43fEInSehuG0RhaId2WQZ6kPlJclxClePjhh/176quoXaLmiZQ4BCZQy6O2ExCjEMimI2HOdFyPN998c/f973/fffrTny5NQ43SwQcf7Ae4cGjC6BCKgF/4whd8I18NPCkiFSoD8hkR/scee6zPspOOyPKx/LreMi2KhVz7URqE2bNnu0ZhjpRhGIbREtS7wDvLSPO8eUNdV9esPiPOpKRgCJDOxwgxThQ3dT7fc8893WWXXVZTah7zYr0wjhSJY/SYtD+LRBlGYyliui0qfOPHj3dvvvlmRb9jEIY+UsiPI2eOo0PE/7e//a2vvUK0IiRM0SOFb5lllunjREWJS+kDHDUpDMZFpBDQOO200/r8dubMme6b3/ymvxaSSnjQQQd5YQrUC7k3rLbaan5gCyELIm58FydmkTfmSBmGYRiFpxEF3llGmvv3n+Z6ewf1GXFm5BRhiTjVvjxT85jGJM4No7kUId0WZwHHg+a199xzj7/mPPDAA27TTTf1AzkM6kTlxYnckA4YRoiINiFYgfAD60UEnWvZtGnT/LwloqP+TDhsRInuvvtu99e//tWr+0Xh/7PWMkVh2fg9qYbR7IJbb73Vy6iTosiAFctEmiHOHnViZ555ptt33339NFtssYWPnvF9uQbFtWKOlGEYhlF4GlHgnWWkuatrruvt7VpoxBmnKVS8CrHUPMNoL5p9TuM48eBaR6ocDpBAVpxoDI8QnKt99tnH7bHHHqXPdthhB/+IQg8nFPmoRfrUpz7llltuOf856XTUXiG9jpDO0ksvvdBv+Z+kGiWcMuTQQ+eGz3DmFHXCCSJF74QTTihNQ+r0xIkTfaNg/ZYUQpQKgRRDok8IcOBUMd3OO+/snnjiiT6pifWgqzdNK7FDePLJJ/3zeuut1+xFMZoM6TmEmWkYR68Dw7DjrRgwunjzzY+5GTP+V6QcZejQrd0hh3zBGxLVQl3AgvTBcxcaaV6g2vdp99GPPuH233/vitMIQ5GMRqfm2bXNaBRFPtYw2OkNR084+g7VSjPP6XpDZAjqHdGJQhSMlMGohDnRMI4nLU8YYWO/4liGUSympxar2mMhq29gESnDMAyj8DSqwDscaR406GL3n/98/MM+Uu/7PlKLLfZHt//+C/pIVYql5hlGe9HO53SjHShBamEcUadI6YZJy5vmROWJOVKGYRhG4WlUgXdU2IERy9dff903jqTJZDuNOBuGYRi1YY6UYRiGUXgaXeDdziPNhmEYRj6YI2UYhtFBUAgcpy7XCjS7wNswjPbA5AGM3pwkIsyRMgzD6CAnSnK25JOjhERhODnpreBMWT8lwzBqvYYA1z01bzU6k/fee6/PMVEt5kgZhmF0CESicKJwmugIz4icIlSt4EgJS7szDKMaECig0awa16ICx7XQaF3mzZvn72NxAhRxcN/DieIY4FjI8ps0zJEyDMPokLQ8fkckSoYDz7xP6vlhGIbRbiAcA3KmjNZm/ocNgJFLr0RpECdKx0ItmCNlGIbRIWl5OF/8jhE5RaS4CfG5YRhGJ8C1b4UVVvBNZrmeGq3N+++/71588UWfqZA1XZN0vlojUS3jSDFS+uyzz3pDYY011rAQrGEYHUkeaXlEsHC++B3OGE4UNxQ+NwzD6CQwpPMypo3mNw7mPphHk+W2cqT++te/um9961u+wzEh2KFDh7qbb77ZDRw40D366KPu4osv9iO022+/vTv33HNbKsffMIz2Jm91vDzS8vh/IlitqtpnGIZhGEWiOW2LMxaPnXzyye6UU05xEydOdA899JCbO3eu6+npcX//+9/dMccc43baaSc3fvx4N3v2bHfppZc2e5ENw+gwR+n//u//3IwZM/yzil31HYM8XJt4zTPvw2kqBaeHkTdJtlablofT9LGPfcwNGTLEP5sTZRiGYRht5kgxYnrQQQeVutQPGDDAd5XHIPnxj3/s1l57bXf00Ue7FVdc0Z1zzjnurrvuqslIMQzDyEo5RylMw8PR4Zn3fF4tRI5Iw+M/iCbxbGl5hmEYhtE8CutIoaaBIyV+97vfud/+9rc+je/pp592X/rSl0rfkaoyePBg99xzzzVpaQ3D6CTKOUr1UMdTWt6gQYP8a55bpf+TYRiGYbQjha6REjvvvLN3kk488US3/vrre2MFdY4QjApGhNdbb72q/kO68kZng/pL+GwYcXCt4JpBCnL0GqLrCHKsOFAShuA9Tk94nanmeKPvCQ/g/+26Zdi1zSgSdh812uF4k7ptWzhSN954o7v33nt9HdQGG2zgVVaio7AoddRiUDCa/Mwzz+SwtEY78PLLLzd7EYwqUSRINUT1+o+4fhUM8sycOdO/pqdFlDlz5rjXXnttoc/teDMahR1rhh1rRjvych3stiw1yC3hSJG+8o1vfMM9//zz7qc//alP46O4O2rA1NILhVqD1VdfPYelNVoZRjQ4GVdeeeXM/QiMhXn11Ve9SMxbb73lVTd32WUXX89YTxgMefvtt0uRIBwpnJmll17an9+N/i+mQSBHjQKp84wuhx1vRqOwY82wY81oR96vk932wgsvZJqusI7UU0895a677jp35ZVXlkJrOEpEo4hK/elPf3Jf//rX/ecYKy+99JJXoaoW/kPpMobByWjHQ+XgPJx99tleXbOra0k3f/4w16/fNHfFFVe4/fff333nO9/J3akRDK4QgWLfhX2WWCZSf/OGKHg5GfGs/2vHm9Eo7Fgz7Fgz2pHFc7bbsqT1FdqRWmWVVdzjjz/uzj//fHfEEUe4f/zjH27SpElu9OjRbvnll3d77723+8Mf/uA22mgjd/XVV/so1brrrtvsxTaMjmaBE3WnmzVrpHvvvf1cby9OzXtuiSV+6np6RvlpLrnkkrr0W6qHwEMaLKMJPRiGYRhG51JYRwqvktooRrDpF0V6H013t9pqK//9cccd5w455BCv7kdtFCPecTULhmHUFzlCL774orvtth43e/ZIN3fuoaXve3uXcHPnHuZf9/QMd8cee2xJLEYy4kSNOH8J0XM+V6NGhxPG71UgWm2fJcOoB6+88oobO3asj5zSv4vWHlHRJMMwDKO1KKwjBWuttZbvGRXHkUce6XbYYQffnBelPgwvwzBqN/AYuGCAQhEiHBr1Loq+x/n54IMPvHrcPffc47q6BvhIVBzvvbe/Gzx4tP8vFDijMuJhOh6fV+pIEcnCCeP3LBdOlPVZMoqa7jpmzJi6p7sahmEYHexIlYPi9XoXsBtGOxt4Z5xxprv99tu9A9TbO8x1dU13o0ePcTvvvJM75ZRTfP0hThJiCdQn4qggnsBrPsNpwfkhgkxTWuZBOl8cfN7bO7SPUEye6Xjqs5RHmqBhNDPd1TAMw2gNWtqRMgyjchTxOe+84W7ixHt8Kl7UwJs8eZTr338Rd9JJJ5YcKaXOhe9xxnCseKBY19U1zXV1vR/rTDFv56b5qFe90vGsbskoElOnTvWRKJyorOmuhmEYRutgRUWG0cIOEdGdGTNm+Geco/A930ene/31130fI3qmTZgwwc2adZ438OT4yMCbNetcN378eP8bOTgLvv+fwwNEpgDnarvttnO9vXO9IxbHgs/n+toQQcSItCalCvJs6XhGXimrl19+uTvnnHP8M+8bzbhx43w6X1q6K9+T7moYhmG0HhaRMowCE1W0U30SURxqk3Bq4lLuJNqAmuU777xTEnNQKt5DDz1Utp6pu/sS9+CDD7p99tmnT+pd2O07TO9bdtllfUrg5Mkjcbn8PMIoV3f3KF8TEo68Wzqe0c41SQsk+StLdzUMwzBaB3OkDKOATpPqhN59991Ss1ecF9LeeE0ESI4TDhbvw5Q7iTaoaazEHJSKR6PcLPVM/F5RJ9Ut8Z75857loT6Knkq8Hj58uBswYEl3xx3DvbAE8yCdj0iUjNgolo5ntGtNEmmsOHGVpLsahmEYrYM5UoZRAHB6SLnjGYeEh9LnAAcIcIZwlnC05NDwXTTlLhRtkBMG/AZHClW+cvVMCE8MGfIVN3To0ETVvjhBh+99b4w74YTjS0qARKp23313qwExOq4mieOeSBhOXLg8aemuhmEYRutgjpRh5Ew1DWZJv5Pogh5CTlBYp4SThEMEOF3RlLtQtIHp9J1S8ejH9sMf3lzWwDvwwAP98vMIib6PgpEqiXPDKFJNUlSCv56stNJKPhLb05M93dUwDMNoHcyRMowqwBnB+UEeHIeFSA91FzzUV6mSBrPMRyl8cnxEnNgD/yO1PH0WTbljGtVIhb2VSMVbe+213W677eYmTDADz2gfiliTpHRWImFZ010NwzCM1sAcKcMImtKiaoezcdhhh7k111wzsX4J5wiHiWmFokGAsxLWKmVtMBs6UCL8D/4b5KjxH9QnLb744okpd7yOi5BdfvllbsCAJczAM9qGItYkMaBBTRbphJbuahiG0V6YI2V0NIg5nHXWWe7uu8f6lCBGi6kdos5Co8U4TDhYEnfAsVFaXZITRCSKaXlkaTA7YMCAUn1U6JCFESmcIAxApmF+SrkLHbS4lLskMQcz8Ix2o8g1SZbuahiG0X6YI2V0ZL2SUvNoSnvvvT+PbUqLwte8efPdUUcdWYpEEQkKI0RJMI0kx7M0mCUFD4eNB8gB4xlHCkeLabJEtSrFDDwjKUJLChzOO45HK9TxWE2SYRiG0UjMkTLaEjWhnT17to/mqH7ojTfe8N/jpNBs9p577vFOVJLC1+23D3c77riDGzJkSCmtrpwjpQiSlPayNJjFQVphhRUqFqkwjHbtwVQtVpNkGIZhNApzpIyWjzBBtGktfZJI2xPRVDwiS1mb0j788MPugAMOKIk6hOIPUULRBwzOQYMGZXaIrJ+S0exoUpF6MFWLpawahmEYjcIcKaMley1J3nvmzJl90uCoTQprmNKcHlL7qIkqp/A1a9asUoqe5qdR+ajCnuqicIrKKfUZRpGiSUXrwVQrlrJqGIZh1BtzpIyW6b+kXktKrZMDQ3QJ2XB+g6HIPOJEG6JQc0TT2XJNaZdddvM+aX38z/LLL99HDS/6vaXlGY2m1mhS0XowGYZRXFq1jtIw8sYcKaPpqXj6jPolCTTE9V9SryVFh/QMqklCClzKemnRKNhyyy3dLbfcWlbhi7S+7u7uWAfPIk5GEcgjmlTEHkyGYbRe5NswOglzpIyaifZYAhwZnBicH/U84qG6pWjDWhwULtA4JnKAkvovRSNS4edytNSwNg3EHXbZZRc3aVJ6U9rVV1/djhKj0OQRTSpiDybDMFov8n3++ec3ezENo2GYI2XUHF1SJAn4TjVEeq0IEUjee8kll+zjMCkSpXQ8nqP9l9RrCST8oGnlRPE9y0baHk4cDyBShfOm1EDeYxBeeeUVbqmlliw1pZ0/f4jvI+Xceza6ZrQMeUSTityDyTCM1ol809DeMDoFc6SMTOCgxKXehZEkiUDg2OC0hCgNj4d6I4UOk77T7yUmEfZfUq8l/pv5K/pEfRS/wTlafPHFS6l35STHBXUjpDwxWk/j3d7ejdyhhx7q1lxzTTs6jJYgj2iS9WAyDCOPyPfEiRPdVlttZRvT6AjMkTIyQSQqLvUujCSpbgnCGqVQNlxEHSaiTUSfmKccq2j/pbDXkiJLTBs6T7UqfOEcPvPMM27FFVe0I8Ooq3hKnuQVTbIeTIZh1Br5pv2IYXQK5ki1GfUy3lT/lBZJ4j2OVfgd8B0RJDlHLFfUYSLaBOWW3XotGa0cwa2XJH5e0STrwWQYRq2R72WW2c42otExmCPVRuCEkJqGyILEHfIy3nBsMAbTIkmg70i3U8RINVJxsuGmgmd0UgQ3TjwlL/KMJlkPJsMwqo18I+IkYSnDaHfMkWoTMNJwonBOQnGHvIw3okM4ZeUiSThWEE3zM4fJ6CSSIriheEreWDTJMIx6kjXyTWo8KfKG0QmYI9Um4MiEkShFjCAP4w1HjMiWRZKMRtOKjR+TIriheEq9sGiSYRj1IkvkWyq+htEJmCPVJvVNikRJLU/iDnkab1afZBSt8SNRmCKSFMHNqiRpGIZRRLJEvs2RMjoJc6TapDgdZ0kGm5ypMKXOMNqx8SM39CJSLoJrGIbRyljk2zAWYI5UmxSnawQc5ExJ3MGMN6PVoq1ZGz8yKlrUND+L4BqGYRhGe7NADcBo+eJ0jYB3d3e7JZdc0ofaMTAtGmU0w2ki3WPGjBn+GQeKaOvs2bP9dzzzXkqP1TZ+5HtSSwzDMAzDMJqBRaTaqDjdRsCNIqaoqjnzRz/60czR1qyNH5nOMAzDMAyjGZgjVRCsON1oB9GTuBRVPkMIpZJoa9bGj0xnGIZhGIbRDCy1ryAoNW/QoEH+Nc95NNI1jKSUu7jUOkWUKknDy5KiSs0eThVkibaiANXb++6HDR5dYuNHpNANwzAMwzCagUWkCoSl5hn1iizhzHzwwQfeoYlThdS0OE70IyMNb5FFFqlY9CQuRVW9zSqRAs/a+LGoQhOGYRiGYbQ/5kgZRouCczNz5kzvoOC04JiQ6ibHKKxVwpnCiRowYMBCDhJoWh44Ojhdiy++uE/Jq0T0JC5FleUZPHiw/6ySdMEsjR8NwzAMwzCahTlShtGCESYcoTlz5pR6hsE777zjpxk6dOhCtUpqkEi0CUcqrFMKpwU5XXLCKhE9SeufVKmCZJbGj4Zh5MMrr7xSOs8YkCFt1s4zwzCMdMyRMowWMFSiESaiPqo54j2veRBJCtP5VKtEZAknSo5XWKcUTovzounkfJVLw6t3iqo1fjSM+sF5vqD5dY9vKYBaJkIvY8aMKUV+uQYYhmEYC2OOlGHUmXfffdedddZZ7u67x3pDhRS1rq7pbvToMW6PPb7mvvvd7/reX2lEI0yqQxKqR+KhSFBYq0QUis9xnvQsB4l5a1ocLuqjeM/3iJ5UotpnGEZrscCJutM3v6ZvW1iL2NMzyk9DZNgwDMNYGHOkDKOOEEk6/fTT3cSJ97rZsxc2VMaOHeUjQJdddlmqsxKNMCnlTsip4nul00Vrlah5wklSJCp0kKLTLrHEEqYaaRhtztSpU30kCidq7txDS5/39i7h5s49rFSjSHqtpfkZhmEsjDlShlHH/kvPPPOMmzBhoneikgyVCROGuyOOOMJtsMEGifOORphwgHDAIHSocJTkICXVKkWpZFrDMIpVl1RL37dx48b5KDkDPHGglonQC8t44oknVrRchmEYnYA5UkbHExoi1RKtYZK8+IQJE1xX14BUQ6W7+xI3adKkVEcqLsJE1EipfFHVvkprlUx63zAax4svvuiOOeYY99e//tV1dX3E9fau6Pr1ezOxLinJWUq67mTtQYgDR01UXNNr4HNSkZnOMAzDWBhzpIyOJmqISNVOQgtZidYwSV787bffdr295Q2VWbNmpc7fokaG0T7CDrfd1uPmz1/czZu3huvf/zXX1fWi++c/93b//e9arqfnu33qktKcpaTrTta+bwy8ICzR1fV+7DWKFGRaDjCdYRiGsTD9Yj4zjJYFI4LR0xkzZvhn3qcRGiKM9GoUeO7cuRX9b7SGSfLiSy+9tOvqWmCoxIGhgvDEkCFDyv4Hy4hBw7Rh5MkwjNYSdiDV9403/upmznzEvfHGn92cOSPcEkuMdYss8oKbNetcX7dE2l/cNYpn3sepc4ZtDbJAK4He3nd9vWYcCz6f61MODcMwjIUxR8poG3CaXnvtNffWW2/5Hks4UhRTv/rqq4lOVZwhAqo/ygoGDul2En2QvPiuu+7qDZFyhspee+1VxRobhpE3ODCXX365O+ecc/yzHJr8hB3O8/WSigCpXnLOnHPdEkv0uH/960u+bom6JEhzlpKuO1n7vq200ko+lbC7e6QbMOCm0oAPAzy87+4e5b83oQnDMIx4LLXPaBtoSBsKMqhnkiS/42oHoiIOMkhI76uEuBomoltrr722N0R6ekZi5viaqFC1zwwVw+iMfkpZhB2WWmq0++hH7+1TlxR3jQqVN+OuO5X0fWO9pM6HsAT/TTofAzxab8MwDCMec6SMlqGcOhXpeBgZOEE4UWFvJRVmR2sHooaIIlEDBgyoaNnSapjMUDGM4lPvfkpZhB3mzRvq+vd/vU9dUpqzlEftJPNivZA4l4Lgsssu69P+LBJlGIaRjjlSRktQiTqVnKdow9q42oGoIcJ70gKrGXlOUr4zQ8Uwik0j+illEXbo33+a699/SJ+6pHLOUl6Km6yXSZwbhmFUhjlSRkNQNAgHiBFVnBoaxGYdPc2iTkUUic/CvkpAhCqtdiA0RHDOqLOqB2aoGEYxaUQ/JSI8pAkS4QqdNcHnXV1z3Uc/+suF6pKsPYFhGEYxMUfKyI1yvU74HGdIjtQHH3yQuedJFnWqwYMH+3nyEEzDg2WotHbAMIzOoBH9lCTskFQvOXDgCNfV1esOOGAfq0syDMNoEcyRMnIhS6+T0kG3yCLemcIZkoxvOUcqreBaMI8VVlihjywwhIXZJhluGEaz+ilF6yXnzyeN71Xn3Ptu/fXXd9dcc7VbddVVbQcZhmG0COZIGbmQlnonpwYhB77Tg2n69++fqedJVnUqS4ExDKMeaXd59FOyeknDMIz2whypDqLWOqU0yvU64T9DFT1FlrL2PMlDncowDKOatLu82xRYvaRhGEZ7YI5Uh5BHnVIaWXqdKPJEZIr/Zhp9nwWLNhlG/aDxrOSvSWEj+lKp41CuRUGRsTYFhmEYRqWYI9Uh5FGnlEbWXif1iIYZhtH8RrSVtCgoIpZ2ZxiGYVSKOVIdQh51Smk0qteJYRjFbESbpUVBK2Bpd4ZhGEZWFsiaGW0Pjo0iUNXWKZUDY4mUoCFDhvjnVjKeDKOzG9Ge50UWpFinRrSzZp3rvyftrxxZWhQYhmEYRjthjlSHQHQoTM8hMgU4U9ZfyTA6kyyNaPme2qmsgzVcUyCtCbZhGIZhtAOW2tchWJ2SYRj1bESbtUWBYRiGYbQL5kh1EFanZBhGvRrRWosCwzAMo9Ow1D7DMIyCQVSHKNCMGTP8M+/r1Yi2t/fdDxvOupob0VqdpGEYhtFJmCNlGIZRICQjPnv2bP+aZ97Xw5lSI9ru7pFuwICbfGRKkSje592I1jAMwzDaCUvtMwzDKBCNlhG3RrSGYRiGUR3mSBmGYRSIRsuIWyNawzAMw6gOc6QMwzAKBHLh77//fqnPW6NkxK0RrWEYhmFUhjlShmG0FDSHpa8RIgyoySGE0E41PCYjbhiGYRitgTlShmG0BNQNnX322a6np8c3iaX/EdLdY8aM8YII1PqETadBtUWkxRHRwUmpR51RnpiMuGEYhmG0BuZIGYZRWEJH6KKLLnJjx050s2aNdO+9t5/ve4S6HBLdPT2j/PSXXHJJn9+idocDRo0R6XI0jP34xz/eEs5U0ZfRMAzDMDodc6QMwyhMGl7oOOH8fPDBB27evHnutddec3ffPdbNnj3SzZ17aGn63t4l3Ny5h/nXPT3D3bHHHluaf6PV7wzDMAzD6Cysj5RhGLmDA3P66ae7TTfd1H3ve9e5m29+zD/z/vjjj/cOVrTRbLR/0qxZs3wUaZFFFnEPP/yw6+oa4CNRcbz33v4+3Q+nrVnqd4ZhGIZhdBYWkTIMIzcU8Rk+/Hw3YcLk2DS8sWNHuX//+z/utNNO7ZNqF40g8fq///2vf7z99tuut3eYn08cfN7bO9Q7Z81WvzMMwzAMozMwR8owjFxQRGnq1Klu/PjxqWl4kyYNd4ce+g23zDLLlFLtohGk/v37eyeK1L6ll17adXVNc11d78c6Uzhpzk3z6YPC1O8MwzBag3ZXYzXaF0vtMwwj1inihjZjxgz/jLMTvldKXjjd66+/7p2hRx55JEMa3gA3ZcqUPql2RIqIGBE5AlL6gPdbbbWV6+2d6yNacSz4fK6/+UbV7wYNGuRf89wKQhOGYRidQloaOJ/zvWEUGYtIGUaHgVM0c+ZM7wQR/SFyM3DgQP8+KvLAa9LviAwRIcK5kfrd4MGD3TvvvFNSxeM38NZbb2VKwyNdL0y1i4sgLbHEEu6jH/2o/26PPb7mxo4dyRy8MxamC3Z3j/IS6NERTFO/MwzDKC4LWlrcmVmN1TCKhjlShtHmhEp4RHfmzJnjnSSBM4TAAw4NzhLTMx1OjBwnpuc100j9DkcIB0s1TUzD50R+yqXh8f3AgZv5vk84SVn6J33ve9/zThXqfIMHj/bOGOl8RKLUR8owDMNoDUgDpy8gTlRWNVbDKBqW2mcYbUycEp6cqLAeiegP4LzwOc4SThKEYg1R9btwHvrt5ptvXjYNr7f3PZ+GF0214zX58UOGDPHP4Xc4XYxM/uY3v3GnnHKUO+SQL7jTTjvav+fzaDNewzAMo7iMGzfOq61WosZqGEXDIlKG0QKRJEVnICliE0dUCU8qdiJ0kPQcijyE08hhCtXvmE7f4UQRtVp99dXdbrvt5iZMSE/D22CDDaraLoxMnnjiiVX91jAMwygG1NfOn1+ZGqthFA1zpAyjYEjAgSgSTgqODfAZzgoPPlOtUpqAQjRqpNojEXWqAGdI6X0SguD/9J7fE/1RjVRY06T0vMsvv8wNGLCEpeEZhmEYsZB10K9fehp4b+8rbtFFv2xb0Cgs5kgZRhNlXXFCcEbmzp3r31MDxGc4SEIpdqWT9sNaJZwZRa2SHKloLyWm0/xChwpHCOQoSeRBkSd+JzGKMBLG66QIGel25LZr3Zdddlm3++67W667YRiG4e8HY8aM8ZkKYY1UNA38hhtu8PdI6mAthdsoGuZIGUadePfdd91ZZ53l7r57rM/zJkWhX7/p/sZBatt5553nHYzQaZLyHYSpdOFnvCddD0cnlA+PI0kJT9GlONW+pJRBpRZWoopnaXiGYRhGHCuttJK/F/b0xKeBDxw4yr333j7uv//9lCn4GYXFHCnDqBJFg4j44IDg3OCg4OCgXHfOOee4iRPv9Y1p42RdcZqOPvroUn0Rz1GnKHSiQtRvKZQPj6OcEl45R8kwDMMw6oXUVm+7bbhbaqmL3Lx5Q13//q+5rq657t//Xs/19n7UdXX9082efazr6bncFPyMwmGOlGEEThHRG5yatCaA0RqmqLNDCsILL7zgJkyY6J2oJFnXu+8e7lMbVlhhhcQaphDVRyECIQnyUD48CeulZBiGYRQRqbGSKXHjjbe499/f2C266N/coos+4RZd9CXXr99/XP/+1FG963p7F3F33XWXO+WUU5q92IZRwuTPjY4nlAiXOMPrr7/uXn31Vf/MY8aMGd55wtl67bXXfF2TokJRcIoeeeQR19U1oKys60MPPdTHGQvV8eJuOIg+EFVafPHFfdQrTWjCMAzDMFqBBQqwq/nXiy76tJszZ5R7443H3cyZD7o33vizmzNnhOvtne8mT76n2YtqGH2wiJTR8SjtTRdzHBmeiSzhLPFeog28l1hDKB0eBUeLmqh0Wdchvjku8wh7OymCpHopUgVxoJTGV07y3DAMwzBaCYSYurpecUss8aybMyc5k+O554Z7ASdr0GsUBYtIGW2F0u4UQeJ93GchOEik8vHAoZGDJCdKzpIU7/R5GkiDd3VN97KucVArxfcU2y699NIl54nfDR061D9WW201/+D18ssvH9uk1jAMwzBaHdLcaeSO05SeyTHAGvQahcIiUkZLEpUNHzBggH/wGQ4RkR0cJJTzAAdJn0V7L+EY8UBWPIww8VoiEHKeFBkKm9RGo1K833rrrd0tt9yaKuvq3Fy31157eSfJMAzDMDoVBhXXWGMN99RTpMxbg16jdSh0ROqZZ55x++yzj1t33XXd5z73OXfxxReXCvEfffRRt8MOO/jPUUeLRhmM9iCMJqleidqlqVOnurfffrsUceI1tUu8Vn8jpcdFP8PRIp0vKuIQrXkKI1N8L8cq7GOh6eVk8cCh23jjjd0BB+zvurtHugEDbipFpohE8b67e5SXfbX0BMMwDMNwbuedd3aLLvpaaibH/PmvuD/96U+pglCG0UgKG5EiknD44Yf75qVXXXWV+/vf/+5lL1dffXXvWB1zzDFeOpoTD8WXSy+91J155pnNXmyjRtW8UKIbEIHQBZPv5MxIuU5ODc4O0xFVUtpd2Icp/CzaewnhBhwu1UYpvQ+nSK+1jCwb6XdEwsJoGJ9FU+4k69rTM9wNHjza10w5N81HonCi9L1hGIZhdDp77LGHt+XSMjm6uj5wf/3r0+7ss8/2tl9RoG5LzedJwcd2tYHSzqCwjhTy0ThJJ598sn+/3HLL+ejTE0884R5//HG39tpre0cKiEhtv/32flqrH2ld1bwwJY/0O5wWPmOfMk1cKh0OFA4PnysFLzpdNA0v2ntJTWvliElWHDnW0FELhR6y9FySrCsDALrALrvssj4X3C6whmEYRiW0u7GerUHv/u6//13TD1Byb232+mM34NT19PR4Jd7584e5fv2muTFjxpQGTMMsFqP9KKwjtcEGG/iHIDLwj3/8w335y192EydOdFtssUXpO+pdiAg899xzbr311qvq/zCwMaaNxjNr1qyS8yKHSCl7vGbfS01P+0qoXkkpn3LE5DTpAhZ+hrPE5+H+RkqcCBORKebV3d0d6yyxLJUeJ9zwjjjiiD6f2bFm6LgMnw2jXtix1rpgrI8YMcLdeeedzrklfXYDYkUY63vvvbcbPnx4oYz1Wo41nBIGzJ988jy31FKjP2zQSx+pud6Jmj37O66r67+uu3u0u+OOO3x2UjNhIP/OO8e6WbNGepGM0PHr6RnlbZcLLrigqcvY7rxfp/toWjualnCkotx+++3eyGUE5rbbbltoFAJDmKhGtY4UFypqsox4JLogZ0SRnTxQRKkc0Wm0LJIO5zUnkpY1XMboZ9RUpTFtGil4htEYXn75ZdvUhh1rRixXX32Nu//+h3yD96ixfscdI90778xyxx7bXIciz+sakaknn5zr3n13T9ev3/+5+fOXdf/61+fdYos95gYOHOHmz/+Y6+39mHv++eebardRs33HHXf6/ZIk137HHcO9+JSJSrXmfTTMXmppR4qTZfTo0W7kyJFu4MCB3vCOpvDRa6eWUX5Gc6i/MhZ2MHE6eF7QMG+Bh66oDtLdtY6EEZEiGqSIFP/B/7FP+U/1bVKtFP8NEoHgN0zLsVHrsuCIcTKuvPLKvnbKMOqJHW9Go7BjrXXT+R544P5UY/2BB4a7M874tltxxRVdOxxrn/zkJ12/fr90c+ce6Xp7F3GDBp3tPvaxPV1v75Ju3rxhPkLV2/tPN3XqAG+3NSsa9/DDD/t0vjS5diJnTz/9tNtyyy0bvnydwvt1stsoMcpC4R0pjGzyYClC3GWXXfxnpPGRIxyCUEEWzzEJjHFqYoy+sJ1Dh0Xy31K5w7khGlgLzBNnSTVSzBdHmbo47VvEIfgOGtGYlpPRjgejUdjxZhTtWGv3epxWYcqUKWWNdcSM7rvvPnfiiSe6driuka54xRVX+IjbIos865ZY4k7fpDcajXvqqVG+BqlZohOzZ892vb3DUuXanRvqpzN7ovXuo1kypQrvSOFlkv86bNiwPop81E4hf/n1r3/dvyea8dJLL/mGpUa+yIFRjVKY3ocDFKrfVQvOEHVuUdU+OUkmIGIYhtEYrHi+iIOZ6cY6NVPRweV2EJ247bYRrrd3nneikqJxzRSdYIABYQnk2uP2Dw4fSr1MZ7Qvhe0jhaF+0kkn+QarF154oRcekBgAan4PPvig+8Mf/uCnvfrqq32UCll0I19wasIGtHpI4KGWKGAIzhIXG5xhns15MgzDaDxnnHGm6+m50xfPT5/+uJsx40E3ffqf3axZI/zniAEYzTHW42hXY51I0/rrr+MdlLRoHNE6IqfNAAXe3t53fXQsjgWfz/XRXKN9KawjRd+oRx55xCv1felLX3Kf/exn/YPeUuuss4477rjj3CGHHOK++MUveiEKTjqlfhn5QWQozD9WvZIU8bLIgBuGYRjFbHTOsxraU4/M/XTWrPN8BECj7IoAzJp1rpd5Ju3PaAydaqxjX9Dypl+/TxQ2GqfIWXf3SDdgwE0lZxfnlvfd3aP895YS294UNrVvrbXW8s5UEkceeaTbYYcd/DQo9ZEaZuRPmHZHqqXqo8hFrWeNkmEYhlFZQ/Ms12hS9zA8o337uM7fddddrqtrQNl6HCIARavHaVfK9VZqZ2N9QTRueqFT5xjEV4oh5waOHcuEc6s+UkZ7U1hHKgso1BRFpaad4UZsDpNhGEZxG5pTX4pzJEeKNHg5SOH1mxR5NTpXyrYcsZkzZ5Ytnm+3epxWoFONdaJx9MrCYQxrpIoUjSNyhtgFdVoSZ1l22WX9srejc2u0mSNlGIZhGJ0MDpBaQ6g9hOpa+ZzvQ0eK9GypsALPvMcRwwDs6rLi+aLRqcZ6K0XjWAaL0nYm5kgZhmEYRp1QtCdOkbQZyqo4WjhYEg1Sk3KWba+99nLXXHNtagRg/vx33XPPPefn0az+PZ1KnLHe7jL1nRqNM1oHc6QMwzAMo45pd3H1SHk5UzhAzDersuqAAQO808WyqW+fhIMwxPfdd193xx3xEYCBA0e5f/97Qzdx4r1uySWXbFr/HqNzZOo7NRpntA7mSBmGYRhGHdPu4uqR8nKkcIBwzhR5Uuoe/6UIWNQwjQoIsWy8h4suutDPb8KE89xSS13s5s1b0fXvT7rfXO9YzZ79HTdgwK1N7d9juA+dqAUy9dFGtT09o/wmaidH11LnjKJieuGGYRiGUQeUdhdXj5S3smp3d7ePEulBb8WkyBef4WDhbOF48Zg9e7aPnuFYrbnmGq5fvwFu7twj3L/+9QX37rtHuzff/I2bPRvDfNGm9+/pdKZOneojUSZTbxjNxyJShmEYhlEHlHYXV4/UbGXVtGgZ6VO9vZ9w//znqbG/NfW+5jJu3DjvyJpMvWE0H3OkDMMwDKMOKO0urh6pKNEylkmy6Txw/Bb07zH1vqKCo0tNlMnUG0aLpPZxcb3uuut8cd8uu+zizj//fPfiiy8uNN3f/vY3t/baa9djOQ3DMAyjpVDa3aBBg/xrnvMUmkgD5w2De8aMGaUGvCFExUjpw3HCqZo3b55/T/+pHXfc0fX2vvthnx5XyP49nUzo6MZRhEa1htEpZHKkLrzwQnfFFVe4VVdd1W200Ubut7/9rdt5553diBEj/EXYMAzDMIyFwWnCoB0yZIiPRJE6J+cGZycvRymcl9QCqXviNc9vv/12n98rKobzBJJLJ82P+iqU37q7R7oBA24qGewY6LwvUv+eToRBbXN0DaOFUvvGjx/vvvnNb7pTTjmldMHls4svvtg7VZdddplFogzDMIyW6sHUqlLo5eYVV//ENEwr+O6jH/1oqX6L70g7JDLF9rb+PcWllRrVGka7k8mRItS/yiqrlN5z0WVEZLPNNnNnnnmm7ztxzjnnmDNlGIZhtEwPpkYi54aGuESBcFh4/84777jll18+V1n1OLVAPUIWX3xxP204H+aL02r9e4qNObqG0UKO1FprreV+9rOf+foobgKCpmg33niju/rqq915553n0/4MwzAMo9ZoUiN6MDUSSZ4zMKneTTyTdkcqXSXrVE5WPU4tUI80MQycO0WvSBfk+3r173nllVdKDVZJfaTeyiIo2TFH1zBayJE699xz3RFHHOEjTzhN0dEzmvIRamY6wzAMo7PJI5rUiB5MjQTnZs6cOd5R0XrhSEGlzmE5WfU4tUAGQfV/UTEMNedVvZT6StUjAsgxsaCZbI+X8EZ9DuGEMWPG+HQ0Ii04CUY2rFGtYbSAI7X++uu7iRMnuttuu22h1ACB+ATTPfLII3kvo2EYhtFC5BFNalQPpkaBc/PWW2/5ddC6IO6Ag1Opc1hOVj10kBQR5Puo4ISm5UFkKJrml7TPHnvsMV8bzfoss8wy7qSTTnKbbLJJpmVf4ETd6WbNGun7IIW1PT09o/w0l1xC41/DMIw26iO13HLL+YtlGkSlDjnkkDyWyzAMw2hR8ogmFbkHUzVI/pxID9tDThTRn0qdwzhHKZo6GW3Sy7asdZ8xj+233949//wLrrd3CTdv3hDXv/+f3a9+tYf75CdXd/fdd59bYoklEv9j6tSpPhKFEzV37qGlz5nX3LmH+dc9PcN9loul+RmG0Tby54ZhGIaRFQx7RV6gmmhStAfTgAED/O+JgtQqHV6trHitUAuFwANOFE4KTlS1zmEoq85zrel3WfbZAifqJTdnzij3xht/dTNnPureeOMJN2fOSP8536cxbtw4n85HJCoO1Of4ntopwzCMtopIGYZhGK1Jo2XE84omKarSKAW/ev9PtCZJohO81/fNQvuM5UJ0ggfLxjbh8ac//clHonCikqJJzz9/nk/7S0rzwzGlJop0vjj4vLd3qJ/OMAyjFTBHyjAMo41phox4NPVM/YuIJhVZwa8R/6P5sA+ISLFt6iXsEMJ+J5Xw1Vdf9f2jll566T6OLf9LxOy1114rqfcBy8Y2oSYKpyktmrTUUhf56e64447YaYicISxBg984Z4paKeem+ekMo50x1cr2wVL7DMMw2pjQOcCJ4Zn3ioLUC6WeIUaAMzV37lzvlGCY49hVkjInZ4wIDvLhUpjjOU8apRRYj32SlpLIfN98802/PjhJ7777rps+ffpC/8dvJO7BcuF48ZptPnPmTF8TlRZNmjdvBe8sJ0H/yd7ed72wRBwLPp/rpdANox3hPD/99NPdpptu6r73vevczTc/5p95z+d8b7QW5kgZhmE0AYzWWbNm+XoZnutV89NsGfE8nAZ+J8eJ5cYZ4D0Gfp7bLY/armbsE0UdcVLjnFXU+iR9LpELtmFUxY//lzy7lkvL2N3d7fr3n+GjSXEQTeJ7HOc0QSokzru7R7oBA24qzYvf8r67e5T/3oQmjHYlVK2cPv1xN2PGg2769D+7WbNG+M/53mgtzJEyDMNoMDJ8idJgqPJcaZSmaM5BPaNJSkFTnyPWAYcgrC/KA/6HWi72A8vNcz2UArVP5AwqWicHJm9nlXUJW5fIQYo6bvw27G8VNvE98sgjSzLlcfA5jlE5dV/6RO2//96uu3u4Gzr0M27o0K3dkCGf8e/5nO8Nox35n2rleb7OUNFd1RnOmnWu/560P6N1sBopwzCMBiPDV41HeZbhm3eNTLNlxDHOcRQw2iWuQDRE0aQs68s01PUo7Yz1YB2YT56RtSyy4nnAPEmvY7vIUQEa9qJOWOm+KRfhYj3C7SQHKepMa7nC5ryA0uBWW23lJc6ff/585uBrosIeUAMHjvDfl+snxX6jTxQS56jzkYa47LLL+rQ/i0QZ7UwW1crBg0f78+LEE09s+PIZ1WGOlGEYRoPV7xqZbtdspTi20TvvvFMSVohGk7L+P8Z8tGEszmfekbVo/6V6IMcQZxJnEFgn1uf1118vRZWyUq55McISONNS49M+4PPocq2wwgp+f+HkAY4dIhR8R5+oBRLo53lhCWqilO6nPlJZwWkyY9HoJEy1sj3J1ZFSHrYp7hiG0W6OUJ7qdzJ85UjVO92uWUpxeUaTwsgaKGLCc9bIVpFgf4eOpT5jfSqNTJaLOvK83HLLuWnTpvn/ilPtE/zv8ssvH/s/NNt99NFHvcQ56nwIS3zsYxt6h6hcJMowOh1TrWxPqnKkzjzzTHfcccf5RoAhU6ZMcT/60Y/c/fffn9fyGYZhJErG7rTTTr4IXo6Reg7FvcfAVASgGkcoT2nsqFOg+dYz3a5REuL1iiYpska0BCeQeeAsKG2w3g5h3rDuikaF6XbVRCazpCSyD3DSVlxxRe8Q1QJOU5LEuWEY8ZC+OmbMGJ8KG/ZiE6Za2UGOFHmeBx544EKO1DrrrOOlVw3DMPIEo3uB2lGPzzGnqWdX1zQ3evQYt/POO7lTTjnFG9QYpiiSMequ6ItUyiTtjBHJ+0odiTzT8WT4MqLPcpM+hdpZPR2BUPSB7ckzj7wlxOsZTWI69h2PZjiE9Uh5lBCEnCge1UQmG5GSaBhG9Ui1sqdnZGydoalWdlhqX6gABNyQCfcPHTo0j+UyDMMoGcjDh5/vJkyY7CVjKdQNbz6TJ49y/fsv4k466cSSI6XUufA9zgOGOw/1x6nEESpXh1IpGL1E02iAynO9jeA8RB+qJc9oUrPl3PNCKXTURCndkke9I5OGYTQPqVL29Az3whK9vdjM03z/NJwsU61sY0fq6quv9g/Jpu6xxx4LTcOo6ve+9728l9EwjA6pVQo/Vyreq6++6saPH+9mzx7ZJx1CkrEwfvxwt88+e/t0v1DmWw4PEJnCYFU6VaWOULPV74oi+lAteUWT8nZom71PWO56qwQWRWTFMDodU63sYEeK3M6NN97Y37QOPvhgN2LECLfKKquUvueiutpqq7kll1yyXstqGEaLEucgRWuVUAbD0JeYg1LxHnroIdfVNSBVMra7+xL34IMPun322adPpELGNoTpfYrKVOIINUoau140SkK83tGk0KFVmqLWqRWjOUVPyctTZMUoVo3p1772NZOcbxKmWtmBjhQpe2Ha3rrrrus+9alP1Wu5DMMoKNHRaYwp+t/QfwbDFmOdm7QM2qghxu8w3olgh7VKqH4SLVG0Qql41BH19g4rNS+MwuekR/B7qZ/JMOd96DhRH8XySTENmH9Wp0hGr7ZBJb8tAo2SEK9nNEkOLcbgrFmzSrVFzHf69On+PtVqzlSRaaZIiVG/GtN+/aZ54QOlk6mnnWEYDaiRopEeUqqGYXQWcorkmODoSG1MUPdCxGnYsGHeoI0aYryGuFolvQ9T8agfQliCXjVxzhS1Ul1d092QIV/xRnScap/6J/E/Si0Lo1+VjLK38gh9ND1RPYVYBxyTejuE+n/tDx7aH5XA9BKswACUgc9nONTmSOVHu9SkdTILnKg7Y2tMe3pG+WlokmwYRuUsGJKtwpGiE7lhGJ2FIlGqNQqdKNVPSsQAgzbOEFPUKK5WiWfNDwMbttpqK9fbO/dDaViXKBm7ww47lJrMypDmvZZVQhOIHVDgr8iMHC4cI/2+3DZgWpaP5WXeOAc4ZkVH0ZxBgwaVooGg7YKDKGW9ev0/KZzAttN/sz+ybPsQqd2FBj4PM/DzJXpetnJNWicydepUH4maNes8X2OqwSjVmM6ada7/nrQ/wzAaFJF66qmn3PDhw92zzz7bpw+GeOaZZ6qZrWEYdUBpOGFUhhSv0NnIWvOjSJSECqLRqFDcQQZtNJ0LA17zCWuVVCMVijmQirf22mu73XbbzU2YkCwZu8suu/hl57dRGfS4VELWme+qkQLXehF1k/odzzgirEPRo1JKTyQCFU3za0TKFv8hpyc8VnCm5NRmgWn5XZgmyMMM/HxpdZGVTod2NaTzpdWYoh5H7RSNlQ3DaFBDXiC/lu7ohmEUE6Wh4SAopQ6oZ8KQluQyTkWWFLVoE9GQ0KHStEmGGI6capVCBy5Jweziiy9yvb3z3YQJw72wBDVRpPMRiaJg+phjjik5BCyfhCz0nv/h/4l+yBGUSEGlUuAsFzVhqs2RIwWtVDfSrJStqDOu/2bfVLL9uPdwzPI7OVLMz+5J+dLqIiudDtd5aqLK1ZgynWEYDXKkCAF///vfd1/4wheq+blhGHVSXsIJIKpDVAZUkxQ6URA6Q+qzxChzuYhEtIlolFBqXAZtaIjF1Srxn6FoA+ukdZGgA8t/8sknu0MOOcRNmTLFpw0OGvQlryZKvWao4KYoBa/D9ZTjIOlv1dRUKgXOMrJMcgZ4VtPfIqSVZVXmqkT4IU/566gzrn1RjXofNXEcC1oujjmLlHSesqCRDNcAhCXSakzpY6TrrmEYDXCkUOx78sknzZEyjBwpZ6wSRTrjjDM/TNUY4JXsiMpIeem8887zxjPRHxFNvYsSKrcRISpnzEabiMqBkBEug5jHm2++6R26MN2NZZPzguJaOI8wIgahoAORIsBpOuCAA0qpeKT+6XtFhcJ1V5RF32l7KK2P78PXGPjl0vtYF2qMSOXT71l+1qWZaWWVKnOFwg+K4rE+HIdhVC5vcY2oMx4eM5VuP+ZljpNhJMNgE9cA0qDDPnzRGlMGXAzDaJAjNWrUKHf44Yf7m+h+++1nOemGUSM4UHJOZPhjvKo3DgbwBRdc4O699+e+MW2c8hLOxNFHH11yHiopvA+jK+WM2bCJaBhhYhlx9uT0yAjn/QorrLCQep8MeEXEwhodCKdV2h0GfChooZTFsBg+ul5RQQJF3/T/obOZNb0P55BtK+eC/dbsupFKlbkk/PDaa6+VtgPgILJe7DOmyVv+OuqMy4lqxR5QhlF0VlppJT+Q0tOTXGPK93FRa8Mw6uRIHXbYYd6gufDCC/2NmVFi9WQBGmgaRqeTNR2KaaZNm1aKCETTnjD4X3zxRXfPPfd6JyocVZTyEtx993A/+ogBHCrkJdU0hd/LOM7qDGg9cJzU5DY0xvX/ODI4JmEz3mgKnpyXUPCB5Qqn1ToojS6MKkk2PbqecpBYVk3HflBTWs0/rLEB5kPEBGM/a91INT2p6qPMlXx89PQM94qrocGkfcf6s+/lTGufsQ71qKUKnXGruzGM+kI0WtcAhCWoiSKdj0iUotWGYTTQkTruuOOq/DvD6AwwUBnpl6GKcUraHT2RwlQ3vmdkPpQCj+ORRx7x6Xxpykvd3aP9IAapb2HdS5IzJUdE9UphjRCUcwRwNlRjozojEb7GUWE6BCZI9ZPYgJCjpL5GGPEY2vxO04b1WPovCRQoGqZ10XfMSw5ZqDIoFT+IqsfJucqiwBc25212X6lqlbnkzMoRDKN3SaqLeclfW92NYTQGro8MejOQovpJWtgw8GaRKMNogiPFyWcYRnknI6zN4TV1QRioMrLV50jGa5IjxfwYRUxXXhpSUpMLHQUcmIEDB/r/Dh07OS+KeuFocMNl+bI4AjhFaY5aCPPDiQQ5P6FzFNYuhZ+HYhAy4hW5E3Kg5ARpPtRPhcqAYXNeNXMNFfdUP6R5ZE1dyzv1rRqBh2qVuZivnM5QhEMpkGDy14bRHuA0mcS5YRTAkYLHHnvMTZgwwaeUkOI3efJkt+SSS7qDDz443yU0jCaSZMyWM3LlZMi4D418NX4N06bKiUIQHUFYIl156VXX3b2ZVy4j5U4OB/PFwVKEJkzJCiNDcuhwPsJlTEPKd2nLrnmzzZRWp/8Oo0GqXZJcuaZVKhnLznYNI0/6XmmJigohBhEXUWI/hf2TlNoXOmiK0GVNXatH6lulUa5qlbnYHhwroXMJYZ8xk782mk2eqpGGYRh58r/Cpgq45557vAzx3//+d/f444/7mzCjzZdeeqn74Q9/mOsCGkajbtQY2OqthAErY5Y0L17zzHtu6HGf8zpKGJESoZGNUSAnIUyrirLlllu63t65HyosLQyf9/a+52666SY3evSYUoQG5wADXCl15Yx7jGkp65VTr6PBbTkHUCjqhYEeNk8NnQ8cITmcbBemZbuo5xTOjZwUzVN9iPQbrkM4UbxnP8Xtk9Dx4fdhippqqPQ6C0wnh4y0RLa1emZVSxjlUjRNzm1SlkBv77upx0ecMhfzpaZOTicPHHEJTYTT4YQNGTLEP5sRazSKpOtw3LltGIbREhGpa665xquDHX/88W6ttdbyn1GXgVFy4403ukMPXVhi0zCKNrIpQxcDFQNYRj2f05sGAz4uZYvvMJrTUrlwMnSjDx0G1SXFpU2FYgo81BuJ1yuvvLLbaaed3D33xCsvDRw4yr333j7uv//9lLvjjlFu7tx33amnnurnKWnurA6PRB/KqddhfLMtorLjSWjAJUzZE8yDyIicJabFsdJ20G9CJI4QOmKhkl5SFCda88N7/SY8FiQDDmmj4YrqKAopiAJyHFSjRFdplKsWZS6p6BlGEalX6qxhGEbTHKnp06e7L37xiwt9vuqqq/reMYZRxFQQULpUtNBeaW+6MWO0YxgnGbMy+KOfh04GBnkosa0oUaiMF21Wy7IpDU59ddRQ9+STT3L85aRJw91SS13k5s0b6vr3f811dc11//nPGv79Bx9s42bNWjANrQmIHiRJgyeRtTmtoiVyNpRul+RYsQ5s0zC9L6yBkkIf20dCEywH0+OoMI2aBoPqspSKx7xnzJjhhTlw8IisEMmjVipMx1TtGk6WasXCdEOhEXAdH0nOGc8sI/s7rE1jXRASUUSpEqoReDBlLqNoRM85ziGljWY9J+qROmsYhtFUR2rNNdd0kyZNcp/73Of8e13gqJNShMowmkVSfYmcEhnVUWU71ftE5bvjjFlFeJKMXKVMZTEiQinxsLGs0sW0PPz+nHPO8f9z990THTZ7VxcOxgDX1dXPLbnkD9xSS13mI1POLeHuv/9+70xVS5bmtNRFqrEqpDlsfIfgBVEpObFhw9xQ9CDsK8XnOErhiHSYGsl3bLfLLrvMTZo0OWhWPM1df/0NbocddvBOqNIAge0adfjiRCeYL8vDeqaNhod1W2G6If9Tzch5NQIPpsxlFK2OVCl4Ot84lnlfiaplvVQjDcMwmuZIkTJEL6knnnjCX9iuvvpqPxL83HPP+dQ+w2hmAXFSKogcKym1hbU20YgE7+UkRI1Zok2o6JUzckN5bK0nBgW/lSGgdeZ7pZSFAgwiXAceOE+LLPKymzNn1ELNV0nz43v+p1oqSe9jGh7R1Ls4FLFheykVTvtC+yVM14uLABL9URRJqXiXX36Fu++++2ObFd9330g/7YknnuB/L6dZKAIWHgOKyOl4KDcazr6M9v9SFLKakfNaBB4aocxlxf/tT5Z9nCaKouuwzh3OYZ1PWcVswFQjDcNoO0dq4403dhMnTnQ33HCDv0iS6rfGGmu40aNH+/Q+wygHN1HSnpTaxSOv3jtJqSByDmTg6iavG3woQ85nOAla1qgxoWaiijYl9V8KR2UxtOVsKGqhxq8ytuOcqBD+i2VzbpZ3opKarw4ceF5JyCKs0coqDiFYXvYTyxi3XxR5Yxr2H04Jy0d0LQ45Tuzn8Dcsq6JUPJQmx7Shuh6PMBWP1wzi3HtverPi++4b7vbdd59SLVC4naPqgVqG6HZLGw3nuGBfKjoXpnJWO3Je1D5LReibZdTXUcq6j9Pql3Qd1nU1HCSKqoemYaqRhmG0pfz5Kqus4mXPDaNS1IRWNTAapcyrgDgpFYTCf0WYIDR49TuJG8gxwriISkaDllEKd8yDmpqosSHlONXiCL3mmca99HkKPy8HTkJa81VqqKJCCoqcyRlJn///muyyThhVSYYynzFfIkVyGvR/UbRMEjiQk8l/yEEKUwVBx0ko5hBGrX75y19maFZ8iXv44Ye94EJctC9c3rAPF+ukdKRy0UfWJzo4wOfViE0UGSv+b33KOUpZ93Fa/ZKuw6FKp67JlabmFXVQwTAMo2pH6tFHH3XPPvtsqXA/hO7ZhpGEmtDK2AwFCvIoIE5KBYlGmDCSpfIGRFL0muWLc4yi61HO2GD+YSQsDuaB4S5RhXIsSEMr35w3/E+NCqsGCadSTmASSnFTf6Y0JzfqvCb1YeJ7IjdhhDDOsdN8eOj7pJRHhCXKb4+hfVIdw9HxMH2P5VZaH9soLSoZhc8VqWznfjdW/N888kqpLHftyrqP0+qXooqkoVJnuXo/wzCMtnakLrjgAnfbbbe51VZbrWRoiKQ+OIYRjTCECmfVjFImEVXCC1PvFGHSiCzLoBQyOVHqLySFOBkXUSOGecsh4LdyDEKBBtXOlEunI5Vt2LBh7sUXXywbLeKcW2SR11Kbry6yyOu+VoZppQYoI0gOY5Y+Ryy31iHNyQ2NpnBbxsE0pONJUCKsmwprldRfS84Wr/VZKBaBeEW5ZsUITwwevEnpWNN89D+h45QUdctCJ4ycW/F/66dUlnOUsu7jtPqluOtwNap9hmEYbedIUR910kknuSOOOCL/JTLaHtXuhOlu4ShmHpRLvdOIrAijURgOTLegFmlB/6M4I0YRH0WdFPEJBRpYn5kzZyZKgocDD0yPVLf6KSX1fkLS+5ZbbvVCCmFNULT56l577VVKS6TRMOsfjkCzDdLU9hShUT1ZmpMro4n/QZkvSx1WKOoQik7omAjTgXS8yPkLU/G22GIL96Mf3ZK6PWhWvMcee3jnkn3TzhGjemPF/62fUlnOUcq6j8vVL3XCwIJhGJ1NVY4UF0sk0A2jGnSTBjlTHFNJggbVkqUQOowkhYRS6DhGpIVF5yWluqj0ddh/iQcjsNT3aL4hcmSIhgC9jzBw0hroIu6w/fbbuylTRmRuvho3Aq1oT5LAhbYBDljYoDatr5Rk5bMg4yz8v2iULKroF6b4SSSE9dx5553c5MnpzWjVrsFSimrDiv9bP6WynKNUyT42Z8kwjE6mKkfqoIMOct///vfd5z//eV/XYRiVEJfyoVoXohl5pX7I8IhLvZNzk+awhHU6cc155YjIeVKz3WgaHDLqUgiU8pzgN5xDSpFlvYcOHeqjWHI2o/Cb00471Rs3EyYMd93do51zQ51z03wkapdddvFOKT2niEh97Wtf85Gu6Ai01iMpWhbXoJb1wJFL2jdhc960+Woa1V9pP0Qdu1C0ge341ltv9amvY704lq666io3cODZrqdnuBs8eLSvidL2wIlSs1ojH8x4bu2UyiyOku1jwzCMOjlSyy67rB+N33bbbd3uu+/uR4TDZpe77bZbNbM1Oogw9U69kRR94NjKQ04Z4wAHKC71jroaSIueMD2GvhymuOa8LB+GfRipiqbBafRXyxGi96F0OtMrsiPHSw6PHDYeZ599ljvggP29Gh3TE8164YUX3IQJE31D3vnzh7h+/Wa40aPHuH333dd961tH+bTBuAhcORQpYtulpRLFyYWnzZP9odqnsFaJR1wKHp8nGX+XXHKJF7oZO3asTzHkOqXrk2G0OnmnVNbLUXrllVdK56AGcuwcNIzasf59beRIMfrrf7zIIm7SpEl9vsMQMkfKyEJcnZKchUoaNiah3j6KYISpd1yQiATJWUlyLGSwhNLpSc15QdEmnpUGp9Ff+q3pf0LVOvVMCp1HRdPCbSJHTs4Hr4k8fetb3/LretJJJ7sJE+6JbUp7++0jvRN1wgnHV+xEgSJvUE50gu1RzoHCwFJaEr+Ji0DGGYjljL+8m9HajcsoCkVPqeSaffbZRIV7XFfXkm7+/GGuX79pbsyYMaWocJjKaxhGdqx/X5s5UoyAG0atxNUpKdKDAxGq31UDBoacpbjUO9L7tAxhM9gocdLpitDwXv2ncFT4PdMrEibHiIdqgFi3sNaHR6gKqIa/rL9kxMN0QNV6sd3U/PaJJ55wEyZMSG1KO3nycLfXXnuWmtJWQtgDJi2VSIqIOIfh9KTlhYIiRTH+0rAbV3vRDk5xkdPtFjhRd7pZsxYeyOnpGVWKGhuGUTnWv68N+0jBH//4R/fkk0/61+utt57bcMMN81ouowMMGKXeReuUlB4Xqt9Vi5yluNS7MOVO/xsiCfRQElsOT6jgJyeQ6XHcyilqyVnU/+FU4TTxTB2SIjQsm6JVcTAPlp3H+PHj3fz5i5dt0ouzdeSRR1a1LVle1a8lwbpS49XqBivYjat9MKe4vkydOtVHonCikgZyqF8k9dbS/IwiX/Op1da9i3T5oogTWf++NnOkMPC4IP7mN78pSURj7G266abu6quv9saWYZQzYNLSwCTykEd6X1hXoJ5OinbhJOHMhZLdqtVSXyOWkYuqliPOwOYzpQ0mKWqp7ieur5RSA4HtxfZh2V599dVM6/n000+7efOGpDalnTdvBT9dNbD+AwcOTOyzVJRR8zyjDnbjah/a1SkuSj3SuHHjfDpf2kAOIjAsa56pt4aRF1wLSL9XtgjXf+wEBgaL4ExZ/742c6Quuugi3zj0lltucRtttFEpOnXGGWf470aMQJbZ6BTSjNc0A4Ybf1inpFQwwCnhUY20b5pCYFjDRPQHZ4ll5pn0M6bhoeWIptylGdhykJIUtXBCiDBJCj0OiWFIfCKrlDj07z8jtSkt3zu3UqZ5KQWRdW7GqFz0mNJ+iDvGNC37jW0nRcVaGpaC3biKQ60Ocrs5xUWrR8KRYxnSBnJQ0mQ6wygiRKK4/3Lf0z0cO4HPi+BIWf++NnOkpkyZ4kaOHOnlz8XGG2/sTjvtNDd8+HBzpDqIcikz5QyYsE4pTJWTUl410r5JERJu4tE0P9Uahb2KtJyhSl5ocMnAlqIeF18tsyJLodx5KDqBdDjKekko9ZD5h0qY5VhnnXXcM888m9qUFieLFNxQTY//YF+lqeE12jiOHlNqqsyyqnZOxxhoWu0PppNzXEvUwW5c7ZOW125OcdHqkRaIx0xLHcihHYEahBtG0eA+pEwY0OuiDLYUXWymk6nKkQojByFxnxmdnTJTzoCJ1imFTXAxmso1ga2EJKcuFLqQiIReh9EyHKBQATDafFbpgIpoYfTHiU6UQ9sIJxOnIBSaSILeUXffPdYNHBjfpHfgwJGO1SYlF+n3uAtxPS/I0UbIPEucg+3Eeso4jh5Tqh9jOpY5PMZA08qZlTNKtLOWqIPduNonLa+dnOIi1iPRZoBoWNpADj3dSD00jCLCvUWiU6EQVJEGW4osNtPJVOVIffWrX/UpfKQqSWCC1D5GwLbbbru8l9EoMOUiTuUMmNBYxbBmWkWFuIhlaQKblSSnLpQ213+rcW+acqDmoZErHB4cJ9YvTXRCaYBp82UathHbhHmWS/Fj++ywww7uvvumuIEDh7ullhrt5s0b6vr3Z5R4rp/nfvvt51ZffXXXzIiC3ocS7FJthNDZSupJFT3GNC3PcjpDBchaboR246puf+c5appHWl47OcVFrEdaaaWVfEphT8/I2IGc7u5R/nsTmjCKCinsyjTR/YaBOT43jNwdqTPPPNMdddRR7qCDDuojNkG9FHVSRudQLuKUxYAJjVWlxnFcaV7lmsBmRU6dUsUUwWBAgAepf4hOpEVWQ+Ne66xaBOan1LI0ow/RBgQs0mqTiEYpFZBpcag07yWWWKKk9Md/4rSRMvP971/rU35uu+02168fjuvrmKHesKFxL3UTzTCSw4hCNIqn7aSooOYbHlOhw6ptHx5jmlbiIIog8l+tGnUoMmnHQD3U8fJKy2sXp7io9Ui6vhANw5FjGUjnIxKlui3DKCpcxxCWKKpqn9FmjhQj+D/+8Y/dY4895v72t7/5z6i9CGumjM4gS8pMVgNGYXWl14X5ynnkKbMMCErglIRNbt98801/Ac2SQhdFToEcqyyiE+q1JONQKMWN5QwjdpX0fSIqTEqPlLyWXXZZn3ZT7UhwNCVPcuyVGMlhRCHaDDhMoWC+oSy9jilQyh7zih5j4bQ8mAfOpaTa28F4LgrlHKV6qOO1U1peO9cjsU/yvv4YRiNR6xHDaFgfqU022cQ/jM4lz5QZfovxJUM9axPYSmA5Fb2IKvOo2LTS+sCwvkrOXznHMuy1JGchr4a1GC2VpvTERRkgNJr5jn3DQIoihlmM5DCioHUVoWPFPLXu0WMqTbUvnFY3QnOe6kM5R6ke6njtlJbXCfVI1Vx/DMMwOs6ReuSRR9xPfvITX/jKjZIc6YMPPthtttlm+S6hUXjySpkJa4KihtecOXP6RGrqocyjYtNyyJmSwIEcPx58RppgktFfxDSjpCgDyx4azapxwvGURGwWIzmMKEBcqh7/ReQtFL6Ibp+kfV+kbdnulHOU6qWOZ/v4f1g9ktFIityk1jBa1pG666673LnnnutrorbZZht/s3ziiSfc4Ycf7s455xx3wAEH5L+kRtuDsUT9UFyfJQxxmuXV2hwvTZmHGwT/o4Z8UdSfiAfLgMMEcSPljbjR5FXUnxRlCGXhQQqCEsrIaiRHIwpEtNQvC3ifpdGv0TiBhySyqnBaGl59aaV6pEYdm0bnNak1jJZ1pG688UZ35JFHupNOOqnP5+RHX3/99eZIGVUjSes4uJjX2hwvTZmH+S633HJu2rRppYiLnKc0Y78ZRkGeRf1ZZOEl564apbhapTQsolA/6iHwkEQlKpz1NJxfeeWVUh0OtUCksXVSHU6r1CM18tg0Oq9JrWEDFS3rSFGcH1cb9aUvfcn99KfkZxudTrWjkEq9i5P7zqM5XjllHgQKuFF88pOf9Op4RSXPov4ssvAymtk+CDnkVc9l1E49BB6SqFSFM29YzwXNaHu8BDjqdQgvUDOkSIxUNDuBotcjNfLYNDqvSW2nYwMVLexI7bjjju7WW291G2ywgTesgNqWm2++2Y+IGZ1NLSd3Wp1SXs3x2kGZJ8+i/qQoQ1rqolH7AALTIrdPxFPP1Wzbegg8FDW6uMCJutM3o6WPUtirqKdnlJ+GSI1RDBp9bBqd16S2k9FAxVtvveWmTJniB4gpjyBCj31uFNiReu2119xvfvMbt/nmm7s111zTn1jPPPOMNww23XRT32MKrrvuuryX12gBahmFVOqdJMRDrDne/8izqL9clMEcp2xOE9uJnl9ZBhA02MAz+4+6QCKh1aQ81UvgoWggbEQkCicqVKvr7V3CzZ17WKlmiHS3IqW3dTKdcmy2K9akttipc9xfRo8e4yZNmuS6uga43t5hrqtrmrvpph+Wekd2UoS+pRwp6kh22223Pp+tuOKKeS2T0cGjkGHqnRrO4kCRTlZEtaBmXWTzLuq3GqZ4xyhUXwzfx/XUkpQ7UfpyAwgabNBNjmfeV5Py1CkCD+PGjfPpfESi4njvvf298AI1Q0VOd+sko69Tjs12pdOb1BY9dY6U5smT73OzZ1uEvuUcqQsuuMBHoDio4kDNz+hcah2FbJXUu2ZeZK23Tn2jSUSIVGSNI89+JWLEaz7j9xzX1NGppxbzyzqAkGfKU6ccCwgqUBMV14QW+Bz1OqbrRIpo9HXKsdnOtMr9uNNS54jQM2hkEfoWdaSOOOIIn9qXJAiAk2V0Lp0yCtnsQmqLIlWG9g0GJtEk5fsrkoSThGOkptBypDQwEL5nv+NYhT21+L1SUssNIGieYS+tWlKeinws5BUlQZ0PYYmurvdjnSlqpZAAZ7pOpNnXo1Y8Ng2jVVPnLEJfHKpypP785z/7kCKiE4bRqaOQVkhdbEM9/DxMxeOh5sKKBOEQSe4dhyh0hiD6Pq6nliJMWQYQok2KZQC322BDnlEShIy47yAsEdZICT6njxKjxZ2IXY8Mo3NS5yxC3+KO1De/+U13//33u89//vMdO/pnpNMJo5BWSN2cKEaSgxQa6igOhql6YSqeIlByjuQA8Z55hjVOYepd+D5M71NPLZaT/w3rqpIGEDTYQMoIaYRIzS+zzDJtd87kGSVZaaWVvMR5T89I9p6viQoNm+7uUf77ThWasOtRXzjGOrW2x2j/1DmL0Le4I4VU789//nPvTMVhqX1GJ9ApKYz1JuoY8Uw7BYxu1SjxHsERjHIcJ6XSMS1OFI6IapWYHwYUESMZ8GEqHv8RRQ4S0ykixTOobkmfy3HCKYvrqZV1/zNtd3e3V0Hlud2cqHpESUilkQGDsAQ1UaTzEYlSH6lOxa5H/4PryfTp0/21QX2PGGRBOMGuz0Y7pM5ZhL7FHam77rrLHX744W6zzTYr3SANo9PolBTGRqV+6b0iRsDnGENqDAwSfWB76/oT1irJUNf7aCoezg/OGOAYKZrFg30nZzhNtc/2dXOiJOwbUmkYBcaAIb1l2WWX9UZFp0ai2u16pEhSGGkmSlxJRInfq6ZRxx3nP5+bI2W0Q+qcRejboCEvI8Ck9hlGJ9MJKYyNSv1SqpyQE4ThzWs9FBlS9ChaqyRDnc9lwIepeEyLQc73wDww1vhNtHYnanTV0wh75ZVXSs4BaRvU+rS6c1CvKAnbpVMlztvhepSUuqtIks5N4JghIl1JRIn56noBem2NgOu7/9qJVkidswh9CztSL730kr/hjx8/3veUinLrrbfmsWyGYRQ8DQ/kuFQTsQlTv8JIFETFHpRqJyNL/6tUOz1jqKtGKjTgw1S8uIhTs4wB1uecc85xd955p08lYRSUGziFzkpXa9Wmiu0SJTHyq0tKEyBRJCmKBkCyRpR0XQgjoTysEXB7yux3auqcRehb2JHadNNN/cMwjM6TDccRUbQH5OCopomLe9aba5j6Fa1dCh0rRZV4Vq2T0nVI+4mrVeJ1OQO+CGk+1113vXvggYd9UXPRlKE6KUpiVBeJAD6bPXt2n96STBsXRUoTIFEkKam1StaIEg4c/831QfPjOsXnRm2E+2/GjBm+v9LMmTPdCius4A488MCWj6K3YuqcRehb0JEiPx3++Mc/uieffNJfpNZbb726NOLFODrhhBPcGmus4Y477rjS548++qi7+OKL/cjI9ttv784991y7WRtGjmDcENXBQBKhAyXCEWRusDg1OFNZ1NmiMuBRdTxeMy+l4qmWCSOO/8GJSlPGa6QBX026C+l8iPYgr1tEZSjDSItEkHIHHPNxTk5cXVKaAIkiSXFUElHi/3DgTLUvfxT5v/DCi3xW0v/6K93vrr32Wu9cnH322a4dsNQ5o26OFIYPN/bf/va3pdFojCmiVFdffbU3bvK6cOMgYWjgSIm///3v7phjjnFHH32023nnnf1o7aWXXurOPPPMXP7XMFqdcka9nCQMIc5dzuMll1zSp8Qp5Q2jiXM9jAzFjRSHqHYJJyeLOls09YvaS5ZHYhC8Z5lA07AuRUsPqzbdRY0ei6oMZRhpkSSuH0kRJBG9BqQJkHBeK5IUotrISiJKuk4Y+cJ+GjlypJs8eUpifyX23wEHHNDymz4pdQ6dAJRWicRZurJRlSN10UUXuRdffNH96Ec/KkWhiE6dccYZ/rsRI0bksmXPP/98fyB/5jOf6fP5j3/8Y7f22mt7RwqoLyAqdfLJJxfKuDKMZhj0XOyJIinVDvgMA5/zCYMEIz80VjCQMHhwYEjRkNGkdDuepayXhmqdKlFnyxo5KvK5XW2/JPpIzZ8/tLDKUEbro+OQcz7reRxHXCQJdK4nEb0GpAmQcK4oklSLap9RPxiAmzRpcmoU/c47h7utt97a22ntQJg6p0Ez7rHtXCNm1NmRIieWEYlQtW/jjTd2p512mhs+fHhujtRRRx3l81S//vWv9/n86aefdltssUXpPQcwo9bPPfecTzGsBm4GnAxGZ6Mc/zDXvwhg/NC4VTLfRGqiAgRMg8EdLnvUaEqLEHEO8FuM+zCFT0ZSuZFnzQPjh/moXqqo51WWbZoV1lHrHr2mpK3/oEGDXL9+08sqQzFdUbdjM7e7UX5bq6ea6hAZRYdqtrlqjkIBh3IQ6Y4euxzPOgYwPhWJZjoGehj1j6NdzoFWZkE6X3p/pe7u0b78YpNNNnHtBn1UcaY4f3Qu8J77JlEqo33strDMIHdHKmnmefeUwomKg9G1aL0AF2ZGCap1pLjhWCNhQ7z88suF2hhhTyTAYcLwCEeCMZIwQqo9D+UIvPnmm33EH6LzC0eiw9d6z0iyRqkx4pqBRs6jo+Xh51FxCwzMaEpRJf8X1+iXa5UM1zjWX39919s7N1UZiu/XWWedtrk+KUqax3Y3Kj8ucWA4LtOiSFn3XfS/ojBwU7RrqVEbzz//vJs/f0iZKPoK3uFox32fdI/lvKK5etFIuhe2Iy/X4XjLklVTlSP11a9+1afwEQXacMMNS6l95JJut912rhEHcjSESk1GLaNVjC6svvrqOSyd0cowosHJuPLKK+dW61crOCNz5sxZaAQYo0YpLxy/OFdczNNqmtKiSir6ZlCCEeJwJBsHi+8ZXea/qI1QY1yWg981K7oQRjhYDjX11bqyXAMHDvTbUCPq/IbvuG6EfalY/mpGFcOR//B/tW+S4Djbdttt3QMPJCtD7b333m7LLbd07QDGFftKo7m1bncjHa4JODNsb85hHCipXFbT/yYumgh8xgCKIt78H/uzKNdQIz8++clPun79fpkaRe/qmuG6uzcq1H20065h1d6TWpH362S3vfDCC5mmq8qRQtSBtLuDDjqoNELFRZp6Keqk6g0OXLRmgBtELT0iONDoM2MYwMmY9/GQJABRThhCo1yqJ1Adkp65YOL8sLwMJqTJB4ev45ws1nuZZZbx/4+xlbRcpNM2suYLx411lQGoWgl9H4o8cC3ipsa1SbVK+j3rp+0mJ1HXMG2Pavd72vZK46ijjnSDB3f7ugKEJaiJIp2PHiWt3kcqzghRyqeodbsbybBN1bg6eq+rdntzrcnymdGeMLBzxRVXlO2vtPnmm9flPtps1ARe9xzuJVzndd8sCtwXw3ue7oWyF9qRxXM+3rJm91TlSGGkIPjw2GOPuaeeeqokfx7WTNWTDTbYwP3pT38q1U4xOkCT4CFDhjTk/w2jml4rcapuahybRe1NkabQAQqV8fgfHAZFZuOcKX2GIcv8eCiaFKr2Nav/T7ThL+sjBb9w5HvYsGF+faMiD6oJ04h5KK0cpkfqZqiapkrEMZKodnuxXBdccIEvZg6VoWgI2W6S52mKbZ1MNdL5WQiFHTT4wjHPsc9nRTL8jPbpr4Sztfzyy7t2REqz3Le5H0ERr19pbQaMfKnYkeLgUf8WCgm50XMQVZMmUC1InnOi/uEPf/BRMCTXMQDXXXfdhi2D0TlkiSSpPgBDHkNfcr1yjPhdnKqbQu9pam8MXKjPUliXxPxDI5TpUdwLL/D8NmxMi9HOe+ZRD9lW+iLJGeCaQNf3rM5AVEKc96qd4b2cQAxB9aaJ3izSHCRFoNTcl/nzXn1RpBzWLDqhqWKaYlunUq10fqVGH9FA4D+4PnDcd5rSWL0c1k6jXH8l+khlTYtqVeSQFPV8skGrAjpSt9xyi/vBD37glUl43myzzfznp556qnv88cf9COohhxziDj104VBv3lB4TXNe/o+cVG46hJrjil0Nox5GThhJAi6iEjBQXyYuZGpMq9/HjQ6FkZK4USP+C+dMaWv6H8mZh0YoF/G4kcBK+q9UA5Gjs846y91991iv6MSNtatruhs9eozbbbfd3DnnnO2XIe0mkxRdiktH1PaJ3izYlnKMQgdJ+ys04EkBYFAo7GFTlJtguxLtG9YK273exne10vlZYR6cF6oF5D2v8/yPTndYO42k/kqKore7umK9z9k8sEGrgjlSOCn0jCKVjhS+UBkP42natGlebIKmuBxcRx55ZK4LSRphFP5jhx128M15WZ5G1WwYnUXSBTOMJCmyoe9D8QI1plUaXVxKUxgpiUt1UqSJZeHmr3Q8osJFMEJZ/9NPP91NnHhvbIPGCRNGuXnz/uuvFWlGS1x0KSRMVdT2ibtZqJg+6iCFkblWMODblWakjBbZ+G5ECg7zitZItlKaj4zUWq5/4bV8xowZvo0LipFcWw888MC2S6NtBJ0QRW/VtLlWHLRqa0fqjjvu8P2hGFmOQjodD9T6qFu48cYbc3ekklhxxRX9wzDqNWqcdsFUJEk3dgiV9cLGtKTY8ZtoSlNcpCQu1akoxmfcdkaWe8KEiakNGidNGu473RMFSlqPuOhSnGwrDpYibJXcLBq9DWs9Ji0Nqbnbv1Ejz41IwWFeSveFItampaVQ48wq1VfXW95X4tQqQn3hhRd92AtpgOvtHea6uu531157bdsJuxj1o1XS5opiN7Q7mRwpLkAYfOXohJCuUTy4+b7++usl+WseeY0ap10wwyaXGFsy/kNFODXu0/kTZyg0IlKSh1GZNDo/YcIEb5SkN2i8xD344INutdVWS5x/XHQJB1T/FafaV9SbRa2RDEtDau72b+TIcyNScCTMAmwTrk+Nqk3Lcu1J219yZrUPuMZOnz7d/eIXv/CDUFkjSvz3yJEj3eTJU2Ij5z09o/x0pKwZRqXnLNFNHHSOyUrrg40OcKS22WYbd+GFF/qD41Of+lTsNK+++qpP7WuXfidGa8CFDCeKm7TEF/R5HqPGSUZOGEmCaJNXbtoSZQkNh2ZESvIyKtPSHBnZTW/QONRPlzZi106pCLVGMlohB7/I5LX9GjHy3IjjnnkRxUVwgvkTGc7rP5JUSvmM2kltP67PSYNcaftLzqxEZC677HJ3zz33VBxR4no9adLk1Mg54gnU/ZgBbGQ9ZzmeL7vsMl8rRn3w/PnDXL9+09yYMWMsytkhZHKkUGA54YQT3J577umGDh3qVl11Va9Dz4WRgwgn6rnnnvOfM61hNAouZGEkKkwDy2PUOM3ICSNJakxZROGCvIzKpNF5DLSurmllGjROcx/72OZlR8CLGF2qhlojGa2Qg19k8tp+GkhB7IVzG0OeiEjex2gjjnu1PGBANK9eK3GDNDhPIIl1OaFS0oy79qTtLzmzfHbFFVe6++67v6qI0gLna8nUyDkKdBjEnVj3Y1R3zlIfPHbsRDdrlkU5O5VMjhT9ZW666Sb329/+1qfn4DQRWucixwVZfQV23XXXwuWIGsWnlrQzRaJ0k+Zmq7qlvI7FJCOnVYz+vIzKpNF5znuUPNMaNPb2vudrpIq8vfKsSao1ktEqOfh5kXc9WF7bj2Ug+kzUm2uMIs5EN5hXkY/nRmzvuEEaHCm1f4iSNMgV7i8pbso5Y9lwAl988UV37733Vh1RQlkuS+Sc6QwjC1OnTnU9PT3eibIoZ+dSUR+pL3zhC/5hGEVJO+MGrJQ7OVNhVKgo1NJfqVbyMiqT0hzXXnvtsg0a+X711Vd3zTASVbBerg8YUQcZy7Wqs9Va99Ju0rVphns96sHC7QfqR1ZNI1rtA+bZDmmWbGeuQ3ls77hBmlB0J1QK1GecY/x3uB+0v1iWUFCC6XBacWapiSpXi5kWUeK6S8pVWuScXkiN7InZjrBfSSHFkdZzK54nWRg3bpxFOY3KG/IaRpHSznQDBjlTGGr0UirCxZt1I92VUatm5U/nZZSnpTmWa9Co7xul8CUjkfXGMONmTkpWXB8wKYBx7BFhZ7pajeVa617aqV6snKNUj3owbT/28ezZs/08OearaZzZbmmWbIO8tnfcIE2YGaDsgBD1iOOY0H7Q/pJokFKndW7yWLAfq48o0eOI625a5JzrFYNcRnWECovsZ4419me79uriWOOeblHOzsYcKaOp1GqkFN3gXOBE3dnU/Ok8t1FSOmO5Bo21EI0c8Uz6EEabGo1GFb5kJKqJMdOx3nF9wGTY8Z6HZNdrNZZrTf0sYupoNf18yjlK9XJUmDf7UjVN1ToN7ZZmqZrSPLZ33CANIjv6H80/dLCoJ2WfRPcDz1xH+H24bbVsXE/K1WKmRZRUglAucm5CE9Wjc12DgzzzvlWjt+WwKKcB5kgZTSUPI6WIBmfR8qcbtY3ybtAYRjP0Phzh5nO9D52tMMUoashF+4ABzphUwfS7VjaW60G1/XzKOUr1dFTycNLaLc2S457zJq4eqdK0x6RBGggdbqVY4iSpdipuP6QdC3vttZe75ppra4ooNTpy3mm0W/S2HK0c5bQ+hflhjpTRVNrNSAmx/OnaL9xhNEPpd0I3a44ZGYRRQ0zGWOhYRfuAqf+X5q/Gna1wHNZSe8e2JTKn7Yb6Ytr6xvXzkRObNupczlHKs56p0v8uctS7XoYOESG2bVw9Uphul4cYj+D4JDUvbFwetx/S7gcc3/vuu6+7447qI0r1jJwb/zvf4q637UiWKGfR+klxbinlGcKU93ZNwaw35kgZTaXoqXm10On503mIOYQjnHG1FmEBu46d0BADRsCjDlLYB0wGG/VRjJgXUcI+79o79gvKq2w3tiPbhn1Ce4skZyrs5xPWwKhHUNKoc7nBkjzrmSr976JGvevZkJn1T6tHqkcaVtb9UO5+cNFFF7r+/fvVHFHKO3JuLLyfQYNgRR+QqgUdc7fdNtw3nueY7Oqa7np757qddtrZnXrqqc1exIWuK+yj8H7Kfa+dUzDrjTlSRtMpamperXRK/nRSQ04u2HJelJqHsxLWKpW7cIcRBTlGIrwRMKomgytqiCWp9oV9wIruOOVde0ckSrVjcoYwqvk8yegJR5vlwCrSkzbqnGWwJK96pmr+u4jUuyFzuXqkvKlkP6TdD8KI0l133eVmzJjhBg3a3G2zzTZu2LBh3hFvhf3brmg/v/XWW34ghOjnMsss09b7Q8ckjjxRzjlz5rill97Cbb755v7ezjWTQQsG75q9HaJZBWF6PINhLKtROeZIGUadaOX86VpHzjGUMJiUPqeUPL7ngs0ji9EWHeGMS9WLqjTGGWJxzkEzHPio06mo0WuvvVZyRtJS7Pj9M8884267rafqfjrA/yuiBHqdtj/iUvDk3JaL8mTZ1vUUnch7P9e7vqARtSaNFtGoZj8kbWeMdWqmwno9BGjK1esZ9Yft3t3d7a9pPHfKfqANyDe/+U2feaHzVANURNv5fIUVVmjq9tByMYgWDkTqPdeBWtOpOxFzpAyjThRZJaqeDTmZt0a5lPYVXqzldGUx2qIj2YxwMh9uSsD7Ioz0VZveqDQ2Pi+XYienlVHPWvrpgBzd0IiWU5plX1Si2peVVlHHq2faXZYGtXkZOs2sT81y/UnbztXW6xlGveB44140bRqppgsgEvXwww/7floMkO25555ugw02aNpOUBZGWGssdC7ZudNER4qN/9hjj7lf//rXbsSIEXnN1jBamiKqROVpCCaNnIcNkvW5jGOl+WU12oqc+hkVbGCdGBlX7yoe2iZxvapU8Mv3quVKSrGT8UjqSC39dICbusQGwjonPm/WvmiEYZ/HAEK90+7KNaitRhCi0WmPaduZz1WfxTqp31t0ndK2c7X1eoZRT8Jo/dVXX+Puu+8+P+iluqmbb/6RO+CAxvSPjIPzkLTLUMkWJLjEw86dBjpSGEmPP/64+81vfuP+3//7f+5vf/ub/4xQrjlShlFclag8DcGkKAKRIo2khwaOIjCDBg1quVoGto/kv4H1iKZEhCj6RsSG7RTXqwrkaJVLsZPxiLNTSz8dYNsT9apEta/e1LueKa8BhEak3Wlb1FsQol5pj0nbGVgnthXXA0WR4tYpbTtXW69XbrlbrZbOKBa63+FETZlyv0+/blb/yDg4nrn3EiHTuaL7ctYsEaNGR+rFF18sOU6///3vfTEhO4OiurPOOstttNFGbo011qhklobRERRJJSpPQzApikCKA85UdORZBmJRDZQkY4rPXn311T555eH2ClOLomDwqX9OtFeVnsMbWlKKnYzHr371q+7662+oufaOdSuamlY9I155DSBoP8gpljONw5wnjRaEaMR2hvB6oGMfKukpVUu9XrPSNTuZTnFSWTcEUIhE1VLDWk+4N7MflC6sVHPdd4p2T2gbRwqFKBwojCIiTjhMJ510ktt4443dLrvs4g3EtdZaq/5LaxhGzeRZi5IWRSiSMl70Rh6n5AcUSCsFj21Dmh4FwkRukhylsPdRGmGvKmqiZPzJEJcTlZRiJ+MRFawddtjB3XffiMLV3hWZvAYQ2A8cFwwkCubFPs27ULuRdWN5GbvltjPHtwYTFIGttKdUeN1hX0gdVA85bVmXvxHpmp1KJzmpHJvURNVaw1pP6l3r2olkcqTuv/9+v9G5iG211VZuk0028U6UQvWGYbTOKF3etShpUYRaIgyVNJtVk0EZt0TD5MTJaVEeOCgdT07MzJkz/Y0klFrnO94z33LGdlzxbogMPeqjVEcV1nNo2dhWSSl2YbrX8ccf55dx8uS+vUuaWXuXN5U2DG6UgAPTESXiN+w39iH7jmMsb8O7UYIQeRq75Zy/aA1lGGUqZ/Axv6iTxHKG9ZfMl31RyfI3Il2zU+kkJ5X14bjjelzk/pFFrjtuW0fqd7/7na+BIqWPyNSECRP8xQqjhhPjD3/4g1tuueXKFiobhtH8Ubqi99bJ0mxWo85SnsMxkYiFogOhIQcScgjfC65nzIPpVQSsYnacM7ZRtAYqK0pp1HaWc8dnctaUDlmup5jSvZZcckl33nnnusMOO9RNmTLF35SXW24rd9BBB7VMJKqcIEGlDYMbKeAg4z+Mosg5a8VzNU9jt5zzx3cgZwpHlO/jokihs6QILgIteav3tYpiZCvSaU4q16iurnvavn+kUaEjxUG//vrr+8e3vvUtfxGjRgqnigeGzXe/+10v97zhhhu6Cy64IMtsDaNjafYoXZFHpMo1m503b7475pijvTMSTbcL+0uFzyL6eZhapM+jDhjIAUoDIw7DMPwd184VV1yxj/GPalJoWGg5shoWodHHTfvQQw/1xw5FxM28OVcSYS03kFBNw+BGCjg00vBuxLmap7GbFkli3/EdUV6pWwL7OnSQGq3eF+f8EaUeP368X9ZyEXEjW02hosC6zrZjzyIkzi+99LKW6h/ZKTVshVLtIz1liy228A/ghigRil/84hd5L6NhtB2dNkoXvWDLwJIhqhxtjBYiUThRSYW6t98+3G2//Xa+CW+lhM18Idz+coBk+Ok9aVwYfeq9FIVl55pILRXfl0tHC43wcLmyGuHN7P+TV4S13EBCNQ2DGyngUMR9UAt5O4ZpkSQVu4ftEZiGfRIXRWqEel/o/LGMl1122Yf92uIj4s2Qrm5VwprCcOCLgTBqUpvdpDZvCCjsscfX3Nixxesf2ek1bIVypEJjhIsZGxw5Zx6GYZSnk1JJJBuuJrrRqBEweswFHSfKuSVTC3WpCaKg98ADD4yNSJWrVwq/j/5eBpsMMhlsGH04S9Reqf6C74iYhE2BeZQzpkMjXMvCfLIa4eXSvSqpLWtWhLXcQELYMBhCQY5aR7HzOPealR5br5HjejiGSccEAw2KIOkY4P/kcKWp90Vr21g+ljMP9T6dv6effrobO3ZiYkS8WdLVrYpqCqXyrOuqRHfasVaKDC2OxQkTwhrWaa639z1/PT7vvPNcUQjPU6Xbsq+I3DNY2W77pqmO1IMPPuh+8IMfuOeff95deeWVbrPNNvOfH3LIIe6pp55y66yzjn+NNK9hGO03op3FQJehJyUtLsrhyDPEOTr6jHlnKdQlchU3n6yOlcQBomC0ERmTGAT7RA4g30lYAMOAG8yQIUNcpURHv3kmclXJDSsu3StLbVm5kfRqDfVKI6zlhB/UMFh1byG1NqTN69xrdHpsPUeOswo7VELaMSHRF0kvS/gFktT7OA9Zd9W2MR+uAwxisG1CBTLSZx966KGK0/KmTp1aNiLeTOnqVkX7RceVrtNcg7nWtlu9EDWsRDWPOOIIrylAmugyy3zJbbvttt45YTCBa04RnBSdp+yTMFOEcy6v5t/tTiZH6rbbbvMe9nbbbee23377Pr2iOFD+8Y9/eMEJpBxHjRrlc0QNw2hdwYc4A/2223r6dGkfPXqM22uvvdzo0ZeURoW58CYZwOXg4p2l2SzfDx68SdnI04LpF6iqaZRa/X4w5EKBCinmaWRc78ORdPYTv80jeigjnJsVN9k8UoXK1ZaVG0mvxVCvNMqTRfiB+i9Sf/iMfYjzKgn5Wkax63Xu1bvOoN51leWEHfJU79M5pl5cgn2cpN7HCLnWP6xt4yFDnO/POONMd/vtt394rRrmr1VZBxPGjRvnByGKKl3dqrC/FOWPwjHSjrVSrM8GG2zghg0b5s+joqoW6jxV1D8cXKpEsKWTyeRIEYki3H3wwQcv9J1qpQ477DB3+eWXu2uvvdYcKcNoQcGH0BDkYq+mfThMSV3af/Yz8sCdu/zyy/xvmUe1ThQ3ma985SvuxhtvSi3UJT1i6623Tp1fmEKCkcWDRoksn0bD1RSUGwZpe6B1lsiBbjSskwz6okUPWadnnnnGO7q1NIGsxVCvNMqTRfiBfaZjKu+GtHmfe42oM2hEXWUj1PuIIBEp4n90LuIw33vvvT67hf9FtAoRFR2r0do2mmMzPZEn+qqhVrn66qt7J+qOO34We63KMphARJxIbpGlq1sRjoUF23bhXnwcY+1srIfnLc6K7iU4V0UYPNV5SjqfBjtYXs4zlrfd67Yb5kixw8MoVBKf/exn3Y9+9KM8lsswjAZKTWPIxF0w+bxcl/a77hruTj75pD7Sw9WAQU0bhd12281NmJBeqEsD8FmzZpWMyXBUW/n3EN4IoiPkMhTDmq1wxDwUwmDd+Bxjrh7RBtaFR9hPJ0t0Qwb8gsL42ppA1mKoVxPlySL80IhawjwiSY1Q4WzEtsjT6Es7JtTjTcIO48aNd/PnL+7mzRvi+vef4f7858f9AO5+++3nLrzwwtJ5x28uuWS0mzhxYp/o+E03/dDttNNObvLkSW727FFVDybgvJMOa9LV+cI+7+7u7uOA6hpcibpiq6sWSmlWKqRFSJ0LB7U4H3WuKUOgHeu2m+JIbbrppj7axIjPsssuGzsNaTI33HCD22ijjfJeRsMwqqhXUkNTDDrVIugCzkVTanNcPJMcoEceeaSsgU4xLcsSJ/5QKTgsNJtlPhMnJjebJR2OZddFfs6cOX1qscLaKE0THSEHbuKKvkVHzMORdN1sqrnhRRvLshyqC5LEN6OBPHPD5VoK2mdp0Q0Z8Kw/aUy1jKTX2rC2mihPOeeg3rWEeUWSGhEtakRdZdTo0zlVTa+ttGMiFHYYN25SbARp4MCR7qc/vcOvK1Ek1pMi/UmT7o2dfvJkBl8WrWkwAcEs0gBbSbq6VeC6Kqda111lBbSzsa7zNrzPKlW5KKlz/D+1W7oWahClSJkXLe9InX/++T7MvtVWW/mo06qrrup7lnAwcHAQZqdpLwcG9VSGYdSHrIICXJynTZvWx7mIij5wUZfRnsQCUYdsXdq54DJ99H+yIKdHBbinnnqKO/LII3w7BebNAA5GjpzFqAHOtUj/Gzpz4Y0gboScz1T/FDdiXk2UIpoiiZOjIms+Y5uzXBKy0PKrjkApFhQsk45Iw10cR2SCcVZDh1kGfJbasnJNIPNsWJuXc1DvWsK8IkmNiBbVQxAi7RhQM2T2Sz2MPoQdyqWjDhw43NsURJHYpkSi0oQgBg48z/XrN9PNm/eJqgYTkK7mOtrT0xrS1a2EjHWl88qJyqJ02srovOV+LOeEh9LEixKN03JyD+ceBO3s4DbckcKIYRSH5nQo4Tz66KOlEVZGhXXxQbWPUQfDMPJPOeJChxOVRZoXw7sahyYK5zPRoHTxh+neQA9vlKF0NXDTgFDum+Xjc9VU8R2vMdq4wZLmlzRyHDXA5YxoPlLci/YoiRshj7uJVxJdUcRJxueC7dJVkvCWwRuuv4xsyTaHv1PU8MILL/LX3P8Vzd/va1BDh1kGPGqp119/Q00j6VnqlvJ2pLI4SvWsJcwrktQoFc68BSHSjD6dQ/Uy+hB2cG6J1AjSUkuNdv36/cvbH1BOCGKppS5ySyxxp/vnP0+tajABOLeUBkgEC+eL34URcaM6OB9qGaRqVVg/gg+cq9z7uM8pzQ8BoyKhc5xrCw6VWhy1+z5qiPw5F1MUungYhpEvoTHOxVXGd9jTiHqlu+8em0lQQAZ6rWy55ZbulltuzWyg60YZl28toQcMQI12R1WclD9ebjQ/aoDrZhwXXaq1VqZcfdn06dP9+kQb7IZ9oqLrKcdJKYaSiVe63+WXX+GmTHmgbNG8DHgiUjvssIO7774RNY2kZ6lbaifRlbwiSY0czW2Eep+MPilZSokza5pnFhaIDwxJjXbPmzfU9ev3eimKVE4IYt685d1HPvKb2O+zpuVx/HNucR1V+jTnFxk5DO4URSSgVSmayFIzGhMLzl8cqqKoFjai1rOjHSkMo7vuusvXZnAxQQp9vfXWq+/SGUabERrlGCVqfhdnpEblYrPUK6kGgPMzD4jo0PJgypTsBnqaMS6VPKWOhZEkOSNsoyyj+VmjS1n3RdinhgdGMYpg6omlZoV8TuSN/8L51XJzjaRRsHrbYHgxXRyKvsmAVz8VzaecwEdYNK8oErVlrMfkycm1ZUVvFl1vCfF6R5IaMZrbyHqseqR5hoZZv34zUqPd/fsTCfq3P58WtDFIT19ddNHXnXMvuwEDbqo5LY/piIizrIrSco6yHfJWZDTaH44V7omKRHHeamCxKI5KI64tHetIPfnkk15elBDkiiuu6P70pz+5m2++2V1wwQVWdGkYCcZCODo9YMAA/5Dsr6apRJyhmnqlLGCwqn5HjlsYLTr22GP8RZ4u7VlTXZKMca4hWjZGdpU+xHcqwNU0STeWrI2B+Q8MH25UzJt5sg/4js+5ofH/SluSsahlZnu8+eabJQNb24PPMayUuocjdeWVV3nnJ1QSI5KHE8r244YZjUqpPk1F1zwzz1//+tcVKfDJcaWm6rzzznWHHXaor6ti+yy33Fb+2l1JTUezmkU3QkK8nnVHjRrNbWQ9Vt5pnuE+Jtp93XXXp0a7u7q4fvb6dgc4U+WFIN53u+66ixeq4Rwh4sW52Ns71+288y7uW9/6Vun6mGX5WV6lKmvgS9fsohi/RusQDp5pAA04n4tAMwfR2t6Ruvjii92XvvQl973vfa/UzO7qq6/2sqSmXmMYCxvwSFlzkdQFkxsxogMq3K7Uicpar6QaAB78hy6K/5vmf5LfLMvAgQNL9U2gXkvhhZNlP/vss9y3v316yYGJij9UYoyrlipUccoSfSgntIGiF84R6xyOpAOv+R/2jeqywrS78KEeUryW4RRGznQDXODY9nonKqnP1pQpC/psnXjiCaX1kNMkB0q1YnLkFsy3MgW+8AZII1vEgdj2pGiVqwmJUm+Bh6KlleRVd9So0dxG1mPlneYZ7uNVVlnF7brrrm7ChPhoN6p9bMOdd97ZZ8EMGTKkjBDESC+Bjpz6GWec4ZvyMugyaNAXvNPGNYftxv9n3bcsr44JCAVtimL8Gq2DBuzCe0x4n2o2zRpE6whH6umnn3ZXXnlln47gXNBwplDsI0plGJ2ORltlxAspykmxhwuojPO4Tu951CthIGBQhyPtXBjLRXvSRqQwZJLEHxohIqBmm0lCG//857veYVEPKBHtExXtHxXdD/ocQkdH89BvMbaz9Nm6777hbt999/GGnBwyOWNy6nTT4r+qUeDL+wbYjDqGZqaV5OHENWo0t5GObiiHrtrGWgrko/uYwRnmSToqQhHz5q3g+0hx7MP22+/gjjvu2JIjo+j3bbeF6asIY7zntttuex9x4pwkJZeBnjDKrtRbBrkUyd5ggw3KLm8YORBypIpS29LKNDqdt5kovT28D+mzItCsQbSOcKS4QUfV+LjZQ1g4ZxitQlLqVy0KOjLGQpGIsB+QBAXCVK561itVYwznaZCn/X+0PglUnxRGzOT4MbLMCHOaw0I6z5577rFQXVK4L0JnKnwffq/US/1W2wHCkUOOmV/+8peZ+mwh477vvvv6+bFOMvC0HMqV5zNqqypV4GuHG2Az00rycOIaOZrbKEc37wL5aK8yzjUGPw455GA/IEHZwH/+s6pvuL3LLrv4c5lpWQb9H0IQiF6haEmN4uDBm/SpR2TZ+FzOD89XX33NQqm3NPE94ID/KWAmLW8SXMstva/10nmbCdd+tbwIr3NFUu7rVDGQhohN/L//9/9834cQDgI+f/HFF/t8jnqUYRR1hIvvGbUMG+Rxs9WIdLVEnYIwsqEaIB5S1AtHpiDNsWJajO3vfOcCn651++21CQok0QiDXDdPiTvE1WWB6jHYT3fccUdmh2W//fbrM59o2kRUxCP8//C9DGuMLEUUow7YW2+9lSkNj+3J/MJ+V4pyAZ/RSoI0Krb3Hnt8zY0dW1kvm1a/AVbiiOQ9ip2HE9cOzmy9C+TD5qRhvQgRpG9+85vutNNO89fmqAPL/5PKSpQdSAvkHIi7ZrJsHB/ajzhRSam3oQJm0vJyjkfRtcGK8Guj01TidPyzzkrn1nXC6ABH6tJLL439fPTo0X3eczKYI2U0CxnpqkGS+ppU1oCLtL6POjuhM1StMYahwUVSI6ISNMAgwWCQRDfCBxjQGAnAe2D0N3pjCWtdvve9Me6EE47PXK9UKfUyyBUFJCUujPqIJCl0KYVlcVgYiS5HnPHFtmb7819K52EbyGjUiHXY/Jdp2S/l0vD4ftCgzUqOkm6ezJ9jkRsr/82xoe1OPSrTVtvLphXTZbIKP9RjFDuvaFL03GF+nKOttB/qWSDPupPdoj5Vmifbm+ughB3i0HEAbEeEYJIGn1SfmiX1NlTAjFteznGuK0qPDrMJrAi/NjpNJS462CJbA2e9qNeHVryXFNKRogmvYRSx75JOblJNOcFDJ0mGWKiyxgUgmlYVVzNT62iTDO/QIMOA4P/TjDPEHrLcWCTN2+yLqPaDomxMg3pc3HQYNWEEKgsYRDgUC4Q2sjgsm2Qu3JUMe1hYr6iTiuyB+TEd6ybDSWmam2++uU8RSkvDo36DNLxoc2DAKWO7dHd39/mO/zz99NN9CtMDDzzgt9/yy++SyWFu5XSZLMIP9RjFrkc0qZX3Q0ioaBnWCjHgU016n64VYdsDXavTBrEUBdN+wcFJUibV/CppGZF0PeXaIxEbRSpBacdG9XSiSpwGW1rh+tAKy9gyjpTC6YZRBMImqHKUOME5TtXvRzf+UBlHhpbkvsOLNyQ1T63WGONGX6kxVqQbS3gRBQxa3odGULQIm/VWOp4utpIQrtSJAkXstt1220wOC7UScchAkxHEexw+1Xro86hTHW5/1TDJ4CNatfrqq7vddtvNTZiQnoZXrqidbaPIhXpase5EIffZZx/v2GW9eRUxXaaSUc1yy1+vUey8I7FF3A/VoG2tlFTB+cB1mOtuJeuTJOAglcw0GHTQgBjnhlT14uA/KmkZkQT/xSBItJ2FBsaM6ulklbhWuD60wjK2VGqfYRQFNUGNSojyOTc4jUaGkSUMfxlaKqAOe4IAF3Ju0lzYm2WM1fvGEifyEOZph+lTGElh+k7oBCUZL6D8b11sQ2MnSz1YHKRmUnw+aVKyw7LLLrt6oy7sBxWKRETV+IBjiHVlWh0fLLvea/tjNGFIhftFjvPll1/mBgxYIjUNL+pIyMFkXzM/GXKqC+P/SQVU/6lKbl5FS5epdFSz3PJHBQv4XPPOU0Wt1pSWou2HaiHywiBKHDj8lRpVtQwKse30fzyI5CY5QWxvnK2urocrUsCMQy0bjOak87Yjuj5IdEUDwEWS1W+Xa1i9MUfKaDk0ohme3IpMcbPD4I02l5WTFB1hjFPtQx63WdSzYF0iGzyHTqScUYxdnAY1ra3GoZTEMD2zWI+DDz7YOwNSLawUqdwxD9S9Fl10ETd2bLzDctJJJ/l9J1EH3ZhEVMhCjlJc7ZLq2MLtz+uk/TJq1ILI06RJk/wyDB26o9tzzz19Gl7UkWBUWwMBIAEStjufMZ3kpjVYUMnNq15RzWodi0pHNcstvwYbJFYix5nlYjvnkXaSR0pL3tLhzYLtvaBGceHBD9WgVnKNShJwyEp4HjDAkRZNQnjmhz+8uSIFzHJYzUjj03nbEa4P3At0H1LUt1pFzHotY1EyZIqMOVJGy8FJHNY5SYVNRjDOFAa9HCQ5UWFUJ2mEsZZoVF5UEtWq5KaOwaNRvzjVOkVhQkMla6+reInhB93111/vjZSjjjrKVYMcMBw81o9Gm6eeemqs0AbbAsdYjraa64YOIw4TKZeKZCRts7gIYNJ+kdHNbw488MBSFAsjIM6RUH0Vy6ZaOkVVQ6ESOZ6V3rzqEdWsxbGodFSz3PJrsEHponJyFZHKI+0kj5SWvKXDmwXLifOXdG3UAE1cDWDS/EirTapvSrvm8F14Hmjfxx1LHDOk3nJ9GD++MgXMJKxmpD50YgoZ1wfOATmPEqVSRK4I6x1eiyFsKdBK17B6Y46U0XIgLKGRXl10uQCptxknf1r0oJWR8h3GmQxsGZsS1QgdxdB41m+yRocqEd1IkxgeO3aU+9e//u0ba1aC/l+OX7nGwFEnWgpbRJyyjmwmpeBFj6NwOgwAHjhpWWp6kmrztE+i6YaVOkL1iGrWYuhUOqqZZfklDsI253vSUKdMmVJyromE1qJimUdKC8vI8kmKm2tULdLhlV4f8qzlYZtG25+EsH8rWScNcEWFYdSwPGk7x50HAwcO9Gnd0cEhHhwPI0eOcPPnz3MTJtTeMqITDf5G0IkpZLo+hPcBKVgWJb1P12Kp7bKMnIOKpLVzxLASzJEyWg5upNTCxKn21atwvJHoxhxGjxTJUFpelnm8+uqrbsUVV1zI8MiqagdZnK4sEsOTJw93e++9l3d0wu7uafOWzLiMlSzORDknOs3QjI42K9VEBrCiMKqX0nSSr+e/NKKYVNOjNNRQ0AJ0A42mGyp1LawbgHJOUqgMxbS1yuvWYuhUEyELz9+kddB+Hj16jJswYcKHkdBh3kgmEiojOanZaiPS8viNUjil/gj1MBDD/niC/+H4JFpUC1IdTVPJq2SdVGMYNsDWoEcYoY2m48ZFvaSqx0OCFbrGYPyx/y+++GJ3xBFH+OOE42jw4C+5r3zlK+6Tn/xkRdfD8DxQCwQe/E+7DNY1g05NIeN6wnkbNqOPKlQ2G45ppefrPsWzDSD8D3OkjJaEC0wRLjJ5oYsSqUByoEQ0gpEV5oGzqe2k2qdy8wnTJbM4bVkkhru7R/vpDjjggD5qimGD2hApK6r/lqSGs6YOxRnh/B/bV4abRr5laEZHm9kPSsFjeeTQsU250YWpeopasZxJNT1yJLTeoGVhXupjpSgjKA1QRiHLr8/LpdjlmYZUi6FTS4QsbR2Yx3nnnecmTry3qmarjUjLk7MZDoaEBnmeym9sXzn1Qv2Z+E5OSrUgyJDkSCm1utLjSee2zi05qmwfvgudWIQlklJudf5yjjCARGNuahUZYNtyyy39uq+99tp+HqGjyfro/M+yH0IHW02K5fTlVZ/XiXSqeh/rJ/GsENY/VKhsNjrmIbRFihI5azbmSBlGg0iKhgA3YUmHxzk61UqyRwuzufnLGE8Dw4P/zHKhzCYxPMQLUITOmYQkSM2RkY2DIQel1pS0UFwjGv0K0wajSoZJKXhhFEYiEMByamRaIhdxNT2KMsqZ4vfqW8WzDDylXyoVM1Tv02fUmJRLLcozDalWQ6faCHHaOrAtJk6c6GbNqq7ZarnlxZCXscx/V5uWF03d1OtKjfhyyGGLpoyyzJzztTpSafVIbJ9KjN5yx5P68ek7nlmHf/zjH7HpirxmmuHDz3fjx49nrJ+rGE0bfHRym222dRde+F2/vRUVloPGfLPKuGu5eWiwS4M9LK+l+FVHp6r36bgN0XWuSMeThJuiSsmVRHPbGXOkDKNBDhQjpKrrCqMhugnXAxmeMmQx2l5++eXE/5Nzg1FBFEe9n6ICFSELmuVOL9Msd7pbaaUd/QhxXFqd6ttENJ0rqVYpDYlrhMZl0jbSfNNS8Mr1lJLggYwA/l8qTMB+DiNMobCHUsi0XeScRdX7QqeuXIpdnnUH9VSTTCNtHcaNG+e6upasqdlqGjr29d/abpzHWdddDoKKtUPyrq9R1DTuWOe4zuMaE9YjhcditKF0pceTjEmd71wX2DZa7rDdAp/HOaBnn322Gz9+kvvXvz7nPvKRP7neXqLdq7n+/V91999/v3vuuefcDTdcXxJziW6fLIIZWu5p06aVGq/z0ABKO9f01JtOVe+Lqg/LOck6kNkIwnR83Yf0mWGOlGHEgrHEI4+oCNGmMDQOSmlTzRMXJDlZtUSg4ghTTpTvrNojoXQzjH1NF6bqxMmJC1Jnbrnl1rISw3vttaBGKgm2BcXhRK7UbFk9naTAh9GSNUVN0RtFEsL1DdMXw+hXOEpeaU8pfa79jJEYbi/dFJkHzqocrNBpAz5XvZVSm3iwDNoucq7SUuzyrjuIRpW0v+rpWKX1jOK4nj9/WE3NVtMIG3uH0ST2T1aVOpaf4zlp/pCXscT2Z13jzlFFM2slrEcSXDPK9WGKI6zji6ZvhqqXitRKgZN9wbogKsP1hHkghNHT0/OhE/WEmzNn4VTPl18e4S666CJ35plnxi5PVqeW71H+xMhXuwJFLltN2r5oKAKta7bq0LiutmsfLwbOVN8Xve8XReFTtVzhdVHX5H8VYPmajbmThvEhqn/hJi6VGkZIlR5Wy40h2iBYzpMunOGFqVIniptO9ELGf5H+RTqPUgTCC7cI/0vOUljbI1UhGWeKvqj4lOeVVlrJ7bzzTq67e6QbMOAmH5lasAzv+fdxEsMywqlnwAgiSsZDURwtW1gjodQ51jW6Tmkk9b+Rg8H85ARgvGEkyWmTKpxSu1Rki0Gp6fS5xE+0L5LSHpTGF5dqGFXv03wwHKX+xnKrj1KaCAefKRqitNG86g5k/HKO8Jpn3ld7niShdcC41jaA/6kkTisdb9U2W00iFBWIwvZPqheKLn+a+qUUuvLYbhx3RIZCFMGLi8JU+x84kGxTolP8H/uB6yTnczXrEaZvKvqs81vpihqw0ICIHEMdc0QnSeUjEjVnznl+QEcOtlI958wZ7h555Bf+eh63jTRgkgX2K9tUx6SWS+ekUR3a/mxHDV7x0HWmHeFekuSAc0xlvc/VE4k4KTVf10TO0zfqcN1vNcyRMjoGGe8zZsxY6KYvw5CLVjh6zw0SQyeL0RSH0lYkLhCdN88YItUYOkrDw1nigYMk0QIMHEkJR9O5uHAzvaIuYZg+WtuD0UTanUaPeb3KKqu4tdZay62zzjr+eY011nBXXXWV23//vV1393A3ZMhn3JAhW7khQzZwgwYNd7vttrMXBYhuazVEVlF/udQj5Y1nTVGTw6h0BBFNFdOIJ/teOfpq9qr/lIGEAT1z5kw/Gi7jS+l3quvQzT/NgI4zzsPpWTfmyX4KG0njHKs+CnDmkiJzoWOoUfS8UmTSjN880TqE24D9yjmz1VZbud7edz+MeLpcmq2GcG4l7cOsER5t97RjgX1d7fUlilJl5fjr2qNBjzxg/jhSyyyzjF92ORPVOtNp6ZsaxOB8ibs+KorE9RyHqbc3PdUTZ+tXv/pVn89lHIYiL1m2ga7beqiPWV77shNRSrP2Rbg/iuBQ1AOOJVLp4zIF2BZZaprrTdp1+D91uO63GlYjZXQEEh4IU1K4QCk9R4ZhNIogx6fatBilJoWNVqMo1143ZN3Us+Qqh0X4cfU7celcocqVCnuZZ5wyHq+jKRVhSpdudMzj5JNPdnvuuacXAGCEeumlv+DT/vgvagpw7jD0wigdKI2jHMofz5qiFpVF1v+FsupKFyOahAHEfpDRxnT8h0bgtM1V3/bmm2/6aWRwh+p95VQWo9+F+5v5yUFhf7AtlX4Y7hcZtM1Ix2tk3xcVZCvNUufLsGHD3G677eYmTEhutrrPPvtW3U9K2z7O6VX0IktaC8chTkY0vTSEcyKP1KWkXmoyfPIkLzGTtBRUqSfGXR/ClgELzoNZviYqLdVz/vwh/r+S1EIrSaVS8b0GxLQ87Os81Rg7CZ1z4XUeeN3OEvO6TkfvHaqTKkL6HP+vLA3On3DQ8P2C1HI1C3OkjLYh2kw1vOhiJBMxCOtRlJ6D4RFnGEK030+lqO5Gxp8MeDlBfKb0NZaZRxjZiEMRJC5mUdWruPqduHSuOInwcGQ8NGTC6TDC1ZhPqYDAf7DMGGv77rvvQtuQ9aPmTDeKsCYsWiMUR1jTlDVFTQ6jhD60PGHkK1Tv0+uo0R6mX6ouSZGocB5qpJtlRJ7fEG1SxFPHHjepqHpYWp1QJTfYosihV4rEBeR868bN6xNOON5vs9tvD5utTnO9ve+5HXbYwZ144glV/6+iSUk1VhzTWQUKmE+Ytho3r7xI6qWW53+ArplKu63WqEpT8NM5TApwtKYwrGHbfffd3ejRo72wRJroTf/+M0rR+tBQBzlXWR1BbWO1SAjPhaKorbUaYf0ZhA6V0sjaVXgizBAJkcJnEWrEOObVjFf3zHkfCioVwdlrFuZIGW1BOSNREaWwh5GKlkPDMIxWCF5jrFVDVJ1KhPOTQaCbRiiPHb2o6j1RC1Jr4pTs0hrSpm03OSk8K0KmbQgYjWGagRwJFeOHikPhsoYOigqJQ/WfcLo4Zyp0bmUMsmxZpHH1XVQSOg4ti5w8UCQqlLAO56G0PpZNka9wuaNRSCIF9NNi2aktoykosE04JthXUbVC/Ucob61tWYlhUSQ59ErQfo5uSzmzxx13rG/2fM8993zYbHVTt/XWW/vtomWs9gbPwITUNuPgmpFl+ykSm+TM5JV2lxSJhLB/UpGMqnKKkKr90kBMtI5UCn677LKLmzBhYqroDQ72Nttss5ACpu4H7IdK6qQ43iC8dlcyDyP+XGH7RR1yRbzb1Unlnq4WIVGKkN6nY16CSmFPxK4Pperbcb9kwRwpoy3IaiRGI05RwzDJYFKkoZoLRWjUhBGdcCSfSI5ShSC8SIVRHz4PZcOTGlRmXc6woDuMpIRpSDJk40aERZjTHjpJoHVVHYFqsfR/uiiHKnShwRneWJRmp/S7WtX7ojctvueGJmcqGhUMjS9tA/WmYZlUlybDivdEnrhBXnHFle7ee+/1zYt7e4e5rq773aWXXua22247d9ppp5bSBZUGquOR14p2MU85WIpIZb2BFVUOPS2SrOXWsRFF25/RWgRNdKyFgxNZewQlrSdGfFJUKqvktWpqkiLN1L3Vg3DbFtmoKnfNUopfNNqrNFv+78orr3RPP/20e/758xNSPUe6HXfcydd4qkF3eC6objVrVFXRExw8RbF1jalHZLZT0LWFKGQo1KTrfrumkXGMc/2Pu85lTSOuN7qO6dzRvXzeh6qynYo5UkZbUM5IlKOim76MfdUN6OJNLY/U0cJC17xGwpJG8tWYV0ZPKJSQxUhNMkbLGanq05IkmRw1FOPk2WVAhdESfkf05eGHH/bGFtGzHXfc0S233HKlWiyWC+NIst6K7GRRLdQ0lTQtzDJfloP9o0J9OS68Dkf0Q4dQ68tvWDeWSY6gIlg4Uffdd7+bPXthWeaf/3yk/49TTjm5NCquCKneqweVHP1qUqk0T0W4FG2rVrK5Eoc9Cfad6nnkaEed43BbxBHWBEadcGB+WeXK4+DcTHKkdHxkQZL3oeqVfq/zv55Reknm59Wzrl5GVdI1i/+K1qoq/ZbjgzqpBx980B177HFu8uThbuDAi11v7wquf//XfCRqu+229+dYWHeoeYSqqpVEVRU9CbdxvSKznYTS3jkWdG/R4FS9ei42mzAFWOh+yLFVlIgP1zGp02r5/vOf/3T04IE5UkZbUK6ORMIDGtWXjHZowOjiDRJ+ADkZeYy4ZEljqdTIgLi0RtVLpdXEJPWGEqrdEkmOjopP5cxefvnl7p57FH2hbmW6u/nmH/n0m9GjLyn9P8ujtJpK0X7Mot6nfl1ZOrEzX0V8NLrMb8MCdR0bUtZT+qiOP930VUdDJAonKkw5kiwzTJw43O23377eGIxG8vRe2zgcNKgklUqj+qExqpTEWkc7yznsSb/BidL+077hOTQaNPgQCsXEzYuojmortG6C31ZriChdNu444z+yGs3hIIr2HftRqbj6r3pF6bU92P8YbHkaVUpn4/gKaxkrXZ+0FO2wXjEkrHXi+n399de5xx57zIvecP0bPPiLXuGRqKWUTRVJ0vmlZylcNiMya/QlvMaF+70o0Zl6wPWfY0kDZmHUtCiRuOhg8LwP9w/Lx4BTJx7/5kgZbYFObo24K9UsrCORUl3aDS/s3RNGWaKqabWQZSQ/NEwVGZMMt9LkZGRIMjaa1ogSHdsiLd0xTMcLiSpnAUaSojK6sSklT9uH34wZM8bde2989GXSJBTWnBs1amSp7qeaEUZFHhRhTLuxyolOqxGJOohSMZTaWrT+SUa1nBsdI3HqjtRE4VCmyTIjlPDzn//c7bfffgvVbvDg/+PSEitJpdKovpqHSiKb+dYy2pklqpT0u6jCJMgglyKhjNWwpjGKjqEwFVbo/KllIISeSZxP0Zo+0v6qqQWSxL7Wm+OsWuGPJJIEdPLoJxV1zuVAVdO0OGuKdtogSFS2HKXGb3zjG31kzXWuxEWSopkBjY7MGgvD9VfHVShI1M71OGE9oBwU1YKyLVjvZkc7o9ex/354PeG5HtexVsD6SBltQZY+B3yGcTZkyBD/HHei8xtdrJX+JLGJelzA4npbhc1O1cMKI06F3TJYWX7Wjc+T0hrL1cRws1Lz2XAEP0zV0Wh52FMqjNZJ9hvjiea6RKJmzYpvisnnjBQ/88wzfv1qURLTb1mftP41Uv7iWc2Ltfwi6qCwLopQhs55OLLPvHSMhZEqpeLJuOOmSFQuTZaZ75XSIccNFBVTRE37RssrJzarkxCO6vOs0d1qi5nDqJKUtXQslOstoto8LUtItEkt+4LzNk2UgRs4EQVtdw04iFoGQtR7TftX+77SZr+6BqkOTw2fdS7n2Y9FAxvRbZynsIWc81B9UymxWY6BKGnXrPDzED6LpqcqHZcoJccEz4r+1bvHmpEP3G+1z+UE69xr53ocrjU6h0K4/mMnFKH5bfQ6tvjii9e1n2DRMUfKaBtk+HJj58TWxbeSgnrJkTMCrZFGnIdq6yvSCB2msKGl0vFCxTkZz6Esd1jHFTWYFE1K+lwoKqeeSbpxad5axn/84x/e0cN45EYWOkBh6kWW6AvfP/DAAzWPjrPMLI/qktIu3jKWFLEoVy+lRqMYV2Ez5XDkOxzlVooD21DOVTj6TWojssxxEK1DspsbE7/V/zEyyXEo413Hd5g+iLGK0yHHI63pNIQiDNoOPDTaWSlhVAk0P0WV0khzbJTeF5IkriLY/qHDo/nkMRAiZ5x9xD5h3zBPam3itnM5oumZ/J5jWNeCPGB9VWcSRn7z7icVbT6tY6AaYYC0axbneTjgo+cwap607orCKv1IEexyA2uVUu78M7ITXrPDzAcdy+26bVnvpPuTmscXhUb2Eywy5kgZbUUW5yELOE+rrbaaf5BbX4+RyjCNJRzNCSNMSkuJijyE/TUwjEKjQX2WWIe4z0OjQyOzzCN0jhRdUASD90RWSNeRcRQ3OsxFPkv0hQibboxZkTElh0/GclYjVOsdp8a38HL2+vXV/4L+T/tAkSP2F/8rWfdoKuAWW2zhenvn+tTGOCTLTB2HHFrWE+NOKZMY7don4TIK/g+VKyKCM2fO9E4Myx+N1EVToELYt9U4BElRJeXRJyFjN4k4IzwaSQyRs4nDI1XLPAdCZHgjnCJHOxwAqWTb6TqlPmKK6PG+0nmlLW8YdeEclxhCnrAu0ZTHaO1SVqIOUHjN4sF5oOulIkw4zlGHNlz3UPFR6Ud5beMsA2PtavA3As5jRRs5HnSeaFu367ZNG2BMSm9uBuF17IPgXph2n2lHrEbKaCvy7m/DfHAOdPEKpcfrNZoT7Sml6FNoqKt2IMzrD5dTxj/PXOCUKsZ/YnCEI7Bh5Cs0iEJCdR69jyOMviQ1xST6svTSm/n3GDpxDYjVZ0s1DDh5oWMHGmHWtpIRmpSiozSksIYuLbVQjRC1j6I3t1D6PMzf1z7QcmLEb7/99m7KlBGJsszbb7+DVzSU+AYPZLvVe6hcBE2pVCBRDG3PsJ5AdV9xVKKAmDWqlNZIkv/hu1deeaXP+unYijPCVbsYt98kIa75CtXYqDdXrcXQefTj0nWKh9aT9YqmItdKWL8j9cK8YV24poQRzjCqXenyhuIN+r32HdcXOVl8p2tbnJiOHixbVGUsbn/Veq3Ps0+b8b/jgX2Amm6oDilBqXbdtmnqteXuBY0kFDDqDc79Wvv3tRrmSBltRZ4qSlwIFIHRxUv1H3mMcIdKg2k9pUIJVP0OB0ojc9xkZIBJWpllxICIGp1yDvhd2FtHF8Ik5yL8/6g4QMiWW27pbrnl1rJNMdX3haLwXXfd1TsRLBfrxDLJEVDqU5xRHUZnZLiVM1xUwCyRjTRHSiIAqrsJFZRCp1NpJ9FeWuH8jz32GP98333DvbDEAiXDaR/KMm/njjnm6JIDzX/IKMwqBx+37NpurIPOAfUqSZK7p99VJXU/6iWUNDJcbvSU33O8a7rooEIUjn1FMrNIiEsIg2gdUvxE6ZZddll3wAEHuNVXX91VQzQtTw5+uJ2zXqc4d/kt57OaYGftTVW0AvkF0ej/9YyLq13KOj8ecQp+bCM5Slzf2P7lHBftL0V049oG6FofCtIoJTDrtd7SnOqDri1hRoCuk610nlQC9/MkcSQ5kM0WnYAw3bz3w3uhzsO0QbR2wxwpo+3IS0WJi5Xk0sNmsbVIKVfaU4qbfSgBK+NckQuQ4R1ndCc5CknrEG2mG6IaLQkgxFEu+jJo0Eg/n7vuutc3pe3X7+fusssu881UTzrpJL9MWjelNmYhNKzT6jJCwz+rFLrmH34WjaBoe4SRqfA3HD8nnniC23fffUq9tQYP3sSn82EYRiN8SelyWYimaEqMQwZotFdJCNu+kpu0oj+kFMaRZfmJJMXJ/cYZ4ZVIiGuQ4Xvfu9Tdd999QSPkB9wNN/zAHXDA/u473/lOxaluYT8u1d5kiYhG0b7AAZPSoeZVj54sckhwQEiHy1OmOEkFrxZjr1yEJ4uDBGxLCfWEgzOh7D/zVHQ5jEBXElEq14KjU0bn84btGN4DdSxIsbUdYbCHwZ+kAS8Gh1QO0Gw++PC8Ca+j7JsipSDWG3OkDKNM/UeoAiYjL++eUkpRk7SragLkVOhmHL2whqkOMlrj5MyjSBAg2mtJ38UhlTFqRLhIhilsmhevjzvuWL9c99473A0ePNrNnz/Ep/tRJ+Rcl5sz53z33nsH9nGwenpGuX//+z/u8MO/WZUTEUaI0uTUZfhjYGdRDJQzh7FPNCNuu8al3mmULgr/jdMYXfa097UiifZQuZLIU9L6qxdIVpgWpyfOgc1i6Og4ZxkVkUkywiuREGeaSy+9zE2Z8kCsFD/HHFxyySWZ1zXvtDzmxb6IGh18hqhFXqPOaoegQnCWM0+Z4rRrmb6vlHKOEoYk0eXw/5TiGjouGjxRw2/tM0XnOSd1/Qqv8Rpdz3qtD/udaXm1vStxsI30GrzwuRbV1yLDsbTiiisudJ/SMVlry4p60PvhflEmhARBirSM9aI93XnDyOkCHt54w4t5niPGXBTVA4ubbpJ6X9LoVDiKnxWJGAipnYWGr1J05EAxDREnLvIYHxLjkLKdnDlen3DC8e6WW37kvv71r7ldd13L7bHHdj5CNXv2CDd37uExsujnurvuusuvt9Ljwr4v5Qj3TZgWmWb4Z5k/25/9klanFPc5v8uzX0+1aHQ9VFJS3UES1TR+jCo+hvL55YgKAyh1TxHhaiXEX3zxRd8IOVmK/1zX09Pja7QqQcsrBTmdM9rflQyyRI0MbTvOJRyfvAibfLLc9ZApVuqoDL1ahR3Yp6EYh/rGhY5SKBwTRivC9VJtZCg6AcyPwRHmpWtheB2Rc5b1Wh8eF3qfVVXUKC+DHoV9gyPdroITrDeRqbCOOmz0Xm3LirwZ8KEKqNKcw8bq7SwIEmKOlGEkoNSXevWUClWeNG/+hxt+nHpfktEfdbCypKxF10FqZ1y4MWhxqqSOheoZo2Nx6oWsA4XgcVEgRV+OPvpof7Ht6lqyrCw6aW+hA1dJdEYOGKQZLVL5S9umIRhyRAhaDTkkOn6ijnOeSJo6VKDkfdYamWqM8HIS4g8++GAGKf4l3dixYyteXxnJSuOSwR/WU2YlTAsVSmPLOz1K1EumOEzHU6sGrmOkIlW6PqHKJmiQJnSyQ6dd66d9EcJxGEat9VA6phQB9ZnSAHVcZV32sAWHGqUrDbSaAQrjfymw4aBQKIPfzg4qx2VSqr0GFJrN4MGDS6qyIcqiaef9Iyy1zzASkHNBZIjRH6nlcUNkFJuLXC0KfjI6QkNARlmcel+0XidLCpzqR0LxBpY7rm9KWORN4bUU8hi1xZHAGOER1laotqAcWWXR+S+WMS09L4mw0D3NQNSFvZzYRCujddNxE+21I4MvbjvjgHF842BI4fFrX/uaFwbJkp6n/RfWmWQ5RypVPStXq7SgEfKwsscc61gLUQNCEsDVXBeqFRcph+qEhBzAvGuxwnS8UFGTY6PS9DZFksLrnK6RzJvzPOwXpmmS0vsQWYmDa5ui7RwLanug+fE9x2VW0YksNVlGZbB/NOAYpq4rpTfPer8iwTpJICmp116z13uxxRbzA68aRNJgR1gr2O6YI2V0PDLW4k54pUFxE9SNMQxj16LgF8r76gYRiiZE1fviap/CkVguZjIiMCa5oSsVL6ScHDROT6gmqOXRRTGsrch6kcwmiz7dfexjX46tA8tiXMqIknhHktESGnvtCvtUNRpR51cwyssxEE13uvLKq9z48eN8tGb+fARBprkxY8b46GKSOIPSmjh2MGwk1y+DMosBXakaXrlaJZTkyh1zzi1ohFwN2r7R9FqWvRIDh3NQ9ZjhvsjTyWFbaQBBaae1ikHEIedWAzeh8EQ1su4cu5zHYdPncEBI7SGi1wemD1XD5JwnQe+1VVddtRRJC68NcoKyLntYk6XjI4ykNdvwbUVCYZZoH0X2fzvXoFGfK1XdENYdB6va61eezP/wHOdcCQc36jFYU0Qstc/oaJRex42PmxyjkVwQwjQMpZHoBh6mS9USulYzOwxOKeHp4iP1PtWOYFCQYqcwOg8uoNQo8b1qABh1vfPOO90NN9zg7rjjDr9ujLLOmDHDP7Os5ZpG6qLN/KIRsGhtRdaLJLLo5ZrSOjfX7bzzziWjQ5G6akboMXySGswq5aYeI/9FQA19MSJJyYyLPgLHEs666pJ4XHfd9W78+Elu1qyRbvr0x92MGQ+66dP/7GbNGuF6eu50Z599duL/8h+aD/NV89Ss9SGVNqkNa1I4TjR6q/PpK1/5inPu3bLHHNG2Wovgw3MkTjmunKEkWXdJ6fNefbHygG3D9UOGDdeMehieaqgbNvJWVLyaVEKle4aDOaA2D6pjjRLWPwldz+LQdKFDGzq2zC/rPlUkje2gfckgV7lIuZG9OS+ojrbda9DSBjuKcjx9JKiR1bnJg+O/CDLt9cYiUkbHRZ3CKEzoJIWjkDgdGDKKuoTGUihxXYmqU1o6VHiTx8gJUwajTSPD6JmiR8znqquudvfcc08g8zzdG8Y777yTO+WUU/qoW3GjL5c+JUMoakzwrCiBVMfKCSuUb0o7yhu0TKd0regIfSUoMhe3XiwzkZgiUy4KF03vDD/HuJCCXdjANBp9VOqqlNaQ2504caJXuAt7gEmcAXp6hrtjjz02Mc2vlh5L1ajhpUmI0yeNKFpPz8jEY47v01IW02B5iWRoP4SKb5VEO8PrQF7S4XGo9xyONYZ9PZBzS02U+qBxLqvGUKPVlcyP/S/DDLSNGI0fMmRIKVsgSjQqxfZMqilRLZSc+XB/hpGwrGDcqwmwSaHnQ9h7jX3Syr3XKkEDVNG+iUUaCFzqw2sYhOUJ7J9alDtbBXOkjLYnrrGj0tM06q2RU1BkSIabRj1D5wn0vtrQdSgZHBq6EJd6F64HyMHjInvFFVe6KVPuj5V5njx5lOvffxF35pln+PmGanVxReeSQo9TqgsNEaVTYJQlNQ8U/Cey6ElNaXfYYQd3zDHHJKbqVENSgbeM71prY+qFIixKWwkjczrmwubMbH+iiKEhzjQYmBi0EuEIj/uok87nU6ZMKSvOgJw9tVMnnnhi7j2Wqm1SmyYhfsYZZ5QcwKgUP477eeedl3m/xC0vBnPYTDiUzq72OqDfJqXe1ntwqVbUYgDHPFo/yT5BjZDoWFbYxnLKwn5+GgSS0xIHUSkNSvGcds4v6O22YJpwICeMjldqWOpc0P2l3dPQ6k04cBLWUrZ7CpkGk8JjUBkiRWCxSPsDDdqqLpBBj2pLIFoBc6SMtietiF0jkGG6HvBaN2duilwIlPcvlE5Uy8ixBB6yOH3heqhRMMuJ4UnD0bRIwvjxw93BBx/kb0JykJJGSlUTltZQT5E4lknpiWlRKeVOJzWlxfCSUluesuFq3hq9gLOOGHRFqJOSEiQOEftCI+9KjVDahFTEVE+n1CEeShviWGDbsm7UCG299dZuzTXXTI0+6rjCyK1VnKHWHkvVGEqaXzRizG8wpOkTRRTt9ttv9yIa3d2b+rQ/IlZsJ6kNVgNRazm74UBLVrXCcB2igyVJzm8e1Pt/JE0eB1G8ShypMIIciu9w3HPMp0nsh/VqGtlPWi6OOa4LnDccN7pOalCnkr44YWRO/dF0fFbS5NdIv8bISZXKa7vC+aJsEF1jOJYrOY/qzWIfnmMc89hLOk+VyRJGh9sNc6SMtidMN4pGYWguywkeLfZWXn+Seh8X7lpV+yp1+sL1CCNoDz30UNlIAhGgSZMm+VQmlr3cSCnr+/LLLyeq58kJw/hQH4msxDWlBda1GrW+NJhf3AVcBjvf1ZOkFIwwcqTjDsNA0ShJO3OzVNpRmGYJbH+NxvNbopI41AtSO4n2TXe33HKr22233dwpp5xc2r7RNDsdV9yUiRDWIs5QbVQpzlCSaEiWVDcZGBBGjDnOmQ/LtPvuu/v/lyx3WONY7Tmch1phLcqF1dKI/0lyWCo9x3Wu4tyoLkYOkXpNpRFGpTlfkmpplAoYN5CkVGHqLrOOrDONrtehMxZdJqMy2K4MYHAv1jWUZ+qD65ESWwRYJw38cA3TAJtKE4qkWjg3EMYIz02W1Rwpw2hRlG4UjhhrhFtpKIyihCpL0QuypqtE/S5vpy9Mm1JzSuDimkVaXKO6qsfi90pdDHs+REdv4xyBUGY4D+eH7f+/KNXgUpQqD5Iu4DgEOBWVRKXUvyS6znHbSNtZxfdyhNRzQ0a35qcon+YliXI1I41zzJgPxuFFF12cmNo5YcIoP/+TTjoxNs1OxxVRmuuvv8H/JoxsVirOEEaVlNuvNL8skZpomoiMpbRc+1D5LipQot/p/Nb32u+11FbkoVaYpCipY6ZS8YpK/ictxbdW0uo4KnUyuSaE0fNQdZDrWpKUvxxEwWABjm9c2wO1epCgj9KVVXeoAY1KnE3tP/V00/lXhEh4K8M+0H063K7cC9vRkQLVJCuazDW1nlHraukNrq0hOnfacf9YRMpoe8qNcPOs0R3ltXPDTbooMR8ZTrqY53UxC52+aOody8kNPSqFmk1anEjCZj59TM6RRuYVOYirlSrXI0o3sGrht1dffU1sJAVximOPPSZVbSsLSb2i1P+ikg7xOAJsb4w3to0UxcLoURgtVNRDRefAdg9TM6N1d0IOVHhTihqmTIMTeu+996amdt5zz3C3zz57u2HDhi2UZqfzg2OeWrX77htRsziD0mHDUX3VbWUxosPaLTlAEtCIO8dYdu3HMD1XDpa2e+iQxjUqroZQrbDWCE+jehClDS7lhWrX4qg0zSd0rpVmzYNjX6mtSQM6oQHHg3OA+q3wvAq3gdKVw2ix5q0oZ1bkuIfzCxuHG7U1mA73m6L67d6rS70bw3sD26MoqXP9UwRl2tXRtbPZaHt0E2aUXKPlUWOM10QoeMjRikOjQWoOKEdCI++1SrBKPpibtRp7hilqSpNSfUxWaXEEHbbZZpuSYyalK+bPf2HwcBMKu6XjMNQbnChFUmbM+IubMeNhN2PG42727BH+c76vlTThClJEKjFq2E7sf1JCOVZCyeowEiIHS4ZYaMDLiSonqJFl9JppsohE8P2jjz7aRx5cDkYoI37CCce7HXfc3g0aNNwNGbKBGzJkKzdkyGdcd/dwt//+e/s+UpWoralpqmoYNAhRafqZosdJ5xjnzYK+UQsiK6wjTrJSdOstzxtVK2Q9lUaZpBQXh5ZFgxMa8Agjcnmg6wzLpjQ2/lMpiXnAMZVENeuiSLmi4CwrThXnZJpzwjbEgBNyqKLTxEUFo+epovBZtxHnW5jeqteV1tAZ8a0HwrpR4H1cq4R2gmNeg2zh/YXBvSKs9yIZ2gy0G+ZIGR2BHCXkcpP66lRi3Mlg0w1Xo+a1psbIqA3rs9STRw4Q3/GZDCxJi3d3j3ADBtzkI1NAJIH33d0j/feSwk6KIGm0Vf2X6j2qx/8QiZo1a7iPpCiapkjKrFnn+e8Zda6FtGJ0GZSQ1rAzhH1AwTzbSil50bS86LO2OfsxNPqSomWVsCC1s7xIBNPJcVZ9idAAA88nn3ySu/XWW9xBB+3hdtllTXfIIXu5Bx54wIs2pG3LKEpp0mvd8LM6F5Wmn3FeK71WEUBFnhV1VvQCeM8Ibh7HeaU9sMo5oDK8w2tMnul9us5wHVGEWimJeRmiWpc4qu2/xzEsB1gPDTSkOSfR9WHaOMcrrEOMux4oCpJ12XXcKWKtKGk7jso3EiLQijCHA01s41p6O7YCSdc/jlvO3Waz+OKLJ95L27Xfl6X2GUYFhPLESulS+haf5zHSqNoYjJDQ2JVBFfY50U2fFLgkafHttluQIpcFOVONUJV65JFHMolkUDsVJ06RFdYJpbm4GrawRq4S41HCEOGIYDTCFDpTGj2tps8Q+z2s2YBw32cRieD7gQM3KTl+GCHRbcH2IVrENBjZ2uaqEWEbKf0rSz2g0mVl+IbHbJbjq9L0s7TaKpY3rtVAXsd4rWqFIVxDFNEKDXscnjxrDJSSGArYKGKa1/lPxFcR2LiBFEUaK03pgvCcY9vwX2z/uP+Kin+wDVW4HzfiTzSTacP6RNC2yjpg1ixp+3ZH4guI2kT7i9WjprBVqCRNvV4s9WFKb1xLFM5N7iOVnvdFxyJShlHFyLNG2mWY6gJeSdpHlv/BAOCCpPoQGWhKwxMsD9Lit9zyo1Ik4aCD9vTv+bySOiPJlVYSpakGjPYsIhm1KOtpRJ/tlzTSzoWfup9Km4WGaT/l0vSU8iWhkGr+JxxBD+V+t9hii0ypnV/96lf79DqKytsrgiBjMeydgxFIIT7bL21bhoQGf9irTQIalaSfKQ21nCqXar6UFilJfY3U5hGVTvpfpUcqnVCS9OH5lAWWXylLUWERRYvzQtFJye4rZS4vQ5QoeNJ5pXTlalK6lPIaRjrLpfeF/8X+Sho5V+QfQtlyUL1aufM9LhuCdGCOB6VsZz2PjOTzBIeX/aNU99CZalfSrltFWO/FFlvMO7nRAa9QWKndolIWkTKMGDjZiWJER69D4YposbJkxPMYzVWxvvoxCG7iaT1akqTFK0U3+7DhaN5kFcmg11S1yIgLa9ji9o2kimWQZbkhZRXZkPQ3x4giJZUg4YLwOAjlvpXaOWVKkkjESB+VlGy51k99c8Ltwf4OZYVDZ1FpSVmFFMrJVtdDva8Sae+8G9KG6xuNJun/KpHNDtF65HV9aZSqHMtJ7Vpc7zH+q9JrC9FXfhNdvtCZSlLkUxRIvXc41pPEMNhXGOnRfah5cY5Umv7cKGn7TqITxTw4ftMckSIo4y222GJ+OZGkj9YYQrtFDNv3aDOMMnAT4wY/Y8YM/xyODJL2oVqOcOQwWsMUjoaFSnu1ImMq7iaelCqTJ+qpktYzqFayimTQVLaSyFg4rfaHRpjT9o2crjxH9TRPpX0qYqHIT1bCGos4SN3cbrttIyIRG/j3fM73oXBBmGIXEt6Ak1IVK5HKxlHDIFUELZStzkJahClpJD8UC2C/K+oS3rxD0Zg8owNJ0SQNzGQlup/DyGeeRkhoiIZRwzwN0QUDJvHHbaXXsTAKIcJjOU08hmmI6OmYZ15p1xWpmeYVTWuE5Hyn0YliHhy3aY14845aV8tSH55fccJKRYic5UnLOlLclI4++mj3mc98xvc1efbZZ5u9SEYLkWRIhX1KktTCVMMko1gpMXrmBjt9+vSaL2ZJBlO9najoyFYlAgOVUF4kY5Tbd9993ac+9amKZJmjkRvtF/XdyEvBLwuhgcpDIiHRIulKe3NE3+Nk0SeqXGpnuRS7MOUpfEDY8DarVHYWxcysI/kSFmDbERVOMmTVpFWiD0qpDNNuK1EErIS4aJK2WSUKfhwnSUa+mgznbYiGRr7qPvNA4h9xSOGwEjhPo+mCoTJmksCFpmOUXMvF8ZgEx0O4H8JUV15XGk0L07WllKjaWqM6QjEP3bd1vhfBmagXpCczoBCHpNCbzWIx95JQQKedaMnUPi6Gxx57rH/9s5/9zP31r3/1TtWkSZP8hc8wqk2z4OYWZ0BGRw5lRCalkXAhY37kClebtlFO9rreaN2UFlcOpW9J1bDcMjL9cccdmyiSsdtuu7sRI873Rl4etWflUnIYOed/8izYjaZlho1WKyHsTZX2X+VSO7Ok2GGohvsw7KMjNbpKo0q1pC7pvNP2kzBCXGpiKJoRNtgOJcQlIlCv6EAY8QvPA/UoyrItWC/WL+6847zMKx0sTFVWSp9SUBnZZrAjj//RNo8e95KrrsS5ZpnlDIXOps5viU4kIUdUtUvljM5on7fw3lAJYW81nVfMpxN6H9WLsCE2KbW6TnLucL3I6/gtIgMHDuwjxhMKxtQrHb9SllxyyT6tHHTetFvEsCUdqT//+c/u8ccfd/fcc49bbbXV/GPy5MnuwQcfdLvuumuzF89oAZIMKUkBh6lEStMJT36pPqXBhbwWg4eR1WZeEBXFUGPeNMcIw3rllVf225VonGp4or+JGpYYuERM9t13H6/Oxw2RmqitttrK3wSJPLMd8hpdVB+juMaF7Cf+86WXXqqpyXAcMuglkZ7F0YxSSzoE+4f1Ux1JWoqdjGuMeNV34XCxH3iNEfvQQw+VUj/JCMjSpLda+G9qWVT/IIMB4s4viWZEjd9QzStUBFSEQJHLWmsMOF/0P9F9nDUtT82iMQijsJwY5Hmk3coQ5ZyVIl4ot55Xk08pEeqaKiTEUcl1UlFEXRPCbazeUmHz5SihQ61H0vWF40F1b9FaD34zdepUn2aV5XhRJkMoHqP5FKWZaiui4ya8b2vfMRjAfakd0YBCHk5+vVgq5l5SySBcq9CSjtTTTz/tQ5urr7566TNS/J544omqHSkOwrRRLKP94IIbjh5rBFtGWjhyCNxMK8m/Zj4YgEkh+CwjTvVypMIRrCQkuc36yplJmx6jQrU8YapNSJLzEBdJUT1INRGcJJgn+4Rtm2YIxxmwtaDlr3ckMayr040LVMfHZ3yv/mRKk4uC8cixF0ZoeH3ppZf6LADnlvwwejjdjRkzxu29995u+PDhZdNA2Zdq/srysAzlfqPvw22o9BBJjkdR6ldUOIH/R3RAqWwsSxj1YR2RVF5uueWqHjVVOkvcvsZhy3qfURQtbj5S8qwk7VZOXJwzp3NVx4zSN8udK1lRDUucw6J06Equk4pwRbdNmP6ZRPS4wRHC4I6DbYWjGT0Xwggj3zFNluMlVF7VsrOseW3nopB2rNUDtVmIglNNxLPdDHfB9VOCVKEDxflRFHt20If3EpVLpN13ina8RbdrEl29jSq4yJFrr73W/e53v3O33HJL6bMf//jH7rHHHnPXXHNNxfN78sknreCzAwklwUNnKkyBClN0QDnu+n2WdKssaXFpy5hXPnGYTpJFpCEalQllscuNfIWXlVpHyPKcV9Z9guFXyX9lveDmQdJ/hf3FRJwhXkm0LTxHrrzyKjdlygNu9uzhvvdXqAw4aNBIt+22W5ftVxYnw59leXQ+RkmrNUs6d8L9r/0cCmlER7arIem/486rao/DPNX1JGQSJ3JRy/WrkvWpNK0yXOZwVB6idX0hGuQJtx3HVpJMO8tV7jqcdb8mbWf9j1Edafsn72O4aERFiGq9dhl9Ifq93nrrubaLSHHg/P/2zgTarrK8+29AUQiFIEPbDGBFbB1qxRkrIMOyBAEBBRUUECcqQYKIzI0Eg0tAi4Lt11ZXATGiYjAJmKgMRVusddYqIiAiIVWkmgCJn6Dcb/02/u/3ZLPns8+d8v+tdda999xz9vjuvZ//+0z5MIB8w8ouN/jo4TJTH2YvCB2LPUgUX80sCrOnscw08LClnO/222+fzWzXeS74LrPb9BDpwi9/+cvSBPiY/F+FSlaz7XnjSwaqDAEti1kjZojzHgPCGRVmVbXeOmO+DXljaVBYFuEeVTPIhPe1WR/HqOvDq60IixUiBeeQ8xXzXNTjjHujZsCVQM8YrgMPLDOJfPdnP/tZWrlyZVq7dmFat+7YsO1bpHXr3pT9/qUvLUinnXZqmjNnTuXyonhpuj2qeqeKlTo3jG2uxaJziWepyDhl3YRwss677757gxh+/V9jpGuhlbJiMxxLvK9NZ8i53jhuRXDcZs+e3ep+99Of/rRw7Jfdy9heQgibjJcm/OQnPyn9n85JlxYV8q7rHDLmFUZYFF6s86DjwDEuC9VW1cgqY5xrcpdddqnd5qpnBvkkbNOwivuMJVVjbRhUHVeecVPZtuvi5Z9q2zus8Xb77bc3+tykFFIk4uZLyeLebFPZKw83164hWGZygvDmQuahy8WtUBHeUw5FEdwEeOAhkBh3dQ1WCefpOrYUglQ088wNQ1Xpyox4Ga18hjLv5BFiMHANUVacENmisDMVd+CYxIRdhcA0baqaX24XYpWffFnprvDQRdz20UtIhlnTbdP5VBiehE9+VjG/Dn1X51SVIlX2V3k+PJgU4iRDks8r349xLWFfte/q/8R6vvSlL6Vp06Znnqgi6F21zTYXpBUrVqT58+cXfoblsV3xoan9bHJ9KMxTkxsa14xncrTy562qwTLfY51c+0UTFQorrarqVgXHsij0TEYf624iptgHJi6Krn/OJ/9vO165b+SPN8uRcaOxpnEFfT0b63q0tV0P5w/Rmp9E5dirB1nZ+dU9QPtaJqRYFueqSkjJy1V3TuNxjmgsKydrqlA01oYBx7VqUrPLdTKZmCxj5oEHHsjyunTvUr5u20quYzXemk5wTsoahM95znPSbbfdtkEzPcLzMPiMaYqEgKo4aUaTi7sq1pbPKFm5SVx7ndCqAgNX+S3R2NZMPNugKmwiete0fx/4wAfT61//hnTZZVelZctuTZdf/tl01FFHZ+/LQC3aT4RiUVWrupCiPsubygPBcWC/qwzkpijBvayXUJsZMh3rKHaqwiflUdcrineJMuWlqTQ3P+M51pjQ+mI1QAw1DEuFL/G+SoFLXCGIeVX1UWKdWuajyfazCxsnA++TM1XVK0nln2V0sk2IP9bRpJiIxGe+DHVZ2fImJcTL+rEMWvmKiYqyccp+1BWqEUUluuM4G7Rce1wP3iCVQtd9hTHT9Pw0Aa9LGV0mSHT95GF8aSKgDPWW03KqjCaux7p72s9//vPa46TjXBRCKfFu2sNxZWKzjIlQDnxj57e//W12jcju0gQwf/d1HxsvJqWQwoX+lKc8JUt85qH0gx/8IH3xi1/MKn0Z0xT1m5EnIYbK8X6+H4n+jwGrm0ETo74oL6Qp8hJILMnQVtUqDDZeCDo1P5WnQ/vxaG7LF7OwrNWrv5NWr74hrV797bR27TnZ+5dcUp1XiEEiA0HtBerC2GT09iF6ZHjniw4MCsZsWS+hNonf0SiKuXVFuRB6j5lwDGSNDYkmXhib/K2QPI0BiRDGnsq4K+QoegfVA0gGpkKc4nFDaGG0VfVRig0VHzX+Vo32+nrsMcAjsKqykpx6ksUeOsC2N2mGy3ZKHMZXmQHK9VB27amEuPrQxPOj8zcIMpjLaJMPwzGN+xHvVX0a3hwvCQaNKQlzQjv7MHaYeS67J7D8LoJNxzJ/zlQuvwwVixBV/ae4B9ZVSWzahyyK7HifyIfrmnYgpIq8ERzX+AzbGMTKHXfckb2aiPux4oEHHhj1ROmlMT/Z8wMnpZCC973vfVkJ3pe85CVZxaiDDjoo7bHHHuO9WWYSoTCMsmIGMmwjugHo/Sb9fapmYZuWJ5ZIitWvyJ/iRslnMMxlZEoY8iKcj3CrNWsWZLkt8igot2XNmr/L/s9yymB5MnS1HXVwTPhclTHbFgwjzZgPinoGlfUSYrvbNgFGGOHh0HmS1yh6TySGEUJxNp0HjMrE6hxyvPlbeWl5ERET7Itm5ZUXF/dP4lrrkOEW9z3vDeH9vfbaK42MrMsKSxTx6PvrslLodWNZ508VnDDemxihEnaizgBVCfEiVEIcEM0SwPLu6boexAhhDJXdG9pMMEiUxaRynUf2oU+vlM5PLKWscdGHUcY6yu6H7A/3mbaU5YrWVe+DuE9VHg2JyjqPWhNhq/L8+SInGn+mO1zLeZEKjIOp7pViHBNlwPOC31VWn/cmgph66A/P2/zzinMzSFrORGDSXrXPeMYz0he+8IX0/ve/P33yk59M55133nhvkplkREMRYsgQYOApP0j5AgovkwhT6F3ZDDb/x6AadDtZn8K05EVjnTJwuGEqPC/epG688cba3Bb+Tw+nMhTipXBGjkmdOOKY8Lm2gqQM5RDkz9EgxFAzkEEuD00893X5NhwfXnFWHyMew0shexLBrAPRRBicPHtKllcpZJVbrqpKV0cUUtq3/ENMeVVlYXaaPScncO7cuWnGjHPS9OkfG/VM4Yni7xkzzs3K19f1k1IvHR0TPfChblayiwGqUuRV4X1xckCTECwvTiD0LRpYR5vlSpTlxYJyH/sylHR+NG50bJXL0Idoq0oGZ+y33ZeqvKS6ZUUBn/dO5lHD1zLaeJQYFxrPyoON3mTTDRUG0fkAXf8TpUntsGAccw/XdauiRMoDHm8222yz0XtJnBBkOyd7efpJK6SAh9+ee+6Znv3sZ4/3pphJiowoGcp6EEos8cI4JB+Jhx8zwzExUmFXRWJKBh9CZ5AbGTdCDDqMbz2so1dCMcZFidwILHJX6nJbymbrWCb7F70VdWFLoNjnKq9AGzRDXmRMtkWeIbxHnDcV1VBulG7qOvcyYpU7kveKRANIxRt0LniwqeiAwqUUGx57GOUbHquIyKD7WteDi+2pCrOTsQeUNt9vv5enrbdekGbOfE6aOXPv7OeMGQvSEUccnhYtWtRom+Tp0bHQsW8ikKMBqrwxTSioql+Ec1gmgjVLLdGssFj124JBjRDlw+W3gfPdZqa4LBco9mHqC00w5ENTlTM1KHVGU1WeXRGE3OWPr4zJuutH909RFdKrSY2y8dTGoyTRJs+ilo24nygehMmIQpX1rND1PFatKcaTGOIa8yjzY3y8+KM/2Eo6L5qw4rnaNax3ojApq/YZ0xcyojBEMCh5mBEuw8NZYklFAcq+r+pQPAQlIFR6WuE3/G/WrFmdZl5YNsuT0S/yjUbz7wEigKapeBCKxBQeBXJfttnmxaOV54TC3tTwL87WslxCCMqMdJZDg16FcfVRvpxlaja7601XBpaOJfsho76och2/8yCWQZxfb9wnzgHHinUoxKeoEl88ZrF6X58l3ou2r4kBIpEj7yNwzClGwTGYP//E9NrXvibzYHLNbLvtS9Jb3/rWWk9UHu1r/NkEzo9CIGNJar6Px4D/xYkOif4y41zhfXrAx3OgZQ+Sh6Tqn/lri3Vwv+EY4u1rQlVeYp+z7RxjtkvhbHFmvw9vMMeaMVV2XBlr8f7bZHlcx1RDjGNJoifmtOaRMSdYDvteFRKoSbP8+dAkF9dP3bbruUHFQU20yOvHuWS88rww7WGyRfeHGMmg/N6pip7PijpQlENMRRhPnpCzlVTsRRU08/fuycSk9kgZ0wdcuBgzO++8c/bw4uZTlofDTQCBQNVIfsrg5MFPjH00mGIZYZVp7oI8HJppi8Q8hiLDuUluy8jI+rTvvvuOLov1MOMf82hYLmE3mp2X4VmHQt76EAhsG0YeRlg+90c/mzRIlrHMzRujiWVSBr7MeIseprKS1iIWgcjnIUEsbFI0sx2rLfZFnUipC7PLi3+uFcL4jj/++EbhfHli+KTKEssL0vRhjFEURZSqERZVgKrKVZI3TNslYZsPQemKCmwUGfJKgu/jPPYpwHU/ZLtjOKgmhfqYOa7KR8oXgWgC51j3bG2vitQwVppeUxJlZY2cWV5Vs2WMwaYeJXkZo/DTergvTYRwrMmIwqt1f1UV1EFD7Cc63Gt4bmucqvWFrt2J4PF5wh9sJU2IakJiIoUgdsFCypiGcJEzg4gxIe8Df+vil+coGjW6ifGTh2yXm5mMTOXdbHAB/yFJHiOCm2gMUwS8bdW5LQuz/2OcxlnYohnZfNnmpgZmX2EV3HyVLxZzX+KMubwqVcT+O02KHKi6o0qKN6EunCQaZfn3+67cVWdkqzR6WZhdlUcW2o5pzY7G8u9tymzLSyjhLGGscMi8aGlaQrwofn9QYSvhV0YbA6eqqlzfJYRllOVhFrlt6F3Z8qvC6OQpbIoKl8RJFY0PNasuI4a2QlVBHc6XQnyLxgXjj/tEm1DLsuu9z9y3jTHKhAJMjDF+xl6IU32/CVnXPVahc4zxQfI9++Y3f4jeUV9A5X5P1vL/FlLGBLiguflgLORzLhARMn71ip4meS5kHOcNWP7ucjPTrLY8HbEMumbiMXBYNzPJ+QdGWW4Lf/P+CSfMG90+hUuV9ZWKN7qms+B9CCmWIWNYDwwVCsnnKdUJEbZbjTrVY6lJAnNdyXehcdCEWJa8rPreWBATtIvOV5kRr9nzLuOZ4x6NWM5F0+uDYxwLdMSZ16Jj36SEOOJcBWVicZmq4ghNqDPgmh4/8jTLxhXHoe/cmnyTWxH7Nw6rFHqXSSfOJ+NU51HLZozxftnkRj5fTfeXMq8UIi8uv+hcVDWHjVSFmzUtp27KPR9VkQZTEXmTCWfWpCNjv+mk4VjxyCOPZJPQn/jEJ9Ill1yS/eTvyVr+3zlSxvwBHqSIIhVW4MYT43ZlvOVnPTUDrnwIHthFQiTezNrc2GNsMevCUOBhHhtKysApmuUtym0hJ4q+a8rPiCFvVcZ8vNGVhSwVEUtV14kFfTaui7/JgVAxiHxDWwngpmJHHoxYva0qD06Crek+tCkUMRFKHissqqxXl8ZczJkBfueawSBsmv+n8UwRFs3w63xrNr8ub0iJ+vkKXfG85teJcUEonf4v4cV1wz7E/CtNUsTiI4PAcoruCYDRjRek7p7AdsyZMyetWrWqcB+5FtvkXNVRNn5jD64+cqWKvE8c+7b7kr//6hrk2pa3Ol/UBRQtENensNMiwy7mv5ahtgVlDZ8F573KwzdZZ+jNxPD4yKuuypAToejEww8/nN7//vPT0qVLs4rBNHonT/tf//XS9MpXvjJ96EMX9dLiZCyxkDIm1zAu5jUxm4nBxwOWB7FyZKJBLTe6DDFe+cIBMpa73szy4VU/+clPRn+PHhke3mUPeOW2VFFX8CDOwiLamoT5KOEV41khSGXV5IrC9SRiVOpd+TXy/GhZeSO/KcrJqDJk83kMdTQVdBMF9gujVhMIGKNRXKoAQZGXgO/G89KEWAY9lvPXbH6dsGB7ENZ5QaHiKEXCmGVynvMil98Jo2L2Ok5YFBUf6QreJNbRdfwJtodllfV949j1JaTYnjKvVNvzXVUYgHts0XXbNrwv3n9jWwGJKe5Xea96PAeI7HjsuGeViV8Vlam633BvrBNSdYU36iZ5TDO4vng26rrmvEz2kttlMF6YMFAIuxqy86ycCPt85plnpmXLrk1r1y7M2rJQBItUA/K1ly07N7sePvCBC9NkYvynQo2ZIMjjBGqGqtlKQo5USlk3Jt2o9LCMDS1VLSoa4DwUVcK8j20VMbl6kBnMfLnjImKIF4YphlAsF11VQh2vhZLCywQJ+xCXlU+c5bzceeedmSEnD1RMqu2Czk0VbPt4hd2NBfKUloXZKWSkzHvWpceQ+pMV5SLVLSv2gIuljjVeisLlVDa97DxKnAwjJIh7RFmBhdgcuAlVxlDTPLMmINiK6LOnVL7JciQWP2mC7r/5SpkaE2WiULBP99577+jfVc13Oc75vLui5TVBRYrKljHVG8mOd27zVIP94hpgLH/84x9PF198cbrsssuy8NXxFlJ33XVXWrx4cVqz5u/SunXHjlYSHhnZIq1b96a0Zs3Z6corr0y33357mkxYSBmTCxfSzLiMNIXl8B5V/XjA8h4/8yXNZeCph0lRGEmsftcFjIuyogdFBQyaEo3Ssv/HGVblEmBw6pjkvysBFfOSFJJYJtwkjMrg/3gjJEoHFTjyglRVVZzqFZ+iiNU5zFdRKitAoO+29bTKiI7Gbl256oiaBceGw7EiY5ERXpXv1KVaXBswmMuOX77gQRV1FTP7MrzLCkLoHtlHmFBRIZC4HsR82+WViZKq+6aIHva6a577XhVNxxPHefbs2YUVWYc9JjcG6nKbpxo8Fy+88APp9a9/Q7rssqvS0qW3pssv/2x63euOSKecckprT2+fXH311WnatC0zT1QR69cfkYX7ffrTn06TCQspY8IDLYoQiSlVgsNw4DM77bRT2mWXXbKfRTM8Kk5QJXZ++ctfdj7udQ9W9Y1oKqhio1sVy+AVhRE/EUusOxbhUFKvvEx5TxOf00ygqsNpnYOIIBnufZYLZ8au7Ng2Lfc+0anzOMaCI0VVlMpi13WttCFOOug6k9Bo0vckGuESgVqWhHueuhnZ8cohaFu0o6qCX5+GUmy5kM8R7Ks3DfePsnHZZdKpyjted7+J968qUSbxWxe617QAiCYpdIzj8ejTy7gxUpfbPNW48MIL0zXXrMhC51av/k5avfr6tHr1t9PateekJUuWpXe/+93jNp7uu+++9Mgjswt7WgLvj4zMGsg+Gg8mv2VgTE/w4OTBqBlXVexSSeS84cDNiBsDuQ95cRGryVXFvneBB0CZQSvxw0M5bj8UbY/2k7AtQnko+6sQKF484DF0eF8PdGb789XV1My4CCVm8z3yEOo8Tk2RB6Iv2KaqG3iV8TpZqDvudT2U4njK07Q0fFnPl5jvxvWRr5pZ9n19V0a+kquLDKW6Uu7541N2jXelarw2rfRWFXbXJSSuCt33JE7jxEtfYUJ156Qst6yMqgmkJvedKNyqStcTClrlpW1bll4V/GKodr5Ev2lPUWGaPicCJhKEzi1ZsqQydG7p0mXplltuGZft22677dImm6wabcOSh1wpCk9U3d8mIhZSxgQwwDD0NTuIcYhRkq/exXuICTVOxAD/2c9+tsEDr+qhXTZj3gQZNkWhILyPYYoBwGy9Zvkl7qIHRyXUlaCvCngSOvrJMSAcT81lVRUrv/1NjJQ+y5uyvtg7pg+qDNDJdnPvgio9lfVQUp5gnljkoQ3Ka2GsMq40hiS868qhx1yppl6tqmIMcR/4iUeBMFI8I/wctMR4X+WuVUK+CI5hX6XQda9hu1VWnPPEMe+zAEJdPlKbfYk95vJwD6vznCKQtD4m1sp6SnGNcN+nGmQVTfNWY6iq7uWKDJiq3pOxgHOYz20GFdSZSjQNnVu+fHkaDw455JA0MvJgVliiCN4fGVmfDj/88DSZsJAypuTmK+NORSNiMr5+l9EZq8rlG5oWXngDlCLFiMLAUdloIeGnB4VCDDVLrzyS2LcoJv0TM648AoSTwvIwaFkm24tRwL7zM4YQVRmIefoSPhJSfXqKJJzbGq9ThejRKeqhlC/yEKssqkDFIN3uNRGginBNxIUaqMozpZLqZR4T3i8z3FmfQuz4yTiXp42f/D1IDhLbWjX+2+RtlOUWsXyu376KQWhyKeZQcpz68NA1zUdqc8zVsLtqfFeR9yJVNQ4mH6Uu7Lfp5JFK9Es8qaIfTEXvyVjBeCCXmWMZn3lcIxOpSe1Yhs4RGTIe7LTTTlnl4BkzFqbp0z826pnCE8XfM2acm5VA5zqYTOfFQsqYAmSIyTOTnyHnYZufuY/VrIoKLxTlMXVBs/iIPR7yiAlVzuOnuphjfGDwaOa46IHO9irRXSZibAkAAE1WSURBVGWfecn7VBTeJRBSMjjqDMRInx4kvARqttkXVUZbn+uZqEShXRRip5lzfSainkxdUM5bzGVoMuEQvVqaTMBIYlKjTExUeUAUYqey3JpI0bLLClm0MZbLyPeGq4LzUDYem1Si7OoxVFuIPjx0cT1VYPi1KcaB4Zy/v8b+dFXiKF/9tKqyILBdZV4raJM7mA91rZsUMO0Kp8SS/aoCO5XCJpuFzt2TVSUdLxYtWpSOOOLwNGPGgjRr1q5p1qx90syZu6att16QDjhgv3TSSfMbRSNMJCykjClB/Y648eZnyPlbnqj4kOUBqKa56pOTfwjzGXUd74pm8WnQqVljeWe0nRg7Mkyr8leKvFRNkdFcZyDm19eXmGpjeDalylBu43mbrAIs5rAVhdjJK1U2VromCuuaYp2cVwn8Joao8mz4ngplVJU5rishHr/DNnH96Bpi2YM85KuKK7DsNoKBay5/fOR5HiQPM78eFZSJ4VG6xzTpJdeEsvLwwPrarEf5rkWeU+XAVnmy80UnyjxcEvpqA5E/r7xXVSmySrjqOlNDeNNPk1o1ay4rqDOZaRI6l9K6dNhhh6Xx4vGPf3w6//zz080335xOPvm4dMwxu6Xjjz8mXXnlJ9NZZ501mqfdJtR5vLGQMqbDDLkq/MnAUkNR5WmokSeiiQd2zCtRgYe+t5OHP6EmKjHO+/m48L6JhlqVgTgs9GDs09Co6t3CjHEXT+Jk7EFVFWJXFYpV1sS0DuVfIYBU4VGCqIkgUJnjeK2VGeB14Vh4s2Royzursa12CF0f8lWGedvqfQprrAtT7APOQ947zfa28RbVCamqKnhlDaGbltdvM5mTHxt4M/K5gTEvL1bd0/u697edMJNw7buX2cZOUQRJVcTFZKRZ6NzB2T1jvL09O+64Y5o/f35673vfm44++ugNWgA0jUaYKEyeaVJjxhgekBh0msHUTK+MS5LWMbii4chnNDvOTKLyiTDG9DBX3yK+Rx+mQR+U3HAQTiw3Ggya3e+rSl7VDLr2mW1pUr1Nyb99wHFUE+QulePyyDjESM2fG/XOojpSG/rYrrEkGppFDzWOg66JIjQm2qDxk18mYxsxRLhWFdo+HWstB68J12HeoMXILWvSyphiPGFw8P24PF1Pg8xkY5jrms3DvaFo7BWh8XjHHXcUihxCLauKa7Sh7HplPU3OTxMQD5yTMk9zm/VIsOr8xR55KqDBevLjTXl6EcaOBH6+qp6OC+cBsaf1qQH5IPd3xi0TBIxtnjsITYf5dYPziif5+uuvz+7veHP32WefyjDPyQihc7B48YK0zTYXZDlRKa1KIyPr0gEHHJDmzz8xu8dwnU0Ub+dmFbbWZMBCypgSeGBxs1F4ERd2jFfXT8QUD1NVXOJhKrHFi4e/DDa8WAoV4oHLdzF0ut7M2LYiEQWxJ4lyA/qefWN50bhp6pHq00PGsngYqvhHX6XVMWKKzouKfQxztkwVFfs6TlWipwgdx6qHGscBQ70IroEuBnyZsGE9dQY021c2y8p1FvMjVIWxTBCzv5rooPy2jGP9L4bOdbl2OXYcI8ZQkbekbOwVUfU5lt91G/NUjccm56cphMmVCam2XkCWpW3WeAaEku7v0YDjhXjOixUJVs4Zgkq9iXgeMDb4G6O0L9GqfSU0VdEOKvaTbwJv6uFavuCCC9JnP7skq1o3MoL3Y1W69NLL0oEHHpAWLFiQidSJICr6Cp2bN29eVgqd5zOi/qUvfWnmBeJ6UGhj1/v0WNtaEx0LKWNKyHuVNEuvhzn/14Ufw0iUwKqbsowl/q/y0oKHMgnbXT1TrEdd28tCqpQkPox8ImB2TyEofRr/TeH4Ko+tyDAdZLllINza5oa08ZhVNXTuQlNPoZBQkGhgDOXHJ9cGRmTRcnlAd5mNLzt3rKPIqxTBEOJ6KppQUChe3B6WhdFcJt7kccLo5jNRWCrvsI3gicijTcuEon1FmHBNNaVqgqQvbxHHq0yoqtplH4Yo46bs2mp7bctAk4cxGmgqStHUi6RzxrYxox+9svl7vjxJOl7cmxB1Wm8TFKqq3CsVPuL9yWJgThTOPPPMrBktTWopDU71OsLdyBm65ppzs8+cccYZE8ZD02foHDAZxP1Mk66aWG3j/R4rW+uhP3hf21wr441zpIypQEUhqqr3xYIOvMdDOxYs0Ey+ci0iChHqmsug9RclOiu0D8NhEE9UDImpy+to84DvM58KMVpVxawtdZ6tNlUKRVth1Hc4ZpvqYflS+YyjfBU8ro2yXCn2tUsRgqoHZ+zvUwRjr6jgicKwikLxinJfhIQSxyA2/Y2FCwYJ76sq043xf++996Y+iG0KBoFzXTWG+koMr8oh6xIuWlW8QeJo5513zl5NogN0z1WFVkSvWkVET1Ksgsr/qHLYpkiJvF4xxFaeKdMcvM6LFy+ubFK7fPk12ecmS3GDtqjFSVF/wImyz0+YxLmBFlLG9FC9j4eqYvuVN6TSwBhMZQaIckJi6FAbtP4qAcF2DmKUy6iuQgnnbQRGn0IB4wKDpk2FrDqqihy0qVI4ESgS8XXIw6lQ1DimmxSdUBnxNpQ1PY5epSp4AOtaiGGtZWO47NrUdxBKsfKmBHZflfGqis4gpJoaOVXL6ctDLNFRBEKzz+pnFJ7IC1zOgaIAhmmgsXwmAZjFL+qVJaOUe3ZsYK1CP/Ik5eE7+R5VVbCemIul3ydL3shka1J73XXXTVmRmi+8oqI83Cun6j6PJRZSxrSoiodQUhlVfqr0OA9RJaHL6OI9PDWaYS0ydqJhNmjDzDLULHWYxDCn8RIYiLm6/l1tqGsw2yb0arKSNwi5FqKnSeFNRSjXp+14LhJnVV6lCNuj6mm6ppRvVjQuYoPh/PoklJTrWCTEBq2MVyf8m/bkKhOg2peuvb2Kwifz5yfeG/uqBMY4oIoXoZcSw301US0TSvwk1PK2227LvJ/cTzhu+fWxbbF4UPRQqjBEGRynpoYrx1qh0nrxd1VlQ9O9SS3nbqqKVN3ndB9kP1WVdKru81hiIWVMDdxoJJzUrFa9boBQET1M5TaX4adwDzVZLEL5S12MnRi60peA6IqM3PESGBxHxGvZce4CXq4yMTCZQg8GIS/y8322qsZdl4atbb1KechFkaDi2uWFwC4TLXUlxPE8kMNYtJ9sUxfPm6gLhW167DCuqwzsfHXRQZBXRwI1/uwzTEhNVDmP3N/66C/D9xBL9Drj3oxYQigpHC8WT5Ho4d6cD2nV/up+z/hS2J08SUXw7GhquLL/5HCpRxXr4FgwJsa7dPXUa1K7KvvcVM49c7Pn4WEhZUwNurnG6k/RcODBKk9INPb4XVWzWEadEcgMaRcDQaErXfJ2+kIJ19qe8ZrlYhv6FFISA2V0Wddkas7bxNNUVT64TShTV69SWVVFGbqqUlXW7FYV2aqEkoznIgbtKVU1htocP0LXykL8OGeIhj7Q+WFdjGWONSJHzcjHqpdfWzj3CMpYJp8xwd9MYpUV49FniiZRNCYVOst4qQoX5Xi1Mdb5LOGU6kWo8TioV25jokmT2pGR9enII4+c0pNjbvY8PCykjGlhOOjBqXAWeWGo9hT7i8SeUYQW1DUAFV0S9EWfxRa6oMpVMF69ORRy06d3TmK4iC77OdZVDYdBDLGra8TcpdhBW69SkcHANakEaxmgZR6yqhBFCaUqwVMVAloH21pFG6+ewnWGWXQietj5yTp1P+x7AkU5oBKU6n/TJRSa7ys8Ti9NfFVV+yzarxh2pzEWjzPXRNF44T22o40IqsrRNf00qX3Vqw7NJgOKcuKmEpO5oMNExkLKmAZgMMRO6OrDoLwAREyZocVMMA+9WIGpDPVS6AI3xbIQJYgzu8MAQ4SQmboiBMMmX5WoD8qMFh5GG1OMeSy6IOry4roUZGjrVcojA0GTGjJ4MXLLRE+Vx5jCD4i7MgYxvjDKMWz68EpVhff1OcGg3ExVLuXnMPq+KEk+FnZQo+G2QkLerXxOqsLtyu6N3Nfz+6WwO3kA1VOK5aslBjlemkCLZdIVTtimel9Zjq5p3qT2iCMOTzNmLEizZu2aZs3aJ82cuWv290EH7Z+OP/747HzY22e6YCFlTANUAl3J9zK6+FsFJcqMSSUhy2tVRSwl3oWqGXuVPh0msUnpeHmlMDxkgPVFmdHCfjLjuTGIKU0EFIXYlc3Aa9y1HdNdvEp5ML6LytiXGeFV4wUDtmpygHUM4iFAAFVdu029ScoryiNB2tc1MVZhQlpeHHtqat42p5RrNEYTxB5pHP8ybx6fZ/zmx5zK1+t6UFEfiRx9Xv/TT2jjUarK0Z3K3pNhNKm9+eab08knH5eOOWa3dMopb0/XXHNNOvnkk7NzrwlSFYkypimTO1jfmDFCYUbcaCWm9EBWUzte9AopEks88Ih15wZd10+oayl0PdzxCpWtY9g5VBKC7CuGVUzeHivkLeyTqpwMxgaGGPkXU5WYUA95o189pYrGvwRQ28aP0asEMnwxIps2mS2buOAayXsZuL7LmvOyHFXvKzNeV61alXkhunplEI1lgr1NThDXHUa2+hCBjP0+DW8dj7G4npVf1KX6Xb45r46BJpbkWaPyoUR2DL9l/cqhyjdOj2IsNs1V2HdswB7HMetsuv1sN/fUu+++O914443Z70za7bvvvpnIatL7yjy2Se1kaFRrJgf2SBnTEIzHWJ1Ps91Kvq9KHJch1iTHo23j1khVk9RBl90UzbTWbcswRR772We+GA/bqhnkqVztCWJj3rIQO851WYhUl1LomlTINwfmb/UtqxMmZRR9t6qEOGBMY7RWNfAdJFeqr3BYFc+IYWXxXjXZiP2UolCJBW7aeNFUpZH7Ay8JfQQKnlVeCtNj3SoslK/eBzq+Ch3lp7x/GrOxPHr0WjX1YrOsv//7i9LRRx+TLrvsqrR06Y/S5Zd/Nr3hDUel9753UVZt0J6pqduo1kx8LKSMaRnepxC/+HDXTHJZ6JwepuRZ1AmGpnkgZVRV7+u7EEMRbLvCbtqUQu9LSOmBWFVAoAvK/ypiY5i5jDPoGJ2Ukc6XhS5r2Mr10rXYQZHxzziuEy11EwpFoVo0gi0DjyOGF16nMgYJt8rnOMbS723Hl6q9yVMiMcDfw+gpp4p4d9xxR/bi976M+7LCDvzdtry+ku2V88rPfAEHFZ7QfTLmtua9SLFKYnwe6B6kcD6Ox+LFi9NHPvKR9IlPfCK7dpreh88888y0bNm1ae3ahWn16u+k1atvSKtXfzutXXtOWrHii1nImo3+brhRrekDCyljOoSyaNZRM5p6uMtgyRvwekhz464rma1Kf11p4vkadoifSrk3rVbY5zZx/FTZCy9DX8JxY0/ujpMIvDAq84Ys47ss1wQh1da4rvIq1Qmzqjw9xkSR8YmQqiohznXJPlZ5OwfJr2C8SvzE64H32h47FT1ge5nAkQdkkNDhsvUwDpg8UY8jjkGXHmJFqLBDPObyBHXNZ6kqqy6vqjyv3Ls1cVbmRYohpPJwSUTJm4QXadmyW7OfRx11dDr99DNqx/Bdd92VCbA1a/4urVt37GhT2ZGRLdK6dW9Ka9acnZYvvybdeeedrY+BcaNa0w8WUsa0gId5LIEeZx9l+MWkYsHf5FDwoK6qcCYGzS3CIKsSJjHfZVio/1KZYZqnz2R4jjcGI4ZKVSXDtsusSnAfr+IaTZGxOAjqlxP7pOX7bFUVVCEMqQ1VXqUmYWqEchVNXHAcyoRxVQlxNSOuCuUcNMcR0cBEiI4jxjuerra9g2K1NwQHL/7uImirQJCyfbEYhMLu+vKUSLwqp0m/dz3esYADx0X5TLzPuqjSiOfo4osvzn5qjOc9g2UFfHif44yIWrnyi4XepGuvXZnOOOOMyu28+uqr07RpW6b1619X+P/1649I06ZNT1/60pdaHwPzKG5UawbFxSaMaQEGTkxWlmHJw5jwDYQURkXRTCOfJTwMQ6msKEX8rDxYXeB7CLai2VrlFyhcZljEZsRNDDe2heNblvBfBcf+hhtuyPaXB+Pee++dhTZ1WVbdejjHRaFW41Vcoyldeu80gbGOwFTp7Sox3PZ8cJwxmsvGad01ojw9xoWElxqoKgwvfy7ZjzIBoOp8hIeRp5U/pn1MBOh6UV5lLJ0tL28TEAWIDL4Xjx8eFoRBvnBCVxTuFr1omkzqu0Gv1hN/doH9lmdVx1cTZGeccWa68sorM4EyMjIrTZt2T7rsssvT3Llz07vffcpoKGAcS0XbSHGIz3/+85mIwpsk5E2Cz352QXrXu96VFUEoAg/oI4/MHvVE5eF9ttGhfd1R7pzCOiWmN4ZwbdMP9kgZ06G/jZKeFfKhMugIpG233bb0IY/x1rToRNvyvnmqSlIr4XnY8HCq6rEVUa5ZGwOJfbjoog89JnSGv3m/732sCrvkvFb1GuqLQQzIYYmpeEyqwvG6UJW31CR8LDaqlvdAIbhFBmhVCXG+h7GldgcSD/JK83sf+99H7yAJzKJroE9vkcLd8o3IORZ9tgXguLJM7l28OEZdik4An2dMSKirOe+ZZ56VPvWpqwo9SHiWzj//gkZjjmUxsYMYq/YmbZmWLFlSeQ/fZJNVo01k89BUFqFX19TZVONGtWYQLKSM6TB7JTGlBO4YzsKrqqcOBkyT3J1Bw2+aCrZhguHHdlQl6EfyzTLruOSSj5SGzvA+/+8bhXcVgZBqIhoHEUfDEkODEI31uupzbScI8BCVhWdiTNflyKh1gULCuHZZnkRREbrG8z2MeOl9jFyMe4ky0DU96LWr0DM8eCpljnho09xY+y2Bl+9n1Je3SHlxmlBiu2OFvb7CCGM56ngNFOXq1RFLw2tCjLzOZcuWVeQj/V1asWJFlo8kEcr9vEgssuxHPZZ13qSZlfmwhxxySBoZITz5k4X/5/2RkXXpZS97mSv3GTNOWEgZ0xIe5hhlsRGjDEkZKFXhRkpYx5irMqDbNG0soy8PSb40bFNkrCnhvU8wnjBs1qxZUGn44CXsk6rmq+znsKsiTkRieXM1aK0Kj2w7rvEQ5QsD6PcmOTJqnMpPiYsyI7iqhLj+Fz+DZ0rXB/cFtqdtPlNZhdAoSoC/2xRXUHW6mH+ocOS+xqmOA4JXx7PPYxHXE++ZMU+1bdEJFZZgu+TVuv766xt4kKZnn9N9TU1+lRsbxyee1GnT6r1JVZVNafZ9xBFHpBkzFqbp0z82uiy+y98zZpybDjzwwGy89HWcjTHt2Pie+Mb0gDxSypOKv/MQrXo4alZZ3ouqUuXMkg5qkPVB7OPTtf9S30KK5pRNDJ/rrruu10IQnK+yECuJiLZG6kT0MrUlegXmzJlTKlIYR1Wl5KvKFAt5g5t68vi+Gq/KgObvquujqIQ4YLBrPxUaxovxjUiLpbS7EgUcP1m3ira0Ka6Q9xbpeHEO1Hy2D1T6HlHJdvKKYXd9rUel2yVsY3+sKk9x3TXH8jiv9R6kWdnnNLY1rli/JtgYC3jPjjzySM5WrTdpt912yybXyrZ90aJF6YgjDk8zZixIs2btmmbN2ifNnLlr2nrrBemgg16RTj/9tF7GnDGmGy42YUwHeIASoqREYz2UZbBo9jQm1yupOSbJ1xWd4OHIg7usP0/Tku3jOVOJB4J95cXvffGo4TOr1vDhGBOqhfjpo4cORpPEcFFCMkYURt1kbH46CAqz01jFQ1F2vrkuyo5flUBVgYc4+98kJ6lrQnksIV5W9EH5THiLCMPTeacIR5s+anliSGG8d3TxFjEhEwUYy+RaUG+svhLrlcul7dc299E6gOPO8S0K/9W6mhbjkPCJTXQZr/IgFd1THvUgrUrbb7/HqAAvG1eAoHrlKw9OS5cu5G6UTeywXJaDiMKbtN9+c7NJHsY11wTLym8/4oxeUfPmzcvyqRBdiOO99torm7CI+WIbe4sGY8YDCyljBsg/4uEVDQdQeWHyoGi8GEWWErCVsI5xWNczatC+Lxi29CMpgof0MBp0RuLsvUKq+uDRxsP31Bo+22yz22ghiEF6/DQVuE3P61RAxr6KC8SxqnCjMgHQpgIdIEo47qpop0a1dTlZRX3guhR9UPU7eUEkxLieuebZtrivGMaDVN5EICr0DLRetqetCNVkCvvDNS8hyv60PQ9VyEskL57CE/u45uVtKao2Ko9d07wvzhmig3s44ozJLyp9XnrpZZnIiVX2NvQgrc9C6ZiciWI8Hj+OM+Oe8TB//onp97//XVq+fEGaMeOCLCeKexLLmTt3/+z/Qh6lsnNBZb/58+dnv3Nv4f7DPujaq6pEaYwZHg7tM6YjKuSgh3jszSQDSvkTvM//FeOv0JAmRuCgYV/KxyqCh3eflbXqCgxU5c60hRlZQmOqQ2fWp5e//OW99VHKN90so6lxPxUoC7OrKnaiHJUu3hWqYjKLz8++Sng3KfqAgaowXjWhVXl/vQ86DnV9x+pgDOl+EZePsdy2uAL7Ie95LAhRVXCjC8pbkqBSLlYf1x3biUDjmOSb82qcNb2XKSSP46CqfRTEOfjggyvzkV7xildkAhcBw/VflJfEvZ/7qqISzjrrrHTllZ9Mb3/7Uenww/8qvfnNR6TFiz+RiagYotjmmshXZNS5LKtEaYwZHvZIGdMRhebFOP1oZPN/ZtExXHiwysCIuRl1fXKAh+sgM9uA4VnWw2cYvV7K+i9xPPryCmFE09tl5cpzSkJnFmahM3iNMHYwsvpsQqwZ5KLzsrHMCNeF2THuJECEDOsuAr6LV6kMzh1CRyFZhHblzyV/M17j9SnRqBA/tRmQZ0CCnX0e5NqScKSJscLPdKxVXKFpyK+OmbxEEmXK6RxWn714bxzUUyIvkiakOAZsvzxUdTlvkaKQPN47+eR3Bg/S+aN9pJiw2X//V6R5844f9bIRXlfkRYpeTP7PTwpPvOENb8iOD+dN74OWx7lps/3KfdO4YP8HHXPGmPZYSBnTEYVwyTMRjQYelMxW8rCuy83gIUsOQxksjxnoQXIZ+s5P6tp/iWbEdcKxDRg2sGJFNHweDZ1BRPF/zsUdd9yRnas+hRRwXsqMn655LROZePyUv1MVZsexIewNA1gGfKxAN15hSFyPCBQVYODaZBsZn/F8ymBV2F6sFBdLiCvfRgUpVBlP3quu+8j3oscvhgm3CflV3yR+xnOoPlV9nQedb4XL6ZhxnHQ/HOQeJs8gy5QnifODQGnbRDUvyrk/sb14kI499ti0cuXKrCjKdtvtmYX9se3aJ42HonBCNUJW3lIMuyNCAeJ5jD/bTJaxzwoR19gYqwgDY8z/x0LKmAHAcJQRBjK04mwlM9ZVD3hmwpkZ50HbNJG/LfFhO14gODkWGAB9hZ9gTBEi89rXviZrgMkx2mabF2eGTzxWGDQkdMeQoD6omv0lR+7ee+9NU4W8MU/OGUabyogXGbLyqnBeMLDVv0elsfl7EOO6iVepCBWKyefy8H7++4xXtjV63+RhU84W61WhhXiN8Tdie5AQRAmySPSAN4HjE0VvPI9s/yD3lqptlreEc1OXA1RHVWEH3svnLbVFniS2GUH9pje9KXtP4X/qN5UvI5/3wkYvpkS3wu441vIkgY4RqOJjV2GZj3YwxowNFlLGDIAe7qtWrRqdoVSPKR5seUNb4UB57xQzlXUeI4TIIMYOD+rxrOqkqloYnRjVfYo6jgv9VurW35cnrAl4GieTkMqXF4/vxXA1kGEMdUJIpbGZ8WcMR1Gfr4A3DK9SERJ0cf+0jDIvC0ZrXijxnoQS68WzrOMio7xtGF4eeblkdGv9bcLl5CWJ5c+13xw/zktseNsVzokEqrwxKsjTJS8uT1VhB5bP+S+rftc0dDAeZ00S6LznvYJFYZF1YXdFniT2o23z9K6VKI0x/WIhZUyPIX4YEDzUVQY5PhyVoB49TxhoGGFNQu80+931QYlhX1a9byxQ/yW8UghHjldRKeNhMox14cVAHBYxc+bMyrDN8Qbjixl1xqFC9VQVDmQMSzjxPyX7txVCccYfZGTeeeed6YorrsiEFmPj0EMPzSqU9elVKtpvticax7yKwqKiVw2vpsS4BE4USmyL8na0XP4epPKmquzlrxXOTdNwOY6HQpDjMuL+91G9T+c45l9JrEHfYWcq7BA9Rl1bRpR5eBCYLC8vvpVzWeQZrAq769OT1GfOoDGmGxZSxvSAZq0VAiQDJfbL4WHM3zG0JhphTULvBpnZZhv7zE/KU7f9GAw6HirC0bdnajxAAJcZQggsxPNE3EeMfQSCKrrFgiiIJXkxZAyq2pvCnVRMQE2X60LsNOOvhrj8/PCHL04rVqxIm2yyZXrkkdlpk01WpQsvvDDzLtKIVE1oB/Uq5YmheHHcKo+oKESR647jwT7XCaW4TX0VcJBQEKybfWhyT1CZ9jJB16Z0eBU6x7rPxHsNXpq+w860zZq4krDp4mGr8vDwO9c59y+OFX9rwqFIHFaJJXuSjJlaWEgZ0wPqai8RpRnkmH8gIyaGjQBiAngg15U01me7gjEz6DKKUMUpll2Vu4GxrqITGC33339/muywvySllxmJeN/6qlRYhHJfZEhC9LLEXk+xXDRiVttcZECScxKrjyknJBrcKnqg814VYsfvnG9dB4iolSu/mNauXZjWr3/dBhUXFy8+N/sMjUj78CrlYVvYPs6bwl35HgZ5Ey9PmVDCu8c2KbwvhoF19SbLKGeZcT8VatlUNMTjo2VFz1of3qK4rTEfEY99H6GDedhmxpSORxznXTxsZR4eCWmFEWrioWwCpU4s2ZNkzNTBQsqYnsAIUyK9YEY2Pwsce8LoeyqjXSekBm2eS4EA1lfllepSlEKhQU3A8MOIHc+QFIzHOLs/KNHzmKdLyXeFR8VclqJzonA8hUrGHB6F6akXkYx5jFq2SeS9SUAIqARTXizkt0NjSX3UykLsYgluvHR4ohBRsfnpyMgWad26N2W/L168IM2bN680zK+tVymPrjflWEloVIUrqklu3nvDBAUgFhgLyrURfL5r0QkZ5XhE5MHVPUZFHZqIBgkbhWVq/Gt5fXiLhl0QokkLCsY9+9h3GfC2niSLJWM2DtyQ15iekUGm8CflNmGEleUEYWTx/7pQIIyfNo04y5rzVq2na1+ZpvlOSpIfT/oUUaJMSGJQ0U+pDRhpCiFSaB0GIr/LgwAKMUMc06BW+UIqdqJwPP6vsDoKYNxyyy3p1ltvTT/96U+zQikY6KqqJlEl8mXL47rjpEGTEDuJlhtvvDETTXiiiqAn2LRpW6YlS5bUepXwrmnbolepyRiTEIteBv4uK8pSdo2yLom3eH3FcukK4+2CPCKcXy1PTVybhuWpupzyyjh/EuGDVE4s2laEOvmBEuycD4Q+x6iskW3XdTExoEkDzr9E7TDKgOf3zflJxhgLKWN6IhoqseGiSiDz/2gERzCE8Fypz0gZGGiDGCGaVa1aT5uyyl2h2tpUoq4iGcdcBl4TGD8IhZ122mk0JEoiWJ4f5ZwgJCSC2A7eU2ly5e+oV5DC8zRGEVCx308V+bEbq/hBbDBaFmLHe/zvxhv/Lf3ud3+ahfMVwfv0BCMMtAr2FZHKscCg5viop1MTD6nyvCR4FMpYdg2oD5MKZeh3jq9EkrzGCjOL3hKJiUFEQ2xo3EY0MG64F3EfYswgvBEEiCq8OhzrYUxwqCCEco3anJ8mcH2wPxJTbZvzGmPMIDi0z5ie4IGOQZUP5ePhzmw0Rg8Cpsw4xLAgjImY/zKPCcZZH/1YmMmXFyLPWBRG4HgARvBUyJOSYVt1zOfMmTNaAly9ZWKIZazMxgsDl+8pV0meJX2HcydPir7P5/W5GLrVhLoiJHnhlB87sW9OWYgd4Xg0R77rrp+mTTfFu/ObQjFFrlRKqzYIQSxDApZ1SRTF9+v2iYmJ66+/PqvIx/W5zz77lHoQ4zKj2GKfOa+IFI59kQevj+p46lunwiBdRAP7iODss3R4l2qNfYXeuXiDMWY8sZAypidUJplyzjIqNYsvz8Ds2bNLhRSfYRkYSxjPRQYwxhuGGsttYmRWMRaepzqmSsEJ4JxX5eYoZ0IvDEqM99gXSPA7Y0D5OkUiJy+2VUGviD6aMZcJLYUSKpRV5dKLCjdg8H/jG99IKW0xWlgi5kgJ3h8ZWZeVQq9D1dPkHVKeWL5Rah4ExAUXXJA++9klado0wm5np2nTVqVLL70sHXTQQemCC87PPHv5deVzHAXvERYJeZGs9watjhdFA+dax1venTYCqM/S4V37M/WF85GMMeOFQ/uMGUL1Pgwu5avEnIq6Bz4GIUKqyshQpbRBQ2P6KM08CJqZJ3xtvCgLtWyDCoxwTurCLjU7r1LwVeJGRm3XfK58g91Bz3fZtsoLJU9DXYjdo8J5xywPaqutFqbp0z+WeaYe3eb12d9bbXVOetrTntaon5T2NVbIa7KvZ555ZlqyZFlW8GL16u+k1auvT6tXfzutXXtOWr788+nd73534bksWrbGAOeX6169tuIxUk+5QQWEwjyVh8mrS95RLB3O7wpDHCT8sAi2lWOjIh38dOidMWaqYCFlTM8oIV0z9KoqphlyDIuifBQ+p9yhuhlhjCjyrsZbRAwCjWoxqjgeiMfxQAn3EgF5MIaVfyHPS9EyMAyb5H5gRHOeVeWvCXnDvYlIUB5NXkz1sb78MYjhiKp6F/cv74HBk4rn5/77z0rr1x+ettpqQfrjP941bb/9PtlP/p42bZN0wAGvaLS98m5w/OUFZpsRtmXHmKqEixcvTmvW/F3mEVN4oaoGrllzdlq6dFlWlCO/LtYTRRLr0t9sh8ILJaaix64vAdFH3pHKoMccsbj8vpAXDYGtPK++wweNMWa8sJAypmdi8rOMVxmj8jhhZBWBAUron2Zxq8BAVShRF8Y7GVs9pWDQMMUucH7IW8Oow6iMBjGoshnngRAvNanNG50YyHhZeHF+q/p06Zi3bYocxUwTIaXE+7awrwj+eBwiMVxVxOIMjHfGJV40eR/y23HIIYdkYXtbbHFVWrv2/HTvvTenBx88Lv32t7ulBx98e3rggflp2rTfpcMOO6zRNquAhSYtYgW+Mi/N1VdfnVUFrK4aOD0tX778MesCrm95nuUN429ywOR9UXU8vsPY6VNARM+mKjJWVRssG4ux7DvbO8zS4a52Z4yZijhHypgh5UoRlhVzYAiZwejhf7xuv/32Qi8B36EYRBMPAqWsMd66gKCrq4o2bNhXlRFWrkYdMiCbIuERRa3KPqsiHuKBWXjOkQxl9duRIV5npGqbEMPqC5aHdSHe2oRO5QtTNNn32E+q6ljkUfnv+P/4e1FFu3g+6HV0ww03ZMdRhRvy45NQzle+8pVp2bJzWHomWh58cP5oztSMGeemI444onFYnwps5HOXopcmL14Y9488Mru2aiDjs23DWYTTsPsosQw8bgrJ47yy/6rO2GTZ8g5xrnRN6BocRulwY4yZilhIGTMEZMhEww5DB2O8LplbSetNPAptPRv5bcTIrfJqtRUtbYlVzDAum/TZyefkyBtRJA4kXGID0yJDVrlrmonnp5qfdtmnfDPaCCJNgq3p8tR/SX8r967JuYnnsMn+6DMSRZwTRMLee++djdt8zpZydS655CNZk9184YYDDjggvec9C7KxpmN+9tlnpd/97uF07bUL0owZ52eihc+PjKxPBx98SFq0aFHj44NwUN8s0HFSyFqRdwXxvskmqyqrBk6bdk+aOfMVAzecHUZ1PF0rsVKiQhrbVAXsowqgMcZszFhIGTMkmDGW0RsFD0Z0XQ4UniYEQN8hNnnoI4NRx0x2ERIrwxJTsXErxi1GJ9tStj7NvGM07rDDDtnnZAjyE5GicCWWxYx7DBtUw1mJR4xewvZk+LKvKl/dhSalt1kX57fNMWV72DcVF1BIWdkyNO6Uo9NmHD1WFCFy7kmXXXZ5mjt3bpo37/gNvDGsi8+vXPnFrHAD4XKIE3mYrr323IS2OeOMM0bFA6Lq5JNPTocffvioWHvSk3ZLe+21V1Ymvs2xUYEHiabYjBiKvCuEF1544YWVVQNTWlcYXpgvGFMnlGI+Uxybg7Yw4P4QJxQQQAqpbLOcImHo/CVjjGmGhZQxQ0TekghGFYZ8VSlkjFkM/Kp8G1EWRtYUQrDwPhShsKGu1JXdjv2X1N9KRp1EibxNyjvh8xjicZ8pXKEcGQkx5etwrGVY57dFnic+Q7hlWWnrpkTPT1mIFe8hpNnmNsTwteihKkOfK6PM41QlilauXJh9d/78E0eXQ9ETRBefj6JEhRtg+fIF6cgjjxyt5qewMraPMD7lnSlfp43IUHlthaXFSQs1Lc5DeCHrXbx44Wh4YdxPwgspvc4ylbNYtj1sq8qvq7BMFErD6qOEsGYZUaBxb2kblufS4cYY0x0LKWOGBHk3ZXk1GGc0/azKUVK+RZ3Bdffdd2ez+F3FVJXBqrLOXcohK/wMY7So8S/gPSgKsStCxqmKGKhaGWDA5hshA4Z6k/LhLBNB0GdJ+HwPpQhCkOIUTYSyYD/yTWDrKPLsVHmc9txzz3TTTTdViqIVKxak1772NaNe1RtvvDFbTlXhBsL3rrvuurTzzjuPvo94U4ijRJTaBrQRGU3ylopQ+ODixQvSNttckB0HmgDjiaKP1PHHH5+Ns7pQPBV6yE8c6NofVh8l7bcKerBMh+UZY8zYYiFlzJCoKuaA4VXVeBcQBsycq8FvGRhQiIAoLNoQDbE88hRUFYIoK2CAUYdYZD/Zl1/+8pcbCCqFneERKdp2tov/KURSQkLeJjwqfI9XG0FSBtvWR0l4HTNtv4RBPmwqehybNMwdtKGuqPI43XTTezLRVCeK8GTh0QH2ERFSV7gBr18UD/JKUdBB1QC7FDvokrek8Xn++eenefPmpSVLlmTX6vbbb5+JSX22SSiexqTGs3LGdD0NS/A4LM8YY8YfCyljhtyct8gbo9wewsnKQrzwWDDrT45PXU5NWXWyNjkmLCNvrKv/FeFyGINF26AS4TIeJSTYFnkElBeDsYoXos5I5T16amkmv2rb+8wja1o5sAqdW0AkqEx23rOBIY3XSuFsdUSPRlfqwvCe+MRr0yab3FcrimJREM4xHq3qwg2r0nbbPSpQhlHsoG3eUoTqgPPnz39Mf7OmoXga7wqDlWdNoanDFDwOyzPGmPHFfaSMGSLMcJeBRwWRUjb7jtGl/Ke6kLO2BQUiRb2RtEyJIQQf3oOiz0hE4TEiBwZPC/kbGLEY3IgnjFN+4oHhs+yXysNj5GL0xiag/A/Dty8vTBMQhOoXNSjyUii0UB6L2DRVBQPaMOjxqAvDe+ihl6RNNyXEsTgkVaIoNlAmt+rRvlAUaHgsvE81PnKk8uJhWM1aVeCBY67zwHhqUhVSTXV1rOtC8dRTipcmFXjxftxP91Eyxpiph4WUMUMEL0yRYY4AkVFN+FsZhENhhKkaXZOiDW1BqPFdGYCagacIBQJKs9568T7bE8WXZuIxVvE48UIgsf2EVvE3YgkhpYapEb5LrpdERlG+07BhXxC2FLyIQmEQZIQjclUZMQresRSKTcLw1q8/bDTMr0oUIZ4A4UB+3sEHH5xmzFiYpk//2KgIYzn8TeGGV73q0Ow6QEzn8+2iyGAsMgYkvLvk5sVjzDFXryVejMO6ZaoZNp9TPl6Vl0zXT6ySGMMLjTHGTF0c2mfMkEEo5Utqx4R0ynjnc6VUqEEGIZ4SNUrlvfhZBEBZdbImNA09UvUxVcbLJ9VDXiAVNXAtg89V9V/qi7JqdewP78kj0keYH0iYallR8DYphNEndWF4jzyyfZo27XFp663PKa1mN3fu/pnYREzLo3bqqe/O9vPqqx/bF+rAA5sVbuiz3xLHmNBYhdnFUvF1IbBtQ/Gcq2SMMRsvFlLGDBmMMAot5BuGAu/J4yRBIsNPpb7zlclUUlnhYvyPGf1BwqGKckwQHBiTbIf69LB+CbphIOFYVfGwCBWJqBImdf2RTjhhXrYc9pl19yVyWE4MiYxCsY/iFm2gTxP7W90/6Xdpzz1flm66qVgUvetdJ496MBHU2j/6Sx166CHpy1/+chayue22e6Xdd989E6kILoV/KuQz30sthuPVfbYOjjGTEwrR46eKWTQJgW2be+RcJWOM2TixkDJmyEgoKVxNHgrQT3KpKK6gPkEy/AgNjLPkGJWEJ6mYwzC8GogoihKoWh6oCeywGvMKFZ/Ac4Jw5NUEjoGKOpSVWi+rVjd9+j+kFSs+lH74wx9kQoPS1/JQ9YHOJdumXCARy3WPBYRqIhpXrizzOC1M++23f3rnO09K73jHCWnlypWZINl22z0yzx3jlOPLSyIFb6nyvzhu5EJprEjwq7eXPEOM4Xxp8hiOV/fZOpRvxXdZTteKgMYYY0wVFlLGjAEKzYvV10AJ6cygEy5FaJvCifJNZxVuxqtpaeYusCzl88TS5vlwwraiqmnFOfVf4nggHKtKxEfKBFR5tbqH01ZbvSdtscXi9MgjW6Tbb39c+tnPrkqXXnpZJqbe9ra39ip0yBEqyr2K42EQ4vFVvo7GHEJC5xCPEh6iojC8/fabm3mWNGZf/epXj+b/xNw2lq3lMf7kQZJ4ig1oNU7YhqoQu0HC8YroqyKgMcYYU4aFlDFjQAzNw6As6iXD73VGXjRSMVyVTE8oGsn5fYT55UOfioz8aJg3pWmJbwlD9gMPB2JqUK9bUbW6GTNOTJtvfm26//7H9lNavvzc7FzNn39iGhSJmqJcH+0Xx7PJPjJmYhU5xA5hkAgQjhn/U9idBIQqySHaWT/H94wzTk9HHnlEJi757tZb7z4ahpcXvIyH/HvK4VPOXgxRjOOC9UtgSXyXhdgNGo6Xx7lLxhhjho2FlDFjQFujTmIi/1l+RzTxfr48ODPuiA6+izenq5jKhz5Fw1iiqmuelMqlF/WsAt7nMzE/qg9vzYbV6h5OM2a8I22++bJ0//3nFvZTghUrFqTXvvY1rfNzio5nPqRPSIDIC1Pm5ZOAUr4a3kr1NiIEk+Om0EaV+uZ3NYflPQQXx0ECi+qLr3vd60bz8yTkis5L/j0+qwmBIlS5jm1i2QoNrQqxG0Y4nnOXjDHGDBMLKWPGiKZGnXKUonFLQ14MegQVJcR5lYGXapBQP60j5kjlDWQVAmhC3psRRVRZBb1ooLM9Tfr/NK1Wt9VWC9Lmm1+TRkbK+ymRO0TYG9t2xBFHDLRuNd8tgmPJsVDZbAkf4G9C8Pj+o0Lw0WOGeKJ4icrVM174H6GDLEfjJnq4VBGP/7NOrYPPdCk1L1EHCCQVI+G8yevKtvM55YfpVRVi53A8Y4wxkwkLKWPGiTKvE0ZzXsRgoCKudtxxx8xALRI5QuFWXWEbKErAduTD6pQDg+Esb0psXlq2Pfnf6yronXbaqRuUjyf8bJDwPlWrmz79I1lO1EMPvTBtssn9pf2UeJ9tGlTA4QWqKt/N/xFFCv9TBTwVIUEUFQkdCRm+r0qKnBf9zHsQQccvX5K+aY6W8qJizpMEFGOSZbB+CWUVmmBsI5DUl6nKG+twPGOMMZMJCyljxgF5neRNwAjFC4SAKRNJvEcxCmbzVSWtCHmNBgGDFs8Q3q2890tiSsZ/l0p+ZRX0yE9auXJhttz/83/+Mfssx6hJefMm1eqozkdhiYceekmaPv2jpf2U2BYKMGyzzYtTV/AQkeeFWCb3p0hAcC4RHwgiUDU85RVVCVSF8OWLPEQUMqjlRC+S8uz0d/x/WUimwjwRTsq5UjipPFLsN/+XiNI+Ny3y4HA8Y4wxkwULKWPGAYxPvA0ydDFg+bvOA4KxjNGtfJMiw1fL7IM6z5bKtbehuILehvlJy5cvSCee+I709Kc/fTTHZtDS61Sjo8Q51fnWrz8sbbnlRZX9lKhiR6hhFxAeEss6V1UNZslXQoCsXr16tDdTEy9RFE8SOfnvxff0GXmWJLLYPm2jtl/jkt/VfLdIDPJe09w/Y4wxZirRj7VljGmFvE4KjVLYFO/LO1FENFSVV5OH5eABwZAflCrx0rUIRFEFvXx+Ev9fvHhxtg/y0gwKx+tlL3tZ2myzX6RHHtkhW89WWy1M06d/LPNMwaN9pT6Wtt56YVYCfc6cOaPeMAkK9U3iff4u8v4p9E7hdnyWc8a+IDrKiPlLTSjLYcN7FN+TMGJ7lbPE5/g75rBFAS6BxXikeMnMmTMLK0LyN++X/d8YY4yZqtgjZcw4Im9BNIjJJyGcTr2cisSLKgCq71QeBAjerUEqzrGMOiHVReBsWEGvPD8JMcg+9tlwWLlSeJzWrl2UvUfxiT/6owvS738/K2266d1p2rR1ae+998nytBAFClHjd7YpNgnmHNV55Pg+31GVu1iRMA8imcIiTb18LJNtyxd5UKW+GMbH9m+77bYbVO7Lh+IhmlRWH/i7bTNcY4wxZmPBQsqYcQADVUIlCinex2jFE0KVNYosRPBYES5Gzg+z//xdFn5HGemuRrCqvFXBcpsIiaoKelX5SU960ks26JvVpdx6Wa7UypXnINnS/fefkx58cF7aYotPpc02+2p6/ON/nPbc82Xp1FPfnYlZRIVKydOni/2Vd4efTYp6xFwniRSOb1mxBUqAr1mzprYkOqhSX1GRh7JcJYfiGWOMMf1gIWXMOICYwKCWEIl5TTKyMYTxZERDWoa4ypvXiYuuZdD5XvRa5FGFti4eqegVqspPevnLX54Z/WyDwhSbiimFs4H2QdtKrpT6RFHi/NGKgauydSKy9H/Wpbw1PHtRNLXtoxUbzLJdVecFgcyxj4VIYs6U3uP7OgdVwimPizkYY4wx/WAhZcw4EEuM4znCOCavRR4mQvdUxrqoGWosClDmrcFT0bUMelEFuEhZoYsuXiFylWLVvhkzFqa5c/dPT37yk0crvSEeY1+tiPZfDWklQPgdDx9iI4bjcVzmzz8xa7b7/3tYvXi0h1WE5eAdQviq51OX/VaDWXKSlDtVNzZiAQf2Jf5NQ157lowxxpjxxULKmHFCBSMUJqYwP/WXUu5LXiTFXj7qOVT0OfV7Kgsjq4J1V+XyRHHQRVhUeYX23/8V6eyzz0o77LDD6HZLWLBNKg8evXkgD5oEoERVWfEGRFOTZrusizBHxFSX/VUooF5sZ115+iKvEeKp6HPGGGOMGR8spIwZR1TaG6JnifcREjRrLStxDng4EAt8Jt9XiveU61TVFLYIPEF4cYo8J9ELFsVBUxTedtJJ89Mxxxydbr755j8Ilb3TAQcckJU8h3z/JULexM9//vPC/CyJUYnTWHShK9o/jiXHW7lIWk8UtkXfVRlxPscy8Jw17alkjDHGmImLhZQx44jyW1TKHGNbeS/ySsSwtHz+DwY5RRGqQsVUcruNkOKziC8EC+GG2lahpqwgsVImJtTMlc/ohbjg+zvuuGP6i7/4iw16EAHCSh6mov5L7E/Z+mL4XR8FKlQunG1ESKl0fRRrKpGu9WnbVIZc1fT4vvssGWOMMVODCS2k7rrrrvSa17wmXXXVVWn27Nmj72MkXXjhhWnJkiVZgvUpp5yS9t9//3HdVmO6EEPz8l4e/T9PUd5UmajAyMeY75IrhWgh/E2iRssDKssR6gYKueMzsQCFBAjXa74whQQkHicJKwkmBBXLYv06Jgp3lJBq0mup6Dg1QWXKY/+lWMAB4cp2SqypvxSlxdnOmF9WV/jBGGOMMZOXCSukbrvttnTcccdlieB5LrroorR06dJ08cUXZ0biCSeckHbaaaf0zGc+c1y21ZiuYIAr70d5TsqXqurjpPfr+ixpuXU5OXWeqVjoQF6j+B5hiBBFV9n2SxwRmodoYTJEXi2F0Cm/ie9LlLQVg2ooq7C6JqjRroSfPH8Kx4tFQuSpi72WHLJnjDHGbDxMSCHFbO+xxx6b3vzmN6fzzjtvg/9hTF1xxRWZF+qFL3xh9t5RRx2VFi9enBYterTBpjGTBTV8jca+PDCIkpg/VRS6Ju9HVb+hQXNy8oUPtG350LvoSaoSgVHUqAJhFJAq9a2XSo0jWOI+VQlIeZIQafKWKfyu7Hv8H0GoprkScflwPHnqjDHGGLNxMyGFFLPCn/rUpzJDJi+k7rzzzsxo23333Uff23XXXdOyZcsGWieGWj4XxWx8qFJdXcW6vsCrE6vuRcGkIhJlaLwqR6dIuJCXQxgey+lrfFMOXEUTJHb4mxe/y6vUFLafax6imIwNaSWotA8Sa/E7QgUgWKa+y+/6HMeKv3mpYAX7QlU85X0hwCJ9Hr/xHG9m48VjzXismanIb4b0HM3bZBNOSJ100knpK1/5SuH/vvCFL6SZM2emVatWFRqeGEJz5swZfW+rrbbKZsgHAePvlltuGWgZZurw05/+dEzWowp2+Ys1eqiKLmTydDReJULiciRECD/jFRvSDmObo5jR+01uQKIobE83MS37vvvu2+A6V4GO/He0n1H4IMJUHKKoyh434Pvvvz9N9fFmjMeaGSs81sxkH29N0iLGTUidddZZpepxxowZpd/DeMrvGKE3g84WMyP91Kc+daBlmMkPY5KLkWawjKthg3dHVeAw9mXoSyTgIUFkRKHB/3hfn5N3hs8oLE6/C97jc5QQVyW5rlAgggkNLVdCBy9O7NtUlZcUizGoH5Ve8jRx/LV8JjoI7Yv3Bt7j2Om4xV5c+p3jw/cG3eepMt7MxovHmvFYM1OR3wzpOXr77bc3+ty4CSkqXHWBpG4OGjPyW265ZfaempcOAoZXPpzHbLxwMY7FeFBhA4SPjH95ThA+KuKgwg78j3A0/a5KebE0OJ4bxE5smMty+R7XDqF+g4DnRgIn/kTcsT7WoVC82Cg4flb7ynXLS5X7eE83wvge+8Y9I1/5btB92djGmzEea2as8Fgzk3m8NY2qmZA5UlUQ0ses+je/+c205557Zu99//vfzyppGTPZiFXxYoEDeVBiQ1o+i0hCYFSVBkdkScDERrn8vXbt2tEKc12JVQD5XdsqEcT65SVTBT7lKynEDlgGRRv4WVcV0OXDjTHGGDPRmHRCCiOMnlEf/vCH0/Oe97zMULz00kvTvvvuO96bZsxQq+IhuOSJinlIahYrYvGKIto2582DsGGb8mJOgodtVXhe7I2l7xY1pi3aHvddMsYYY8xEZtIJKXjHO96R3vKWt6Q99tgjM9LoIUXPKWOmAgidsoa0EjExrK6oT1TMXYrv4Rnq0pw3EsWSRFvssxT7TqlkuRvTGmOMMWaqMaGF1OzZs9Ott976mPcx2OgbRXgfxhr9pCZqMrkxbanyOpEnVCZihHKKlD8FfFZ9lAbNJyxr0hu9S/YmGWOMMWaqM6GFVBUYhi94wQvGezOM6Z0qr1OdiInfJ3yOAhOq3qd+SYM05xUWS8YYY4zZ2Jm0QsqYqUpV6FwTEaPv45FSjylVuBu00IQxxhhjjHkUCyljJhhNvE7D/L4xxhhjjKnHQsqYCcigoXMOvTPGGGOMGS6P1iQ2xhhjjDHGGNMYCyljjDHGGGOMaYmFlDHGGGOMMca0xELKGGOMMcYYYyykjDHGGGOMMWa42CNljDHGGGOMMS2xkDLGGGOMMcaYllhIGWOMMcYYY0xLLKSMMcYYY4wxpiUWUsYYY4wxxhjTEgspY4wxxhhjjGmJhZQxxhhjjDHGtMRCyhhjjDHGGGNaYiFljDHGGGOMMS2xkDLGGGOMMcaYlkwbGRkZSRs53/rWtxKHYbPNNhvvTTHjDOPg4YcfTo9//OPTtGnTxntzzBTH4814rJmphu9rZiqMt4ceeihb3nOf+9zKzz2utzVOYmwwmzgWLKjNWN57PN6Mx5qZSvi+ZqbCeGO5TfSBPVLGGGOMMcYY0xLnSBljjDHGGGNMSyykjDHGGGOMMaYlFlLGGGOMMcYY0xILKWOMMcYYY4xpiYWUMcYYY4wxxrTEQsoYY4wxxhhjWmIhZYwxxhhjjDEtsZAyxhhjjDHGmJZYSBljjDHGGGNMSyykjDHGGGOMMaYlFlLGGGOMMcYY0xILKWOMMcYYY8yE56GHHkrf+9730q233ppGRkbGe3MspIwRd911V3rxi1+cVq1atcFB+f3vf5/e//73pxe96EVpr732Sp///Od90MxA3Hfffentb3972nXXXdOhhx6afvSjH/mIml555JFH0gknnJAuvvjiDd6/6aab0v7775+e97znpbPOOiv99re/9ZE3nbnlllvSa17zmvSsZz0rG1M8Kxl7HmtmGCCgsMO4dx199NHp1a9+dbr//vvH9d5mj5QxKaXbbrstHXvssenXv/71Y47HRRddlJYuXZoZJB/84AfTeeedl37wgx/4uJlOMIM2b9689Ktf/SpdddVV6Q1veEMmqtatW+cjanoBA+K0005LX/ziFzd4nxnc448/Ph1wwAHpc5/7XFq7dm12TzOmCw8++GB6y1vekk0y3nDDDdmzcvHixenqq6/2WDO9w6T2O9/5znTyySenZcuWpeuvvz57bjLmxvPeZiFlNnrWr1+fiaijjjqq0IV8xRVXZIbvC1/4wsyDwOe4cI3pwre+9a307W9/O733ve9NO++8czrkkEPSn/3Zn6XrrrvOB9T0wnve8570+Mc/PrtfRT7+8Y+npz/96ZlwnzNnTjZr+5nPfMZeKdOJ22+/PR144IGZcbvDDjuk3XffPfMGfPe73/VYM73zwAMPZPYXURwwffr09JSnPCUTTeN5b7OQMhs9j3vc49KnPvWptM8++zzmWNx5552Z0OIBITBOeFAY04Uf/vCHaebMmempT32qx5QZCscdd1xatGhRJqbyYy/ey/74j/84bbPNNunHP/6xz4RpzXOe85x06qmnbuAxuOOOOzLj1mPN9M2MGTM2mPD+2te+lr761a+muXPnjut4s5AyGwUnnXRSev7zn1/4YpYDw7YI/rfppptmMxxiq622Sr/4xS/GcOvNVIIxteOOO27w3tZbb+0xZXpjp5128tgzY86VV16Z/u///b+Zx8D3OTNM8IQiqt761remZz/72eM63h439DUYMwHAzfub3/ymdJajylu12WabbfDe5ptvnnmpjOkCY+oJT3jCBu898YlP9JgyQ4dJIY89M6w84wsuuCAtXLgwm2z0WDPD5KMf/WhW+Is8KDyj4zneLKTMRsG2227b6Xu4hhFgJNVuueWW2XvMfOTFlTFtxhRV+yKML48pMx5jz/czMyhr1qzJ8ohf9apXpYMOOshjzQwdQvfe+MY3ZgL+k5/85Lje2xzaZ0wFhPRtt9126Zvf/Oboe9///vfTn/7pn/q4mU4we8bNXyVbPabMWI69eC+j4hV5oGWhzcbUwUQj1dJmz56dTj/9dI81MzSolkxLh9g7CqGEN2o8720WUsZUXSCbbJL1Jfjwhz+ceQ0oj37ppZemvffe28fNdGKXXXbJkrEJSaDfCg8HylR7TJmxyCugOuTXv/717O9LLrkkm8mlB5AxbcGgJf+Y5+L73ve+rEIaBix5Uh5rpm+obkvFW6qS3nPPPenLX/5yWr58eTbWxnO8ObTPmBre8Y53ZL0y9thjj+zBQSI3VbGM6QpGx9ve9ra0cuXKLPzgla98ZTa+jBkmz3jGM7IZ3WOOOSbLDSV/4EMf+lA2YWRMW+jdc+ONN2a/x4pptAqhHLXHmumTLbbYIsuNoiIp/aII7zv77LNHJyHHa7xNG4k+MmNMIXgOcBvTV4qHRL6ssDFt4UbP7BmzZlQdMmasuPvuuzMj+C//8i8zY8QYjzUzFbh7HO5tFlLGGGOMMcYY0xL7840xxhhjjDGmJRZSxhhjjDHGGNMSCyljjDHGGGOMaYmFlDHGGGOMMca0xELKGGOMMcYYY1piIWWMMeYxrFq1Kv35n//56GvXXXdNRx55ZPre9763wefuvffedPzxx2ed5ffcc890xRVXPGZZv//979MLXvCCdPrpp3c60jTD5rvPe97z0m677ZYuuuiirCWB6c7f//3fp9NOO82H0BhjBsBCyhhjTCknnXRSuuqqq7LmhvS8Ouqoo9Lq1auz/9FX7U1velMmpj7ykY+kN77xjem8885LX/rSlzZYxn//93+n+++/P918882djvSJJ56YvvWtb6ULL7wwnXLKKemyyy5Ll19++UYrcC+++OKBlnHNNdekf/qnf+ptm4wxZmPFQsoYY0wpc+bMyZob7rHHHumDH/xg2nzzzdNnPvOZ7H9Lly5Nd955Z7rkkkvSX//1X2dd5ffbb7/0z//8zxss4z/+4z+yJtY///nP0x133NHqaH/1q19N//7v/54uuOCCtNdee6VDDz00vf71r3/MOjYW7rnnnux4d+XKK69MZ599dnrqU5/a63YZY8zGiIWUMcaYRmy22WaZsPrZz36W/X3ddddlIX+xgzyi6/bbb9/ge3iiDjzwwDRjxoxMVLUB79asWbPSs5/97A3W8b//+7/pV7/6lc9cS7773e+mSy+9ND3rWc/ysTPGmAGxkDLGGNOY++67L+2www7Z7z/+8Y/TU57ylA3+v//++2dhgORFwbp169J3vvOd9OIXvzi98IUvbB3eV7QOlvMv//Iv6QlPeMJoDtVZZ52Vnv/852e5WHhcWC8QBve6170unXHGGemv/uqv0nvf+97Mo4MAPPbYY9Pvfve7LFeIEMUzzzwze//lL395+vSnP73BOqvWAXvvvXdasmRJFjKHd47PnHvuuWlkZGT0M//1X/+VDjvssEwUzp07NwuxE3yXZfzkJz/JctHYVsTn97///dH9IFeN0EpQ7lrbPKdFixZlyzbGGDM4FlLGGGNqwfuDACE/ivA9vYeXKYJ3ijDATTfdNPv761//enr44YfTi170okwAfe1rX8v+bgrr2HrrrTd4j3WyjunTp2dC5W//9m/TV77ylbRw4cJ0zjnnpC9/+ctZAQxBftXs2bOzkMCPf/zjmTjjs3jHfvjDH2af4Xe8XOR6/c3f/E0mlK6//vrsf03WAeRu8R3Eypvf/Oas8Ma//du/Zf8jBBLh9vSnPz197GMfy9Zx8sknZ6GLAmHG93bffff0D//wD9l7CxYsyH4efvjhWa4a6wZ+5zVv3rxWo3eTTfzYN8aYvnhcb0syxhgz5XjnO9+ZvWDLLbfMvCzyaFBsos4wR6DsuOOO6U/+5E8yMbV+/frMQ4XHpgmsQ6KsCIQZnh7C1ajoB0960pPS0Ucfnb0PT37yk9Pb3/729J//+Z/pox/9aOZ5wqv2rne9K/3mN78Z3TeKWfDzJS95Sfr2t7+dCaF99tmndh0IRECIfeELX8gE3ste9rK0bNmy9KMf/SjL7SKna+edd86EGLD/N910U/rc5z43usw1a9ak4447LivaAWwz2yiByovjp/BGY4wx44uFlDHGmFLwmuAhQRzg1YnCaYstthg17MWNN96YiQZEB6F3hPKRU0UYWhRXTYVU0ToId6M6IAUoqAiI0IrL43eKWygsTqGI06ZNy37GnC7B9iGiBEIFUQR165CQohAGx0kgtggdhFtvvTUTVfE4gMITgWNLGGLR940xxkw8LKSMMcaUQqEHwtGK2GmnndLdd9+9wXtU5UN4UJjiF7/4RVZ4gh5QeKOAHlAIqfnz5zc66niT7rrrrseUACdcj3XEHKQ8Vf+r+yx9qiQam66DQhxV7Lvvvo8JxXviE584+juCL/5tjDFmYuNgaWOMMZ3AU0XY2wMPPDD63je+8Y30zGc+M/P+qLDEAQcckIkxXuQ2IbTWrl3baB0vfelLs5wmVQqEb37zm2n77bfPhAeeIwpbsN74f/Kw2oS/3XLLLRvsB9XtEIrQdB1VIYi77LJL+p//+Z/R48ALMXjttdc2+n7eg2VPlTHGjD8WUsYYYzpBjhB9pd72trdl+T54mwjtU2U5PE94lLbbbrvR71D1Dm8P+UpNOPjgg7PcInKHKORAyCC9kFg3qIgFXq8VK1Zkr1NPPTXLO5IXrGkuFs2HEX/nn39+liOl/ehjHW9961szQUgRC8Qn+/D+979/g1DAJtD/ie9QtZBt/MQnPpFVUjTGGDP2WEgZY4zpBDk8FGRATJ1wwglZg16KUVACnZA3KtI997nP3eA7T3va01r1kyJ8D/FEbhGFF8i/oggD1e0Az9c//uM/ZiXHESm88GJRfa8NiCJywKjER5EISp3vueeeva0DMYj4wfNFqXX2g2OmwhJNIY/rAx/4QFakgiqE//qv/5oJU2OMMWPPtJE2QeTGGGPMFINeTL/+9a+zHlDGGGNMU+yRMsYYY4wxxpiW2CNljDHGGGOMMS2xR8oYY4wxxhhjWmIhZYwxxhhjjDEtsZAyxhhjjDHGmJZYSBljjDHGGGNMSyykjDHGGGOMMaYlFlLGGGOMMcYY0xILKWOMMcYYY4xpiYWUMcYYY4wxxrTEQsoYY4wxxhhjUjv+H4t36iZk1MesAAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# --- 方法 2: 基于距离 (Distance) ---\n",
    "print(f\"正在运行距离法检测...\")\n",
    "\n",
    "k = 5\n",
    "# 距离法使用降维后的数据\n",
    "knn = NearestNeighbors(n_neighbors=k)\n",
    "knn.fit(X_reduced)\n",
    "\n",
    "# 1.计算距离\n",
    "distances, _ = knn.kneighbors(X_reduced)\n",
    "kth_dist = distances[:, -1] # 取第 k 个邻居的距离\n",
    "\n",
    "# 确定阈值 (距离最远的 top 2%)\n",
    "threshold_dist = np.percentile(kth_dist, 100 * (1 - contamination))\n",
    "\n",
    "# 记录结果\n",
    "outlier_flags['Dist'] = kth_dist > threshold_dist\n",
    "\n",
    "# 2.绘图\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.scatter(X_pca[~outlier_flags['Dist'], 0], X_pca[~outlier_flags['Dist'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常样本')\n",
    "plt.scatter(X_pca[outlier_flags['Dist'], 0], X_pca[outlier_flags['Dist'], 1], \n",
    "            c='blue', s=40, edgecolor='k', label='距离异常点')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 距离法 (KNN Distance)\\n阈值: {threshold_dist:.2f}, 检出数量: {outlier_flags[\"Dist\"].sum()}')\n",
    "plt.xlabel('PCA Component 1')\n",
    "plt.ylabel('PCA Component 2')\n",
    "plt.legend()\n",
    "\n",
    "# 3. 保存\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_2_Distance.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "129fd6ce-9ced-45ee-add7-f845045f4d71",
   "metadata": {},
   "source": [
    "## 3.基于密度的离群点分析"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "042ce267-07cb-4e5b-b7e8-ebf24d312ec4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "正在运行密度法检测...\n",
      "图片已保存: output\\HT-29_FEATURE_3_Density.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# --- 方法 3: 基于密度 (Density) ---\n",
    "print(f\"正在运行密度法检测...\")\n",
    "\n",
    "# LOF 在降维后的空间上运行\n",
    "lof = LocalOutlierFactor(n_neighbors=20, contamination=contamination)\n",
    "y_pred_lof = lof.fit_predict(X_reduced) # -1 为异常\n",
    "\n",
    "# 记录结果\n",
    "outlier_flags['Density'] = (y_pred_lof == -1)\n",
    "\n",
    "# 绘图\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.scatter(X_pca[~outlier_flags['Density'], 0], X_pca[~outlier_flags['Density'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常样本')\n",
    "plt.scatter(X_pca[outlier_flags['Density'], 0], X_pca[outlier_flags['Density'], 1], \n",
    "            c='green', s=40, edgecolor='k', label='密度异常点')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 密度法 (LOF)\\n检出数量: {outlier_flags[\"Density\"].sum()}')\n",
    "plt.xlabel('PCA Component 1')\n",
    "plt.ylabel('PCA Component 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_3_Density.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "913e7367-3f08-4cd3-81a7-c7849f0ba143",
   "metadata": {},
   "source": [
    "## 4.基于聚类的离群点分析\n",
    "### 4.1两阶段离群点挖掘方法（TOD）"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "id": "ed015bca-421f-4371-9854-ffb8ef635eec",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "正在运行 TOD (Two-Phase Outlier Detection) 方法...\n",
      "   [TOD统计] Ave_OF: 20.3432, Dev_OF: 5.2022, Beta: 2\n",
      "   [TOD统计] 阈值: 30.7476\n",
      "图片已保存: output\\HT-29_FEATURE_4_TOD.png\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA1IAAAI3CAYAAACRaGpaAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjcsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvTLEjVAAAAAlwSFlzAAAPYQAAD2EBqD+naQABAABJREFUeJzsnQeUFNXWhU8zMORhAEGiShBFxQiYA+ZAUDEhRsyiYnomlDD4q4hZVMyRETAgQUWeOQdMYCQKkkSJkmFm/rXvcObdKaq6q7ur8/5YvYZO1dVV1VV333POPqGysrIyIYQQQgghhBDimyr+X0oIIYQQQgghhEKKEEIIIYQQQmKAESlCCCGEEEIIiRIKKUIIIYQQQgiJEgopQgghhBBCCIkSCilCCCGEEEIIiRIKKUIIIYQQQgiJEgopQgghhBBCCIkSCilCCCGEJIXNmzfLqlWrpLS0lFucEJLxUEgRQgghxJPZs2fLpEmTfG+hv/76y4glN3788Ufp1KmT/PHHH9zihJCMh0KKEEIIIZ68/PLLcsstt8jff//tayvhtT169JDvvvtuq+fy8/PN3+rVq3OLE0IyHgopQghJI7766ivZaaedZNq0aZUex2PPPfec+f/hhx9u7jtveNwva9asMQNeRAd222036dWrl4k8KGVlZfLss8/KMcccIx06dJAzzzzTRBP8Mn/+fNd1xO2mm24yrzn77LNdn3/00UcrLWvZsmWy8847y/Dhw123ldvt4YcfrthW//d//1fpfUOHDq3YVnidvgefcdhhh8mQIUMqRVS8PmPKlCmSLLy2FW7Kv//+a7btPvvsY/broEGDZMOGDVvtj9133126desmTz31lJSUlET87EsvvdQcDyNGjPC1rvfcc4+0bt1azjnnHPn0009l3bp1smnTJvNcXl5epb/4/LVr15rlE0JIplE11StACCEkOh577DHZuHGj/PzzzzJw4EAzcN1hhx0qZvv9MGDAADPIveCCC6R+/fpmmZdddpm8/fbbUqVKFbn//vuluLhYbrzxRrPskSNHmoHxmDFjKg3eI4H3Y1Bvg89TOnfuLDfccEOl57fddttK97/88ksz0P7888/liiuuqHh81113lVdffdX8/5FHHpE5c+aYbQEaN27sex1r1KghL730khnsY5s++OCDMnPmTHn++ecrXnP++efLCSecUOl9EAvJYvDgwUb8IiqE/eS2Xa+99lqZOnWqEVA4Pm6//XZTi1RUVFTxGrwP2+2jjz6S++67z3zPu+66q0KwLl682BxHoVCo0rKvv/56I8BmzZpV6XHsF3zWjjvuKNWqVavYv48//rg888wzZv+efPLJMmPGjErvO/TQQyvd/+KLL6RBgwYBbS1CCEkOFFKEEJJhqJDBTD5o27attG/f3vf7EXmCYBo9erSJNoFmzZrJhRdeKL///ru0bNnSRL8gcE499VTz/N577y1HHXWUERyI2Phlu+22q/gMN+rWrRv2efDZZ5+ZQToiYqtXr5Y6deqYx/FX31tYWGgEUaRluQHhqO/D98R9iI+FCxea7QKaNGkS07KDQkUbIktu2xX77eOPPzYC+Pjjj6+IUN19991GYCl437777mtuEC7Dhg0zAnmXXXaR9957T2699daY1g+ivFGjRjJv3jyzr5o2bSoXX3yxeQ6CFNsUUajp06dL79695c033zRiF0IPUTPsP0IIyTSY2kcIITkGRMHrr79eaSCuA1mkWmGwi8HtAQccUPE8BsHbb7+9LFiwIOnri0jUWWedZQbdSOdLNLpdEJ3JFL755hvz95BDDql4DPsP+9OtVgmcccYZUrVqVXn//ffN/ZNOOslE5H777TcjzF588UXz+Lfffmvuu91+/fVXk4a6zTbbmNdCuHXt2lXGjh1b8TkNGzY0UaqCggKpXbt2hQjGfRx3iEBCaBFCSKbBMxchhGQZGDzDZtrtBjFSq1YtUw9kg2gGHm/Xrl1F/cqKFSsqLRORLGfaXaJBuh4iQ0ceeaSJukFUJRo1VQgq1SzS/giCP//8U+rVq1cRrQMaTdMolhO8FtFHrY2DqMJN0/qwfgCRPi8ggOxUwHvvvdcIKdRqoaYK9VFI/QsHnsfrCCEk02BqHyGEpCGnnHJKzO9FCp5X5Ag1RldeeWWlx1auXCkvvPCCSbnCoBipg4gWoIYGtUcYcD/wwAMmQnPEEUdIkCCdzFlzpWliAMKpZs2apj4H9TYffPCBJBLUAD300EOm5gcROOXOO+80N6VVq1a+LcGj3R+xgPopbCcbvY/nvEBECPvfDTXcQE2VF6iZ22OPPSruw40P9Vx77bWXOVZwTCHK5cRZI4XPQJSUEEIyCQopQghJQ2CagNon5cQTT/T93ieeeKLCJc2JpmDZoB4IdS0XXXRRRQQCRgXXXXedHHjggeY51GO1aNHCuNpFQ9++fSvdh5HDscceW3Ef4gjugV5mFKiP2nPPPY3AQ10PnATt2qUgwHezxRxEFNbTNlzo06ePdO/eveJ+NMYe0e6PoFAnPKdxRDSRuebNm8uTTz651XMwtUDUCWmibujxiu+u2wuRp+OOO85Yo1911VUV6+i1bQghJN2hkCKEkDQETnnRGEjY2AIsEhMnTjSF/3BZQ2qYAtvzjh07GiGDQTPqZS6//HKT+hUNN998sxFACsSY02zC63sitQw1UTCYsIUO1klNMIIAwnHUqFGyZMkSueSSS4zVeJs2bSq9BimNydgfsYKooZqPKJouZ6f7OUE0ykuU/vLLL8Ya37ktAOqjINDCpT8igofaNqQPgjfeeMPU3p177rkm4kkIIZkOa6QIISRHgfX1bbfdZqy9nalWahKAKMzcuXONa1w0UTFbOEGA6A3CyS8QcBBRcKLDIBw3uMtBSPkF0TRnryQINLXq1jofrBu2wdFHH20iMFoflClArCAVD059CiJ3+pwbSPlDbZWb0EP0CCYUBx98sOt7//nnH3N82NvR5t133zWW+ZpWiO2J6BQie1gfCDj0p1q0aFFM35cQQtIBCilCCMlBkLYFe2oIE6TweYGoBIwo8Bo1oUgWqI+CAQaiYyrE9ttvP9NzyK9JA4Sc3WhY66CckTE7FRHmDIjUZRIa9UN/KKdtPOqV3EAPLggciEcnsLnHNsa2d2Pp0qWexiMQc6iTgmhSUxP0JEMEC1FNgP0KkXz11VcztY8QkrEwtY8QQnIQ9IhCA1Y05oWFtQKBYdcowXACjV/hmpcIMOiGfbbTJAFREggBiABbwGFd0OhV084iAUtviEAYSECEobkvlovv5QZSCPFdkeqIaJzacsNow7meqG9Cv6R0ANvr8MMPN/VuqDtCCh2+M1IgkUanxhHo8wSr9E8++USefvppOe+887aKSOF4ePjhh43I8UrBw3K8hBREFPYZGgdrZBFmJahv09oyCDzsg27dupm/aBRMCCGZBoUUIYTkGLA1Vxtx1AQ561pOPvlk8/+vv/7aOOi98sorCVsXfIbToRBRDKSFYQCug3Fln332MeIGYsiPkIIVN74vlgfhgHogpDOecMIJnu9BVAppjHDl0+a2EAG42aCRbf/+/SVdQHPd//u//5NBgwaZbYT9CEMIm6FDhxpnPYgnvM5ZawYRBdMRpDmilsnmp59+Mil5EJT//e9/tzp2ALbzhAkTjDiCIEb6KJYD4QQxBeGMG6JR+Iv1xHZFzyuvNEJCCElXQmVq60MIIYT4AJcNZ91RpQtLKJT0NEASP2jEfPrpp5vIHaJZzvon9IhCnRMEEoQWIk/ayFmPi4EDB8qMGTPk5ZdfNo/Bke/aa681VvKIdsLlD7VViObBqAKiDvbviHxBBBJCSCZBIUUIISQq4KSHaIwXMJSYMmUKt2oG8sMPP0iHDh1chTAMJhBFgiDyMpkAiDaFcwqM9/WEEJIuUEgRQgiJCjixoUbGC6RrOZvsEkIIIdkGhRQhhBBCCCGERAntzwkhhBBCCCEkSiikCCGEEJf0xUcffdQ0rHUCxzr0soqWBQsWSK9evUyfKj/Awhz8+OOPphmxrpcCK3c4EhJCCEkNtD8nhBBCHMBt7sEHH5SDDjpIWrZsWem5IUOGGMc5FTduQPDALnyPPfaQGjVqmMfQ4Pa7774z7nYK/g+XO9iy24YLP//8s+njBDtxmHu8++67xpL9wgsvlNNOO830x7r55pvluOOOMz3BvIDpR+/evSsa47oBB0asw/vvvy/NmzfnsUAIIT5hRIoQQhIIBsEwXtBbx44d5fzzzzcD13Tj448/Nn2X0J8JFtiPPfZY1Mt46aWX5LDDDjPvv//++414sEEUBYJg7733lquuusr0JbJBtAZiAY140V/q999/3ypKA4vtfffdV4444gh56623JBGoK52KIOWjjz4yLnPr1q2TyZMne74f3wPOhmh67Fwm7OFtIYWmtHDLs9l1113NsYJtiPfhhr5as2fPlmOOOUaWLl0qCxculGOPPTbs98D6w/wDwsvrBjHm9l2D4I8//jBNfyEosU+vv/76SlE1J5dffvlWva/s4xOCENuBEELSAUakCCEkCdxzzz2yww47mEHk448/bsQCREDt2rV9L+P11183EQOIiKCBYLniiiuMALrgggtMJAMNVBEp6dGjh69lvPbaa3L77beb5UCMoS8Qvt/FF19snod4RBPXLl26mAH1iy++aP4++eST5vmNGzeaz0ZvIXz2N998Y+6//fbbxlIdoJnuBx98YBrhQqTdcsstZh333HPPQLYD1gFiRftkQRDhc9AHKT8/3wibM844wzSPRX+k9u3bbxWxAvgOfsQJRA6sxp124vjOOF6wHIgsWI9jn0A8vvnmm6aXE3ovbbfddrJq1Srzns2bN5vHcXNSv359z3UIZ2UeDxCb2N9Vq1Y10TOkIT7yyCPmO7n1jJo4caK89957Rtw5Wb9+velbhSbDu+++e0LWlxBCooVCihBCkkDbtm3NoBtADB155JHy7bffyiGHHOJ7GWPHjpXOnTsnREih0eqBBx5o6oIQMcFgdubMmfLOO+/4ElKIrCAVDiIDQgpos9U+ffqYwfSIESPMwP++++4zAgJRCnx/RBgwOMb3Qx0R0tjQuBVNX7///nsZPXq0EZ4QOOPHjzfvP/74481noIYJ64z1D4LFixeb1Dnto3TdddcZUTVmzBizLRYtWmTWBal9iAyde+655nuj95KNHXWKBWwTbP8lS5bIb7/9ZoQQtoWmB0I0QUA5j4W777670v6CMMS2fuaZZzw/C98P31drsoIC+wrLfOWVV4zoA5hIQLNep5BC5A4i3KufFAQYopfYH4QQki5QSBFCSJLRQTYGuckAkSxEBMJFo/r16ye1atWqJAAKCwu3Ss3zAiLnr7/+MmlqCqJbEFjTpk0zaV0waDj77LPNwB4gygQhgMchpPC3U6dORkQpEJyffvqpES9IC0SE56ijjqr0PESCioF4gdCDiIFoQuohRFy7du1MFAxCEI+tXbvW3JCiCbFz+umnGwF50UUXSdOmTSUIbrzxRiMSIdTw+RAiDRs2NNsBfw844AAjPE499VTzegi5Z599tiIyBwGDbY8UStRbRRNFQoQKwjdesJ9wDKiI0mNKo302iDZhssGtRmv69Onmu/3nP/8x350QQtIFCilCCEkiSG9C2hpExD777FPxeHFxsRks/v333yZyhRS2XXbZxTxnN7f9+uuvZfjw4eb/SINq0aKF+T9SvzDL//nnn5sB9P77729qiRA5Ofzww8MaI6iAsEHkABEziAM/QEQ51xWiDOs3d+5cM9BHXY+zUS/S4lBHo8tAlCrc861bt66UiobnkfaF55DiFxQffvhhpZQzCFGkJGLf4aYgOoZ1xr6DCFQhBbMKgP3gBOl5TvT1APsPnwmhBOGJKM2kSZOMwISwwmMQcqjV0mMKorxx48YVAuipp54ywg/piDjWIqXvQdz8+++/ZltCmOK7KA8//LA8//zzJrUwGnDs4easc4K4s0GtGR5HBAuRJzeRpamhEJiowdO6LkIISSUUUoQQkgRgsKAg5Q0DXa1bQUrbHXfcYeqFIJ6ee+45M2DGABOvefXVV83rIIxgQoDUM4CBs4LZeqSdIbULEZ8777zT1GVhuYgC4BYNEAYYXGvEIxIYgCMi5EzNQpQLaVt4HtjRCX1eLcYRRdFaKOf7wz0P8JqghBRECiJSAOlkiAhhO6AeC4JFa5AQrcPthBNOMKmQbdq0qSRMnWYUEMlw0ENt2LbbblvpuUaNGlX6fAgL7G9E3CCckQJ56aWXmuXi/jbbbCO//PJLxXKx7e1oWN++fc1t1qxZ8sknn/j63khVdIuo4XjDesQLJgEQVdSaOBWBEEo49t1qzTBZAAEHQYjjBBMGmBRA3Vi4KCshhCQDuvYRQkgSgEkBBoCIEkAswZkMERqd8UdqGNzNUAMFEYSIEOyoAaI5uMG4AeJJ72NwqcBtD5ES1BXBCAEpVeoEhwgHamq8bm6pVDDEuOyyy7aKKHiBddGUPRtEpSCidF2dr9HndRnO9Dw8r7U7Xs8DXUYQQLiqYLvmmmtMpAT7Cyly+HwYHqCOC/9HWiRS2BDNsdMiUTeFKBlMKvSm0UMIPvtx7GvYnCvYzxBNEM3oWYUIEY4L1G8h/Q2CDWYbMOMAEEtYjlvUCfVViPLgs/UGcYJ6K70PUYdjDvVpbuB5re+LFaQMIsqKY9OuC0QUdccdd5QzzzzT9X2or0KUDRFbRMVgtIGaO0w2aKSSEEJSBSNShBCSBFq1amUGo7ihXggpX6i/gUU2BrCIUuBmg5Q4vxx99NHGNQ9iCg1cMdOv0QVEvCLVSCkQJIhuwXUPjnl+Qe0K0tMgDu06FqwHokaaYgYxYIPnNcID0eZ8fvny5WGf14a0GpmKF0SDIFzQOBfiF9vgoYceMtsFLotI+cN6TJgwwQgoiBlESexolLruYZ9DAEVi3rx5xszCTqNE5AoCC0IXgg3PQRBDkEBcwAb81ltvNb2qYD5hp4naQFxhOUOHDq14DOuLxzWipX2tgqiL8gJCDfvqhRdeqHgM2xKiDtvSy5xjzpw5po7ONvPApAP2EdYfzoaEEJIqKKQIISTJaKqdLQrQfBW1HzZ+o0GolUHqINLq8BcmCJitR1QJ+KmRUpBmhfWC+IrGvAG1SxBLqKuCqNP1wnpoCiIG/xj0q+MeQJRHa8HwPCIwNnjefj/EpS3WICScaY7xgLQ5iBX0sIKQQkobIijYtnCbQySqZ8+eRpji+0EMwGDDmbKIbecWoXMDAkbt0hWkwOF74vNHjRplastgGgKHQrX/RioeUjCR+obaITcQzYNBB8SHgqgO1hfRIYAUznvvvdc1OhkEOPYgFNGXzE5pRN0XRB6OTyc4/iCyIJA1kqeopbwdkSWEkFRAIUUIIUkG9TyItKAuBgN0pHphtt5OnyoqKjINWW3RgYGj22AXg270O8IgX+tM7LoYvzVSEF6afhhtvRGEAIQgIgUYGGs6FqIdSDPUgT+ECpznYJyA1EM45OG+Po80NDS9RYoi0uWwPtp0FlEXfI+nn35abrjhBrNsNABGDRNqhoIAaXuIJGkUDJESjTbBbAJRP4gOfD+4DCIihQheIsD+wD5HvRQEB/aL9uQCSAXt3r27OY5sJ0MbRD+HDBmylRDBcWe7I8I0IxHRHTSkRuQM643tZwMHRNQC2iAlEsBFUtNYnU2ZcbxDpDot5wkhJNlQSBFCSBKATTZS39AXCEYTGIhDOACYAiAShAEx7KsRlUHan7N/E9zhMIsP62uYHsAIAbVRtmkFRAtMDlBzYxsYREIb8MINDZEwWJYDDOTVaQ8DWkQyvCy+EVVDJAfmBIgiYD3OOuusisgaDBsQmcDz+A74nqgDUhc7fA7ej0E0IjEQWYgOaYoh0tEgWlCvBLt19FFCBExdDAHqkiBUY63pQQ0SbhAuTrBOSENDiiJEFL4LomlIg3Si6XLxgO2AFNDPPvvMOPVBRCOiB4GNCCCiTdg/EH04FtzEJATnwoULK9VPaWqfM6UTghW1V05i3aaYHECNGcQ9tp0eU7qvIdadgl0Fv34WUl8hbgcMGGAmFRDhRKQQUUCnYQchhCSbUFkQZ3tCCCGeM/IYDCr16tUz4gHiCQNiBZEVFNBDaCECgkG0M9UP9Tso2EdPI5y6ITC0+S1SviCekG6G5SJtC3UxEDNubmhOYLXtrNEC6OujpheINEH0uA22FRgfYKCLwTtEGYwB7BRBiB8INggCpKhde+21laJlcMGDqQDsvyEE0YAVZgQ2SKdDVAopaVi+7SgXq1W3Ewgp2HQjvQz7DCIG0Sk7XQ91VOghBcELUYPvoelmSAdUS3g/4DviOzuBUx0MGVBHB1GEOi3sW6wfHBlhSoFUPQhruOE59zVEE4QWDCwUOORhv0LkKBD52J6aNmcT6zaFUNbj04lt3W8DkQzuuuuuiscQuUSdGmr/MAGB6BscFIOqiyOEkFihkCKEEJI1QEhCnD3xxBNxLQdphRCksEGHQLVNErzAa2CMAGBF79Z41g1EnCCiYVChIPIFYQXLcBhPQJBA5MBgAaIXPZUQxUSUBoINohpiC+l/WAc8hognomdOcQRBDlGo6YsKxCC+N9aHIoUQQiLD1D5CCCFZA+qrkAoWL2q5jkgP0glh5uDlaofoICI6duTNK/3RDRhnOO3b8RjqmxB1sl0Q0UcKkTJEaDSVDylusGxHaqcKOTym9veEEEISAyNShBBCCCGEEBIlbMhLCCGEEEIIIVFCIUUIIYQQQgghUUIhRQghhBBCCCFRQrMJEfn+++9NsbDdZ4MQQgghhBCSe2zatMm4m8L0JxyMSG1xXGI7LaLHAly6eDyQZMDjjSQLHmuExxrJRsoSNG7zqw0YkRKpiER16NAh0J1AMg/0V/n111+lbdu27KNCeLyRrIHnNsJjjWQjaxM0bps2bZqv1zEiRQghhBBCCCFRQiFFCCGEEEIIIVFCIUUIIYQQQgghUUIhRQghhBBCCCFRQiFFCCGEEEIIIVFC1z5CCCGEEJJTlJSUmF5BJLPZsGFDxd8qVar4duvOy8sL5PMppAghhBBCSE6A3kCLFy+WFStWpHpVSACUlpZK1apVZeHChb6FFCgsLJQmTZqYprvxQCFFCCGEEEJyAhVRjRs3Nn2H4h1Ik9RHFhGNql69uq8oE4Q0ek8tWbLE3G/atGlcn08hRQghhBBCcmLQrSKqYcOGqV4dEtA+BTVq1PCdrlezZk3zF2IKx0I8aX40myCEEEIIIVmP1kQhEkVym1pbjoF46+QopAghhBBCSM7AdD4SCiilk0KKEEIIIYQQEhcbN26sSLUDy5Yty/otSiFFCCGEEEJIhgHjBIgX/I30Ohgy4LU2r7zyinz00UcV9/v06SMjRoyouD9o0CCZPn266zLHjx8vRx99dKXHLrroIpkwYYL5/w8//CCHHXaYLFq0KOL3+Pbbb2WnnXaqsDLPJGg2QQghhBBCSIaxYMECOeKII3y//oorrpArr7yy4n7Lli3l8ssvl9dee01atWol+fn5xv0OTJo0ST7++GPp16+f67Jg7lB9y2uVk046yQipE088UV544QU59dRTfbniYVnAubxMgEKKEEIIISTLmDdvnrz++uvyzz//yDbbbCMnn3yybLfddqleLRIgECmff/656aNk1/xcf/310q5dO7n44osrHkPKHRrRgrfeesuIJBVTjz/+uPn/b7/9Zo6X33//XT799FOz/KFDh5rnevfuLR06dKhYHno2VbH6Nt1+++2mp1Pbtm3lzjvvNELsuOOOk8GDBxuRds4555jX/f3338YlD+usrFu3zvxdtWpVpe+3efNm87dBgwZpe9xQSBFCCCGEZAlwIevfv78UFxdLnRohaVG/VOYvryL33HOPnHnmmfJ///d/FQNqktlAkLjZuEOkILpTUFDg+j6k66F+CdEomzPOOMP1/4hKHXvsseb/1157rbz//vsVaYV77LGH3HLLLbL77rsbIQVBh/TAU045RfbZZx/zuvr161csq1evXkZM6TEIgYe+TqBTp05St27dSkKqc+fO8sQTT0i6QiFFCCGEEJIlQESNGVUsRd1XSK/Oa6Vmfpms3RiSl7+uJUNGFZvX3H333alezawANT3//vuvERRIi4MISEV62tKlS42dt/ZH8iO2EeWZP39+pZooNx577DHz3TQ6dMcdd5hIFNIE//rrLxk9erS5j9cor776quy5557So0ePrZb37rvvVrr/5JNPylNPPWX6eyFy+tJLL5kIVqZAIUUIIYQQkgXMnTvXRKIgovoctKbi8Vr5ZXLBlvsDi4vNIJhpfvGLKAgJiBIICaSnIbKy7bbbJl1MQbBgn9pRJCcQe4hUYV217umNN94w4uWuu+5yfQ+iUIgo/fe//61Uz7R69Wr56quvZIcddjDfFVEopOVh+XaPLo1a4XG3preIRr388sty9tlny8MPPyzdu3c3Bhg33HCDZAp07SOEEEIIyQLGjh1r0vkQiXLjzM5rzfOonSLxgUgURBSEhJo04D4eTzZIk7MjQmD48OHGCU9vqG/6+eefzXN4LW4QQFjvJk2auN7wvFu/JTj2rV+/3kSRYDCBuipErg444ADp2LGjceFDbRRS9fbbbz9Tk+XGmDFjpHbt2nL44Yeb+zCnQDQLqX+ZAiNShBBCCCFZAAa0qIlCOp8beLx5/TLzOhIfiLQguqNCA39x32kxngzcxI7t0IfIEISPU2zhcYgeiB+AqBoiR/o6/N/uCwXw/ZCO16VLF2NtjsjmTTfdZNLzbrzxRvMaRJggsGBw4gXE0v333y+PPPJIxfq3bt3aOP7ddttt8uijj1Yys0hX0n8NCSGEEEJIRJCmBWOJdRu3HlgD1ErNX1b+OhIfEBswV9AeTviL+06xkg5AqKB+ypled9ppp8mUKVMqboceeqgxk7AfQ/qeDYQPolgQSlqTd+mll0bsZWUDUQeRd8IJJ5iolc1VV11lHCcR0YpmmamCQooQQgghJAvA4Hb1+jJjLOEGHl+zQcJGCog/YCyBlDptdIu/uG+7zqUzRUVFsttuu5lolN7QnPe+++6r9Nguu+wiI0eOrHjfrFmzjNW5irJtt91WZsyYIe3bt5e99tqrUmof/o/HsAxNeUTU6+qrrzZiDAIMtVUQVmDNmjUmAoZ1+PDDD01UbeXKlZLOMLWPEEIIISQL2H777Y3FedGoYinbUhNVybVvYqF5nkYT8QMhABGRDq59sYD1hRU5IkoK7NBhN37eeedVPIY0PTvKBpGD+7b7Xs+ePU1KHr470vHs1D5ElVA7hvfMnDnTRJxg2Y6aKvSZQp2VpvAddNBB5rVYB7gB4rU4XlE35deRMNlQSBFCCCEkZ8j2RrXoE6XufMMm1zc1UUjnQyRK+0iRYIBwSJVwgniDfblaky9fvtzcB4jwINKj9wEiPXgdrMUhXCKlzWH5EDXoN2X3HVNRhec3b7FEd0tn1OUjrVCfh4EF0glxHOKxTz75xDw+depUYzTxzTffVGrUCyt01GGlq4gCFFKEEEIIyXpypVEtvgP6RCEtSgVjo0aNTIQgmwRjrrN48WITBcL+hlhBhAc3BeIELo4K6reQfvj1118bpzyIE1u06G8ErwFDhgwxrnpI/4Mbnxv5YerB3Ew36tSpUyna5XwtPtteJywfUdZ0JlSWCZVcCWbatGnmL6whSW6DHhC//vqryfW1eyEQwuONZDI8t4npTYNGtQO6ujSqnVgop51xJhvVZvmxhkjNnDlzTFQG/ZCIN+gVBfFVUFCQ1puppKTE7FfsT7deVbEeC361Ac0mCCGEEJITjWohotCoVu3BtVHtbV1XmOeR9kcIKY8epbuISgcopAghhBCS1bBRLSEkEVBIEUIIISSrYaNaQkgioJAihBBCSFbDRrWEkERAIUUIIYSQrIaNagkhiYBCihBCCCG50ah2YqE8/WltWbcxZB6Hax/us1EtISQW2EeKEEIIIVkPG9USQoKGQooQQgjJAGDNrQ1WUfNz8skns8FqFLBRLSGJoaysTH7++Wdp3LixuYUDTXerV6/u+tzbb78t7dq1kzZt2pgmvffff7+cddZZ0rx5c0lXKKQIIYSQNGbTpk3Sv39/0+eoTo2QtKhfKvOXV5F77rnHpKsh0gKRQPyx3XbbydVXX83NRUhAhEIhc4464IAD5MYbbwz72l69esmMGTPM/yGoIKy6d+9uzmOzZs2SRx99VF577TX59ttv5eWXX5YLLrgg7PJwHvz6669lzJgxKdmfFFKEEEJIGkeSMEAZM6pYirqvkF6d15pmsqjtefnrWjJkVLF5zd13353Ab0AIIeU89dRTRuBABFWp8j+rhTVr1sjEiRPlk08+qTQJtH79eunZs6dcddVV5jGcCxFpQsQJouvhhx+WpUuXmufOP/988/qqVavKu+++a96Hc2Y4sB54PT4/Ly+v4nEsPz8/X2rXrp3QXUchRQghhCRALDVt2rRSJKlx3VL5c1lIhg0bJrvvvrs88sgj0rp167DLnTt3rnk/RFSfg9ZUPF4rv0wu2HJ/YHGxXHHFFUzzIyRH0m3xmTfffPNWj3fu3FlefPFF8//Ro0fL448/Ln///bfsuuuuMmjQINl5551l/vz5csQRR5jX1KpVyzx28cUXS5cuXXx99oUXXmhuyhtvvCEtWrSQjh07VtyfNGmSiTA1bNjQ1zIhyJYtWyZ//vmnHH/88fL777/LW2+9Zc6fv/76q7Rv3z5sNGzatGly+OGHV3ocka5LLrnEnBsTCYUUIYQQkoC0O+T5/zF7pgzsulJ+W1xVRk+pJXXyS2WHhiUy87cf5JCDD5Yze/cOm5o3duxYs1xEotw4s/NaGTa5vhlYMV2NkNxIt+3atasceeSR5v8QQNdee61069atIiKDaM6QIUNk4MCBst9++8kDDzxgxM/kyZMrljFy5EipW7euSYm77LLLTEqdU4x4sWjRIrnzzjtNJHzmzJny3HPPGeGyww47yG+//SbXX3+9WTbEXIMGDeSoo44y73v66afNa9etW2fqqt555x1ZtWqVlJSUyMqVK+WPP/4w2w3LaNmypbz00ktGpGG7hmPPPfc0AtKOSCULCilCCCHEY6Z5zpw5snjxYmnSpIm0atVqqxnncGl3gyfMkL1abpQZS6rKa9/VkqLuq6JOzcNMNwZpeI8beLx5/TLzOkJIckh1ui1S1nDTiEzNmjWloKCg4nkImKOPPlpOPfVUc7+oqEj23Xdf+fDDD000HCDlbaeddpLbbrvNCKMnnnjCt5DavHmzfPbZZ1JaWip77bWXiSb98ssvJiqH1LwPPvjATCTBgMI2ijj77LPl3HPPNcKoTp06JlqkqX3Ypio+IRRvvfVWs85O3n//fSP8nOyyyy6V7o8YMcJ3lC0eKKQIIYQQl5lmpM81Kdgki1bmmUFStarlaXm9t0SRFi5cGDntblyBTJmbL0N6rIopNQ8DE8x0o++Rm5jCes1fVv46QkjiyYR0W4iaPn36VNyHaEK0CGlyKqRsIKCQ+ofzn59IGsQbblWrVpXvvvvORMcQAUNECHVPiDphWfpaG6Ts/fjjj9K2bVuTAoiIVmFhoUnvc34+BBvEmopGoM8j/Q8gmgXxVqNGjYqIFNIMk2XAQyFFCCGE+JlpnlggHbffaJ4HzZo1i5h2N3RSXdlUIjGn5p100klm9hafbw/aFDy+ZoOYSBkhJPFkQrrtihUrKkWoAO7jcTcQcYeIwfONGjWKuHyIF9RXHbklvXDChAlb2Zqri955551X6X1ffPGFTJ061Qg7uO2hjmqPPfYwguy6664zYgh1XUhXhFBDWiCiU4pfgYT3JgMKKUIIIRlFogq8fc00jy+Qq49YKQ8UFxtHqUhpd03rlcjS1VViTs3bfvvtTc1F0ahiKdsySKss7grN86ma+SYk18iEdFtnFAggsuP2uNfrw4Hz0scff1xx/6+//pIePXrIY489ZowtvEAKItL1EE1CBExBNAoCSZeJ1D6kHLql9iFK5QeItmRAIUUIISQjSHSBt6+Z5nfqYthhXofaqUhpdwtX5MnmUokrNQ/fS9OFMNONQRreg0iUfm9CSHLIhHTb+vXrbxV9gqkDHndjyZIl5tyJFLtIrF271tRFISIf2iLAIKQQ8bryyitdlw2TCYgimEjccccdsnr1ajnhhBNM1Ajrtc8++8h9993nev6GIILQ0s+CrTlAfVc49HWJhkKKEEJIRpDoAm9fM82FJbJiXciIGaTDfLa+LGzaHdZP/x9rah4GF/heqLnQSBzSb5D2x0gUIcklE9JtERWCJbjy77//moi705BBgTkExJGfiSitV0LPqNq1a8srr7wiL7zwguktBQMJNNVFjRQcAyGUEF1SPvroI2NJDodAiCtEtvBarCvSIFE7hXWwU/uQMjhu3DjZdtttzTLw/A8//GCiW3D+Q6QNNVJquqGCCy6AyYBCihBCSNqTjAJvXzPNy/OkXs3yiFC3Vq0ipt21bdvGFFMPmlAQd2oeXkOLc0JSSyak2/bq1Usuv/xy4953wAEHyL333mvOb4ceemhFyiEa2M6YMUNeffVV44T3zDPPRP05zz33nLFBhxMf/r98+XITqYcwQxRp8ODBlV4PEQUgpGwgftBXT/FK7fvpp5+MjTvqryCybrrpJiPkANbhjDPOMCnXU6ZMkb59+xqx56fmKx4opAghhKQ9ySjw9jXTvDEkISmrmHFG091IaXdoMomL+sBxU2XopHrSooHIguUhpuYRkqGke7otBBNqkFCzBDe93XbbTZ588knjbKfAfRSGEejBBBGkDXUjgQiQ0r59e3PexHkQ5hGwOkfkCOl/qHeCaMP/nf2dsAxYoUMMIc3v4IMP3up5+3MUiL0DDzzQmFMgCoWUQjj/wZACqYL333+/HHfccSZVEO0q8N0feughSSQUUoQQQtKeZBR4R55pLpB9ttsowz+oV2nGOVLaXevWreXtt9+uZJLB1DxCMpd0SrdF9MUN9JDSPlI2aHCr1uGxAAGj7Lvvvq6GEPXq1TMRsEMOOcSc/3Bz1ruiga6m9jm/A+qbkNJnA9GEPlhPPfWUuQ9ReOyxx5qIP4TUaaedZtILYf0OUQgbdkSv5s+fb75zogiVIcEwx9E80g4dOqR6VUiKwcwJ+ixglgUzNYTweEsPHnjgARkx/F75/tYFnml3ew1pJpddeX1c6W/OPlLboo/UijxZtykk1fJCxspc+0glq09JEPDcRnislYsANNlGtMKOzpDgKdtSv+SMRsUDar3q1oXhT2VnPu0jhRRBpBQqiHahbiuWY8GvNmBEihBCcohEWYdnS4G3c6YZF1rk/MNYArOqNHgghJDIhEKhQEUUsEUUwPJtm3NbRAEvERUkFFKEEJIDJNo6PNsKvGnsQAghJBIUUoQQkgMk2jo8GaR7gTchhJDcgkKKEEKyPC0vGdbhuVbgTQghhFBIEUJIlqflJcM6PJkw7Y4QQkg6QCFFCCFZnpaXDOtwQgjJVve5AQMGSO3atU0D2Gi56667TPPboqIiY8BAsgsKKUIISWN3vCDS8vD5iGCt2xjytA5HrRFeRwgh5H9ARN1+++0V96MRUxBRN998c8V9NIgl2UVln0BCCCG+hRJ6G916663mL+5rGt4NN9wgBxxwgOl79OU7z5q/uI/H8Xw0+EnLw/MQbV6ghmj1+jITwXIjKOtwQgjJNhCJUiCKII5iEVH2coLk77//luXLl2/1+MKFC01j22Tw999/S66S9hEpHAS//fabVK9eXdq1a8ewKCEkreuV0IDw1TGjAnPHCyItL9nW4YQQki1oBEpFkf4NF5lyiqg777wzprRAP+B6BJF2//33Vzy2efNmufDCC+Xoo4/2XfeKibTOnTtHvZ5Lliwxn/PII4/IgQceKLlGWgupqVOnymWXXSYNGzY0O6p58+by7LPPSkFBgXz00UcydOhQ+euvv+S4446T2267zYgtQkgwDBw40OR0P/3009KnTx9uVh/1SkUvj5SSUpGiHisDc8cLKi2P1uGEEJJ4MZVMETVu3Dj5/PPPpUGDBrLXXnuZhrXbbrutHHvssbJgwQJ59dVX5YUXXjDj5tWrV8vzzz8vu+66q+uyqlatGlMvwcaNG0v37t3NOHz8+PFJaYKbTqRtah86FV977bVy3XXXmR3z3nvvmWI9zAL//vvv0rdvX+natau88cYbsnLlSrnvvvtSvcqEZA2IAuNigHS0888/P9WrkzZovdKAruX1SipsVCgd0m691MwvjSsNL1FpeWodjovupVdcJ/sfc55cftV/zH08ns7NeAkhJNVADEEUhUvzS6aIeuutt+SOO+6QkSNHmuACBA1qsJBCPmLECCOi3nnnHSksLDQiZ8qUKZ4iSoUUbrFw9dVXy4oVK9K+F2FORaT+/fdfOeeccyoGBwhbtm7d2oimF198Udq3by+XX365eQ41CohKQXgxKkVI/A5FF198sZnMePTRRzMqnTYog4dY65WaF5ZIs3olgbrjBZ2WR+twQggJPjKVTBEFUBd17733yh577GHun3vuuSalb+nSpXLqqadKlSpVzNj5+uuvlz/++KPSe/fff39Zu3ZtpQk03J82bZoZYyvr16+Xww8/XB566CHXdSgtLTVjBkTEkFrYoUMHyTXSVkhBQUNIKV999ZV88cUXcumll8qgQYPksMMOq3gOYcz69evL9OnTY96JOBBwEJHcZt26dZX+ZhN+Iw5I5fvkk0/kyiuvlF122SWiOUK05gmJAOswePBgGTNmjNSpIUasLFgeMnVLp512mklTDCLisnjxYmkepl6pSb0SWbgyL2IaXr169cz5xu/xhnRCXCAHjhkjwyYXSjN8v2UhE4nC98PzPH+RXD23kfQinY+1DRs2mME/Jgpxi4X//Oc/Zhk47wKIJ5SaICJjp1LjdbF+hh/OOOMM8xdRIIxhIZgA/v/cc8+ZDAoIoGOOOcY8hv2Rn59vXoO/yPhCxoMCIdapUyeTeq7ccsstW22rH374wQQ7Dj74YBP5QkQMY4aDDjrIPI/XLlu2zFyPL7nkkoRPxuK76d9otjdei/2I7YK/bsv1s+5pK6RsunXrZkQSQoe777672YHO2VcMTFAvFauQwkDs119/DWiNSabjnL3JBpo2berLeQcXBaQIIH3WjxPPokWLJNU88shwee/dyVLUfeXWdUuvjpYVK5ZL377/uzjECk6285eFPIXSsbutl2Hv1DWfa9dIVU7DKzMC1T7f+DneevfuLUcccYRJ4cAFu1P9+nLIIYdIkyZNZObMmXF/N5IbZOO5jaQn6XqsIX0Ngioe+vXrVz65NXCguW+LKEzq4XlEcxIFxsH//e9/jSBCJobWQ7Vs2VJ+/vlnk56PeikNOuDahfWdNGlShZjCuNdeR32N/RjEBgSF/RhqriDSILpCoZCZpHR+V0w6PvHEE2Zbn3XWWZIMot2neD2+7+zZsz1fo9sq44XUU089ZXJBUQe15557Sl5e3lYpfDVq1IhrRhYHQtu2bQNYW5LJYGYCJ/8ddthBatasKZkOToDIma5Vq1allAMvMEOFCwImL3ASxMlw7733NtEpr5kZRI+d/Pnnn6a2ESkGMItBISpO8G5E81o3cBGZPPm/RkR5GjyM/6/ceONNUS3XDZhuoEbKSyh9NhPnpZAUTSz0TMNDBKlLly4xHW9Iadb3EpLL5zaSvqTzsYbBM2zBMYbEuDEeEJFCOpstonA91EhVIoFwgas10vuQsYVAA4TR/PnzjdCB2QSupfvuu695PV4LUaT7A2l/GPfa2wCPQfjYj2G8DezHZsyYYeqn8VjNmjXN+5zbEpOFGE8MGzZMDj30UNlxxx0TOs7BfsU+jTb6he+LwIxbWZDfCcqMEFJI3UPBO3beyy+/bNL4nDUGUOd+lKMX2PgYbBICcHLIhuMBBaZIOQDIc9bQuxvffPONjB492vx/woQJFY9DOHz44YdG7LidpBCR0rok5Enj5GOceyxr8AcffNDU8SDdQVPsvGzE3V4bDsywReqzNGxyfXn77bd928B6sfPOO0esV+rV6wxzYYE7Hz4XaYZI50Mantf3ypbjjaQ/PNZILh9rODfjBoGgIiFWUBNliyiA+xAPiayNAph0vOCCC+SXX34x19+ddtrJPI6AAAIOSPuDwIJohOM1hBReg9R9e5LVNstAMOLHH3/cqkbq+OOPr9hWMH1DNAoeBXgsFAqZm9u2RCQKdcUwv0C0LJ4xejg0nc9rPbzAa3Es4Dh1E9V+RVnaCimEJpF7ifxO/TLYCfjiOEi+/fZbOfvssyt27Jw5c6RZs2YpXmtC0gu7AeC7775r/nqJKQzwcXLFibhnz55mhgepfe+//75MnDjRRKVwYmzRooWZ9cLvDiLqpptulDo1qhghNG8pBEOZdNx+o7x4wTIpqOndQymcjXg0/ZaC6LMUDX5sxCGUkGeuArNRo0YmF519mgghJPNxGksgEqWiyk+fqaCAqIHdODwEEGjAxCkEFNYBUaNevXqZa7gTTUu03V4xpkYfKVzrFXwHO20PLq94L8bhkahSpYq5zn/22WcZZVoVLWkrpFq1aiXff/+9MZaAg9isWbPMLDmUPmoCkB6DGXTkaA4fPtxEqXbbbbdUrzYhae0w5BRTcMFErQ7+In0WJ7sTTjjBzM7ghtpDuMbh5Dzujddlpx1byWefieRVEamWJ7Jxs7jWJQ2ZWCC3v1kgd5+y0rWHEgQbIlEQUfH2Wwqqz5Jf1EY8klCiOx5JpqMkISQ5eLnz2Y8nS0zB+AHNcCF+0FMKYu6ll14ykUCYLa1atarieo+I04ABA+TEE0+UJ5980oylI4HrnG3EACGF92FCNRzr1683Y4iOHTuaWzaTtkIKBwFqozC7i35RSO9DmhLSkwAOmvPOO8/MAuDgQDoQ1C8hpDJ6ItdZJYgpzGIhtQ51SRBEa9esNPeRAmDXPNWoUV16dMqXSe0ayy+z/5ZLD10t0xZUk49+ry4bNol02XmD7NXEqy6pQK44fLVs16CkUoqd9lDyk46H10ZKx4OAwQUjvMFD5D5L0UKhRPzglcKKYzaaFFZCSOoJZ3EeTdPeIECDXQQYnn32WXMfY2HUIkFcoU4NFuho0ovMFJxv7KgQ6m394BRMOJehVjgSjz/+uKmTQw1ZtpO2QkrrEexcTRtYKiJvE8154dQHoUVILs9w77fffvLll19uNeON12FmCLNI6qKEesPCOvlSrWq+bCoJSVmoPHfZFlEovjymQ5nstd1GKSktlfxqeVItr0z23m6j/PFPnsxfnie7Nd8kstJDCL1TV17/rqZcfeRq1xS7oNLxgu6zREiQBJXCSghJLX76RCVLTCGrA6l5iPYg1Q41SDCewDUcE6U33nij6S9VVFRkaqmQ2YUABMbLXml2mPTBsiKZM9imTXl5ecbqHLVVSDEEWAbcZeM1d8oU0lpIRQI7KVd2FMlN3MQS8o3fnDjRtASojRnuBmXy51KRYcPKpFrVkLRpJLJgRfmMd5s2bYz5Q92aVeTKq66WGtWry/otFqErVm+ULrtslLq182Xy1DyTxoc0ANCuWZ4sW1dNdmu+Rtat3ySz/lwuHXZsXLFeBTXKpG6NMiOsPIVQYYn8s7qKZ4pdkOl4fuqWCEk2GNAElcJKCEkd0TTbTYaYgtstLM7RLwoTqLjeo0UGrLwvu+wyEzWCcEKm1mOPPWaytlDjjO+BIIQbMG2DKUU0dO7c2UTUUW5jU1BQILfeeqvkAhktpAjJVtGEk9+HH34gs2bNNql3aAK7YHkV2VRSJlXzMBslUtRjlWtt0j7brZUJV6wy9wdPmGGMH1Cr9OZmkWN2L5M160Te/an8Mz/4RaRGtY2yfpPIrrvuavKf62yaIU3q7yaby8qF0k33vy+r126U047etWJd69QolX/XVzXRLLekJCOElufJNnVKXVPsMJsWZDqe37olkjukQ00SHKuCSmElhKS/iEqWmMK5DGl9GCugrhktS9TBDucTTKIqcKXD5yKTC34CXrz55ptRr8dOO+1k/ApyGQopQtKmhmKk1KwmUrVKqaxaHzKz1u22LZFFK/Jk7j+wGC2Tqw7/Vx7+oK4UdV8VpmdSeW2SfX/UN7Wk4X5lJhUPwgyomIKIAihInTtnhtw09GU5uNMuIvn1ZfjwOfLNTwtkr52byCWn7lPxeW0bbzY9k35aUE32cvlORghtDMnJe6/zTLFLRDoe65ZIOtUkJdtRkhASPHCojUZEeYkpezlBoL4Atj8AUu1sEWUTTkSR2KGQIiTFM+E4yb4y+mXjfvfzwqry6re1ZIhLtKloQoF8OL2G1KleFn6G26pN0vvf/JEvpx32v1S8g3YS+fT3/4koULt2LSm6pa/MnvqejJn8q/yxcLrUL6gpF568l9zZ70ipWeN/g895y8pPHR9Nry7fzai9lRAaPKFAquaF5Pznm3im2DEdj2R7TVKyHSUJIf5AVoRfUGcEYNoQbURJXw8RpcshmXcMhINCipAYxdIzzzwjU6ZMMf2W4DIJsYR6pKlTp5qaJD8z4aihGPXyy1LUY6Uc0X69DBjX2KTseUWbBowrkJ2bbA4/w23VJul9kTIT5TKpeHllW4koUFpaJn/9W11O7nGsDLz8CPnw9+ry88Jqcki7DVKvAC8uM++Ha9/H06tLh+abTDTpgnsK5K6360qz+iKLV+YZ0YSO6pgVQ/GrV4od0/FIttckpcpRkhDijl6D4XCHlDc/wJwBzWtjJRn9pEj04BgA8WYoUEgREkWUacmSJfLdd9/JtGnTjLCoWqVMNpeWp+Etn/uFLFqZJyEJyQm7/St39VxphEe4mXDYltbMLzUz549/XFtqRYg23f5mXflzeV74GW6rNknv9+q8XjaWhEwq3pp1GyvS+gACTSqqIArfmVpdPptZW2pvWf4Hv+F+dSmoKbJyrcimkvI+UotWVZNV60JSJiFpu/MexmYV7pnR1iUxHY9ka00SHSUJSS+Q+gZnO1zLASZBs7lZbC5QUlJixi66f/1EoiCicAzgWPDznnBQSJGcxpmGd9xxx21Vb9GvXz8ZP26c1Kou0rTeZlm4AtGekDSqUyIr1uW5puHB9AFiAyYP4WbCEdFqVq/EvBdRpGaF5f93A4+3KCyROf9UDT/DvaU2yb7f56C18nujTfLOtJBYTcqlyy5S7tpnHi8/EekJqW69prLfXjubPhLz5883J56datWqdB8XoS++OIWGDiQtSMeaJKawEpJeaCNaFVMksyktLTWW67Bmj6afLESUn6bEkaCQIjlZrwSL0L59+5o0PJgv1MoX+Xc9LMSHmVlkdP1u166dHHnkkTJn9oytHPIe+aC2PPBuXSOiIpk+oCFtuJnwhSvLI0yIIi1cET7atOTfPOnQYqMUTSzwMGkoMI9hWU9/WtvUKu2z3UZpVKdU/qiyvpKIKqybLz8urG4iTNWrIzJVJiv+3Vghplq3bm3s1t2a8kXqak5IKkjHmiSmsBKSXiAC1bRpU2ncuLGZLCWZzbp168yYDmM7v+maOC/HG4lSKKRIVoIf1UUXXWT6LEDcwD4ckSQIpby8KlJSUiq18kulbeMSI15WrgtJQY1Sk4o3d+4fcvTRR8l2220v8+bNdRVLEF+1ozB98JoJRzO977//zoigk/ZaJ/e8UzdCPUVI7j1lpTz3RW0j1IZOqitNCkpk4cqqsm6jmD5SU+bVlr2G1DG1F6hTmjJzpmx3XV3pe+X/ltWwYUPZZZddTPGsHWFavHix6U8F3n//fTO7Azc/QjKBdK5JYgorIekFBtJBDaZJaiNSoHr16lKjRo2kfz6FFMn4CBPQxxo0aGCEwIQJ401qnVvaHaI0oPse6yrXMU0skJP3Xiu7NttsHPIgoiCa3MQS0vBa1i/xbfrgNRN+/vnnm+gX1glLOr3T2or/uznh4fEejzaSlttUkZrVyoywyqu/s/Q9t7vsv//+pjGfs4cSCl2HDh1a8ZkQRoi0eUWYPv30U3n33XfN//UvxVRukQ49mGKBNUmEEEKSCYUUybheS0jDQy3R/GWIMMG8IWQKzFs2KJN5S2G1XS5uBnULk3Y3rsDYjG9VxzS+QD6/aUmFQ17TLfVLTpA6t2CFf9MHr5lwDPx69eolo0e9bNYJBg91qpeaz4YTHj7fpPttKi+GPfzwI4ypw7Jly1zd8DQVz24kaIsoCKhIokifp5jKPdKpB1OssCaJEEJIsqCQIhkxC273WtII07Vj6slr39aSgd3+9xgEzCUv1pcvZ+dHTLvrtMNGKf66VuU6pi3peJccskZun1jXuPC5iSWThjc5QhrexpAct9t6U6sUrsEsGvwhhW7kyJGysbSKVK1WnjqI77KitJHsvNt20qlTJxO9ijYqYDcA9COivMTUxo3ltVMku6NJ6dSDKVZYk0QIISRZUEiRlKbi4TH0HBoxYoTnLPgll1xS0WtJRcvcpXkyZkotKeq+ddRp+4abTTQoUtodbmhuW6mOaUs6nnHIq18isz0c8rZvWGJMHAaFScMrqF4qJzy0jazfXGWrZrTJGvjZjQSjTc/D65HmBzHWpUuXuNaDpH80Kd16MMULa5IIIYQkGgopEqhYwkANHv2IYHz11VfG7AHRlcJa5RGWe4YNM8JDU/Ew0IMBRNUqUinaZM+Cf/vttxW9lpSx39c0Isgt6oR0ukU+0u667VGydR3TlnQ8dcirEirzrFn6bl6+6SWlaXhN6pWYz12/KSRNC/H/qrL7HnsYkehn4JmIgR8bCeYO8UaT0q0HEyEkfcnUOkpCgoZCisR84nRGkpoUbJIFy0Nm8JZftUw2bi5vVAuxsnhVnnl8n+03yvfz8qVrhzVy72kr5bfFVeXIexvJwDD1TAPG/SZtG1WuVYL4QU8lN6EUTdrdYx/WqVzHtKUHkzrkYem7NttoaqeQ9ldem5VnXmd+QFWqGPe/tRtFZv9dVWpUC0mNfJFFK6vJmb0zo6aEZD5BRJPSsQcTISTzIt+E5BIUUiTmE6dXJKnXEw3k+z/zPRvV7rXdRhk9pZb0O3K1TPqphtSpEd5GfMjEehW9lnSQB/Ez3yPqhLS70zqu9Uy7015Ln86s7qhjKjDv++8vNYxrH6I5bdq0lZ9mzTIGF9Wrlcnsv6uYvks9evSQ66+/XsaPH28Glvn5+RVN4YJKyyPEL0FEk9KxBxMhJPMi34MGDUr1ahKSNCikSEwnTq9I0t//VpFv5+W71i7Zzni1qpXXJoWLLIHyuqVS+WNp+Ylalxkp6rRzk81SUlruzoe0O0TFYBwB4QSx1LbxZpOyV3dLHRNc8dBHatwPNWX0N4g2hYybHowgFi1a5Fm7xBQnkg6pL0FEk9K5BxMhJHMi3xdccEEK15KQ5EIhlWUEPXjzOnF6RZLC1S4BdcarXrXMiKhwkSWAma5/1qBhXmmlWiWNOnnVL93+ZnmvKKQYQlDNWFJVquWVScv6m2U8xNIWO3HJry+9TjnFNKP9/fffTX3XDjvsIFdddZXstNNO5iUsWifpbiEeRDSJPZgIIUFEvpGpcfjhh3NjkpyAQiqLBm/9+vWTcePGVTZ3iHPw5nXi9Iok+Ykwoc5o9pKqRkT5qmfaINKtW3d5c+KECmMHRJjQX2nzlqjT0El1pUkBok7VTHQJ9VsYNH733XcmRQ+iaPXq1TJlyhSpk7dZdtthB9Oo1tl3CYLq119/lZYtW0a9rQhJlYV4UNEk9mAihMQb+V66dCk3IskZKKSyREShR9DMmTOkdnVEXUpMs1hj7oB6pJdHxjx48zpxekWS/ESYYNawqVSMqYP2b/KKLGn/JQzwCgoKTK+l9ZtDMmNJqDzC1GCz/P1vNWMMkVd/Z7n83O7Ss2dP1ieRlJAqC/GgoknswUQIiTfyfWzDhtyIJGegkMoC+vW7SubMnuFp7rBnyw1mcBfL4M3rxOkVSfLrmNd193IRhfVEvVJpWUgGjqtn0gIwo4WTMWbQ7Wia3Wtpzpw5snjxYmnSpIm0bt2a5g4kLUilhXiQ0SSmsxJCYo18IyMEGSCE5AIUUhle34QZ8PHjxktRjwjmDvkS0+DN68SJGiW3SFKjuqURG9WCD6fXliPur11poHfppZdWuOB5Od9xgEfSmVRaiDOaRAhJJH4j30iNR4o8IbkAhVSGF6djBrxWdYls7lAttsFbuBOnM5K0bcFmWbBMTI1SflWpqGdqWli2pUGuSHeHbThd8Eg2NX5MBwtxTjYQQhKFn8g3xjSE5AoUUhlenI7BZfMIM+DG3OHvKjEP3iKdOO1Ikt1PScUfTqoUTLlNLGIoFe538UILcUJINuMn8k0hRXIJCqkML07HoHShH3OHktj7v/g5cbKfEnETTfXr15dZs2YZoR2tGEqF+1280EKcEJILMPJNSDkUUhlenO5rBnxjSHr06BF3OhRPnCTaCNLMJSKlpWWmQXM0YihV7ndBQAtxQgghJDegkMrw4vRIM+Awd2jbdkd58MEHE/xNSK7XJDkjSEv+rSIHDm1sRFS0YiiV7nfxQtMHQgghJDegkMqC4nR7Bvzudwqlab0SWWCWWW7uABGVbrUkJP0EUjw1SW4RpLHf15Q61ctiEkOpdL8LCkZwCSGEkOyGQioLitM5A07CCaclS5bI999/L1OnTpW6Nau4CqRFixbJJZdcIr/8NFWKuq+MuibJLYL0z+oq0qKwJCYxlA7ud4QQQggh4aCQyqLidM6A5xZffvml3HHHHSYaBDF96KGHSr9+/aRp06aVIktNCjbJguUhwb8TdvtX7uq5UjaV/E8gffXVVzJz5kwRKTNNnWOpSXKLIG1Tp1TmRzRCcRdDdL8jhBBCSLpDIZUGsDidRBNhWrx4sbz55kRZtmyZETrN6pXIwqV5MmrUy+bWpnUbmTd3jrvb3cQCyasicvcpKysE0oBxM+SA1htk2oL8mGuS3CJIJ+21Tu6ZXDemaCvd7wghhBCS7lBIpQFMzSPhcNYubdhUIiWlYqJHTqE0eHyBzJo9K3xkaXyBXHH4atmuQYkRSEMn1ZV1m5HyF1sanlcEafuG5csvmlgQU7SVEwyEEEIISWcopNIIpublhsnDfvvtZ9Ly/Lri2W54rbbZJGc93dBTKH34e3X5cnaEyNI7deX172rK1UeuNsIGAgppffNXVI25JskrgtT/hFXy++KqMmBcgQydVE9aNgxVauasYskNTjAQkv5unYQQkstQSBGSpEhS88JSmbe0TIYNE6maJ9KmcUgWrgjviud0wzv98QZGNHkJpeaFJSbVL2xkqbDEGEGoQFqwPE96dV4vP/yZH5fpSbgIUo8e3aVt27YmHdHZzDkSnGAgJHHE49ZJCCG5DoUUIQma0Z0+fbq8NXG8Z61Sx+3WyKArVoV1xXO64S1dUyWsUGqCeqmVEQwelucZIwi7YXOfg9bK2o1VYk7DA4wgEZJ5kSRn/7do3DoJISTXoZAiOY89EKlXr57ssssu0r59+7hmdOctDcmaDaW+apXCueI53fAa1i6V7+blewqlY3dbb1L3wkaWNobkuN3Wy9Of1jYNm/fZbqOpl/q/k1ZWrBeW0aSgxIiu9ZurREzDs2EEiZDEiyWnO2cskSS3/m/RuHUSQkiuQyFFchb3lJaQrF5fJqeddroMHTrUV0qL24wuhMiTn9T2Xavk5YrndMPrd+RqOXVEQ0+h9NnM6ubvoAnukSUIp3o1Q9L9kW1Nyl2bNm3kh9kzjajCa9XN7/Y3C+TD32tIh933kBEjRnAQRUiaNcnGb/eP2TNj6vsWrv9bNG6dhBCS61BIkZxNcwmb0vLqGKlatWrEgYjXjO7KdSHZrr7/WiUvVzynG94BbTZK28abPYVS0YQCCYlIq9Y7ysDxsxy1SmXSocPustdee8m2225rlq2z2m51TayPICQxzJ49W/r27WuaZOdXDUnLBmWy5N+to0nhzlGDJ8yQvVpujCuS5Nb/LRq3TkIIyXUopEhW8L+Z25FSK1+kWWFpuZHDsGHSrl07OaFrVzn11FMrBhVBpbR4zej6akZr1Sp5ueK5ueG93e9vOeb+RsYJ766360pT1EXhszZBQomcfvoZJpq2aNGiClEZzuABYhHf089rCSEBnKdGjpSa+aXSbtsSWbQiT2b/HZLTOv4rOzfZLHdsiSZBaEU8R40vkHnL8kxqbiyRJLf+b9G4dRJCSK5DIUWygptvvlleGf2ya5rL4Am/y8MPTZf777+/YrY3qJQWrxldX81oN4bk5L3XRXTFc3PDW7Iaj5RJrYJGsrJMpHCbanLiYYfJVVddVSGAoqlVYl0TIYmnIsLUwyUdb2KBnNZxrdzWdYX5rdeuXTvyOcpKD44lkuTW/y1at05CCMllKKRIxqftIbo06uWXzeAk3Mzt1UeskuFbZnvz8/MDSWnxmtGN3Iy2wDyGiBTqk8K54tENj5DM76fkKwo+vkDev/ZvI6C++eabiOeoZlZ6cCyRJK/+b9G4dRJCSC5DIUUyvs9JjRo1TJpMpJlb9G7S2d6LLrookJSWcDO6cMHTZrRIwUNN1IIVeWbZ1fLK5KvZ+bL7oG1l/aYqcmbvyK54jBoRkrn9lHxFwd+pK2/9VMNM4oDI56g82WaP8vTgWCNJ4fq/RePWSQghuQiFFEnqLO+cOXNk8eLF0qRJE2nVqpWv2d5IfU4KChv4bkJ7ySH/msFCWVmZceeLN6Ul0ozuj/NrSLduXc1sdEVhecMy+WtlSGb+XUX22GMPGT58uLRu3TrKLUoICZJE91PyZexQWCKLV+YZIdPrhI7yww8/REwP3lwiFWIrlkgSI96EEBI7FFIkab1OkMLSpGCTLFq5JSpTNSTDhg2T3r17e872+kmHGTCuTNbl+zN20JS9zZs3B5bS4mdGF9/N3j40dCAkfUhGPyVfxg7L86RZYZ45d/Tp00fWrl0b9hzVtm0beeC9WfLUZ4VxR5IY8SaEkOihkCJxE6nXydw5s9xneScWSMftN5pZYK/ZXj/pMHe+Xa9imZGMHeyUPbhiuQsg9JE6zfdAxO+MLgcqhKQnyein5M/YISQfT69RMYnjZ5LGrzsnIYSQ4KGQIglLiXnkg9rywLszZEiPVRFMIFbKAx6zvX7SYbZrKPL7IjHNZsMZO8AiGMYOmrLnJoAKCwulffv20qVLl6jrISiUCMlMktFPKVIacPn5KySn9yqP0PudpOF5hxBCUgeFVA4RT51SLCkx1fJEalcvi1hcLRIys8Fus71+0mEWLA9Jhw4d5OefpsnAcQUy9O260qReea3B2k0h8zn9T1jl6Y5nD0SQSvPrr7/GtC0IIZlJsvopOSNM6Hf35zKRdRtEdt9jdxk+/BHXekmKJUIISU8opHIs9S6WOqVYU2Jg7tCyfmQTiBXrQp6zvX77nDz66KMyYsQIGTlypGwqDcmfy6vIxs1lUqNamXz1R03pfEcdulARkqHW4YkmWf2UaOxACCHZBYVUrrtR+ahTijUlBuYOsPuOVFxdr2aZ52yv3z4nmMV1psCoKISQZO0AIZlrHZ5okt1PiREmQgjJDiikshy/TSDD1SnFmhJz0l7r5J7JdSOaQISkLOxsbzR9TjhAIST50aREW4cnA/ZTIoQQEi0UUlmO3yaQ4eqUYk2J2b5hieyz3UYZFMYEAs8P/6Be2NlepsMQkr7RpGRYhycDnmcIIYREC4VUluO3CWS4OqV4UmJ++LO6tGrdVgaOnyVDJ9WTbVGfhXS/TSGplheSKXOrS+/e/nqeMNpESPDEG01KhnV4MuF5hhBCiF8opLIcv00gw9UpRSKaXie2YyDqmtjzhJDUEUQ0KRnW4YQQQkg6QiGV5fhyo/JRpxQO9johJDMJIpqULOtwQgghJN2gkMpyIrtR+atT8gNTYgjJLIKIJiXLOpwQQghJNyikcgA79S7eOiVCSPYQRDQp2dbhhBBCSLpAIZUDOFPvWKdESHqzYcMG+ffff2Xjxo2Sn58vdevWlerVqwf+OUFFk2gdTgghJBehkMohmHpHSGaIqL/++svYklepUkXWrVsna9eulW233TZwMRVUNInW4YQQQnIRCilCCEkjEImCiIJoCoVCUlZWVhGhSkRUKshoEidrCCGE5BIUUoQQkkYgnQ+RKIgogL+4j8cTAaNJhBBCSGxQSBFCspZ58+aZukC4zsEwAbU+6W56gJoopPMhEqURqdLSUvN4ImE0iRBCCIkOCilCSEYJIRBJHCE1rn///qbZLPokweIb7nQwVtB0NURi0hEYS6AmCul8iERBRGFd8TghhBBC0gcKKUJI2uEphIYNM6YIeKxlgzJPcYT3jhlVLEXdV5hms5UMFEYVm9fAyTIdQR0UjCWS4dpHCCGEkNihkCKEpB3hhFDRhALp2mGN3HvaSldxNHfuXCPA8F7b0rtWfplcsOU+jBXQDiBd0/wgmiicCCGEkPSmSqpXgBCS3al5DzzwgNx6663mL+6HA+lsP/zwgxQXj5QBXcuFkDaKVSE0oNsqGT2llsxbllfx2G1dVxjxhOWPHTvWRKwgwNyAxTeeR3ogIYQQQkisUEgRQhKSmnfDDTfIAQccICOG3ytfvvOs+Yv7V111lRE8qHGCcHL2T4LAqV09ghCqXiavf1fTVRxhuUgFVAHmBI/D4huvI4QQQgiJFab2EUICM4Po2rWrFBYWyqBBA2Xi+HHuNUpvvC6bNm2U66//T6VGs9o/adWqVdKiQVl4IVRYIv+sruIqjrAeqJ1atzHkugysB/ok4XWEEEIIIbFCIUUICcgMIiT33DNMunQ5XD744H0p6r7Su0Zp/AQ5//w+0rBhw4pGs9o/qUGDBjJ/WSi8EFqeJ9vUKXUVRyeddJIxoIBosz9fweNoNqsOgIQQQlJLJraqIARQSBGS5cRygUKane0aB6GDx/T+XXfeKa++Mto14jRo/PtGNIVLzbv7nUKZNGmSnH322RWNZrV/0jHHHCNPPPF4eCG0MSQn773OVRzhu8HFr2hUsXH4O9MZEZtYaJ7nRZoQQlJLJreqIARQSBGScxeoYdKtaze5vG/fiv5EBQUFFUIJUaH169dLSUmJ+T/S7zZv3ix5eXlStWpVmTVrlowaPcoz4vTm1Bom7S5SjdKyZcsqNZrV/kkQe926dZOiiRNdhRBc+07vuFa2a1DiKY5w8VV3vmGT65vPQ8QKYksvzoQQQlJLJreqIARQSBGSixbiEycacdTv6qtl+fLlsnLlSiNoIJYgqMrKyqRWrVpGOCFKBFGF/+M1H3zwQVgziAPabJTHP64dITUvJAcVFFRqNGv3T7r55lukWrV8Gfj665WF0PoyI64mTqsjPyyo4ymOsFxcfGFxrtG4Ro0ambQ/RqIIIST1ZEOrCkIopAhJ81S8/fbbT7788suoUvN8XaDGvy2nn3GGNGnSxESGAIQSIlkQWbhBPEFUhUIh8xcgkhTODOLUjmvl/nfrhE3NW7uhzHwPNZpw65/00EMPyfXXX7+VEAJ+xREev/rqqyNuc0IIIcnFT6sKTKThfM/zOElXKKQISdNUvOb1S+XPpSLDhpVJtaohad1IZOGKckOHE088Ufr3v9UYM7g1bvVzgUKdEqJLvXr1Mo+pUEJUCiIKUSigIgp/QSQziEZ1S6VaXkgGT6gXtkZpzz33jLhNvIQQL6qEEJLZsFUFyQYopAjJhFzxiQXScbu1MuiKVeX3x4+TzZtL5JZbbtkqqhPNBQppfYoKJUShNL1PjSAgrvR+ly5dIppBbCoR6dGjhwwcP541SoQQQrbCT6uKeUvL5BCaTZA0hkKKkBS65kGwQMzMmDFDiotHRrAML5ArDl9dyUK8d+/eppbJKaR89VJaHpL9CgvNfZhKAAglpPlhmTVq1Kgwg7Bd+9q3by9nnH6GFL0y2jPi1Lv3maZG6aabbmKNEiGEkK3w06oCaeBPPPGErFmzhg5+JC2hkCLEEjuLFy824uGCCy6QnXbaKa5ts3r1ahMxev3117ak6pXJAsvWdcCAAUZcwakOVuDhDBxMrvg7deX172rK1UeurkjNe/fdd6VNmzYxX6COOuooqV+/fiXXPggnGEA4xZmaQoA777pLquTlRXTFY40SIYQQN7bffvsIrSoK5PROa2XXZpvp4EfSFgopktO41SWh/gf3I/Ww0F5LcLWDAMGykP6GSE69evXk1ltvlbcmjjdRJjdbV1iMX3755SalbsWKFdKifln4VLzCEmMr7rQQV/vw6C5Q5XVKSNNzE0qRoCseIYSQePlfq4qRctfbdc11btHKPFmzISQdWmyUGlXL5N/1Ibmiy0p5gA5+JA2hkCI5TSw9LCCgEEmCZTiEk5o0KEhBmDlzpowfPy58qt7rr5nIUdOmTcsNHJaHIqTi5ck2dUorpeYdus02ngIoGb2UGHEihBASKzoph3Ty5599Sjq3Wic/LagmP86vJnP+qSabNleR+SvyZPWGkFTNK5NXXnlFrrvuOm5wkjZQSJGsr0cCbjVK/npYjJTTTz/diB2tFVq6dKlJ2/MCEaZIvZbKbV0L5b333jN1Tocffrg8++wzYVPx1mwMycl7r6uUmof3urn2AUaNCCGEZAJwim3TuHwS8ZdF1WRIj1VbTW4OnlAgb06cSCFF0goKKZIVogkRnfIo0HiTogfHuj+XhWTYsGECL7o6NauYx+ZbNUron+THIhyf0adPH5PCh/opnPCB3VvJCQwkmkdI1WtWv0xWrVpllgHnveOPO16KJr7tmSuOxxCRevrT2hWpeW3bto24nRg1IoQQks5gknPe0pD8tqiWFHVf5T25OW66ufazQS9JFyikSMbXNUEgzVuKlLUy6bj9RnnxgmVSULNMrh1TT177tpYM7LbKNW2vVZsdo7IIR+QHNVEQU2oV7gUMHBZESNVbsCwkJ2y/vRGBSAe87vrrzWcMfOMNk4oHofXnP1jn8j5SU+bVlr2G1Ak0NY8QQghJNUhzx8Rn7eplviY32UuQpAsUUiTtLcKj7bd0+5sF0rfLahkzJfzM1oBx040Qi2QRfkCDBhXiCf2U9P/apNYZlcL9I444Ql544fnwqXobRE499VQTGVMeHj5c/nPDDZUsw/fdd1/58ssvK+7jgsPZOEIIIdkCDJLatWsnpct/jji5iWshIelCWgupX3/9VQYNGiQ///yzmak/7bTT5D//+Y/pefPRRx/J0KFD5a+//pLjjjtObrvtNs9aEZJZ0aX5DotwuNvBFQ/7ff78+b76LWFWq06Ema2hkwplzfqyiBbhcLbDZ0Mg4S9qjzS9T0UUBJX2YoJrX+fOneXMM3tHdM1zE0RuqXj77bdfXNuZEEIISWe6desmI4ZPD9+g959Sqf7tt2bs4OWoS0gySVshhWL+iy66yEQmHn74Yfn999/liiuuMDUhu+22m/Tt29dYR+OHB8eX++67T26++eZUrzYJ2DUPx4E69EBMjR071le/pW/+yJcWhSVhZ7ZaNhQpq9NOiibO8BQ7xx93nDRr1qzCrQ+GE0jbQyoebqB27drmMaeQT4ZrHiGEEJIN9OzZ04zlwk1urt8Ukl9+mmrGDk5H3UzJqiHZRdoKKRgHQCRde+215n7jxo1ln332kR9//FG+//57ad++vRFSAP16EJXCaxmVStwJYs6cOaZhLVLRWrVqFfeJwpdr3vhxct5550nDhg1N9MePiQP6UIiUyfwVVcOn7S0TufiMrrJo4UIZOHqUyb02Ymd5yESienTvLjfdfLOZ9UI6n92o1k/PJbrmEUIICYpsH6z7adB75r5rZacmm80EJSbXU/39I2XVhOtFSbKDtBVSe+65p7kpJSUlMmvWLDnkkEOMM9thhx1W8RwczxARmD59unTo0CGmz8Mgfe1a9yhHroITxODBg2XMmNFSK1+kScEm0ygPJzWYH6AwFNbgAwcOjOlEMWbMGKlTQyIWlr711lvSq1cvkz7nx8QB/ZZ6dV4vP/yZH7FGqWvXrtKyZUs5v08fc4FasmSJdK5d26SR7rzzzlu9D8dhtMcJLngXX3xx5fXksUZEjBOk/ZeQRMFjLRuuxeXXTEz44TqIwTquVbFeg9PxWIMowYT5gHHTZNikutK8fom5pqP9B8YE/3fSStlcEjLtQ0aPHm2yk1IJJvJff3WMZ1YNygBuv/32lK5jtrMuQddRrYPPWCHlZNSoUaZWBjMwI0eO3GoWol69eqZeKlYhhRMVarLI/3jkkeHy3ruTTT2Sm6kDHPJee3W0rFixXPr2vSLqTTdjxgxpVhjeNQ/OdYiCYd/jgIaQfv755yL2W+pz0FpZtb6K6TvhNrNVNLGeHH30USZ1UPf78ccfX+kHxOOBJIs//viDG5vwWCNRX4uL4rgGp+t5DZGpNX9Nk1P2Xi3/rK4ijeqWyr6tNsiXs6ubazragGxTp8yMIVJ5ncbYBBPNYWu2x4w25lO2qRTJnOsoMpGyQkjhx4LoR1FRkRQUFBjnNGcKHwr845nlx2yOn548uZRCMHnyfyOaOlx9xCp5YPJ/5cYbbzKRnWjYcccd5eP3q4S3CF8ekoMaNTJdzyF28RknnHCCFE18y1Ug4SRbNS8k5z2/rcxfKrK5FH0n6pnZK4gyWI4jEuU1i4cZDfwYd9hhB6lZs2bM248QP/B4I8mCx1o2X4tjuwan67GmY4NLDlkjVfPKpP/YenLKO9sYAynUPiNC9e+GMqk9d64Zt6UqGvf+++9H7EWJsccvv/xiTKtIZp3bUGLkh7QXUitWrDB5sChC7N69u3kM6V1O+0v09/GjHL1AtAODdVLOpEmTIp8g3kGdUMi87u233466rwPEzIMPPhjBNa+8ABWGDuqK17//rVK9eg0Z+PrrW5k44Bhp06aNqaVSq3Bg24n7sQ/Hj5HHA0kWPN4IjzUS87V4cv2YrsHpel6zxwa/La5a0cpk68yYn00NUqpMJ1auXCktItVs1y9/HccTmXcd9ZPWl/ZCCioT+a8tWrSo5MiH2qlvv/1Wzj77bHMf7mkwQlB3NRI/EB0Rm9UWlsiKdaGY+zpELiwttwi3a+WUhx56SK6//nrfAindLjCEEEJIINfiLOutpGODwS+PlJLSMinq4d0PMpWmE6h/hrFEJFMrvI5kL2krpFCjcs0115jIwnPPPWesp3FDWh/c/DBj8c0330inTp1k+PDhJkoFW3SSxBPE8jypV7MsrhNFPBbhbv2WCCGExA6us8jwwEQm3EqRCYCZXnUsJcklVwfruPZPmzZNZv72Q8RoHCZUUzEWwOQtDD8imVqhtp9kL2krpNA36oMPPjD/P/jggyseR6PTF198Ua688kpji11YWGhqoxAG1tQvkqQTxMaQhKQsrhMFLcIJISQ1Ygm9+ey2Dngcpk34C7cxFVK4j+ssHHIpppJLrg7WMTZAy5uN/0xN22ic36yaVFu0kxwVUrCehpjy4pJLLjEua3gNnPpwgifJ7eewz3YbZfgH9QI5UTC6RAghiY8iwbQHA0/8xevwHhVJWAYe19qAqlWrmuXp+/A8hVRyyeXBOqJsC9I8GhdPVg3JDtJWSPkBDjXp4lKTjdgniKGT6sm26CO1Ik/WbQpJtbyQTJlbXXr35omCEEJShUaREF2C2FEhhZYRblEk1BTjdXgMgglp9HaECu9FNArP6Q2vQVo9nifJJ1cH65kQjWNWDcloIUWSe4KAoQf6JqAfQuvWrX253xFCCEkcGkVSNIoEAeQWRYJIgljSqBP+4r6m+SFCpeJJb7iPZcbjjEtiJ1cH65kUjWNWTe5CIUUiwhMEIYQEW48UFNFGkSC0ILBUIOGviiSsG6JYWGdbdOlgHs+T9LoWo8+UiiukuCE6kw7CIihyNRpHMgcKKUIIISSBaXdu9UhBialoo0joyQeBhHXDOuE1KpKwTlorpfVWuizc8DhgnVTqwTHVv39/KS4uNn2mYJEOdz+kwqnASFWj2iDJ1WgcyRwopAghhJAEpt251SMFJUY0iqSRJ40i4bM0yuQcmDrFklMk6bo5hSAai9K9Lz2AiBozqliKuq/YulHtqGLzmlQ1qk0EzIwh6Qr9wgkhhJAEoGl3bvVIQaFRJLQCqVOnTsUNvRW9Il94DAILYgvCCzeIJLU+dxOCEGX4q3VXJHXMnTvXRKIGdF1hTBjU0U4b1d7WdYV5Hml/hJDEQiFFCCGEJACID02PA3Y9UpBA4KA+Bi62KNDHX9wPF/XyI5KSIQRJ9IwdO9ak84VrVIvnkQpHCEksTO0jhBBCEoBt3uCsR0o1KpKwTmqbjhvS/Zz1V27GFCR1oE4INVHp2qiWkFyCQooQQghJALZ5Q6Jc+/y6BTqNB/AYekrhea2TKikpMf2n8F5N/0tXIZjLINo4P80b1RKSK/hK7cPJc8SIEcYlpXv37jJo0CCZPXv2Vq/76aefpH379olYT0IIISTj0LS7Zs2aGQECcbNw4UITLbDrkaIF78Uy3JalJhGoe8L/8XfZsmWV3q9iCPVRQO3SncYTEIL16tUz/8ffIB0HSWxgLLZ6fZkxlnAjHRrVEpIr+IpI3XnnnfLSSy/J8ccfbwpaP/30U3nllVfktNNOkxtuuEFq1qyZ+DUlhBCSUyS6B1OmWqFHWpabWyBeoz2hAJ6rUaNGRdoenkO0CVEpuwbKdvEj6UEmNaolJNvxJaTeeOMNufDCC+W6664z93HixWNDhw6VL774Qu6//35GogghhGRUD6ZkouIGDXERBYJgwf3ly5dLkyZNArVVdzOJ0JsNJkHxWns5WC5roNIfNqolJIOEFHKmW7VqVXEfJ1yElg866CC5+eab5YwzzpBbb72VYooQQkgg0aRk9GBKJhrlwfVUa5LwF2l3sCqP5jtFctNzM4nQm42zBgriTqNXSBfM5AhgtsNGtYRkkJDaeeed5dVXXzX1UZhNU9Bd+qmnnpLhw4fLgAEDpFOnTolcV0IIITkSTco2622Im1WrVhmhot8LQgpEKw4juem5mUTg2q2f52aGgeVpvZT2lcrkCGCuwEa1hGSA2cRtt91mzCUQeVq8ePFWz19xxRWmg/bUqVMTsY6EEEIyiCAauSarB1OygLixo0OI/sDcAQInWnGIZSEiAaGE9+Kv7abnZhLRoEGDsGYYSPOD6MLfZDTfDWeWQQghWSWkdt99dxk/frwceOCBW+VYK926dZNx48bJjTfeGPQ6EkKyBNSDXH755dK8eXMz6DvvvPPMLD3JLoKIJkUSC5mGChqIJ2wLiBWYPYBoxaEfNz3bLRB/nfbnqYwAurkK4j7FFCEka/tINW7cWK655pqITjIYGBFCiBOkDh1zzDHyzTffmL/t2rUzbqCLFi2Sd955hxssiwiikauzB5M6zi1dujShDn6JdApELRSWqymPSKGLVRwG7abnd59pJAnbCK/BOiDNP5rvkG31b4SQ3IUNeQkhSQHunhBR1157rdx7773msbPOOkv23XdfGTNmjGmnQLLDRjyoRq4qFpLl4Jfoz3HWJKnphN23KVXoPsN6Ie0QN6wbtok26MXfBQsWmNcp+P/8+fOlRYsWvvdvttW/EUJyFwopQkhSgDFNnTp1pKioqOKxzp07y+GHHy7FxcUUUllkIx50NClZEYxkfI4uB/sAESlsm2QYO2C/ox7rzz//NCmFqJmyhQ8+FxEzRIjVvQ9g3bBNmjZtWiEAgdqpQwzihoa/foVUEBFLQjKZefPmyeuvv26iu0i9RfNk9v3KTCikCCEJByY1c+bMMc6ftWvXrvQchNSwYcO4FxJEqtKogowmqRjDYBvL0cG7DuqDIlmRkkTsk3BRRzy+ZMkS81kQSatXrzbbTmsV7WWouEEEUQUOLNt12Yq9jfC6aOvfgohYEpJp4Hffv39/M3lYp0ZIWtQvlfnLq8g999xjmiijP1ikekaSXlBIEUJiBgMotD6AOLrppps8X4eBtBrX2Hz66admQIdZb8xoezmLZSMYRK5YscKYD+jfRAibVKdRBSEaIAzWrFlj1lnT4SAIMMDXtLMgSFakJOh9Ekms4rel1uc4zgCiYc4oEj5f7dl1vXQdVaAp9jbC33jq35KRbkpIOgARNWZUsRR1XyG9Oq+VmvllsnZjSF7+upYMGVVsXgMXbJI5UEgRQmIGIur22283/0eDbtzcUGc+FKXbIurdd981kSoAG+RcEVI68MVfDEIhEjCwTURqV6rTqIKIJmGQDcdHTYXDd4Ag0PqioLZZsiIluk/wfXCDKMRnwXo8EWIV+8B23FWB5BRuWC8VqbqdbaGE7YDfMraR3eAXr432txu0WQYh6c7cuXNNJAoiqs9Bayoer5VfJhdsuT+wuNi0FGKaX5bZnxNCiBt2mh5EEcSRG9rIu1atWpVElD1DbhewZzs68NUUDvxNVM+eVNuIYwAOsQDhgM/HIB33NZrkBwy4UdeD9caxhGXiWMKxE2RkzY+teBBg22PdIaCxHbDvsV0gUmI5BiJFuLC9VPQAFUFOMa1RIbxfBR5eh22vzyEdELVU2A/4DtgP0RhNEJKrjB071qTzIRLlxpmd15rnUTtFMgdGpAghMaPpfDfffLP5q+LIGZlSwYWBnS2iwB577CEvvvhiRjh2BeV+l8x0u1Q7xQUVTUK0BtvHjrpAgAQdWUtGpESFIUQUxArAd8L3QT2hNsQNKuqIaBEmKtSNT/eBM4qEz4SpBPYXRJ7+diGcdH1UTBFCogPGEqiJQjqfG3i8ef0y8zqSOVBIEUICEVMYFHqJKTQFBRBRKHpXjjzySJk9e7b5f2FhYVoLoSDd73Tgq0Iq0el2qXKKs0WDDvLx2YgsYUAfq0EBwPfQv0HWSSUL7G9bWOpj+D7RpitGSknEX/SChE05PsvNtU/B5zZp0iTAb0oIAXDng7HEuo0hVzGFWqn5y8pfR3I0tQ+Fq1TShOSmmIIo8krzw4UB9VFffvllxWN4PcTW119/be5jQB8t2hwU9VXaJNTrPmb6Ye0MAYH34a/WKUVbh6IRg1jT8TTdDu8HmuaXyPSoINc/WhBNwgAefzGI18F+LAYFiJBAbECAIL0MkZNo9mO6gO+u0Sg73S6WyKSflERse2y3li1byvbbb89UPEKSzEknnSSr15cZYwk38PiaDWKs0EmWCymk8WBg4mTSpEnGvpEQkntAFHmJKfzFAO6PP/4wEy4qojD4Rd74zjvvXMmIIpoIkQojpCOhWSgc8NQRD/fxuN7XXjqxCIkg0/FsUYDBM/4mOjJkmz4geqhmB0FbiEeq08Jnq7mGRpP8gu2D/YcbepJBlCVTEAa9TfA91HxDI1S4xRKZxHbAhAWiv/ibaRE6QrIdTGBgjFw0sVCe/rS2iUxpJAr3h0wsNM/TaCIHUvsw8DnrrLMq0nWUXXbZxVVgEUJyA03n0/Q+FVMYPHfq1El++OEH89iNN95oHrvsssvMOePyyy93XR4G2hBAKgLU8hpoM1AMptVpDDcVShAI9n0MtnXwjseiFUJBu99hoIt0RkTJ8DfRA99kWYiHE44QtRC+2HYQVro+sfSUSpWde1BoCh0ipZpuiRsep3EDIdkJ+kSpO9+wyfVNTRTS+RCJ0j5SJEdqpGwrVYALM9J2WIRKSG7jFFMqfDBovPLKK+Xhhx82M24aoejYsaNcc8015jUYUKqzmzqHYeAN8FoVACqidPYeaWO2wAHO+3iNOpHp89EIoUxvIposC3E/0aR4e0ql0s496H2C9U73fkpBmawQkuvgmoE+UbA4hzsfUs+RjYG0P0aislxIDR8+3Nx0ENOzZ8+tXoP0lHvvvTfodSSEZKCY0kiUgsjRkCFD5IQTTpBHH33UpOV16dLFiCtEizTtS0WUuoth4I3BvzYUxXN4TJuH4i/qP+zmoPo6+z7eg8/Q90QrhDK9iWhQpg/xEEQ0yRa02ptKv1MmRnPSvZ9SkCYrJLXMmzevYvCO9E/U4nDwnhqw3a+++uoUfTpJiZCCWu7cubO5YJ177rkyePBgadWqVcXzOKG2adPG5K0TQrIX5+w0fvvof4O/Knx+/PHHSiIK4D6i1nvttZc88cQTZhCPgRnQWh0MjLXnFP6P5amIsqNLANEUHUhrRErdz3Rgro+rcELPG4gJjWaBpUuX+hZFOujVbRDNe9OBZFmIJzKapIIWg0GkfapBA5aLmjhkRWSamEpnIjX7JekP9l///v1NM1j0KYIFN9zj7rnnnop0Mu1pRwhJkJDCxclO29ttt91k1113jfLjCCGZjM5OqzBR9zTcYK8Mvvrqq0rufNovB3z22WfmtRBTtpjRCJTe18cAHldBZKPCCeJAI0sqcmyRh/sq0rB8TS1Dmlsss+yZPEPvTE/UqB++A4RJogWhfr7uDxXO0X4mXq/259j3OsDHYzAzoZAKjmypSctlIKLGjCqWou4rTDNYWG/D4AAucUNGFZvXIN2MEJIk1z7kduqgiRCSO2gkSmuNVEQp33333VYW53379pUDDzyw4rHPP/9cvv3220rvU1FkP6aiSh+z7+PzMaCDSEPtVcOGDSvWD+hAGvd1XdVoAjVXKPDXyEy0Dn46Q6+Oa1g2xAGEWbpj22Rj/XXb6nZJtI04Ph/NXYGmauKzsT+idd3D/tNUc6D/5wA/WPD70OgwyOSatFxk7ty5JhI1oOsK6XPQmor+RbXyy+SCg9bIbV1XmOeR9kcISZLZBIQUISQz0DQcOyqDKI4tNvzW/GgkyhY+OsByiqgDDjjA1EpBZOyzzz5mkKt26Hgd7mu6sDYJReRKRZI6u2HQr+58eF5nyJFGrI0L7QgRnODUrQ/LVfMK1HCqeMB3tlMDNTrixwpcB+pYF005xF8IEYiEdI9KaXoiIlDONL9kpGzhM1T06LGD9YCYUlHrB7xW6+R0WbhxgB8smW6ykuvAZRnpfIhEuXFm57XGPQ61U6zZISRJQurnn3+WgQMHym+//VapoaDy66+/xrJYQkjAaBoaBII2fwWrV682A2m1XIao8JOi5mwiqjz11FPGwlvZb7/9jEjS9+Cz9957bzPQRXof+OKLL4yw2X///c1rnMIH/8fjWK5+D6A1TroezhoOtUHXdCT8H6/HMrTeSmuDdHY9GitwrBNqwrQ2R4WUrku6C6lUp2w5xbh+NvZNNNuvQYMGFb2wVEhheXicBEemm6zkOjjPoyZKI1FO8DgsuPE6QkiShBQa8gIUKvKiRUj6oI1pEZUBGGBCMNgiCthiSPssqR15uMGsWmhrWpWKqAcffNBMrqiIQgQKUS9dPqJBeI+KKxVTn3zyiVkOekypcIIhhG2FvmTJkorvoD2j7OiJ3WgWr9EoBf5vf099nVp/a4pgtFbg2AYwmVAxgL94rzoJZgrRGD8EaX/tFOO6L2Jx70PdLmqidL1wPWKkJPecBYk3iNrDWALNX93EFGql0MdIo/uEkCQIKeTSPvbYY2YmmRASDJEGq06RBHFip5LheTR3RVRJcdYwObGd2yBSIg1mnU1En376aSOiFIgo9IXCcrGeulx14sN9iCxbTH388cdmYI3H8Ty+F9AUPbVFB1iORpg0FQ8CUNPsbGybb31Ot4em9eF5+/9YdqT0PmwDpBsilU/frxbtmZRWZhs/aBQP3wfb247KBW2u4RTjKqK0J1i0y6JwIiS84zImvWEsgRopJ3gczWBhhU4ISZKQgmPftGnTKKQICQgIKBUnOvDH4FV740AsYPCqTmUA4gEpZk2bNjWDSSwDj6l4iKbw3o6uRBrM2k1E7fXBQLtt27bmeyhYD0SYsI54PcQHvs8uu+wikydPNhd40K9fP2nfvr0ZtGv0TF+rEQx8N2wDra9R0aM1Tm6C0W7gC/BXo28qIGyx6Te9DwIW21bFBbZDutSN+I0eqfEDxLduB93u+F7YZ3hN0PbXTjGuIioTe0ARku5sv/32xuK8aFSxlG2piark2jex0DzPflKEJFFIoanmRRddZC58vXr1yqhZWELSbUCL18yfP79SI1pFrandoiQaSdIifRVNtnBAtMStpknR53Vw7FcM6PdAcTLWAWl8uBhr5Eg/H0IGj7ml4J1//vkVqXgwsFEzDPzFetmv1e+gaXR2VAnv10iVc/vghnXV12E7aVNaXb5dYwOwHERMMNj3WzcSS0+qRBBt9EgbFOP7Y9+rmNZ9hvckopbKFuOsuyEksaBPFBhYXGyMJVAThXQ+RKK0jxQhJIlC6oILLjAX5zvvvNP0HoAVut3/5b333otxdQjJDjTNTgeqGJyimBfGCc50PAghFQHh0vCc6MBWi/R1QkMFhF2A7yamVIhobyW7RghEEgIQGxhwQwRpVEaxv4c224XYQrqemg2ACy+80PzVwbpGhDDQ1hopjSopWtOkBgW4DxGg30WfU8MKuwZKm/Pq9nC6x6m48uPAZzfnTZe+UtFGj7SezO7npdtahVIQTXTdYN0NIckB50eM1XCuhjsfrkWNGjUyaX+MRBGSAiF15ZVXxvmxhGQ3EBkaYQE6+FyxYoUZoOogW9PjdPAajZCya4CwTPRSghsfBvG2UICAKSgoMJ9tCzt1ttOoF4QGLrhYlh8hAFEUTqjZYHnq6qfixxZHdu2S/bhtBqGDeI3cKSqgVATpcpBSqA5/zua8Kvpsxz18d12eWqT7EUJBp77FY/AQbfQIy7WbIdsiXIUS7a8JyQ4gmmhxTkgaCCnMYhCSC3gNZiMNclVk6ODeHuRr41c7bSqSKQSwIyd6XyMuKhRQ1wIRB0GlggPvQS2VRmjsQbVt0GA3ubXXMRzqfBdp3fEabDNNq9PPtr+T1i6pmYS+VsUA1h3b1Y486fOalqhRIZhBuEWUsJ/s/kma2mcLNI3Q+U1dS0TqW6xRrmijR9geOFZscQnsPmO0vyapJkjXSEIISbmQ0oaa48aNM12zkeI3ceJE0yDz3HPPDXQFCUnmhRqDVQxcMYD1GsxigA6x4meQa0ekFHuQjUGBplVFSu9TkWFHf7Qvku20pkYI2jfJtj73I3h0G0Ryr4O7np8Gtvq5mt6nDnv2YF9rdHTb68Df2TDWTj2z66RULKjjH+57pSjawkct17GtgPazisaBT8UL3oObCkG1f4+FWKNc0UaPbPHt5Qapr+PAlaSCdEqdJYSQQITUm2++Kdddd51x3kLzXZzYkLaDHFwMIvr06RPLYglJOM7eQwAXaHW7A3gcvWkwEHYbzOI5DJjDDXIxGNXBuQoAoAN/t7Qp20wBNzxm9ygCSFfDemmKoL4H9zEQxqBYne/0M1UY+Ekb1AiGGg6Ec6/DYBvbwmk77oWeJ+yUPQXLQGQE64r1Vltz3Q76Hhs1RwAqxGwnPa8BlzNqow2DVcTpsaDiFISbDdeojkYhFUQBcRzE4kQXa5QrluiRuugRko4kKnWWEEJSJqQeeeQRufzyy+Wqq66SnXfe2TzWu3dvM+hBc04KKZKOqSBAZzadhfaa9qYXZgzaMTD2GszqgN/5uC0yMCC3Lba1jseOENgDX7Xy1jQ4TdnTZrR4LZ6DEYKd3uZ08NN+UGoL7mUN7oXf5rRqTa5iQ9fHS1hhfbBN7fQ+uwZKHfqwfdRoAuuB10Oo4DXaNBhoZE5T8TSi4jXg0v9r7RpEltaK2emGCraz7getIXITZ/iLdcT+tmvTbEfFaAd88Rg8MHpE0gXnbw6/IU0b9fubSETqLCGEpFRILViwQA488MCtHm/durUsWbIkiPUiJPBUEBUlOqh2OttpvY/TvtttMKsRHq9BrqZM+RlE6P8hFuzGslq/o+uj6WJYptYH2QJJxZSun98olBd+mtMinVcbq+o6eIHnEDlDVEpFrN0w1zY9wHdQIYTHIZRsgWSnRmrEDdgDLhVmf//9t0ldczoJOgWfm+kE9geWie8ZbjbcFrY4lvQxdVSMVkjR4IFkQx0pzsOaYqy/EdyPJjUvUa6RhBCSMiG10047yYQJE2SfffYx93XggjopjVARkqoCYq9UEBVWKko0tcwWJHZNk4oEZ72J1khFqkOx7bH1e2JAgffqQEC/s91M12kqoeuj3yFcKp0dfYpHREWT3ofX4OZMvXNDIzbYXpoKp/tC94udrucWAUT0R6NIdiqeGkSo+HM22lVUNCsaAbOPAY3I6baONBuuTYMV/exYZ87T3eCBxf/Zj599HK5+Sc/Ddoqx/p78mtkATioQQrJOSF1//fWml9SPP/5oTpLDhw+XhQsXyvTp001qHyGRwEUUaU+a2oVbUAXEXqkgdpqbpr7pANxuzArwGESCrqtzMKHNRDXa5NV/yZ6VxUBbxYZGLbTxq91MN5wA8lOPZDve2ZEz4Mcd0Abvx37COrrtF4284TXYfxAl2HaIrrmhwgn72X6PNhTW9dM0ObzWdtdTMwdbIOn/vQSLNut1Oh56uQfa0T57u4WbDcdxgX2p0Tk7lTPWmfN0TdFj8X/2CyW/+zhc/ZKeh/W8ak8SOd1DM3lSgRCS28QkpDp37izjx4+XJ554wpwYkerXrl07GTZsmEnvIyQc2oRWa2BUHARVQOyVCoLCf40wAXvAq+9TcwMVRrhgb7PNNlt9hq4jBhcqBlFT4xxsYBlqGmFHLPT/+IvGvejzZD8eD5oCqAMZHQxp5EzFSDh0u+AvvhMGVV4iF49huRBvKhr085youYMaHKjI1N5XmrZn94nS48Q2c7CjVnaqpdd3cQolt+9qRyN1+2i9mZ/oI76Pc3IAj8diNpHOsPg/84kklPzu43D1S3oe1vfbkxPRpual66QCIYTEbH/eqlUrY3tOSLRoE1odbNoGBUEUEHulgjgjTBgkq8ubRi70/2rqEC5K5mewgeVHMnzAMjBwV1OFeNBZX6cboM4Kaw0SRKWKQC80xU37M4UTuU7x6tWHCc8jcmNHCN2EnW11rs97pTw6H1NhbAsjp7CzZ8ft9D2st6b1qQ048DMbjsc1UpnNM+cs/s/8lMpI5y6/+zhc/ZLbOUh/m+Es+QkhJCeE1EcffSS//fZbpR41yhVXXBHvepEsRiMMtsNZLLOUXjid8OzUO40w6Yys9mVSYwJdHxUQbq5v9myrDtBthzzboEFrZyKl0yGVrUWLFjJ79uy4olIqANzcAHUQpILRth/3Auut3yGcyLUHTfa2dAOvQSqwGkrYdVN2ZEmb8KrY0ubD+GubRbhFvuxIpw7unINCTa/UAaNb/yTF72A1F2bOWfyf+SmVkYSS330crn7J7Twci2sfIYRknZC6/fbbZeTIkdKmTZuKGVvFTskhxA1tQmunu9mzmEEQKfVOZ2QVOxqFYxiv095NGAS4DWI0yqRRJ4342AYN+D5wjfOqbbJ/L3g9+kRpP6VoXPdU/CGqpb9Je1D/zz//mO9vz0BjG4Rz29MIjbNJrtf2xnbF58CZz89626YOtumE3ZjYNm2wDULsCJNGqxQVZyqW7AiT9vfK5ohRomHxf+anVEYSSn73caT6pVyYWCCE5DYxCSnUR11zzTVy8cUXB79GJOvRizRQMYULsJehQaz4KYS2I0k2thU6hBHS0ZzLUqc6p/W13X8JN8zAao8jp8BQAYABPmjQoIEZ4EQSURrFg9DBe7VWyEsYuM1Aa9TGy+BCtwEEmN2gNlxfKbWV94MOzuzPc0bJnI5+doqfmoRow2KISID9otvULcLElKL4YPF/5qdURhJK0exjiiVCksO8efPk9ddfNxOWyKw5+eSTZbvttuPmz0QhhZMqLNAJiQW3lA8MjJctW2aiGUGlfujAwy31TsWNH5MC3Nya86oQUfGkzXadaXCwUVeHQHWeU/AeO4qE7928eXMTxVKx6URNDFS44K+bIUakGWj9HpHs1BUIKnwPuPR57Ru7OW8kh0HdXtqE2E7Bs9P79PtiOy5durRSfR0ieEE4PZLo4OA5s1Mq/Qgl7mNC0gNcI/v37y/FxcVSp0ZIWtQvlfnLq8g999wjZ555pvzf//1fpUlJkgFC6pxzzpHHHntM9t1334pZYEJiTb3DSUKFDgbHiCgEYYWOwQEEkFvqHZrCgkhRH5ycVDC5NefF+mFgb0eqnGlwOvur62Gj923rdLxeIzsqvFTwOBvY+p2RxjKRMoibWwQuEhopwrYLl0rkZhcebpnYH1r7ZNcqeaXg4fFsN3MgJBkplRRKhGQGEFFjRhVLUfcV0qvzWqmZXyZrN4bk5a9ryZBRxeY1d999d6pXM2eJSUg1atTIDKiOPvpoOemkk0xoUQu3wYknnhjkOpIsxa1OSQVCNA0bvdDePhrBsFPvMBixey15CQsdsNjW6V7NeYFGm/BXo0U6+4s2Afo5tmud9kyyxaNG0+xtokJOxYc9I43PwnqoIyLA+iGKY9cxxiKi9H36G49kOoH1iCSgEEFTEYj3uAkitwFisgd/bDxL0gWmVBKSWL788ku5//77TeZDw4YNTQnLfvvtl9LNPnfuXBOJgojqc1B5iQColV8mF2y5P7C42Ji8Mc0vg4TUww8/XP7mqlVlwoQJlZ7DgI9CivjBrU5JxQGOLdv9LtaBh4olt9Q7u9eS3QzWiZt1ukZocF/7TyHag/fj9RoJU2GEm9YAaYNYu7+K7QqoDX/x/dVG3E4H1FovbDdtfrtkyZKtBJJG3yDQkAIXTjBGwu4BEy6VSB0R8bn26yHobEORTIgisfFsdpENojgTokjZsJ1JboFr5HHHHSczZ84wAqVZYYl8NytPevb8RNq23VHefvttcw1NBWPHjjXpfIhEuXFm57UybHJ9Uzt19dVXJ339SIxC6v333+e2I3FfWDX1zlmnpOlxtvtdrKhYcku9s1Pu9HNt1ALdNixQwWM7+KkIVNe8SI5aKhb18yB4IJrwF3VIGqHBumm0yg0sA+seKbUPy4k1EuVcb61f8wLfFTVe2TCQYuPZ7IGimNuZEC8goubMniFDeqzaKnVu8IQZ5nm0/EkFMJZATRTWyQ083rx+mXkdybA+UmDKlCkybdo08/8OHTpIx44dg1ovkgMDmHBpYGryEER6n11XoD2dNNoFkQQxZ1t2a62W9jXCOkIQ6Hq4DbDxmKYN6vo765e07setr5SmBgJsL2wfrNuff/4pQaC9smIF37+goMCzz1K6zJoHORvOxrPZA0UxtzMhbnz++ecmEgUR5ZU6N2DcDJP2l4o0P2R5wFhi3caQq5iC4Ju/rPx1JIOEFAamyMfEAai9djBQO+CAA2T48OFm1prkDuEGr+EGMPjh23VKmgoGtP9PLNa+4RwC7RomRH8glrDOWk+E1+Cm6+FMuQs3wFaB5OWoBRGCCJNaobuh6XhqPuHXSjwSaujgt9mvpiDiO8OSPdmW4c5jSveD2zGmr8V+w7ZTR8V4GpYCNp5NH+IVyBTFyYHbmWQaDz74oBFN4VLn7nq7rqmdGj16dNLXDz4EcOdDdMwWegoeX7NBjBU6ySAhddddd8ns2bPl+eefl06dOlVEp2666Sbz3ODBg4NeT5KhKTORLqx2nZKdKqdOebFY+3pFSBD6dqb5aa2R3atI19PLGU8H2Oqop9EerLNGlmy7c9t0AtbhM2fO9FxXTT3E8m0Dl3iBSEREbPHixRX1YACfgX2VCjc8r8Gx85jSpsraL8o+xoC+VvcHXqfiONaGpYCNZ7MnLS9bRXG61SNl63Ym2QuMJVATFS51rmm9EvO6VLD99tsbi/OiUcVStkXYVXLtm1honqfRRIYJqUmTJklRUZGxP1c6d+4s//nPf2TgwIEUUjlEpJSZSBdWZ52S3QQXg6ZITWCjwUvU2UYXaiKh/7ejZRBAtgOgs/mspgNqRAuDfjfTiUjoNoLIhCiwjSZiAUWympKH7e418ErkAMzZCBl/1ZwD2wnfUwfHzmNK68fwOqyzfYwBfa2KWRWjiHbG2rAU0CUte9LyslEUp2PdVzZuZ5LdwJ0PxhLhUucWrsiTfXZqKKkCfaLUnQ/GEqiJQjofIlHaR4pkmJCyU7Bs3B4j2U2kiFOkC6s9WMXAWo0R9Djz0wTWL16izrY218/Wxr3hnAN1GVrPBcED4YTvF850IlKKnW5D7f2EZfpJ8cP3w3dRIQpw32mWkexBlj3g0/t2vZa6NgJbbHn1pHIeY/pa/FXRaTtAxjMbngkuadkeJQkiXSwbRXE61n1l43Ym2U2/fv3k1FM/CZs6t25TyFihpwqMKdAnCiU1cOdDdg3aEGn7IZKBQuqYY44xKXwYoKnBBFL7sKOPPfbYoNeRpDGRIk5+Lqz2YFVT4xB90GVFagLrFxV1miqmEQwcx7jh5ATTiXATAvbgXr+zdhTH8jS1LNygD6YNMLAIV5uEaJSmAuK1EFS6bESY1OkPnwnRhnqzZMz6xjJItgd8ziiebieNCupy7WPKFqzAeYzpa9UcRCOI+CzOhif3GEhElCSodLFsE8XpWo+UbduZZDeo7YfF+aAJM1xT5wZPKDDPp7qfFIBoosV5lgipm2++WS699FI555xzKplNoF4KdVIkd/CTyuH3wqq1O5pep4NofS5esA6oFYIosZvcogcTLLtjSaFTUaDCyo/phPZa0sGhoiluWE87YtekSRNJFc6UPLVjj2aQbA/4nM6Bdi8tLNe2pddjCmjKHpblPMbs1+KGZUBcqlU7B3XBHg/hhFIioiRMF3OH9UiEBAP6RMHiHO58MJZATRTS+RCJ0j5ShAQqpJAu9OKLLxo7yJ9++qnC/tyumSK5QZCpHHgvBl86UPfbBDYasJ4avdCBHgTUsmXLzPpHSk91S2u166tU/EUSlnavJRULqWxY6xZlAPagGc9h3+D3rxFDP4Nke8Cn31WxhRWWqd/deUyFc+2zX6s9uCieEkMkoZSIKAnTxdyhwCQkGJDlgT5RGNPCnQ/GEh133sZEf9IhEkWyuI8UDjAeZCSoVA67Jsg58Fq1alWlSE2sqFiyB3q46QDdz4BPxZQaHKjwww2PIU3Qa9CfjukvXlEGrLs9aNYaJwhPiB6/g2R7wAfcUvXwWYi8havl8tr36bQts51IQilRURLuY/dtwnokkmgwSaITjfgdp6IdRrLAeDYVFufxMG/evIq6KWS7wAaddVMZIqQ++OADeemll2Tu3LnmQgqLxnPPPVcOOuigYNeQ5NTAAPVDbn2WMBBfsGCBieTEcxJXsWQP9HQgjwsEPgfCyMtMRftbYR0gmIBbNC5d65WiiTLYtvBAHQTVKMPvINk54ENES/tluRlikPS1wfbrwknXtuSQCQIz3SzaiX+w33Dd1Wsi9iF+//Feh0n84Prcv39/KS4uljo1QtKifqlp3IueU+rkp/XbJA2F1CuvvCK33XabqYk66qijzMX0xx9/lIsuukhuvfVW6d27d/BrSnICtbR2AydzzIzFcwKHWNIeUDoQhEDQWbbGjRvL/PnzKyIuKp7CDfZTMSgIsqjfjy282rlrjZJbrVKmD/gylWTaYEfjwsmBM0lHi3biH1xvtfWEMxWeQiq1QESNGVUsRd1XmGbClXpLjSo2r4EBHElTIfXUU0/JJZdcspUdJHba448/TiFFYp6F1NQ7N7tvnRGLB6wHZtO8UhVgUIALxY477mjyptOVIIv6/djC66AZ2wdGDqms5yKps8GO1oWT5DbpaNFOgkmFzxXSMXUOmWCIREFE2ZbttfLL5IIt99FzCnbpqV7XXCAmIQWXM7faqIMPPlhefvnlINaL5OgsZLg6JU3Bixc1JMhkgizq94oyhEtdJPFPIOC1sNtHxFP/xrJtk22DnQ5CielimUG6WrST+FPhs510Tp0bO3asWSdEosC8ZXny+nc15Z/VVWSbOqVy/G7rzfMQgLRLT1MhdcIJJ8gLL7wge+65p5mhBjAJePbZZ02DMJLbxDMLqal3aiFuoyl4JNii/khRhlQPmtMV52Ae2wk9v/xMIOhkA/5i/6EuEJHQWFKecs0Gm+limUOuHZvZRrhU+GwnnVPnEB2DsKuaVyY3vFpPir+uJXWql0mLwhKZvyJP7plcV+rVLG/tQtJUSC1atEg+//xzOfTQQ2WnnXYyP65ff/3VXODQ3Aw9psCIESOCXl+S5bOQduqdNpzFiRvpZOnoFpSqmfGgi/rTIcqQjsLIdl+077v11FIrd0wuRZpA0MkGndHEX9yPJeUp1wwemC6WOZG6XDs2s41IqfDZSrqnziHFENGxm16rJ699V0uKuq/aSuyhkfD333+f9HXLRWISUijIP/HEEys91rJly6DWieT4LGSmpN6lcmacRf2JjSYhQqRF1hDy2K+YlcX/8Rjej+MadXTaUwvL8zuBEGTKU64dC0wXy5xIXa4dm9lIplyPcyl1Dplfw4YNk9Hf1JKiHqu8xd74qabGi3VSaSikbr/9dhOBwonaDbj5kdwlV2YhUz0zzihSdOi+wXkL0STN99dIEkQShJE2hVYhpRMD9n3sdwgru6cW3q8pqZEmEHSZdi+teFKe0vlYCDpKwnSx9DwfZeKxSUgmps6h3dDuu+8uM3/7oULsOTmz81oZNrk+66TSVUhdfPHFJrXPy1kNIovkLrkyC8mZ8fQeqNuP26l4uGlzYY0EQRCp3TsEkS2GgPO+W08tjTD5mUBwNinWAXC2TTYkIkqSKxM10cLzESG5kzq31157ybq/vjfr5AYeb16/zIhCkoZC6rvvvjPOJTCdICRXZyE5M56aKIaXQLIH6nActFP17FQ8jUCpOFIBhPtYpl3jZKfe2fft9D7tqYX1xOfadVVeEwg62bB06VKTRgir+YYNG2bdbyYRUZJcmaiJFp6PKoPjI9dqe0jupM6hxGbxqmqybmPIVUxB8M1fVi4KSWKpEsubLrzwQpk8eTKVLslpcFHGTLgOnPGXM+PRg+2GWbOFCxfK4sWLzYVp1qxZJpKBwRCswWFwg+f+/PNP8zwew/tWrlxphJOm3GEwjYE7BlA6gMfjEEvaTBL/d6L9UfAetftF1Alo3ZJGqnAfy4Eoq1evnvkM/MXgHscELlzNmjUzf8MN7vFcYWGhEYH4m41CIFFREmwrv9s5V+D56H/gvLFgwQLjJozfNP7ifriG74Q4U+cgUMKlztWpUcWkzqVK7K1eX2aiY27g8TUbxPS9ImkYkcIg5p133jFiyg2m9pFcgDPjwaZ+6X2NGAE8DqGhQhWo6QMEkg7Q7VolHajrfWcqHhwgEcUCEEYazcIN+1TFcDjXPkZB/MEoSfLIlvORRpLsSDOixNFElPB+rWnUSCh+/3icUSmSDalzEHvoZ1U0qljKtgi7ShbtEwvN8zSaSFMh9corr8hFF10kBx10UMVAhZBcJBdSGJOV+qWpcoqeWyCsNGKkpg54Hd7nVqukaXZ4XNPx7FQ8vBZiCc8DLAODNbzHWbvjHHRxEBYdrGdKLplyPvJK3dVIkv42AX7PiCghbRdW3H5+g1iuni+A/p+NgBO7/7KJTEidQ1NgtWKHsQSEHdYJkShtGkzSuCEvcvr33Xff4NeIEJK2OOuTgAqXWCI2duqXHYkCTrMHTbXTQZZ+rtYo6V+IJK2Rsg0JkIqHaBT+7xZxysbBQKrJligJCa4uKZwBiUaSnOgEiN+Ikp4XbJMY3NgIODtt9hOVOgcvAER37BqpdEqdw7UOTYHRzwophoiONWrUyKw7I1FpLqTmzJljdtobb7xhVLuTF154IYh1I4SkoW04hIhGe4AKHNxH5Acnd78XVzv1y1m7ZAsrjSrhr9qOa7oO0n5UINkDdfw/0gA+nSJM2TrLmylREhLbMQrwGOoV7ZYoeK1bFCmcAYlGkrwcgf1GlCDg8Nk4P+jycJ7C4yQ+7P2HutZJkybJ33//LU2bNpWzzjorawbw4VLnHv2gtjz4XoHsuOOOZiwMMZXK743PTkU/KxKHkDrggAPMLRlgcNSvXz9p166dXHnllRWPf/TRRzJ06FAzM3LcccfJbbfdxos1IQGCwQ2iOhggKbaAUuwZZFxgIWrUhCOSO5vTBtzpjof/Y1maiqe1TBjE4XMgosI54yVzAB+PEMJ2w2xits/ykuyKRCDlDuCYdxM5bnVJ4QxINJLkRjQRJXweBBxd+4JHI/933XmnvDHuDaldPSQtGpTJ5GUhefTRR4346N+/v2QDztS5ZoWlMnuJyKaSMqldXaTK6ukyYvi9JnKlqXS4VpHcIiYhhTAimDJlikybNs2c4Dp06BB4I16cuCGQYGoBIaX8/vvv0rdvX7n88sulW7duJrR53333yc033xzo5xOSqUQa1KtIwkAIQgiztXXq1DEpcZryhkETBvN2ZMhtpthGa5cgcvy4szlTv5AyjPVRMwjcxzoBfQ2+S7pFa+JNd4EFejo2UyUkXCQJ5w+vCJLiPAeEMyDB71ojSTZaGxlNREnPEyRYsJ+Kiopk0lsTpaj7yq36Kw0ZVWz2X+/evTN+0ztT58aPGydlS6bLkB6rXL83wOtJbhGTkMIAAQfWF198UZHWg8EPolTDhw83s8RBMGjQIHMgwz3F5sUXX5T27dsbIQVuvfVWE5W69tprOeggOY1aiSOKpKl2AI9hgI/fE36z+A3bgxW1/YaAQYqGDpo03Q5/1VkvHFrrZA+OIuE3cpTOgiLefkkabQvaJpwQPQ7xm/f7O3bDLZIE9LfuhfMcEM6ABL8VjSTF49pHEgcm4CZOnGBElGd/pTFj5IgjjjDjtGwAqXNaMxX2excXm7FxuqQ3olWI1k7BFCPVKYjZSkxC6q677pLZs2fLc889VxGFQnTqpptuMs8NHjw4kJW79NJLTZ7q2WefXenxX375RQ477LCK+5j1xaz19OnTTWQsFnAxwMmd5Daa42/n+qcDGPwgaqE234jUOFMIND3MXnfnoCncwBy/AbwXTWLtFD4dJEWaedZlYPCD5Wi9VLr+rvxsU7/gO+p3d55Twn1/3Vda76XuYnofA8t03X7psN1J5G0NUaK/Z4gS1LOAWLa58xiNdD4AiHQ7j2H0XdNjAMe4RqLxOkz0oGDejWz7LWQiqI2vUyMUtr/SsMmFpvxiv/32k2xhzJgxUqeGRPzeo0ePNhlTqf7dYxyu6ww3vwXLQ0YInnbaaTJw4MCsOueuS9C4zS4zCFxIobgQoV3bta9z587yn//8x+ygoIQURJQbmF1zqmqcmJFaE6uQwoHH/ldE+eOPP9JqY9g9kQAEEwYe9kwwBkkYhMTakkCFwJIlSyqZPziXZ89E2//X+5hJ1llqDOJSgc6cO2fL7ced5hYYYDpTiqL5PLdGvzhX6cA1HNifGj20WbVqlWlGnE04v2c8251Ef1xCwOC4DBdF8sLtGLU/ywkmbtLtXEriY8aMGaZWKFx/paaFZabfaDbte7/fG69L9VjykUeGy3vvTnZNvSx6dbSsWLFc+vYtL9HJJv5IwPHmJ6umapAqLVk9pTBYdKbLoCYjntkqqPO2bdsGsHYkk8GMBn6MO+ywQ2ApqvECMYIBtXMGGIMaTXnB8YvBOAZJ4WqawkWVNJ0MkxKYIbZnsiGw8Dxml/FZqI3QxrhYD7wvVdEFO8KB9dCmvvpdsV4FBQVmG+qMOt6D53DesPtSYf0LCwtjWgfdXvbn6r7xc7zh9dkeqcHgCt8R30u3UzzbnYQH5wSIGWxv/IYhoNTlMpb+N27RRIDHMIGiEW98HvZnupxDSXDAqe7j96uE7a+0cHlIOhUWptV1NFnf+/gdd0xpSiPS+SZP/m/4FMTx/5Ubb7xJWrZsKdnAugSN22bOnOnrdTEJqWOOOcak8CGdrmPHjhWpfSiyO/bYYyXR4HOd3aRxgYinRwQu6ugzQwjAjzHo48HLACKSMYRGJLSeQOuQ9C8GNxA/WF9MJoSzD7b/7yay8L0bNmxoPh+DLa/1QjptMmu+INzwXXUAqLUS+rxt8oABIwZ4GOhprZK+H99Pt5uKRJ1l1+0R634Pt738Hm/Yj9kMhJSmfCrxbnfiDbapNq52Xuti3d5ux2i2H7fkfyA17MEHH4zYX+nQQw9NyHU0rb/3+jLp2bNnSr8zMsYip17Wl7fffjvrLNNrBny8+Q0OxSSk4I6H+qVzzjmnYhCCwQvqpVAnlWj23HNP+fbbbytqpzAbht5WzZo1S/hnExJrrxU3VzdtHOvH7U0jTbYAsg0J8DkQDBqZdRNT+hgGslgebhpNsl37UtX/x9nwF99HHfzsme8WLVqY7+s0edCaMJ0xt00b7PRIDCzxGq1pisYcwwv2S4pMOMe2XCZRPcRsYwedfMExj2Mfj6WzgQvJvP5Kxr1uYqERHU2aNJFs/N6DXx7p+r2LJhQILi8jRoxIqXMfJhZb1A+fgoiaKWcwgsROTEIKs71wzvvyyy/l559/rrA/t2umEgksz/FD/eabb4x4g1MgBoC77bZbUj6f5BZ+IklaH4CBPAb6aterwgjvc3N103SwcG5v+L1pnyU7rRbLtweheD0c9yDMIDj0vXZjWogJ3Mcy0q3pq9NCHPe1dgb3VQRiIKi9aZxOYuEEkkagtLkvlo/72hdFncNI4gjn2JarxGud76e9AM4JiAYCfAbODzjuc61PWbY2vU51fyUMzOcvExOJ0j5SftOiMolLLrlERo4cKQPHFciwd+pK88ISmb88T9ZsDBlh1bbxZilKsXMfMjbmLw+fgoh9FUtqLwlISOGErI0w4ciCgwUnpGTulF122cU05z3vvPNMHjYuOgi5uhW7EpKIQY4dSQK4MKuBgfZlwu9CG9Pq+93sre1IiZvtNT4L4kzT1vRz1M7cHoRiUOA2ExhN/5Ugo3DRDFq8oktu6Yi6fZwRDmxLFUa2QNL9ZQ/gkQKAc5ndw4aDqsTi7BuWCds90YPveK3zI4Fl4HehtYC4j//nWp+yRArWXMPZXwnRDTgtwiIcY8JsdVecMGGC1K1ZRcZfvlje+qmG/LO6ijSqWyon7bVOtmtQYsTLfe/WN9skVWlzatMeKfUSVugkyULq+eeflyeffNJYI+PvQQcdZB6//vrr5fvvvzc/IgibPn36SNAg+uU2M3D88ceb5ryIhiWrZoPkFl6DHDuSpJENfd42L9DGtJpG55bSZEdK3FKdNNKEdcHFX9PxMJmRDoNQe4ACsJ7at0qdBP0MWtyiSzZ2qqJuH7cIhxbTOwWSHZnLhAF8tpJJKZDJGHy79WcKuocYluWskcykPmUq+uI5/yVasOYiEE3ZVmfjJ22uXZPN0q7J6rRMm/OTeonn2U8qyUIK0R70jEJNEkSLbTF+yy23yPz5843ZxH333WdOVBA5yQCOI9niOkLSc9Y43CBHI0l6YQe2s57dmBYpdniPM6XJLVLiluqULoNPt+2sAxRsD22iqX2QNJVQI3PhBi1u0SU3C3MILI2wRRPhSPY2jPeYZBpSard/sgbfyagbw7I03RekY21auBRqiFlN9dXzLe5HI2qTIVhJdpMpaXORUi/1eZJEIYUGY+gPdeKJJ271HOqScINbHwrAn3rqqaQJKUIALr6LFy+usL/GLahZ43CDHLvJJQZbOvi3HeFwsVfBpOvqHCgkI1ISxKDSa3ZeByQ6yME20O3hjMyFG7S4RZcgQPWz3Fz70klkBhnJYBpSard/Mgffyagb0wkPgG2C32qyatP8nHvC7S8Vs7oP9Byr38WvqLXP5Zr6a9djpts5hKQfvtLm1pf30IINeaqiPpFSL0kKhBROODoQDEc258aS9AQXQIgoHKNqvqCPBzFr7DXIsSNJwNnkFRdtrSW0Bw6piJQENaj0mp3XgY32mnK6BdqRuXAz4JlYP5OoSAbTkFK7/ZMZLUrGcY9lIYqLAR6Wj/rAoD4jXH0kXDd1++H87DXJFW5/qZjVHm1602X6FbV6Lsf62JEtfC7Oj6yVIvGmzQ2eUCD1apXJqJeeNkEFjf6kqh9grqVeprWQOuqoo+TOO+80M8G77rqr62v+/PNPk9rXpUuXoNeREE9wobUjUXYaWBCzxuEGOXYkSRtTpqNxQVCDSq/ZeTW90MGJOhYCTfPTyFykGfB0jC7FQryRDKYhpXb7OwffSFnVyQJMHAR9jCbjuNeWB7iOB9VrxW2SBuIJqMW6ilB10nQ794TbXypmNY1ab1heNBElPZdr9oKew/X9rJUisaTNbVuwWRYsE1m/KSSnd1ord/VcKZtKttQjjSo2r02lHTpJEyEFK8t+/frJKaecIs2bN5fWrVubBnwYLOEiAxE1ffp08zheS0iy0s40EqUXaZ2tDHLW2GuQkymD/qAGlV6z8xp1Q4Ru5cqV5nEdtGHfuEXm0pEga5LijWTkWr+loOvBgtp+WAdEnzH4xjlGI8441rGsdD6ek7G93SZpIKTsyRQbr0mucGl3WDecT1TMKlqPqmLOT0QJz2NZOCfZxwJrpUgsaXPPPPOMMV87Yuf1cvtJK41zn3lNXplcsCX1b2CK7dBJmggpNOp8+umn5YsvvpB3333XiKYFCxaYkx1mtjTc2aNHj6y90JP0TDvTGUWdoXRGhUhwg8pwtRxqu45BZ6pT85yDRC1Yj9QHTI0ygnBni7fuJdv6LYUbuCeiHszefkD7kcXSiFb3AZaZDW5v2M6omQhie7tN0tgix3YK1Mc0kmTvh3BpdxCtOK/AKRXvVTGlk2b6ulhqpXJhkiLZYL8ihRRCWv9m4u8kEhBGaL8DO/THz15uUvzmLcuT17+raWzRt6lTKsfvtl7q1Ail1A6dpFkfqf3339/cCEmXtDO9AAMVU7ggYlCfjSfvWAhqUO6nliNZUToMtrAOds8ubbJrD8rxvfFavAbPu/UB09QeHHuYGMLr4h0sx1v3kk31YpGEUiLqwXT7OaOksTSizbY0S2yDoLa3mygBdi2THUXS55x1SZHS7jQ1GJEkbbit57JYa6WyZZIinbAdFrGfcaxhf2Vr/ZnaoVfNK5MbXq0nxV/XkjrVy6QFGvWuyJN7JteVejVLZcmSJZJuwAxDjSiQ7ou+UoyaJakhLyFBEu8gJVMGnKm0sg5yG6UindEWTVprYTdA1hlp1Kk5B+XaxFht2N36gOnADvfVsj2IwXK82yodU0dj6ecTSSglSqhg2diXWtMUq2jItgiG1pQGsb3dRAnEjn6OLt8WWPid6qSHvR8ipd3ZtVIa3dJ9Es3+yJRrRiaiv3U1V8DfaKKFmWqHftNr9eS172pJUfdV0svFgAK9VtOF2bNnS9++fWXa1KlSq7pIy4YiC5ZXMW6EqTbHyFQopEhKCWKQko4DznSzsk73beQFBmOY1dS0TTWvUHRGGmBQ5ByUu82UO/uAAcxo60y3vi+TB8uJINZ+PpGEUiKFShAiLdsiGNqeIAgbcC9RAmzBrSmWEElaO+W2H8IdC27pmlqzFu3+yNTzYbqTbdHbSMBOfNiwYTL6m1pS1GNVJUv0WvlWndT4qSm1Qwf4jcPDYOTIkZJXpcysr1P00RwjNiikSErJtkGKG7Sydo/KIb8cg7pwaCQKr9PeXE7s2gvnQEwHY7awcvYB0/5fmt6Hz8yU4zCe9AzsC0TmdH/AHjvc9421n08koRRkPVO0n53OEYxERbEREcK2DcoGPJwZj4LjEymWduNyt/0QqQ5T90M0EVGSPOyoYS5MSMEfYPfdd5eZv/1gRImN1kstXpkn1fLEGFMMGjQoZesKETX65ZESkjIZ1C2M6KM5RtRQSJGUkgtpFrk2S6dEMnPAAEnTfLzQdD7gFFF2pEkdAp0DMYDHnQLJ7gOmAzbUR2HGPB0t7L1mF4uLi00xM/L050eRnoH9AsMg3b7YNtgncGX1ElOx9vOJNFkSZD1TtJ+drhGMREax8f2TbQPudz9Euh4wkpTeOCdFNKU33Sek4mGvvfaSdX99byI7YFOJSP+xleulqlYpNe5+cLREK6Fkp87NnTvXXCsO32m9fP1H/laiT0FfrKGT6smrr74q1157bVLXMZOhkCIpJ9svjtlWY+G3IScGgipecEEFECtaq6S1TuGEFAbo77//vvTs2VOmTJkizZo1q3jOFlYYnKnhhHMg5uXaZ/cBS3fh5AQiasyoYinqviKm9Ax1QNP0RmxLDKrxuNegJ9YaFb8mJUHUM8Xy2bkYxU62DXg0+8Hv9SCWej2SWHQ/L1261EyEYKKsYcOGWb0/GjduLItXVZN1G0PmPAwRNWaKe71U0eiXzXGa7L5SY8eONRNuzQpLjLBT0ecEjzcp2CQTJkygkIoCCilCEkw2py96zZxjoIQBk6bPqejB8xBHuNlNOr3ArPmFF15YqU+YMzKFZaFFgwoyt4GY27ZOhYB3ik6dmVy0aFGFGAmXYof3//rrr1JcPFKKuq+MOT0Dn68RJaD/DzeIjqdGxc+2TqTpRND7OdHmMcmIYid7gieW/eC1nWOt1yOJB9sdads4p+Fvtu8H1EkhEwBC6Yj2600kCiLK+9w8Mul9pZBa27x+qTSpV+4mqKLPCQTfopV5svbv6Smv6cokyq+ChJCEz9KhiTX+j7+pvtBjwIGT68KFC81fHRzHM3Ou0R/cx2ykbU2sBeYanVJx5da0U/n555+lS5cuZv0AhBJmnDGLrtELRLh0u6Yj9naGKMTgAulreBx///7774pmo9guSP1Ayh22q9uyMHhETVTt6qGw6Rnau8QLjQqqKNX/hxtE63GMtEgIV71hsBTE8YzPts1D0jVyq/vB3o86qA8Ke1tgEgGCR4+RoD5HG91qtFYtxpMxwePn/BNuO7vV6ylar0dIsuqkunfvJoMmFMitb9STOvllYc/NNauVmdS5ZIL62T+Xihy323pZvaE8OuYGHofIwvUl3PWDVIYRKUJyLH0xyPoLr5lzu0GyPq6z3prmhwGb1yB5/vz5cuCBB5oZsYsvvlieeOKJioF7OuE0bMBAFGJIe1dp5M2rVxUGhwDPay2XV4qdDh5XrVolLRqUhU3PaF6/rEKAuoGol5oN2HVOeDxVx3EyIrdBRJKSYR4TrkFtLIYQyU57DLed8bjWZ2n7ArfzT7jtHGu9HkkN2d6zqE2btoL5n/d/qy5tG20OnzpXb7OMHz8+qalzJmo2bJh8NrO6EXNFEwukTIWdw6q93babJJRXPez1gyRISOHk9uWXX8qnn34qgwcPDmqxhJCACXIg6JUehNx4tVa2BzhqJIAoUjijCZzEjz/+eHnsscfk/vvvl3QA28eOPOB7QCzie+I7OmfVNfqGKBq2k1uvKqBCK1KKnQ4eIXbmLwuFTc+Yv6x8FtILDGxhLBGNa1+iSXQ9U1ATCMlIu4vUoDbIWqlEpD16bWeA74RthfOBuj66fadw2zmonlLO9c60Wrp0B8fADTfcELMpTqYAo5wGdUKycm2pLFoVIXUOqXV/z0hq6hyiZh12310GTfhRbj1hlfTce60MHF8gwybVLU/3W54n6zeFTGPho3fdIM9+Xj3s9YMEJKQwgECTsc8//1w+++wz+emnn8xjSPOgkCIkfQlyIOgVRUD6F4SSc+ZZB4iRBigdOnQwF99k4zWYwmN//vlnxcAP2NvLtgJ3ggGf9s9x9qrSv+o6GC7FTgePxxxzjDzxxONmBtHOw1fw+JoNYmZ9w4Hvlm51eomMeAU1gaD7QUWximkI5iBJtiFEMrYzsM8HeuyDVPWUSpdef9kIxoKvvzomZlOcTAGiA+fcTSUh2VwiYc/NECwiZUm3Qx8+fLgccsghUjShQOrUKJNWDTcbATVjSVXZo8UmOXSn9fLw+3WlapUyX9cPEqOQQkdkFU5ff/21qYPACe7QQw+VW265RTp16iTt2rWLZpGEkCQTZJF5uCiC0xkPA5z77rvPRKNuuummsMt1q5365ptvzDkIdVMqAmMVSG5OfgA1TJqCh89Aml7Tpk1N5MZLKNm9j8Jh96pCvYsO/nQgbteNuaXY6eARLliI1g2e+LZresaQiYVmtjebUmfSaQIB+wHHBa5/CpaFfRpv36tUGkIEFZGJtJ1xfNvmMV5RJL89pbAv1B1Ubyra/K4/e/0FDybRxowpF1HZ3rNIU+c6br9Rvp2Xb1Lk3M7NEDGnd1or43+saVxok0mbNm2kd+/eppdUpx02SPPCEmlaWCLH7rpePp1ZXYZMLJB9ttsowz+ox+tHIoQUrHYhoPDDQMQJgumaa66Rzp07S/fu3eXqq6+WnXfeOdrPJiSnSVUqSdC1KOGiCPZzt912m9x1110Vz0USU6gfgkPdnDlzzH1M4OD8Aw4//PBKr4UowUAWs8oA0TAVcSpatPEu0HQ8FTEwfUBEQQetKnBwH2kbkQbbbo2CbXSgh/ooraOy6zl03bCtvFLs7HSvK6+8yqzjwPET5e53Ck1N1ILlITOTqCkzmU60DYOjESWadqoRiGgEEF6HKBHeg/2GfagNo4PuwZQsx88gIzKRxJ+zhtKOMtm4NeDF8pwiCetp119iudgX0ax/rvb6SyQfffSR1KkhlYwXtEntP6urSGHNMqmVL6Z2CmPITEZT576d+qMRUJvLRAaMK5C73q4rTeuVyMIV5alzZ3ReK3eevFK++SM1Bjp6XUC2BwTttgWb5OH36si6TSGpEgrJlLnVZffdO8ill16akvXLaiE1efJkc/LCCRwDmP3228+IKM15JoRIxqSSpKq3DsSNcvPNN8tBBx1kbk4wEELvqGnTpkl+VZEli+dXel4HrVh3vNZutqt1ExBP9kAOqJGDfd/+TIgbvF5z9rWYHZEHbKNY3dI0pVG3s4o7PKZiTdMhI+Wla7oXTDduu22A9OlzgUyaNMnUlB3euLGcc845GTO7G8mQINqGwck0cNDBvx1FUXGWib/VICMykcQfngMqpiBE8bxbFMkWSxrBxQSLnivd3Ps0cqzufX7WP9t7/aWCFStWmAkeRGTcmtTChnvNhlIZP26c9O3bN+NrpTR1rlpeqeTniYk8ff9nNQlJSI5sv1bOO3CNbNegxESnIKyOOKlT0tcR2xiplAiOYJISE1W33XarrF/8l9TMF2nZUGTOjJ/M98imGra0EFJfffWVqYHCjDAiU+PGjTMnQFywcdJByg2akkVyfCKEpEcqSSpcBDUCBREF3n33XfPXKaYgon7+aZp02Wm9rFqzUV7d8D/3vxo1qsv6devMdrJFkaIDKjex5Pa4nVqkjzsFGFABFA4M4lTYKRj4tWzZstLgH80q7dlvXQ+/g3B70Adh0adPH3PsIGUylQXC0URYI00kxNIwOJkGDskceCfjtxpkRCZcJAn7Ds8hyqvulgD72hZIyXbvy+Zef6kC2QOIksN4AcYGnk1qJ043A/tMr5VC6hxKW9b/87P8ubyqtNqmRIacuMrdYnxTFTn//PMlVeBagYDIf//7X1n69xIp6rHS7Je/V1eR0d/Uki9m5cvLxSPNb/TRRx9N2XpmVR8pnFh23313ueyyy+TFF1809VFw00JtFA4eqFZYFR977LFy6623Jn6tCclwcjWVBCnB9jkCYgoncx1EQWQgEnVou/WyZt1G+eCX/733wHYiR3cok59+/skMxCKl07nhJbxsUWPXWgCkceGC4jVIxn5DhKhVq1ZmckkFBP46RZRbvyRdL7+D8FT2/wmqt5JX/zEVq7E0DI7WwAGpnLY9fTTLTsd9kE49vPT4VwGMmx4T2F4aTVbUydKtB1Qk9z4VavG496Vjr79MB+PD1etFHvmgtolEDeha3qRW3ey0VmpA15Um1QwudplOt27dZOmaanJ6x3KL8ac/rW2EJIBwxH3UT8FsAhEsbQWSqoghrrUDuq6Qs/dfY8TuAXc1Nuu4al0VqZlfKuPGvSGXX355Stcza137kOd/2GGHmRvAyVFNKD788MOg15GQrCOXUknUNhzpbOCMM84wwkTBeQPfHbWXms6HSJQtokCn1iLNm2ySz2bWMHVTmNxxE0aRBJb9vNNAQgdsOiDTARsGfTjvIT1R6y/wHAZ/eAxpeRo5iDSYtme/dV2wHL+D8EjpXqno2RJthDXSRAK+E/6v28c25IjX0CGI316q0mMTVVeZiIiM1zGBqKJGkPQYwOdp6l449z5nbZstaON173NG/rRpMO3QY6NJkyZy2mmnyYNjRkut/NKwTWqHTa6fFbVSPXv2NIZKOzfZLKd1XCsDt9RJwdhh0co8WbMxZB7H83ek2LXwt99+M9da7BekXXpHDMeZicJMjximnZDSCxDASQYXFLiW4EYIyd1UEh3oqZMWBsD2zLOePy644ALTdBe958AXX3xhzinGTnrzhkoiqnVjkY+2/L9aXpkU1CyrGFg5cQojL2GldVZOMGhDpELNILBPVADiOTUWQEQDg65mzZpFvY3sQTiOAfxFWnQ0A2K3dC8MLpEiE0/PllgH6tFGWCMZP2jDYLeZ0Hgb0gb120t2emwi6yr9GjtEQ7hjQk1fcG7Q1+h5wsu9D79DfHetbcNyEJnGJAa2ja43nsNvOB6RSTv0YBg4cKBpk1Oy/Oe4GohnkumEOdeOKpa+XVYa44n9W2+U7RpulkZ1S2XfVhvky9nVjenGwTuuk5EjR6bMtRC/qYIaZbLk3yomYggRle3uiikXUkjBefLJJ2XGjBny0EMPVdQ1nHfeefLzzz/LLrvsYv6PHieEkPSc0Q6yIS3EBGojdQCqgw+vAbCTvffe2/xVMYWotlPgHLmbyLvlRnwG9OlYtS4kLXz27FFXNZ2l1n4/+ByIJV1PdczTmXG9b8+kYz/hvUFED3UQjosZHAODKOiFiBozqjjmni3xDB6jjfL4MX5A/Rfs6PEY9iGON7WQj6eWMFG/vUS7cCa6rjKSsUOQ7n36G9O0PwX72Mu9D7Vtdjqoim7c7NpA3SZIE451P6S6hjVbwHmtR48e8tjDM+JqIJ5JqDPeAyNHmkjc42cvN41uEfU55Z1t/me2sRwtPsrkkksukfHjxyfd1AEZFqvWh+SVb8sNQHIhYphSIQXVfMcdd5gaqOOOO65Sr6iLL75YZs2aZQwnsJGHDBkip5xySsJWmJBsIRWGD34HguqEh5ubqQPAIAlNarUOCO/FMqLJp3aKKaeIOmgnkXff+9/rpy2oJptKykw9Ujh08IPBFi7QuC1cuNCsn86Ga1NQXMBwUQH6ndXkAGAwhu+kA/p0ix7iO8GBqbh4pBR1XxnzrGI8g8doozx+jB+wz/SYCrohbdC/vWREMJJRV5kM9z5EkBBJwufobxGgLklTZCM1J8Z556233jJiCX3V4FbZtm3biv2Av1rniM9Cmlk0v9dcrWFNWI+le+6J0EC8LGsawKozHo7BqZ+OMeLxhlfDpM5NmBqX2cYff/wR8Xp47rnnynPPPVfpMbQswuTl57PyjbDLhYhhSoUUIlE33HCD2RlOtFYKqToPPPCAcfigkCIks6ymMfMfyyBBezBheWpBHi0QU0j/sI0JMHCpVROiaZMMuvww6X9JFyOiPp5eQzp06GAG2Uj1cbruAQx47Noau+7GniHXgaLt9GfPmOtzWguFx3GRTES0AYW/uNn9dPxEN3TgiNnC2tVDcc0qxjN4jCXK4xwcK85aqUTXEgYRSUpGBCMZ28I+BvDb0QkERKai3S7hjgm7Ubffba7vGTbsbjODj+Nd+6c988zTcsbpZ8h1119fSUSpQQkEu5qa+CGXaliTle5WNKrYs4H4iSf2yLq0MYibd96sKr8vrprQ1Dm4I0KIuYHJw2effdZkjri9D9fS+++rbowlciVimDIhhZOoHYUKNyByql5CSGobmmJgobUI6qKFgQXuIxKDWeNYBJCiAkgdtKLlu+++28rdDev5ztSQfDazrqmJQjofepHgxI9edlhnDMIRIdJ1sKNmdm2UDn6cM+QA77f7UNkz5vZMug4KYxkUOxvLYj20LkgtvtGrCn8xeFMjDt1n4aIbOoBftWqVtGhQ3rMl1lnFeBvWxhLliTRgTXQtYVCRpGREMJJRV6n7Qxtca91SLL22wh0TbsYOOCfhdwBsAxcF33PAgAHy1sQJJvK6VfrqK6Nl/Yb1plm1pora1vnRiNpsrWFNZbpbaUmJDBw9qqKB+PzlIVm7oUy6nnCC9O9/a9ZG4v7vzYJKqXN2U+Jt6pTK8butNzWtsabOQRDdfvvtrs+hsS4mqvr16+f6PK6lXbt1l/Hjx4WPGK4vk+7du0e9brmCLyF1wAEHmGgTQueNGjVyfQ0u/k888YRx3iKEpBYMGmDmYBs9OE0fMDiw3fNiRQePGGRAgDg/J5KI0rQ+gIGOiir8xWwm0nIg+Nq3b2/Sf1QA2SmEGOzo59pizh78uM2Q6+cFMWPulSIJkWPPjmObY73UyELruPA5eD0Gk/gLp6RI0Q0dwMOcYf6yUFyzikE2rPVLpAFromsJg4okJSOCkQhDiHDHgDZDxn7BYCyaBrfRgO2NiLhtIIPH8Nto2rRpxedBaCEShRpAz5n9N96Qk0/uaUxg7JYG0fSUytQa1nQGv+l77r1XLrjwQmOGg5TMAxs2lKOOOkp22GGHrOxBqpE49GNq23iTqZNCip+zKfE9k+tKvZqlsmTJkkA/f+7cufLMM8/IlVdeaepN3cDvAq2M8FsZNOEN14hh0YQCwU9pxIgRdO6LR0gNGjTINH2EekXUqXXr1mZAg52Aky7yldG0Fydb1FMRQoJPOdJBPwbi9myxXvTt2VKk20UjaOLBHvRC9GDAY1tXA40c2XbfSOezRdT+++9vJmIgrj799FPz2PTp0026A5oH2mjdktooAxUkal2Oi7c9ENN1dA6G3GaZo4muaMRJB5+6LmrhrQNe+/vrIFtFo/0+u1lwpOiGDuBh8vPEE49HqEOQsHUIQTasDXLAmshawqAiScmKYARtCOG2fCwHkzD6G9LIr0Ypg0br4PB5OC+oCMU5zj7mxo4da2buw6evFsoHH3xgWizYvyNsp2hFbbrVsGYDmAxDH8FcEaiIxKGlx8zffpCbXqsnr33nXieF3lK4HgYJolTYvjfddFPE11533XUybtw4Y9c+7J1yu3aYYcCuHb+rto03SxGd++ITUohCIez4xhtvyHvvvScfffRRRaoKZopVecO1D+F4Qkh02INxO7/f7mkEdJBmgwGHbfoAvBqhBg1O1HaUA5+PxzAY1/Q7ezCuTl2YBUPERYFQwiQNvmfnzp3Nd0QhrDqGAnUKBdq/SdPjMNDT5qqxXqC9amUi1ZctWLDArIOzwa6dbug061DhpCmGahNvNypVkRguxU4H8JjRPf7442XwxLc96xBwjo6Ug++nbiloUjlgDSqSpAIEEVlNT0tUPU0y3PswUQqBpk6W6sTpN80zGnTSRX8LQM9xdm0W0lJh6R8ufbVZ/fJtoXWO6thp1x6moyNjLpFLAhXnUkRykNU1+ptaUtQjTJ3U+KmmB6B9jsbvAumsuNb5EUQKolsvvPCCdO3a1Qi5Ll26VIrQOpkwYYLUrVlFxl++WN76qYZJO4Rd+0l7rZPtGpSYTIf73qVzX9z25zggTj31VHMjhMR/QdZ0NAy83AaptoBSvGqQ8DiEmA4Wwp00gwDrDiHkNgsebjCOG8xr7r33XtNjRCNR++yzT8V3wwBo3333Ne9///33w4op2/VLPzvWfWH3qVG3LziCaU8sPIb9ZbuAYZs7RZQSrjEwnsNn6QAe31l7V+m+0wG5DjLdUuzsKBJqQ/C6geMnVtQhoBAfkSjtI5XuhfbJHrAGHUnS3zGWpb/roFMik1mPlYg0T+c+ts0t9Legvx38Xz8PEzboixYufXXBspB0b9bMDEaDOo6wHI3SqjAL2pGRZC8INKB5PKJS4aKpQyfV26pOCiJK659w7bOvf+FAmQ2OfWRkfPzxx+YxZJR5oZMU7ZpslnZNtk73p3NfQEIKJ5JXXnnFKGY4gMAKHYXfhBD3wYI9O40ZJdzU9ldfE4/JgxN7IKX1Sn7AQEMjH3Y6jC0EEGn2yrOOZjCOE/zQoUO3SufD89rsVqNYhxxyiBm0qIjSvzjvwO4bgxln7ZRz+0Oc6AAI2wT7wE6P1M9V8aSGHLo9MLOnA2zdHrYLGP7v1fTXifM1Wp+mQgl/NYXTrpWKlGKnwhXC9rbbBkifPhfIpEmTzMXx8MaNjTV0NG5QqSq0T0UT1CDrjpLVeyiZ9VhBp3m67WP8/nB84TvYdY/a+Fprs6Kx0daoh64rfsexNOtVEwx74kvP2ewpRfwCf4E1i74NG03dtmCTzJkzp9LjuF4pbpOJbuD3il6vcA3UbJFI5wY/kxR07otTSCE0iIsxTkBIH/r222+NpSKUcrZ4/xMSBDqAh5W1pmbpoBymA1q4HbSIcp4scWLEZ9gF3MC2/Ma6FBQUmNfqoEJ7LdnLUrEQDW6DcUSibBGFGbKOHTtWpObhM50RJr1o2GLqk08+kbq1q5uu7GgoiBRAiKtDDz3UbGN8Z3smHeD/+B7YN2pUYafd2TftIYX/68BJ6690G2J5WJYOYqNBRZMKKP3+OtDTz9FUJ5x37feGq5XCMiF4UdOKbQ+BGa1tbaoK7VPVBDWouqNk9R5KZj1W0GmeXvsYA0ZMiuhvCp+Hm12bFclGu2hioUllwj7Tz9ImvvobxWdGI9CxDD0mgG1og+UQ4gcI+UUr88IKlUUr8szxaqPpfDfffLNvMTVs2DBTI42JSHDkkUdGFF/+JinC19jmMr6EFAY/Bx98sEnH0e7Lw4cPlzvvvJMblhDHbKsO4hUMBrQnC34/2vfIbyTDL7bzEQYIGFDbM+1+ZmODrhmxB+O2GMO5Q0/0kcBFAOYTejHpuk81GXPF5vJBVH75IOqiBwrl+BO6Sb+rr96qgbCzT5Szf5RzP9jraQsdXYa+F4PtSAJT67b0eFBBpo+pqNMBsQ7U7O3vZ18EPbhORR1DKpugBiHikpUSmUyha9uh46YTC7a4D2IfY5lw2sMkBn5X+Iv9oVFj/TxNTx1YPHIrG+3jjj1WLrvsMuMAiJRcN9MbTanFZ/rZtzqJZJ/PbSEVdL1YLpIL9WdIBVfB7yVU1m0Kmdc5UTGF30IkMYXrJFwR8ftByyI/Ispvry8/Nba5ii8h9csvv5hQoYoogI0KMaVF7oRkEl6pX7EOEOzBmG0SYfcDUkMBO5UrFtwG/siFdg6aYxkMBzkgd37+HXfcUWEScc0115jUMx1YAZ05tiNmKvx69uwpd955hxyy43oZfw22sVux7njpecopW12M7O1liyn7vv28nV5kD/SAHX3CMaOpF16DfW3iq9EOLA/fSQd4uh5qwmH3tNJt52dfZINdcyprs4IQcclMiUyW0MW64xypKcq6bTCoi0VEROpVpp+n9YIK7uvn3X333aZWG+ZXqFHcr359E93W3z3WDY87xY+ivzE/EaVwxx7O5Uzvy7x03lSANLtqVUNSNLHA02Icl0EvszaIKYgkZ5q7LZLw/Ntvvy2///67tGnTxpgP+a2pqjxJUWyat5tJimUiq9eXye67dzDXKLRBQlSKgioGIYUD27mDdfbbPsESkgkzXNq3xG5Ei4uuzkjHilMU2NEKfI46y6mjng62nNbYbuC1OJEhTQuD90QNmBM5IMf3HDJkSMXFU80dvOqydHCF/TR69Ghpsk2BjLlidYWIssGFCTPUH374ofTq1avScpypd04TD6fduO2QiMcwGNaIolOAOd0VdT/p98L7kBoF8YRzpUYngUa5AB5DahNeq+JBB+B+90Wmu2FFI0SCnsUOQsRlg5h1gnXHMYnfqh7rKvpjERG6j3GzzVb0nIBxhjOKBPD5mHjROk0MTDGZ63bOxLpheeEi/vgueqyF+w5YX/Q8cqLnhmRES7OZVKXzJhukziHlruP2G2Xg+HKL8W0LSmTB8jwTiUIfqY2bQ/LUU0+a4xKixg5ceKW56+MqsmbMmGG2J8RONCIK4PMwSXHFFVcY0wukI1b/4XuZOnWqzJnxk2z6Z6qpo0IKoJoXOdcxV/FtNvHZZ5+ZBl82OPDx+OzZsys9DiVMSCrQC7LWIKn7mrqs2X1LbBEDdIbUtuGNZTCGgQYGyTojqoYGGJAg5UQbwEIQYQCtIXuNbmDA7bywOGtdEl0zkojlaxQQqTt21EdxcyjUCBH2aYsGZWGLdTGDhpnoSLgNrrCtsf3xWZrOg22gg0a9YGhqngorPV68lmlHmJxCCcvHsYgLJz4bx4bbdo+1qD/TBvR+jR8SMYsdVDTJ+dvB8jTymin7wYkteOw0t1hqhPDdIZa0T5UuU/tGaTqeG3ocAGxHDPS8hJLdXy7c99JrQ7j1xbkX5xVNj7Z/78mIlmYzqUznTSZInevdu7eMGVUsVx+xUt79tYb8vLCadNlpg9x6wirjlleRRjeq2LwHosaJm5iCiNIxxKxZs8zfiy66KOZ1RbQJzoE33HCD/PLTNCnqvnKrvlfh1jEX8S2k7rvvPtfHobJt8EOgkCLJ6rukAxRESHFxtUWSDsRslzVcGJ1pVW41M/EMxrQWCtgDMgwg8PnhBmcwe0inC0ukAbnuB42y4TVwj3N7HaKAdgTKDxgQQXyYwdeyUHhXoeUh2a9ePd/mD9gvOijUwnqNOmmRPcDy8DotgAeaponXq5uZCj8tTscyIZ7sCJNzEA1Rhu1SWFi41QA8ViGUyekyfowfEjGLnYhoUibvBxvb0dJOl8OETyzpfXqu0IisbegSbhJLo2C6XyBwvJxJnZNkXvjJqMG5BwNVOyURaNoxycx03mSjqXP3jxyJ6TwZsqWn1LxlefLAu3VM76Zt6pTKFV1WygNhmt86xZSKKIBxDtL8EbGNBwRNUGtV1H2Fd98rNuiNTkihCS8h6YLdBFWFEk7GSPvQ2X+98OvJ2U5FUeMD++QNvJqnxjoYw4U+2sFYOl1Y7IEgwIAW9+1BkLMOAd9b0/F0wKgWwtGKKKARu6OPPlqeeebpsMW6KDj36pWhAzQdBGkfLK31sF29bFFtb3+tYdIBH6JVWgPlFl1U4ewHbBu7ZgzL0dq6aAfg6ZguE40wjLT+iZrFDjoSm477IRbsPk82+D3gPIzzbjTfx8vAQVNhw4FJB50QQ4ReXfXcCMrMB5+FwamznUU0v2+SXq0WUoGmzuHYGfn8E3LKPmvlhlfrSfHXtaRO9TJpUVgi81fkyeoNIamaV2baDV133XWuy9J0PltE4TqBidggnPXGjh0rdWqEwva9Qh2Vs+9VruJLSEXTP4aQRKNNUG2balxM8ThOUnbdioKBvw60tKDZ7gkCcCLHRRon9lQNxhJ9YXE2oQVuERO8DoMkO33HHpR4DV4ABo/Y3jpgtAc7furB3ED6Tfdu3aVo4gRPV6Ee3bubc5XdD8o2iXC68QEcQ/iumoIHsO52Sh62PwZNGEjZ+0WFs99+NLaQUIGJfY3lQUTpeun6IJqF9Yt2AJ5u6TLRRmYirX8kw4KgBrfxpkem236IFUReMIniBgZy0QrDeCaFsO3083BDJFd/O06wvbXXm9fzdp+ecOCzwqUAktjwm86bTeBctV1DkdvfLJAxU2pJUfdVW6XODZ5QIG9OnOgppJwiSn+naA0SbW1UuAa94VLpmxWWev72cg3fqX2EpAs6o2kPUDQyhYsdBrzO5rIqkpwzjG6ufegBlSoSWbCuJhv4a4tIFaMY7Gp0RQf5saIDXGA3s4wWdbmDoIC1edVq1WTg669XchVCfwsUv8IJEPtOezFpZFJxGlmEq13SOjZ7++P/Xvsl3KDbKSQwq60TAUANSLDd1ahC7aZ1siCaAXiiopqxCotoIzOR1l8nG9SsRIUz1gvbOYjUuSDS8oK2Dk8V2N7YFm6TH1qDGs05ysvAwS/27wATHOEGczjPw1nYLd0Xvzsvl7Rsqz/M9HTebAKR1HlLQ/LbonIR5Zk6N266zJs3b6v0Ptu9D6gZTDRNe/2sY6QGvfP+KZXq335bqZQhV6GQIhmHzjI6e+3oIBhiCqlkKpBURNlRHa8ZxnjEQ1BEE9WK5qKOAY/O+rm51mkUxh6oxJoeY0e8nD2kokEFGE7UWA5sYK+//nqTUoABVKNGjYwjEi422BYQxiq0tbmuLRhx0UHKpQo9r23mZTHutm0jDbqdQkLrq7BuegHSqKptVGL3lIpGCCUiqhmPsIg2MhNp/XWyQdNFVeRqRCqI1Lkg0vKCtg5PFVhPiD+vc6NO0EC0+PlOeA3Sar3qm8KdczTKZC/LK+qkxwzqZzHB4kzndtYl5lLdW7qRLWmw0Tj41a5eVpE6hzqp17+rWVEndfxu66VW9TJ59dVX5dprr/UUUdonKpI1eizrGKlB7/pNIfnlp6nSv3//nDedoJAiGQcujDrTqyddDD7Vkh8Xz3DRg0xGne8wONMBtg421VTDFor24Fnf4zc6FKv4UTCriCgL1sFr0OTn81X4qZhA4063vGyniFaHLUSc4k3Bcx5H9uswAMANIs1PTY9XbZ7uE2e6YbRCKBFRzXgGOtFGyPysv5qDYJvbywkqdS6ItDysI9ZPrbhxjorHOjza80OQtTyYsHC69tpg/0bznXSCyxkp0oblXtvZ7XdQUFBg0rqdk0O4YbIF28BO/7TTdaMllwb8ySRb0mD9OvihWW7p8p9NLZRbndQ9k+tK3eql8uSTT8qVV15pjlcvERXJGj3WdQzXoBeph3h8z5YbZOTIkZ7GGLkChRTJOHAhRS2Mm2tfogrHk4lemO3okUYyNC3PzzK0WbZz4OHX1Q7EmpIHMGCEqMEJFgNKNZtQgYP1CLdstRnXwYofMRFJRIcbaDpnmzXVRAfAOvus9VL6Ok2rwGfhteFqeuyeU7ZQVQtoZ7qhpq7ZdQMgkkjS41+PJaRSxSOo4hnoxBIhs3+/Xt8hkcYsQaXl4T2awqnujyARA0S7P56Cz8HxiWhRPKjraDiXvGi+k9YY2g2wddLDjtA603Hdol7qqoebGlboOQaTOSqasH10n2JdYcEerdC0fwfq2okbPidbJutSQTqZLCWDbt26yYjhv8tNr9WT177zrpMqWb9S+vXrZ66hdk2ULaKUoMUUXAanTZsmA8b9KHe9XVeaF5bIopV5smZjSE7ruFZ2brJZ7nirQKpVlZw3naCQIhkJLlrZ5Oyjg0WkAqmAUpwRDL9gGRCbup209inScux0yVhFlA64dfZdG9KqkLIjiW6foemA2n9LrYb9pg65DcLxedi+OnDTmW8daDpnm7EfNAUP66OCDtsU38tO1dOoFdbTq6ZHhYR+b6DrgmVpHyuNMgJNA9RBIdZfH4+UWhRkGlI8A514ImThvoO9XXVbqhtcvKlzQaXlqdi0J0PsAXmQzm/Yvs4CdO3PhOdUpMRTN+ElpDS1OtrjSX/b+ttSoYrtg+dsEYtUPK+UW/394jeiLRNsoxbcdJ/aBjr279/PfrAFtjYpVtEXVH1eLpJL7n2gZ8+ecu+998rob2pJ0RYbdLc6qQHjCuSll14yx/bAgQM9RVQixBS2PyJnU6f+KPu33ijbNdwsjeqWykl7rZPtGmxpKl+lfB3nzJkjuQyFFCFJwisaAnARVutwN6ETq42vszAbF38djIcDgy58ZixNN4FtE451QLNZfC4uljqYVCMJpOboIBsCQwVKvClptrmGM/plpw06nQy9UvDs76MmEADrqTPTanLhVtOjUUYVU3i/Dv7xVyMJKjZVeNruffoYakwipRYFmYYU70An1ghxuO+AgT22qzZ5xvPYTthG2EfxDGo1LU8Hy7rsWNLynKmb+n+sdzSD+EioYHOmjGKd8duLV0iFq0fC9olm0BvpeNJ+fPoc/uI7oOGoWxRJjy89h2oU0P7NqtDUqLAKNCzXr427rjduOtmlkz1YX6b4xUauufchdW6bhg1l7b9/h7UYv/FlbIP/Xa/DiahEiClklEDYPX728grTCbvvVWHNMqlRrayipCBXoZAiJEkCCgXPWtdlR0P0IpwIdOCpAw0M2v744w/Pz1Nxg0EFojiajuc0qIiERpPU6MN2SnRLq9P6NsWZzuVVqxQONdewB5de20iXGy4Fz09PKR344XF8vt1bCvvZjjDZxh6aQqbbRcWZ073PFnWRUuyCrDtIpJtkOCJ9B3w+tg1uQdet6LGvn62fid+x3++uAkGjZjZB19do1NTtWMdxHcQ5xq5Hso/FaI0bnMeTRmD1926n4unvQMHjXgIU78X5Be+xhSvOafZx72zfgM/xY5ih6420QHUrw00nULKxpidZ5Jp7X4uWLeXfBYvDWozXyi+VpVGIKC8xFetxiZrjpvVKzLpsKhHpP3breq71m0KycMGCnHbvo5AixAUMlnALIiqCaJOmgyia0qY1T7hoqMgCQTSSVOyUEx14au2RoulmGOzr6+xUHTc7cRvneuP1Gl2yIzPherFgW6A4fNWqVRXNlrWnkzrw4UTtN0VNozcaSbC/r52+aEe/7FnyaHtK6eO6nzFItLeXRvewDAzsVGDZog3gca230tQm3LAOul1UXIVLsQu67sAZVdL9lUhh5adnVKIK1e3G3vagHPvHr0sd1h/Hs9fyQaxRXyfY/tgfbr9RjWbGi12PpOCcgehgtNh1fM70TfxG8PsGGqlVB07sC3wXzILjfOKMTNmOlwqiTojiAq9zmF9Ri+fh/IlBvrYr0MhlplnbpxsagdZzttah4byabX28OnXqJCN/+S6sxXi1GnWlcQORdZvyojZzUDc//Fa6dOkS0zq2atVK3p5QzazjwPHefa+KJs7Jafe+8tECIaSi/gUXcU0XwgyppofFc2FwNghW8aSDZ9uZLloRpbPxNvgsDByQzqMpJ4rdhNL+LBVLdm0PBkm6XkCjL7jZkRi8Dul7SFnABQ8z1xh0eYkdHYTDEANuYIiS4aZRHF03u0ZCU+ewPOd3CodX/xsVGCr2dLYZgyQVbeoKp6ld+It1x3fT1+njan6i39drwKZpfG6phk73Pl0OLobq/ob11j5K4Uw48JhGQzTlKai6Ax384jeC/+Mv7sf6O/FCvwMG17oNdBvq52H/2L+boArVbVMBJ9j+fpwosf7h3C+xnvhuQWw3HHeIDNmoqFRRHsRnQEBCOOE3js/DbwTnSfyeY/kedvqmRp/1963pijphoRMiKgydx5zX5+uElZ7P3LaRTpj4AfsV21SPSV0v/U2S2NDtj+2ok1e46Xkmmzj//PNl3cYqRoi4YSzGN1eRqjXqSb2COvLKK69E/RloFzJkyJCYHXhhgw6x9MgHtU0kakDX8nquv1dXMel9d7xVV/5dH5Iru6yS4uJi0/cqF2FEiuQMfpqm4sJoz97rLdYZMTttRQWVDgR0tltT+6K9UGhfJE0t0Vk8FTeKc3ZeZ5XVTMF20nPW9oRLx/MCn61CVC3Q7ffottYBiAqOSAJSHb7wnf1EHNRcQ1Pt7O1hR6N0xlNfj+2itRQ6ANVUEzWswDaGcFSx53Tv08/0+k5ug3P79bZ7n9Zx6UDTrl2DmPOKBCUyHS9ZNtD6HdTS3q1nlN2gVyMWbpML0YLoglc9od8Ij0Yv1OzEDeyboGbc8Tuz6w3t37YK83gJF0mKJQ0rXERRJzGcEWXFeczp78aJipwWLVqYeijb2dDp9Bettb1zfbIxepIsNIJrmxLp/sy2+jNMOp7Rq5cMGu1uMV40oUBO7bhWOjTfbBz8xr7+ulx33XVJX0fYoD9YPNKkGZ6yz1pXu/bVG0LGyh1iL9nrmA5QSJGcQI0H7JQUDJI0PUcHhs6LsA4SY02L0dQku9GqE80t1nQ4jcC4YVuHazTFmbZl1++4zc7bLlda2ItlujnjuaXj2SldOvCwU6CwXDtNEdscaZKYvdaBnopKoAIwEnpR9RtxcNoi6+fZtuqaLoZoEgZA2A94Tm3P8RmaWqfbXOvblixZYl6D7eZ074vksuh8zt7fWJ4KBuwPDMI1/dDeL7hFSqlKVDpeMvu+YP00qqJiGvtJP0/TKiG2dEAMsD81whELuu3dRK9GL/w4+GHd1E3O65jAbyKIwbdXLzV1hQySoMR0uBRUddpzOz/YLQPsZXltYxXi6ImFGie3/RqNK6Na2+tkkK4P9nWQboy5hP7m7PM8wP+z0WL+zjvvlA/ef18GjBNjMd6sXoksXJlnUunO3Het/N9JK6VaucGrDBj3h4n4JLtfE2zQv/nmGylZ/rPc/qZ3et/gCQXy5sSJFFKEZGvECYMqzELa9SianoOBh9vAENgD8FjQ2XId/OkAXkUQHtP0Nawzbvp6LzGls3UYWDpdr9zqd9zSuewBtr3dNF3JHsjYr8MgHBc0ranSdcRnaHG+cyCjM74QUyoy7JowZ42QG3Ykz2+Kmh1Rw2frfrSL7m33Pv2/c9Bup19qXZJGouxlaCNdP5FFvAfRJixDnfw0wuh0D/NTJ+SHdLFDjxY1F1Dxrelw9uBdj3fdpjje7N93LGg0Cce8G/gMvwYFWI6dtuq2rKDw6qUW5GcAPWdq2q1G76Ot+Qrn4Ke/YaQAO2sK7Ro2e1mY4HA7d2q6oJ4/7IG6PcHiVwjqNtYIqP1byLboSbKw68+ALag0nTebjCdwHB508MHy34mjZd3mkOzfZqM0LSypZDEuW6JVEFpPP/20DB48OOnr2KNHD3nkwelS/HVVI6K87NoHjpueErGXalgjRbKCSDUbGlHSGVq9+Orjmo6l/X10sKwncQxwY8Guu0GkQfumIDqDv1prZF80bHtsJ7pOWA4GiFiuXny0t45+nv2414XH3m4YzGitAwYCEB+6DTWih8Gg3TtFByJqguA0sLC/B76XPeCyxRHwEqy2uLWjQzooirT9dV3sv27outi1a/p5zvuK3bBVI1/293amU6mIRHSgWbNmxq1QDTHwGI4LfK+FCxdW7Af9DO0z5lYnFG8tSrQksv7Kbb2BLdztdC0clzp4D7q2AhMT4VLi8Ll+tl+k5QSVdqdotBLHGP4mYuCp0W9sAzVC0f5K0Wxz+xzpds7S2i9N6bVrSZ11SXhtOJt3rWN0c8C0e3z5wT7WbVGH3wHd+2IHvxU30w7bxj6bgKHDmo1VpPU2JXJXz5XS74jVlUQUQOSnSb0SGTt2bErWsbxWqlw0hbNrr10jZJrz5hpM7SNZgd80E2fEyTkr6pVipmIilgGJHf2xIzr2TD4G0TogBXbjVjvqo4NwTR3xalDpdz3tgm578GOnIemFy21GWNFBhJ12aIsX2w5dBxv6eZqCZLvQ2WLFFj8qZHTQFq97n1NY4XlcxDVi5pzZtgdfug20ngrrhO9lpyDiPgZ2WE97O2BQiO2ujm54TNMFNQ1Uj0etf9MeYyqC7DohP/s7Xe3Qw0WSdb312HCi2x/7zLYrt+sb/fYI8vqeGMR7RaX8Wl5rTY1XpFkd5YLG3rZBg/2kLpX2+Ur7/0Rrhx7u9Zri5xRommZrfx62pVttm74W50+83p7k0WMG38VvVFVFHyacNIqt55hERGZzBT23IAppGzXpeT8ol8t0ASJl2LBh8ufy8pQ+u1/T69/VNP2a6tUsk0Ur8mTdpqUpifigVgrNeUuX/xzWrr1pvZKcbM5LIUWygkiDRBUqetHXwb7WDejJG7nz6o5mp4w4L9ax4pXGoo15ddCj6+WWYhfNYDTSIFX7tHgVaDsHim727DqAsiM6zuXZgwytxdIIiz2bHSnFz/5MEE0TTD/L1ZQwjRSqcMH/7QJ1WxDq98V7dECvQtCuxdJjSs1LcNNjTFMjNU1IU+f0vvagUqEfSyqVLtOOosVj2RyNYPcC+07reVRoO8WxvS3csGsCnSIcYHl+7crdwG/TS0jp8eEHtby3o5r6fv39B4kzlVONaILqWafiULe9/h7Uqj+e9XY7Z+GznLWqmn5r/wa80vv0PGXXHerjtqtqNFFV7Dc71RbbOFGR2VxC095xLOi1RSenEtVzMVVApOy0007y+++/mVqjs/dfs1W/pnkQWZtCUrVK6gwdunXrJiOGTw9r1z5/mciMV181+w+1VbnSV4pCimQFkepI1HhAZ/XVRtsewOjJG6jxA9ALchCzupFm8iMN9NwGGcCt9kXrpcLVxITrDQW0dkvxEjrYVvo5dt2XnRKHz8dgyP6+GqmJpX5D96Nf975wJh7O5WrER2eX8V6todDvC/A8Ik54vUa+dJu6fS/bHcwZ8bKjlG73dRvbkwaaUugnWqqz+vZgFMuIpsDei0iC3es9EFG6/3RbaNqmvt925Qu3LEQitLZCv5uC98Y6EaKpkG7HGT7D76DZnkTRfacNqzXqG2QKnjNKr9sD+x+RlCDQRrcQaPiL48uuZYz2+4Sr47PrFW2ctU74TBwLbv27VPxrJEl/X/pX0wv9kkhnzFzHPsfZ+92vyUsm8eSTT8ohhxwsgyYUyLgfasiP8/M9DR2efuopueqqq5IuUnr27Cn33XefWQ+7RqqyXXtIrjlylQwfVWwey5W+UhRSJCvQQYrOuGuqmV2gqk514S54du8eO8ridE2LBz8z+fbA1LZPt225dZCB9XJLa0Q9gDpVeaU72ul4Nk7nLIBBkkZl9MKmKXm6fTQ9xtkPS2uqNDqAgQ7uq+CNFo08aIQx3IVVRbQdUXLiFIjqYqhua1r/pOigWsWNHiNu7o7OKJ5G7ezPtIWenT5o14G4pSVGk0qls/pqE641XFp/FevAxE9Uyet9TodJoANydSTUwao2YnVDjyFnHRXQ3088EyHomYTfk7OmD2l/frebPei2LfaxPK1RDLKQ3stAJ4h+Uk5xrgIqlqbFflO0w02COG3L1f5ef1OaeqfbwBlJcmYGJDsyS7zbD9gRQ/1/tpl5tGnTRjp02F1++elHmTI3X4b08DZ0gMPflVdeKSNGjEiJFXrRKHe79iETC8xj1x+zWurXLpOBxcXy/+29B5hdZbX//w4hQVoSukLoYEWkNylS/ghcCAKCCj9AAQEhdJQiEAhFpSgleO/FRo0oXEoIUqRcQIrSQaQIBCQgCEISILQk838+G75zV152P/vMycysz/PMM3POnLPru/de611rfdeoUaMGhPCEi004/QIZKXJ2JPerugTdeIsKsPmObtY2qqJIStNICU/iAqrFkgAEBhdRJYw4jEilJ9rGtLyfldZYVBMjwQvV9gibqqPZcowixBFYr43WSfZbhf5ptUWC99leZoPZv1aUxGxxeJ7ogpS/+C0DS9svYgeFfVGE0jrndmZfAhFKu7MpjCqMt8cyXleaCAfIcdP/eC1HS9/TMuTElnUS7Kw+vzW7m9UvqQgbVZKylsZCUVG4avPsMRFxk1rOBddtnigDjggRBXvc7XluZSIEA5vIo86vzn2R/HyM7kGqw1PD51aEP7JIa1TctLCFnHOrvsl+sY9MllS9vlke9xgcV+63/NY9B6c1TZCG9+L0VKXjsg2MCX4r+qf1VBHlcXofzr+eX3KCde31RzGPc889N8zoniPMO1e+oANO1TXXjO9I81vS9Xb65s5h9NXDwsonLBY2OWORsOqYxcJxVw8Nn/vUB0nqIY16N1jhvTDfABKe8IiU02+Q4SvjRFQpqFdaGs1WZciVaUJbh6w0FhthUiqijGcryy1j3aaSVe0pZeXZ+YyNrijSg+NDzQHGBoaNejOJqsaSNZpbmR3nWGDclhFdsBLUcbQsDcYL+41xxQNLqoQ2eqdZbv2tNEAdXzvm4vVpefE22lRFDEc5OTImWIc9R/Y8aLzmRV3tWLGwDjW3rULZqFIaeY5NnN6n4yOBgzQ4prbZtE35Ul1eXeSMx1Fiam3qpHPF6ZmcU36a7JUT12PqWmu6n1SauIzerxptVoTXovseP7bNgtZpo+ZZ+64JMcYFE1Y6xu24p3uaXzPons01YSNSSiXtb+l9RKV4vi4y179zBR2WGD4j/P1fc4Zf//rX4fjjj+/VbeT6I12PY3/bDZeHdZadFh6ac3B4ZNKQMPG1OcMH07uSBr2n3zh/GDb3zMRuGAi4I+X0K5rqb8MsaJ6MbhNkpbHIsVLxvIw2m1Zk+2tYxb+qPaU0M6teSyKunWJd/B/nIi0yUgV9j4dhnP+eB+dQdUqKyoGOWZERalXGitap/eUYqj7GpnrayJHSh1ivUhvtOtKic1b1UGPV9hJT5IJIpfZb+2m3UbAdqFwpQpiVYhenQFlIxarawDYvqiRDtuh8ZEUS00Q04kiiRdFG9Q5TGmBTEyEyvJvox2WFP5RqqfTXpnrlxPU7vKZuqOnaCjXBjUUboOr9QZNIVnhGjbHBTh5pnHOfjh3aOI1STiS/25FG2XSfNifMkoKpbAeNMR3r/nZsGdf//Kghr3WmpOD38pRB4fl/D0oiPzTJ7aRk+w3T5wjvTe8Kf/vnkDBm2/R6rgcffCAMBNyRcvoVec0d68By2mGUQVbqnY0aKO1LaQ0y1OV02bx+u50yPPhtI0iskxlZm9qo3zKG0owfGTUy5LN6PpXBGlvMOKY1IFbfLhkldtbeOigYK2WNUKUh2Rq6vGga/5OynlI9LVb63Obv6xxkHUc5M5plt+IDEt/gB9luNfws4/jpHMvZ1PG0kR3VfaVRRQGxbFQpryEu6+F/RPzs/mlspDmgql1MO2+SENdy4yhB3ehR3VYLZe5T/Gg/JYtf5zxkYaMuqk9sGvaFe4rt7QSxU1UGpUxKyVPf5zrn+HCvU+8yriPd29IcF/2wbXIk885Xq/f6JsaFMysShEJN12ZKSFCqvx1bnudvvPWhI0KN1AczwiwKfsiLzznoQ4W8Jx5/PBlvnVDGk2T77+6dJ3Gishv0PjogGvR6jZTTr2gy9902oVXtErVKvNdKk8+8GgZFmGyfJT2UJQyhqIVm5njIYCwoOsIDBqPx+eefT7ZdM3lSkeM9jHS7D1Kcy4pYWIEEbVNd9F32EYeOm+yiiy7ak5qJQWwdEyvCYA1uOVZyNHQ88upMVEthmzJnIREASZzrIW6Pg9YrJ1fLtr/jZdqmwpp5t6/lIHKeqkTs4vVIzMM2pVXdQdZ30pTOyjTmzSJLHMJ+n/Fu62vscY5h3KtOwhrqWRLijAUe5K+++mryN8e0ShPjMml5NiJadrm6T2ls8do26O5LNSCqX1IUVBMEqrGsCseAKBPHQ/czRe44f4wZ1cvxf6kqZtWZ6Xxp4kMRKhvx1L2e+7vu9ayryr2+yT5tzv+h468xZe+h/e3YLrfccmGOru5Eve9Xf5o3HPk/w8Lv75snUfB78NhXwq2HvxoeHv1K4rx88MG74aCDDurIdiI88dnPfjaJQH0rp55r7iEzw29+85vQ33FHyul3lBGVKAMPZNUoqUmq6lKaKAqXEaoZVhthkjMoA4H35czwWwqF+p5mUjWTK+M7K+KStQ+qd0hD6y9rHPFZDCIcI/aVv5Wmpv3UrDHnidesW1LXSvEpI1kuozY2kGLYDhlgZeqzYmEIvRdHUFS7ZNNP8pxNGQNZTlJWulwZbDRKM7dyHjS5kAXHvsrYjqM/MWW2n/GhccC4YIzwO62/laJJEn1Q7ZgkxK3Ra4UwlErJT5GzXYRVp9Q1qNdVnDSdCzlTHHulndU570Uousuki4RtmoJrF4fYik+oH1pddC/TvVc9sHTuyjhIoFpRnStd+5L9B5ZpFVHVALrKWLETY2r3oPtYk8d6oGGvX90zNVFUNBnW1zjyyCPDzO6uMGMm6nxDw6X3zhOO2/rDiM+rb82RCDmc8of5w5vvdoUDN3kzjL/66o6ITgDX+eLDZhQ26P2f//mfftf7K6Z/jULHaRAZxVYFTMZxkz2lMKbsLLse3BiNemhoZtMabjK2bA2VfZ2HinaFLUDPMuKkMib1Pv7G2FXdgmZjZYzwGWbYpJin6BE/CBFQ02MjY/qMrf8qiz6vFMAiw1/1TkXoAa60sTShBu2TDDT1B6pL00a0Cvg1rnBa82qNsprPZsE4zWrqW+Y48H1FWK2Uflo6rq4ZqejhhGiSASfEOjISwrBS84pilm1inLW9UnOUYRen5VVZltJBbdsAIoNNKvgpmq77SHysmr6XWcn5uoIySu2T0ayJFZ071VNxL9F9US0i7H5pHCkl2jbLlnCJ7oX2Hq9Jq7L3eo0L1s/51DYUqYo65WvwwP5uRfV1dmS99dYLKyy/QmAIMgrnHdIdvr76tPCDy4eF9X68aPiv2+YL9zwzV/L7zJvnD4M+atDbCbhOXvqonisN0g9fmjwoyY754Q9/GPoz7kg5TgYy7qwogG7iTfWUAvVXkjEgI0fNdBVRS3MsbJF3FWSsChmm1vCVQyQHis/gFGEw4IygMsQPBpT699gUQgzyxx57LDz77LM9Ig9yOOT4IOig9BnVtenH9n0pwp4bRemKDP8yy5fRXSZ6FH+vyX49dbGpcjIIVXeQRR0nQ3LTsQx2mehl3oRC2nksKyFuBUJi8Y/Y2K6CTcuzNW8631UmWeJouY4d24jj0xRyKoHtbofculQVdW3rOMtJzAP1sfha1D3Fpu/aSBLrsxFrKzBk90tRMkWZBMvk/sOydC+MBX3i+2TZcaHXTFAxTps+1gOJrHRkzg1OdH9zUK+7/vowfPiCSa+mTw6bEU66dugs6X03HfZqeODYV8IJI6cmn7nqyis7sp1rrLFGj7BEGrz/zgddYdH5p4dx48Z1LHLWG7gj5TgZKI2oXT2lbL8oaygohcX2h8pLuYsdrDKRnHgfpHa2yCKLJAYtTpVqD4gsLbnkkonzFBt+7AMzTllRIJvPnoXSDG2Ngc2HL4utq8kzWlTTkndMY8eiau3Q7ICtI4qVK+s0Hs0DY1EGuk1HzYpU5RnhUj0sipoU1SrJuYtFVHRMWjFsZSTLaVCkRIqhVZCTEaePNmkgKj1KtKt+R4ILcVQKgzfLmXryySfDj370o4+9r/FqHSXbgFoiLba2DtLS+xiHdhzY9DDGGGOPe6KtLbQ98qqka9oWHJqIKUo5dvKPqfrD2Qkane/+5qDy7L322mu5SsOLkwclQhNK71ManQQdRm8zNTw7cWJHnJTvfOc7ye/jP6rnUmQK54rXNOhdY+n3w6tvDgrzDAn9uqeUO1KOk4GcC0lg60bOA5EbF/UXrRg7Mjpscb2MMhkhVr0vSw0rS2kvucA/mrHnwaPcf/ZniSWW+JhTpJl+hB+sUh6ztghXkIoX11aotqAMeQam+h7pGCsFqwpavu3FlIYevLYnVH/DKhJyXNJk77OiRYwRxveZZ54ZjjnmmOR30YPaTjqoZ5HGctlrxKqelWlSW1SrpOXYSBl/4wAVjZEqxOmeNq2rKq2IuJRJjxJyAJuMrFvnVmmUGoOaGEpzpvbZZ5/Uc6HopCZVrGKbznc84aL9Skvvy7rWmSRhWdzr4/pBpVlWEZ0oU5PlVINnlpxoe99WSm9/O66IOSyzzDLh3Q+6EqepqEFvJ5wUtvGLX1w5dIXuMHr80LDqiYuFTT9q0MvrndaYFi7a8/Uw3ye6Ewewasp4X8Llz50Bj22iGKM0KPWx0A1cTgbvqwaoKraxp+pqNLsOtj9UluFvZ2KZyZIMtprDKhXPUiQHTRqe7cWl7ZFwgZUYbtUYVcSK/WA7mLmOHaiy/arkUCpFMKuHkS1S76/IcGQ/1Yw2PhYYjYyBON3pnLPPDldedVXSmX7EAjPDpDfmCKeffnrYeeedk872aQ6Y7UemBpoYwRJAKaOcWbVJbZGEOOef9TLhwWckZKGx0aoToeMbp9ey7VVkmdWnLJ4QadLJ4VjJIVXaaSttIYr6Y1klTUWSpLLGuBAoet12221JxJuJmhi20ap26m+Wq5Qv2xJBsH9Wel9OfhaoOlLPKSETe29gnYqalzmntl+dxoeNpPUnue5ONOcFW0fL+e+PPaV22GGH8NMzTg+fHJov6PDJYdPDX//619AJVltttfDOKw+Gi/b8d9Ln6rW35giLzD8zrL3se+GeZ+cKp94wf5hrzu4w+e0Pa3P7K+5IOQMapdfxW6kcKiRXQ16lkcSpYFYBrM4NXEYHhoXSmYRqkrR+DBAcKz3UbZ8TjGG2QwYK26++KaxDfVQ0y6/aq6ymkZJCl7qdjCF+1JBU+9yUsad9Yr+llAi2Rq3q8phFTnNy2WZmmduhjDY7wP5lOU8WTRDYiOLPzz03/OHaa8KYkZM/1mDxxEvHJZ+hs30arEtRhDq9dKo2qZXzhvy/+qko8iqnX+IiapQqB60JJyJuRAsy7qqkcSFkokkaOWf8SOCkCTgOpOgSXWa7ube12k8rDTm3NhqqVF3dXwX3pe9///th7bXXDptvvnk48cQTM8eE7r12IksNrG1T6Lj+yfaB0v0sDSsMkRbhlwpfGVSTpX1XKlp/lOvuRHNenQddJ033XpudHKkzzjgjtUGv4N78z8mDwvTHHuvINpK98vLUwWGR+WaGgzd7q6fv1ddvWDjpe7XE8BnJNk6f2R2eeuqpjvW9ajee2ucMCHhQ8uB+6aWXZklPs06SNdjtZ6ykNdjfVVSdslSeVBel/iv0ZLFNJSXljkHI38zMqfZE0SMVdUu0QrOhqsFiX/gtOegy6VMyCq2UOsu2dShSXKsL2ygDh21gfXIIqyr3xdueJfEupbTZmaLty5JXl9Gq+iL2P23c29RVxhROOeIG468ZH47benJqPv6xW08uLBpupcdSHTW8MhLiTfaWi7dXWMcfqoxb1eeopkw1Nk1Hi1gu28X5bqUtRBYcg5NOOilceOGFPcaSnB9blygOPfTQZELjl7/8ZU9k/pZbbpnFiZFjbtP3FE0meo1xbSNcaVEpkXc8NVbj3n7xxFlZJGaj88l14VLoraHrWOOB+9mll14afvaznyVjbuLEiaE/QepcMjFRQtChU84JjXnffu/D7QCcKCuMcfNh/9f36tprrg5HHXVU6I+4I+X0e6yogxwKRaHimWDJQvNahpvU+9LkV6uoOsVYA48H7kILLZTkRWMcsO7Y+LX7oYatGL+2OaEe2PxWrYZ1mlS7ktc0UlLoaUp1LE9SxGwLKHKXh1JbrGFi06JkbGel6tQhq8C7qJdSp7G9lMCKb+h8yenm2EvBDgNDxrIcSRzntHGfJvJw/fXXh3nn6srNxyfdLy8fv5UeS3Wb1JaRENeEBNcYEMVttZeSti9WKizT7Dltv+Xocf1xHJvYxjqTS3U57rjjEkfq2GOPDY888sjHUuS0TsYFDtNFF10UjjjiiLDSSiv1OOe33357uPXWW2f5jr0ObHNsRTvzBE2kyldGYEXNfvUM0ESOPbdlsZMCtmZO983+VtPTW3B9cM+jbvNb3/pmGHfhL8Kjd14WLr34V2G77b4WfvCDH/SrnkVf/OIXw5xzdIcxE9IFHcZcMzRp4Nu0eFAVZ2/nnXcOYyYMD6fdMF+uMMZx20wJl/72t/1Svc9T+5x+jy1ij9ONZPhZdTPgbxluqt2xjU5Bxl4rM8eKOgk5S2mpd3Y/lP6mbdYsrd5T42C9bwt1rfy4eq/YmiKlfGEAZKFInI0i5Ukcp6XU6FjqeyrKblI2nGOXVivFPuKEzg51UlKCxECwBfpqRqq6HqVGqaYMQ80W5KuwXWNc43ro0KG5aXYaVzgeIxb8sDA4Dd5fYoH8ouGiuqWi9BtbC2Gv1zxhBC0vjhTzHWpfdH2ybhxLRWsVwWolOkX6nQRjbE1QWbVCuw+6rrOu/yYjSO1Yj+1Fh6PEMlddddWPfY7rbt999w2f/exnEzGTP/3pT0mLBBGfZ16zbbH4DuOeMZ83G2/r1ZR6mnV/YcxxXyAjAAfMNn8F1d2VOT5yjhlvfM+2WmglHdwJ4YzTTw/X/2FCGDNySuX0477GIYccEnbc8c5E/Q4Bh9NumD8sNnRGePGNQUkkatjcM8P707vC/ffflziRWTWs7eTkk09Ofp95ySVhniEzcyfifnzd/OEXv/hFahpvX8YjUk6/x6YbxVEYjCyllllHif/rga4UKDWhVQ0Ir+sKTdRRLrP7Iecp/jtGClZyjORU5c2Uan+zUma0XPW8aqq7vCJTTcLybHpPb0elslL0bJNnGWsyFhWV0wy8Uir5UURQEUedA9WRgJXqlzOVl2anccV4nvR6V26DxUmv5xcN140qpc3mK2LM76KaJjmQceRYx4wfpbXqmrE1jnVpQq2wFeXCurRjPUceeeQsMuZ33313eOCBBz72uZ/+9Kfh6aefTlL67r333nDTTTf1/G+zzTYL66+//iyfZ+xw39UxZnt5DWWyAWxUOs/BVSogzpSWLxThraLexzG10TPd31wKvT6ox176u9+1lH7c5xr0rrBiePCFIeHgTd8Myyw0PTz76pxhveXfD7ce9mr425hXwiPH01NqSvj9peM60vh28ODBieP6+c9/Piw+rEgYY0a45JJLQn/DHSmn3xPnvdsZbhWj64GsdLM0uWg+t8IKKyQzqSuuuGJmCl67nD6bNmWjN3rPpsPZKJuMUc3EKoKh/WImOa5D0extliNgZYaZvZ2dyTIOcQiqOoFKu7PpXFnHSMfZOhJ8VnUTiopI7p1zhHOkFDXbL8WqoFk4B3LkpWoWwznKS7PTuMKIffu97tx8fPLht99++9xjZOuWbE80qSk23aBX+2AdRwvfU0Nam3onZ6oVAQBtK9cQy7dqhXVSuKyipM5bOwzvvPtMK8TO1D333DOLM0XB+dixYxPJc86XdaIgdqKEbeEgh1X3aI5V1ix83I+LyQLd+9I+q3uZHDcrFgFVHe9YQMSOO6c6V155ZZJe3Er6cV/juuuuC8sut2L42U3zh0dfHJw04r1wz9fDpz85/eNO5CWXzBLd7U26urrCSx8JY2RNxL0yZVB47713k/tCf8IdKaffUzTDze+llloqaUZLehUPOR64WZEmzW4/99xziQOFkVPUPLSO06dIhIqUJc2LkZbX4DY2uJUGo/xyGZwsS7Oketin1UrlYRuozq5kHSsdjyrgBBGtUy8iOd62fgNsHzCNNzlhfM/WgaXV34Gk5u05iWvHNJ7zDLMi8QZdH4z5rbbcKpwwYXhGg8XhST4810oRqjWRAyVHv2wvnaoNetl2YVNcpeqmnkPCpvK2qjxp1Qo1KVE3wtNbPYjyJpdaBWcKpzzNmfrxj3+c7Bfn8eijj05SAPmRA0OqHz8xOrY415pYUA2gxnUW1vlhTI0YMeJjDr0VCVG6slVi1D2yqlMbO0/WqXKqw/OWlgx5UY/Fh8/sVz2LeEbRIuBb39q5sKfU3ENmJmmznWDuuecuFMaY9kFX+MTg7iQq3Z/wGimn36NZY6XHpfVOUg49hit1FVkznKotkHHKw5aHa1MSrKox0Uy0HrxKUdOsrIzALAfGGtyazWUZ1jizsD5bR6NaKQre+zp5whXUuNh6niLUvJPxxHHinMiQ00y51mkdOJt6pvq2IkENORFFnyljYGtWPZYHj2XEDzzooOSzo8dPCKfeMDypiXrxja4kUpUUPs85Z1LoTVQqz6GSBHS8bTpm6u9Tt7YxraeUalsUReAz1jmwdWag/zWhjle1B1anexDpPqPzo3GmlMRW10NkieOLkwSagVaaLZGFvHoLRCtiNBmEkazrSTVeSqNLu445htRl2YkzftSTSJ9JiwrG16idDChzjDAudYztBFfVGjrn/7II6GuXJwf+j9dmhiH33dfvpLa5dj5VkDqH3Phjj/01SW0sM+HVJMsss0y47757w/HXDA3dPY6dqV+bMDR57+5nh4R77/1Lvzo/Pi3iDAisjHgr0r8y7qxClxyaJlJjZNTa+iybesdDnP8pImIjT3FKk4x1nCQcAFtjk4Y+qzqAThZDNylPnnezVjSmyjo5BzjbkoLXcbb9bOLfOuacRzsjnRdZLIuVjM9DjoicdBt9UDoevw859NBwwQUXhh2+sVtYcfWtw+JLrRjYjYl//2v4yx8vCP819owkd79IIctul42ylpFCr5N+xnUtp0VOlCLPkum3aa28xqFrYpy3olaY5oDaNDbdY5pM74tTEtU3rm5KYhobbrhhMk4EztTWW28dRo8e3fNzxx13JOvmbyiaYJBKqSKA/Mh5ynNO4v3hs2lRoSzpc6HJkLKRRo07pXwqStq0tP1AAbntt97NTz9+94Ou8Phjj3akXqid/O1vf+vpKZVG0lNqyqAweFB3OOWUU3p9+5ZddtnAlnWF7kQYY9UTFwubnrFIWHXMYmH01UPDcgt/EBacd2Z4aTIZGe+Hgw46KPQX3JFynArIuFNanE3fKlsDUsbIUS8Z9SOx8rs2dckaHU1IhsuZarq4vQpNp76wT1k1bKp943eV4ydlOhl+aVLxcdqUTReqUiPBsYhTEOPUzSyxEaFIg2qx2N60qA7wGYxs0vhmzpgRnn3m7+HEbaeEB495Mdx0yEvhgWNeDCeMnFxY3Kw0NdZl5e85HmXGV9X0s7zaKuB/RK2IQpLGy4xtUwZtnR5YWcjIV+RYqYmq9WoKpSQq9VfHulUBDguO1DrrrNPz2l6D8f/KILEQkEAQcJwUuUwjFv+QyFAaKLTaVGqLrrOyE2adkrbvr1i57fT046Fh57WnJVLb/Ul0Ari/FKXOvf1+VxK1ilsI9JaT2x1ovtsVDtn0zbD3Bm+Fmd0hvPVeV5KSOEdXV/j1nfMmju5Ki78frr766n5zftyRcpwKyLjTQ1gRCRnKTdUy2Blu22QUeLjzN+tqB6rNgk40rpW8cV7dQ1nkZOTV16hGrur67Ox5kROmlC85FnXWY51LRStAaXpF2yDhCp3TWN5e0RAZi9SfXHf9dWF0TYUs66TY+hA1KG2Hel9ebRU0EZUuo1aoWjil0laJJklAIXbOea+KalwZFJ2U7H7TqnKMpzXWWONjx5rXq6yySuV7mERFlPZsI515EzB8xqp32h5gMYr8Qxz1V21WlUkX28PM9vdrqq52oEH65+e+8MVw3NVDk2hHT9Rj/NCw0xrTwsnbTemXohPU5jISSZ3LciLZ/1ff/LA2tbf7aS299NJhl112CVwuZ98yf7jtqbnCxNfmDCduOzVpynvTYa+Gh477sDnvEy8PCXMO6u4358cdKcdJgZtQWrNKGXdK3RGKGDUlVaxifWZHJSag/PzeEHfQw74TufxyGojCtOpM6ftSj8s6N6qxgLLRsLLnQNvAGLEy5WVRlMAab7EzVsaw04NVqWJpKXYyLlke9S2tNOhVuqAM3Kqy1XXU+6pIezfdkFb7q7GmKDX3CqXVll1OlhhC01Lo7VaV41g8/PDDqbVyCFDIoT7++ONLjWFERaycuLDOVBr8nygQqYGiKBVQdahpkWbdl2dHafv+Ds/f1VdfPSy/aFfY9ytvhXWXfy/st/Fb4a4j/xVO/fqUMHhQuZ53fQ1S4RiJM2aGJFVultS5j5zIz35yetJfqrt7ZjjggAM64uR+4QsrhekzQ7jv+SGZzXmP3XpqmD4jhIkTJ4b+gDtSzoAlz5DigStD084cxjVMUmvDYLBNbltFxlTaQzw2qtuBeqrk9QxqJ+rTpTSnKpEx+1mdD80w550bOTxNShNrmeyDlT1X5KcstsaiLla4ICvFzkZ7OP8YI6006EWwRA5xLFtdhqrqfWUlxCUak3aNt0JWNEkTM2VJq3fU7yZrpdqtKkezXeqghI1MUTN13333VT6+jKe4NlRjmbTNPGeKiJ5V8Mu7nvKK4bP603VCcn4gwnPpX2/OEfbZ8O1w0temhoM2fSssteCMSj3v+hqkwi626GLJ33N0hbDmMu8nPziRNx/6avjMJ6eHU/4wNGneO+ccIVxzzfheT50bPHhwOO+8XySVUkUKg/yfrIf+QJ91pHgo7bfffknndBSknnjiiU5vktOHyDKkpAKlnPu0mUPVMMkoVkqMfvOAffHFF1s2yrIMpnY7UYL9tWIMvQWGEs4q61Yj5CqyzHHkRucFozrPQMwzwupiDVR+JBJimz+XQU561mso42QVpdjZlCecIBT7mmjQqxoRfvO6SlqdZvJVx8OxI7U1y5AtIyHeruhAWjRJ56usyAYwTrLOZ5XoVhFy7nUvszV8ra4DJ8r2iaIeas8995ylLuquu+4Kt99+e6Xlcp3GkWqrkhk3040/969//atUU27Ggz0Ptk6Vv+PU2Crp2mqQ3lRd7UCjjOhEmZ53fY0/3Xln4qRQe3TLE3OFKx6cO4x/aO4wcuzCPVGpy7/373DcNlOTz//617/u9W1ceumlE+GJT5VozltGvbUv0CevYG6Go0aNSqIGl19+edh1110Tp6rqjc0ZuGQZUoyhuNFq2syhDPs0g1j5+K06U3mGdm84UzJMyijCgW1cWcaoz4o0YSjSwV6zVRj0TThzRSk5ip40iVKQlJapQvaqs9BpKUZp6yqiTIodhirvb7HFFo016G2lNknHiuOnlNqs1ERQtMtK0VsJ8XZHB+J7h1CPojIwFrOuO67LptLBpCpnI35SCGylHit2opBDJx0LVltttVmcKVJIqzhTivrFx1fXd9H4so5omYhFvI68Jtxle6tpLGtSwOukmhadGB5GbrNNMmnTn+D5hO3LnZ5+THtv8HZqaqMiPlUjvk2x/fbbh39OmTN3Eu7lKYMTh6s/0CcdKXKrH3zwwaTXxPLLL5/MTnBC4i7pjpNFliElKWAZFpo51OdFmdQkvtuKwZM3s9obyJDLmx0XODpcixjL+l6WfHCRcyApcWoaMOZwSpsyNNTHKA0MMCJgZR3HKihNU6IQdQyxMs5U3vnRTH5Rip0kxJdYYomwzTbbfMxYefLlOcOuv1owHD9+WNJbqt1g6Num0fY6TLu+ykiIW0VARaIwaDHEW3VSuF6yREjKpuXlNYvG+GY7m0ARQ6mQ6j6oY1U1fU1Nd+2zmOa8pCVZgZQ0Zwrnq+w2S1I8PsaMa45NXm2ldagllZ8FY0NNgO2kiCJ2TPiUHS/KZIjFY/LuSU5+Pc5O39w5jB4/PKx60uJhk58uHlY5cfEwevyw8P9tvkXYe599kudHfwMHkqjUiOEzwuFffTM1tZGIDxGhTrHDDjuEdz6YI3cSjlqu/hIxnLOv6uljsK2wwgo975HiR1HrtttuW2uZ3NikiuYMDHjo2noR9YLSbCcOlC1qptknD8KyAgwsh/5NdaMcQ4cObVuUVfudF/XCGOWaYH/VXDXv8xgVquWJG9KKKo6A6kFkRDcBy+SccGzzDGHbrLMJtP3tjiTaujo13gXV8clglhSzZsRjMB4Ze4cddnjSQ2r0+GvCT64flvQomTztw6Lh5RedESb+/dHESN5pp52SXkBFkUNFfbnW2B62oeg7+r89hnKOJEMfI0NaERa7fhx0pbLF6lY4ujQmXnTRRWsLrVjBjrTJlbLPGUXR0pYjJc8qkVo5cWnOnK5VjRk5C0XXSszpp5/e0yMKNt5447D22mv3NNC15wJnyjbrxfnic7b3VIzOFeM3TanSpn9mEY8bUoezDG6OFY6mJtMsijDyPz5TZrxY5VVtO9ta9TjP7uSNtSZBpIR00Ysvvjgp91hngQXCJpts0pMyhlNNyn5/6ttF64ZPf/rTYdJzT+Q2JqZf04Zbr9IRu3aRRRZJngljLv/9x5rz/vzWecNZNw9NJl5/97vfhZEjR4Yll1xythxvZSc9u7p7q+CiQX7+85+HP//5z+GCCy7oee+iiy5Kbsjnnntu5eU9+uijXvA5ALGRB+tMgeS39b6tHdBn1IMlD814t7KNTeXQyynMujHE0aJYlU4RvDj1MWtdacutu91NLavsOZFUeJVl9pZUfNa6bH8xkWaIV1F81DVCmuWPfnRKmPjM02H0NlOSImLbtX7MhGFh0802D/vvP6rU8qpuT5Ycfl6tWda1Y8+/zrNtwmoj0nXJWnfadVV3HMZOYitIyCRN5KLs/ev8888PY8eOTf7GkVprrbUSiXNL2jkku0TOFKR9T1iHx25zHAFMS620+xSPG7YrK4qFA1V0Hy57XrOOs9bj1CPv/LT6DJ4dYR5enJUAAGqHSURBVLKHchb6+6GKF0MGwXFXDwvnnXdex+qQpk+fHv77v/8r3HjjjYn666eGd4eJr3Ynan3zDAlhiQVmJul/pI9vvvnmYZ999m1LNkirEP0uyryY/ba6BBzsOByv2fO68MCyES6n/8PsBbNYtgeJeg4xI6/Gpfahx8OWpp7MuDCzXRS54LvMbtNDpA6vvvpqZupIWmpLGqqBYNtj40sGqgwBLYtIAZG0OGJAXSKzp7H8cNa26e9W5mtiY6lVWNYyyyyTO4OMLGuV9XGM6hreVZ0wqxApOIecL51flqceZ9wbNQOuAnrGcBFEYJlt57ukHj399NNhzMhZH9ySs4XR4/8YjjjiyMzZRS3POi9lt0eqd1Ks1LlhbHMtpp1LjI0045R1k8LJOl944YVZaqn0f42RurV5WfWRHEsMm7Iz5FxvHLc0OG4jRoyodL977rnnUsd+1r2M7aWOqMx4YXsEkai0yFJaClscmdI5TcNuh8aEmvTa1FfGvGq+4uuYz+o86DhwjK00ukWqkXnGONfkiiuuGIrIe2aQess29ba4TzvIG2vtID6uTPyQLsp4o95w9913bznqMTvxuc99Luy4447hhP+57GMRn2Ri65phyf+5DjvJ2LHnJvfYq666Kplo6e6ekvSViifiTpzwxzB8+AJJuc7sNN545pWhTzpSXBixlCwh3CrKXjHcXJsuNHdmb3C8eQDy0JUAAA9M3mMsZYWJMQZ54OEgMe6KGqySzlN3bCkFKW3mmRuGVOmyjHgZrZJjtj1ilAaWlnYmhTOOCUanJi40I1y2qWq83DrYuphYVrouPHRxbtlHHFX2hXOu+qAqyDAru23sC8apjX6UdaS0LojlqvkbRTIMWqU4yZDke2oGzLiWY5+37xiX6o32xz/+sbCn1Gk3LhCuu+66cPDBB6d+huWxXdZQ1PEqc30ozVOTGxrXGMA0VI7PW16dDN9jnVz7aRMVSivNU3XLg2OZ1SQZo491l3Gm2AcmLtKuf84n/686XrlvxMdbIghKd9Z7Oldlzs+PfvSj5POMv4022ij1Mzy30/YFh5DjxTo33XTTzOshdjI4fzit8SQqyyLdjnObdX51D9C+ZjlSLItzledIKcpVdE7tcbZoLKsmq7+QNtbaAceV88lxPXfs2KSROPcr2jOgPHrhhRcmtUXUVfUHRxVOO+205L49etwlSdr14sNnhhcnzxGmvRfCwgstFP7+978nn/nOd76T3B87xWc+85nEyZk69UMnKnMi7ve/T54drWxr0+Ot7HO5T4pNEPZnkPCAsel5GHyOUxY5AlJx0owmxmNerq16lmDAlMlrL3K08uBGqfoWmxKiWVu2gYeIDYnb6BrI+IwNfdUS8P80I0EqWGmzyEUpRU1K+srZ4Diw36026QXOL+cwq5dQlYetjrXOTV7fK9WQKZVI0SWbSsrfakCrz9lCfbCv5ZDJscJQw7BU+hLnVlLgcq5wiPnJ66NkRR5wgka02FPKCjzIocNhV/PaIuQ0xjLUWbLlZSTEqY9Jo468dTzZlzVO2Y8soz0mTaLbjrOm1PtYD9EeSaHrvsKYKXt+2K4TTzwxHHnkkZmfIeqSxf777598v0p0lu1Mc1YZX5oIyEK95bScvPWqn10eREGKjpOOc1oKZdM9wgYSHFcmNnGibrzx+iRy/tCxL4VbDn0pPHjsS+GEkZPD7y8dF374wx+G/gLX6amnnhruuuvusO+ow0IY+pkw7T2uhe4w7c1Xw1sv3hsuPv+/wnrrrhsOP/zwjqU3Pv/882H8+PFh3rny+0rNO1fIbO4+u9MnHSlC6Mstt1z46U9/mjyUHnvssSQPkyJDxymL+s3IwbCpcrwfq+bp/xi4csLKGPWt5P0qSiCjWxEJtp2HNgYbPzh0ku9WpEn7YSNOaWkuRWCQyEBQ+k5RGpuM3iacHhnesehAq2DMZvUSqlL4bY+hdYjSaiH0nqIh/Ma45Idjy2/OOX8rvVKvNdvGdiq9mfdZDj/8jTEhRTGdaytrLXC0MNry+iipYSnLwfib1GJPKfUksz10gGupTDNctlPOof3JMkDLSIhL/tueH52/VpDBnEWVehiOqd0Pe69q0vDmeMlhUIRejjmNPZtw2qQQmAbLr6POqWMZnzPGWd69Ipajz1NJ5R5YJJVetg+ZdbLtfSJO13WqwbVAJGr01pOTqIcmfRT1OHbryWHcuHG93qS23RDBwYl/5um/J414ifo8MvqVcNsPXg0Pj34lnLDtlHDZ737bMSfyyiuvTCTZl1wgv68UKoNVmpbPTvRJR0ppBDfffHOPYhTKHxtuuGGnN8vpQygNI0vMAAMrThdVdEDvy2HII28Wtqw8sZwkSTpjcFA/xQ2Uz5CiIiNTjmFRHROUSUVjeTJ0y/Za4pjwuTxjtioYRpoxbxX1DMrqJcR2V20CTOSACIfOkyKJNnoiZ1hpTLZIXufPSiyrNqNOVFN1cXb/rHNtC+7T+igpGsL75Nq32lNKY1nnT44gxnsZI1SOnSgyQMtKiOM0ywFWiqSu61Zk9xlDWfeGKhMMcso0dkDnsQm59rTzI2fNjosyEZcy68i6H7I/3GeqklUrWqTeB3afmITIQk5l3r28bERJ8vyxyEkcdXaqG+zzfSI//Zj/99WoR17E55JLLknG0uhtpqY6kcdtMyWMG3dJR5zI1157LQyfJ4QXJw/KnYh78Y0PU977In32qv385z8fbrjhhvCTn/wk/Pa3vw2nnHJKpzfJ6WNYQxFsyhBg4Kk+SPUCSi+TE6bUu6wZbP6PQdXqdqoJJQanomgyyDEGSL9T6L5pIU6leCmdsUyvJY4Jn6vqkGShGoL4HLWCTTUDGeSK0NhzX1Rvo/RIO6uvaJN63sgJ1nkkKpSVlmSdqrpYR8o6ZnEtXF6anWbPqQnccostwwk5DTCpQSjKb1cvHR0T1mUjU00boJIiz0vvs5MDmoRgeXYCoWmngXVUWa6csng8sI0vvfRSY33WdH40bmwfLu47TThtecXgpOtX3Ze8uqSiZVkHPo5OpkWlipqkl40oMS5svzONX0WTnXoG+xItph/3VQdyyJxdYb6C1DmU8jrhRC688MLJc+Kt9z4UlkiD96e93x2eeuqpPqmw2GcdKeDhR1Hryiuv3OlNcfooMqJsAT/IWeIH45B6JB5+zAwza6sCb6XepTlTMvhwdFoxQHiwYtDJ8I7TmjBAWX6WKEUrsEz2z0YritKWAKOLz+dFBaqgGfI0Y7IqigwRPeK8SVRDtVEyzHTuZcSqdiSOilgDSOINOhc4JxIdULqUrV3SvrQrpaeoBxfbk5dmJ2MP9h81Kmy++RZJw0saX/5fA8zhSWNMCrnLoEiPjoWOfRkH2RqgXKM2widVPwvnMMsJZt1MQMhpVlqsatNA57QuSsGMt4FxQY1aWaM5qxZI57jJhq6aYIhTU1Uz1SpFggxVDV0Mtfj4ygksE5G3+5SX0qvrNms8VYkoyWlTZFHLxrmvMi6cWccBUY1W0o/7Ilwv1B+NmE1T57bbbrsw7f0QVl/q/TBmwtDUibgTrhkaPrPYB+EPE8b3yTq2Pu1IOU6ryIjCWFa9CA81brZylvjNa5pA2/f1PxwrjHIewlYu3KbfoCxV1yDjexhLcUpb3Gi0lb4yVg1OKO2N7Y+jJ3lpS8AxJOXgySefTIQMmuixxDLVHLgu2k85UOwHUUlFJ62TDKpHUvPYeJ9tCiXngGMlcQf+tkZau52mNMo6nXlpdoogcAwOOvjgcP75F4QdvrFb+MyaI8NO3/p2uOuuu5Ki5yopl3Hvn7LjQwaoPq+0R8Y+EYM4glTk9Cu9T5MFVklR11QrdUhsa1qtIMvHga3iAOXVJTbZuJtjzLnWcZUzXiaNuQwc67yolARQqiyP6zjuHaXtzYsyKfpYRiREKGU3bVllI0p6bsjZs8qanMv+FjXpLYP9rXdbSz/ui2CTvP1eV5j0RlHqXFe4//77ez3is/TSSyfZCg+9MFf40oj3w+jxQ8OXTlgsbHDqImHl4xcLx109NHSF7vDkK4PDl0a8m6Qp9rU6NneknAEPDzVSl+i0vcQSSyQPwyyjEAMTBwHVSH4r3Y2bGTn2ksEGKyMsmeY6KMJhDUhh6xigTrRG39eyWA/Oiq2jYbmk3cjAluFZhFLemkg3ZNsw8jDC4tofux95yGCR/DGGLMtMc5KFjTBlSVpbw1xCD3EdEljlxDznARnzyy67LJx11lnhjDPOCL/4xS/C448/HupQ5KQUpdnFEQSuFR6MqKyVSeeLsemTku9WFKSsAYrTJ4NAPYQUBY0nLPKcfkXD0uTkbb1UXSSwkRbJYRxk9Yiqeh6bTOfV/ZDttumgmhRqIlqSV48Ui0CUgXNsJ7D0w/WWNgFS5JRlNXJmeXnNlplwKhtRUpTROn5aD/elpmrfBgoy2Me0mH7cFx3I96d3F6bOvftBV/jbXx/pSMTn5JNPDt/41i7h/ufnCnOgKvhBV1hkvpnhexu9He4+6l/h8RNfCWO2nRoenjQkDJ6z76n3uSPlOCXhwUZkSVGHONKkyJE1amSA8JuHbB0jREam6m5muYA/mu3GiJAKXNlCdmuYxYXZaUXasWxzWQOziWgU4ECpXszWvljHRBGAPGz/nTIiB1J3lKR4GawwQBZZkRicKNSl6L1BWuhFF10UjjrqqLDBBhuEL3/5y+H6668vtQ12PXlIGj0rzY7jlNerqOqYVoRAy1V6VVmZbUUJ7QSAjFztQx0J8dh5sk5VXeT4ZcG4Knv88iKxaQ5kK3CNpa2PlMQmoiUsPy+NTpHCsiiiaidVND7UrDoLm9oKeYI6nC+l+KaNC8Yf94kqkcas+2iTtW8DBQx20oxJN171pA/Tj1etkX7c1xzIXXbZJRnvpMilOZFjrhkadl572keiE72vXDj4I6n2r26xRZjR3RXGjJwartjv3+Gwr74ZllpwhlFWnBo+mN4dJk6cGPoS7kg5jgFjjgckxkJcc4EToRlJ/dhIkyIXSvuIDVhe1yle16y2Ih1WBl0z8Rg4rJuZ5LINOmND3qY0ZfWVsmlOZWfBm3CkWIaMYaVjSigkrlMqcvDUB0yOb1HqFsdfDnEZNA7KkHYMb7rppuQ3Xdp//vOfJ04jXerpZk8klL8vv/zy0CRFaXZZRrxmz+uMZ467NWI5F2WvD46xIlFWpZJzlHbsy0iIc5wlKGPFZfLS0MpQdD2WPX7UaWaNK45D07U1cZNbYfs3tksKvc6kE+eTcarzqGUzxng/a3IjrlfT/SUrKoWTZ5efdi6IdpdB7SRakVN30nor3RX2HXV4WG+L74T9Dvx+rfTjvkQS8fnmt8L0mSFJlVv5hMXChiZ1jvd5LO64emeVC996663EacoXxfiwrrwv0YwuseP0A3iQ4hRJWEHKaqqbkfEWz3pqBpyZdowyHthpjoiNgJR1dvQ9tkFCBhgK3JBsQ0kZOFX6H6VJvxdJplsnJStlKQ0rVV3kgOmzdl28/ve//90jBqFohiIacoDLOjuKYFj1tqxzYutnyu5D3Py4LOwjRh0iOkcccUT4whe+EG6//fZkTF1wwQXh2WefDb/+9a/Dj3/84/D1r389NIUMjKxeXRpzsZIgf3PNYBAWiQjE45mHpWb4db41m8+EQB4q1LcOoH6nRQ1VK0Uqnf4vx4vrhn1g+1k/Y0mTFFZ8pBVYTlZtAka3ajTzYDuWXHLJMGnSpNR95Fosc+zKkjV+bQ+uJmql0qJPHPuq+xLff3UNcm0rWs09M22CKx53SjtNm5RR1kHevYbPMKayGj4LzntehM8b9NaD9L2DDz44DBS4v5x++unhz/fcE5577tmw7nLvh8WHzwifGj4jbPGFd8Ofnp4rnDiBNg+ho8qFn/zkJxPRizxRjE8Om5Fk+qTVhc+ueETKcT4C40APRxUBM5upXiNpxhs/SlXSTDs3gHjmU7Obca+esljBC25GdrbUOh48vMs6E3WiR3YWtqzTphQptpt+V3n1VWnpelLDinvZ2NolRebqOC9lajJs1KvMOuqeA47PQQcdFFZdddXw0EMPJU3GFUnBMOSYr7LKKolD1STsV16anQQI0vad71btMWRl0G1vK83mFy2L7UkbQxJHSfu+FRKInUHSqLjWcfDyxEfqQjSpiZog9jtvWWUjIWXI2+8mekpJhTHrnlM1vc9GOnUv0MSHJkqy9olzENer5aVIs21F98oyxmqR8IYmeZzWSKtt7m+wX6TEnTByarhwz9fDj3eYEg7a9K3wmU9O70mbG/eXecI/XuvumHLhsssuG/45Zc5cUYx/Th4Unn9uYp9S73NHynE+QhEn4OGlmUdmK0k5kpQyD2n98FqzjrahJe/bVBJJ22b1DqpKrAann1ZmMGO54zRsiheGKYaQlYvOk1AnaqGi8Kz0O/U+sq+lHiaDiIcFhpwiUPpf3eOqc5MH295qT6dzzjkn/PKXvyz8rI4ndRqoHgIGANEqHoD8TV58kyhSmpVmJwGCLAe4To8h9SdLq0UqWpbtAadaGEnjS9Y87TuM36zzqHSSLIXOVuAekSWwYJsDlyEvElS2zqwMWQ5bkz2l4ibLFit+Ugbdf9PSlVW7lAf7RH2iyGu+y3GO6+7SllcGiRRlLaNJafuBSFFtc3/qJzVvQUNi0uY62a9prbXWSqTQ80Qx3vmgK3x7vTc7UstVF3ekHOcjNDuu6I6MNEWZeA9VPx6wvMdvXlvDRgaelbW1xOp3dcC4yBI9UA1XHaxRmvV/m6qiWgIMTo4FhjaGDIaBfvg/RilpVRID4LP2M/EP68CI0+s04wKnQk5pq46poiB5qoqtNlUeO3ZsOO+88xIVvj333DM88MADhd8ZOXJkIixBs/Fbb701GTfktpPaRXFx08iJ1fmPeyhlCRDou1UjrTKirbGrCYgyy1KEyTYctoqMaUZ43ux/HbW4KjCWs45fLHiQR5FiZlOGd5YghO6RTfSUShMCsevBma+6vCynJO++mRZFKrrmi2b1y44njvOIESNSFVnbPSYHAkW1zf0Fxu6SC+Y3JF5s6IxELa9T/Zr+8pe/hMFzdmX2kyL9cPCg7jBs7tDRWq6qeI2U45gHmn1o2T4kUgPj4VlUG8D/dfNOg/dfffXV2jUGRQ9WDAkp/ZWZFbW1P3KmZJRKvpv3cYAUtYjrlJjNT3Nq5DzxfdUxNYEMd0kRl1XTy4PapKyaGBmvdaWwrQHPw+See+5J/kaJLwuKo4m+4UgJzsmuu+4avvGNb9TaDtu/KQ39T7OVcaQuK2e9To8hGdHqMyYnijGb1/sn/j7XmpxA65il1SJybvMKmZtwDuog0Y6yNUE4ZFkRlqopcWWk8a04R5zS3CrcU0mrSxuXmnSqcq/Mi44XTbrY61tOWda9BeeXSZ88g5x7iqT+89AkRVz3aqOMTUVHBxpFtc39Ba6jSR81JE5zppQ2t8Ki08MBm74VRo8bF0aNGtWrcvCvvfZaWH4RmvNOS/pJnXbD/GGJ4TOSHlhvv9+VRM3ue25ImPxOV0druariESnH+QgeVDwYZTRIsUsGdGw48HDjQqe+wir8WXGCduS+8wDIMmh5n3XzULbbD2nbo/3EgCMKRDqZUqD44QHPDZr39UDH8I3V1TAqikQq+DyGQlMNaeXsNQXbj4ObRSuNgPfaa6+k9smCM4WhlcUNN9wQ7rvvvuRvjj8/bCPiE3V7ShUZkkU9lOx4iqnjzDLrr75gcraVahmrZmZ9X9+1kwFZQihFUu7x8cm6xuuSN16r1Dfl1UlVTYnLQ/c9pU2CotZNiHCUOScc+yrkReTLRK/tRFWedD0OeV6UtqosvRT8bKp2LNHvVKeotrl/NSSeWdhL6tEXB4cNVnivIxGfhRdeOLw4eY6kjuuuI/8V9t3orbDu8u+F/TZ+K3l9/Mip4YU3BoUn/jm4o7VcVXFHynEMGGDMiPNwVEQGoySOVPAezoQaJ2KAk89rH3hFM/91H44ybNJSQXgfw1RF82quK+fO1qIoCqACfYkNqOZIvzkGOECKTkkVq872N1EfZpdle8c0QZ4Bmme81nWmSNNLi5C88MIL4dBDD03O1e67757IoF9zzTWJkh/O1957711Y81EHK/qQ1kNJdYJVRB7K1LUwVq2YBduR5rDn1UopeizDNstQyov62H3gN8eaNFIiI1JUbMVJaUruWsIKaXAMm5JC172G7ZasOOdJghxNUVSPVGVfbI+5GEXH87BCGkysZfWU4hrhvk/ach5l61Ztqqru5RzrKuqozsfhHMa1zcCx7U9CHtTNfvGLK4fjr8lOm/vGmtPC/J/oDn/46yc6EvHZLnH2uhOnjv5RB2/2Vjjpa1MTUQxe8z7b+9CkwR2t5aqKO1KOk3HzlXEn0QhbjK+/ZXQqVUAP4aKHdV31PhlRGDiSjRZy/PSgUP8jzdKrjkRRBhmtKvonRUV1BDhO/I1hiUHLMtlejAL2nd82hSjPQGwXcqRaiRTFyHGuary26kzZyBR/UxvFQ2799ddPFPxIv+Ac8n0cLP53yy23hKaxEZ20HkqxyINN95JARV1FSkW7+K10qDLOhRqoKjIlSfWsiAnvZxnurE81RvxmnCvSxm9et1KDxLbmOf5V6jayaotYPtdvU2IQmlyyNZQcpyYidGXrkaocczXszhvfecRRpDx1UiYzimrWykbgJdEv58kq+vW36ElvwniglpljaZ95XCN1+jrOzvCsmP8TIUmbW/XExcKmZywSVh2zWPJ6pzWmJUp+pNK9PGVQmPR6cZ1fO5y9nXfeOYyZMDzT2dtl7WnhkdGvhDHbTu1YLVdVvEbKcVLgQaY6BBkROBTqK8XD1s7cK61IalZKsct6iKqOqQ62r5SkftUrhYcwaXZsnxwkPp/VqJbv8nlgWUU1NBYcKdUvYAiVTU2qso4iiBKotqAV2XdLXq1KVo+wKuAM4TypTgp4bf/Wa7bj85//fHLMKEhHvIPGvJCXFtgKGtNSgcRgVk0c6Fynyc2rJ1NR/5w0JGdvaxnKTDjY64Exqbo8JjXYjjSHCkcqq5aIfeO4K11VkTJNVJTt+5RnLGc5Bmk1MlmwDdQWpY37MkqUde41Sr3k2HAv5BgyJluNThV9n/0se8z5DIYzctB27FgFVZyjrMbCsfop4weDO+uexb0VRz5rPFWpHWQf1X6gzKSAUw6OnyYJbR2lBHX6S/0ZgjYzugeFWw59OYk6vfbWHGGR+WeG7VZ9J4n44LD84/VB4b3pQ5LI0Pbbb9+R5sFAjdZPrh8aFhs6PbwyZVCY9sGHNVInbzclDB4UEsl2fa63a7mq4hEpx8mAG6wckXiGXGIOsWQ4DpKa5qpPTjwDzWdYVisPR83i06BTs8aKzmg7MXZkmObVr6RFqcqiGXTVVZXhf//3f5NZJiIzqNlZyeGqVDE8y5LXx6hu5C2u21httdXCOuusM8t7cqA4bziIoFo3OVHw6KOPJr/rOCtlsA5SWoqdolJZYyWvziwPK5DCeZWSXRlDVHU2fI+xzzLyZI6LJMRj0Rk5Z8CyW5nJ5rrNikppUqSKUxYfH0Wem+pBpHuNIlP60T2mqfSgLHl4YH1V1qN617TIqZzivPtVLDqRFeGSo682EPF55b08pci07W5XL7OBjiYd1axZ94n+1PRYqXM04I3T5kCpc/+cMigwUnn+9nbq3ODBgxMhpbvuuiusuuYG4YXXB4d9Nnw7qZE69esfOlECx6ovqPe5I+U4NWbI1aBUBpZmulSnoRl8nCYe2LauRAIPTWEb0zJLjBGIQcn7cV5401hDLauWwIIDtdNOOyU3xjvvvDOceOKJ4Stf+Up44oknaq1fD8YmDY283i3MGNeJJKY5HThTOEgx9InCCGSccJxwnJ5++ulwxx13JN3rzz333GR/8xT/miAvxS4vFavug1n1VzhAGDcav2Vrr6SUaa+1LAO8KB2LaJYMbdUG6j6gdgh1U+fyDHOp95VFaY1FaYpNwHmIo9psL9GiJhw2tT7Ign2psp5YXr+KUE08NohgxbWBti5PohO2p5nu/VUnzGzz9SZ7mQ104trPLEGdvkyZ1LmVR7wfdlz9nbDxZ98Nv/vtJR1LnVtqqaXCiiuuGFZYLITDvvpmj7NnQX2wL6j3eWqf42TAAxKDTjOYmumVcUn6DwaXNRz5jGbHbUoMxpge5upbxPeaSIvhgSA1PGswaHY/LQWrKTSDzj5oRjZrXRMmTEga0v7gBz8Ihx9+ePI5aoHoq4RDdckll9TaBo6jmiA3IYMu4zAtlUi9s0gbqkLWdrEsUvTs/xkbGF9rrLFGuPfee8OBBx7Yo5qosXbUUUflzuC3ijU001LsOA5557qOXLOcm3iZjG0epKRr5aHt07HUcoiapElo50mIc5zVFFmprzZK12rzawzzLAXLKqmDGo/PPPNMqpND+lpZSfUisiZjWE+Z81MGnAfOSVakucp65LDq/NkeeRLQYD3xeFOdnoWxIwc/VtXTceE84OxpfWpA3sr9nXHLBIFStbNSVZ1iOK9Ekm+++ebk/k40d9NNN82tgeuL2NS5U28YHhad//0PU+fe7wqM2GdfHRw+mD5HmDR5UJgxszt57u67775hueWWmy0l2yd1oJarKh6RcpwMlDKHUciDLFbv4zdGikQfpLikmVNbRK+Hrvoe8ZoHrlWIqoOVFI8NAqv+ZButNgnrtbNFebO8Z555ZlhllVXCYYcd1rOtW2yxRfjSl74U/vznP9feBgwZpVI2peCX1whTYh9NEDtRsNFGGyVROqJPZ5xxRnLMVCRPvdRpp51WeRax6nGx48lOIFjyDLq6kZAsxyarniVL5ji+FtKuszwVRvZXEx1xxEf/ayV1TveWtPNStQlrnqGu+1YT5PVnKnN+mlDwqxoFZFma2JKAikRUJL0fTxhwvuOxLYdVEWl9lmVxH5fICs+D5ZdfPvnh71adKFJTceAYb3mpqk4+HD/um7vttmu4/NILwhN/vir5zWscj6ZULmcHbOrcKmt8OUmdW26R6WHQHCGcuO3U8NBxr4SbDns1PHDsK+GEbaeGQXN0h/33378j27qdUfFLg/fffi90pJarCh6RcpwM4qiSZun1IJOIg3qqaIY+LmDFmFFUS/LSgocjN/G6kSnWo67tWSlVKpZvRz0RMLunFJQ8g/2cc85JdUA4JmXSArPg+KqOTce6CfJEDpjFrJpuEEfMHnjggcI6jZEjR4Z99tkntErVpsWqsVHqC2MoHp9cGxiRacvFkaozG5917lhHUWNWZuu5ntImFJSKZ7eHZTHuspw3RZwwtvmMjUyr7rBuoboi2rRMSNtXHJMqs7B56UlNRYtUsJ+ndtlEGhrjJuvaqnpts82cO0UYOU6aDJMoRdkoks4Z20bU0EZl43u+Ikk6XtybcOqsaEvZVFUb6edeyfselaoGE0/jr7oijBk5JXxrrWlJ9INoB4b6iRMmJJ85+uij+1U9mlLn/vnUn8JfXxocxoycGvb4SMAB5hnS/X+CDlc/ktyLelvQYWmlIl46LomW7fyxczM8+f/sLDQBHpFynBwkCqGHWFx8b+uoZEzw0LaCBXIeVGthUYpQ3Rl8rT+t0FmpfRgOreSB25SYGLb/7LPPDmPGjEle5z2EUJtjptZy/vnnh0ceeSRJsWgFnFEMoLxmnFVIi/BVkbFOI3airGpfFrE0eitUiUjGUvmMI6I6djacc51VK8W+1slrzxs/RdFbrtO0nj6KUKWl4qXVvgg5ShwD2/TXChe0kt6XJ9ON8d+KCIslS02uKpzrvDHUVKQkr4asTrponniDnKMqUSTdc6XQitOrVhE2ksRvPssP/0NApopICd+z401/e0+papCGPW7cuHDc1pMTR0IpZHIkjt16cpgw4Zrkc/0t2sdkzAuvd4X5hnQnDmQaOC/zzBU6Juhw8sknh52+uXMYPX54WPWkJcKmP1sirHri4slr3leq4uyMO1KO04B6Hw9V5farbkjpAhhMWQaITfOrg9af50Cwna1EaWRUp4Hqz3nnnRdOOeWUcPvtt5dW7iNP/bvf/W4yC0itz3/8x3+EVsC4wKCpopBVRJ7IgRTT6kCdWJYThfhELEDRhDOV5sQXoQinVOvsmC4jOlFWDr9Mup2NKhUZDroWZHja+saYrGtT38FRssqbcrCbUsbLE53BkSpr2OUtpymhGTkdaeBoNql+xj0hdnA5B8oCaKd4A8tnEuCll15K7ZWlthLcs20Dawn9KJIUw3fiHlVlU1VBf3tPqWpceeWVifJbniMx71xd4aabbup3Tiqpc+9P7w6fGj4jtQYJeH/Egh9GrjudirjvqMPCul/9dtjvwO8nr3m/SWGuduGOlONUUMXDUZKMKr9V66B+U0r7Ad4j0qQZ1rQbgjXMWm2YmYWapbYD67jQIBYHoYwzdeSRR4bx48cnBsfKK69c2JCzbIqh+nc1QVGD2ToFsDhRZ511Vur/JHHOTzucqTrEBiHXgn3g5qVzVq31AfUkqxJVskiG3wphqH4xbVzYBsPx+uQoqcYmzRFrVRmvyPEv26A3r96LfanS6DcP0ifj82PvjU3VmTAOuAZIvZQz3FQT1SxHid+kN6GaSfST+wnHLV4f22bFg2yEUsIQWXCcyhrrHGvGrVVe5XW72h70VzjHIxaYmetIoAzHuetvTiqpczxfJ70xqEfBL4Y0uhff6Oq4oMNSSy0VDj744HDSSSclrVFm93Q+iztSjlMAN1c5TjwEeYiq1w2QKqKHqWRVZfgp3QODKSuFSPVLdYwdm7rSDjGJMs1luekJZvUeeuih3O+Q1vbtb387iUiRTvPHP/4x6S3VKhxHnNe8oviqEOXKcgaqphmVcaLE7ORMxU5+3Gcrb9zVKeKuGlXKEhjAoeLa5UcCA3UkxIk8cD7S9pNtqhN5E0W1LmWPHcZ1noEdq4u2gq2HlMCOfjeZGsWxIfWS88j9jXOUJsVfBb6Hs0SvM+7NOEs4SkrHs6IZcnq4N8cprdpf3e8lHCJ1vbxav7LGOvtPDZd6VKlJPGOivwgj9LYyXBqJMtxHjkR/rD0ja+Sd9+fo84IOszPuSDlOAbq5KurDQ9IaDlKEkgNlm9tKNYtlFBmBzJDWMRCUulKnbqcdzhSRqSxnSrVBbCepNj/72c/Cpz/96aQ3UlbRfxU41k06UpDnvJRdVxUnanZ0pvIiTXnywVVSmepGlbJUFWXoct1q8iPNAJUiW56jJOM5jVZ7SuWNoSrHj+spKw2Gc4bT0AQ6P6wLA59jjZOjZuS91cuvKpx7HEork8+Y4DWTWFliPPpM2iSKxqRSZxkveemiHK8qxrqUYdWLUOOx1ajcQKKMMty097rDLrvs0m+EJixMVu68yy45vaX6hqDD7Iyr9jlOScPB5qrzUFTqD2T1JJE8ODOLZYxAPlt3VgxHSv2pOuFMYeSr9of8ZvadprPWibr77rt7jKJ11lkn+f/6668ffv3rXyfGwbLLLtvSdkjlSulGTSBnOO0hixNRJrUrKyUNRymvz48cLI6t0N9pzldvYfcHJx4jPWsWnpn/qmkjzMLbiQuNmTI1cIrScl7YLjXh5NrgGk1TyMxLUZSjhCGbdW0xdutet2wrkyhZ4DirNrMI7lNZ29iU6ITOg9Qy5fCy3qZTo9TLT9egnJU66+EcKj1O92I5QHlqn2nS/0T/lOIdf0/jHXGJODWWdVvV16o1ulkqgU5rynBf/erm4be//W1yv2BCYscdd+xXjoXtLXXajQskqYz0ZyISxbHpC4IOszPuSDlOScOBh5d9cEoOnfdxYrgJp9Uq8T4Gt01RyoKoTF0ZYb7DzHBWqpFNOWwHOEUYCnfeeWfyWk4V7996661J49211lorbLjhhj1OFCilsRUJdIvtWt8UWUYLBhOpX0Uz5KNGjUp+E6n7y1/+Ek444YQkise44Pt5kUQ1b33hhReS9CNYffXVO9JIMi3FTsIbWQ6lBBmqjGkrWy2hCbUPKLMs/V/jXdel6t7SjKS88YLwA85dVtSileiAUvKynClFpcocP5aVFcFSL7Im0PlR+wcrK94kLI90u1iMh/cY/1XWZ2tdrXOOs6OG12n3Ru5p8XqUdoeTK3U9TeBwTFgekyRKqdQ45H88Dzh2ZaW27XazLIlbNCnu0d/JdiS6w9JLLRWuv/6GRJBixALdYcIbXUmmhByMviB2UFbQgecQ6nxM2FJXSbSuPzmMncIdKccpAQ9ODEUeutZI5zXvE1XAmExTvlERMlGroocfn9Xy6jp8WY6UZJyr9BOqCs11MQ5I75Mz9eCDDyYGBIYPThazfXKinnnmmXD99dcn0ugYFk2A4cG68qIkVck6b+wrM55I5+Y5UxhaBxxwQLI95KxznojiYaBboy4LqfmRIsi2LLPMMo3JY5fFNniODXIcSozbtLHFuKs6putElWIwvtNk7FX3FhvHeZMcrJPjn9ffqKjPVZEDxL5mjbOyUT3VFcUNcm2tWdM99lQXVKVHUpX1gK1BVauJqv2U2EaNW02CKdrE8WeZaenFfCetLxrrZmxqzFtRH3selV6qiSxI62uWt92arNF2s06Je3hUqr4jQeuNm/94Qzhx25T+UpeOS77L9/oLEnRwmsUdKcepkN7HA0wPTjlUGHc8ZPkhnSPNGOOBhyEpZyyPulLoerhTSJ21jt6oocJJ4tggPGFn65E4v+CCC8Jhhx2WRKg4ntdee22yTXSdbwr2ven0xjwnibGBIcbscxFyqOqC89UJbEF9WoqdekqljX/VdVRt0GujSqCZeIzSsk1msxwjrpHYCGc8ZtXpsRyp92VFn0i5xNmq60zlTbRUqQnCwcHIVqQElM7WZF2Njke74XpWxKeO+l1aFE3L0LjmPQxrOdk2s0BOW5oDbxtW26a5ihjZBux2HLPOstuvSTwi0tw3+ZtJu8022yxxssr0vnI+7kgw+XXaaacmTXozG9WOG5c4Xx61cfJwsQnHKQnGo50Z1Wy3iu/zCsdliJWp8WglYpTXJLXVZZcFo4S6p1gGfbnllgt/+MMfwnrrrZc4WUSi+Bw9pdZcc81Gt0G1Uk2BUZRX9N8f1Z4stjFvlnAD4872XIq/X0eQgUmFuDkwr4kEFDkFOCZZpH03T0IcMKYxWvMa+ObJ5RfRRAsAK57Bb0Vw7L2qr2H7KVlHRalyVaNoUmnk/sCPHH0cFKJ+/Eg8iHVLWChW7wMdX7aJyRt+K2qrMWvl0RW14nNl67xY1pk/+1n49rd3D5dfekF44i9Xh//53YVht912DSeffFKS7uvCE+3pL8X/O9Wo1uk7eETKcUqCscxMOA9D65DY/jZZNQh6mFJnIeMwi7J1IFnkRcZUJ9FOg4pjw8xpXE+iGjO6zKdRVD9WFqWecfzSisHrkhbFEANhRpgZdDkRGJ0YlTgWOiZq2Iq8dNqYqCM6AWljlXOaVetkr4OsVDw1GI5TtWgEm5UyScQRBSyiTsxmp9FKupVqHBUVsw5p1eXpnLDNSitTVKcdYjTsM2NC0XSc2KoRyCyyhB14TY1SmTTPOIrGuIjFMiTgIOEJ3cttSmQcRbL1M3bb9F3dazkPpDsrRXDTTTcNCy20UKlt/uEPfxiunTA+iZx8LP1swnVhjjkGJb13BsI9qEmSqPYC3YX9pTrVqNbpO3hEynFqpLJo1lEzmjL2NHsZz8orJx4Dp0gyW0p/dSkT+Wpnih/qfLfddtss2yOomeL/7YTjhzHKeSHK0FSB/UAv7taMutJbMSrjPlGM76yGzDhSVWfO86JKRSp0jLssQQ7GRFqEDEcqT0Jcqpp50c5WGvQyXpUmZq9R3qt67CQEwfYygaMISCupw1nrYRwQsVOPI45BnR5iaUjYwR5zOYZqet6krLqiqoq8cu9WA96sKJJ1ohThUk3UmWd+GE0iivTkveOT37vvvls4+qijCscwDjsTT8dtPTlJP5PRr/SzY7eeHCZMuCZMnDix8jEY6DCp82JRf6nX6zVedwYW7kg5TgV4mKveQA9KW3yP4WeLigWvqaHgQU1+exFxsXgdgyzPWbL1Lk2iPlGCPP699947Uekrcqaa3B6ONwYjhkpTaoASDcmiEyp6VZCx2AqSi7Z90uK+VnkRQKkONpHuViaqSipX2sQFxyHLMc5yBG0z4rxUzlZrHHEamAjRccR4J9JVtXeQVXvD4eCH13Uc2jxwSNk+9frS5JIiPE0g51U1Tfq77vG2TdY5Lop4STRDPZuUQqhzEUd9VGcVw/scZ5yoG2+4PokmPXTsS+GWQ18KDx77Ujhh5JRw/XXXhqOPPrrl9LN55+pKmpo7zfeX8ka1ThnckXKcCmDg8CBXDj3IUCF9A0cqKxqEEUp6WJnGuXy2FSMEYyDLYZNx0HTj2tiJwnniB+MDAYoiZ0pF2E3CeWmyfw7nOMsIbUp1sF20S/qe42sdzLyxXbXpMmMnL/pTdI2oZtBGiqVcqTS8LDnyPHU+ZqnT9rOJyQAp7+HQDRs2LJkIYD+qNv6VsyCBBTmeLKepaJFNd7NRNE0mNd2gV+uxv+vA8VR6J8eD37yWo5TmpOv+bY+bmvGmbSPiENSEjs6JJl1xxf+kpsIKIqAjFphZmH7WlMM6IPtLeaNap0XckXKcikaOip9VeK90J1JMqE0i9z3rIY/xVlZ0Ii/6UQaMvSxnSQXPTYEsd+xE4TxhSGEQcjzKOFOdaCZchby0S84rKVTtphUDsl09xOwxyUvHqwPpdlmUcQhwpOSMafJDjlWaASpHJkZOmGprmKiIJeH5u4n9t9Ek7hmKmFRJL1XULO06bzJapHQ366hLZKHJBr0cV/UU40dy4FVFJ4DPMybkqCsCxT03T1kVp7TMmGNZ1EQRLWpFzIB7+KSC9LMX3+ia7SdxZlfoE7XTN3cOo8cPD6uetETY9GdLhFVPXDx5zfveqNYpgztSjlMBKT/JmVIBt01n4SfLgZF6WZnanVZnjMs6bE04UWeddVbPa9tsF4OHYyPDtIwzNbuj9K40cKTqRPqqOEftcoZawRrrRepzVScIiBBlpWdiTBfVyKh1gVLCuHZZnpyiNHSNg41k8aP3MXIx7uWUga7pVq9dG02SlDnXkpobl0H7LQfPpiI3GS1SXZwmlCQKocmmpiJfVrzCXgNptXpFWGl4OyHG8Vbfsiysep/6UMWwbJZDg9e8aNLiBWIG5dLPusNXvvIVV+5rob/UXXfdFfYddVhY96vfDvsd+P3kNe/3h2a8TvtxR8pxKsLDnBusaqVkMIAMlLwaChWsY8zlGdBVU3nSaCpCktaEtciJAs3scsxkcPS2M9XkrLhN70qD89qUuEVfwsqbc65JSctLj6w6rnHEY2EA/V2mRoYJBa5Xfsu5yDKC8yTE9T/7GSJTuj64L7A9VeuZ0saR7is20sPrKuIK7K+Nltk6t6bGqY4DDq+OZ5PHwq7H3jNtnWpV0QkJSyjlUcdYaZ9FkxVyQtXkV7WxdnwSSZ30Rld+NOn1rlwxgzLpZ9tss00yXpo6zgO5vxTqhwcddJD3jXIqMfCe+I7TAIpI8RDWg1d/8xDNezhqVlnRiyxnimW+9NJLLRtkTWD7+FhsqlHsRIGdkbZGa+xMtTOlj+PbpBAEy8tKsZITUdVInR2jTFWxUYEll1wy00lhHFFrUnUc2+tE0eCykTy+r8arMqB5nXd98D/k3KWiZ6XftZ9KDeOH6xknrU49U4x14PjNujU7XkVcIY4W6XhxDtR8tgkkfY9TqRpSm3bX1Hp0n5Bja/tj5UWKi645SaCXFWTR2Na4Yv2aYGMsED3bZZddErGComjSuuuum0yuZW17dvrZsPAf24wMRx55VCNjznGcengfKcepAQ9QUpQUcdFDWQZL3BMm7pMkKfSsfk+ChyOGG0ZKK5Lt7ZqppOu7Zr7pr5PWgwcDZ8UVV0yMQft/Pk/6C07JMsssk9m/p1Vw5phxZD1NOGwYTXKG03q3YESxz32x+WkrKM1OY5UIBdGnNCSAUKX/Dw4q4yXu8VOmJkkpueoTJHW2ovVbCfG435C+q3omxhlpXzrvdftmCZtSWLfHmqJFTMhYB4xlci1wfjgWTfUgUi2Xtl/b3ETrAI47xzdNNEXrsuclDzk+cRNd66BnHW8cU9s7LW1cAQ7V1762bRgz/urQ/VFN1Kw9oIaHLbfcIpnkYVxzTbCsePuVfsa9lnoqnC62YeONN04mLGy92EBv0eA4ncAdKcdpof6Ih5c1HEDywtRBochknSwVYKtgHeOwqGdUq31fMGyzGojykG7FuWB/DjjggNzP2Nn7uBnwXnvtFXoDCUG00uOnrINb9rz2B2R0SlzAjlWlG2UZpGWNXoFTIoU1XUtS5avaB66O6IMaSisKIkeM65lrnm2z+4phrAmTOuAgWrU9rZftqeqEajKF/bGKo+xP1fOQh6JEiuIpPbGJSQVFW3ACYwENRezK1n1xznA6uIfjnNmsApwUnW85bRpvEhtiAsw64/b48T3GPePhoIMODtOnzwijx18TTrtxeFh8eHeS7jftve6w1VZbJv8XiihlnQulnwH3Fu4/7IOuPatE6c15Haf3cEfKcWrCQxjDUbVSPMz0gJdEMqkuRCd4EKvQ3dZmYAQWGdytpn2pHitNepqHtxy7dkL0jggFDkZTzkxZlJKlWecmjDo13cyKFJY5r/2FrDQ7TTakjTvVqNSJrlSNKrUC6+AalxMVN6Fle9gGUhV1ncqBkApcXUeKMYRhzI9dN6+17rL7zn4oem57gXFPavLaV92SjPu4z14rsJ1S2mNM6ZiwbMaZ+kCVgXPCMiSGI5Rurckl7Yd6i+Ew8z2cNvWgiqNIjE++z3t895hjjknS/O64445knGw4bFgSTZKEvpzPKo4g2899lH1WJM0qUboj5Ti9hztSjlMTpebZPH1rZPN/HpYYLjxYZWDY2gzVWORJkfNwbWVmG0gfyerh024nCtRji+PR246U0rEwspps+qsZ5LTzMlAMmaI0O8adevQIGdZ1REDqRJWy4Nzh6Mgpw9GPz6U1WIWcRqX4qc2AjG457OxzK9eWHEeaGNv0M5C4QtmUXx0z6+SBajqbAodGEei4hqnVSImiSNw/NTHE9itCVVTzZklLyeM9jimOqpwT3sehVfRHdWasD+cqLYpko5j8n98IT+y6667J8WFZeh8UtVPEq+z2q/ZN44L9b3XMOY5THRebcJyaKIXL1jDIaOBBSXoH8MDmc/p8PIOZ1ycHWF6rDTSbEp1otf9SUYPVdsC5eOaZZ5Lj16QjBZyXLJpe1+yAHAVrvEkMASMxTrNj3EkxT1Fbq0DXKZUxjF8cFKXk8ZvXcbF+LCHOfjB+YwlxXc/aT0V96vQ4itcf1+3op0rKr/omxdFt9alq6jxwvjUxpPojHacmlAwlGMLxtVL2affVIvgsTvDiiy+e/FZzXqVrqoYKZ5vf9hxIih5ix0XS9fyf/0kSXj0EwaZ7299V7tNVlSgdx2kPHpFynBbAcORhqYeqZtvtbCUP6bwHPDPhPKx50JYt5K+K0kw6qQ5HlI5jwYO/t9WlMDAo6G7aicub/aVGrl0CGp0gLsInDcqmqqal2SmqwtjFWVH/Hklj87qqAVw1qpSGhGLiWp60VDyl8NromyJsqtlivRJasNcYr6um4cXIIbPYCHgZOD5qOhufR7a/lXtL3jbL4ebcFNUAFZEn7MB7cd1SVRRJimX2lVIoVdZYRj6Owual3XGsFUkCHSOQ4mNZlJ4oQZQ428FxnN7BI1KO0wJ6uGuWmgc5hpdex4Y2Dz0iM6hoWclbaqnKOCKtoDz/TiFVLYzOTkRrbL+v3qAo0jg7R5vi9xR1kgEow5jxvdBCC+VOFlhpbP6WJHerks1lo0ppyKGzRjM/aY6xlRBXpEVRIQxZHCWOxxJLLDGLoy6jvGqPo6wavzh6oXS5MtgG4vquTe+rKh2eBcdeDqptVC6notW0sziKBES6tP38rhv50qSAPc6aJLCOYZoTVKUBtCJJvMdkhP5XtXm6nj152Q6O47Qfj0g5TovoIcZDnAcnhpZkkO3DUQXqNvKE8aeC9SypaKHZ77oPSgz7LPW+3kD9l2IRjt6MkrVjXRLSSAODD6d5dgUjjxl1xqFS16QKB6r7kePE/zD8ZCDHUuB1ZvwnTpwYLr744mRigbGx/fbbl2qIWSWqlLbfbI81jlUTE2OjakQ15YzLwbH1SmyL6na0XF63oryp9Mn4WuHc4DSUMZ45HpqIscuw+9+ESIHOsa2/kqIcNJ12JmEHpROqHrVOhC0rwqMaqdj5Vs1lWmSQ+76UWW06oCJmTUWSmqwZdBynHu5IOU4D8BDEGFUKkAwU2y+HhzGvbWqNNcLKpN61koJj6xfaQdH2YzDoeEiEg2PW15vR4gBnGUI4WDjPs+M+YuzjIEjRzQqi4CxJsU7GoGo9MBAlaa3eNWVS7CQWoIa4/D7nnLPDddddF+b7xBxhxAIzw6Q35ginn3562HnnnZNGpGpC22pUKcam4tlxy/WRNlmhqBrHg30ucpTsNjUl4CBHQbBu9qHMPUF1P1kOXRXFuDx0jnWfsfca23+pKbTNmriSY4PTiANUtWYqq9cYf3OdS7GP15pwSHMO85yluj3NHMeZPXFHynEaQF3t5URpBtnWH8iIkQFmG3cCD9SilBR9ti4YM60uIw0pTrHsvNoNjHUiD6RBYUxMnTo19HXYX2SNs4xEom9lUrvqpgLKWLfOmnUO2DY7cy65aJxZbXOaYUfNiVUfU02INbgleqDzLkcGY5pzbI8Jf3O+dR2cc/bZ4cYbrw9jRk4J34qblV46LvkMjUibiCrFsC1sH8dG9Y18D4O8TJQny1Eiusc2ST7bpoHVjSZbqW67nxK1KOs02OOjZdnIWhPRoixZcSL2VR2bMrDNjCkdDzvO60TYsiI8cqTVH0oTD1kTKEXOkkeSHKf/4I6U4zQERpgK6QUzsvEssJo/2u9JRrvIkWqleS6Qkx/3pYmpI0qh1KAyYPhhxHZyBhbj0c7ut4qNPMbUkXxPc46ykLiJZuXt+ywHI1bnlG3ktepLII4mASmgcphiZyHeJo0lxn1eip2V4CZKd9311yVO1B7r/9/1Mc+Q7rDnR69HjxsXRo0alZnmVzWqFKPrTQICcjTy0hXVJDeO3qj+EGeBscB22ePE5+uKTsgoJyKiCK7uMardKeM0yLFRWqbGv5bXRLSo3YIQZVpQSFmxaRnwqpEkd5YcZ2DgYhOO0zAyyJT+pNomjLCsmiCMLP5flAqE8dOqhDBpW3nrqdtXpmy9U5Ui+XbRpBMlshxJDCr6KVVBtUr8VhqZapjsudO5YqxxXm1PJxmWkl5WWh1Kgo8//nh48sknw3PPPRcmTZrUI9hgnSphJbfjbbSTBmVS7OS03HrrrYnTRCQqjZ3Xmhbm+0RXuOKKKwqjSkTXrAiGokplxpgcMRtlkHR1GlnXKOuS82avL6l42jTeOigiYqXXObeSoC/jNEhdTnVlGltETJsUKWinIEReCwqJ/cipbYcMeLxvno7nOI47Uo7TENZQsQ0XJYHM/5VGE4MhROSqSL0PA60VI0SzqnnrqSKrXBfU1foTRYpkHPMqqomMIRmJUvlS+qjGkBTB1IhTfbJU0yGVPcaVegUpPU9jFAdKEdIiBzoeu0otE7bBaFaKndTj/vfWW8Onhk5P0vnS4P0lFuhO0kDzwJnCSeXYcqxwYqqoAarOSw6PUhmzrgEdYwll6G+Or5wkRY2VZmajJa2o42k82IbGVZwGxgn3Iu5DjCnUFnEIGEdEdayKaDsEIeL+TE21QCAKaHuVVW3O6ziO0wruSDlOQ/BAx5CLZ+55uDMbXeQoqedUlrMl46xVIwRDhpn8rEL+3hBG4HhA1UjN7IoM27xjvuSSSyZjRAZ43NMqjnTwOanAySiX0APIeVKqpgz4+HNlI4VFIiSxo2UnC/R9KzCgFLs4HY+JgOeefz78c+qg8M776ZFRaqUmvf5hWmQRcmBZl1Is7ftF+2SdJ+tU5a0L5CBZJ4nrkvORdsytOl6r95hWnAbuQThQ6nfUjkhR2f5MTeAy4I7jdBJ3pBynISSTLEdIaTd6jSOFIVQUheAzWal3GGwYak0IRvRG5KkIIjX9BYzaPCNUNROKLGDI2vMcy1LjFFBIzzLVs8mes9hYVzpp/Lmm1OOyHC3rFGq9WSl27PN9990X5hkSeoQl0uD9t9/tTqTQi5B6GvvNNSRVwDIpqkQyuEYlMW77LKWdS0Xh0hxT3iMtEtImQ5QK2YoDYZ0G9Wlim3HOqjpAVjpcUcpWe15V7c/UFJ5y5zhOp3BHynEaROlXiibEDU6LCpAxhnCk8owMpWu1mhrTiaa4FhXIL7300h3bhrzoX1kkMMI5KZrR1+y8pOCL5OKtgMTGG2+cGNHxz3bbbVe4jVnNQ6uQta2q2VGkoSjFDudwqYU+rIMaM2Fo+NWf5u2JTOFc8fqEa4aGT3/606X6SUGZRqlFLQFUH8X3OU9Z5zJt2RoDfI/lqdeWPUbqKdeqA6GmxnKc+akTTbLS4XK+W00/TINt5djI2eW3p945jtNfcNU+x2kYSSBj4MhoxtBSDRWGRZwWBXye2iHS7igsz2ueixFF3VUrdQA4Ee3qKVUGGtUus8wyyT6o6WWnHCnbg8aCMSwDWWlfsVCFIg2KjOQpqKmXj/oCVWlk/NRTT4UNNtggrL766rP8P83ZSFP9K5uyGas2xq9jxUPrwAD7pmMFcQSGdL1Jb3SFK7/3ofT96PFDw2k3zB+WGD4jTHpjUHj7/a4w5xxd4T+23rrU9trohlXg03EuIwigiImcQUmEx+eSz8lB1PmzETm+p3Q7nCmcZTXobbJ2x9YdWUXGKpLfTUuHZ+F9kxzH6c+4I+U4DYNToOJ+GSYybBVxykrPw/BSnyWMrjy5cwxUUomoO6lDGbn1dmJ7StWRCG8VjFuK9ZGEp9geQ9c2LJaymRpwSoVRx8yKiWCQynHgvGbV9qgupaoD+9hjjyXf2X333cPIkSMLnaIq8ukW9hXDN0siX0qCaSITWp8a5Sq6owkEQQTt9NNPC5ffP0849etTwqhN3gpXPDB3eO2tOcIi888MH0wP4cybh4Udd9yx1DZzbhTd0znS/hf1hMJhkIqddaY1CRI7gWo4S3SJYxRLiGtCQKmFGkOMM77TlOy3jWxqUkbNkWdX6XBXuHMcpz/iqX2O06ZaKfXvEaTMEEUC/p+VfjR58uTSRjBS1nXJq9fqLdhXRQ1i8YWm5Nnj9EpFENh/jGwcUaI6iyyySGIM8z+MTH4wflWfRIQDQzVL1U3vY9TnSaFXUe/TOPjrX/+a/L3SSiuVlphP28b4WMSwr+yndaLs+tKWG58Pq96Xti5SObcduW04YcLwJI1vkflmhoM3eyscvdWbYb65usPYW4eFnXfeuXRaH8c0rTasjDqcHBIpHOr4SN0wTsNTmpqc7lhCnP+rhon18z77oWbLTanjybGXpD3bK5n7ssvubelwx3Gc/ohHpBynDWj21RqhGDsYPsxYk7qXhYrWyzgMraTmsY04ESqQT0Oz3u3CNhNVtKaIuCZHs+lpDoYcF9vANK2RpmbMNRPPbzU/rbNPcTNaC84ZTnUVHnroocQoJxWyauNkew7LfL7oM3FqY5o6nVUc5PzKOdUxP+bYY8MH06eH0eOvDafeMDyROifdb9p73WG7r30tnHzyyaEsOA44A3H0V+mFedEVRZgUibTXE+MmPod1Gs6yfUTGcOrYHtaHs91K7yYb2dQ1oB5jVdLymExgP7RtLh3uOI5TDXekHKdNMLMvg98aaBjReY6UIk0Yck2n2MQgg4xRx0x2GjKK2+VM2catpMNJzjtrfYoWYDQyyy+pb0WNcFJszQgz7jbNTg1n5Txi9JLaJ8OXfZV8dR2y6oIsrIvzW+WYPvLII0nNzQ477BAefvjhZP/XXnvtcPjhh4cvfelLudvTdKpWfGzi10qN0/usnzFvnQcc+MMOOyzstNNO4ZZbbkmcgnUXXDAR1EAmvsqxkcCDnCY5VXL48qIrnAu2S+p1gnGDk5HmkMRpakWOUhP1TGnbwP3BTiion1iVc+31S47jOK3hjpTjtBFFSywYVRjyeVLIGKIY+GVkzjHIWilgJ9Lx8ssvp/7P1pvUoShqYvsvqb+VZvvllCjapIayfB5D3O4zwhUy4OWIqV6HYy3DOt4WRZ74DOmWWdLWZbGRnyyhA97DkWab+dzYsWMTB/Doo49OXSb78+STTybjBsd3l112SRyxa6+9NnFCfvKTnyTvpZ0n1Q31NjY6pLRN6zworYzjTRqfejdJ0r2qaEKVqFKrEaYYSY9rwoTfdl/b1UeJMcMyrIPGGKmaluf1S47jOPVxR8px2gRF9lnF39RJ0IyW33kGDkZRkcH1wgsvJLP4dZ2pPINVss51ajpUb4KBmyWaQfQgLcUuDRmnklDm2OizGLBEAGMw1ONUtDRYJvVrTUrC5wkd4AgiUPGjH/0onHfeecl7W2yxRVhttdVSl7PWWmuFrbfeOuyxxx49719yySVJRApHbMUVV0wiVGUc+d5EEUSpGtqxTMRHKY5youpE0OpElVqJMMXwf6vgJ0dc174cPUWPmuqjpP2WsAXLdFlxx3Gc3sUdKcdpExhxWY4Shhf/Z8Y7KwKCY0Bh/sSJE3OjChhQOAHWsaiCNcRiFCmwanZlFeIw6nAW2U/25dVXX53FoVKfLdK60rad7eJ/SpGUAICiTUTR+B4/TTQoZtua6CulY6btl2MQRzaIOKq3ENxzzz3J79iZYgxcccUVs7z3wAMPJE7IZz7zmfD444+3PQW0CookyjGyqnDWeVBUCsERCT5onFVxMpqIKlmqpuJpTGo8W/XAdjo8npbnOI7TedyRcpw2N+dNi8aotod0MlK80iBiQQoYNT5FNTVpPW+q1piwjDThACJrpJdhDKZtgyTCZTzKkWBbFBFQXQyOJQ5AkZHKe/TU0kx+3rY36UTkOYxl0bkFnARFY+LIBob0d7/73eRzZ511Vq4zFTtR+pyk7+tK4LcDm6Knvk5ZTVibEjtoNapkqZqKp/GuNFg5kHIo2+nweFqe4zhOZ3FHynHaCJLaWY4SERWkkbPS93hP9U9Ec8qKNlSF9cvws2lwqm+RTLqcIOtMKfUPA5jv4nThjMhBiiMyRI4kVW3XhaMm5wL4HoZvb4JDSJSI49Dqum2tlAxqOau2Toganj333HOW76Y5UzRnJjJlnSgg4ged7AdmHQ7gvEr8gPfyeii1y8lQVEmOMdvE6yLFzDqpeOybjr+VfLfRRnd4HMdx+ifeR8px2giRAtTWYjC2ZFTLGE4DEQSMMKnRlRFtqAqGK9/F8JXxy/IQoSBiJiNQP7zP9thZdxmcOCA4W/xgjLL9pFbxmggBjhT7nSahTa2Xev6k1Tu1G/YFRxDBi6Z6bMkIx0mQMqJ1eBVt22uvvcI666zT8z7OEk4TjBkzJqy//vrh9ttvn8WJWnPNNZNGvTiAK6ywQugESsdjTGisM4ZU+4bTUtRDic8RdUVIg7HIGGDyoZV+SzrGHHP1l+KHcVi0TPWK4nOqx8uLkun6UT0gv216oeM4jtN/8YiU47QZHKVYUtsWpGNoxrVSEmqQQUikRJLSvGc/iwNQpE6WR9mogFKepIwXF9VD7CBlNYZNg8/l9V9qCiKBktzGYdpkk00Sg5/94T2lfzWR5gdyTLUs6/Da46UIlJwl/d5oo43CueeemwhTbLPNNsl7CEtcddVV4R//+EciUpHnjDeJoo2AM60GrvYcq8Er+8u41n4Wpdg12W+JY0xqrCKCnANtY1EKbNUomdcqOY7jDFzckXKcNqPUvLhhKPCeIk5ySGT4Seo7ViaTpLIK3PkfM/qtpEOl1ZjgcGBMsh3q08P6bY+gppHjmKd4mIZEIvIU+tjuc8eODdddf12Yd66upAnsi290hQsvvCBsucWWYdQBByTLYZ9Zdxm1vzLIiRDWUYzFLdKcKc4LqnxEqEjxW3bZZcOvfvWrMGnSpEStEQerHSglT06zGr7avkX8T/vHmOFzRKXkcEkohOUUpdi1ko4XwzHGibNCF4qelUmBrZqK56l7juM4AxN3pBynzchRUrqaDFHQb2qpEFdQHyMZfhIR0Kw3RiXpSRJzgKYMfoFBjAqgjGDAsG1nY16h2ioiRTiOZWuVrMR2ltQ6TtSNN14fxoycEr611rQw95DuMO39rvDbv8wTxky4PvnMIYcemjhRMsCbQOeSbUOlzhroVq47y5nieNC49o477ghPPPFEePTRR8OIESPCqFGjkp86aYi2Ji5tP5UqqmPJ9qtHkyYCdIyIlqr+S/VvEh7R59XbS5EhxnAsTW7T8Yo+W4QUAfkuy6mrCOg4juM4ebgj5Ti9gFLzsgrSmUGnNofUNqUTxU1nlW7GT1lp5jqwLNXzWGnzOJ2wqlNV1Jw37r/E8cBxzJOIt2Q5UIBjSCQKJ2qP9f+v/mqeId1hz49ejx5/XfjGN7+ZiDrglDUNkZo0p8eOB+tMPfjggz31PJxzUvguu+yy0uuzSnI4EjqHjC3GI1E/jq8aHcdpjKTGAZ9nORxfnXNFnDT+FEFSPZhVvdN3FNHKSrFrJR0vjaYUAR3HcRwnCxebcJxeoExBOn9jxJPGxe80g88aqRiuRGyIoJCGR7SCqFarCm5x6pPSuSwyiqtQxhmKHUNSumxaXF1uvfXWJJ2PSFQaO681Lfk/tVOS7G4KnfO0Wh9FE+MUP9L44vPIa5wrnX+WiXNG5IU0PPs+61FvJpx1nCainqQCIgyhejTONf+3jmPs8EpiPlZr1DGKJejlYFnFQkWv2N+sFDvGu9Zd9NkyKIqrKCC/69RbOY7jOE4WHpFynF6gakG6nIn4s5Jm5n2cKGvwMuOuCAPRnLoGY5z6ZKNRMp7r1klJLj2tZxXwPp+x9VFNODUcF2qiSOdLg/f5P59TCltTcDzjlD4hB8pKbccS53xPTtXdd9+dfO7LX/5yjzOtSJEcKZah4yjHVNL07J8iNIo6xo5K2nmJ35OTkxWV1EQB55pzqdTQvBS7dqTjee2S4ziO007ckXKcXqKsUacaJSt4QENeojM4VEiI85MFBnIrqX5ah62Rig1kGfBliCMc1onKUtCzBjrbw/9bgWUjLPHO+12pzhS1UpPe6ArrfJR6JyejCWx/rBiOJcdCYh7333//LE4UDhOy6HfeeWfP+3fddVdyfJA/t3VOqhFTfZLgbynisR7WKUeR79aRmlfECFintl8pgDhBRMkkUqGarKIUO0/HcxzHcfoS7kg5TofIijrhNMRODAYqzhUNfDFQ05wcIYn0urAN9I9iO/ixYhaqgcFwVjSlSJghTfa9SEHviCOP7PkO0t7UzrQiqrHxxhsny0ZYwtZICd6f9l534shpO8vWdOVBFCgvnYz/o+jIuohE4SSJ9dZbL6yyyiqJQ52m5sd31l133VnS5vg76zjp/ViSPq1GKw3VRdmaJzlQjEmWwXmVo6x0QMY2DpL6MuVFY11K3HEcx+lLuCPlOB1AUSdJRmOEEgXCgclykniPuhZm86WSloaiRq2g+iQiM3H0S86U6nHqKPkVKeix3P/8r/9KPssxKiNvngfHFQfthAnXh+6PaqJmXefwsOUWW8wis92qI0X9ErL0OMsIZqQ5EJxLnI/f/OY3s5wzHCScKLv+2JlSmt+qq67a40ilOUR2P2wUSamBem3/n7YMtlVpnpJGl+PPOVJEiv3m/3KitM9lRR48Hc9xHMfpK7gj5TgdAOOTSIMK8jFgeV2UwoYDQxRD9SZphq8t8m+VoshWlnx2HuUU9K4JBz5+UPjc5z7XU2PTqvT6/qNGfbTs68KpNwxPomCk8xGJwonS/2XMS7q7bi2YnGWdq6wGs+eff34YO3ZsGD16dI8ThXOURuxMEcFi+7I+H0ecrBCE6qqUfqdt1PZrXPK3mu+mOYO8V7b2z3Ecx3H6E+5IOU4HUNRJfYRUO8L7ec1oZaiqv1JaWh2viYCwnFYN2jznpa4IRBkFPRydcePGhWOOOWYW2e1W4FgfdPDBicS56rLWMXVZgsgLrzmGOENKl2N/cSZwONSkVvViscOpCJGaGUt4IZaqP/300xMnSmy44YZhpZVWyt2PtMgU69P7EoGIG0ArUikHUbVLcuhjWXs5WDhRRPSyxpJHkBzHcZyBijtSjtNB0mpxqCchnS5N8EBGsRQAJWEdg8GOo2AdhKrIicjC9vlph4Iejgz72HTDYY7JzjvvnPo/pbwh7oHTZFPUcBjYJtskWA5VHnyf78jBsU6yXRbrQlzimWee6en/lLVsGvJOnjw5nHXWWcnr/fbbL6mfw2nDgZZTbveJ7V9ooYVmUe6LU/H4LsdbY4/XVZvhOo7jOM5AwR0px+kAGKhyVKzBrCgS/X5QWVNTVIFxTLoYEQLqb3idlX6HjHRdI1gqb3mw3DKORF0FvfUWXHCWvlmtCj+UQfVfwL4RjZGU/GuvvZa8p7Q3fpcR9bBRQzkpHF+WeeyxxybLxQk68iOBDSTAcZKUopnlrO6111490ugHH3xwjxy+RB6yapU8Fc9xHMdxmsEdKcfpADgTGNRyRGxdk4xsDGGMY2tIyxBXeliRc1FXBp3v2ahFjBTa6kSkyirobb755onRzzaoj1JZZ8o2jNU+VN1W1qW6NaJY1mmq2kdLNUlqZKzzwt/f+973klowgYPMsbdCJFZIQu/x/b333runlinLcYrxVDzHcRzHaQZ3pBynA1iJcSJH6gOkCBOpe/y2zXCFhCmsw5Bm1MeNVqugSFAWWUIXTSnobbXVlmGZZZbpUXrDebR9tSzaf/VRkgPC30pzsyl0VWA5RIdwfNXzqc5+qyaJCFdaTVXa2LACDuyLfb3gggt6ZMlxHMdxOow7Uo7TITCY1YdH9UZSe8NoxmDOEpNQdEVNTtM+p35PinBVgXVnCV7EzkEdxyJPQe8/ttoqHHPssWHRRRft2W45FmyTxB9sNA8UQZMDKKdKzWfrwrpIc8SZqrO/SgXUD9tZJE+fFjXCeUr7nOM4juM4ncEdKcfpIJL2BhtZ4n0cCZq1ZkmcAxEOnAU+E/eV4j3VOuU1hU1DyoBpkRMbBbPOQVmU3nbwIYeE3b/97UTCm23cZIEFwtZbb92T5hb3XyLlTbz88sup9VlyRuWccmxbFavQ/nEsOd5qOKv1WMc27btKveNzLIPIWdmeSo7jOI7jzL64I+U4HUS1O0SO5Jyo9khRiTgtzdb/YJCj8JeXKobhX7VWis/ifOGwSP3NOgtqygpyVrKcCTVzlRw4PzgXfB+Rhc9+9rOz9CACHCtFmNL6L7E/Weuz6XdNCFRIJpxtxJGSdL111tQwWOvTtrHfWoaa2HqfJcdxHMfpH7gj5TgdxKbmxVEe/T8mrW4qy6nAyMeYr1MrhdOCyIKcGi1PynKkuoFS7viMFaCQA4JTEwtTyIEk4iTHSg4TDhXLkhiDIjnWGSyTrpd2nMogmXI5rDo/cvRwXNlOOWtqWIu0ONtp68uKhB8cx3Ecx+m7zNaO1PPPPx++8Y1vhMsvvzzpmyIwYGhkecUVVyRKVd///vfDVltt1dFtdZw6YICr7kd1TqqXyuvjpPeL+ixpuUU1OUWRKSt0oKiRfY80RLBOV9b2yzkiNQ+nhWtYUS2l0Km+ie/LKanqDKqhrNLqykBkkO/I8VPkT+l4ViREkTrba8lT9hzHcRxn4DDbOlJ///vfw7777psYLDFnnnlmuPrqq8M555yTGDgHHHBAWHrppcMXvvCFjmyr49QF41viCTL2FYHBKbH1U2mpa4p+5PUbarUmJxY+0LbFqXc2kpTnBFqnRgqE1oGU1Ld+JDWOw2L3Kc+BVCQJJ03RMqXfZX2P/+MQqmmunLg4HU+ROsdxHMdxBjazpSOFUbbHHnskDSdPOeWUWf6H4XjxxRcnUai11loreW+33XYL48aNCyeffHLtdWKo1ZVIdvoPUqorUqxrCqI6VnXPOkwSkchC41U1OmmOC3U5pOGxnKbGN3LgEk2Qs8NrfvhbUaWysP1EgsA6k7YhrRwq7YOcNfsdIQEIlqnv8rc+x7HiNT8SrGBfUMVT3RcOmKXJ49fJ8eYMXHysOT7WnP7IO216jsY2WRZd3U1UYzcMztJrr72WGEGbbrppuPnmm3tS+5588skwcuTIcNNNN4Ull1wyee/ee+8NJ5xwQpgwYUKt9T366KO1++04TitIwS7tYtWlmfY/K+4gJ8QuJ64PqtOQtso223Xp/TI3oLTv2/eskmHcw0kCHWnfiZeJEyZxiDyVPcdxHMdxHCDT5otf/GKYLSNShxxySLjjjjtS/3fDDTeExRdfPEyaNCl1Bh9DTk4UDB06NEk1agVmpFdYYYWWluH0fZjReO6555JmsKR0tRuiO1KBw9iXoS8ngQgJTr519Pkf7+tzis7wGaXF6W/Be3wOCXEpydUFgQiuQy1XDgtRHNu3KW+OxooxqB+VfhRp4vhr+US5SO0bPnx4zzJ4j2On42Z7celvjg/fa3Wf+8t4cwYuPtYcH2tOf+SdNj1Hn3766VKf65gjdcwxx2SG4ayxFINhFBfOc+BaTbvB8IrTeZyBC2OqN8aDhA1wfGT8K3KC4yMRBwk78D/S0fS3lPKsNDjRXJwd2zCX5fI9rjlS/Vph6tSpPQ6O/Y1zx/pYh1LxbKNg+1ntK9cyP1Lu4z3dCO177BuqeLHyXav7MtDGm+P4WHN6Cx9rTl8eb2WzajrmSGEU1QF1LAw1JIjnm2++HiOzriqZ43QSq4pnBQ4UQbENafksThIORp40OE6WHBjbKJfXU6ZM6VGYq4tVAeRvbaucINavKJkU+FSvpBQ7YBmINvC7SBXQ5cMdx3Ecx5ndmC3FJvIgpY/0pPvvvz9stNFGPTVOSBI7Tl+krCoeDpciUbYOSc1ihRWvSKNqc94YHBu2KXbm5PCwrUrPs72x9N20xrRp2+N9lxzHcRzHmZ3pc44UBhk9o84+++yw+uqrJ8bm+eefHzbbbLNOb5rjNAKOTlZDWjkxNq0urU+UrV2y7xEZalVYxTpLctpsnyXbd0qS5d6Y1nEcx3Gc/kafc6TgwAMPDN/97nfDhhtumBiL9JCi55Tj9Afyok6kxGY5MUI1RaqfAj6rPkqtpsFmNem10SWPJjmO4ziO09+ZrR0pJM+RO4/BaKNvFOl9GHL0k5pdVbkcpyp5UaciJ8Z+n/Q5BCak3qd+Sa005xXuLDmO4ziOM9CZrR2pPJhhX3PNNTu9GY7TOHmpc2WcGH2fiJR6TEnhrlWhCcdxHMdxHKePO1KO018pE3Vq5/cdx3Ecx3GcYtyRcpzZkFZT5zz1znEcx3Ecp718qEnsOI7jOI7jOI7jlMYdKcdxHMdxHMdxnIq4I+U4juM4juM4jlMRd6Qcx3Ecx3Ecx3Eq4o6U4ziO4ziO4ziOO1KO4ziO4ziO4zjtxSNSjuM4juM4juM4FXFHynEcx3Ecx3EcpyLuSDmO4ziO4ziO41TEHSnHcRzHcRzHcZyKuCPlOI7jOI7jOI5TEXekHMdxHMdxHMdxKuKOlOM4juM4juM4TkXckXIcx3Ecx3Ecx6mIO1KO4ziO4ziO4zgV6eru7u4OA5wHHnggcBiGDBnS6U1xOgzj4IMPPgiDBw8OXV1dnd4cp5/j483xseb0N/y+5vSH8fb+++8ny1tttdVyPzdnY2vsw7jB7Nix4A6105v3Hh9vjo81pz/h9zWnP4w3llvGP/CIlOM4juM4juM4TkW8RspxHMdxHMdxHKci7kg5juM4juM4juNUxB0px3Ecx3Ecx3Gcirgj5TiO4ziO4ziOUxF3pBzHcRzHcRzHcSrijpTjOI7jOI7jOE5F3JFyHMdxHMdxHMepiDtSjuM4juM4juM4FXFHynEcx3Ecx3EcpyLuSDmO4ziO4ziO41TEHSnHcRzHcRzHcZyKuCPlOI7jOI7jOI5TEXekHMdxHMdxHMeZ7Xn//ffDI488Ep588snQ3d3d6c1xR8pxxPPPPx/WWWedMGnSpFkOyowZM8JPfvKTsPbaa4eNN944/OEPf/CD5rTEa6+9Fvbbb7+w6qqrhu233z488cQTfkSdRpk5c2Y44IADwjnnnDPL+7fddlvYaqutwuqrrx6OOeaY8N577/mRd2rz+OOPh2984xthpZVWSsYUz0rGno81px3gQGGHce/afffdw9e//vUwderUjt7bPCLlOCGEv//972GPPfYIb7zxxseOx5lnnhmuvvrqxCD56U9/Gk455ZTw2GOP+XFzasEM2qhRo8Lrr78eLr/88rDrrrsmTtXbb7/tR9RpBAyII488Mtx4442zvM8M7v777x+23nrrcNVVV4UpU6Yk9zTHqcNbb70Vvvvd7yaTjLfcckvyrBw3bly48sorfaw5jcOk9qGHHhoOO+ywMH78+HDzzTcnz03GXCfvbe5IOQOeadOmJU7UbrvtlhpCvvjiixPDd6211koiCHyOC9dx6vDAAw+EBx98MJx00klh+eWXD9ttt11Ydtllw0033eQH1GmE448/PgwePDi5X1kuuuii8LnPfS5x3Jdccslk1vayyy7zqJRTi6effjpss802iXG76KKLhg022CCJBjz88MM+1pzGefPNNxP7iywOmHfeecNyyy2XOE2dvLe5I+UMeOacc87wu9/9Lmy66aYfOxYTJ05MHC0eEALjhAeF49Thb3/7W1h88cXDCius4GPKaQv77rtvOPnkkxNnKh579l622GKLhQUWWCA89dRTfiacyqyyyirhiCOOmCVi8MwzzyTGrY81p2mGDx8+y4T3n//853D33XeHLbfcsqPjzR0pZ0BwyCGHhDXWWCP1h1kODNs0+N+gQYOSGQ4xdOjQ8Morr/Ti1jv9CcbUUkstNct7w4YN8zHlNMbSSy/tY8/pdS699NLw7rvvJhEDv8857YRIKE7V3nvvHVZeeeWOjrc5274Gx5kNIMz7zjvvZM5y5EWrhgwZMst7c889dxKlcpw6MKbmmmuuWd77xCc+4WPKaTtMCvnYc9pVZ3zaaaeFMWPGJJONPtacdvLLX/4yEf6iDorIaCfHmztSzoBgoYUWqvU9QsM4YBTVzjfffMl7zHzEzpXjVBlTqPZZGF8+ppxOjD2/nzmtMnny5KSOeIcddggjR470sea0HVL3vvOd7yQO/G9/+9uO3ts8tc9xciClb+GFFw73339/z3uPPvpo+NSnPuXHzakFs2fc/CXZ6mPK6c2xZ+9lKF5RB5qV2uw4RTDRiFraiBEjwlFHHeVjzWkbqCXT0sH2jsJRIhrVyXubO1KOk3eBzDFH0pfg7LPPTqIGyKOff/75YZNNNvHj5tRixRVXTIqxSUmg3woPB2SqfUw5vVFXgDrkvffem7weO3ZsMpNLDyDHqQoGLfXHPBd/9KMfJQppGLDUSflYc5oGdVsUb1ElffHFF8Ptt98errnmmmSsdXK8eWqf4xRw4IEHJr0yNtxww+TBQSE3qliOUxeMjn322Sdcf/31SfrBtttum4wvx2knn//855MZ3W9/+9tJbSj1A2eddVYyYeQ4VaF3z6233pr8bRXTaBWCHLWPNadJ5plnnqQ2CkVS+kWR3nfsscf2TEJ2arx1ddsYmeM4qRA5IGxMXykeErGssONUhRs9s2fMmqE65Di9xQsvvJAYwV/84hcTY8RxfKw5/YEXOnBvc0fKcRzHcRzHcRynIh7PdxzHcRzHcRzHqYg7Uo7jOI7jOI7jOBVxR8pxHMdxHMdxHKci7kg5juM4juM4juNUxB0px3Ecx3Ecx3Gcirgj5TiO43yMSZMmhc985jM9P6uuumrYZZddwiOPPDLL5/71r3+F/fffP+ksv9FGG4WLL774Y8uaMWNGWHPNNcNRRx1V60jTDJvvrr766mHdddcNZ555ZtKSwKnPz372s3DkkUf6IXQcx2kBd6Qcx3GcTA455JBw+eWXJ80N6Xm12267hZdeein5H33V9txzz8SZOvfcc8N3vvOdcMopp4Q//vGPsyzjr3/9a5g6dWq46667ah3pgw46KDzwwAPh9NNPD9///vfDBRdcEC688MIB6+Cec845LS1jwoQJ4b//+78b2ybHcZyBijtSjuM4TiZLLrlk0txwww03DD/96U/D3HPPHS677LLkf1dffXWYOHFiGDt2bPjyl7+cdJXfYostwnnnnTfLMu68886kifXLL78cnnnmmUpH++677w5/+tOfwmmnnRY23njjsP3224f/9//+38fWMVB48cUXk+Ndl0svvTQce+yxYYUVVmh0uxzHcQYi7kg5juM4pRgyZEjiWP3jH/9IXt90001Jyp/tII/T9fTTT8/yPSJR22yzTRg+fHjiVFWB6NYSSywRVl555VnW8e9//zu8/vrrfuYq8vDDD4fzzz8/rLTSSn7sHMdxWsQdKcdxHKc0r732Wlh00UWTv5966qmw3HLLzfL/rbbaKkkDpC4K3n777fDQQw+FddZZJ6y11lqV0/vS1sFyfvGLX4S55pqrp4bqmGOOCWussUZSi0XEhfUCaXDf+ta3wtFHHx2+9KUvhZNOOimJ6OAA7rHHHmH69OlJrRApij/84Q+T9zfffPPw+9//fpZ15q0DNtlkk3DFFVckKXNE5/jMiSeeGLq7u3s+85e//CXsuOOOiVO45ZZbJil2gu+yjGeffTapRWNbcT4fffTRnv2gVo3USlDtWtU6p5NPPjlZtuM4jtM67kg5juM4hRD9wQGhPor0Pb1HlMlCdIo0wEGDBiWv77333vDBBx+EtddeO3GA/vznPyevy8I6hg0bNst7rJN1zDvvvImj8r3vfS/ccccdYcyYMeGEE04It99+eyKAIaivGjFiRJISeNFFFyXOGZ8lOva3v/0t+Qx/E+Wi1uurX/1q4ijdfPPNyf/KrAOo3eI7OCt77bVXIrzxv//7v8n/SIHEcfvc5z4XfvWrXyXrOOyww5LURYFjxvc22GCD8POf/zx5b/To0cnvnXbaKalVY93A3/yMGjWq0uidYw5/7DuO4zTFnI0tyXEcx+l3HHroockPzDfffEmURRENxCaKDHMclKWWWip88pOfTJypadOmJREqIjZlYB1yytLAMSPSQ7oain6w4IILht133z15H5ZZZpmw3377hXvuuSf88pe/TCJPRNUOP/zw8M477/TsG2IW/F5vvfXCgw8+mDhCm266aeE6cBABR+yGG25IHLyvfOUrYfz48eGJJ55Iaruo6Vp++eUTRwzY/9tuuy1cddVVPcucPHly2HfffRPRDmCb2UY5qPxw/JTe6DiO43QWd6Qcx3GcTIiaECHBOSCqYx2neeaZp8ewF7feemviNOB0kHpHKh81VaShWeeqrCOVtg7S3VAHRIACRUAcLbs8/kbcQmlxSkXs6upKftuaLsH24UQJHBWcIihahxwphDA4TgJni9RBePLJJxOnyh4HUHoicGxJQ0z7vuM4jjP74Y6U4ziOkwlCD6SjpbH00kuHF154YZb3UOXD8UCY4pVXXkmEJ+gBRTQK6AGFI3XwwQeXOupEk55//vmPSYCTrsc6bA1STN7/ij5Lnyo5jWXXgRBHHpttttnHUvE+8YlP9PyNw2dfO47jOLM3niztOI7j1IJIFWlvb775Zs979913X/jCF76QRH8kLLH11lsnzhg/1DbhaE2ZMqXUOtZff/2kpklKgXD//feHRRZZJHE8iBwhbMF67f+pw6qS/vb444/Psh+o2+EoQtl15KUgrrjiiuGf//xnz3HgB2fw2muvLfX9OILlkSrHcZzO446U4ziOUwtqhOgrtc8++yT1PkSbSO2TshyRJyJKCy+8cM93UL0j2kO9Uhm+9rWvJbVF1A4h5EDKIL2QWDdIxIKo13XXXZf8HHHEEUndkaJgZWuxaD6M83fqqacmNVLajybWsffeeycOISIWOJ/sw09+8pNZUgHLQP8nvoNqIdt4ySWXJEqKjuM4Tu/jjpTjOI5TC2p4EGTAmTrggAOSBr2IUSCBTsobinSrrbbaLN/59Kc/XamfFOl7OE/UFiG8QP0VIgyo2wGRr//8z/9MJMdxUvghioX6XhVwiqgBQ4kPkQikzjfaaKPG1oEziPND5AupdfaDYyZhibJQx3XGGWckIhWoEP7mN79JHFPHcRyn9+nqrpJE7jiO4zj9DHoxvfHGG0kPKMdxHMcpi0ekHMdxHMdxHMdxKuIRKcdxHMdxHMdxnIp4RMpxHMdxHMdxHKci7kg5juM4juM4juNUxB0px3Ecx3Ecx3Gcirgj5TiO4ziO4ziOUxF3pBzHcRzHcRzHcSrijpTjOI7jOI7jOE5F3JFyHMdxHMdxHMepiDtSjuM4juM4juM4oRr/P41rWiqsymIQAAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# --- 4.1: 两阶段离群点挖掘方法（TOD） ---\n",
    "print(f\"正在运行 TOD (Two-Phase Outlier Detection) 方法...\")\n",
    "\n",
    "# 参数设置\n",
    "n_clusters = 9\n",
    "beta = 2  \n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 第一阶段：聚类 (Phase 1: Clustering)\n",
    "# ---------------------------------------------------------\n",
    "# 使用 K-Means 对降维后的数据进行聚类\n",
    "kmeans = KMeans(n_clusters=n_clusters, random_state=42, n_init=10)\n",
    "kmeans.fit(X_reduced)\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 第二阶段：计算离群因子 OF3 (Phase 2: Calculate Outlier Factor)\n",
    "# ---------------------------------------------------------\n",
    "\n",
    "# 1. 计算距离 d(p, Cj): 所有点到所有簇中心的距离\n",
    "# kmeans.transform 返回矩阵形状为 (样本数, 簇数量)，正是我们要的距离矩阵\n",
    "dist_matrix = kmeans.transform(X_reduced)\n",
    "\n",
    "# 2. 计算权重 |Cj| / |D|\n",
    "# 获取每个簇的样本数量 (|Cj|)\n",
    "labels = kmeans.labels_\n",
    "cluster_sizes = np.bincount(labels, minlength=n_clusters)\n",
    "total_samples = len(X_reduced)\n",
    "\n",
    "# 计算每个簇的权重系数\n",
    "cluster_weights = cluster_sizes / total_samples\n",
    "\n",
    "# 3. 计算 OF3(p): 加权平均距离\n",
    "# 公式: Sum( (Size_j / Total) * dist_j )\n",
    "# 利用矩阵乘法: (N, k) dot (k,) -> (N,)，相当于对每一行进行了加权求和\n",
    "of3_scores = np.dot(dist_matrix, cluster_weights)\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 第三阶段：判定 (Thresholding)\n",
    "# ---------------------------------------------------------\n",
    "# 计算 OF3 的统计量\n",
    "ave_of = np.mean(of3_scores)  # Ave_OF\n",
    "dev_of = np.std(of3_scores)   # Dev_OF\n",
    "\n",
    "# 设定阈值: Ave_OF + beta * Dev_OF\n",
    "threshold_tod = ave_of + beta * dev_of\n",
    "\n",
    "# 记录结果 (True 为异常)\n",
    "outlier_flags['TOD'] = of3_scores >= threshold_tod\n",
    "\n",
    "# 打印\n",
    "print(f\"   [TOD统计] Ave_OF: {ave_of:.4f}, Dev_OF: {dev_of:.4f}, Beta: {beta}\")\n",
    "print(f\"   [TOD统计] 阈值: {threshold_tod:.4f}\")\n",
    "\n",
    "# =========================================================\n",
    "# 绘图\n",
    "# =========================================================\n",
    "plt.figure(figsize=(10, 6))\n",
    "\n",
    "# 1. 画正常点\n",
    "plt.scatter(X_pca[~outlier_flags['TOD'], 0], X_pca[~outlier_flags['TOD'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常样本')\n",
    "\n",
    "# 2. 画异常点 (TOD 关注的是离中心远的点)\n",
    "plt.scatter(X_pca[outlier_flags['TOD'], 0], X_pca[outlier_flags['TOD'], 1], \n",
    "            c='orange', s=40, edgecolor='k', label='TOD 离群点')\n",
    "\n",
    "# 3. 绘制簇中心\n",
    "\n",
    "pca_model = pca2\n",
    "\n",
    "if pca_model is not None:\n",
    "    try:\n",
    "        # 获取聚类中心 (来自 TOD 阶段训练的 kmeans)\n",
    "        # 尝试将中心点投影到 2D 画布上\n",
    "        centers_2d = pca_model.transform(kmeans.cluster_centers_)\n",
    "        \n",
    "        # 绘制中心点 (黑色 X)\n",
    "        plt.scatter(centers_2d[:, 0], centers_2d[:, 1], \n",
    "                    marker='x', s=150, linewidths=2, color='black', label='簇中心')\n",
    "        \n",
    "        # 标上数字 ID\n",
    "        for i, (cx, cy) in enumerate(centers_2d):\n",
    "            plt.text(cx, cy, str(i), fontsize=15, color='black', weight='bold',\n",
    "                     bbox=dict(facecolor='white', alpha=0.5, edgecolor='none')) # 白底防遮挡\n",
    "            \n",
    "    except Exception as e:\n",
    "        # 维度不匹配时(例如 kmeans 是 75维, pca 是 416维)，只打印警告不报错\n",
    "        print(f\"警告: 无法绘制簇中心，维度可能不匹配 ({e})。仅绘制样本分布。\")\n",
    "else:\n",
    "    print(\"提示: 未找到 PCA 模型对象，仅绘制样本点。\")\n",
    "# ---------------------------------------------------------\n",
    "\n",
    "plt.title(f'{current_dataset_name} - TOD方法\\nBeta={beta:.4f}, 检出数量: {outlier_flags[\"TOD\"].sum()}')\n",
    "plt.xlabel('PCA Component 1')\n",
    "plt.ylabel('PCA Component 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_4_TOD.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "57530c7f-61e6-4dee-927f-9a807cf9e697",
   "metadata": {},
   "source": [
    "### 4.2基于聚类的离群挖掘方法 （CBOD）"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "8d3b5672-206b-440c-8ddc-2d233b2b07f0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "正在运行 CBOD 方法...\n",
      "   [复用] 簇数量 K=9\n",
      "   [CBOD] 簇离群因子 OF4 统计 (按偏离程度降序):\n",
      "   Rank | ID | Size | OF4 Score | Cumulative %\n",
      "   --------------------------------------------------\n",
      "      1 |  6 |   64 | 39.835909  | 1.21%\n",
      "      2 |  7 |  103 | 32.896110  | 3.16%\n",
      "   --------------------------------------------------\n",
      "   -> 累积离群比例 3.16% 已满足阈值 (>= 2.0%)\n",
      "   -> 判定离群簇 ID: [6, 7]\n",
      "图片已保存: output\\HT-29_FEATURE_4_CBOD.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# --- 4.2: CBOD 方法---\n",
    "print(f\"\\n正在运行 CBOD 方法...\")\n",
    "\n",
    "# 参数设置\n",
    "# epsilon: 我们希望筛选出的离群样本比例 (即 PPT 中的 0 < epsilon < 1)\n",
    "epsilon = 0.02 \n",
    "\n",
    "# =========================================================\n",
    "# 1. 复用聚类信息 (Reuse Clustering Info)\n",
    "# =========================================================\n",
    "# 直接使用 TOD 阶段的 kmeans 模型和权重\n",
    "# centroids: 簇中心坐标 (k, 75)\n",
    "centroids = kmeans.cluster_centers_\n",
    "# cluster_weights: 之前算好的权重 |Cj|/|D|\n",
    "# cluster_sizes: 之前算好的簇大小 |Cj|\n",
    "\n",
    "print(f\"   [复用] 簇数量 K={len(centroids)}\")\n",
    "\n",
    "# =========================================================\n",
    "# 2. 计算 OF4 (根据 PPT 公式)\n",
    "# =========================================================\n",
    "# 公式: OF4(Ci) = Sum( (|Cj|/|D|) * d(Ci, Cj) )\n",
    "\n",
    "# 计算簇中心之间的距离矩阵 d(Ci, Cj)\n",
    "# centroid_dist_matrix[i, j] 表示第 i 个簇中心和第 j 个簇中心的距离\n",
    "centroid_dist_matrix = euclidean_distances(centroids, centroids)\n",
    "\n",
    "# 利用矩阵乘法一次性算出所有 OF4\n",
    "# (K, K) dot (K,) -> (K,)\n",
    "of4_scores_cbod = np.dot(centroid_dist_matrix, cluster_weights)\n",
    "\n",
    "# 整理每个簇的信息以便排序\n",
    "cbod_stats = []\n",
    "for i in range(len(centroids)):\n",
    "    cbod_stats.append({\n",
    "        'cluster_id': i,\n",
    "        'size': cluster_sizes[i],\n",
    "        'of4': of4_scores_cbod[i]\n",
    "    })\n",
    "\n",
    "# =========================================================\n",
    "# 3. 排序与判定 (Ranking & Determination)\n",
    "# =========================================================\n",
    "\n",
    "# 按 OF4(Ci) 递减顺序重新排列 (离大部队越远的簇排在越前面)\n",
    "sorted_cbod = sorted(cbod_stats, key=lambda x: x['of4'], reverse=True)\n",
    "\n",
    "# 寻找最小的 b，使得累积样本占比 >= epsilon\n",
    "current_sum = 0\n",
    "outlier_cluster_ids = []\n",
    "\n",
    "print(f\"   [CBOD] 簇离群因子 OF4 统计 (按偏离程度降序):\")\n",
    "print(f\"   Rank | ID | Size | OF4 Score | Cumulative %\")\n",
    "print(f\"   {'-'*50}\")\n",
    "\n",
    "for rank, c in enumerate(sorted_cbod):\n",
    "    current_sum += c['size']\n",
    "    cumulative_ratio = current_sum / total_samples\n",
    "    \n",
    "    print(f\"   {rank+1:4d} | {c['cluster_id']:2d} | {c['size']:4d} | {c['of4']:.6f}  | {cumulative_ratio*100:.2f}%\")\n",
    "    \n",
    "    # 只要累积比例还没超过 epsilon，或者这是第一个簇（至少得选一个），就加入离群名单\n",
    "    if len(outlier_cluster_ids) == 0 or (current_sum - c['size']) / total_samples < epsilon:\n",
    "         outlier_cluster_ids.append(c['cluster_id'])\n",
    "    \n",
    "    # 检查是否刚刚跨过 epsilon 阈值\n",
    "    if cumulative_ratio >= epsilon:\n",
    "        print(f\"   {'-'*50}\")\n",
    "        print(f\"   -> 累积离群比例 {cumulative_ratio*100:.2f}% 已满足阈值 (>= {epsilon*100}%)\")\n",
    "        print(f\"   -> 判定离群簇 ID: {outlier_cluster_ids}\")\n",
    "        break\n",
    "\n",
    "# 标记样本\n",
    "# np.isin 用于判断 labels 中的每个元素是否在 outlier_cluster_ids 列表中\n",
    "outlier_flags['CBOD'] = np.isin(labels, outlier_cluster_ids)\n",
    "\n",
    "# =========================================================\n",
    "# 4. 绘图\n",
    "# =========================================================\n",
    "plt.figure(figsize=(10, 6))\n",
    "\n",
    "# 1. 画正常点 (属于 normal 簇的点)\n",
    "plt.scatter(X_pca[~outlier_flags['CBOD'], 0], X_pca[~outlier_flags['CBOD'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常簇样本')\n",
    "\n",
    "# 2. 画异常点 (整个离群簇)\n",
    "plt.scatter(X_pca[outlier_flags['CBOD'], 0], X_pca[outlier_flags['CBOD'], 1], \n",
    "            c='purple', s=40, edgecolor='k', label='CBOD 离群簇样本')\n",
    "\n",
    "# 3. 标记簇中心 ID\n",
    "pca_model = pca2\n",
    "\n",
    "if pca_model is not None:\n",
    "    try:\n",
    "        # 将 75维 的簇中心投影到 2D\n",
    "        # centroids 来自于复用的 kmeans.cluster_centers_\n",
    "        centers_2d = pca_model.transform(centroids)\n",
    "        \n",
    "        # 遍历绘制每个中心\n",
    "        for i, (cx, cy) in enumerate(centers_2d):\n",
    "            # 逻辑：如果该簇 ID 在离群名单里，数字标红，否则标黑\n",
    "            text_color = 'red' if i in outlier_cluster_ids else 'black'\n",
    "            font_weight = 'bold' if i in outlier_cluster_ids else 'normal'\n",
    "            \n",
    "            # 画中心位置 (X号)\n",
    "            plt.scatter(cx, cy, marker='x', s=150, linewidths=2, color=text_color)\n",
    "            \n",
    "            # 写数字 ID\n",
    "            plt.text(cx, cy, str(i), fontsize=15, color=text_color, weight=font_weight,\n",
    "                     bbox=dict(facecolor='white', alpha=0.5, edgecolor='none')) # 加个白底好认\n",
    "            \n",
    "    except Exception as e:\n",
    "        print(f\"警告: 无法绘制簇中心，维度可能不匹配 ({e})\")\n",
    "else:\n",
    "    print(\"提示: 未找到 PCA 模型对象，仅绘制样本点。\")\n",
    "# ---------------------------------------------------------\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 4.2 CBOD方法\\nEpsilon={epsilon}, 检出数量: {outlier_flags[\"CBOD\"].sum()}')\n",
    "plt.xlabel('PCA Component 1')\n",
    "plt.ylabel('PCA Component 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_4_CBOD.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d9ab4dfb-65d7-491b-b734-a48e90bfa183",
   "metadata": {},
   "source": [
    "## 5.基于聚类的动态数据的离群点检测\n",
    "本部分使用通过划分数据去训练一个可以流式检测离群点的模型，该模型可在新数据进入时实时更新离群点判断依据。\n",
    "第一步使用80%的数据进行聚类，CBOD的逻辑去筛选离群簇，建立基础模型；\n",
    "第二步利用使用额外20%的数据流式输入模型，根据INN算法来判断该点属于是否属于离群簇、正常簇、候选离群点。输入新数据后将实时更新离群簇判断依据。"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "43c0db4f-2fd5-4704-81d7-707b38babe78",
   "metadata": {},
   "outputs": [],
   "source": [
    "# 参数设置\n",
    "n_clusters_dynamic = 9\n",
    "epsilon = 0.02 "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f344ae6e-c266-4566-be3e-3f140bd8dbc5",
   "metadata": {},
   "source": [
    "带索引切分数据，一遍后续回溯数据时记录离群点"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "id": "a5937512-8950-4403-b4d5-1f59efafa45f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "   [数据切分] 训练集: 4223, 测试集: 1056\n"
     ]
    }
   ],
   "source": [
    "# indices_train/test 用于记录原始行号，以便最后填回 outlier_flags\n",
    "X_train, X_test, idx_train, idx_test = train_test_split(\n",
    "    X_reduced, df_current.index, test_size=0.2, random_state=42\n",
    ")\n",
    "\n",
    "print(f\"   [数据切分] 训练集: {len(X_train)}, 测试集: {len(X_test)}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ab074b83-f406-4d26-9525-68755b200daa",
   "metadata": {},
   "source": [
    "#### 模型建立"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "id": "a3309b69-b7e9-4f20-ae5c-b9de0db7f807",
   "metadata": {},
   "outputs": [],
   "source": [
    "kmeans_dyn = KMeans(n_clusters=n_clusters_dynamic, random_state=42, n_init=10)\n",
    "kmeans_dyn.fit(X_train)\n",
    "labels_train = kmeans_dyn.labels_\n",
    "centroids = kmeans_dyn.cluster_centers_\n",
    "\n",
    "# --- 确定离群簇 (CBOD逻辑) ---\n",
    "train_sizes = np.bincount(labels_train, minlength=n_clusters_dynamic)\n",
    "train_weights = train_sizes / len(X_train)\n",
    "centroid_dist = euclidean_distances(centroids, centroids)\n",
    "of4_scores = np.dot(centroid_dist, train_weights)\n",
    "\n",
    "# 排序并筛选离群簇\n",
    "cluster_info = [{'id': i, 'size': s, 'of4': o} for i, s, o in zip(range(n_clusters_dynamic), train_sizes, of4_scores)]\n",
    "sorted_clusters = sorted(cluster_info, key=lambda x: x['of4'], reverse=True)\n",
    "\n",
    "outlier_cluster_ids = []\n",
    "curr_sum = 0\n",
    "for c in sorted_clusters:\n",
    "    outlier_cluster_ids.append(c['id'])\n",
    "    curr_sum += c['size']\n",
    "    if curr_sum / len(X_train) >= epsilon:\n",
    "        break\n",
    "\n",
    "# --- 确定簇半径 (Radius) ---\n",
    "cluster_radii = np.zeros(n_clusters_dynamic)\n",
    "train_dists = kmeans_dyn.transform(X_train)\n",
    "for i in range(n_clusters_dynamic):\n",
    "    dists = train_dists[labels_train == i, i]\n",
    "    if len(dists) > 0:\n",
    "        cluster_radii[i] = np.max(dists) # 定义半径为簇内最大距离"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a1f58bbe-7931-410d-8afa-dd9478eebca6",
   "metadata": {},
   "source": [
    "#### 生成结果标签"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "id": "229b82fc-99ae-43ce-8307-8166b80c96bc",
   "metadata": {},
   "outputs": [],
   "source": [
    "# --- A. 处理训练集结果 ---\n",
    "# 逻辑: 如果属于离群簇，就是异常\n",
    "is_outlier_train = np.isin(labels_train, outlier_cluster_ids)\n",
    "\n",
    "# --- B. 处理测试集结果 (INN评估) ---\n",
    "# 逻辑: 计算最近邻距离，判断是 正常 / 已知离群 / 候选离群(新行为)\n",
    "test_dists = kmeans_dyn.transform(X_test)\n",
    "is_outlier_test = []\n",
    "\n",
    "for i in range(len(X_test)):\n",
    "    # 找到最近簇\n",
    "    nearest_id = np.argmin(test_dists[i])\n",
    "    dist = test_dists[i][nearest_id]\n",
    "    \n",
    "    # 判定\n",
    "    if dist <= cluster_radii[nearest_id]:\n",
    "        # 半径内：继承簇的性质\n",
    "        if nearest_id in outlier_cluster_ids:\n",
    "            is_outlier_test.append(True) # 已知离群点 -> 异常\n",
    "        else:\n",
    "            is_outlier_test.append(False) # 正常簇 -> 正常\n",
    "    else:\n",
    "        # 半径外：候选离群点 -> 异常\n",
    "        is_outlier_test.append(True)\n",
    "\n",
    "is_outlier_test = np.array(is_outlier_test)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cf713009-cc10-4274-92bd-70335f8c1383",
   "metadata": {},
   "source": [
    "#### 合并保存到outlier_flags"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "id": "0e3718a6-1ee2-4476-b2b1-77e549efe63d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "[完成] 动态检测结果已保存至 outlier_flags['Dynamic']\n",
      "   - 总离群点数量: 132\n",
      "   - 包含训练集中的离群簇样本 + 测试集中的已知/候选离群点\n",
      "验证图片已保存: output\\HT-29_FEATURE_5_Dynamic_Combined.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# 创建两个临时的 Series，索引分别是 idx_train 和 idx_test\n",
    "s_train = pd.Series(is_outlier_train, index=idx_train)\n",
    "s_test = pd.Series(is_outlier_test, index=idx_test)\n",
    "\n",
    "# 合并并按索引重新排序 (恢复原始顺序)\n",
    "s_final = pd.concat([s_train, s_test]).sort_index()\n",
    "\n",
    "# 写入总表\n",
    "outlier_flags['Dynamic'] = s_final\n",
    "\n",
    "# 打印统计\n",
    "num_dynamic_outliers = outlier_flags['Dynamic'].sum()\n",
    "print(f\"\\n[完成] 动态检测结果已保存至 outlier_flags['Dynamic']\")\n",
    "print(f\"   - 总离群点数量: {num_dynamic_outliers}\")\n",
    "print(f\"   - 包含训练集中的离群簇样本 + 测试集中的已知/候选离群点\")\n",
    "\n",
    "# =========================================================\n",
    "# 绘图验证 (Visual Check)\n",
    "# =========================================================\n",
    "plt.figure(figsize=(10, 6))\n",
    "# 正常点\n",
    "plt.scatter(X_pca[~outlier_flags['Dynamic'], 0], X_pca[~outlier_flags['Dynamic'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常样本')\n",
    "# 异常点\n",
    "plt.scatter(X_pca[outlier_flags['Dynamic'], 0], X_pca[outlier_flags['Dynamic'], 1], \n",
    "            c='brown', s=40, edgecolor='k', label='动态法离群点')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 5. 动态检测法 (Train+Test Combined)\\nTotal Outliers: {num_dynamic_outliers}')\n",
    "plt.xlabel('PCA 1')\n",
    "plt.ylabel('PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_5_Dynamic_Combined.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"验证图片已保存: {save_path}\")\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "46054190-7515-4227-8f89-d37e018f1fd8",
   "metadata": {},
   "source": [
    "#### 模型更新与回溯"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "id": "aac4a8d1-f2be-4f8f-9d0f-ca7fcccb28e1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "   [数据合并] 当前全量数据样本: 5279\n",
      "\n",
      "   [模型更新后] 簇统计 (OF4 降序):\n",
      "   ID | Size | OF4 Score | Status\n",
      "   -----------------------------------\n",
      "    8 |   38 | 42.464595  | OUTLIER\n",
      "    2 |   64 | 39.801650  | OUTLIER\n",
      "    7 |  402 | 20.005696  | OUTLIER\n",
      "    0 |  509 | 18.395122  | Normal\n",
      "    4 |  458 | 14.491961  | Normal\n",
      "    6 |  379 | 14.378430  | Normal\n",
      "    3 |  955 | 10.528142  | Normal\n",
      "    5 |  964 | 10.264458  | Normal\n",
      "    1 | 1510 | 9.866616  | Normal\n",
      "\n",
      "   -> 更新后的离群簇 ID: [8, 2, 7]\n",
      "\n",
      "[回溯分析] 模型更新后，有 372 个样本的判定结果发生了反转！\n",
      "结果已保存至 outlier_flags['Dynamic_Updated']\n",
      "图片已保存: output\\HT-29_FEATURE_6_Dynamic_Updated.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# 1. 合并数据 (训练集 + 测试集)\n",
    "X_total = np.vstack([X_train, X_test])\n",
    "idx_total = np.concatenate([idx_train, idx_test])\n",
    "\n",
    "print(f\"   [数据合并] 当前全量数据样本: {len(X_total)}\")\n",
    "\n",
    "# 2. 模型更新 (Simulate Incremental Update)\n",
    "# 此时簇的形态(质心、大小)会发生漂移\n",
    "kmeans_updated = KMeans(n_clusters=n_clusters_dynamic, random_state=42, n_init=10)\n",
    "kmeans_updated.fit(X_total)\n",
    "\n",
    "labels_updated = kmeans_updated.labels_\n",
    "centroids_updated = kmeans_updated.cluster_centers_\n",
    "\n",
    "# 3. 重新计算离群因子 OF4 (Re-calculate OF4)\n",
    "# 计算新的簇大小和权重\n",
    "sizes_updated = np.bincount(labels_updated, minlength=n_clusters_dynamic)\n",
    "weights_updated = sizes_updated / len(X_total)\n",
    "\n",
    "# 计算新的簇间距离矩阵\n",
    "dist_matrix_updated = euclidean_distances(centroids_updated, centroids_updated)\n",
    "\n",
    "# 计算新的 OF4 分数\n",
    "of4_updated = np.dot(dist_matrix_updated, weights_updated)\n",
    "\n",
    "# 4. 重新定义离群簇 (Re-define Outlier Clusters)\n",
    "cluster_info_updated = []\n",
    "for i in range(n_clusters_dynamic):\n",
    "    cluster_info_updated.append({\n",
    "        'id': i, \n",
    "        'size': sizes_updated[i], \n",
    "        'of4': of4_updated[i]\n",
    "    })\n",
    "\n",
    "# 按 OF4 降序排列\n",
    "sorted_clusters_updated = sorted(cluster_info_updated, key=lambda x: x['of4'], reverse=True)\n",
    "\n",
    "outlier_cluster_ids_updated = []\n",
    "current_sum = 0\n",
    "\n",
    "print(f\"\\n   [模型更新后] 簇统计 (OF4 降序):\")\n",
    "print(f\"   ID | Size | OF4 Score | Status\")\n",
    "print(f\"   {'-'*35}\")\n",
    "\n",
    "for c in sorted_clusters_updated:\n",
    "    status = \"Normal\"\n",
    "    # 筛选逻辑同前：累积比例 < epsilon\n",
    "    if len(outlier_cluster_ids_updated) == 0 or (current_sum / len(X_total)) < epsilon:\n",
    "        outlier_cluster_ids_updated.append(c['id'])\n",
    "        current_sum += c['size']\n",
    "        status = \"OUTLIER\"\n",
    "    \n",
    "    print(f\"   {c['id']:2d} | {c['size']:4d} | {c['of4']:.6f}  | {status}\")\n",
    "\n",
    "print(f\"\\n   -> 更新后的离群簇 ID: {outlier_cluster_ids_updated}\")\n",
    "\n",
    "# 5. 回溯标记 (Backtracking Labeling)\n",
    "# 所有样本(包括以前的训练集)都根据这个新模型重新打标\n",
    "is_outlier_updated = np.isin(labels_updated, outlier_cluster_ids_updated)\n",
    "\n",
    "# 6. 保存到总表 outlier_flags\n",
    "# 创建 Series 并按索引对齐\n",
    "s_updated = pd.Series(is_outlier_updated, index=idx_total).sort_index()\n",
    "outlier_flags['Dynamic_Updated'] = s_updated\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 对比与分析\n",
    "# ---------------------------------------------------------\n",
    "# 看看有多少点发生了变化\n",
    "diff_count = (outlier_flags['Dynamic'] != outlier_flags['Dynamic_Updated']).sum()\n",
    "print(f\"\\n[回溯分析] 模型更新后，有 {diff_count} 个样本的判定结果发生了反转！\")\n",
    "print(f\"结果已保存至 outlier_flags['Dynamic_Updated']\")\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 绘图：更新后的全量视图\n",
    "# ---------------------------------------------------------\n",
    "plt.figure(figsize=(10, 6))\n",
    "\n",
    "# 画正常点\n",
    "plt.scatter(X_pca[~outlier_flags['Dynamic_Updated'], 0], X_pca[~outlier_flags['Dynamic_Updated'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='更新后: 正常')\n",
    "\n",
    "# 画异常点\n",
    "plt.scatter(X_pca[outlier_flags['Dynamic_Updated'], 0], X_pca[outlier_flags['Dynamic_Updated'], 1], \n",
    "            c='darkred', s=40, edgecolor='k', label='更新后: 离群点')\n",
    "\n",
    "# 标记新的簇中心\n",
    "pca_model = None\n",
    "if 'pca2' in locals(): pca_model = pca2\n",
    "elif 'pca' in locals(): pca_model = pca\n",
    "\n",
    "if pca_model:\n",
    "    centers_2d = pca_model.transform(centroids_updated)\n",
    "    for i, (cx, cy) in enumerate(centers_2d):\n",
    "        color = 'red' if i in outlier_cluster_ids_updated else 'black'\n",
    "        plt.scatter(cx, cy, marker='x', s=150, linewidths=3, c=color)\n",
    "        plt.text(cx, cy, f\"C{i}\", color=color, weight='bold', fontsize=14,\n",
    "                 bbox=dict(facecolor='white', alpha=0.6, edgecolor='none'))\n",
    "\n",
    "plt.title(f'Phase 3: 动态检测法(Backtracking)\\nTotal Outliers: {outlier_flags[\"Dynamic_Updated\"].sum()} (Changed: {diff_count})')\n",
    "plt.xlabel('PCA 1')\n",
    "plt.ylabel('PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_6_Dynamic_Updated.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a46e2840-c92e-427c-a389-39c2c40a3431",
   "metadata": {},
   "source": [
    "## Feature结果分析"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "03cdef4f-b82a-490b-bab0-dca5fc97d6c8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "========================================\n",
      "【HT-29_FEATURE】 最终离群点分析报告\n",
      "========================================\n",
      "总样本数: 5279\n",
      "被至少 1 种方法标记的样本数: 745\n",
      "被至少 3 种方法标记的强离群点数: 177\n",
      "\n",
      ">>> 正在导出 TOP 离群点详细信息...\n",
      "               Drug_A     Drug_B  Synergy_Score  Votes  \\\n",
      "19       Methotrexate  Bleomycin          -35.0      4   \n",
      "86           Busulfan  Bleomycin          -16.0      4   \n",
      "186  6-Mercaptopurine  Bleomycin           16.0      4   \n",
      "255  Nitrogen mustard  Bleomycin          -50.0      4   \n",
      "334       Allopurinol  Bleomycin          -37.0      4   \n",
      "\n",
      "                              Methods  \n",
      "19   TOD,CBOD,Dynamic,Dynamic_Updated  \n",
      "86   TOD,CBOD,Dynamic,Dynamic_Updated  \n",
      "186  TOD,CBOD,Dynamic,Dynamic_Updated  \n",
      "255  TOD,CBOD,Dynamic,Dynamic_Updated  \n",
      "334  TOD,CBOD,Dynamic,Dynamic_Updated  \n",
      "\n",
      "[完成] 详细名单已保存至: output\\HT-29_FEATURE_Top_Outliers.csv\n",
      "请使用 Excel 打开该文件，分析这些药物组合的化学结构特点。\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# 1. 计算\"得票数\"\n",
    "outlier_flags['Votes'] = outlier_flags[['Stat', 'Dist', 'Density', 'TOD','CBOD','Dynamic','Dynamic_Updated']].sum(axis=1)\n",
    "\n",
    "# 2. 筛选出高置信度离群点 (至少 3 种方法认为是异常)\n",
    "high_conf_indices = outlier_flags[outlier_flags['Votes'] >= 3].index\n",
    "\n",
    "print(f\"{'='*40}\")\n",
    "print(f\"【{current_dataset_name}】 最终离群点分析报告\")\n",
    "print(f\"{'='*40}\")\n",
    "print(f\"总样本数: {X_reduced.shape[0]}\")\n",
    "print(f\"被至少 1 种方法标记的样本数: {(outlier_flags['Votes'] > 0).sum()}\")\n",
    "print(f\"被至少 3 种方法标记的强离群点数: {len(high_conf_indices)}\")\n",
    "\n",
    "if len(high_conf_indices) > 0:\n",
    "    print(f\"\\n>>> 正在导出 TOP 离群点详细信息...\")\n",
    "    \n",
    "    # 提取这些离群点的 药物名、结构、SynergyScore\n",
    "    # 注意：这里用 loc 根据索引去 df_smiles_current 里查信息\n",
    "    top_outliers_info = df_smiles_current.loc[high_conf_indices, ['Drug_A', 'Drug_B']].copy()\n",
    "    \n",
    "    # 把特征表里的 Synergy 和 Class_Label 也拼过来\n",
    "    # 假设 Synergy 是第 416 列 (iloc 416), Label 是 417\n",
    "    # 也可以直接用列名如果列名还在的话\n",
    "    top_outliers_info['Synergy_Score'] = df_current.loc[high_conf_indices].iloc[:, 416]\n",
    "    top_outliers_info['Votes'] = outlier_flags.loc[high_conf_indices, 'Votes']\n",
    "    top_outliers_info['Methods'] = outlier_flags.loc[high_conf_indices, ['Stat', 'Dist', 'Density', 'TOD','CBOD','Dynamic','Dynamic_Updated']].apply(\n",
    "        lambda x: ','.join(x.index[x]), axis=1\n",
    "    )\n",
    "\n",
    "    # 显示前几行\n",
    "    print(top_outliers_info.head())\n",
    "    \n",
    "    # 保存到 CSV\n",
    "    csv_filename = f\"{current_dataset_name}_Top_Outliers.csv\"\n",
    "    csv_path = os.path.join(OUTPUT_DIR, csv_filename)\n",
    "    top_outliers_info.to_csv(csv_path)\n",
    "    print(f\"\\n[完成] 详细名单已保存至: {csv_path}\")\n",
    "    print(\"请使用 Excel 打开该文件，分析这些药物组合的化学结构特点。\")\n",
    "\n",
    "else:\n",
    "    print(\"\\n没有发现 Votes >= 3 的强离群点。说明不同算法对异常的定义在该数据集中差异较大。\")\n",
    "    \n",
    "# 3. 最终可视化 (按得票数染色)\n",
    "plt.figure(figsize=(10, 6))\n",
    "mask_normal = outlier_flags['Votes'] == 0\n",
    "plt.scatter(X_pca[mask_normal, 0], X_pca[mask_normal, 1], c='lightgray', s=10, alpha=0.5, label='Normal')\n",
    "\n",
    "mask_abnormal = outlier_flags['Votes'] > 0\n",
    "sc = plt.scatter(X_pca[mask_abnormal, 0], X_pca[mask_abnormal, 1], \n",
    "                 c=outlier_flags.loc[mask_abnormal, 'Votes'], \n",
    "                 cmap='Reds', s=30, edgecolor='k', label='Outliers')\n",
    "\n",
    "plt.colorbar(sc, label='Votes (Detected Methods)')\n",
    "plt.title(f'{current_dataset_name} - 综合离群点分布')\n",
    "plt.xlabel('PCA 1')\n",
    "plt.ylabel('PCA 2')\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_7_Final_Summary.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ef414a28-d2c4-4085-a9ef-4743c62fff03",
   "metadata": {},
   "source": [
    "# 基于SMILE结构的离群点检测"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b7be8c4a-8c59-432a-b8be-b69bc30a18e1",
   "metadata": {},
   "source": [
    "## 计算摩根指纹"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "id": "3a77838f-7e10-4391-b6fa-0229dc0318eb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "指纹矩阵构建完成，维度: (5279, 2048)\n",
      "正在进行 PCA 降维 (SMILES Space)...\n",
      "降维完成，维度: (5279, 126)\n"
     ]
    }
   ],
   "source": [
    "def get_fingerprint(smiles, n_bits=1024):\n",
    "    try:\n",
    "        mol = Chem.MolFromSmiles(smiles)\n",
    "        if mol is None: return np.zeros(n_bits)\n",
    "        # 半径为2，类似 ECFP4\n",
    "        return np.array(AllChem.GetMorganFingerprintAsBitVect(mol, 2, nBits=n_bits))\n",
    "    except:\n",
    "        return np.zeros(n_bits)\n",
    "\n",
    "fp_list = []\n",
    "# 假设 df_smiles 已经加载 (如果没加载请确保先读取 dataset_smiles.csv)\n",
    "for idx, row in df_smiles_current.iterrows():\n",
    "    fp_a = get_fingerprint(row['SMILES_A'])\n",
    "    fp_b = get_fingerprint(row['SMILES_B'])\n",
    "    # 拼接两个药物的指纹\n",
    "    fp_list.append(np.concatenate([fp_a, fp_b]))\n",
    "\n",
    "X_fingerprints = np.array(fp_list)\n",
    "print(f\"指纹矩阵构建完成，维度: {X_fingerprints.shape}\")\n",
    "\n",
    "# =========================================================\n",
    "# 2. PCA 降维 (SMILES Space)\n",
    "# =========================================================\n",
    "print(\"正在进行 PCA 降维 (SMILES Space)...\")\n",
    "\n",
    "# 降维到95%方差\n",
    "pca_calc = PCA(n_components=0.95)\n",
    "X_smiles_reduced = pca_calc.fit_transform(X_fingerprints)\n",
    "print(f\"降维完成，维度: {X_smiles_reduced.shape}\")\n",
    "\n",
    "# 降维到 2 维用于画图\n",
    "pca_vis = PCA(n_components=2)\n",
    "X_smiles_pca = pca_vis.fit_transform(X_fingerprints)\n",
    "\n",
    "# 初始化结果表\n",
    "outlier_flags_smile = pd.DataFrame(index=df_smiles_current.index)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5b873beb-de61-4086-90ad-0d4e615c5ecd",
   "metadata": {},
   "source": [
    "## 1.基于统计的离群点分析"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "id": "b8d0e907-16b7-4921-85f1-304be9f84fbf",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "正在运行统计法检测 (SMILES)...\n",
      "图片已保存: output\\HT-29_FEATURE_1_Statistical.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "print(f\"正在运行统计法检测 (SMILES)...\")\n",
    "contamination = 0.02\n",
    "\n",
    "ee = EllipticEnvelope(contamination=contamination, support_fraction=0.9, random_state=42)\n",
    "y_pred_stat = ee.fit_predict(X_smiles_reduced) \n",
    "\n",
    "outlier_flags_smile['Stat'] = (y_pred_stat == -1)\n",
    "\n",
    "# 绘图\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.scatter(X_smiles_pca[~outlier_flags_smile['Stat'], 0], X_smiles_pca[~outlier_flags_smile['Stat'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常骨架')\n",
    "plt.scatter(X_smiles_pca[outlier_flags_smile['Stat'], 0], X_smiles_pca[outlier_flags_smile['Stat'], 1], \n",
    "            c='red', s=40, edgecolor='k', label='统计异常骨架')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 统计法 (Elliptic Envelope)\\n检出数量: {outlier_flags_smile[\"Stat\"].sum()}')\n",
    "plt.xlabel('SMILES PCA 1')\n",
    "plt.ylabel('SMILES PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_1_Statistical.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "24d52b6c-a287-4744-bc59-74dfe1dbe5f3",
   "metadata": {},
   "source": [
    "## 2.基于距离的离群点分析"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "id": "9f5ffef7-7091-4964-8ce1-409e8a3632bb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "正在运行距离法检测 (SMILES)...\n",
      "图片已保存: output\\HT-29_FEATURE_2_Distance.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "print(f\"正在运行距离法检测 (SMILES)...\")\n",
    "k = 5\n",
    "knn = NearestNeighbors(n_neighbors=k) # 这里对PCA后的数据用欧氏距离近似\n",
    "knn.fit(X_smiles_reduced)\n",
    "\n",
    "distances, _ = knn.kneighbors(X_smiles_reduced)\n",
    "kth_dist = distances[:, -1]\n",
    "threshold_dist = np.percentile(kth_dist, 100 * (1 - contamination))\n",
    "\n",
    "outlier_flags_smile['Dist'] = kth_dist > threshold_dist\n",
    "\n",
    "# 绘图\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.scatter(X_smiles_pca[~outlier_flags_smile['Dist'], 0], X_smiles_pca[~outlier_flags_smile['Dist'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常骨架')\n",
    "plt.scatter(X_smiles_pca[outlier_flags_smile['Dist'], 0], X_smiles_pca[outlier_flags_smile['Dist'], 1], \n",
    "            c='blue', s=40, edgecolor='k', label='距离异常骨架')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 距离法 (KNN)\\n阈值: {threshold_dist:.2f}, 检出数量: {outlier_flags_smile[\"Dist\"].sum()}')\n",
    "plt.xlabel('SMILES PCA 1')\n",
    "plt.ylabel('SMILES PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_2_Distance.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5c764e4f-0d16-4187-ab6a-792487108080",
   "metadata": {},
   "source": [
    "## 3.基于密度的离群点分析"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "id": "1fdcd567-042a-4a00-9f41-c6bcac2ebc6e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "正在运行密度法检测 (SMILES)...\n",
      "图片已保存: output\\HT-29_FEATURE_3_Density.png\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA0sAAAI3CAYAAABK08B4AAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjcsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvTLEjVAAAAAlwSFlzAAAPYQAAD2EBqD+naQABAABJREFUeJzsnQeYJFXZts/swgKbyVkWRJRPkogBVBRUBCSLoASzop8oqIDwYUAUUAEFBAWUIEpGcgZRDIAgIKACuyh5xV2BTaRN81/3WZ/5z9RWdVf3dM9U9zz3Xn3Ndq6qrnCe877v8/b09vb2BmOMMcYYY4wx/RjR/64xxhhjjDHGGIslY4wxxhhjjCnAkSVjjDHGGGOMycFiyRhjjDHGGGNysFgyxhhjjDHGmBwslowxxhhjjDEmB4slY4wxxhhjjMnBYskYY4wxxhhjcrBYMsYYY7qUl156KbzwwgtDvRjGGNOxWCwZY4wxLWLatGnh4IMPDr///e+b/oy5c+eGT3/60+G6664r9fopU6YUPnfUUUeFT3ziE6HV/POf/wzz5s0Lg7VNZ8yYMSjfZYwxWZZY7BFjjDHG1OVf//pXWLBgQb/H5s+fH37729+G2bNnh7XXXnux94wcOTKsuuqqffcXLlwYbykjRowIL7/8crjgggvCe9/73r7HEScIqQkTJvQ99vTTT4ddd901bLXVVuGYY44JY8eO7fdZo0aNirdWr/fHPvax8IMf/CBsttlmod1ceuml4Y9//GM488wzw5JLLtn27zPGmJSe3t7e3n6PGGOM6eNPf/pT+MhHPhIuueSSsOGGG/Y9/trXvjYcdthhcdC49dZbx0FrltVXXz3ccsstpbYmqVJEAW666aaYOsV3cX+dddaJz3OqPvvss+MAeurUqfH5r371q2HjjTcu9flPPfVUePe73537HIPt7373u2HfffcNd95552LPH3DAAeF///d/++4/99xzYYsttgj7779/vGW3VR687gtf+ELcVizH4Ycf3vfc9773vXDDDTfEbfWjH/0onHzyyfHxnp6esMoqq8TXswzjx4/v2/Z5nHvuuYMyeBebb7553BaNwPrceuutffe/8Y1vhAsvvLD0+1dYYYUoHFLuuOOOcOCBB4blllsuXHTRRVGQLbXUUlF0fec73wmPPPJI3HcAsYU4W3rppUMz8N4999wzbLfddjFipf3qlFNOCe95z3sK33fzzTeHH/7wh+GJJ56I+zTHzlvf+tb43KGHHhouu+yy3Pf9+te/Dquttlr4/Oc/H8XnIYcc0tRyG2NMsziyZIwxA+QnP/lJHIT+7W9/C9/85jfDcccdFyZNmtTQjD6D5j/84Q/hk5/8ZFh22WXjZ37uc5+LqVgMehlonnfeeVEg8dkIA4QJg+Mi8ZAH73/Tm97U7zG+T7z5zW9ebEC68sorLzY4R7zddttt/cTS61//+igqgcHzo48+GrcFrLTSSqWXkYH8L3/5yxhJYZueeOKJccD/85//vO81H//4x8P73//+fu+TsBwsECRZIXnllVfG3/Hoo48OSyzR/xLLb3j11Vf3e4zXEBU6/vjj4/0bb7wx3H///eGggw7qew2i+dWvfnXYfffdY+QqC6IDEf2Xv/wlbnNelyXdR971rneF0047ral1vvjii+N+3Uhq3z333BO++MUvRoGFMGI//uxnPxu31ate9ar4GvZp7Ssp7Dfs/2yDHXbYIXzgAx+I28IYYwYLiyVjjBkgGoi++OKL8e+6664b1l9//YbqPxBFRBgUvWI2/VOf+lR4+OGHw5prrhkjA4iYD37wg/H5TTfdNKZoISq+/e1vl/4uBqdphCzLuHHjaj4PRDZIh7rvvvvCnDlz+lK/+Kv3Tpw4MYqeep+VB4NjvY/15P6RRx4ZI2psF0VomvnsVrL99ttHgZjC8l1//fVRBCGYiKDttNNO4S1veUsUqdmIDuvGa7nx///85z/hgQceCGPGjOl7DdGbFVdcMf42r7zySr/3//nPfw5veMMbotjghmjX70NkDhHG/oV4BQQojzfLGWecEb7//e839J6zzjorClnEEN/NtkCwse/+3//9X3xNvX2FqBlR3HPOOSd861vfanr5jTGmUWzwYIwxQwwDf+oy0sEiYgOoiZk8eXIcJJP6Jki1WmuttXLT/9oNEaV99tknpmSRetdutF2eeeaZUCUQr6TUEeXj78477xxFAdFFxMBJJ50UI208j4ih1me//fZb7HMQSUSnNthggygoEEsIcN3YxqeeemoU4ET+xL///e9oBLHHHnuExx57LD5G1IdUPeqaSFvkPvsK/+e2/PLLR+HRDA899FDcHzfZZJOG3kdq59vf/vY+kcYykS6J0GsEIomk82VrvIwxpp1YLBljTJthgEn6VN6Ngd/o0aPD6173un7v+d3vfhcfX2+99eJgF1JHMD6TiEE2Ra7dkOZFhIf6FAbvCKd2M3369Pi32UF+o79HWYgCkf7G+xCziAmEABEnTB5+9rOfxfRKRBNphETHSK9M4fv4fYn8/PWvf43pd9ShEVHUjdooanb+/ve/96sp47cnLY4at9122y384x//iP/Pmk5kvw/zCMRbo7AsRLEagcgj+60iggKTCyJmjUANINtK+4MxxgwGTsMzxpgS5NWBlIV0uaIIkIwPUmbOnBnTjfbee+84+Ca6QFQA9zEG1aS7nXDCCTHSUmTa0CwU1GdroKjBIQ0MEEfLLLNM2GijjWKU4ze/+U1oJwgAxMZrXvOaGEkTOL9xExT/k/7Wjt+jCCJG1C1hkCERw/Yh9Y3IDqYF1Ndcfvnl4Y1vfGOMRGFmQVoeqZVKiyNlTul51IIhdmbNmtX3PdzncYQC2z6FlE/SN4m41Ir6ZH/Tr3/96zE62AiIFO0HZVGPp+xyc7+Z/k98P1bigz1JYIwZvlgsGWNMCUiPYmAqdtlll9Lb7fTTTy/sSUPKVBYiEAygSbECBtK4mn3lK18Jb3vb2+Jz1EetscYaMd2rEYhQpGCesO222/bdRwCpjiTPAIJ6GAbkiDhqT6hHSWuJWgHrlg7uEUosZ1prg8EAokM0YqbR6O9RBOYOpMAx8CdyBF/+8pejqyBGBEB6HjVl/G4IXMwYJJSAKE9qBU6EighT1oQDcVoEtUwINtaJiCT7BzVQOCsS2cIYgwglIKiIKqU1UWUhXbBVBrp8Tvp7EpXL/uZZM4w0EmeMMYOFxZIxxpSA4vlGTBtSUpFVDwaI11xzTXQrSwfR73vf+2KdB2IFt7Rf/OIXsc4l67hWDyybETkCwZUdeBetJ+lm1M+QWpUObFkmGU+0AsQh6W1EEKjxQXxkHdCILAzG71HEvffeG536cKBDoCAkMM/ASpzUOG7AwB6hggDlNYiAFPoxsW6kz/F/oj0f/ehHc78TYVVk+U390k9/+tPoNqd94oorroi/davs1InqIOQaQaJM5ieC9U0FG8cXYlIQsWtVdMsYYwaCxZIxxlQEohOkR2GL/c53vnOx5ynOJ5py1VVXRSOBRqJbqThqVmQg0hBKWGCr4SoioBGxRNQjr5Fr2mwUUcEycttmm22iCCBS06gwbCdEcegNhRhBzGFCwXIDaXHUdiFcBOYOPJZtVKvBP4KLeiVFblJRxHchlHBEpH4pD6KRzz77bN8y3H333VHQkQII/EbXXntttOBuFpz/jj322MWiQrUgZZRas2zaI9sjjbCxvvX2S2r0EJ+NRP+MMWag2ODBGGMqAIPmz3zmM+F//ud/YrpdERT5M7DmNYOdjkQ9DqYTRLkkZkgru/3220sbIyDWGPRm65KyEa40bRAjgLyUrKGEdEWie4ifD3/4w/0ME3Cmy7oEkvqX7V/FNnv88cdjLyG2KS54uN4RUUTY4BbHNkcY77XXXoVCiVotpfshlhCj2JbTp0sROVIpiViyzM3CcrBs9NlqBAQldW/aR0g1vOuuuxZLNawHfZnYTgOxPjfGmEaxWDLGmArAQJoULuqUHnzwwThw5vb888/3ex0mDwwycaNrB6SC6bt1Uz0O0Qnc0FKRxrLgdoaIKwO1NYgrTBswReAvn4ubWx6k+7GupCWmggxzi+xyEq0YbIiIIE7SSBD1U9kBPc9nU+io0yFSh2W4wGIb0w5SLIkU0USY95E+mQepikcccUSMbinFj/o6lgnxLRDhRAExmCB9sFkQYN/97ncXiw6yLgi79EYkTfVliMKDDz44iiZqvRBMGJiUhcgUETt6LRljzGBSnZwGY4wZpiA2ZMGd7cOD45uEBOKCwabqYdoB35F1/sPWHOc30vAYLKfg8kY0A8GTDvqL2GGHHeL68nk0OMUYgtRDeugUQXSJlEMiKNhyA8YS3FI+8pGPxCawg4nS3poBBzvqmVIDDcCUAfGDSOQ5enDlGVgQzTrwwAPjMsi44+STTw5nnnlm/FyEBeKXG85z3HgtJhR8ZjMmD2x/3ktj2lTA/ehHP1rstfo9MKfgeVwCP/vZz8ZoF+K3KJqYhRREIqmIrlYaiRhjTBl6eltlbWOMMWZIkN10EUQ57CDWHkhtQ3w0kronAbDVVltFAcANAUk64j333BNuueWWGJUhakfKGw2K+T+RI8QCNU7c5zXYnCNKcOUDxDR1SphY0OwYIwxqfKh3I4WOaBV1b0Qo0ybHjYCtOamHiLrULKRdILRIbSRi5hQ8Y8xgY7FkjDEdDvUxDJiLwOGO+hfTeojuIHzqgfU5kTlFBXGDw9KbqCEphPR3ov4JowhE1NZbbx2jSbyOqB2iCSe6KVOmxPQ6RSBxmSNNr5EIF5Em9omBgLhDxA0GbAPEfiP28MYY0yoslowxpsMhveqJJ54ofJ6BdLYpqakWCIJs49YiqN0aSPqfMcaY8lgsGWOMMcYYY0wOnpoyxhhjjDHGmBwslowxxtTlvPPOy+2vQx0OPYGwgm4UnNFuuummUq/V5//73/+OLnrUCpG6Jo8i7NZrpSIaY4wxzWDrcGOMMXU5//zzo4saTWhTMCm47rrrognBUkstVfh+DCZe9apXxQas4uGHHw4zZ87s97onn3wyGhbg+CYwMdh5551j01XqerCt3meffWIDV8QTfX/OPvvs6CZ3ySWX1FwP+g1hWV2rPoimuUceeWTsCWWMMWZ448iSMcaYuiy55JKLCQxsqLG5Xn/99cMpp5xS8/30AVIvKbHEEkssZlRw6KGH9tlri9GjR8f3Y1Ut6+h58+aFiy66KHzoQx+K93GKe9/73ld3PRB0W265ZRRCRTec4moJv4FCA9dNNtkk9zmid/SU2nTTTcMXv/jFxcRkKjRf//rXx95Txhhj2ofFkjHGmEKwqiZiQ9rbf/7zn3gfkQQ//vGPY4PRn/70p+Gqq64Kv/71rws/B9tnIkZlRBm3lL/85S+xtw+RLcQZXHHFFeFtb3tbfI7le+SRR8Ib3vCG+DpuWFvzNw/EEM1ei27tdJojEkZvJFIIs7BtsQSfNGlSOOmkk2Lq4UEHHbTY60g9/OY3vxk222yzsO2227ZtWY0xxjgNzxhjTJ26IqIbc+bMiSlypLvRhJUGqdQxnXXWWWG55ZaLg3ce/9a3vhUjI1kG0kz08ccfD7feemtsvHv77bf39ZbCQptolfoc7b333v3et/vuu4ejjjqq32N8BjVWtYQb64o4bDXUVH30ox+NDWLzIK2QVEUaxiLYNt544xgFoy5so4026nvdhRdeGHsz0XzWGGNMe3HNkjHGmEKIFj333HNhiy22CAcffHCsFUI0ffjDHw7vfOc7Y/3PU089FQfzpMR99atfjVGmAw44oN8AfyBQr7TNNtvEiMx6660XJk+eHN74xjfGCAzLgAAh6nTsscfG13/yk58Mb3rTm8InPvGJeH/+/PlR/JBGiPAoC+8hitOqlDyiYGwjUvDymggjBPfdd9++yBYRsLe85S3xcW1LonvHH398FIYIVmOMMe3FYskYY0xNfve73/W5zlFvQ6oY6Wqkjb373e/uex0D+OOOOy6aI1x22WX9xBI1RgioLIcddli8pWRFFgLn8MMPD6uuumqMXCHUSP/j84444ohw5513RtEkpk2bFqM3pP7BvffeGz7+8Y/H9L4xY8bUbf7KuhJdwliCdaVeShDRQugQ1aFWqxF22GGHKIT4jCwIOtIbs82D11xzzfDYY4/13f/e977Xl2aIeEUUEkFzk1pjjGkPFkvGGGNqcumll/YN6ElfQyB97nOfi5EPBAkpdtyIxCBIqCUiRS4FM4bsYx/72MfCXnvtFaNGKXxuyu9///uw9dZbR8ODK6+8Mkaa3vzmN8d0NaJYpAFiHS6mT58eI14CQYEBBAKonlueIAWOGqgsmCrwGWuvvXZolFqCRqmE48ePX8zcgkiehCrrO3LkyPD000/Huie2B9vnRz/6UcPLY4wxpj42eDDGGFMIA3Rsv7Hy/tnPfhbT7L7+9a/HOiKEE5GdY445Jr4WofSe97wn3HDDDWGFFVbo+4yLL744ppKttdZa/W644REBSh8jYoUd+fPPP9/3fhzqqIPiO/lu7L9JDSQKg7jAUpyoDKKCx3lvXooa4oJlZTkRU9yoI0LI6T43bNJVG5Vl7NixYcMNNyxlVtEIioJlBRUiVEKK7UjUC/OHc889N4pYtseNN94YrduNMca0HkeWjDHGFIIlOFGdqVOnRmvuk08+Ofzwhz8Mp512WkxFW3311aPVNyIKYUX9ErVEKffcc080Vthjjz3qbmmiVxgdkGon6KOECx5CgduJJ54Yb4gf3OJYPiJNNLjFIAHRlYo1IZc9RB9CDYg2vfDCCzG9TTzzzDN9zw8WiCUianx3Cul2ShskHY9tiyAVbNOjjz46/P3vf48RPWOMMa3FkSVjjDG54EBH1OJTn/pUvE90iWjGl770pbDuuuuGCy64IOy2227RdIA6nN/+9rcxPW3zzTfvf6EZMaJ0TY1EiiItQCSFNDoiSdQuUYNE+hmvVW8lDB6ICPE4ZhR5YMUN22+/fTRa4IbIQljpPjfuI9oGm9e97nVRWKb87W9/62vki2hK0wvTXlVZu3VjjDGtwWLJGGNMLjjO4UCXNlAlvY3UsD333DNacJMGR1ocNUMIqzLRo2a4+eabo3AgcvWHP/whRrcQShggSAARaSIFMI1KpbCs1DmxvKusskq8TZgwIQoz3edGtCo1rhgsWB9qkhRdwj0PcwuJP9L/6CmFWYZAXHGfGitjjDGtx2l4xhhjCutz9t9//9znSAUjsvSvf/0r/iVFjNQ4Ik1Z5KQ3EN71rnfFyBF9lQ499NBo4oCY4z5ignQ6nO5IW+P/eZBCiBhJrcCVhnfCCSf0PYb4ILqUZwbB6x999NEoGltdt/TBD34w1k8hOFkn0goxlJBw4/kzzzwz9rPCGINtgGikOW2eGYUxxpiB09PbiquYMcaYrgYRRI8lIjhYapP+xeVDzWaxDKd5LWYLuOIhJBBbQKQGkdIIGCzgcpcVKtRK0ZQVe/KHH344mh+8973vjd9B5AX3uOuvvz66w7397W/v936Wj+WlNkjLjWkCqYUIMUF9FSl7fFaWgViHZz+D5c+CLTjCjYgRFuoIo4kTJ/Y9T2SJ6BimGywnooqGwEWNbo0xxgwMiyVjjDF1wY2OaAYCJu07VAQRKVL4AIc6BFYZEERYg+PuJpMGhAOihjQ/TAzoy0TPJT73+9//frj66qtjHyVqqRAQ9B9CMCGgVG9FjyMc8yTgBMIOYZS1K6dmafbs2bEBbNrDyRhjzPDCaXjGGGPqgqBAWJAOh9kCkSVFZ7IgNNKeSgisbJSoCCIrQP2RwNQAkUO6X2oJjs04zncIKUV5MDsgMkMKncwfAEFljDHGNIojS8YYY4wxxhiTg93wjDHGGGOMMSYHiyVjjDHGGGOMycFiyRhjjDHGGGOGq8ED3d6xuHWHc2OMMcYYY4Y38+bNiyZFZXrUDYvIEkJpqNpJ8b04SLmdlfH+Y3z+MZ2Er1/G+4/p1vNPI9pgWESWFFGiYeFgQ2+RBx98MKy77rq5DQ6N8f5jfP4xVcTXL+P9x3Tr+eeBBx4o/dphEVkyxhhjjDHGmEaxWDLGGGOMMcaYHCyWjDHGGGOMMSYHiyVjjDHGGGOMycFiyRhjjDHGGGOGqxueMcYYY4zpLBYsWBD74ZjhxyuvvNL3d8SIEQ27YI8cObJly2KxZIwxxhhjKgP9b5555pkwY8aMoV4UM0QsXLgwLLHEEmHq1KkNiyWYOHFiWGWVVWLj2YFisWSMMcYYYyqDhNJKK60Ue+y0YsBrOi+q+Morr4SlllqqoSgRQpseTdOmTYv3V1111QEvi8WSMcYYY4ypzCBZQmn55Zcf6sUxQ7gfwNJLL91wSt0yyywT/yKY2I8GmpJngwdjjDHGGFMJVKNERMmYZtH+04qaN4slY4wxxhhTKZx6Z6qy/1gsGWOMMcYYY0wOFkvGGGOMMcaYfvz9738Pl1122bDfKjZ4MMYYY4wxpg3gzkbdDL1/aqWG8bq5c+fG14waNarv8YsvvjiaFLzzne+M9z/xiU+EN7/5zeGzn/1svH/EEUeEvfbaK6y33nq5n/uud70r13qb71t33XXDT3/608Jluueee8LNN98cdt11177HXnrppfDkk0/2e91qq60Wxo4dG7oViyVjjDHGGGPawNNPPx3e/e53l379/vvvH77whS/03V9zzTXD//7v/4Zf/epXYe21145CCjttuP7668Pvfve7cMABBxR+3n/+858ouNZff/1+j1966aXhoosuyn3Pd77znfh9ONItWLAgbLbZZvHx3XffPWyzzTZRsOnzHnzwwXDSSSeFLbfcMnQrFkvGGGOMMca0Afr83HbbbbHBahpZOuigg2I06DOf+UzfYwgTIlBw7bXXRiEkwXTaaafF/z/00ENRAD388MPhD3/4Q/z8733ve/G5vffeO2y44Yb9vp/PI/KEfTbRpAkTJoRbbrml77k8DjnkkHDooYeGgw8+OEafPv/5z4dvfetbMUKFUFtjjTXC+eefH1+7ww479IuEdSMWS8YYY4zpKGhWOXv27Ji2xEBt3LhxfbPtxlQJREpevyjEE/vs+PHjc983efLk8Nxzz8WoUsqHPvSh3P8TXdp2221zP+u8886LkaAHHnigZhRKcEwhrEjD23HHHfuEHD2PhqNLocWSMcYYYzpGGDHAfP7552MdCDPd1FC8+OKLYeWVV7ZgMpUV1s8++2zs/aOGqfVg/15uueXCU089FU499dSar/3JT34S123+/Pnx/umnnx5T74Dj43Of+1yMIrENiEq9973vDS+88EKYM2dO/D8cdthhYeutt+77zBtvvDHMmjUr1kcBjYKpTeIz8pa1m7FYMsYYY0xlB7r//ve/+wmjhQsXxtltzXIzA64BsaNLpt7+M1TCeuedd471SGk0KAtChIgTy6oI0OWXXx5WWGGF8N3vfjf3PUSTOAZuuummvsdYx0033TQcddRRpZaNOqRU8JD+93//939RZM2dOzcKqd/85jdhp512ioLsH//4R18dE6LLYskYY4wxZghAADEQY2ArYcRjpDYpHYi/DC7zZrzN8CZv/xkqYU1kJ1vbc/LJJ8dbyiWXXBLrjvRalptlXWWVVXI/l+ezqXEbb7xxrIdCeG2wwQZh4sSJiznisS2Idt16661hjz32iHVIQNQWocRjqqdaffXVw9FHHx3+8pe/xPolTB2GE44sGWOMMaaSIIAY5GWFEfUTDPY0ACba1O1F5qZ1+89QCOu8Wp/U+Y79+OWXX15sP+bxu+++uy+SQ3SMyQK9jv9zPKRstdVWff9nfS+44II+MSSoh9p8883j58iGHBBWOOGtuOKK/ZbzxRdfjKYU2RoqWZ4jBvMsyrsBiyVjjDHGVBIGcgwOU2HEgIwbEQL+IpQYqFGLYky9/aeqwprly6tnIsLDTSBWqCP62Mc+VvpzccMjypTCdoDs49OmTYupfRxPeu7ll1+OUSh4wxveEPs+yUkPoYaQOvvss8PrX//60I1YLBljjDGmkjBgYyCWCiNSkpZddtn42FAX7ZvO2386SVgfeeSRsRcS9XkC8YdleJq+xzoefvjh0To8C+uNG15RZCkL9Vz33ntv3/1nnnkmRpbe8573hAsvvDD2WCIN7wc/+EE0oBgOWCwZY4wxppIggBi85bmZdcqA11Rz/+kEWN4Pf/jDUQjViiztu+++hdEyBCLGDHk1S7WYOXNmOPfcc6PQwmyCz0AsHXjggTGtb5dddgkf+MAHomEF27ibsVgyxhhjTGVhYFtrcJtnDa1CdZy6YMyYMTEa1SmDZDN4+087YZ/E+lu23uyT3FdqG9bcuq+UNl639tprR3FTT9Dw+RhYECUqajCLWLrmmmv6RZY4XqZOnRoFUDYN79FHHw3HH398uOuuu8L73//+cNlll8X6JY4z8dGPfjTWRZ1yyinRepzGtWeccUY8xroRiyVjjDHGdCSyhuYvg0JuDBxVxK+6DFlG4+plwWQGC1LYiMAgZKgdoh8SN3H//fdHMSLYX9mX77zzzijwqWHKihnEkYTLt7/97Zimh+PdFltskbsM6r2UcsIJJ4Qrr7wy7LnnnosdD5MmTQrvete7Ygpgmmb3yn+/k7+851WvelX43ve+F6Nejz32WNcKJejprSdbuwA6FgNWjIMNJ2dyO+mcTDMyY7z/GJ9/TCfQCdcvGmwyWy+hpAL+IsaPHx8Heaa6+w8RF6IbRFfSWh2zODSVZX9nv24EIli46FWZBQsWxH2BfaCZZa23HzWiDRxZMsYYY0xHouiRbvUg7YkUJNc7mW5g7NixTb2v6kKpanSnIboxxhhjuh5qQRRRKuplk4U0PWOMKYvFkjHGGGM6EvWCkWAqU1kwFA1JjTGdi8WSMcYYYzoSCs1XWWWVviJ4IkukGOWlGSnqVMWGpMaY6uKaJWOMMcYsZsFdZEVcxegSLnc4j+H8hRMeN5afdVK0ib+IquHSSNMY0xoslowxxphhjiy4sSVGaGC1nW1iWXXBhMDL9lvi/9Qo6TGEks0djDGNYLFkjDHGDHMQGQgl0tpIVyMK02mCKa/5KPctjkyVwJHx5ptvDjvuuGPD0dt777033j7xiU+Ebua8884Lb3rTm8Jqq60WqoDFkjHGGDPMIfKCMFJdD39161Zx6IiTGQrY7/7v//4v2n5vs802Db33hRdeCMcff3wUWiuuuGJ8jNRTJjpoYJuyxx57xGaxRfbiiLbNNtssnHrqqYs99+yzz4bTTz89fPnLX44TDvfcc0/4yEc+Ev7617/G52+77bb42P7775/72WeffXa85U220D/pmGOOKWyiCyeeeGL40Y9+1E8sPfXUU7F3l6B30mD1TLNYMsYYY4Y5pKgRSSKipMhSWXe5ThRKTz/9dBy0sa4IRdaduidHoUwrOe6448KZZ5652OMcVwcccEDuZMSvf/3rsOqqq4bDDjssXH311YtFSxFF2223Xd99xBL77jXXXLPYMf2///u/4WMf+1jusiFGnnjiidznaHL7yCOPhG9961vh6KOPjp8lYxSOm+9973thl112qZnW+z//8z/hxz/+8WLPbb311rnnFZpLv+Md74giiGN0v/3265vAufHGG8M3vvGN8K9//StMnDgxzJgxIx6rF110URgMLJaMMcaYYQ4DD2ZtGeQwQMGKW5bc3Tizz4CP9ZMwZMDJ4xZLppWQZvfGN74x/OIXv+h77KyzzopmJIceemjc/9gXcW+cPHlyv9Q89s8Pf/jDMQoFCKcNNtggTJo0Kd6/4447oqh473vfm/vdzUSFmThAlADLpOWcMWNGfI7//+c//wn//Oc/w8MPPxzvr7zyyuFLX/pSv89h2W+99dYYuQKOr8MPPzx88IMf7Hs+CyLorrvuClOnTg0777xz+NOf/hSmTZsW3v3ud0eBiFhDYG677bbh+uuvD7/85S/DYGGxZIwxxgxzmL1m0JN1w+vGBq6sX5piqP+7/1J3QvTk0ksvjYP8FVZYIey2226Dlr71zne+M6y55poxcolg+Mc//hE233zz8NGPfjSss846Ye211w7f/OY3wymnnBIt8L///e+H0aNH5wqe0047LXzhC1/oJ5Yef/zxQrEERHYQZ0wIqBcZf/X/t7/97f1ej0C67LLLwsknn9yX5ic++9nP9v1f6Xd/+MMfwm9+85vFxJLWXZElokR5dv4prCui6O677w7rrbdefD3bDIg2DWVKsMWSMcYYYxYzSEjrA7K24kRgsulBnQLLz3pkUw7df6m7oI6HaAZmAT2jesLCcQvDiNkjYmrcXnvtFY466qi22+NvsskmMVWM21e+8pWwzz77RDFwySWXhIceeih87nOfC7vuumsUStQHve1tb+sTS+yTRHklaIjuIKy++93v9tUcISZ4fsyYMeGGG25Y7PtZzy9+8YuFRi0c4ywD0StEHdsM1l9//XDIIYfE7yiClLnXve51fYLm5ZdfjpEx4H0cYxJy06dPDw888ED4yU9+El03DzrooCiA1lhjjSjmBJ91/vnnh6222qrvcxQBzk5maFkHA4slY4wxxhTCoIRZeQSTZqWpL2CA14lpa9iHa6ZfYolZbPdf6i6iULrgvDBj8xnhxde9GHqX6A0983rC6IdHx8eBSE47wSiBlDFS2yTMMGn46U9/GqMy1A1ttNFGUWiQbkaN0MYbbxwfIz0PAc/rACFCGtp73vOeeJ/3YuCA4UMeW265ZayXqpWuhojadNNNY80TIGAwbkCwPfnkk+E73/lOeO1rX7vY+y644IJY90e6HDdg/Yji3XTTTaVc7C6//PLw85//vO/+nDlzomjjXLPvvvuGK6+8MgqpddddNz7P8Ura39e+9rX4fyJzg4XFkjHGGGMKYXCXCiXN8lLPwGCu0yJMamJrN7zuhfQ0IkoIpRc2eKHv8d4le/vu8zzpZO1MyeP4QHAgcIgoAWmA1O5cddVVUZwgGHB/w8SAyBHRFkBApQ53CATEj4wcpkyZEl7zmtcUfvenP/3peLvzzjtjdAZRJKh/QmxgwpCFKBVwnDOBsMoqq+QeQ9m0OMQdluYTJkyIYhA3vbzJFM4nCL8PfOADfZEoOPfcc8P9998fBdKyyy4b0w0xgyB1EtOLVFgNNhZLxhhjjCmEQZqEUprOI8HEYKoTBVPaxBYxqPQ8i6jOh7obUu+IKOXB48vevWysZTrwwAPbsgwzZ84M9913X4zAIFoQS+x3RE5IR+MGCCJsuakZlAFCXMYXX+xXN0RUhYioeN/73hffk0XpaYpksS2InKZiifqnvffeO4olHd/ZNFTuf/zjH+8TQixPKn6ytue8/qtf/Wr8P9/H8illMOXII4+M55ENN9ww3gSufay/IrxE16hdIoLGNiTylsIyseyDce6xWDLGGGNM8UDhv654mklmkKJ6HwZQ1CAwaOskwYQ4YrkZWDJwYxBKfYQiaLYU72wQJNQokXqXB4/3juuNr2sX7FfU/eDyhs02KX8cJxw7RIWI4Cj9LQ8mIhBLWHdfccUV8bhDWOk4ZD8l+sTzqXD59re/HS688MLFPu/iiy/ud58oFjcgQkW0KYXGueLBBx+MqXF//vOfS607y0gNFVGtLNRe7bnnnos9znqQsqjIFtuJWieJP2qZ0lRZJjYQgCeddFJoNxZLxhhjjCmEwQupMyqwVo8UBoPMXjOYIULTSWKJ5WW5WWbVLSGWGICyTrYU72xI3cLMoWd+T65gonYpzF70unZBFAaRwz5GKl7fd/f0RHMJzB/kIketD053pKAhCBBG1AzRb4k6Hm5ElvhMarHg4IMPjvtwNsJDTQ81Ukxy8DyudESxqIUS1BnhyEdKIMc13yeIrOLYRzPbdILkxRdf7LMC12OsG658WTg31Ios5UG9Frc0LY/lJvpEDRVROqKAO+ywQxhsLJaMMcYYUwjigVQ7Zrplu81giBupNwyaOs12m+VVw0uQONL/9deW4p0JDnO43o1+aHS/miWByUOYu6h+qJ0QScIMhfokzBnSCYi01xD7Ge54egznOPbPV7/61f1E0Ic+9KFoM44ZAuYO55xzzmLfmabTkW63/PLL9xNKtV6f3scSnOa0RZEl+iAh2PJg0oFIVRqdEkTD+Kwi6LX0wx/+MAox+lPhHMj2wU0QsfSrX/0qpuzhAljPjrxVWCwZY4wxplSND4KJGWYEFPcZ0DF73Wm22ywvqXepfXhqI25L8c5mrbXWirbZcr3LuuFN/NPE+Pxg9FvSgL5Wn6Dsc9RSYSOe1giyz9KklsgMn0l0SrbdKQgpoj2ICgwTzj777Fwxk/feMixYsCC+nzqiIut1jiEiQGlkiRRXvvPrX/96rsj52c9+Fteb57A7x9wBYSVw2MOFj9ccc8wxMUUPAUq9V7uxWDLGGGNMXZjpJcKkWh8GTfxlwNRpFuIsL6KPARwDUgZ/OJNpQGdL8c4HMSHXO8wcqFEi9Y6IkvosDVYUk/2NuqUU6nnk8Mb+p9dyTGEXTkoa0R3+P3ny5HgjPY6GsViSk+J3xBFHxM8mekQdEOuFUOE1GCQQ0cqzxGc/L4oG8/3UUqVCbd68eX3CBZHyrne9K9ZPpdGy7GfkiThSAhGyRIayvPWtb439nRCJoNRAllVikmXafffd4w0hqAa97aanV3HnLoZwJqSuG4MFJ2PCl+wAaVdmY7z/GJ9/TJUpun51S4PavPWwG97Qj38YlD/66KNh7bXXjgJ2oFAPRDQCMwcME0jRG4yI0kBgPyQlb+rUqeGPf/xj3Ib0O8oeZ7wOEfXII49EsZFn890O/v3vf0eBlqYSlgEBVDZ1jteyL7APNJNuV28/akQbOLJkjDHGmNIwYMsO2jpRQOWtB/c7LUpmaoMwapc9eLtQWis9l/Kc49LXbbDBBvE2mKycY1lehsGqMWo1FkvGGGOMaakNN1GFTrMTN8aYPCyWjDHGGNNSG25FmiyWjDGdzv+v3jLGGGOMaYENN/c7zU7cVIthUFJvOmT/sVgyxhhjTNNQN4GblwYn/OV+p9mJm2ogO2pSOY1pFu0/RfbmjeA0PGOMMca01Ia7E+3ETTXABGDixIlh2rRp8T5OerV6FJnuZMGCBfGc0qgxBJM1nI/Yf9iPWmEqYbFkjDHGmKahLgkzh05zwzPVRRbYEkxm+LHwv41zsSdPez6VBaHUKit1iyVjjDHGtNyG25hmIZK06qqrhpVWWim3wanpfl566aXwz3/+M1q/0wC3EYhst9Km3GLJGGOMMW2jE3swmWrAgLdTe/OYgUeWgHNFK5oTDwSLJWOMMca0BfdgMsZ0OhZLxhhjjGkL7sFkjOl0bB1ujDHGmLbgHkzGmE7HYskYY4wxbcE9mIwxnY7T8IwxxhjTFtyDyRjT6VgsGWOMMaYtuAeTMabTsVgyxhhjTNtwDyZjTCfjmiVjjDHGGGOMycFiyRhjjDHGGGNysFgyxhhjjDHGmBxcs2SMMaYhnnjiiXDppZeG//znP2GFFVYIu+22W3jVq17lrWiMMabrsFgyxhhTinnz5oXDDz88nHfeeaFnVE9YOG5hGDF7RDjuuOPCXnvtFY466qiw5JJLemsaY4zpGiyWjDHGlCIKpQvOCzM2nxFefN2LoXeJ3tAzryeMfnh0fBy+//3ve2saY4zpGlyzZIwxpi6PP/54jCjNeMuM8MIGL0ShBL1L9sb7PM7zpOgZY4wx3YLFkjHGmLpcdtllMfWOiFIePM7z1DIZY4wx3YLFkjHGmJoQLbr55pvDwp6FYcz9Y8LIWSMXew2Rpt5xvdH0wRhjjOkWXLNkjDGmrqED6XbzRs8LY+8bG8b9eVyMJM18+8y+KTdql8LsEN3xjDHGmG7BYskYY0zDhg7j7xgfXzNzy5nxL4+FuSHaiBtjjDHdQkek4U2ZMiVssskm4b777hvqRTHGmGFBPUOHWW+dFUY/NDos8dwSYcxfx4SJf5oY7cPdb8kYY0w3sUQnpIF89atfDXvuuWfYeOONh3pxjDFmWFDG0GHcnePCSpetFHoW9vT1WQI3rTXGGNMtVF4s/eQnPwmzZs0KBx544FAvijHGDBswaqDprCJKWeLj40LYdO1NwymnnBIjSkxuHXLIIf2a1oZZIRx77LFho402iq9bZ511Bn1djDHGmK4US3/961/DaaedFj7ykY+E6667Lmy66aZh0qRJTX1Wb29vePHF/BnSdvLSSy/1+2uM9x8zmCnMF154YVi4cGFYeeWVw0477RTWXHPNUu+dMGFC6JndE3rm9+QKJmqXRr44Mmy55ZbR1IHz69e+9rVw0SUX5dY43Xf7feEd73hHzBL45je/GZZccsk2rLFpJb5+Ge8/plvPP+iCnp6eUq/t6eXVFYTF2n333cOTTz4Z/y5YsCBcfvnl4XOf+1z42Mc+1tBnPfDAA2Hu3LltW1ZjjKkS8+fPD6eedmq48cYbF0V4xi4MI+aMCL1ze8M222wTPrvfZ8MSS9SeK3vmmWfCZ/b7TJi5+cxYo5SFOqUJt08Ip592elhllVVKvX78bePjxYll2P/z+7d0nY0xxphGGDVqVNhwww07N7J09913x8jSqaeeGrbaaqv42GabbRYOOOCAODu63HLLNfR5zGKuu+66YbBBET/22GMxIrbMMssM+vebzsb7j2HC6MorrwzPPvtsWH755UtFh4jw3HTzTVG4ZCM8PL7sxGXDd77znZqfsf7664c999gzRoog+zkYOuyxxx7x/MwynnXWWSH0hDDi5RGxD9OC8QsWr3G6a1x4ZZVXwk033hQO/eqhpaNcZmjw+cd4/zHdev555JFHSr+2smLpX//6V5z5JMVDkPNOhAmXpkbFErOZo0ePDkMFP/RQfr/pbLz/DC8wSLj44ovD1VdfHSZPnhx6luqJDV9HzB4RTjzxxD4zhbxUNs6PF120KBUujfDIxQ54njrQes513/ve9+J5mBqkZe9eNi4DvZSwCGcZjjjiiHiLfZhG9oYFoxaEsX8ZG8beMza8tM5LYcbWM/o8VxFaC8YuiDeiXaRWuxa1M/D5x3j/Md12/imbgldpsbTaaqvFPPuXX345jBkzJj721FNPxb/k3htjTFc3ge3pjenIs7aYtVhUh95H8P3vf78pFzuEz6WXXlpXrCDG+I79998/vh7ThxVXXDHsuuuuUWhh5nDu+eeGV1Z6JYz696h48Zk/YX4YOXtkWOafy4Qlpy8Zpu85PQqmWOM0Z2RYMGZBFF18ljHGGFN1KiuWsAlfe+21wze+8Y14QccRj5nULbbYIgopY4zp1iawM98wM4y7Z1wUSkXRIQQVIiYbHSrjYteoWOE7ssJKfZiiUJo+KlfUjb99fFjxohXD9D2mx/s8/vKkl8OEByZEUwhjjDGm6lS2KS2pH2eccUZMu8PgYZ999olFxMcdd9xQL5oxxrS1CSxnZoRRregQ0SOiPVkQIaTr4WKXB4KFVLqBihUiWGHJECNKNKjNbVy7+aywxKwlwvKXLx/G3zE+LvdSU5eKaXy77bbbgL7fGGOMGdaRJVh11VXDCSecMNSLYYwxbSdNnxv3p3FhwbgFTUWHSJFjUmn0Q6NzXemI8LRCrPDdcTloy1Crce1d48Ko/4wKL639Upg/cX6YcMeE6D50+umnR8HGctSrnTLGGGOGikqLJWOM6WSTBtX5lBEFafrcwmUWxrqfWj2OiqJDa621VjRfUF1Tnosdzw9UoMTvfjmEBRNqizoMHZaYsUQY/cToEB5d9PhfH/5ruH/q/TEChrCrZVhhjDHGDCUWS8YY02KTBlocXHHFFYsSnZcOUfTUEwVp+txL674Uxv15XNPRIb4DSOubePfEGIWiwaxc7PR8o4IuG8E69thj64o6TB16l+oNK4xZITw347mYZtiIYYUxxhgzlFgsGWNMC4XSe97znjDlkSmxbodUuigm5vWEuSvPjc5xRaIgmz6HoKDOp150qEjw8B2f/OQnY+3niBEjYlqzXOxYTpzsEFOxae24hQ1HeYhg0fPpiiuvqCnqWGb+0Sdq5hYzGzasMMYYY4YSiyVjjKnBK6+8EmbPnh3mzp0bu32PGzcuLLXUUrmv/eIBXwxT/jEl3xnujvHhlRVfKRQF2fQ5TBNg/G3jY93PgtELwpIvLhmjOLzuU5/6VNhuu+3C/fffH8IoXhgWEzw0fd1zzz1jg9m0T4Vc9+jFNJAoz0knnRT+ct9fwuO3Px7v560zInGpfy/VMjtzY4wxZjCxWDLGmBpC6d///nd0qrv55pvDc889F6M3e++9d1h33XX7vZbXXHnFlTXtvhE+CJsiUZCmz6kJbO+o3tAztye8buXXxUjOzjvvHE455ZTwrq3eFUJPqNmHiYaxha57NZrWlo3yEH363a2/C+985zvDY7c9tkjUjV0QU+8UTVtq+lJhvfXWC5Ofm9xSO3NjjDFmMLBYMsaYAhBHRx99dLjq6qtiZES1P6f/9PSw915790tXk5V2PWc4hEGRKKjXBBa+8pWvhAsuuiD+H2vuWoKHNLx2Nq3VMt966619dVojZo6IdVoIuaWnLR2jXDQSP+GUE5oyrDDGGGOGEoslY4wp4DtHfSdcfe3VYebmM+umq5VpBkvUBTFRTxTkNYFVVOiCCy8IL6/xchj1zKiaggdjhyuvvDJsvfXWbW9ai2D68Y9/HA499NBckcdy//CHP2y7nbkxxhjTaiyWjDEmBwb4l19+eRRKZdLVEEAjX6jjDDd7ZAgLmxcFigohuur2YRrbG6ZNm1bTda/VUZ4ikTdYdubGGGNMq8HY1hhjTBPpajxPJAWIohAdIXqSR3SGm98Ta46aFQUxKjR2YVgw5r8ue/N7cl8XHehm94Tx4xe56aWwnL1ze2suZzuiPKQs7vWhvcLE2yeG1c9dPax+6ephtfNWi/d5nOepEWMdp06dGv9y3xhjjBlKHFkyxnQNA+kblIXPiAYLJdPV6kVPxt8+Prxm3deEE088MS7nWWedFe6666742s022yx84hOfqLusrBMi6OVJL9ftw4Qgeu9731uZKE+9eiyZaWBrjtX5Sy+9FF588cVY71TkPmiMady10xjTGBZLxpiOhwF2tMMeQN+gVqSrZZvBEgHiM8K8ECNKLM9hhx0Wzj///LBwiYV9znH33HtPNI3YaMONYu3POuusU7MR7FJTl6rZhwlhNmnSpChC/vWvf5Vy3WNdsk1r20FRqh4DPX5HBng9PT2ht7e3bwDoQZ8x/x8dF0woLFy4MB4rHDuwxBJLeKLBmBZjsWSM6Xha1TeoVpPYonS1HXbYIUZJNKP77W9/uzB6QiPY8y88PzZnzetJdP8D94d3vOMd0Zo8T+ARFdpoo43CfbffF2a9ZVZ48TUv/v8+TGP+a9k9vyf0jOiJzXHHjBnTtOveYMP2I6KEUAL+cp/HjTGLUASWv/Pnz49iSSCURo4cGY9vTzQY0zoslowxHZ1a18q+QY2mq9HwFYE0c+bM+Bpme5999tkwYcKE8LnPfa5fRITlPPe8c2saRiB8ekNvOPf8cwsF3sknnxy23HLLKK547/zx86NIWmLGEmHeCvOiU974+8aHfffdt240rSjKMxSwHZkpZ5ZckSUGgjxujOkfgdWkAgIJ0QQcLzy39NJLe6LBmBZigwdjTCXhok8kZosttgjHn3R8OOuqs+Jf7vO40k4aNWJopSnBQQcdFJdDA5YFCxbE24wZM/pmf0WZPkyIn94RveHl1V+OAg+hmOXVr351jDwRPZq7ytwwd/W5Yc6mc8L03aeHl9Z7KUx4YELsAZVtmlt1qLHQjDjRJP5yn8eNMf0jsJpU0A34q7Q8TzQY0zocWTLGdHRqXTv6BpVNV8O1jYGL0mEQTfzlMURUWm8jJ7u6fZheHBH/SuDlRX7SmiM1y0UkZWuOZJbAd48ePbrSRd8sF2YOLlI3pn4EVtFXboKJGh73RIMxrcViyRhTObKpdSNnjQzLPLJMGPHSiLBwmYVh5sYz+1Lr2tk3qF66mgYuGqRo8ELdQLbeJi7nnNrLSTpdWBBi/VEtgVem5ogB03PPPde3HAinqrvLsVxVXTZjqgATHhzHilozUcMxzkQN5yBS8JZZZplKT4wY02lYLBljKkdfat16L4YJv5sQTRZIUaMRa+wvNK8npqtdfPHFYffddy9lxNDqvkHpwEWRJZkSKC0vrbeJTnbHHVtzOaOwCyFagxMpqifwatUcEaFRLQPiCgHnom9jOps0Ais3PM45RQKJY/75558PL7yw6JyD6cuyyy5rIWVMA1gsGWMqh1LrMDEYPXl0mLXFrFx77Kuvvjp85StfKd03qJV9mNKBC4MRTB6IKkkoZettMIyglkjmDXlueHoca/CBCjyiSaplALvLGdMdFEVg1dRZzpy8BsMZGafoNS+//HJYddVVLZiMKYnFkjGmcsTmq7N6wuj/LBJKRe5xk2+bHAVQvb5BRxxxRDSFaGUfJsGAZJVVVomztfXqbfgeZoLpszTuzv/afb+wyO4bsAKfP3F+SxrDsgyaTY7bzUXfxnQteU2dOdeQIqxJHJ0DEEvuX2ZMeSyWjDGVQ81XEUa13ONo/CoThFo1PFEotbgPUzP1NggyBNoXv/jFcMYZZ8R0w2fnP7vIl3RCCGOfGBvCI61pDItYY0AEDKDyol3GmO4gr6kzj/EX8QSpc577lxlTHoslY0zlIGVtvfXWC3/7999quseFcYtS9mrV8LSrD1MZVCOUjTbxPd/61rfiLU0NbGVjWL5nueWWizbmfHfV3fCMMa1v6qx6StmNy3Lc/cuMKY/FkjGmkuy4445h8kmTB+xyV6YPE6l7RTbdrUyLyXOja2djWCJJDJTYRoil7PLZptuY7iCvqTPnHc4BpOLJ7AVkBmGMKYeb0hpjKskHPvCBKJRwj8ujrMtdO/swlU2LUbG1ei8NNRJymFLwf/5mm+gaYzq7qTPnHIwc5H6naLPNHYxpDEeWjDGVTcUr43JHpCZ1gMqmmg1GH6ZG0mKqUCuQV99gW3FjOpdaTZ0dRTJmYFgsGWMqSz2Xu2984xt1U92oARqKPkx5aTGkxFWhVqDKQs6YKtCJaapu6mxMe7BYMsZUFtJKarnccZ9BDYN9cvL5m42QlI1QtdrcQQ1rWR6ECEKpKm50VRZyxgwlauKqvmkcs0X1hsaY4YHFkjGm8hSZIDCIQSTJ5UmD/zlz5vRLq6sXoRqoTXejaTFDTZWFnDFDXcvHeQVTBE3CLL300n31hlU4fo0xg4vFkjHDnNS6GoFBOlqroyztQk0XlU4GCCaasT7zzDN9hc31IlRDkRbTbJpPK9KDqizkjBnqWj6lpfKXcwyCyWmqxgxfLJaMGaYwKDj88MNjtAVrbRzjMEKgvkfRFkRGldGABoGUwn36CyEE0tSZdtp0t8NWvFXvy8P1Dcbk1/IBkzA6v/B/cJqqMcMTiyVjhilRKF2wqFlrto5H9T1EY6oM/UJIuUvT8IBBDreqps4060ZnFztj2l/Lt8QSS8RoUtqbiFQ8p6kaMzxxnyVjhiGPP/54jCjNeMuM6BAnS+3eJXvjfR7neVL0qgyDFwY2qVBCfHAbOXJkZVNnmnWjs4udMe3vVYRI4rzCOYTbxIkTbe5gzDDGYsmYYchll10WU++IKOXB4zxPfU+VIQqzyiqrxBlhiSQJDwY7VXV4Y5lYNgm8sm50zb7PGFO+lm/ChAkxar388suHSZMmxXNMGvElwsuE05QpU+LfKjSabiVEuanrnDp1ap/jqDHDGafhGTMM4QJIjVJek1bgcRzjeF0nzAYjFlK7X6XRVNXhrVk3OrvYGdNe6tXyIYyefvrpPmMZor2k7q2++uqVPNc0SivrIo3pFiyWjOkSGnFJw/UOM4ee+T25gonaJay1U/vtTogw4X6X3QZc+Kvm9tesG51d7IwZWp577rkolJiQUb0hEzM83g1iyXWRxiyOxZIxXUCjs4FYZuN6N/qh0bFGKQsmD/QgQlh06qxw1d3+mnWjs4udMUMHkxtK9wX9v4q1kc3gukhjFsdiyZguoNHZwLXWWisKBrneZd3wJv5pYnx+qCMww93tzxhTLYgCIyjUAFvmMt1SNyhHwHT9XBdphjsWS8Z0QdodFzdoxF2NyAoQeVn27mVjjRKpd0SUFHnp1Ka1fW5/my9y+xNy+wOep0lt1dfFGFMdlltuuXi+JfVOYgLHPB7vBlwXacziWCwZ0wVpd1y4lUcvK+16s4GkoBFZQTBIDK244ooxRQ8BwWcfcsghlU1jG6jbHwKR9a5Ck1pjTOeICcwcqFFSvSFCqRvqlcB1kcYsjsWSMRWOGOXBc//617+imGFGk2aJ3KhRYsaTi11ZdzVAGOUJhk5OY+smtz9jTLXgvNot4igP10Ua0x/3WTKmghEjLLD5/wsvvBAjRQij1LZWOfNElHiNcuYRSFzo6BMyEKvXTm9am7r95dFpbn/GGGOMGRoslowZBBAVJ5xwQvja174W/xaJjNSoQeIHEESpbS2pd3JhQii9/PLL8XlE0mqrrRZFwEB6YnR601pSCXvn9ka3vzw61e3PGGOMMYOL0/CMaSON2lfn2bYCESQ9z2Ok3+kxQECNHj26bmpI2V5MnZ7GNhzc/owxxhjTfiyWjGkjjdb95Nm2xgN1iSX62dbqMUQSr0Fw1Uu7a6QXUzc0rS3j9tdII19jjDHGDD8sloypkH111rZV0aMxY8YU2tYimlZdddXFBvlZIcB7yvZi6oamtfXc/hpt5GuMMcaY4YfFkjEVsq/O2rZyf9asWX2pemVtayUE+IszHjdFoMr0YuqmNLYit79GG/kaY4wxZvhhsWRMDQaSptVs3U9q20qkA5vwRm1rWeZUKCEG+Kv1KNOLqWzT2k4lrz6sXiNfY4wxxgwvLJaMKSCbpoVwef7552NPo2WWWaaucBqKuh9EEuJL7nkSAAgj1T+xHqxDvV5M9dLYOp28+rB6jXyNMcYYM7ywWDKmgDRNi3ofxBMDah7DqnvOnDl9oiMv6jTYdT8s71NPPRVNHwTLm97XY0SWygi+WmlsnU62PqyRRr7GGGOKMzD4/7Rp0+I5leyIlVZayedW07FYLBlTcOIniqTGrwyqFZlhUI0AQTTxWkUosuYAg133ox5MRagvE8IAoVRlJ7vBIFsfZjc8Y4xpjDyjHOpslQYOTC7STJ16W09GmU7EYsmYghM/J3o5yEkoSXBIlPB/BtlF5gCDWfdTr9ZG/ZmIKrkuZ/H6MGOMMY2RZ5SDWOL6yfVGTdT5y4SexZLpRCyWzLBNF+AEDhJGSsXiOSIvpA8wS8bzKWoIy0WB/9cyByhb99OKfj+8j88pguUjbZBld12OMcaYdhjlaHJR11jVzXqSznQqFkumq3niiSf6RMqyyy4b3va2t0WxAhIWMj9Q1EjOcQghRBMzYnKU03N6vZrF1jMHqFX3U6vfTyNgIU4dlS5UeSCUXJdjjDGmXUY5qWEO6JrpSTrTqVgsma4E4XHooYeGCy68IPY6Iv2tZ3ZP+MEPfxB22mmncOABi4SLTuZZ0aToEuJFaXYSSogn2W8jPmTP3awISdMY9Pm42T3zzDNh4sSJpT+H76Y57dSpU/s9rugXyzdhwoSmolbGGGNMGaMcMhjSmiVNPjKhZ0wnYrFkuhKE0oUXXxhmbj5zMWOFq66+KiyYv6BfpCdrr4144eSuaBFRKU7+WbcfcrAVoeL1CB9oRIwojYHvYoZOs3BcgFIxVwYuRogihBZCjs/lJjMDiyRjjDHtNsqRGx4Tf4gnu+GZTsZiyXQ0ebU+CAUiSgil1LK7d8nevvvXXHtN2GOPPcIqq6yy6LnEwAFxMXr06Cg60vqhNGrE9+KWx/cqTQ+BhcAh5Y+LAzcoshbPpjHoc1IbawmeRuB7+Ey7vBljjBkKoxzuM4H44IMPxowHrqnGdCoWS6ZjUa2Pwv3cnn322XDuuefG1DsiSnnw+MS7J4ZbbrklOtJBmmdNeh0iqlYURqlzKmqV2FKeNrVD3NI0OMQVn5tN1VMaAzNwer/S/xBj+o5WuLy1wkjCGGOMMWa4YLFkOhbEBwIjTVUjOjN9+vRYo0TqXR483jt2UZobgoHojeB+PaGUps6pZqkWLBOCB6GS12tCaQxExFgmRbSyqYEDhe+nOaCa67JMCDpm/SyYjDHGtAquMzNmzIiThfqr1HVN1pE2bitx0wlYLJmOtf3mBJw600lUUF+EmUPP/J5cwUTtUs+cnjBp0qTYOLaZSItS59LvrYVeg7hCFPH+9Hv4PyJNrnhqekuUq9G6pVriUq5F6nvBfUW8jDHGmFZmfXCNZFKTxrTKApGJEtcfN6o1nYDFkql0DyROsNzP2ntnG8WmbLXVVuHn5/w8jH5odL+aJYHJA01hd9ttt6abkqYOQI3AsiKYss1riwpliTIxE9cKlOYnu3NFxnjcGGOMaQVKU+f6BfyVYRH/1yQj1x83qjWdgMWSqQRpryHdh7yoitLTRDayQ1rZdttuF66/8fp4P+uGN/FPE2OtEr2P0j5MK6ywQthhhx2iXXe9SFMqbJRWUJa85rXp56bfxwWm1WQjccYYY8xgNKpNH1OEyZiqY7FkKhFNmjlzZhRK9DZitomTKGlikB3YK41MQipv4L///vvHv9ddf100cwiUCOHqPTdEoXTEEUeEQw45JJx33nnRDGLhuIUxde/Y444NO+6wY/jSl74U34+IQrwQjWHZUvEkYcNjjz32WJ/Qq4fMGwabMWPG9EuD0DbjcWOMMaYVpGnq2Qm67P/dqNZ0AhZLpuXkOa6lhgwaoHPjMUQGNwbxpN1pxknkiSX1QOI5/Z8bokZi6stf/nL4zGc+E2677bYoelZcccWw6667xohSFEoXnBdmbD5jscjT1ddeHT+LPkz8RbzxHSwbkZ5svyL+v9pqq4Unn3yyZn2RbMmzNuSDBbVcrAM3LQ8CkMeNMcZUl05yMs2mqXN9V6NaTYbqOu5GtaYTsFgybUunQxgwu4TjGiJCLmzcGLBj883JkgE78FjqTFcrbUy1N/wlBxrhxfuJRqV9il796leHN7/5zf0+7/HHH48RJYRSrT5MH/rQh2IjvTRtgPXKqzfi4rDmmmv2NYOV8USaNsj7x48fH9P9huIix3eSotgpF1xjjDH519W8ibuqoDR1rvFMkHJ9Xn755e2GZzoWiyXTlsJOTpZq1MqJvajeCHGDyFEhaF4dTfYxPkM3nZT5WzTzljWO+MUvfhHCqEW1TLX6MN18880xZU+RLs2EFeVYZ5vB8nouFKwjwk4OdENJLUOLTpq5NKYq+Lgxg3ld1bVI+11Vz9EsF/W/tKvgb5q2bkynYbFkWoKMEojaED3ZbrvtwoQJExYTB3lpamltEiAqlFrHX4klnWh5vOyAXjNyvF523PQ6KtOHCWvybGSI766VY52KEVL/EIJ0LtcyI57YRkTTsjVQQ0mnzVwaUwV83JihMkyoZRRkjGktFkum4cFBWntExOTYY48Nl11+WTRKQIRglPCzM34WHekwWpBVdS2UxywjBUVwVA9UtCzMrBHq58JBup9S/YDHx44dGz+Hz1eKX6k+TLN7Yi61okESTGkNVtkLHEIJ4cHn8Bn8ZVlY1qoIkk6cuTRmqPFxYwbTMCFNSa83cWeMaR0WS2YxaqWzEZVJ7axPOOGEaNE9c/OZixklyLobo4QiEEWgCwBFoIomZS8G2XQ6ojZq4JpX68RzCLtsY9cyfZh65/WG3XffvS+Sxfc1GgnSBS4VakI1TUU1UIONZy6N8XFjQuUNE9Ka3G5PaSNj5eKLLw5Tp06NqXw77rhjWH/99V37ZAYdi6VhTlYYcSImIiMHOO4r+oHwSOuPyEXGmhuhVGSUwPMYJayyyiqLfbfSCuTIJmc8OdulF4O0I7gc6sr2CcoKlTJ9mPbcc8+wySabhFZc4Ni+KWlDPsThQFIpWlUv4ZlLYxrHx40ZDPIallclhbsdMA44/PDDoxET9cXKWDn1tFNja4/Pf/7zfeMHtgfjktVXX73rxaMZOiyWhjHZfHtS6zRwV/qZojbYYqcpbvCb3/wmpt7VM0q45ZZbolGC4ATP53Kio64JocRjqTlC9mLA4xJKqdNcs2T7MFGjxMmYiBJC6bvf/W7u9mrkYqULHIKpyOVvIKkUrayXGK4zl8Y0g84FHHMcK/xVBNvHjRlsc55uIwqlGq09uJ4edNBB8bXK3GCMgiOtr1mmHVgsDWOy+faqqZHBgtLEIG+wTySojFECrxOxXqinJ1dspBeDtB5Js7cSbwMVSsDAhvRAol6IOcwcONHuvffesQ9Tq4SJHIHYBkoFTC3FBzKwamW9xHCbuTSmWbLnAh17eY2rjTHljyuuP//85z/Dueed23DGCtdXygQcYTLtwGJpGJ+UNIBHGCFCFFVSL6S0ziftxC3KGiXQV4iBBKIhLx0vXS6WCaMGliW17M4uTzPIpCFdB5aHqBeDG0RSOshJI0lqnEvaXKPCRM1gFRlTkS6ChL9K02t0gNXqOqPhNHNpTLMUTVIglDjXGTNYdIttfToBcc011zSVsQKMY5577jlHl0zLsVgaRnBCws565syZ/Vx10o7aIGGSihP1NVKkqRGjhG222SbaZyMaigSSBiBZMdNK1Cmc9Wfd0hlhRFNWKKWzx4gd4IKEuGxEmGSbwerzlOJIVIttgBBrZGba9RLGDD42QzFVoJts69MJiDg+aTBjBZQGazt10w4slobJ7BKvwZCBqI3IipI0eqTnZOct4STRxPNrrbVW2HmnncOVV19ZaJSw8y47R/eaWsukFLt2wnZRbRR/622vvBRFlpf3IGgarTfK9l/i89S4l89ViiF1Y6QeqparFq4zMmbw8SSFqQLdZFufTkAwqVkmYyW9PjJG0TawnbppBxZLXTa7xMwSYWiQAKEuhmiIoiNKb8um2XGC5XUq8mcwLntuOdCljWNpPvv9738/9jLCtSYaJeBaM2uRUcIuu+wSjRJ4nhP4M8880ydQOCEiDFjegabXFaFlZf2J7OgCUibdLDt7zDIrFU8Nc5utN0o/W9G0tJ8Tn83sGq9DNBXhOiNjBj9lyZMUpgp0U4QznYDYdtttw2mnn1Y3Y2X77bfvuxYrvZ37yiAxppVYLHV4Y1ilxTFwV2pXlrzH0jQ8naxIA1PTVAbp5N8zuEB8aUCfmhQofe7rX/96+MxnPhN++ctfhmnTpsXapK233jqmtj3++ONx1idN32P5iXBlBVuzqP5H68L3abYt2yeqaLCUZ6Ge1hdxn8/lObZ1q2y6tf5p5E7fyTZT898iXGdkzOCmLHmSwlSBbopwphMQK664YrQHx/WuKGNlt912C29605vcb8kMGhZLHYZS1zixpOlyeW519Uhd2fg/QiGNmEiU8bhqmzR7A+px8NRTT8X7NHHN+45UKKWPD6Q2STNqEjGkxq222mr9XpM66inqpkgO70WwEXGC7ECKdUyjbGwXDZLyBleNzFqnF4ZUMGmdZLrB/WZ+V2O6lWajQ61OWfIkhRlquinCmZ2A+OY3vxnGjBkTLrzwwrDs3cvGjJWAD9LcEE0djjrqqLiuvK8T19d0HhZLHUDWlU3pdI2IjTSKlL6XAQcRJBVGpgMQamvS3kZCPZIkstpdb5QiQSExg1BCULDc6XZiuYjKKLWNv6yDaq64jyhCDCrylR1IcbLmuXoDs0ZnrdMLA6/lOyVE1QxY69VpuefGtANN3JCeChwfjUSHuillyZhujHBmJyCOP/74cMABB4RLL700jkWIOO266665rT2MaTcdIZauuOKKcOKJJ0aryOGGBuISLXlRmrIojUxCCTEg04M8OAHLeACyYqvdIkm1VYKZpOWXXz5GhCRMEBSaYZJgAQSlomCp2NMgSe9FUBGVyhtI8Z4iK+CB2opne0plB4JaL34jY4Z741eOZ00oCI43jrsy0aFuSlkyZrhEOBFG9EM0ZqipvFjCFOA73/nOsAy1Mlhg/VW3kg7iG4X3MrhIjQ5qfS8DEGZthyoNjEEMyyoHunTWDAGRnU1L02x4T4oiSaAUt3TQ1ehAqpW24sAyU9+V59I3mFE7Y6pCeoxxDGgSRA2zZbtf9jjrppQlY4wxg0ulxRKD1sMOOywOJOsVunfrYCF1i1P6WSNiidczKMCRrlYUCRioE+5GOOj7hgIGMwglBjJ5gxmtg4SFZp+13VQLBBJAaRqijBsA4dXoQKrVtuLpemV/H5bLmOFGeoxxbOu4VCqtjjsoc5x1W8qSMcaYwaPSYgl3talTp0bBdOSRRw7osxjADsXAU4N4/c0ixzOlvCFuuJBrAK5ZVNAgvEx0CRGAhSaDfn0H4osUL57j8exy4mRXNpKh6EmrIh8SNKwvqW/8JS2N5WYGOV1u1geHPlmZqzZJtVRp1EiW5+n36HkGSogbuf/puxS94vG8fUbmGlp3RZM0+61GtyzrQPe5evuPMd24/2SPsfSY5jEZxHCMNXKc0Rybmz7HkxHduf+YxtAYIXutHSjef0yV9x9Nppehp3cglmRt5NFHH43uameddVbcUAimZmuWHnjggcoU8mpWVMIn74SUtfXO1u5ooJD3I8vIIEUN2/RZ+m79X7bg2e+pR7oc9d6Xt05yystuk3S5syj1hltK9vvTBrv6q/fmfVc90vfpftF6NvrZxgwHGjn2ssd42XOdMaZxiq61xnQ7o0aNChtuuGFnRpa4CH71q18Nn/jEJ8JGG20U/vSnPw34MxEl6667bhhsEHqPPfZYWGONNfqsq5VOkqbXpSKCZdWMqiIfMiyQVTavoSks0ae82SC+d8aMGX3vy4sKtWLgQ3ofYLqQjTKxTIqysGyqJyoze8WyM9PF86mw4j28H/Gbvlcz0TwmISgnPNJtst+VnUkjOsQ66D69otj22SiWfgNIBSfvUSSvHfvPpEmT4vIYM5T7TzMz0CwD6b06HrnxnlrHS/a4U+os5xAubq2a+Ta18fmn+8lea5XVQgSW42wgx5r3HzMQ2r3/PPLII6VfW0mxdOqpp8YL6mc/+9mWfSYnAaVfDAVKE9NFPy+gl0Z/GBAwUNAAQ3n5mDSw09TKtycvn5S7Vs+6pk5yEnGIDBzq5AAnMSh4nUwl9LxufA7rk7cenMAlCoW2Gb8j71f6mwQMf/m+1JFOzXVTZy3eq0ijmvmmkUc9j8DV+mQ/t6yteKvg+4dy/zWdTSv2H/Z7RI+OXf5yjqpl3c17JHpkrKIoL+/n+CyCc4NrjKqBzz/d26cMdK2VmYpSYLle1jvGy+D9xwyEdu0/jWRSVVIs/epXv4qNRN/ylrfE+zpoN9tssyik+NtpcMKRUEoHDXlpY/o/AwkNyGV2UKYhKoOTVgolNUhV2iDfocESf/lullmW1xJU6Y6YbaYLiJRZs2b1mTmk1HKoyzNkSG24syYNqf26BCjIPjyvponXTJ8+PQ7YGrUVN6YbaaaxK8+l54Q0Ba9eanS32yIbM5gU9QPkmqqxSTrZqZYcA2nebEy3UEmxdN555/UbwN53333he9/7XnycxmSdCEKiyAwhTzRxoqrnXpeeANWHpJUiSTa9SmVTTyHNPvEc36volyy7FXVhvXge+3Pem7X0Bh7neU7Y6brWcqgrcraCvJlozYZn67ayznh6Tmk/fDepju7PYkxzjV15LjWpSY8v9zgyZugnOzgOubYq80MTukrLc/NmYyoqlrAKT3n66afj4Ju0qE4FASHXOw0Y0hQy3SeSQR1Q2bQuToAIEp3kWoGWS0KJ5UC4ZcWImrrq5Ku0HNUzqIkur6+VdsjrszNX9ax+i2ad05kwopOKUCmKlHXxywvDpvVj7s9iTPONXRWF5nVpr7N0gsMYM3STHRyPutbiQMt1knGIMmA8sWFMRcVSFtLxmnXCqwrM0iACiaIoLUU1N0V1SGmdjSzDs6/juVY6/bGcmlVSyl1WpAhs3dOTL+9L09xYLjWBzYuqadBVNHPVTBpOXqqBokfpgE3fn5o0QBqZqxXFckqCGW40M3Gg94COP44hzoU+hoypxmSHrrUcr7p+yoTKzZuN6RCx1C1wIuLEVGbgndb4pAN43vv888/HwQbvJ6rUStTnqUxBZ/bkSzRJDWGVspetVchGmBS9aiQlJ69INW1Um001kAth9ru1bETyJDq1LghY1SS5dsKY5hq7lnlPrePZGDN4kx2eHDQmH4ulQabWwJsBA+YMisioyWkKj6vOh5NcI24eeaQpgUStaqUAZgc1vEa5zjr54liC0FAkTGmHcs7LminwmGa0BlKkKnGXl2oAsivWbBmiiGXVDLcHbMYM7PxVdAzVe0+t49kY0xrKCqFumxx84oknwqWXXhprl5kA3W233cKrXvWqoV4s02FYLFUETmDUZpVpBKfIDX2BEBsM+ut1os/2cuJ93BA2sueuZQ6RN6iRCQXP5Z18Uxc6kGDKSz8EBCA1UKrxyjO4qOfIlZdqIAOK1KdffZrq1UAZY+rTrOhpxmHPGNMcw+k6x3nl8MMPj8ZgPaN6wsJxC8OI2SPCcccdF/baa69w1FFHuVebKY3FUkVQL5KySDAx4EcEIHSyKXlKjVO6Geg7sCWXaQPpfkqf4z2IMHonpSJIfVGygxpueRbaGvCoZxTLKeHCY6kYasRWvJ4jV16qgbqTN1KYbowpT7OipxmHPWOMqRfd/u53vxsuvfzSMGPzGeHF170YepfoDT3zesLoh0eH8y44L77++9//vjekKYXFUkVoZnAgYcEJQqYMSt1jwIFIIHqTF/0BTio0f1XkR45xfIb6L/C5akzH55UZ1GRnmWXyoHQ/HpMzoNICUqGn9cqzFa/nyJWXasBj1Hk1UphujCmPRI/Sh5XuyrHaaoc9Y4ypNe5g8vVXl/4qzNx8Znhhg0XZKtC7ZG/ffSJO+++/v1PyTCkslioCg4O8PkS1YHCiVDY1rlWkJpsWlwqD9KSiiBKkTnEMWBBIigrlRZaKBjV5s8xEqxRR4i+fxyDpySefXKwxrAwh8mzFyxapZmezyxprGGMah2NKEyBymOR8wiQIx2rRsWZrfmNMK0jHHbgnk3pHRCkPHl/27mVjLdOBBx7oH8DUxWKpIiy33HLxYG8E1eFk0+CyEZNs4bWEjxrHFqGO3ggyXsv7ykRnikwWNHusQZSWI2tSweuKbMWbdesZTrnaprupYsEyxyDRW7VFUJ82juFaqXh23zLGtIJ03EFZQ++43ph6lwePU8P0+OOPx/OoJ09NPSyWKgIH60orrRSmTZtW6vVqFlsvlSw1WUid4BQtSo0f8kjtvqlzQjTVEylKrVHECHEkcwcJsLQpbNYlT0KpyFbcwscMR1pZsNxqwcUxyaRKOsnBsnCc10sx9vFsjBkoaUovk889s3tCz/yeXMFE7VLPrJ4wfvz42IjXDpymZWLpqquuCjfccEO8+G266abhgx/8YJg4cWK/10yePDl87nOfC7/+9a/LfqxJQCwhRsi3lUBJ+xSlzV8RKnlucVmY1U2FkiI7DGBk/pDX/4jneJ0KteV8V8Y2WLM7crYDiTJFlPSYBlZpt3CtY6O24sZ0M1EoXXDegAqW2+kQpXTgNP2W73P9kTGm3aQpvVtvvXU47fTTwuiHRverWRKcM3vn9Yb3v//9/VqHOPvEDEgsnXrqqeHEE08MG2+8cRRIp59+enwMYfTJT36ybxDPhXLq1KllPtIUwIwIgxWMDZTSoihS1oaXA5yZYWZT1NdIVtx6nWoI9LzECQMZRZZ0k5iSUJFphJ5XmmD2hJJn6CC7bgkhRaT0eXqtBBloUMVruLm2yJhFkC6CwEEoDaRguRWCqwjXHxljhoo0pZdx0Ad2+0B0w4PsuW7inyaGnXfeOay++urx+TTd3z0XTdNi6ec//3nYfffdw7e//e14H/V+5plnhpNOOin89re/Dccff3zcSU1rYNBRz5BAdtsIJaW0ccDzeBpS5r0SQWkNkcSQ3qv6JW4yjeD9zz77bIwG8TiRInKB+UyJLl6XZ/7AsvM8hg5CdU40gk37L0kUAp/thpTG9OeSSy4JYdSii36zBcutElxFuP7IGDOUpCm9jEsBV7yJd08MvWN7Y2oeEaXtt98+HHzwwfH51KzKTbLNgMQSA983vvGNffdpgsoFdZtttok7HAqdNI5sWp5pnrw8fn4HxIqiRak5giJDelwhZRVe855sU1p+L57PijJ9Vypo9PnAayWWeB7BlbUVlxDLswROB1W1omLGmEUQsa9bsDx2Ybj55pv71SGl5i+XXXZZ2x2iXH9kjKkCTMwee+yxMb342muvjW1SKCV43/veF1ZbbbW+8UlqVuUm2WZAYmnttdcO119/fdhll136Pb7eeuuFiy66KBxxxBFhv/32C9tuu22ZjzNNwEH89NNP9zV1lXBJa5mA5znwFVJm8EIkR2l9qWmChEk2YpVnK56tacrez0aWlPJX5J7nQZUx5WFio17B8sKZC8Nf7v9LuPfJe/vqkPbYY4+w5557xtcgoqhRqiW4EGS8zhhjOh3GGW94wxvCuuuumzshnM3cIZPGTbJN02KJ6NEXvvCFGE068sgjY12NYAc75phjwqRJk2Jdk2kPRJTSCE7WYSp1tcv2P6qV1pdnKy6RVMslT9/HLc9WnM/Ka4brqJExjbPjjjuGU087tWbBMkLq3x/8d5i/7Py+3PyLLrkoPD/j+XDKyafEKBMiqpbgCrPDYq0IjDGmUymamK3l5Osm2SbLokKROmy55ZYxgsTOlTqcpRBZOuecc8I+++xT5iNNgyj1LXXES1Gkiefz+h/x2zEIIvzMXwklokhYZ/J//hKqJkrErRZpLyTZinPjc/lLmh3LkP1OY0zjrL/++mHnnXaOhclj/jomCp54vM/riffH3zF+URHzyN4w9p6xYdyd40LP3J4wc+OZ4cYbb4zNn3fdddfQO7c3Cq48EFdhbojpe8YYM9xgzML4SZO8KhPgLxF3lSWY4Udp6/DXvva1fQVzRWy22WbxZloPMx6qO0pFk4ST6n5I1yljKQ55+bmYOYh6PZhEPVtxY8zA4NjCpY4obl/B8rjeEGaGWLD84nqL6pBWumClaNiwYNyCMHL2yEXRohGL6pUOPfTQmL8v17s8hyieH+oGt8YYMxRk66nlGMxf92Ma3rgpbYdA6mN68CJiEEk0VeN+M2luaU8kkGlDWg+VJbUax5Bh7NixTq8zZhDgWMOB9KCDDuprKHvfffeFex69Jwqi0ZNHh1lbzFpMBI2/fXy47vrroliij5Jc7zBziIKLjgBzQ1+fJWOMGa4obY/za7ZvnPsxDV8sljoEhBA9AeSGhzhCQBU1bJVznsLGvD4rbPLyc1NbcaJOEkx6TLbirj8yZmgg8iO3uhNOOCHce+K9MbUOoVRkCf7IbY+EJ554Ir6XCBX1pxJcK664YkzRc0TJGGNqTyZn68XN8MBiqYNAoOSJo6xJAwf0tGnT+jV85TluaQ+mvCaSiCHgvbyGSBZQh+RUO2OqBSIHe1yEUS1LcNL2UkvwVHAZY0wjDIfGrTZ7MCkWSx2OTBrUewmRw1/Zdwv1E0h7MBU1kYRuPxEa0w2stdZasYXD3/79N1uCG2PaznBp3Jo3mZxnnmWGBxZLHY5EDRGgbE+ktAmtxFI2jNyIraYx3U4nzphiKz75pMk1LcHp0WRLcGPMQBkujVuLJpO7aR1NeSyWOhxFlGT4AESXIK1FgrQHkjGmO2ZMP/CBD4Qf/OAHNXsw2RJ8eNOJkwCmc2p5ALe4btu/iiaTVRNepn7cDKM+S6a6cKBKHEFe+l0qlhxGNqb+jCnHFX+Vtlr1VDyc7Ip6ME24Y0LYY489bOAwTMnrp8d994wxzcC5URO0oIb0+tvt+xfXg6effjrMmTMnXh/4y/2qXyfMwHBkqcNhNuP555/va1qrCBO3tBdTnhueMaY73I9qWYK/d5v3hm9+85tDvYhmiBguaVNmaGp5+Mt+hTkUfeDS/Wv06EUNsNn/ZMXd6ZEnIkpMULOuOp4Qijzu6FL30jKxNHny5HDbbbeFP/zhD+FnP/tZqz7W1IETziqrrBKeeeaZeMBy8uKmfNtOPSEZM9ipR53sfkTEOM8SfNttt40znzxvhiedPAlgql/Lo76MiIfs/iWxhJBQzXSnpDcXoYnp9Hji5uOpu2laLHEx/uMf/xgFEjfus8O87nWva+0SmrowCGRA55x0Y5qvP+oG96OsJTjr8+CDDw7pMpmhpZMnAUz1a3kY+5F6V7R/cS5lIpf+jN0Q2WS9EEbp+nLz8dTdlBZL7Nx33nlnFEaIpClTpvQNKD74wQ+Gd7/73eGNb3xjTPUy1SlENGY40kzqkd2PTDcZJmgZEUpcp/nL7H8nTgKY6lJrkol0NUVeuiWyiZkDxxICMC194HEzzMXSxz72sXDvvffGneO1r31teNvb3ha+9KUvhc022yy86U1visXFjigZYwabO+64I/zwhz8Mzz77bGya/MlPfjJstNFG8WIGjV6gPelgusE1MbuMGtQhlpjhr6K4M51JrUkmjgtFXrolssm6rb766nbDG2aUEksMRDj5cqKdMGFCvE2cODGedI0xZrDhIrzddtuFKY9Mib2FFoxdEEZOGRn+eNsfozvcqT85Nc5ucs5S0XEnX6BNdegEw4SiZeSa7X5bptXUmmTivMs5WO547Jfsk3LPq8ox06hgyovMppN3yy+/fAwqvPWtbx2SZTRDIJauuuqqmJeq+iQcl0488cTofsJOf80118QZhde//vV9vX6MMaZdRKH0jylh1hazwouvezEKJqyy6Sn0+O2Ph89+7rPhzDPOjLP+XIydemSGk2FCJyyjGT4odY3aJvZFxNMLL7wQ98cqRWRbPXn3+w/8Prxm3deE6667rs/swnR5zRKzUTvttFO8ATVL1C7dfvvt4Ze//GV0wEM8bbLJJuGss85q5zIbY4YxTNhwUUIopU1Ye5fs7bv/+G2Ph7///e/xfKS+SU49MsPFMKETltEMH4jyE1FCJFU5ItuOybspt0+Jz996661DvZhmKNzwXvOa18Qb9UwcBNQ0STwZY0wRTzzxRJ+9NZMwu+22W0MNU0lz4GLERSkPHh9357hw9tlnx4mbbNpRJxTnm/I083sOZB/oBNfEwVjGgR7HZnjRjdFOjq9bbrml7uTdlNumxBQ9p+QNI7FEA1QiSKpXmjp1arzYvPnNb443cjSNMSYLkyqHH354TOPtGdUTFo5bGEbMHhGOO+64aBJDY9Uy/YCmT58e0xwQTHnENIgxC2LKR3Zw2AnF+aY8zfyeA90H2uma2Coh385lbNVxbIYX3Rbt1Hnkxz/+canJOyb5LrzwwkFfTjPIYunnP/95+OlPfxoL1/j79re/PT5+0EEHxagSDRCJMn3iE59o0aIZY7qJOMC64LwwY/MZi6Uq8DjQWLUemMuMfHRk6JnfkyuY+MyRL4wMK79+8cFvJxTnm/I083u2Yh9oh2tiq4V8u5wdW3Ucm+FFJ0RkG0HnkVmzZpWavGPsbLpcLGHmQErLvvvuGzbccMN4E//3f/8XnnrqqfDnP/85/OAHP4g7z3777dfOZTbGDBHNpt48/vjjcSaaAVZRqgLP77///nU/j/PLnZ+6M4x+aHS/zxIM2hBS++yzTzjhhBP6LSs5892WCjKcaSa1p93pQM1Gh6ok5PW9DG6nTZsWbr755nif4+fcc88NM7eYOeDj2Awvuq2Pnc4jtKwY+Vj9yTvc8UyXiyVCh9/85jfDLrvssthzG2ywQbxtu+22YY011ohGDxZLxnQXA029ueSSS0IYtSglIQ8eX/buZaMQO/DAA2suy9Zbbx0mrTUpPHb7Y33vTWe3x98+PkwYPyF8/vOfX2xZEUw8zrJ2QyrIcKeZ1J52pQMhMEhTJ/0TEBaNRIeqUtOhCBfL/oMf/iBcffXV8TjqHdcbwqwQekNvWOLZJUJYGEIY0fxxbIYfRdHOTqwj1Xnk4x//eLjzrvqTdy5RGQZiiR0Y9VwPZpK4MBhjuouBpt5Q28hgq1aqAs8TBaoHF1HaFeyw4w7h0dsejfngpDkwe8dFCaE0a86sMHPzmYst66WXXxr7e3zlK1/pilSQ4U4zqT3tSAeSwOBz+TxBfS8TDWWiQ1Wp6VCE68STTgzXXHtN7nE0/o7xIfSEMHPLRcKwmePYmE6uI9V5hGABvf1oWVE0ebf22mvH8THHRScIQbM4mXmhfN773veGY445Jvztb38rfM2TTz4Z0/C22mqrMh9pjOkQaBNw7nnnhhlvWZRCJ8Gj1Bse5/lHHnmkZp1Rz+yeKGby4MISZi9qUVAGJm9u+fUtsZfSW97wlvA/K/1PeMdb3hF+fMqP42Bv5ltnFi7rlVde2Td4pcF21S/Kpn5qD79j2d+zmfeUFRgM9rgRVULoIMzLRocYRCHaGDzyev4OhZDnu//1r3+FK664ovCYn/XWWXEmfeSskQM6jo1J00+ZGOCvJhiqTHoeOfeX54a1J60dxt82Pqx8zsphxQtXDCv/YuV4f9KrJoXTTzs9Hs9EnRGGatBruiyyxKzyAQccEHbfffew+uqrh3XWWSfuIDSgRVkjlCZPnhwf57XGmO6Ak7pS72ql0E28e2I0gfnsZz8bZ8WzqRQ77rhjOPW0U2umKoS5IVqrZuuM8mofNBtJ+wJchhQduPjii+suK2lCv/3tb50m1CU0Y2TQavMDpdDBggUL+qJD/B/KRIeGuqZDqVDM7F9//fV1j6Nxd40LyzyyTJiz6ZzFjmOOW2PKUJX002bQeYRr1R//8MdoD871CDMHHsP07NWvfnU8H7z88svxL0KQdN1VVlllqBfftFosjR07Npxxxhmxh9JNN90UZ5qffvrpuDPTlZgQJHULO++8s3P/jekiswYGTzxfN4Vu7KLUmxkzZsTUo2wqxfrrrx923mnncOXVV+amKky4Y0K8qDAhU6YmqqgYnnQ/3tuKdD9jyqIUOiJKRJMQ7xJMjUSH2uVg10gqFDz33HN1j3mlvoKO44l/mhiPV5s7mLJUJf20FTDZd8455/RNeLzwwgvxmGKduAHXqF/+8pdxIoXro/uTdWGfpc033zzejDHDw6yBE/5yyy3Xl0JX5PbD82ldIwO+1MmLGzVNDCZ/demvYiSKwRjvYyYaofSPR/9RuiaqaDaSdD/WpdayOk2ou2m2SS2zvQxuYMyYMXF/brRRLccW+7hS8sjAaORzhsq1Mjv5sNJKK9U95kfOGRnGTh4bxk4fG48pjmOdP4wZjpbi2forpbTSuJYJiIcefihMmTwl9Cy1yDDF/cm6UCz99a9/jWqYkzA9ld7//veHbbbZpr1LZ4xp+QCKWoTJUyaHWW+YFV7Y5IWawoTB5nve857wszN+VjOFrndeb3SpY6DFxS4vlYII9UknnRR7s2kgx7mEZtYf/OAHG7IVL5qNJN3vtNNOq5vu5zSh7qTZJrUMaLQ/6THSZlZdddWmGtUikoaikLtZ18rs5MP2228ffvqzn9Y8jkYsGBE+9alPxUgax/Guu+7qiJJpmKFOP20l6aQDkSPa7mCSwrE4f/T8RRMQoSe8MOmFMPMdM0PPAvcn6yqx9Pvf/z7aga+33nqxLmn69Okx3586JtuEG1NtNIDChIEjft7oeWHkEiPDuHvGhZEvjgwz3z6znzDhdQysSJ3jokWa7Y477Biuvvbq+Hw28kPqDa0DlIPNoKtWKgWCJ7UVpkapTJ1RakdcNBvJMrPsEn15y+o0oe6l2Sa1vIbXEhXSvotYGspGtc30NGvWtTI7+bDaaqvVPeY5jo444oiWra8ZvgxV+mmrSScdOM6uvf7aum6S7k/WZU1pmfn91re+1ffYRRddFGepmFnC6MEYU00OO+ywcP6F5xeftMP/twCWWQODNI5tZvy40WeN/ir0XIkpdGMXpdARUUIoEfVJacTJi8Fgo3VGtWYjlQbE7DoiK/aHcZrQsKDZJrWIBBk08B69fyiKzJuNDg2k8XPe5MMhhxwS6w8vvuTieMwHDmUfR8YUokmHp556Klx+xeXxmlt0LOKUN2eTOWHB+AXuT9YtYglDB/qSpBCm/8Y3vhGd8CZNmtSu5TPGDAAGUOeff36YuUW5k7bMGmbNmtVn38qsNulIJ514UvjoRz4arr322ph/TX0QqXfMQjPAYsDFxAnvUyqe7F9rzRry+c3UGRXNRjKQZFaPQWGa7uc0oe6n2Sa1cq5TVFTvH4oi80aiQ2l91rnnntt04+eiyYejjz46tg75+9//Hm2PfRwZU4wmHegD2IibJMc4kyI2HupwscQJefz4RTPQaf0BkKpgjKkmZ511Vli4xMLSJ22ZNWDqkJ2RZ0D1xje+MabjMiBlEMprlllmmb6ojuo/ZJOK6OICgLAqKnRHxDBr3uo6o2y6n+l+mm1SO2fOnLhPU38jtF8PJo1EhxA3aX0Wx91AGj/nTT6wLUmvpX8izrfGdIJhy1ChSQeMYuq6SY5dEEa89N9oNtfdWT2LjbNNBxo8XH755eG2227r9xgzb5dddlm/GV8eI33HGDP03HnnnfGkXPakLbMGUuvyZuTr5ZbjKMYAK372f2foGYBiKc7FLq/QXq0HXGfUuVRlQNNMsTjPETkdiBveQGg2OrTPPvv0q88i6lPPwc5OkKbbDVuGGpZrzTXXrJstgZvkwmUW9rvuvuMd7xiCJTYtFUu/+MUvch+nEWWKxZIxrYd01+uuu66hYm8NwDgp1ztp947qDWP+OiYWbu+w4w5h+eWXrzsjnzdA1mCz7/OTVCil9eVd5Fxn1LlUbUDTbJPawW4SKbty0tsAc4lGokPZ+iwmOE473U6QZngbtlSBMtkSXHtfnvRy33X3TW9+U0x75fzJ9fdLX/pS7NtkOkgsPfTQQ+1fEmPMYnChOPmUk8NNN960WLH3nnvuGW24uYBkZ9CVDoc73N8f/Hvdk/a4B8ZFG1NEGJ9Jyk2tGfmiATKiKEUXuHqF9q4z6lw6dUDTLsq42On4yR4zDJLKRoeadbBzw1jTzYYtVaBetsT428eHsFQIK1+5cuid2xuWGbNM+NOf/tSX6TFyysjw+w/8Prxm3dfESVKnwHZYU1pjzOCCA+WNN92Y62R34cUXxllpZqAA0wUGUVxIeJwB7E477RSbwMr1LvekHULY75P7hY997GOlB1JFA2QMHki7o1geNJBj1rxMV3bXGXUenTqgGUoXOx0/cuDjL8fMu9/97rr9jVS/V+RgRwrhhRdeaCdIMywNW6pCmi2RdZBd7zXrxdpfJkduuPGGOLH5ypqvRKG0YMyCGHFaaupSYcrtU8J2220Xbr311qFenWGPxZIxFUOz8o888ki48KILa9qPXnf9deFDH/pQTCFSt3AEi2arqcXY9n3bxhMyrneYOcSZK1LzKCrt6Qkf/vCHo7NlKwbIiCL+YvAgwSQr5k7tym66d0DTyjqsPBe7JZ5bIoz/0/jYu+yBBx6IDZOZENDxAxwn2nakLjYSHcqrzzr++ONjD0Q7QZpuNWzhOFQqalVNH9JsiYsvvjhMnTo11kHusMMOsb4Q86O77rornP3zs+PrRz0zKiwYtyCMnD0yjPvzuHjsz3rLrDDljinhjjvucEreEGOxZEyFUnWUnsNF4KqrrqprP8qM1S233BIHUKCBqoQMA7EvfvGL8T7h/J6FPYvMHP6b+bP3Xnv3zYC1YoAsBzEGcEWOeaa7aMaBrtvqsBZzsVsYwoTfTYgRIiY35k2cF/7y97+EzbfYPB5zRIPZTkwuEInl/zqWGokOFdVnOUJruoE8wxYeo9avKjWS9eBYTFvvcG55+umn4zF/7HHHxua0szafldsD8cXXLHqM6PQll1wypOsx3LFYMmYQBRIzTDR2nTx5cuhZqicOhAjNH3vssWGdV68T3rnlO2Mqzuqrrx4vCHWLvcf2xtelSLwQYeIvA1cstPfdd9+YF82M1kD7pdQaIHdLN3bTPge6qpNNM0XQsL/TbHLChAl9QrDIxW7CHyaE0ZNHh1lbLD4IIvrEJAbRH74DwaSBH5/N7LOjQ8YsIns9YYKxk2skuV6TeUEWyHPPPhfPEbV6IM4fNz/8+c9/HsIlNmCxZMwg1jL09iyy084bRP3j9n+Efz76z3DW2WeF7bfbPkac6hV78zyDqxTVB6lnDKJp6aWXjp+3zjrr9Iv2cJFp5gLTjQNk0zydLJDz0u3SNFOEDYMbOTpSD8iEg2rzeB0pNprYGDlrZIwo1RoEETX63Oc+F/uP8V0SYOk2dHTImMVRLSTHLcfkM888E2666aZ4DGOsUMYpdiiJPZh6e2NGCOeLej0QR74wMsxdODeeM3DHowdiJ0ftOxWLJWPajGoZZr5hZhh3z7i6M0mzN50drrvhurDl27eMTjm1ir0pFt166637HkMYyVBBIIoY7DEzrt5HvI6LzUDSFzp5gGxMrXQ7RJNS43hONYBETzm2aGLLc5qYQPRoYoMGzxzT9XolEWF202RjGoPj9LHHHgs333xzND4gBZaobhgfCg1VqhphwgSmZg/EMQvCEjOWCL0je8M555wTNthgg3iOIvPEgmlwsVgypo01SY8++mjMNZ65xczQM7en7iCKmaQwIoQZb5kRbv3drTEt73d/+F1hsTe9VTBx0Iw4tQ4MADmhMpBjQMfgjxnw1MabAR4zdDzOSXuwe8yY7qYqTWqbdXVkmRlo8X+e1wQDj+m+Bm78f6uttooRYSY2qAmkULtMryRjTHk49r7zne+Eyy6/LB5H80fPDyOXHBmvrS+u8GKY9f5ZYfSURamugMFC1eAazeQlGSF1eyDOHhkWjF4QX4NA/Nvf/hb+8pe/xOjU2muvXfkoWjdhsWRMiwaFDJw4mR9zzDHhiiuviOYMzAgtXGLhIiH0p3F1B1E41THYmr3R7GjewIlw2222ja53ffajc3pixGnnXXYOXzv8azEsDywHNy0HN1KFNLCTc53uA2KJtCJO3FUczJrOo2pNaptxdWQyQWmmHB8cR6SyIpgY6Oj1eg8zvdtvv308Tl9a7aU4yCnTK6nb6RTRbDonS+PyKy/PbaWh9hgzt1zU5Jm0d5zoqiYmuNaSxssEy8/P+Xl+5sjCEJa7drnY+3DEvBFRMD0/5/lw4JcOjE/3LNMTn+uUKFo3YLFkTBMXex5nZpiBlMQHf0848YRw/Q3X953MEUhL/WupeFJfuMzCuoMoZpp4ncwb+G7c7Pbee+/wm9/8Js4ocfJ///vf31fvoIJR1U+wbAzu0gEd5DWM1Wx6pxTHmurTSU1qa9meK82UY17iL3WtUz0T8PiXv/TlMH7c+HDBBReE3tBbqldSN9NJotlUn8UcJwvS2OdsMqcv1ZXsjqqlurLvkw3C+YMJlmuvuzY+noo/hNKoaaNya5vpjbjwlYXR2XbuynPDueefW9ko2rAUS08++WS44oorws477xzWXHPNvp33u9/9bnjwwQdj93DctmigZUynokEdF3aECPdVm8CsMhd7ZoaeffbZvkJNgbsN9txpX6RUIL207kuxf0KtQRQnRF4n8wYKv4E0uU996lNxoAEMQhBqEkcsB12+WU6EU5oiBOlyirQ30nBrIGraRyc1qS1je541M1ENoCy/EUyIK45Rudjtt99+4f477i/VK6lb6STRbKrPZZddVreVBmns1AzO2XROpVNdOb9wzjjyW0fGccWVV14Zxt2Z9ECc31OqtnncX8aFV1Z8pbJRtG5iUVe8Otxwww1RBP3yl7+Mha0aGDLbjRXxe97znnihOPjgg6OgMqaTUJSICQFqjZ577rl+fYJU5M1Nlp9ZoQREfrIncwkfBNKC8Qvic6QLjPnrmHhCBJ7nfuyr8LoX4+uy5g0M4BhwsFzqMcGAgxOuRJHc7wTLzok4RQNYBBLvJbUIOr2BqKkOqTkCVLlJrYQQkxL8n795kQ/ukzbHpCDXOmaGieyOHTs22vAzSJHA4v8Mfvb+8N5h4u0Tw+rnrh5Wv3T1sNp5q8X7e32of6+kbqWTRLOpPlyj6xoi/DeNvRNSXRVhOvUnp4Ybrr8hTFhmQjRzCAsWrUstUYhwYvQ+662zwqh/jwphyRCjaGaII0s/+MEPYtoPhXXKiySiRN4lAmqjjTaKj9Gd/IwzzojRJ2M6LVWEGWL+ahY0C88r7SaPvL5IqUACTm6aGWIWjFxkrEERTurYjXBi9pkQPYMzzWDzV/UTiijxuAamWjYEkv6fphchjBjcpSl7fFanNxA11aLTmtQ24+pY7z2sL2kxzPaq+fRAe5t1GrVSHI1pFIQPbndl0tjjZOPc3rDDDjt0xIZGNF1zzTXh73//e/j6178e/jXvX6VrmxlH8FhVo2jDSizhY7/77rv3CaWHH344Rpv22WefPqEEb3zjG8Opp57avqU1psUgcBjYMahL6w+agfS8vL5IM98+8/8LpDvHhTAuhJ4le+LJffyC8WHO/DnR+nTM9DFh7PljY0Rpp513Cl895Kt99UfAIENRLh6XTbjEkhzuWJc0osR9UvQ4IaveykXXpl20swdXp+27w7FXUprKzDlJzpxVF82m2jDRgKFBvTR2zBGYbNxu++3i5GAnoOv2pptuGnbcccdw1rlnla5tjsJp5ohKR9GGjVh69atfHdPt3vSmN8UBJVElLlDkZafcfffdtiA2HZV6h1iComhSIxS624xY5NBDFGn8PePDezd7bxxEvfe97432nzS0vP7668P06dOjs90222wTJk2aFN+q+qPU0S51tdP/OdGqKF1/Wce8QaX7I5l20459zIYB1Sf7G+m8ilii1qvq4tZUFxrOUusnW/A844OeET1h/L3jw/bv3z7s/oHdw49//OMo0hESVbbZTqOwXP/PPOvM0rXN1EQjELvdMKYjxNJBBx0UhRFdkkm9o2bj0EMPjWkFQH72HXfcEf/yWmOGknqzzzzHPpzmzg9UKAGRm+232z42lM07mU+4b0LYededw7eO+FY8McqxDtvhT37yk3F5FNVKHbcgFUi8hsEHs7SarQXS7EjbE57BNd2EDQM69zdCKHnm2wwU1fphaIDbHWnvYVaIKXeIKSYsqfO98MILw8c/8fFF7TvG9caMjyrbbKepy1zD1YYA8izSVdus2mdKX6oqBIeVWNpiiy1iY03MG2bMmBF3SGbFxdlnnx0L3r/yla+Ej370o+1cXmMK4URDpEh23qSicfHGuY7CbdLklFZapsg4jTbxWRIqWZhBBQQMkwW875prr/n/fZFm98TUOmZ+jj766JgakNqOp/n8NKyTC58+V0hM8T2Q10jTVIdOSxmrOjYMqD7+jUw7KaoFfPvb3x4FOdfDH/zwB1Fo5PViqmqz2mzq8je+/o2w1KilYvPdCXdNCPNGz8utbSaaxmQrGSmqz9pss83CJz7xCYunFtPT24op9YrzwAMPxL8bbrjhoH83swVYq6+//vqxbsS0Hk4wnDQVxoai3VoF57XgNbqlER1mTLMNXhEuRHQYCKc1Q//85z9jah3LhUh797vfHS33dVKENF1FESI9p5MmEAUjagVKsZMjXva9HoxXg2w60lD9Rp1+/kkFJ9tS1t3pJAETIY5aVGP/0SRQdiLHv9HwZLDOP+xjXCe57u77kX37te9IieZJt08Mt912W0eICdx5CVSQtTVlypToerdw7MIwYs6IEOaFMG78uDB71uzY+D61Heffhz/84XDMMcdULopWpf2nEW1QKrJ0zz33xIXlIlULZuzPOuuscNhhh5VdVmMGBAOpp59+ejHb7CLKmDekESQOUCJBRKey9UKchLjx3aSnIpqo6cNeH1thQv6y7+Yv72XAxzIzuKtVBK+/nCy4CPB56cmC1ztqUV2cMtZ6wSk3ShsGVJdOc0I03YFsuEnPq9eLiUgNAuTLX/5yqDoIOpaT2yOPPBLOOeecWNuMydpDDz8UZs2eld+49o7x4fwLzo/HYNWiaF3dZ4l+Sij2FHIqH3300cVmlfgxjRkMcwaMEbiVFUplQISoAS0CBUHDBZ+Tzvjx4+MMqdLdZKrA6xkgkKKKUFK6HAO7NBLF/9M+I2nvFv42EnEYyHvN4BiH8PtLdLeyx0y6//OX+51O3jqlgpPjTDOksssnZdXR1PZt/3b2rTKm1bCPcR3Otu9I4XFS2mhwy+R+p5xDlWZPtGje/Hnh4SkPx8dnbb6oca3WV41raVHCeOPcc8+N0SkzcEpFlvJSmhBPVd/BTPfXJDGYGgiKFhE9UjNNRXlATWAVIWIArAGvBsISa4oeaUZVxw3v0fe4z8jwiISoLxZ/iQhqnxhoXVk3OsIVrZOOJf5yDOEMqYkLcHPT9m5/pQQ3it02zVDBxGFe+w4R3eNeGBn+OfOfsacRphCdcA5lHKJUw+uuuy68vMbLYdQzo2pG0Oi/1LOwJ9Z2Dbf2BUMWWTKmKhd0ojdc1BmIDkSsMwAjIsQJEmt8wt2rrLJKjNQglBBIjz32WEy/08AXExO+ExGkGqa0Ua0EkfofKWUvdbhzSkr3kkZCSFlm/9Ign/2mFb99NtrCX6V2dipF65Q2XNZ9YDt2w3pXJTrUjfuUGb69mHpf6Y2223lE2+35PbGv4a9//ev4WCfs78pWYZlJM6Q+acG4BbUb145eEHoX9Iaf/OQnYcsttwx77rlndK02bYwsGTPUcCJj0NmKlDsJGlxksoNXiTKEkQZqmsnOmjuAZrv1mYoipT1GeJzBs/uMDB8nMP3mzFpyn3SkVrjhdaPbWNE6cUMYcUzKXIXtymPdsN6tbgDLuUj7XiOz5bX2qU40BTHDFyJF6623Xnj49odr2m7TAJ6J1zQbpMrnEmW9sMykGS4YsyD2V8qLoI2cNTKu6xKzFg3vZ700Kzz/7PNhyuNTwu8/8PvwmnVfE6NTPrbbJJauueaa2HRWsINdffXV4c477+x7jBChMa3q/M4JTAKDxwaScifBk36mvi81V1C4W0JJqXPa57nxOgYkvI771DYxUNHyIej4HiILfHaVw/umdTbfaWNBXYDZB2o5gTX6vdnvkBlJJ9vGF62TjlO2D6m3HFeYqKQ2/p283q1Mn2PbcGPbqL5L+1a9/bgb9ykzfMFCe/IJk8P428bHVLQ+l7h5/992e+z5Y+N1m3N0J+zvynbhWkKa4cuTXg7j/jyuf+PahSFM/M3EsMw/lokCav74+X1243NXmRvXe/SU0WHK7VPCdtttF2699dahXq3uFEtnnnnmYo/97Gc/a/XymGFci6SieMGFm+eYIU3NEhpNtdPgipMhAzCc60hVAZ7jxnczEGPQmqbV6a9S7xh48Dr+z+s0EK4l9CyUqk2r6oAadQJr5nu70W2s1jqp/oX/p/Vg3bDeAyVNn1NNpVIWOUeVnS2vtf3T87ExncDuu+8efvjDH4ZZm86KhSYjXhoRFi6zMLy07kt9jVzpe0i/ULnXco1Xan8Vr9csE2UCNNz9+Tk/D0tNXSosWHpB7LMEL673Yljh8hXCEjOXyHfH++/rZm45M/6dctuUmJL31re+dUjXq+vE0kMPPdT+JTHDgnQmnQs7A0TVAWWRIFEKTtoktp5A4uTCBR9hpNQ9fXeKao5SQaTIUNqzKbUMV/5wOlhzUXPn0iqb72xjwbxIUZm+QbW+t8x3dBpl1qkb13ugpOlz/E2NZhqZLa+1bRFRxnRaKh5tO2hAO+MtM8LsjWb3CYfYZ+lPE6ObM2n4mkzgWi4n26pmgnBMUlu93bbbhetvvD7MW3peWLjkwkURtNvHhZ7eniiU0v5ScscDXjdnkzmLzB/uHBcF5YUXXjiEazSMa5aYnacnEw04jSmaSeeEpLSRevAa5euqp5FEDaSGCkR5aACrE93jjz/ez5WuHkqxk4uZBJO+QwMID9a6i1bWAdUSzdlIEqmboKhA2e/tRmFeZp26cb0HQpo+p3Ojzo+NGop0yrZtRbqs6X6OOuqo+Je+S8vevWys8wmzQowo7bTzTuGgrxwUjx2haz40Okk2mLBcX/jCF+J1gtIYmtE+u92zYfnrlo/CqKY73p3jwpi/jYl249Q8Pfnkk4O+/J1MS8USEaj9998/dtw1JosucmWFEmiGlJ4qvFf1RIoGMSuP7bcumnKE4rWx50IDqXuqMZEgUpRK/ZTcz6izBlLaH+oNrAarZiMbwWIf1vKxH3dC7rxp7UBeKcgYygDnuXTCp5H0OZ2nSMHrxhTgbrTNN+2BiQKasTIexTqbMQHHBal3kyZN6jvfp3A+rrrRw3LLLReX/Ytf/GLYcMMNwzHfPSaM/evYmG5Y1x1vzIIw6t+j+uzTn+99Pp6vnnvuub5zFp8/nFOba2E3PDNoKH2tEQHDoJITHwMIqJfilF5MNVNUFr5HA2ZOGgglz2B2BuwXNBlUCqWMOVSzVmtg1e46IF2QGBArSsnnsw+zr3LjMdfhDK+BvPqmpAM3HiPiuOqqq5aKtKXpc+yv3SaQ2pEua4YPpK2pxxCCST0as2ZR2p+UyVJVOL5JH6TmGuH3y1/+MkaIFi69sNAdDySQ5i01r88+nUnmp556qs8RkHMI56I8l2BTcbFEhOqII44If/vb3+LJcI899ggHH3xwn7OZ6Sw4CaXmCWXqj3CsSSM6tS6K2YspaMa23vcweFV9lMSZL8CdAQMmhBIne4kOpWrKkbDWwKqd9TB85tNPP93PoITceC5ULBv7mm5OKxpeA3k5b2o/VWQRsVRWAHRK+lwr6EbbfDN4pJNi2bFHWp9cZaMHrcfyyy8fI9KnnXZa+PCHPxxmvDAj9Czo6e+Ol9dfamSI9um9Pb3ROvyggw6KApLxzr777hte//rXx4k9i6UOEksMKD796U+H3XbbLfzoRz8KDz/8cAyprrvuuuEDH/jAUC+eGYD9pVLcisQSz3EgI5J00JZxm8teTJVeVRRh4nWE5ldaaaVS6VqmmrBfKKKkOjMGruk+Vm9g1a5BJxcehBKDYVBNCfsl+5qt5YfvQF4mN5r8U2sCHmMA4/NRf2xxbgZCOilGvyKJpvQ6wXmaCdYqGz2kwg9OOeWUKHReWfmVKISgyA1v1L9GhbkrzQ2jpo0KUx6Zsig9D2v1J0eGu790d3jVmq8KP/3pT4d03TpaLCFcytBK55xHHnkk7LjjjuHLX/5yvM+A9o1vfGO47777LJY6FNlfKl1KUQBQrVBaf5SXrqLIFAMM2YrrpJZ3MVVqneqc0kiSTp6yJjadiSJK6e+r3z91MWykHqhVheSaGNBysJ/L3bFVjWrLwOCAmycDqjOQ5znVrqX9Xrhpdtt1OYtPlPGX48hpq6ZR0lYEjCnYtzjWNLnBJK3GFlVO70yFH3WOu+66a7j0skvD3JXn9u8v9d/UPJi3/Lzw8lovh3H3jAuhJ0Sjh6yoeuL2J8Jn9vtMuP2224d6FTtTLG222WZ9F/tapIOTgbLJJpvEm+CC8o9//CNsueWWTX0eyzYUNqhyXEmdV4YzDGoRvszecJLiosfBjngRpKFMnz69b5vl5RhL/HBSe/bZZ2O6Hp+hegENWPj88ePH90WOeI8aN/K93K+yPa73n8aQcUjaUFiDWKW91fu92deICOkiyr7KRYk6tnQ/LYMGwRoQKz+cix0X5nbvfyw3681f9vuBrIsppujcU2t/4zleo/TfdL/V56nXnM5xw+38kz0WlV4rc59OOIcPZ4Z6/6kFqWc6H6qHosYa3KZNmxYzYZTBUsXzJdcQbnL/QzD1juwNvSN6wxIzlgjhv8k7WIxzf9yziyaFEUpFFuOP3/Z4OP/886OBBOMkUv6WWWaZrtx/GtEsPb0lqu1xE2lEBKFyW825554bTjrppHDTTTfFwW8jPPDAA85r7iAYQKT7W9G+pwunBqNCgwzN1JruR2lu2WLdZvYFpfNl0ax/o+RdZLPiv120el1M/e3dqv0tJXuOGy54/zWDvY9lMxPS/otVh6ydn//857GFD+cLRA6TLKr/Jkts8mOTw78/8u98I4j5PWHlc1YOm26wafjud79bOFndTSAIEYYtiSxRNzSUTJkyJRx77LHhyCOPbFgopQMW6p0GGxTxY489Fu0qh0qddxKkCpGvr94zkD1J6QQmVzFmF4di1nUw8P5TDk7mtaKVjSDr+fT9fL7s45v5DdmvtWzsq4N1LuDiycwpM6M6ngayLqa9sJ+wH7Pv6TzH7zVU57ihPv+0+lg0w2v/aSR6qYhSWuea/iUaT5Slyqy//vrRJQ8UHVPdJOv10Y9+NFqI17MYJ0UxXf+JEydGh85u238o9+l4g4f04oGxA6YOO+20U9OfI9OAoYIfeii/v1Pg95a9smZ7UhvwtBiTxwmdcwKram5xq/D+Ux9qgJRrzoCz2focjlPZeadRKqU8NArvadVFttFaKgxMeL16iA10XUx7YZ/j90nbH1ThHDdU559GjkU3rK0uVb9+cZ6Uo2oRPId4V98mxDqBBOzJq4b6TWZbtRBZGvlyfYvxabOm9Xt84cKFXTl+biRjrtJiCVX5+c9/PqyxxhrhsMMOG+rFMYNAXtFzNlwuNzxmO2zx3Vm0c0CT7XVDHQM555ql5zHNUKv4Pu/72913aTB7+RCRoP5PM6ZVWReTTztt7DuRsseiG9aagcDxpRYOeSln9COiyS2uzD0je0Lv+N4w4sUR4bjjjgt77bVXrBmqUk2TWhkgAtP1wUBr9pzZdS3GF4aFsXxF6Wm9vb2xt9NwPh+VEkvnnHNO6Q9kUIKN4UDhx/nSl74UBztnn312PBlyY4aJHcB0JxyIzH4wEEzT7zSTWGuQa6oLxy7HMimWQJSj1U5faa8b9auRCQikeem8puj7qzpgbaaXDxdwjiNEE1RlXUx3905q1aRI2WPRDWvNQGHfSmsOgXPnySefHK677rqwcImFYcGyC8LIOSNDz/M9YfZ6s8P85eaH8y44L74WMVW1VgZcZ7lpLIUb8dRnpvZZiS9mMX7H+PDia18My/xjmdjw9nvf+1583bx58+K1cji7c5YSS0cfffSgiyUU/G9+85v4/3e84x19j7/5zW8Ov/jFLwb8+aaacACSG8vAWg1lGeg5glT9QREnZ8QJIiX93YCICCfZtOhds16tsmhNe93I+TBF363aHb6zVqPaKlwM0u3LJALbS7PsbL+yTTmJwlY5DcZUD/Yz0qI5XvS3zDHR6ihPmWPRDWtNq6KYad1SFEo3XBdmbjEzX1is92KY8ZYZ0YDss5/9bFhnnXUq18pAE2ZAFOzev9wb3fH6WYwjAOf1xHWc+faZYdQzo/omNqH3vxNzSoutsq36kIqlhx56KAw2r3vd66JgMsO3H5Op9mwxvxOiVmF+npc1tiyPEU4SRWkNGkJGbnVlBvuNXiCyqRTZujctZyu/v9Wkg07WKS3UZfllBOCUOtOuKLCOE5mnlBE8QxHlccNaM1AUxWTf5Try5JNPxogSQqnIZhvBMf2D02PUiZIRXl+19NWUjTfeOCy91NLhpQUvxeVe+tGlw4iXRoSFyywML637UlgwfkFf3dKEtSf0M3lYuHBh37W/qtfMdlLpmiVjTDXImy3WQAoxpG7o2doypcJJKPF/WbIq8pM27nziiSf6FdDusMMOMSpSJp0nvUBkOyKk9/l/2gS0bKPawYJBJe5MrAvLSHFr3sVJonC4zfCZ9h/nigLrWCWqVHZGeSiiPFWtMzSdBfs2RkFMDJBWhwgi2pIHjxOZQXAQnbn//vvj9asKhg/Z9FXgWszx/LWvfS187etfC0s9vVSYs+mcwrqlffbZp++x3iQtkbS+ql0zBwOLJWNMXfJmi9XoVLNOQgOs1GmG55U7nQ7CNKDhsw8//PBw3nnnhZ5RPWHhuIWhZ3ZPOPa4Y8OOO+wYvvKVr0SBRioa4iyvdi29QJA2JNGU5qCn/+f5qg2oWPann366T1RCrYabvIYogCJ9xgx0/0ujwMC+yI3jt4zgGYooT1XrDE3nwX5DVtPkyZNjjVJNm21S2F4YGW8YP1x88cXRnrsK+2CavorTnyYS3vrWt4Y111wzPHn7k/G5xdILbx8fn8fcITvp2JNcs4cbFkvGmLopd+qgrVQ7zRxrUJ9t6qdGfvyf2iU+h0EYAy4NxpjBUy3aIYccEgtlZ2w+Y7GT99XXXh1FGa9BODBDVmTQoAsEJ3N6RWh5tYzqNzRYRiGNFroTUdLAVNs2r2+4trG253DMIc/D9tEDQ1EhYP/ThIeiw2UEz1BFeapSZ2g6G/ahO+64I4SRYVEtTy2b7dkjw8ixi+p9epftjZEl0ldbUavXStSCADguTzn5lPD5/T8fnrztyTDuznGxt1IUfPN7olDi+TwmTJgQMz6Gen0qK5ZodNUIDz74YLPLY4wZ4oFlXsodgyXdZwBFhEiDdeVFp7PIGuCTQiaTB30XJ9xUNDz++OMxooRQKsoNv/yKy8OHPvSh2G8GscPy1qqFkFHIUM40N1PozrIqKqeeO9mIGEiIEmVL65mGM7aPHjiaGFEUWKmyKhQvI3gc5TGdDtH6MD5E17t6NttLPbVUNHoY+9jYeG0bzFq9Ro/rdDnO+NkZ0R4c1zsE3sR1Joa99967zy5c6Ho0YcKEsPrqq/dLFde1lYa93R5tKiWW0ov0RhttFF772tfG29prr10pb3ljzMAHlnkpd6S/QZpao6gRr+Okyf/z3PDSqE8el112WQijFqUD5MHjE++eGG688cbw4Q9/uM/Nrl4txGDONOcJz+x2ZPDJNqZnR1YwChXPprUiyhOnR4Yc8biPUJJYHY455FlsH91aRzD2LaXX8viKK65Y+niqSpTHkUbTDERP6KM0+7Wzo+tdUbpafPy1L4b5E+eH3im94X3ve9+g1uoNxPCB5UMYyR48D16jNPmXX3459lri2jRr1qy+mmXWj/EDQqqbBVMpsURIEkc88jj5+7e//S1cccUVcaMhmNZbb714k4gyxnTuwDKvQBuUhqO0Gj3HhaVZ+E5SF3rH9dbMDe8d2xtnsoBBXHy8jbUQjQyyioSnLpZKV+Riw/LyOmby8qJMzNCpx1iaarfaaqvFZcg65FWx7mqoKNpv2dZVqCEYjIH+QMVBNipEZJh0VvbLTtluwpFG0yy77rprbDg7f9n5MWqUZ7MNz77v2bDk7CXDxD9NDLvssku8FuIcySSXJhuqMJGVPa7Vd4/riDJBWO68lG8m6Hr/m8aemjuxfjJK4nrF9XnccBdLuFFRFMZNsMHpg4Rouvrqq/vNNjsNz5jBp9ZAKa8GqcixKq9AW6/LiquBXAhYHgZiREgwc6iVG87zpNXR50EmEe2qhcgOshA1pGWwnAweswPQIuGpi6Vc6zRLzzIX9Xjis5mhK0pxcIpTMdn9lv1Ejcz5W6UagnYM9FslDtKoEO/nGO1EHGk0zbLWWmvFnkSxjvYtM/pstmXmsNQTS4WepXvCir9dMYS5Iey5555hv/32WyyKxPWKYwl316GesKkX7cUqXQ6sSv9Oa2affvrpON7/+9//Hu+//vWvD7vttltYaaWV4msUuar6ubWtYomZOUWV9Pcf//hHnC0lsoS9ryJL/DXGtAYNfDjZ6sTLCalWnZEGCs8++2xM9+J1/J8TIANHzQalQiiN0uQVaKeiq1bRtnq0qKGwBqoyLWDmjcE/j+HQw3pstdVW4efn/LxmbniYF8JHPvKRtjheZYUk20niJ7U/53nSD/gtmEBSimGRVTI3thGfr0gQ24PHaqVosE61BGBVUpyqRna/5a/qutj3qlRD0I6BvsVBf9yo1gyEo446Kv6VQyvZD2F2CL1ze2M5yhve8IZ4Pdt6661jirTSz7P7INdeTZZx4/pIH8mqRWGYCFRWQwr3T/rRSeGG62+IVuqKrj340IPhkl9dErbddtvwxS98MZ5zGYN0wmRU28RSGlHaZJNNwgYbbBAVJd2KlRIjUJ/MABtjBgaDIyIMGlSnooNBd2qlrcG+nN4kgjgxK6KhZrBysysSP0XRC8h7TLNmqm3KNoQVvEaz1HyfTsqkmG2/3faxU3pebjgpDszyqX9FK0/EeVGkrCNYWuQOLDcXQLYFF70iq2RFoXgdE068j9+K36iqPZ46mex+q/1e16gq1RC0Y6A/mOKgyrVAWjaOSR3XEss+5kxZuB7Sa2n//ffv6/1H3R4pelyLdO3gGJBQYgLwlltuidddJtMQUmQK6BqrGh9eV7V2DyyLjJtSvn/s98Nvb/1tmLXFrMXrtu4YH2644Ya4fof/3+Fd7czasMHDvffeG29FOA3PmNbASUeCghM3JyKJJUVAGNwrhzgNn8vBRmF0TmYyRtDgX2lleQOeouhF+lg2mqWmd/r+vB4NPMZFh5k4CTvggtQbemMHdMwcmMUj9Y4UB4SSZvlaTTobr7QtDaqyM2wpmukndYHonSJoecJTVubaVu1MIRzupPst+xkidTD7/bSKZnoVDVZ/oyrXAmXPSarF0HLpmKuy2DPVAmF04IEHLva49h+uE9xOPvnkcN311/VFobh+kTGx3bbbhQMOOCDuZzoueX3VREXW1VaNeSWUXihwqqWe67prrwuf+fRnopjshMmotokl0u6MMYOLbKRFtsGqZoHS16SkEaS075EEE0JpIOYMqdBIXXaKSE/CXDiUqsayIDYOPODA8KE9PxT+8Ic/xM8jaqNZvIFSNDjSbDzbSvnajcD7iKbxWRTNFvVvcq3R4DNU/X6GatkHa32rnO6XXTYmljTrLwdKqKrYM52Dotfs/wil62+8PszcfOZi0RceDz0hHHzQwX3v5XpXNVGRZqZwTWadbv3drXFdXqzhVIvxRc/CnnD99ddH6/FOmIxqe1NabAPJ1ad2Qtx0002x4ItQI7aJnXAhMqYT4KSj2h8GIzI2EIoQgeqQ9HxqPa3mkkoDSAf0jQiMbL1U2qhWERmRF1nSfQYwGthp2eX+Rk+3d7zjHW1NtUsHR1oPNYBtBrndqSarCNcaDS6dLFCbWfbBWt8q1wJll01ReLaBjk0ijlUVe6ZzYL/ivM+4mIgSQqko+kLGBBOBpJxLYHENYl+syjkpTdMnXZ51emXlV8KIl0fUdKqlhmnESyNiaqGyJuid2G09mEqJJTbCIYccEu66665w7rnnhk033TT+2IQWEUvMqHKyOfHEE8M555wTTR+MMY2RJ0504U/rgNTzQIN7CSIJpvRxza6mYorPJmqTPUGn5gxpY1lFg5TOx/uyjWqzQiMVdUICTh3A22nWoNREzbCznNF1L9PviHOX6r9S8sReETLNqMJg0XSPQG1m2QdjfQcr3a8ZdBxyvBfZN1dZ7JnOgesV18tf//rXMfWuXp9AaplIKQf2Sfa3GTNmVCKqyXUzHVPgdM06zV1tbhjzwJiaTrWYPYSFi1yzGRNMnz590XNd1oOplFj6+te/HpUmYoiZXzjjjDNik8hPf/rT4ctf/nIcYJHXSYOrU089td3LbUzHUCY/Pi/6QQqNitPloiaXL6WVcIKTkJJgkkhSTVKRg172+znGNQjKEzsg4cHnpnUBmpWC1G2PZUhrreSG146BXVpwq9qgrOhRE1eth3piaBtlzRy0Plr3LCoeV2qhMd1OVdMbNeDTMcwxqV5R6bJVWeyZzoFrBpOOOKSW6ROIsJJAl8kPVMEUge/XNZq/LCvrRI+psfeMrelUq55TmFkoQyM1VemWHkylxBIRJYTSO9/5znifHP3TTz89Rpi+8pWvxMco2P74xz/ed98Y038Ar1xgThyqb0mjH7qwp6khivDweOo8qRN1XiQlrxdQvRMVn6GmqUU1UIJ1kPlB2qhWJ1ouBDgBDUZ6QSpEueikdV4sR2rSwPrJ+CLb74jfQ/UNsvnOvjaNriltUEYbVRgsthsXxXc+rfgN2xEVbsVyacDHscwxqZQiJmxS105NKFVN7JnOg32GTKqea+v3CeSamGYi6NpehfolHReKxLKsLPPC0QtjZGz87ePj6/Lc8LgOYmLBeCTP1EkRpmHTlDZd2bPOOiuemEjDS2GWNmslbsxwRb2EmIVNRQjHkk5OGnwLXqfIkE6okKbEpbOg6YCiqBlt2vdI1tUIAg0oVMeUNqKrh96nZUgFHhGvgRhHlEXRMNVLaZk4B2mdsihNkcFR2u+I12oAmApPXpM1y8j+v5NqYbrRAW040oy4aOVv2MqocKuWKx3waRyiSZT083WOrWXIYkxZdt999/DDH/6wZvSld15vjLzo+pMaLlUhqqloqzIv0t6HM98+s8/1btyd48KCMQtiY17EIeBVgJttHlrPoV6/VlBK2eyyyy7RupdCNvqLnHnmmeHtb397eMtb3tIXacIx7/jjj+97zJjhjAbyiJRU6KRwXzM5MglQdCnt1cPAQdEOXegRNhyPXPyVepIdaADLIJc3btnanEbrc0Q6YztUM7SIQKXTgNZRUZ+iVELI63fUyfUt7abKDmjDjWbFRbt/w2ajQ61arqL0Ok0EZT9facH6LsY2Fk6mUdZaa61Yi3TeBecV9gmkcSuRl7R3nybcqhDVVGqtzinZ3oeztpgV5mwyJ9YvLf340mHE/BFh0qRJ4Vvf+lbfeqWkdc5cZ5V63/ViCdXIip922mkxPxO3qmOOOabv+X322SeKJeqZDj300HYurzGVI2+QwEBebm+1UJhaUSYVJqfCg4ERs6AgcYQI0/+VAqcby0FzaPWAqCeGygqlNL2NaLPSCtrhvpXdpqwjxbCsT5pGky6XSCM/Qu/R9pCzoFNwyuGi+OrQrLhox2+YpgErzVWGKWWjQ61arqJaKn1e3udn+zKxLqTrscycS/NSmo3JQjABAXTBhRcs6hM4dlGfJSJKCKU08pJe8ylf4To61PtXmlpLbzpgLM+xfNXVVy22Ttttt11cp6JMMk1YcPwxIcE1XGmwnTohUUossUEOOuigeMsbiHzpS1+KK7/xxhv3Nb40ZjjP8pa90KdNY5X2xU0nFBUry7KfEw6PcaLRYF8paDIt0OPpdzQLyzF+/Pi+ND5EW/bk3mpxpEaSqcNfWnuUbRib1hdpXbU90ya9+jzWRz2WOvXEPdi4KL46NCsuWv0bpuc+Nebk+s/ncQ4rGx1q1XIV1VJpAJj3+RKeqlfUeVTrwmNONzX1YH8ns4oI02WXXRbrkrlmk3qXjbywn5LZoOhmmjI/lG0O8hqoY9pGmuEtt9wSJyuL1ikPJho4lgiwcMvLfumk627DBUZZoQQyfjBmuFE0yyuRUyuqowiHjilOkNkTiKJTnKi4qZ5G7nZpCpqiSvrseqloRcuk9DRuCIsyJ8aBkA66tG5almw/qSLyUhx1slYKo2zPZV1uOt8BbTjSrLho9W+YnvuUHqzoOIPBstGhVi5XUSpt0eeTeqdJlbSuNP1bBbcy0xlssMEGYcUVV+yLWuZd+7WvpcdHlWpCs1EmUvL23nvvhsYTjEXU0kQTrUTRdH5QJHrVVVftmGuI3RiMqUHWICEbWSma5U07Yaco4qHZ11oOdnw3F3Nex0mL92gWt15vI31P2nepFlru9D7LpFS7VpHOnslunPt56YKKmDWKInRyxpKIHM5RJPabgaRBdHKD14Ew1LO9rRQXrf4N03NfGsVVtLtsdKhouaAVqTu11jttSq3oM6SR6iq4lZnOIN3XJHg492p8oGsedf7sV1xjIY1wyniJ+4w92j1ZWS/KpJYiCxq4FnPcsI76P8joSvdVLtApPZgslowpgBMYJ4o0WsP/NSOSXmyzs7zMovC6tO+Hcnh1Qq114ddMEyccXcQ1OIKsxbfsSLP1O5x804a2qcNeKvBwsCOKVK8f00DI1gfIGr0V6YJCQlXd1fn8wXDmqzqkhUiYNztrOdwMMKo029sq0dPK3zA998laX0XdbLtGokPZ5Wr1ts9+PtsOp9JavdWq5FZmOod0X8OEiX2MaxL7r/oQaZzAZIB6/UHavoO/TJIOZU0T38tY5/nnn49jEU2QaKJXx3s24qTH0kmHdBykv2qlYrFkTAfBBZQDlxOC7LU1sNcBrjQxpWUUzfKm5gd5PZCAE2VRfyTelxUTqkVKo1c6WYFEAq9JRZqarlLzVM/2uhUnraLZ+DRtpyhFoVl0sVG9F+vId3mQs2jgx36S7eHl1KLOdQBstXV3M8Ire+5TxFzNsPU5zXx+O7c9n8GMtqJJafRdg7u0XjKNdBnTzIQC16Vs3z+ROtSmTeV17R/q8416OkL2WE4b3nO8asySTkConUe67kr3lwNwJ+DIkjE5F9C0HigbreFxHeD1ZnnzijfllJfOagKzSMymauCfigktQ9oniAEJJyCdjIkO6aJeK3Ww3SmLKqZmPWTJy7JplriZWqpa8Jmsn07YSmEY7jU1bPtp06b1RRezvaU65SI1VHSaA2CzooQIi1J7uZWN4GTPfXxfViCx/zXjktfObc+EGOcIOXmlE2Jq5ZCmMHOf8xq4L5NphHRCoUwaW5oxwvGS1iFXgaVyIsCqMU4NXtSuBJRuyPkAdC6ATurBZLFkTOYCqqLelHQGkv+nB3i9WV71XFIUqZ6Nd97sU1a4SbDxeUSMsoOPwc5zVtpMmtucht0xp1ABuMRMI5ElDWKyIotBDevfThvzThf/GvCRRkF6qLZlp1ykhopOcgBsJm1NTbMVSdex1UgEJ+/c1wqXvHZue9Y3jSDp8/lLVEy98VSMzvLLaIdlrko6pqk+WbMEnY/L9DBUNKaK55u8c44MmrLlAIoecZ1OI0+d1oPJYsmYzAU0LcSEbJqG0u/KokhSI9GU1Owgtcbm5CIRMJiioMjoAngcMZSKo2wtUtogstEmuLIv18BFQottke1T4cFLf/Gf7sfAQE+D1uEcdes2B8Bm0tZkrJKawei4Hchsditc8tq57dn/lTmQntuzJhVp+pDON5BGzny+MY2YJTzxxBN9kZgi0oauur5X0Whmduacw/HDY3Ke1QSM0nOZwGX5VerAYwilKp5P87BYMiZzAU1FU3rBlBFCGevp9ORGj4FmLLxT0aGGsyxnq6yva+UfpydkRcbS0DqpNQgkyM6W5Qmh9DEVg5dx6uOEOxj25d0q/lWflrosQVVnK6tEJzkAKm0t22strYfIe4/qBrLnnIHsH61wyWvntmeAxnbJ1lAg5LKtF9LrgLZN1dMxTTVR7Q8R/7zskRQ56GlCsopGM3MzqbKyC1cbk9SVVsZWjU40VwmLJWMyF9DUMpaButLuyl6sFZ5WyLneiTFLmmrHBZwBAyFsbq0aMGRD6HlNYNN6l6J+EY0gIcp2Te14JQJlNco6qyBWqYbDhVbNIEr8a9tlm/Xye/P8UF9wq06nOADye+s31YCe45lJDfapvHWQEUpakJ3W5LTDJU/ijb8Y3NTav/PqI1phJc77sCtmhlu1JBKNaU+2NEUP9HiV0zFNtWHfo7Er+3EtdFyqJqiKRjOjclJlNZGQmgl1i9GSxZIxmQvoQELEqgNQulpqnVmWtDCSmSVynYkmIZZagZaR2SkV/DMwyIqf1MiilfBdCKJ0EJXmZqcXheE0KGmlXbLEf7Z+jIsY27MqF1zTGjhPkQ6b9mCTq1bRb6xUN5BgUroMMKDjedUjNLIseS55nGs0Y85ycl4ru3/nHRtMrnAeacZ0QWYU+mylEqfnHUjP22lNV1XTMU31YT/KusPlvUaTC9m2IFWJbI7LSZXleIROSF1uFIslY3IuoEVogFlkB84FPa1PUiSlTBRGF37gos+AV3nyrYpWcAJGyGnwU6vTeCtJc5g1MMtaDbPODFq68URbhlbaJUv8Ex1UHw9F8Kp0we1kqlRHwPdyHKWzu0qBURQnu5xFqW78n9oKRdn5LCaR+Pyypg95Lnncl6ucPrvs/p09NmS6QOSMx9jH+eysbXnZbQdpXWr2fKg0PU02VDUd01QftfeAWhOpauxKdovEU5UmEZeq0Uy6KufFVmKxZExJUlc7zdQzkOBxLtycGGTRrBSONH0jm06mqBOvZzY3TxRo5rdVjWCVBpPtL9JKsvVWqTmFBnU8l1oNC7ZhJ55oWzFwLrJLLhrs1oPXsc0ffPDBGJnsFGe3TqCKDWsZyLOPpGKb+wgL7VvZ5cxLdcs65MkdtBHRnn6ujg0EV9o+QOcfRE69fTt7bKSmC0rX1WP8v9HfQg542SbewHJpsmu11VYr9XnGFME+zvm8njMuMI4g4smxXcVJxKUK0pQ74ZrdKBZLxpRsVKvi6XQwq0iJGtgqgpLWi8gRigsxJxGd8LKNaNuBZmT57rTYu9HUwLKo35OKzLN5zPXWtVNqRGoNnBmopbPcRcYZZXLAlapYNNgtC+6FfE4VL7jDMQrYjqhUXlqMjvGyy5l1yBN8VjNRyKyNuFoHSIhpeTT5xLmWYyZ7rsgeG2nD7axl8UDc6uqZ02TXrRMndszQwj5C3ZIcZOtdh1X3w3XVfb6GDoslY0o2qk3z2LN9BBh4Sjjxf+qLlI7HRVwpUIMx85xexBUFk9mEaKVpggZhrOPyyy8foxjDiaxVMqlB6i2BE6K2DftFLbGTN9gFDQAHkprHd3eKs1snMJCmqe2KSuWlxfDZSrXVuUjLX9YhD5qNQqbHBmJJ+3S2QWfaQy0vOpQ9NjTAVNNOHRupC18j4o7JhOw5Uuuvx3hNkYmPGtcWZQgYk6Im6kQ0y0SYOHbY14fbtbVKWCwZU7JRbfbim0ZnOOFxMdXARDUD0EwefTPCSAME9TpI0wDbiQYnrOdwHCikA2f+n/bnEhLcbKOilKaiwa7qOwZaa9SJUbuqMpCmqa2sTav3G5NSx+cqFVbRnXTgX8shL9uDaOrUqQ0J7fTYSHsWZclux2x0KHtscD5lUkICTNEqzrnNpJgyeOXzuKW9ybTsfJ9snIHlSIWSjn22t9owGFOE9mcZLeVNIGSPj7xzvqObg4fFkjElG9WmM66QzvxzkdbFNFvY3IoLJ4Mr1a1odpjHuLgXnUzbKZI0iNC6q0ntcBwkpAPnItcwpdRxYWQ/Kup/kx3s8pvjGuZao2oxkKapA4lKNUNq66tzFoXjedbdeQ55qg1iFrzRSFjWRlznq2wNZzZan7dN8uqriOawLjovK6VPwrDINj0Lr1l11VX7TTxpG+SJQ6VZp+l/OsbtMGka6btEhFLmS7UyPrLiv4p1k92MxZIxDTaqhbQ7NfnHqVBox4mKKJfC9RpwtIu0yRwFzc8+++xiphZsm8FKKxwKGpmxSwfOtQSq6jV04/PrDa4HMig37SMvCig3R7UNKJpAGEhUqlHSz2Wf02CsyLo7u17AgExmDI262GX3XzmDytY8nXxK+xmlfd9qCR5NaPE8g0alEXLuarSXWCOR19TRTIJSaYC1GgEbk93ndLyx37DP5jnnaoItneBoZ4TaLI7FkjGD0Ki2WWMJhBGDY06CzTSCLYKLOnVVcpHSY6B1paCU9ZNDXZ5dejeelBvt6ZJe8CjaLWPFzueUSdkpsmftxu3eaWQd33DKTN0r+b04folY5EVvBkMAS5gprU2RTw3uWT72Q74/aysOLCf283kpyGlPuqJ9sih9TsItL/VIZhLq78SxmCd48gaLSpuWjXorB49qiqs056JlR4SyjpxfNanm49Y0ch7RtTZt5J6d4BjsCPVwx2LJmDY3qh2IsYROlq0SSYILOYMKvgPxx/pJHGjwprTCbq91UTqPIgKqWWDAldfTJS/dQduIfYOLnQaEtURT2ZSdbt/+3QC/Yzbiy+/PY9nfuJYAbnUNQirMOL7T6I1EvURMXq8inROy6H0cC/XSf4rS5xj46RyUd5xI9BQJnuxgMY3UtXrwyDJwTi7byoHXa4KLdXCKlClDNh2U40+TKtmo7mBGqI3FkjEDblTbCtJBknLwW11zJBcp/VUn+myt1XCaBU1n8lKzDqUaakZPUUUeqzVjnV7slFaRit50MCeL+U7EhcX9Ubpu9phVU9gyArgdNQipMCOdVvtddlkVcdK+Kje6NPW41nc0EsHhNQghtVLgfWlfOlDkppbgyQ4W09osfUarBo86nvP6yNVDkywy3xkO51XTPOm54cknn+xL206vHeyLK620klO0BxFHlowZAjS44KSnXHtAvLRjAK20QX1HNu0GhuNFXK5WsvfWIFKpQMywpz1dysxYpxc70nbS1LzsrHcnzgK6sLi4hiVPFJcdVLerBkH7o9JJ86yKs+5vEkC1bI0lGJqJ4GSjQnmRoXqCJ5vOmApBGTC0Kr0xXbc8AVmvb13aJ82YsshERI68qhuUY6RTtAcPiyVjhjCakea9NzJb2SzdbMrQTE0YkR9F20ADP34XBq4afAEXrEZnrDWgU+NiDQhTsdopaOBO+hQXbNKLJDCHe2ExvyPCWFHIdODMcf7444/XrfVrdw0C350954g0IpP2KkodP7NiQK9pJoKTRoWUipd+ro5JRb/zjpMik40yDaAbJV03CcSUMo1F015SxpRBzaG1z+m40PXKKdqDh8WSMYM4ONeMJwPnvAtu3uxqs2iGW31Cxo4dO2zS62rB70BRezpwUZpDahNPXRcDtWxPl0ZmrLNuR51qkCGBz1/Vz7E+KmIf7oXF/I64YlKLk02Z4T4RHbYR+1FRal27axDY31i+ovNLKuT13eynLG/aIyl73qolaGotSxoV0oAwjRDx3fWOk7zBYjsmIPhMGkyrZqmZ83M6yDWmDOz/qn1Ljz0eN4OLxZIxbUQOSqRiZS+wRRfcRi7EavaY1jgx0ODWzma4Va+hYVCS3pcxh1LI8mZ4GQxqMIMIoAdG6lLUbE1XN8z+MchO67qUDsL2SF0ChzNYhXOc56WWcYxqdrioKXG7XfL4Pv1WaR1danvNX5ZB93kPvzPLIAc7DfoRfrLuZjk5z8nkol7ftWxUSE1yW+0clzVvabYfHK/H7Oepp57qV7tU9lwtO3MPck0j6JygLAe3jhg6LJaMaSHpoFoDCqV6NYoGTNnZXA1W0nQZzfwClt/d3iA2r+YrbbyZiiFeywVnjTXW6GtaCWnjScE2yxtQDabgqaJ5gvZhpd0pypAOljsppbBdv5sGxYqypce96uCKmhJnBYT2T4wZWrUfMFiXwOU3zAog7us8wnqwnPzlmOC8kkYZ00aaRF1A0Vlek2ebnl3fdu7Xjdi5l4HXs/1Ua6hm0fXg9Z2YdmuGHtclVQeLJWPakKqUduNuNqVOM7sMnhioaKCvtCcuvgzq25GjX2UUHVJKWF4Nhkj7r0yfPj0OEotEKINC9ZYaqm3YavMEfQ6z/kTLBrpu2b4f/H+ot1lV4BhkH+I4ZLukYiJNYeP/DNjzmq1KQLTLRCOdqU7r9EA23akLnUxNEMsSS1lTFK0bpCl1ebbpgxkhkp271kXbfiD1dUqVVDp1LRRR5LhLI/xVnAwx1aUbMhO6AYslY9qQqpQWRzcLF9sVVlghpvasuOKKceCSd5EdbrOVcg1LC+FTl7msm5Z+C0WhUhGbvpbtmzb9G4oLVCsd0Xgf9VmqJ+Jzm103BqdyR0sLjRmwso+a/jVHRBKy+1q6n7ENa/2m7XTGy5oiaPCv3kBa1tRwIq1Hkwgs6r+U1v4NpI5NAknLKrQ89SJEek/WnVDNPZsRKRKbLFMZll9++b7jg/WhVlIRKfaRVASDRZQx1cRiyZg2pCppUFQr6lELBiLM5HJBHW4zTNmZ16zDFQOMtEmf0oeKonjpgLWouS8zv8ysD7WzWysd0VgHrS/7Eftjs+uGKGJwqpoUmYaoR5dZvOaI84DqDLiplpDfgv211m/aTme87HmEATz7RNqfKK1NAwkp3qfIGeuQFUxpDVTarmAgKXTZSSfVaNbbl/XdqRNdWjdG5K7RiQOJTfVPqwXfo4ksRQpTN0KlbbIsRH7lwNnKSKIxpjVYLBnTYrKzq3kRj+wgP4XHSd1gINqs2OrkGiS5xoHS5ZR2qOc0AGp0+zBQTd+n5pgIpXbYNQ8kOqEaFw2g8tK2aqF6IjGQdct2lnf6UP42yut7Irt1mSUwCNbAmOfyIsPtdsbLkm3omve8hAnLi7sfy5em4EHal0mpZ82QptBlz52aAChq+Cu0nBJc2VRBBM/UqVPjcjZiLMHznJ/57Fo9qJjs0mdpn5CxRipGeS37h5w3WxlJNMa0BoslY1pEUaoSF0Dl9qdpevEA/G/BfGpZzQVb+fhpcXK3woCA2W1Zc+cNQFR4rroK9SxqhLSPjEh7Jw3GoLRsdEIDURXfNzMTzjqoxgMGum7DJbI5EIq2Eb8pt2w629NPPx1d1rKiot3OeCnpPpFOUsi4Q2Jdyy7hnNYQabKhrBtePYpS6CAVGgiWJ598Mtf1M11ObmlPJ50/WH5uiryWjebgrqkoUXYSjO/g/Wl6qlKA0+VP0bHZrh5bxpiBYbFkTIsoSlVK8+pTYaAZTs1ID8eBqNJtag0kRFooD2oYqwGenMhUKyIXKgY06aAmTRNiUKd6jXYPSsugfUH7CPcltBnU0dyUfUrpmbVmxBXVALYJn9HJrnWdWhiv35TfLisA+E1Iwcr+JoPpgqUoluqj+D/bmsfZX2QlnopsXou1frtIxVut2k+Oa6Iy6mOX7c2k5eQYUjPlvGh0Wl9WJprD5yNy1TuPc4+2X/a3khtnrWbAStesyqSNMaY/FkvGtIgyqUrc5/FOHPQNxL2KmWfl52vAIpvvsrOncrOSuUMaKcqm2WigwcBJQgPSmqW05qZKvwffzSBV20wz2EofTNeB1xbVN/B/ZsAxCGG9WuGGN1RCpl3ucIOFBtJpTY9QBKnIGa+Rer6BmBZowiCdiNAkhmoESVtr5Hua7XOkFLo0MloLnUdUC5bdN9LUwSJUg1X2fMRn1pt4yE4GFS27JnfSekyQe18n7OPGdDMWS8a0kDKpSp2YzpQ3GIa8AXJanK2BYd4gpZGmjpC1+1YTTc3Y8rzSa1Ihxl+EAgKkKE2oar+HZvslkoTWWf+H1I44ux6q0SIliG3QDgZDyLTLHW6wf1OWOQvr8thjjy1mMV1vO7ONGUwrotrsds+LYmmfSp3f+KuBPQKIiE0tscDr1Y+pERc7LROveeKJJ/rMLopSdFM0mcDr0n2Dv0w+IJhqwXtbGc1Ja6/qLXu2DpNjF7HI+nfKpIAx3YrFkjGm4cEwTSgVIVLfJw3UNECoRyNCKe37IieuNDoFGkzoMUVoqhAtahTN9sthMdvfKF3Poa5vGAwh0053uMGCKF+R5TTbT5EPhAgD+6xwym5niWn1dhrIds+bwNE+SFNcpbFqf2O7kyoqYZVFNtmpUALeX3YZeZ4JDZlj8LcMSqnLTtDwmGqWahkztCpNlfVU6l8ZNPHDfj127NiOnRQwphuxWDLG1CQ7SOPiL6thOfppRpdia/6WHSAUoULpFNylVHvAYDJN50NEpJETBmkIpdVWW60S6WSNfm5au8SANa9vl4xChrq+oVEh08w2Hmx3uHaQRl6LUFSEWzadLLud023RTgEpUa79La23KhrEp7b16fKWcbErMjxpNAqt4yV12tQ65NUPZR3sWjHB1Oh5MP0tO3VSwJhuxGLJGJOLBhnMdMv4II1siNRkYSAiKXUQVNqMUDqdBk+Kcul9Wo6BDKTblU6W97lEEVi/WgYNKk7nvWoWqt5SWl99fjPGDa0Sho0ImWa38WC6w7UTljfPZEDR0uz/ea1S3rLbOWv33S4BmUaUslbh7Md5TYllepCXOsdjMrqpV7+UThqoGW49JDB4rZrAAsuj9Ul74ClinXWwa8UEE8d4rXqlIjp5UsCYbsRiyRiTW5Sdpr2oP4xMGiCtFxoIigzJ2pcIEWl8eQOGovoKlnegA+lWppOlQoTP1MBJA062JetYy6AB0vVVjym5/EEj/WHaJQwbETLNbuNa7nCd5JInx8xss9WsNXbaZJnjkPfVMmLQZEI7BKT2ubyJEMQS9Vaa2ND+KKfPolodXocLIOm8WQe7WoYnMoipBecQNZ5lW6fbmc9gW/Ea6hbTZc462DVjTCEUBZSNeBpNrFe/pOOR93bqpIAx3YbFkjFmsUE0g4Rs6k1eel3ehT8vZawI9aFiQJEaRyiakjf4zquvaIXDYKvqYrJCRPVbLJcic5rdLlNr0g5DkFYKwzI210VRyka2cZE7XCe55KW9fxBBihbmkU4WsO2IehQZMbRbKHKMFtVbIZhknIAY4TeQ6US931WTCTKTKPrdFFVjOTieiqI1mpDQ+UeiUql36aRLkfV5alCTLiffu/zyy/f1ZqolotIoIM+pjkr7u5YvreUCtpmiYvw/T0R20uSAMd2CxZIxw4g0f18zxukFmefUWDd1lUsd6BjoKiWm0cawKXyfZl6ztUWN9pgpY7Nc7zNaVReTFSIM0jSgZVsraqC0oKGoS2i1YUItQZcKGokDDXxTm/fh4pKngTqDbPUHkh1+OsmQ9g9TjU+REUO70X5SDwQF5wd+B0wKytQm8Vrel6YcZknTb7WvKCWVc8jEiRP79l8dx5rcScVomZTVPIMa1VkhotLPK3L3y4sCKoKuFMr0PKDJEx0TvI//Z9MCO21ywJhuwWLJmGGCZky5uKeOUMxwy9kqWzuhvxIQaS0Rn5eaPIhsVCkv0sRjfF+RVe9AoynNDCoGUheTpu1IiCh6wvopFU8DI5CBxUDqEpqdZR4MwwQJAVnIq5mumgsr1WggaUad7JKnfZxtwXZK65DyBupD2W9HEY8yEWP2c5aZv6TUFkWksrAdlHJYKx2V31Y9joqc+HhdXo8m7XusC+e8bIQIUge7VCTKyEbun4q254nz7PJKAGWb7Oo3T/uqQdE+3ImTA8Z0AxZLxnQxXESnT5/eL1pUBBfn1GRBr03/MjhAbDF4UqQgLw1Pj+nir4LqNP2Ez2pXPn4zg4pm62LSfjL6Lq0rgzDVLvA+1lepRKy/Bk/NGjRI/ErsUAfCLHu9+op2GyawTZ5++ul+opyBKdtBNSV8L+5jA6k96gaXvDJ1LDJFKDsgbnWqFvuxaq3KoN+hll160fu0nnnrUM+AQcdEveazNNdNBbacB7O1WXm/SbYhtmrGak34sFz0jJLYUppdOmmkCFS6D2e3gZrWduLkgDGdjMWSMV0KF9mnnnqqKRMGpejlzXJn00fkJqXZUwbdqldQobUGGAwe1O8kHSi3mmYjDhrgKFLE9lOjyDQ1kcL01VdfPb4n7SeTHbQzwJTTVhrVasVgluXT4FWilUHXjBkz+hpZ1lrPRlMdG4FIiXoApSJZ/5dNswa/w9klLxV3cj0UmmyAsgPidqRqsU3Z3x9//PHSyyEhkDrPlfkePr+ZdVBvJ/Umq0ca4WX5OFaVllzLwU77r9ImFT2uhSLyOq8q8qy+Svw/uw/zHoSf9gl9pyJRnTw5YEynYbFkTBeRDsIpum5UKKVRpdSWmL8MIiQclGOfN1DgIk8htEwaQDOn+px259gPJOKQRory4LMYuBHFURoV5Nk5SxRkhUgrTBuyaUbpejLYYz3S3lODYRwhJJSzaUdFg9h2uOR1CtpXtcyKimgSQsdO2QFxu1K1eC+RIvb7eo50qr/hOyUA6gkYrZ/MWhpZB4krpXw2ggSMzpV5DnbpxFF2f9YkRb00SbYH+2i6Tqyjakaz+zCTIek5TOddnUdlzd5pkwPGdCIWS8Z0CRowKOWumf4eIFGhgUAaSdKARlbFabSlyOK7yEyinTQbcdDstIRSLbc/xGg6aMmmLPJ9pMOVSR1qxWA/FWqKotUSS+1cFrZJrearwEw+A2++SwKhmfSibLoTy//ss892jHBK91VIxYVMDFiHsgNiRVV1DtBnlW0EW29Z2e/rRW+IovBafgfV5qURxiz6vXWM8r5GIsMSV4rWNEJao6lzHttbJjapOMlG+rTMqlVstiYyb+JC2zh10ASdd3n9YJ1PjRnuWCwZ0wWkKSiNuFcVwcVcNrwqLpebm0QRdQxKmSlr8T1YNBtx4PV5xd0p6aAl7SmTDtLKDnAHkjKl7Z/25JE72FA35dUAOUsaLeHzlYakRq2qaWomvahTncKy+yq/q9LCsuYDEpe19mee06A83Vf5zCeffHJAA2xZn1OPphTQNCUNEOhyh0trgOQEl9YzKqUstckGWYmrPpJ1qrU/SLjwmVknu0aR8YjOaRJqwDYkUszzGEG0qiayFtlGwKDUZraZMab9WCwZ0+GkKSipgQIX9HrpMnlo0CGxkHVzkyjSAK6qKVBFYi0vegLqA5TnBFhr9lyDRg0M03qcet+fbVjbSMqUGpzK3VDLqwEoy9bILHsr07cU1cxuP0U5UhMMOYGxHZWO1kx6USc7hdWbWGhECCqFKzUT0Pam1o4JFaJDWbvrRpaV30uRr7S1AN9HbZPS2GRkon1AA/wVV1wxtz9UatCgZebG69gfWG7WQSJbQlKpjHKgbDS6xHIh8ngfnyEjFonO9PNUhziQmsiyrppFkTjt20Tg0t/SPZiMaQ8WS8Z0AAwE5GoHDA7oY6Jc9zQFJdvosFFUm5SmdGkAwS0riqo2EE0HHMCAihuPM7DQQEwDHjXU1OA9ra/IE0p6r8RQI7PF9RrWNpp+xiCJ72Yd9J5UyGL2wOfqb63fqtU23BLdimqIdJsqMsZAVVEDlrEZ4d3JNuL1UP+z1HmNv3l9ibJmAmk6rgQIxwZRKpmUNIrECd+jqCAwSZC6RGqCJY1+8hiDfKUIctN6SGCl6a2p2MtOCKXNYmWSIMOGeqTpdTr2+T+fo75vSslVCp4moBRJa6ULI8tOxE7npzLIVp7txzHfiZFVYzoBiyVjKkY6OyimTZvWbxDPc7K71aCQi3k6G5lecPP6IeXBYAARwMU3Ta9jENAJF93szLQeY33YPrI7T9OGJFgQnwyU1NAyrQFiMK+ZdLYFhe7NpBvWa1jb6KBL38t+IPHH57MN0sEcg2OWvdZv2EobbonTWoI9/Q4ZQmQd8sqknbVj+asGYjivBkyD5Ox2kZkAx3P2fWl/taLoZz3SJrFKUUM4SaTznXx+eg6TiFU0Kk1z43U4T+o3yyOdCErNVPgubmmNpOqNilD0VVGvtL9cur+oNij7WJGD3UCMFlJDhzKoJQHrIFv+To2sGlN1LJaMqRCKPEj0cAHnQq20E5G6nqlGhYs1g/rs7GtamCxXp7T/jeC19Ojhgi9Hqiqm16Vk007UBypNDdK2ytYg6XHNKGtbMdBUPxMGf61c92z0oyjFsdn0M9mVp6JYIpn9ggFpkWV7K2240xRB0Gy/CuZT4a79GIGV1qwMZlPhKsP6FJkzqA5Jx622jbZFrb5IaU+jRqnXk4zfLq/WJusol/YWKhMNSp0m9X5F2zRpgcBme2lipOhzUsGmz83uL0UCvMjBbiDnCRk61Ou5JdIG190eWTVmqLFYMqZC6OKrgUZ6MUzz/nXRlmUtKBWPm17H81zYVTSvNBX+Zt3yuOBrZngozBlq5dsXpdYpApamz+VF1iBPMKX307RD9YGq52TX6DplB2fZhrUDTT9LDR9SVLvG9zLjnyc86g2AGxkYpimCqZAlHVDrLqMH4P9phGQwmwpXnXpNXeUqmNauaFuoz1re4FuR6GYpOkfotyPSlE0BTP+v6FAz7Q3SVONs+4LUyTKNIEMafWXf0zKqQXI2Steog91AKDpvlakLZD26ObJqzFBjsWRMhVBESXUx6Yxrto6mqIcNs8wSPZqd12tVz4LI0MVfLmTUDAzmADIdwKp+RxG0NJIApJWlPVR4LY1P0/XW+hShWej0NSroZkDRbESCdWBZNBBXil5edERRvvS7NLBtdNtr+yltMFufkodc+oqER94AsFmXuexnqR6F92ajDmw7IiSkQrIvNmslXmb5+X72fwaYnWC9rOOjlqjgOcTS1KlTY72NtgMCILUQFxKr7RhIa3n5HWuZLaQ1go2STiRla/EUidc6pvtMOuGkKHK95tiK/soBNC/tcaDUS1mthSZAVKcmN79uiawaUwUsloypELrQZwcF9azA00GlmipC0Uz7UKfZZQewKl4njVBRMAbWFDwr0pZNTylK8SlCA05tKw3oEIm1tkdW1KW2zuqxot9MlsdrrLFGX/QuGx1hwMX31tr29SIh6faDbPF7EbLsbiQ9p1Uuc4o2IVSIMGWdGll2nM4Y9MkFTb+XvreZgV82TVHuZqqVqnoRvCKStdC+z774xBNPxH2abaXIiIwV0nSzMtb2zS6vBHx2f9QEASKF36DRXnCaQMpOeKivltaJfUx1cCmqOwReJyOHMuco7S/tQO6FzSKRxO+qa0Bqxd5I7Z8xZnEsloypENkLfb3Bb95gIL2gF6WKDEWaXa0BuNJiuGlWNGudWyuCpKhREYr41GqQW2TznYoSzQBr8JrWkmhAz6AH50IG/Xk1BLy/VnpfXiSHqIFmjpXSlm4/RWPK1DsoqoVoK8NAaiHyRB8DedYDwZS3f6tOT/bJ+m3rufmVWX4JBqVj1YqyVYXUTKFM9IH1xcVtqJpD12pcq+VnGSWKZblfJv0sNV1BGEg4MXmh35Ab+xjbQOeTNA1Vn8P25Lcv2gZlJwlakeKp9OJ60XEtu8huM+3n/L6cYzq195gxVcNiyZgKkb3Qp4NUzRpmZ2zTzvP8vxNy1DXQztYbaXZVQimv7iBvMJF9TGk22i7jx49vqv4oHTClTT5T4ZN+p5aV1/KdZWoI8kwq0kEa99Wgk8c0a88gUPuGooll03mydt61aLYWotZATU1G85Bw1jbVfq9BpdwDJVi1LLWatGr507oQHVtVL4KX4GG7sA/UExWaMJEd92BPjMi6XLWURYJY4l6NVeXwqeM+bz3T/SKte9L7RdakRimgWQvwVPhkj0NFYGtNEgy2GEmNUvLqLzURoGXs5N5jxlQJiyVjKkZ6oefCywx8URpOmruvepROyFFX6l0qMFIbaXWol3Na1uwiJeuOlX2OwZhquOpRa8CUjXLlpUamv0UZd7Y890M+IxUImnVXjYlSqlLbY227Rty02K+0rLXERnY9NGBl25DeU/S+WgM13sOEQBFpfZ4ssPkMajP4P8geWgKyVpNWLb+2E5+RRiaqPsGg+iNFX8sIJrZVO+pryqBtyj5LamXRMur35RhVY2YingibvMhU+l5FyYomiVKRSC0XZC3A2W/YD7WvZtH5R6nB2X0lu49rYqOW62Qtq/16pOfBPDdTnae0jHbIM6Y1WCwZU0F0oefCSz6+UtPSAbpSiVTPI/e2Ks4YZkWIalFS0cG6KHVIhfhCPUSEbLY1kNHnsQ008Gg0LSZvljiNeKWD1HTZs3bIoO/MqxlLawiUCpT20JJg5PVpg03Zv6c9YrJCTNutTDoP34dgYpBaS2xkU7m0v/G3yFmv3kCN19Yq/s8up357pQ9K+Oiz65lWpMuv96hmplOK4JXeVuRul4XXaHvUc5psdf2iJhq0T6b7YtpfSelwqW2+DGiUmiayx1y6HdL6nFrLk76f/Td1Hs2DZWI5tD2y+4r2cUWTU7vyWsdGLav9VBDJXELLnXdMZydt0mW0Q54xrcFiyZiKI8e0dMDIABczhHopSO2mzEArT4QojSwd6APrRdG1mssy2EjFAp+t9a6VhlU0cKq1vHmRENWKZEmjOCmy8SUFL1tUndcwN+2HlabVyURCkSRQREX3EYZZowj+jylG1jyhHvVqdyTeWSeZW0g0Fb2v3kCN37GeLXYWRQP03RpA1kunS6MMnWojnhpk8DvUg2NKKWhFqWLQjjSyNJqXJa09VIQva5uvc0LaiytdL/3mvD/PoS77G/NctolsKsJrof02r+can42ATZ06tbya4Mk7NvL2QVnt8xvoGEsnUdJ9PT0faJJJtWh8F5/DJJualXdb7zFjBhuLJWM6ACJGXHibiZa0a2CowX9ay4OFNt+jwSsX72wNjmZ1GQjxfJqipYF0OjBMeysNJK2oXn1BXiQEeEwpW1p21T2o31MayeKzWO7Uqjq19s6bxU4/F/hs1SGxjRg8KQVLKYqQ/T35/+qrrx5/B72nXhRC/WbK1O5IqAgNYtUIVKJXYrbWQA3DDX7bRi2TVbOnuqNG0+mG2tykFTWNbLeiRrWg7aB03qJ0SKiVRqbfs5nlVDQvFRNp1ESD/DxhpsG/HBFT+J3ZX9VTqsxxrohVepwqDbUeOpfl1Tzy/UXNdxUxyx5Ttc5D+g79PpxH0uazOu65r8kmlkETTLwekZSKKd7POWqoJ9aM6WQslozpALjYM3hpVe+igVws9R0MNjRznKaIyMlPdUnq45S1N89LI0tnPDUwLLM8ZURVvWLnvEiItp2K0LV+GqCIdLkRDqrHkihUJK0W+j4NgtKmuFpHUnu0/Vhfft/UJU920VoeXv/YY4/1zcbnfSfbhAEt31lvxllmHEqb0iBOxfISMBqs1xqoyRmPgWOallkP/SapYQPbZ6Az5p0UcUpTEfMc0SQiWQdFGIqMCvScopnqy8S+U8+yvIwoZR9WLzKdL9i+9NSqVSfHPqlzSZn9ot5xzi0VPBxPZSj6bj6PdSo6ruS0lxXwZUwXUkEvm/007VBROR5XjziOo7R9gI5FbcPB7qNnTDdRabHEoOMb3/hGuP3228Paa68djj766PC6171uqBfLmEqSnbHkIskFVn19WuGElH5HGlHKm1lNyQ4OitLIiparaCCbpuvpcxnwUVTOzHNefUHRoDHPkCFNfStygpOQYXCXHdSklBUEmi3m7+OPP96vfknRpiKXvKwYVm0TaYGqkcojNdSot2zaNnmOjNpWoN+HZU4HqdnfMq3rUjShXoRL+7Maiw5U3HSaxXJejYtSQJXaBggl7dMyK1Gam/ZhTRCk1uTqw6T3DJRUwDfqqJem4SqiwmNF9VhlXewaEWCy2U8bQStyW3RMK1qcNUJpxHRB5yS9TlFdHdcSxBJg+q1UC6ZUVT6D/buq+7MxVaeyYokTzf777x//f8kll4T7778//O///m+46qqrSvcHMWY4kde7CFKb6UZtkotsrTVYLSK1My+KItVKqSsbIeM1yu8HLVO210yZGpo8QwYeY8CJEBIM4lS/w+cVNeDMUmZwxudOnDgxrue0adP6BJZ+M6U4FrnkFYlhxBKz4LXEGo+zrpxfi34XhIlSmdLPSv+fFvDXs1pWiqLSGhWFq4es4dPo20DoNItlpanWmkBQlCiNNPB/pV3yWiYVZKstJLY00M5zfWwH2QhxmmqmY1/RTH57jjvq84iA6TGlsYLWocjFToKlzOSFUvi07yolFmp9Bq9hfTh/cGyxv6brUbR8IntOKqrTVPQQ1HBZyBCmqH7KGNPBYumee+4J9957b7jmmmvCq1/96ni7+uqrw8033xx23nnnhj9PxdqDjfLKa+WXG9OK/UfRFc3E6kKcihsu3nLZqwfvY4CtGWdd4FV4XW/grb+8jwG4nPv4fu7zGXnLoe/VrK3qfFRXw/8ZgBB1ydY0pDn9vI9BBOID5MyVNm/VwDBdDowHuGlZspEilgshI6vvRswU6g3MtH0RYhoganCliIsGgWn9U9p0k3XR+mi/kdhT0X8RDAgfeeSRuP7aZ1SbpUJ8BqR5boD6fpaT12hQme5vSt1M1yFdz0Yar7KM2d+uWXTsaJm1r7PdtC9UkXRf1fGkaBIUbUvEEZMJ2ofS31ARnHTfb/f1i+9S+mp2eeQEqse1n/Da9NhLBQwoXTTvONdfni9z/D7xxBN9kxOchyAVkUUTB2k0iG2JGEwjerXOQ0W/c0p6DtWkg1Iq02WT82R6bhgMPP4xVd5/8kyaiujpbSQWPYj84he/CGeeeWb4zW9+0/fYySefHAdRpOY1wgMPPFDppoPGtAINOFNS8SDKDu4Vjcpe/NPPq3WiSQc9jQiK7HoUfWe9k5yEWrZAPDujnM7uZpeh3vq1cuY9/Y3yfjc9njro5b0/myIno4U08tPMMqW9sPSZeWQFVDrTrcFcdj0b3Z4azBeR/sZlxFet3ztd704gWx9YRN6lP40Ii0adFZsh3Z+K9uv0ftlzgMRe9rdLzzFljof0O4tS7jSRU7Rc2QkkvS49phrZZ9N1URQ3/f70XCGy5wZjhjujRo0KG264YedGlggXv+pVr+r3GCHsBx98sKnPY9Zm3XXXDYMNipgC60mTJvUrEjem1ftPNiKjC7hStNIIAa8lOqO6JqVyKcVVbmpplCrtHp8dYOQJGWZguek7y5LaUytSkabZaOJDj+X16tFrKSJXZKnetmL9SFdT9CM7aExTYDQ4KdMnKKVWNC5vgKXtrgGUrNNlCZ0OZHmtCur1G0+fPj3+zvqMRpc5XSa2p6JLONmB9iFFZIS+Q2mDfL/c77gpsqTeNKqRyfaqKYLfdPnlly/9u/LdtfZB3kekRe8DDSrVXLXM51QBUtPSY6QI7cMSKWnkmN+C9eU5nPHaff3imGe/yNs3lUam5eH3YP3SPmhFyJK7VtS8zERqnsCXyYnONTrXpu0OUoGk45O/vE7powPZZ9P3aVuoh5kaXTfyma3G4x9T5f2HLIqyVFYsqZA5hYFXsyFkThhDmU7BD13ldA5TbcruPxwjZfoekUbGiUgXdaXIyV0p7XOSzqhqRjYVKRqIK0VFDSLL5sZn66KUGpNGGTToSJcnHeils7EaVPH9DKjzloPBGa9nWfmLOEtTVLIzxSJ1gWtUKKXr0QjaFnw39QtsW5ZfIkNiUttFPXjSZqCspxpwDgR9Jt/NYE8OjXwntSMSPHID1O8gEcTvobq3dF/SYC+NghVtX46DlVZaKbe4Xyl0WUt6vq+emyT1O2rom6Ze6jNVrF/GlXIokQNemX0tTW3T5AP1ORrI63ho9/VLFudF8PtxbmGwr/0/29soD357XpdtwstjqodSTWAzxybLnZ7zANEtV7rsZIv20TStLnsuYlk4HzFpU8vBLn1fuq8zQcTvVyV3R49/TBX3n0ayQiorljhhZxvvkT9epo+GMcOVoh4ysu7VbGPaq0cDVT2ugWw6OwnpLCoz+3JhKroYN9uwNp2VTYWRImR6bTqg1Xkhr8FlHiqWZp00E5wdLA1lCktWJMpmWduUWfjU7UriIpvbnW4/LjiajW9G6Ol78nrHpA5f2YbBqdFDkYlGtk8V66fC/VQky9BB72Hf4W+2pk77sh4rk/MuQanvz6YgAgPYgfT6GgxYPpazyJUxRXWM6aCB7Tl16tT4WwxGFEIGE/XMFrj+8zvSRyydCKgH+1FRE15NCnFLzz310PlojTXWiPfZn5mASk01smm1WQe7vHNRGi2r52BXz1Wvk/uJGVM1KiuWNtlkk3DkkUfG2T5SY1R7lBdSN8YUw4Wc1BwNOFN3rHSQxPMaaGoQwWyOZknV2yMVIrXc7LKuZxQ3K/2qVsNaOVVpWTRgYwaXyIQGyKBmr5A2uMw6a/FemQ5oIK3tUWZQOZhkU34QSsyo43CmOh0tb+oWlod+Y21HpWJyXm20jjOtg8hOWqVOgyrAT+sosq6D2f0mayvNfQb9tcQ2z6VCScuWjaBJHD755JM1o56yaWY9iuqh+KyqO4rJUVFNV8tEEyWCeS37RmrB3W7Ynjr36LjOQ9FsJn3KIqOSoia8isZwTHAfQVbmXMD2UYRR57k0FTWdxGC5GcMo/S67/2lbq7YvFXG1HOzquXsaY4aBWHrNa14T1llnnfCDH/wgGjpQq3TjjTeGH//4x0O9aMZ0FAwu0saw2UFyOqMr5zrVxEi0QCMpdhrkQlpbo/SsWg1rNSjKDmgUdVBkQk0rQZEwWeiq/5DSjBRZqDd7PRQolVCpkNnUHbY5QilP3NTq8yJ4XvbmbD9ECL8x6UK1BqdZ5DyYWsGnDWbVz0ffqWVqpmFsragkz5F1kDYVVV2UBJOWU78/9xEBsnFm0i27D2vfqrVd8o6fKsJvrFqyMhFRju1sOlor+yzVQhGSWqJOv2uj219plWk0NC8aw2eT8qaebbW2VzphJMt5Hsu2MEi/R7WEeejYUTRTgonvqNVzLK8v3EAbMxtjOkwswTHHHBP222+/cP3118eTEpbhW2655VAvljEdhXripIXJaSQidWZS/yPQYFUNJcvMpmuQi2gpmp3PDuyzM70aZKSDAM16Kz1I0QvZTqtBJ5+T1sTU+u52CKdG0oPS96j2KI0SSQCQRqRtqUhNI8utmec08saN+xTvy1ChbAqSoivsG+nnpel1MgrJ9oMZaINYIEKUDky1jmlqqbZVdp24j1hiP1pttdVyBZPSsrLCVcdQJ8zcp7+HaltqoX0vjR7q/43k9TcD2xOhUEsspfu8zlNlhL6EoiYViNIW9ThS7ypEOLd039FxzV+idkrF1ORM3rKnNXjZXmPZiQCJdPZzpRHrHFe0v+WltA5lXZIx3UylxdL//M//hBtuuCHcdddd8eS00UYbDfUiGdNxyD0qz5pZhgXZQQDUu+hmL/oaPNTL/a/XsJbPUhPItCktAyr+Lwe2bDRGAiutsapFq4VSs4NKpe/ot0iXL29WOSvy6jncqY5HLmeQpiU1irZ1NkWoVTUStRrEsp2yQim7bCLrqpf+v1Y9iAaqmlRI30cEplNm7vV7cDwSVau1vyudVfsf+4qO0XZHYtmeiJOy38O+QHpdkRNmEew3Mn8pisawvYgwcf7J1sPpufT3T1Po8o7D1JG03kQAn63n+BwZuNTa31yXZMzgUGmxBJwU3/nOdw71YhjTsVDvojSssnn09Sgqri/rwJWKC3L/GcRkZ0c1SFCDVg2es+5vqT1vKwd2qhkoy0C+P6/QPo+sACzqdSSydu9sS/aFVHA06pCn9cwzemgFtQrXG2lOWOu30Kx9Xj1INqUwz1yikyCNU8K4aJtkhRH7GeuvhrBFtMJxjdcjQtkPy4gflpFoKwIDU4VG9l9+c5Yxe74Bjo1stCe7bnpdasSgtM+8qLWszvXeWhMB7FuOFBlTTSovlowxA4MLNQ5ScsPj4i0L3mbJK65vxmFNaX95AywNIpQSk96gWfvuItKIjeoFGkWDy2Zd8xoVWxpkpn1W0s/QjDe/e1rjw2tT6+RGv7fI6KEWWdMNUvXyfvtaheut6uSudc8Te92W3qTITeq6liWt+dI+gzjk+OS8gVkEt3Rb1IqSNLqtEHSqZ9Q+XOsYkhnC2muvHZdBNZb19mMdm2n9UK31yHudajDTNLu055IiTBLY6T5uBztjOhOLJWOGAao7ahWyFE87z4tsxCdFr2VwJDvsPDtx9e1J3dzaTVZklBVLSgdiYMk6MdAqO0s+UFSAn/alSiN3adQtuzxp/yYNTsuIJn1uOmNeD35TFc8L9ZPJmi3UKlxXr6OBon43tepBOlUcZVH6GDUxquvK/s56DPGtKC5CgWMQEaXGxmx7ar54neqM+L/SaXmeOjhEQiMCU785pAYdRVGjPCt6zhm1okxpmm9KatKg45b7CEy2W/Z1Or9pYkTnNCL1eRHyFDvYGdOZWCwZY3IjOko1kSNbevFX49q0BiqdFc6mkzGIYFDFDYrEjwbVDMjEULjXNSJ0UrtfBpDN9jFqhjSKlY0qlemxkworDSLrNegkIlQkdItgf1IvHQ0uVauWTYUr6sWkwapq8JpF3z2cnMNYTzV+5bhWWq4MQ7T/ygxG+4KigKnphZwmQQ2dFWlSOlra26jMPlL0m0+fPj23Eb0c6bK1Wby/6NyiuqPsb659ST2SNDnDOuRFhdKJiTTdLhuxKvod7GBnTOdhsWTMMCetO5DttgY+IJvvdPCTpvZoYK2Bl/6fNY4ApbuAXPMYeGuwwXOpzXdeVCkbPRmsyFMWDfyVesO26ARb6Szpbwb8tvwm/DYyz9D2VX1Jo2lp6XbRgDpr614U2WE/ISoiEwwta7O/eTNirx21OoNNuk1xA2Qd2J5p/Y1S4RApRGrSKDFigvVVFFVRFO7rfCGnOomnRnpS5UXz2LacMzCoAPV6yzPaUCqfDBKysK5EivK+QwYYaWNlSJdfUaF0UiiNfJdJSe22FE9jhgsWS8YMYxTJUb5/tt5GAwEJGQ0e0tQeDWLTgYwGDzzGe5544ol+n59+h2pplNbSSHQEBlsosV6pUxp/szbTnYDEntIHszbfiAp+G2pVtG7sA4go6ljUtFhCt9bAj+fyUgF5jP2jqGEs+yX7mIS8BuQSdo3+9qRKvepVr2pyi+XXuBB9YTs10odsqNHAn9+QZVZKJOSl6KWRJFCqnn4TRVu0P6WmHAOB7+D3KiNOFbXR7yJRw3kF9Ntk4TH26dSwgX1aYjD7+XkNsRuJUnZTiqcxwwWLJWOGMQzyVEyfna1PU+k0m5wdPCi1J28Qw+NPP/10P0OGWqRpQbVen31cg/XBECsaHKlmq9MEUgpCh3WQy1sWfkcNNLXe6W/JoDFtQstNdR7ZgSP31Rw5i1Ke2F94DYNaDWxlFy4xrmVQRK8RYxH1mdL3NGt2kjqaKXVNYpn/N2tyMJjkpYMVoW2cTa3lMQRiGm3hfloD16qeVFmBobrG7HmnqF+RGiPzXJ7BCMcA+6Bq+FS/lC5/GhWqlaJsjOk+LJaMGcaoa7wGxVnSlLe8wU+tQQx1R1lL3XrUem1eYboGKwyOWilc0nqE9HM1OO40sqYbGujXmxHXutZzJ9PnKhKkmhPB//mdsr2PUrRteY3SPhWhSBuJ6rUMdNl/yxg+MABWBAUBLyMARSwQjkSdygx6U0czljUt8m8m/WwoyA78a/WuEppQSVNmgW3Hb4FQ1vYos281Sz0Xvrx+RSyzxGG6r8pghOXXvqe6pLzld1TImOGJxZIxpm8gmp1l1v9Vi1Br8JMdxDQjKvIG0rXqkhgMlRnoNQLCcaWVVlps8NeJyMmMASGk6Wv16iXS+o+yQlTmCXliQaJWUYqiiJCiVirIT5c5rQ9hgMv68fvXWj71uuH7iSil/caEHAzl9FZr+6SOZlqmtN6lFelng4EG/kxupIYq9VBEj22fut7VijK3klq9irRO2bogflu5a7Lc+u3Yd9zjyBhTD4slY4YxpKJoYJq1/9YMMoM/Bj7cJ7e/aCCUteBtpn9P+v2Is7w6qixpmlZRD5lGloNBvAbVjUbGqgLCgN+Wv4888kg02SACkPY7YvDITalTaZSEbc9AslYkKEsagcyL9rDPMCjnuXqpc3yWnO8UrdFn81haqE9xfp5jmpCTm0xJ0mVN4fu4KU0L2A8QmukkQZrCJudDpY8qUst27xTSerB6KKJEjRuCJDVqGSyzgnq9ivIiQBhaSNDqPXq/3ueokTGmCIslY4YxzM4zKFZ0hsGE8vwZPCkfn0EurylqPsnAkYG3mkNme/40iuo/yiBjCaVFpfUV2TS6st/d6mjVYMLvtdZaa8X/Z0VEtt+R3OjS7aXBJ/9HcDXyW+gz2BfYhlkDiOWXXz4KCkRIvWidloX9LNvMNrWNpuEy0REG7RoQI44koNPC/lp9ePL2E9ab7ZWmFWZT2GTDnW4j1p1tXeVUPMG6NXK88pqsu+VAm9I2urxFTYtrvSdtuJs62bWqrsoY071YLBkzjGFQw8x5ah3OQE8F6wx+NJhOow+8ltoUNW1k0JRtxKpZ3FaTpuVpYC/b4PSxTk2dGwisN4YFQgNZ6nTSyEAaOczrzyTBWa/nUi1SAwiJF5ksyFmxnrFAaqih9UM0cV+DcgmmWsuB2Coj0FK0D6UukCKNQnAc4Bioeh5FVqtetyTSiFsZ+F3029ZKh2vn8jbaqyiNaqaCucghzxhjUiyWjBnmpAM/ZugZTEgUpQNlFXQLBiyIJAbASplKX9MusZIO7hmYKk0rTRkbrKawVYIBa+pEJ7MNBvASLVlBlGeYkfaQkYAeKNqfgMF0Km7zolZKw+R19WpUaqE6OrmXNUJar1crsqbaqjRC0UlGIOqdVTaCyLohPBSBrpUO167lbbRXkSaFshHKtOmsMcYUYbFkjOlDTSbLig3VebQ7kqNBclpXxWCaAZAKyxEGw4E8q3S2Qba2hm2ilMg88iJG2d9Q21x9pQZCGq0iHU89ceRSp89Po1DqgdPsoFwD6lrpd/VQ/VRRWl0zaWFVQ79B2d8ZscR70nS2wVzvZuqL5JRnjDGNYrFkjOlDzlFlYFCliEU6mG0HGpAp2sBfvp8UKP6qoW2nk7X4zj6HIFKz2HSGnBv3p02b1jeAzUaTBrJMijgNdBuzb7GccrNjGRmk46qmCGE2WqA+OWk6KH+L0qfSBqZZu+hmkMAjQpVXj9NMWljV0Drw+5TtH8bvwW+RCvhOW29jjCmDxZIxpg8GOgwKy5IOnrMDrIEYPNSqVVLvlNS8YCCRg2aXpR0ueQy2V1xxxTggR1QUpQylM+SpaUMzhhb1yKZfDhSlxjHAxqWPKJPWKzvQVr+l9Pfl95d5Q7bJqIRkal8/kO3BZ+D8JsGWl/rXTFpY1dA6yCVR27vMtpPboNYb8hrGGmNMp2KxZIzpg0ENUZpGBsjquYJw0iCrXWKC72DwPNRRpHasm5y5VlhhhXg/rT2SPbMiM0qV4vfCcU7ufYNhc96K35b3sy4YI6RmDSlqcKuIUvY7VV8n+BxsxBE21OAoIjSQfaVs6l+ZtLA04lVFEaE0NUQ52109sWrBb4JQWm211Uo1jDXGmE7EYskY00czqVupEQADJ1l4Z1PKBprO1cnNYcvAdmGQr1l5ORPWahgqV7J2idMiYTzQaFNa45LnNqdBt6Jl2feprk4RJjXD5bO0D8JAl5Xv4LdIG9U2g6J/Sglk+fhdSausmoiQaGL7I8zTYzkL65Juk2yvNUWBiVi5XsgY06m0x9vXGNORqFdNMyiyJIc6FemnoklNT3mcGwPbdlmMdxpsCznYYXPN31pCKWWwGucqItSKzwH2B9Y5u54adLNN8t4n0uai2o9Slz/2RT3e7H6m3mEDqcdBLKgZrwwjWGcs3VtVW9aOtLx666voEfuq6s0Aka+oHjdS+6q4nsYYUwZHlowxfWiwo8LtRh3QNBBUGhSDLgaZSp1jcKVIgEwaWl0TUzXUf0eNftkmcn/ToF7RkGwT2SqiyIgaASvao5uih2V/V1lRP/zww7E+iG0l0V4vkiMBnvaGklW6zBZIU2T7agDf6D7NZ2JAMZC0OSI0LCPLhtjUNkNoFBlHDDUsDz27tHz8Rumya1vzGGKIfVftA7QfqB8adErfKWOMyWKxZIzpQ5EgBjiqQ2okaqGBlFLyNGhVhIC/DFgZUA20+L6qpM5g48eP70vfYmDMgJ1bdsAuF7JOIGt6gJBQnRXw2JNPPtmwCFa6VvaxrC19uo9JJKXPsd8ikLTdU5EzderU+B2N7HfU8KTrNxDU7Dld3rw0xKqBaMJ4RDVXahmgSRG5L6bnDwlZNertlL5TxhiTxWLJGFO3032jaVoIAj6LwRMDJv7PTZbX3SiS0lQvhBIDRAaXSkWqJTw7RSgBv6kij1nTA9UatWpgnHX3yxouaGCuAbms7/l/nsDh+Ub3vWx0qxmjBkQFx1QRnSAkUhMLRCfbWY2Ftd/zf8QzkSZFnlS/1El9p4wxJsViyRhTs9M9Az0GPxrQlzETYBClmhMKuxlQ/r/27j1Y6rKO4/iDAqYQIMgdBdRulhbgZDkmWmk1jVrYlI3peEE0TUylHCaiyUkZL5V5GTA0MUnMtFL/QC2t1GzMRIxCDRouIRB3BUFBo/k8zufM7yy/PWfvv/3teb9mds5hz57d3+7+PD6f/T7P99F16n5Wr6DUqCYH5sqGXyN/yu4Bu4OSp9vlOSAmX1sFYb23afsdea1RvZ5r8n79muo41DLcAU6vebHwoWNdv359SVPx/P7qOamyIvpeneKS09HUpVABIdnaPe2/hbTz0x8u5C1IuKroaZiumLnFvatPup1+xv5LAPKMsASg053uNfhReCpn41kPWjW4FAWwcteLlKOSAXrhFK+OeO2LpxSmTfMyffLuoJS3qpEuCn4Oe55WmAwghd3ovN+Ru/jVMrgWuy+//npMXbRZsad+FQsfblyg4+3ofdHz8nochcNly5bFypB/x+eNH08fJhRrga7XUa+V16wlOfDlcSPX5Nolf22VfacAIImwBKBT7ipWboXEC/3V3c2foDdDVywN7BQI9LzcfKKj56VPy4cPH942BcvTFPW7qpb50/Xk1MU8VZI8hc3hRxwWXEEqFlqS+x05INZSsvV8YWXJ0/Fc6fJasY7Ch6pEuo3OSU05LRbEkmGocP1VYdDqaO2RA6TDUtrruGrVqtTNh5tVMpD6Nff3pe47BQB5QVgC0Cl9aq9P2DXQ8waopdIASoPIcqpSjaJBvgeoqnx5illyMOvwoOeg27hFcp7CUEf0/EaPHt22mai4G11hA4VCrjA5THl9Sj24qYPOJ59LHqj7UmoVw2voVAH0WiLv0+THKue4PAXQFabkcbi5hySDkr/3fkSi22ljXU2FbeZqk5+Tnl9hgwcAaDWEJQCd0sBNVZRiay9KkWW4SE4V0gBP3dyS0+jEbY8lGZh0O1WPvN6q0Wuj6s1T7vSc9dq48lduYKh0s+FyFE77cnvxjlpvd9SQITno1+ugSlOlrex1/6506T7134v3KtL3DpEOlro4JCVbbHvqqo6tWaszfk7JFu2sSwLQqghLADqVXIfgjUTzQoM5TyNMG1i7g5sXpKdVjQqnf7USt3EXrTuq1b5XtQiVyU1nPS1O76WrTB01Vkh7b5MhRr+TNuivhP970Lo2V9d0v5pe52PUuafKk47dLfSTGzYnp7m6QUizhiXWJQHoSghLAEridQgaYC5ZsqTqVy25sam4o1Ytw4gH0h0tNE9WVSqZZph3qm5osN9Ra+tqgk411SZXkNyG2k02Sp1uV/jeerqYg4guOke0fknniB6jkjVX7oKo81m/r3PIa50UkHTMCmh6LFe5dFuvfSucnqfjaPZ24qxLAtBVEJYAlD1I0uCv2gqEPkn3ovzkFKVahSUdo/baKdbO2YNWdzmrZVUlT/R61zoo+X5reT8KSurS2FFA0nvq4OM9ldydTzxNzkFE54HWoXlvpkqCku5Px+awr3PIAVHnoKc26tiS56OuW7NmzR77jrnJBut/AKA5EJYAlE1Ti9QFrRpuDlAPGqQOGzYsdWCtwbSmZrkxQd6n1nmaYaX7G9VrD6ha3KcrNgojChHa06ijCuErr7zS9r56OqXDh6fveRNVnb+q+ijkuDOiW4WXQ8emDnvav8nT7ET3p/OwMKAV7mnm4/AUQx1vci0dACBbhCUAZdN0Ig3walGJqbaapIGlPrHX8Wigq4GpGjikfTKvoKQOaJbnkGRund0szyX5fmrwryDivZDKvR83DdD7qjBkasSgoJEMTHpvvfeTNwIWfa/qjW+rn+v+dL2rQPp3srlFOVydKgxZCl4OZsX2ftJjqiW9zl/2JQKA5kRYAlA2DfJUudE0omoH6qX+blqoclBSu2VNJXOra3WuU3hyS2d/ut9q65HcUa1ZgpL4WDw9Te+BKyzltlzXc/O6o+ReT2qeoICS3DzZDRPS9sxyRUkhXyEmGZ70e163VUmlU8fmDw28Ds/vic5JnaOddYpj/Q8ANC/CEoCKaPCngaA/EXcHr1oM3JOdyTzY1mNpsOt9jjy1SYEtbXDciFbWWUiGxqzbsac1cHBg8Eas4rVDAwYMiD9LbmRbjIOvp9V5c1xvfKuwpPvylDx931FlyI/nzniuXHmfIzdaqIaP2Rv66t+asqrj038bHU0jLLXdOQCgsQhLACqW/ER8xYoV7/xRqXBjUjd78MDYnfI0jUub4nrAqK8aTGp9iioMrUTP2a+fQ4JfBw/m67XOq5q1Tg4fGtgn1wclW3K7yqcAoJAipVbF3Dih8DpVD3UOKER3dD8+Vt3e51jh5rCuPurYq+lE58Ck+9OGxzpfO2pfXm67cwBAYxGWANREchpUuTQo1IBXg0tXjpKfqHtdiKZPiR6n1YKSnr/WryS7pOm19MBdr1GzBKXOGk24quQKk8KRpkDqOenfyfU8lT4nB0k9ntYref+iYuvo3JnO0zV1PF6zlOzM6OdSbctzHZsaP3TWvrxQubcHANQXYQlATSjclLsmxQPTAw88sG1NR+HajmItlluNKy8eLBcGiWabUpjcRDUZlDz9zI0nPN1Nx68qoSs4CrvVTHtzYwZXgpJ7dhXS9Q4frt55HyRd74qY1xipkum28pW+NoMGDYrnrEK+Xyfdt7vzFateeYppsXbnAIDGIiwBqAl9iu5NNkvlaXYd7Smj8OBqQKvS6+Bub7XqMlhPGvD7omqgA4ubfej91HvmaXYOfw4Lur2+V2DxpVy+Xz2Gwk1H96Pb+vXV4/v2heee232reYnodxTUSw0qXseldUpqOqJA6GNSsNP9+LGLnfN+7Tw10Gvv2HcJALJBWAJQE6oIaRqZWnOXMtjX4E+f6uu2a9eubZv6pK/JNUoedLcyT7WqpHV1FlwpUbDQ9EFPD9N7r/dQz6MwNOt6BQi9twol4o1jq6maeKqi1wp1dMyi41IgVXt5d84rFkrcxKTUyqbuxx0Ak63Ok8eqAOW1TGl0vW6TXO/VWTc9AED9EJYA1IwGdKNGjYqDS32Snvy0XwNEDVQ9iNaA0iGhsKW3BtWavqTuaa3W7rsV6L1T9cRByWtqFGzdirsYT21TCKlVw4pyK3G6vcKPjqGzUOLNY3U+6rzsKNipUtWnT59422LNKxwyi60/0vVq5kA3PABoDoQlADXlwaUHe8nBsbu8SUfrQVxtWLduXdv6jWaehtfsx1fr5zpw4MA47VLUXEGVwXKn0lWyUW0t6TxUuPEUQjcUEbU2L2wyoj2ddHEnxsKpobqN7lPnrHR0PnT2AQD7LgFA8yAsAai55GBPA09Ne9Lgs5xpZoUtmLdt25b5O9WVQlExev4KR27/nbbPVbO/P25Pr4CnTY3T2naLKknaGylZRdNF0031YYDOa30A4PVX+n1XqIq10K92LycAQGMRlgDUlT6ZV9CpNOw4MGXJUwaTA/Fm2Rw2CwoEK1eubLrnnXxPHIbSjtGtzQubJrgToYKOqj9ex+Sw772OfHHlVCEpOe1OIUkBP7nezs0fRD8DAOTDO9urA0CdaFCp6U6V8GA1bbF8I2hwq0YAWrTv40keW1fWjM8/ORVQIcUd+5JhW1UfXZLT7grbdif3gfI0UIWowvPQ7fIL1yfpe92Hzhv/vluG6zpVqQAA+UBlCUDdaeCZlylsPk5XArpCN75WPu/UfU/T6BRqvKmxKjvJLn6WbHnu91/3UWxvJIUtrVFKdtQr3KRZ4UgfFrjTntdAAQDygbAEoO68v045ezBlJTm1Lg/hrlUoVKh6o1BRq3Cq+1JA0sV7KCWbSxR2nHPbbh+Hg5LXHxVO2/OGtl6L542FHbYU0ghHAJBvhCUADVu3lNykE0hSaFEFxoG62HqjSrkTo4KPwo3ORX2vgKNqkv6tNUm6qPW31imJg1KxvY40TdNVJFeXVIVS5SrZPAIAkE+sWQLQsHbibjedBa8bqXT9FOpLgUQVIIUkTZM76KCDYhCpZXMPBRlXjbznl84Jb46sSpPbhGu/MO3z5Wl8bu5QSKFIVTEfp6fesS4JAFoDlSUADeFBaGcbe9aKBq36hF/hSJUEDZQ1MM5yb596cmWjVhu9ZsHt4hU0NL3NlSa9Z7WuSOrccHjS4xSuSSp1r6PCfcVYlwQArYWwBKChNDVp9erVdX0MDXzd7ltTrDzQzmuI6Iymivk55nmao6szqjBpKpyCjCs/XvPW2Yau5T6Wp/u5AUMl2EQWAFoX0/AANJSm4g0bNqxueye5VbPXqOQ5PJTKra5rvc6n0dxUQ+vbFJQckhx63Xq72nNHoUj35ddLlcdia5IAAF0blSUAmQQmDVTXrl1b0e9rAF2sSuQBd55DQ1em903T2RSUdI64MuhQ46qhw2G5kr/vqX5al0TXOgBAGsISgExocLp+/fqSpsZpMOt1R5py1lEQIiTlQ3Ifo+R14mDkyqCrQKr+JKtond23+Ha6DzWMUEBizyMAQKkISwAyocqBOoytWbMmNeC4q5jbL69cubJtQT7yTdUcVRfVFEHrk9xu25u7OgypwuSgpK8KOvq5O9oVo9vqomCt2ypkjRgxgs1gAQBlIywByIwGzBrIbtq0qa2TmK7z2hFVFzZs2BAX++dVclPTVm0wUSoHHlUKVVUUhyNv5Oqgo9dNQUcBSr/jdUbSr1+/sGXLlg43OdZr7m52av1dSmc7AAAKEZYAZErBKG1hvYKSqk6qPOSVg4CeS1en10JBWN3sVFFKa0ahfysAeU8sT7l0O3RXibyHkUK0K0y+L28MKzRuAABUi7AEoClpILx9+/ZcrUHSQF0VEG92qovXWuGd1u2qIHZUEUrut+R1StqktnCdkQKTgpdeXwcvVZ7082QDBxo3AACqQVgC0JRcfcgDTx9LVpG6+pS7QgoznU2ndFXIzRlUWdL3+uq1a8ZmsACARiAsAWhKqkDkJSR5U1MqSLV7TVUVUlXJ1ag0bAYLAKg3whKAppRce9KsPF0M1Ut2w1MXRK9X0jolBScAALJAWALQtO2ltWYJrc/7Iuk9V2hK7qWk6lJaAxAAABqBsASgKQ0cODCsWrWKyk0XoECkoKR9t7xeza3kadAAAMgSYQlAU9IgWRuJeg+merTf9n4+mkqX3Bg1L40l8sybxioQ9e7du10oYk8kAECzICwByMUeTIsXL65piNFAXdUMVTUUxrQ2xpugonoOnmmvp17zAQMG7NHhDgCAZkNYApALbiddze9rAC+uHmlNlNfIoPYb0G7bti0G0GQTDP1MlSPWIQEA8oCwBCAXVAV6/fXXK/59TffSoF2DdYUjVzyYcld76manTWPd8tuBVK993759Y0WJqXYAgDwgLAHIBQ2wVQmqdJpcPdY8YU8KRg5DathAswYAQJ4RlgDkgqZtDR06NPz3v/+lQ14TtfvW2i9vyKvqn4KSp9ixaSwAIO8ISwByQ+tgevXqFasV69atYwpdg5s1iLoH6qJpdrT1BgC0OsISgFxxteLVV1+NU+vc+pu1R7UNR7p4jZeqR3qd9VVrj7zuCACAVvdOaygAyBlVmMRTwFqRAkoW9HoqKKnFt5o16DjcpEHX0ckOANBVUFkCkEuaBvbGG2/ES6tKttxuRFt2hSS3WFcVaciQIbGLIE0aAABdFWEJQC5pKp4aPmggv2PHjthWnP2SyucNYvUaqkqnoLTvvvu2W49Em28AQFdFWAKQW8luawpNK1asyPqQmp4qR5pWpyqSLqw/AgCgOMISgJag6WKqkuzatSvrQ8nF+ieFJlWQNJ0RAACkIywBaAmqLOGdTnaaTue1RwqPCpH9+vWLTTHUQXDnzp0xXNL6GwCAnIalu+66K8yePTts2LAhjBgxIkyfPj0cc8wxWR8WgCalANCqXfFM4Ucbv0qysYWCkaYjqnOd1x35Ndm4cWNc26XpdkInOwAAch6W5s+fH2bOnBmuvvrqcMQRR4RbbrklTJ48OTzxxBOhd+/eWR8egCakSom7urXSRrDuUKdpdKoOedrc5s2bY1MLUcVI1xc2Yti+fXtYv359rCwBAIAWCUsrV64MM2bMCOPHj4//njRpUpg7d25YsmRJGDNmTNaHB6AJqWKybdu2hm1Qq9baCjQKKHpMBZNaUkhyC289xuDBg9uFIbX1BgAAXTAsnX/++e3+rZCkQcPIkSOrGnjUejBTCrXjTX4FOH/qR9UVhYvXXnut7oHJbcoVYFS5UfWnVtMAdX96HqomqWKmylElgYy/P6gG5w84f9Cqf388a6MU3XZnNMn/0ksvDU8++WTqzx555JG474dowHPaaaeFQw89NE7Lq8SiRYvi3H0AXYfChv4Q1ntqXvJPaKWPlbwPfc9+UQAA1Jc+jDz88MObt7I0bdq0omlR8/Lt5ptvDqtXrw6zZs2q+pNaBa5G03Ncvnx5GDVqVGzTC3D+NIa6wK1bty52f6unasOY/lhrLaYCkgKeqki1WmPE3x9w/iAr/P1BM58/S5cuLfm2mYUlV4468thjj4XbbrstzJkzJ/Tv37/qAY06RWVFb3SWj4984/ypjDrHvfLKK5lMwe2MmzaoU129O9Rx/oDzB1nh7w+a8fwp54POplyzJAsXLgxTpkwJV155ZRg7dmzWhwMgh7SeaPjw4bFznJo/qMpUj5nHpa5XUjjS+ku3+taHQLTyBgCgeTVlWFLZbeLEieH0008PJ5xwQlt7XA0uNE0FAEqlvxvuHKewpEqTyvvJcJNs011N57rC3/fGsPqqfY7S2nsDAIDm1ZTJY968eWHr1q1xU1pdTO3EJ0yYkOmxAch/pUl/X7T/kDdw1ddyglJaJUn341bivk991RQCVY8ISQAA5E9ThqWpU6fGCwDUmkKLLq+++mqsMKkldzm895GbSCg0aXqdrlOzhsL9kAAAQH41ZVgCgHpT17ly9m9QNcnrixSSPL3OjSSoIAEA0HoISwC6JK0f2rhxY0nT71Q1UjceVY1E0/i0d5vCE1PsAABoXYQlAF2SpsqpGuTqkipF4ml5Ckhed6S935LNGZhmBwBA10BYAtBlDRw4MHbHU0ByNzytP+rTp0+cYqc1SFSOAADoughLALosBSF1x9u0aVOcVqdwxN5HAADACEsAujSvOwIAACj0ziR9AAAAAEA7hCUAAAAASEFYAgAAAIAUhCUAAAAASEFYAgAAAIAUhCUAAAAASEFYAgAAAIAUhCUAAAAASEFYAgAAAIAUhCUAAAAASEFYAgAAAIAUhCUAAAAASEFYAgAAAIAUhCUAAAAASEFYAgAAAIAU3Xbv3r07tLgFCxYEPc2ePXs2/LH1uLt27Qo9evQI3bp1a/jjI984f8D5A/7+II/4/xea+fzZuXNnvN+xY8d2etvuoQvIMqTosbMIaWgNnD/g/AF/f5BH/P8LzXz+6P5LzQddorIEAAAAAOVizRIAAAAApCAsAQAAAEAKwhIAAAAApCAsAQAAAEAKwhIAAAAApCAsAQAAAEAKwhIAAAAApCAsAQAAAEAKwhIAAAAApCAsAQAAAEAKwhIAAAAApCAsAQAAAEAKwlID7d69O5x99tnhpptuauTDIufuuuuucOyxx4bDDjssnHjiieGpp57K+pAAtLgXX3wxfOUrXwkf+tCHwrhx48I111wT/ve//2V9WMihBx54IHzyk5/M+jCQQ0uWLAkf+chHwgsvvJDpcRCWGmju3Lnh6aefbuRDIufmz58fZs6cGa688soYkj7xiU+EyZMnh23btmV9aGhyGzZsCBdeeGEYM2ZMmDBhQnjppZeyPiTkhP6+nHfeeeGoo44Kjz/+eLjhhhvC3XffHX7zm99kfWjImbVr14Yf/OAHWR8GcmjXrl3hiiuuiB/afPjDH870WAhLDbJs2bLwox/9KBxyyCGNeki0gJUrV4YZM2aE4447LvTv3z9MmjQpvP766/HTFqCjKvY3vvGNsGnTpnDfffeFM844IwYnnTtAZ5YuXRpOOumkcNlll4VBgwbFD2lUXcr6013k7+/Q1KlTw5AhQ7I+FOTQzJkzw2uvvRa++c1vZn0ohKVGePvtt2M61oDliCOOaMhjojWcf/75Yfz48W3/Vkjaa6+9wsiRIzM9LjS3BQsWhOeffz5+oqsPaL74xS+G0aNHh9///vdZHxpyQNNe9P+s5P/D/v3vf4eDDz440+NC/mbTrF69Olx++eVZHwpy5h//+Ee49dZbwwknnBBn2CxfvjzT4+me6aO3iEsvvTQ8+eSTqT975JFHwj333BPeeuutcPHFF4fvfve7DT8+5Pv8GTBgQPxe64Nbo5sAAAmUSURBVAVuvPHGOPBVlQkoZvHixWHYsGHh0EMPbbtO0/FUGTjllFN44VAW/T/sjTfeiNM5gVJn02j65h133BF27NjBi4ayKpLf+973Qq9evUK3bt3Cyy+/HNdMfv3rXw9nnXVWyAJhqQamTZtW9I/BmjVr4h+Le++9N/To0aMWD4cudP7069ev7fubb745fko3a9asBh4d8mjr1q3hoIMOandd375946J9oByqZl933XVx3WSfPn148VDybJpzzjknzqZ55plneNVQsueeey5WljTWOf744+N1Rx55ZLjkkkvCySefnMmHxYSlGvAn/4V27twZLrjggjjvm+kLKPf8SXrsscfCbbfdFubMmUNVCZ3q3r172Geffdpd9653vSts376dVw8l27JlS1z7duqpp8ZBClAKDXI1XVzjH6BcKjLo/2HqAmwK3QrhK1asICy1moULF8ZP5dTYQRfRVAaVFR999NHw0EMPZX2IyMl5NGXKlPjJ7tixY7M+HOTA/vvvH7vhFXY469mzZ2bHhHxRtfuiiy4KI0aMiIv0gVLdf//9YePGjbGbomiQq/NJ1QEFKX0FitEUci070HhZU/Fk1apV8evgwYNDFqgs1ZFaHaoikHTttdfGN/vcc8+t50OjRWhR48SJE8Ppp58eFzq6m5mqBvrkBSi2QF/hWp2EPHVq0aJFYejQobxgKGnNgNZSbt68OVaz33zzzXjZe++9Y4US6IjazGudtmmtpNac6PqBAwfy4qHTsbMaEk2fPj12wtP/x6666qpw9NFHxyCVBVqH15EGtPpULnnZb7/94uCFVpooxbx58+L6k9mzZ8eqki8PPvggLyCKes973hOn/qqirU/o/vnPf8ZqNhtDohRaUP2HP/whdsBT23D/3dHeS0BnNL5JjnsOOOCA+OGevi+cHgwU0rly++23x4rkl770pfC1r30tnlPXX399yEq33foICQDQch3x1HpeG/spcKsL3tVXX531YQEAkCuEJQBoUWro8Oyzz8Y1TOzxBgBA+QhLAAAAAJCCNUsAAAAAkIKwBAAAAAApCEsAAAAAkIKwBAAAAAApCEsAAAAAQFgCAFRD+zbdcMMNYfz48XGn9YkTJ4Y1a9a0/fx973tfvGzevDn+W199XSFdN2fOnHbX/frXv47Xa9f2Ynx/hZe//e1vbbd5+umnw4QJE2LL9M985jPh4YcfLut5Ju9X93HqqaeGJ554ot1ttm3bFqZOnRrGjRsXPv7xj8fXRZsAFzrppJPCmWeeGaoxZcqUcNNNN1V1HwCA8lFZAgCU7Cc/+UkMNAoJCgfLly8P3/72t/e43csvvxy/vvTSS3V5dc8+++xw3333tbt84AMfaHvsSZMmheOOOy7Mnj07hrrLL788rFixoqzH0M7xut9Zs2aFD37wg3GT37///e9tP7/kkkvCggUL4s7y3/rWt8Kdd94Zfv7zn7e7j/Xr14d//etf4fnnnw87duyo6Ln+9Kc/DQ899FBFvwsAqE73Kn8fANCF3H///TGIfPazn43/3rlzZ5g8eXJYtWpVGDFiRNvtFJI+9rGPtYWmWhsyZEg4/PDDU3/229/+NowePToel4wZMyb86U9/Cg8++GC4+OKLS36MwYMHtz3G0UcfHV544YUwd+7ccO2114a//OUv4amnngq/+tWv2jb8XbZsWQw2Z511VrsKV/fu3cNbb70V/vrXv8aKXDl+/OMfh1/+8pdh+PDhZf0eAKA2qCwBAEry9ttvh61bt4aNGze2XXfMMceEX/ziF6Ffv35t1ymcOCTpq8NEo2zZsiVO49OUQenZs2f42c9+Fk4++eSq7vfggw8OK1eujN//7ne/iwEm+dwUrPTabNq0qV1YOvLII8P73//++H25li5dGubNm0dYAoCMEJYAACXZe++9Yzi64447wo033hjX7PTq1SuGgd69e7fd7r3vfW+7sJS2Xqmejj/++LB27dpw3nnntU0D1DS6kSNHVnW/mlI3aNCg+L2m1ik8JX30ox+N0/722WeftusUkI466qh4qSQsaZ2SqmQAgGwQlgAAJZsxY0acXnfLLbfEUKJwUNjUQGFJFRFN0VuyZEn8dz2OI9mEwdMC5cQTTwxXXHFFeO6558Ipp5wSp+OtXr264sdSNe3ee++NDSQ+97nPxetUPerbt2+726m6duyxx8YAKXru69atiyFKFwUs/bsce+3F/6YBIEusWQIAlGz//fcPt99+e1yzo2YPam6gtTyqgHTr1i3eRpUQBajHH3887N69e48KTC2cc8457abVaapd4c8///nPh1tvvTUGHQUnrTcqp0rzwx/+MF58/wpdDksKgqq0deTPf/5z2HfffeNUvTfffDPeXtWlL3zhC2U+WwBAVvjICgBQNrXK1loaTXXT+p1HH3207WdqaKBQ8sADD8SvPXr0qPkrrOYL6n7nyyGHHJJ6m+nTp4e77747bN++PVxzzTVlPcYZZ5wRm0XMnz8/dr278MIL23623377xftMWrRoUfjqV78am12IgpE64Gktk6Yqas2XAhQAID8ISwCAkvzxj3+M09o0LU1USbrsssvieqXFixe3u62m3qmyVI8peJ3R/koKOabKjq4rPMbOaH2SgpgqY4WBb9SoUeE///lPu+sUkhSqVIVS5enZZ58N5557bjwWXb785S/HipyqbQCAfCAsAQBK8u53vzs2THjxxRfbrlN1RVPMCltbu6lDFmFJjSeeeeaZdtdpc9xhw4bV7DHU6EJrkNwdTzTVb+DAgTFkLVy4ML422hDX1a9PfepTsUlEvdqpAwBqjzVLAICSaHNXDfqnTZsWN3lVRUmd8dTYQKEgySGp0k542pNIU92S1H67f//+8Xt1u9O0t6QDDjggDB06NJx22mlxLZW6340bNy5Wex5++OFw3XXX1eyd1rojbUB7wQUXxNdCVaZ77rknblSbXK902GGHtf2OjkUNGzQ9T88FAND8CEsAgNL+h9G9e2yYoLU/3//+9+MaHAWoO++8c4/OcA5L+lo4Xa0UF1100R7XqQPfpz/96fi9QpouSWeeeWb4zne+EzeF1RRBhZdZs2aFAw88MFx11VWx4UOtaKrdnDlz4v1OmTIlBiOtaZo4cWL8uQKRpv8lp++pMqfwqCClBhQAgObXbTeTpwEAAABgD6xZAgAAAIAUhCUAAAAASEFYAgAAAIAUhCUAAAAASEFYAgAAAIAUhCUAAAAASEFYAgAAAIAUhCUAAAAASEFYAgAAAIAUhCUAAAAACHv6P8p/R+IHVem5AAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "print(f\"正在运行密度法检测 (SMILES)...\")\n",
    "lof = LocalOutlierFactor(n_neighbors=20, contamination=contamination)\n",
    "y_pred_lof = lof.fit_predict(X_smiles_reduced)\n",
    "\n",
    "outlier_flags_smile['Density'] = (y_pred_lof == -1)\n",
    "\n",
    "# 绘图\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.scatter(X_smiles_pca[~outlier_flags_smile['Density'], 0], X_smiles_pca[~outlier_flags_smile['Density'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常骨架')\n",
    "plt.scatter(X_smiles_pca[outlier_flags_smile['Density'], 0], X_smiles_pca[outlier_flags_smile['Density'], 1], \n",
    "            c='green', s=40, edgecolor='k', label='密度异常骨架')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 密度法 (LOF)\\n检出数量: {outlier_flags_smile[\"Density\"].sum()}')\n",
    "plt.xlabel('SMILES PCA 1')\n",
    "plt.ylabel('SMILES PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_3_Density.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f0d9a203-8734-4a0f-94a8-3a8f1b32f068",
   "metadata": {},
   "source": [
    "## 4.基于聚类的离群点分析\n",
    "### 4.1两阶段离群点挖掘方法（TOD）"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "id": "49e8bdaa-b18c-4435-b2ec-e257e78f8351",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "正在运行 TOD 方法（SMILES）...\n",
      "   [TOD结构] Ave_OF: 9.0561, Dev_OF: 1.4480, Beta: 2\n",
      "   [TOD结构] 阈值: 11.9522\n",
      "图片已保存: output\\HT-29_FEATURE_4_TOD.png\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA0sAAAIzCAYAAADRQoJuAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjcsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvTLEjVAAAAAlwSFlzAAAPYQAAD2EBqD+naQABAABJREFUeJzsnQeUFFX2xu/MkMMwgLBECWJaRVQwK4qgohIMqGtaA/7XuItZTIQRE6CCaRXFzAgYkCBJQVHMETGggAgMiCBxyTAz//M9uO2bmqru6jRT3f39zunTMx2ru6teve/de7+bVVJSUiKEEEIIIYQQQkqRXfpfQgghhBBCCCEUS4QQQgghhBDiASNLhBBCCCGEEOICxRIhhBBCCCGEuECxRAghhBBCCCEuUCwRQgghhBBCiAsUS4QQQgghhBDiAsUSIYQQQgghhLhAsUQIIYQQQgghLlAsEUJIHHz22Wey7777yty5c0vdjtteeOEF8/eJJ55o/ndecLtfNm3aJHfccYccdthhcuCBB8r5558vv/76a+j+kpISef755+WUU06Rtm3bygUXXCBz5szx/fqFhYWu24hL3759zWMuvvhi1/uffPLJUq+1Zs0a2W+//eTxxx93/a7cLo899ljou7r33ntLPe/BBx8MfVd4nD4H73HCCSfIPffcIxs2bCj13btdvvzySykvvL4rXJT//e9/5rtt3769+V0HDBgg27ZtK/N7HHTQQdK9e3d59tlnpaioyPc26HeF70fB3/b3HS/6myYafC+63xFCSEVSqULfnRBCMoD//ve/sn37dvnhhx+kf//+MnToUGnZsqVUqVLF92v069dPZs+eLb1795a6deua17z66qtlypQpkp2dLY888ogUFBTIbbfdZl571KhR8s9//lPGjh0b1WQWz8fE3Qbvpxx++OFy6623lrr/b3/7W6n/P/30UyPePv74Y7nuuutCtx9wwAHy+uuvm7+feOIJWbRokfkuQMOGDX1vY7Vq1eSVV16RHTt2mO90+PDhsmDBAnnxxRdDj7nsssvk9NNPL/W81q1bS3kxcOBAI3BXrVplfie37/XGG2+U7777zogk7B+DBg2S4uJiyc/PDz0Gz8P3NmvWLHn44YfN53zggQei2paff/459Pe8efNi+jxvvvmmNG3aVI444oiYnk8IIakKxRIhhCQZFSubN282123atJH999/f9/MRQYIoGjNmjIkagSZNmsgVV1xhJsLNmzc3USyImHPOOcfcf+ihh8pJJ51kRIUdWYjEnnvuGXoPN2rXrh32fvDRRx9J5cqVTWRr48aNUqtWLXM7rvW5eXl5RvREei03IA71efic+B8CY/ny5eZ7AY0aNYrptROFCjNEiNy+V/xuH3zwgRG5p512WijSNHjwYCOiFDwPAgWXevXqyZAhQ4wI/vvf/x6TWPrll19i+jzjxo0zQpliiRCSaTANjxBCAg4m/ljZtyfbEBsAaVmYACN96+ijjw7dn5OTIy1atJBly5aV+/YionTRRReZKAnStJKNfi8rVqyQVOGLL74w1x07dgzdht8Pv+fXX3/t+px//OMfUqlSJZk5c6bv92nXrp0RrBCS2BfwN9I4CSGE+INiiRBCKhhMkHfu3Ol6geCoUaOGqc+xQVQCt++zzz5GGIF169aVek1EpJwpcskGqXWYmHfp0sVEzyCckg1S3QAiL+XxeySCpUuXSp06dUJRN6BRMY1GOcFjEUW0a9UiUbVqVROdQvqdRiGx39ggfRNRyIMPPtjUwv3444+h+7Ru6vPPPzc1aPq/cxvxG1x11VXmNfBa2D8VpGSi3ur444839VdIJf3tt9/KRK46depkxN3tt99uUiwJISQIUCwRQkgC6NWrl2sRvx8wuURditsFtT1O1q9fLy+99JJceOGFpu4J75ebm2tqWnAfJvvDhg0zkZbOnTsn9PedMWNGGcMCFSsA4qh69epmUoy0LdRZJZOFCxfKo48+KnvvvbeJpCn3339/qW3s2rVr0n6PWEA9E74nG/0f93mBiCJ+42jA54dQgmCCuHaKlPvuu8/sSyNGjDD1aZdccomsXbvW3I8aM1zw2c8999zQ/84as//7v/+TVq1amVo6iD7UWqmwhMhCXRleF2YgW7duNZFHGIGAb775xpg5wKzjqaeeMumqU6dOjeozEkJIsmDNEiGEJAAYFaAWSTnjjDN8PxeTVK+V9D322KPMbajPQU0QJqgAtT8wB7jpppvkmGOOMfdhwtmsWTMzAY2Ga6+9ttT/mOTaQgMCCK58XgYQqFdCdAEiDvUtcOiza4kSAT6bLUghlLCdWVlZodsuv/xy6dGjR+j/aMw0ov09EgUiMMD+HIkAAkmNHfC3pgACuOIhve/SSy81/+N7Peqoo0yq39lnnx1KcaxZs6YRSF51YB06dDACSR+L2jmIaIh4RJVQX4ffBOA1EHlERAsGIBD++A1hfgLgDhiNUyQhhCQTiiVCCEkAcKCLxrTBxhZZkZg0aZK8/fbb8vTTT5s0LgWW4ZiwQqzAYe3ll1+Wa665xtS4RANSoOwifggup8GD1+dEmhpqlFAXY4sZbJMaTyQCiMPRo0fLypUr5corrzQ23XvttVepxyD9sDx+j1hBSp0afihbtmwJ3ecFokrRCk8IJOw3EGMwk1CxhN8JdUzYV3CxWbx4cVTvgciUoumQEJzz5883kaQjjzwydD/2WxhUqN0+UvJsEQZhi8gkIYQEAYolQghJEWAbfffddxtbbNR/OKlfv76JpkycONG4sUUT3bLFUawiAyINE3A4vCElCyAKFY1YQlTM2UsIIgy3K3C/wzbicvLJJ8szzzxjoiDRCsOKBLVD6A0FBzwIUIAInN7nBtLzUOuEnkvRiiXUkunfTq6//voyEcho679QFxVrJA3pelp3pzj/J4SQioI1S4QQkgIgpelf//qXWZFHup0XKM5HcT0eU94TTtQrwTwAUS4VM4gofPLJJ76NESDWnAYGqEtyRrjstEGYDSBykkpo9A79k5yW64cccojrc1ArBOEIgRitkEE0Dhe7rgsRLESpYAyivxcur732mnz11VelXgPRHry3F177GqJ0eF/bFREiEfupRpOwTd9//33ofkSkILwJISQIpM4yHCGEZDDooYSCeDSn/emnn0K3Q0TYNUMweUDzU9SEJANEQjR9yjYmwKQYk31M9O2JM7blueeeM5NjP5bVZ555phF6MG2A0EKDW7wuPpcbSPfDZ0VaIqJqiDoBmFs4txP1Ro0bN5YggO8LdTmoP0OEBdbv+MyIwKHOB4ICLFmyxKTNffjhhzJy5EhTWxRtmiC+E32Ofj+22EQD3QYNGphas3feecf08+rZs2epx8GlDqYLsDdHA12kA3br1i3ie0M8o14J0T98LmwHfiu49Gnq3gUXXGDMH2A0AUe8N954Q/7444+oPiMhhCQLiiVCCAk4WPlXC27U6NjA9e2ss84yf8PeGe5ziAwkC7wHnP9sYGs+atQoEw24+uqrS92HYn1M0CF4/IglTMDxefF6EAeIfCD18PTTT/d8Dib8SDnEZF4bvMJYAhcbNHO98847JSigwey9994rAwYMMN8Rfke4wtk8+OCDRlhAZOBxsdZ+uaXfAfyWqClCU2OINdR+wfEP4sgGggd1TPh9Ie5g/+0XmDggugTRDJc9mISgWbKm+kEUoxkvnPIg1JBiGm30jBBCkkVWiSYNE0IISUswzDvrgGzgvsYaEUIIIaQsjCwRQkiag2gQoipewGDgyy+/LNdtIoQQQlIBRpYIISTNgYsaal+8QApYtI10CSGEkEyAYokQQgghhBBCXKB1OCGEEEIIIYS4QLFECCEBAz1pkBanlw4dOphGtPPnz5eggZ5OcLCD0x1czf773/8m/D3Q8wdNZ9GXBz2cJk+eLMkA/ZrwfePaC9h9v/nmm5LKoF/SxRdf7Po54Ihn73u4nH/++aW+H7cLvhdCCElHaPBACCEBZejQodKyZUtTc4TeNLBvhlCoWbOm79fAhLhp06ahJqiJ5Oeffza20BBJsJKGScSwYcOM3bezT0+sLF261HzuQw891FhLwx4cfZgaNmxoRKRfMNEfN26c/Pvf/45reyAG8d6p7Iw4aNAgY/qBnlZOfvjhBznvvPNKWZTr/obPjca4TmBfrzbghBCSblAsEUJIQEFvnf3339/8DcGD5quIsnTs2NH3a0AgoK9NMsTSiBEj5JhjjjEiBvbjmHwvWLBApk2bljCxhH5LVapUkccff9w0vz322GPNhB49lKIRS8uWLTOvEa9YSnUjjJtvvtn0w8rLy3O9H98telYhiucEv4Pzdvzec+bMMfsZIYSkIxRLhBCSAkCMgO3bt5fL+yEidfvtt4eNKvXp00dq1KgR2jaASXhxcXHCtgMREIg9CCWA9zrqqKNSPhWuovjzzz+loKDARI+crFy5UlatWuWrebACAdq1a1fPpreEEJLqsGaJEEICzrp160x6G/ohtW/fPnQ7Jr0nnXSSHHzwwaau5Mcffwzdp7UkEBuY0Or/dj0OJs433HCDiTpBkED8rFmzxtyHGpS33nrL8wL23HNP2WOPPUKvh3RBRL4OOeSQhH12bC/S+mwaN25svpONGzca0eSsl9GaL/DYY4+Zv7XPlH4Pffv2jWl7vGqWtm3bJvfee68cffTRcthhh8n1118f+i4VvC+2bcaMGSbNDemFNt9++6384x//MN/fcccdZ+qHvLYB7xULiMg1aNDA9T7sP2hOjOhTu3bt5Pjjjzf73Y4dOzxTJBFFRAomIYSkK4wsEUJIQEE6lFK1alV59tlnpW7duuZ/pD3dd999ZmL797//XV544QW55JJLZPr06eYxWlvSv39/OeCAA+Tcc881/9v1Nrfccov8/vvvMnjwYNNrCbUnqJPC6yJC5JWqFW4iXlRUVKreJV4gwDSqpOj/uC8S+NwnnHCCSS/Dd6Hfi36PiWLAgAHy0Ucfyd13322ibQ8++KCp54KgtZkyZYq8++67JrKz3377lTJduPLKK+Wggw4y6Y2//fab3HPPPbLXXnvJ6aefXqZuKjc3N6btxO/sBdLzKleuLJ07dzZiD/+rYMP/TvDZIKqw/xFCSLpCsUQIIQHlkUcekVatWsmKFSuMwQOiIa+99prUr1/fREwQhbj00ktDUQukp82cOTPkHKfF+RBIbjUocLGDkNJJ+3vvvSeffvppyAgAwseLSpVKnz5++eUXs42oCQpSsf/f/vY3c9m8ebP53+17iBc1j8Bvgkifip9rrrnGRF+aN29eSizhN0RUzgbCD9Ey1KUhMoULzD3wW5dX3RQEXI8ePcz7AuxPW7ZskTFjxsh//vOfUkIL6aCIsN15551J2RZCCAkKFEuEEBJQIJRg8IALUrMwecXEFSllMCx4+eWXzcVm8eLFvl//5JNPljfeeMOkWqFIH5N1pLgBTP4j1SwpW7duNVEq1LokOiWrVq1aIaGj6P+4z41E1kz5AUIR4hKRJCf4PWyxhNQ7p1ACderUMREkpNfNmjXLRGwgnFq3bi3lBUSlE7gQIpL1xx9/hPYNtYyHkEIUihBC0hmKJUIISQE0LQ5RJgWpUUgxs/Eb1UG9D9L8IDhwjT5OSP1CdMiuWfLDwIEDzXZBYKHmJZFAaEAY2iB1EJ/Ty0Ld/o7KE6RJ2jVcwBZKAGl2Xjz88MPyxRdfmMv7779vRCyiVRBN5QHS7jQSp0BAa02WDSzs4UwYjY09IYSkIhRLhBCSAsAsYO3ataY4HwIHpgeYyKq1OMjPzzd22qeddlopu2ekhDlBuh3Sx1A/oxP6Dz/8MHS/35oliCuIqqeeeqqMEUMigPkE6owQTUItECI4qA1CmhqAOEOEwwapbk5Q8wXwXThTCONl7733DqWm6e8BZznUgv3f//2fr7S5efPmme2G4QY+G1L4kGaJyF95iSX0X8J7I0qojB8/3ghTOxoGwwekbN5xxx3lsl2EEFKRUCwRQkhAQQ8bTEwx8UbUApP8U045xdx37bXXmogOxBPc8N555x2Toufsb4R0LjRyhUsbJvPr1683tUq2UQSaysIYAj2NvJzS3NAmtKeeeqqZUM+dOzck0FQg/Prrr2a73VLP/HDhhRfKq6++aj7v5ZdfbiIaCxcuNOYHAO8DIQnRh/5TMJn4/vvvXXtWIQryzDPPmM8L5zd8l85IUCxAbOJ7h1hF7RFqxGDSMH/+fGP84Ads28iRI813hd8KaW/4nG6NY5ECCYMHOy0uEVx00UUm9RICFJ8Jrn2zZ8+Wfv36lapXQsomxKvtzEgIIekKxRIhhAQUON1pPQuMGOB4p/1sevXqZWqFcBscy+Ca9sQTTxhxZIMaGdTNXH311SYqozVFmOjCKhwCCZN0RKRuu+024+LmNCXwAiIM9UFvv/22uShooAujCQAHOlieo3FtLCBahe1D1AOfAa+NdDUIRABzihtvvNG40GFbkJYI0QJxZYNo3EMPPSQPPPCAsVKH0FAzhkQA4YrXh6Mgfhd8v/htvOqqnOD7xnbh8txzzxnBiXogGCs4wfeA+xJtrgBzhw0bNpjve/Xq1SZihu/a6caHqCSijuVZT0UIIRVFVgnOnoQQQkgSgBEAIj1IKyOEEEJSDTalJYQQkjTg7IYoGCGEEJKKMLJECCGEEEIIIS4wskQIIYQQQgghLlAsEUIIIYQQQogLFEuEEEIIIYQQkqnW4d98842xzK1cuXJFbwohhBBCCCGkAkEPw6ysLDnkkEMiPjYjIksQShXlkI73RSNIOrQT7j+E4w9JJXj+Itx/SLqOP9Fog4yILGlEqW3btuX+3uhy/tNPP5nu8TVq1Cj39yepDfcfwv2HcPwhqQjPXyTI+8/cuXN9PzYjIkuEEEIIIYQQEi0US4QQQgghhBDiAsUSIYQQQgghhLhAsUQIIYQQQgghLlAsEUIIIYQQQkimuuERQgghhJDUoqioyPTDIZnHtm3bQtfZ2dlRu2Dn5OQkbFsolgghhBBCSGBA/5sVK1bIunXrKnpTSAVRXFwslSpVkuXLl0ctlkBeXp40atTINJ6NF4olQgghhBASGFQoNWzY0PTYScSEl6ReVHHbtm1StWrVqKJEENro0bRy5Urzf+PGjePeFoolQgghhBASmEmyCqX69etX9OaQCtwPQLVq1aJOqatevbq5hmDCfhRvSh4NHgghhBBCSCDQGiVElAiJFd1/ElHzRrFECCGEEEICBVPvSFD2H4olQgghhBBCCHGBYokQQgghhBBSih9//FHGjRuX8d8KDR4IIYQQQghJAnBnQ90Mev+ESw3D47Zv324eU6VKldDtr732mjEpOP74483/l19+uRx++OFy1VVXmf8HDBggF1xwgeyzzz6ur3vCCSe4Wm/j/dq0aSPPPPOM5zZ9/fXX8u6778qZZ54Zum3Lli2ydOnSUo9r0qSJ1KpVS9IViiVCCCGEEEKSwLJly6Rz586+H3/dddfJv//979D/zZs3l2uuuUbeeOMNadWqlRFSsNMGU6dOlQ8++ED69Onj+Xp//vmnEVz7779/qdvffPNNGTt2rOtzBg0aZN4PjnRFRUXSoUMHc3uvXr3k5JNPNoJNX++nn36SRx99VDp27CjpCsUSIYQQQgLLkiVLzMQOk7499thDzjrrLNlzzz0rerMI8QX6/Hz88cemwaodWbr55ptNNOhf//pX6DYIE0SgwOTJk40QUsH09NNPm7/nzZtnjoWff/5ZZs+ebV7/wQcfNPddeOGF0rZt21Lvj9dD5An22Ygm1alTR2bOnBm6z41bb71V+vbtK7fccouJPl177bUycOBAE6GCUGvWrJm8+uqr5rHdunUrFQlLRyiWCCGEEBI4kLp05513SkFBgdSqliXN6hZL4dpsGTp0qPzjvPPkpptvNpM/TNRq164dWm0nJEhApLj1i4J4wj6bm5vr+rxffvlF1qxZY6JKNv/4xz9c/0Z0qWvXrq6vhWMIkaC5c+eGjUIpOKZwbCENr3v37iEhh55HmehSSLFECCGEkMABoTR2dIHk91gn5x++WapXKZHN27Pk1c9ryD2vjZGNmzbJbbfdZmooNm/eLH/7298omEgZtm3bJv/73/9MPVBFCuvVq1eb3j/aMNXPYkG9evWksLBQnnrqqbCP/e9//2s+286dO83/I0aMMKl3AMfH1VdfbaJI+A4QlTrppJNk06ZNsnHjRvM3uP322+XEE08Mveb06dNlw4YNpj4KoFEwapPwGm7bms5QLBFCCCEkUCxevNishkMoXX7sptDtNaqUSO/d//efMNHUTmACpxNiRpeIDfaLP/74w0zmkUJWkcK6Z8+eph7JjgY5gRBBxAnbqhGgt956y6SfPvDAA67PQTQJUaB33nkndBs+46GHHir33nuvr21DHZIteJD+d8cddxiRtX37diOk3nvvPenRo4cRZAsXLgzVMUF0USwRQgghhJQjsCtG6h0iSm5ccPhmGTwtzxS49+7d20wu3Va8SWYDAY2JPIQR0scgKipKWCOy46ztefzxx83F5vXXXzd1R/pYbDe2tVGjRq6vi/udqXHt2rUz9VAQXgceeKDk5eWVccTDd4Fo16xZs+Tcc881dUhg7dq1RijhNq2natq0qdx3333y7bffmvolmDpkEowsEUIIISRQIFUINUpIvXMDtzetW2JqOjDpKy4uTvsicxI9ENAQCSomcF1Rwtqt1sd2vsN+vHXr1jL7MW7/6quvQpEcRMdQB6WPw9+oJ7Lp1KlT6G983tGjR4fEkIJj56ijjjKvozbkAMIKTngNGjQotZ2bN282phTOGiq1PIcYdLMoTwcolgghhBASKJB2BDOHLduzXAUTapcK12bJcXXqmEgBJmqoRSHEBkIA4gITeo0sBVVYY/vc6pkQ4cFFgVhBHdGll17q+3Xhhocokw2+B+C8feXKlSa1D8eT3rd161YThQKHHHKI6fukTnoQahBSL7zwghxwwAGSjlAsEUIIISRQoAkmXO9g5mDXLCm4ffO2EmNbjJSqGTNmmPQhWosTG0z4MZGHoEbUAwIhlYR1fn6+6YUEFzoF4g+W4Xb6Hj4jDFFgHe4Enxv1f16RJSeo5/rmm29C/69YscJElrp06SJjxowxdYJIw3v44YeNAUUmQLFECCGEkEDRokULsxqeP7pASnbXKJVyw5uUZwrl4fiFiWCNKrvMH9ZtFhkyZIgpph8+fLhnHxmSGaDWB5P/ILjhxQK29/zzzzdCKFxk6eKLL/aMlkEgwpjBrWYpHOvXr5dRo0aZ4wtmE3gNiKXrr7/epPWdccYZcvbZZ5vjEN9xOkOxRAghhJDAoU5e/QsKZMj0uqZGqXCNyKZtYoQUJoFjXh0l7ffcJl8tqSJZUiKt9iiSwrU5Mn78W/LVV1/KSy+9bFKJatasKXXr1k2ZSTJJHPjNK+p3h0CD9bfaeiP6if81tQ3W3Pq/prThca1atTLiJpKgwevDwAJRIq+FARwnb7/9dqnIEsTj8uXLjQBypuEtWrRIHnroIfniiy/k9NNPN2YrqF9CdE655JJLTF3UE088YazH0bh25MiR5hhLRyiWCCGEEBI4MPkbPHiwSQF68803jekDJm1I0cMk8phjjjFCaU5hFcnvsaFML6aBEwvlogsvkGeeHRmyjIarFwUTKS+QwoYIDPZl1A6hHxIuynfffWfEiC1sIEo+//xzI/BRw+QUMxBHKlzuuecek6YHx7ujjz7adRu095LNsGHDZMKECXLeeeeVOR5atmwpJ5xwgkkBtNPstu1+T1zjOXvuuac8+OCDJur122+/pa1QAlklkWRrGoCOxQBWjOUNBmfkdqJzMpqREcL9h3D8IalAkM9fmOw9+ehQ2by92Aglt7qmkbNrSr/xuXLC8SfI7XfcYW7Lzc01kzwS3P0HERdENxBdsWt1SFnQVBYCC/t1NCCCBRe9IFNUVGT2BewDsWxrpP0oGm2Qnh5/hBBCCElbEGVCjVLNKiVhezHVrFoi78+aZVb4AdKekIJESDpQq1atqIUSCLpQChoUS4QQQghJKeB6BzOHJnlFYXsxNatbJJVzRGbOnBm6HfUdhBDiF4olQgghhKQUqFvaUSTGzAG9mNxA7dKytTlSp7qYwnqlIhqSEkJSF4olQgghhKSctTicvNTMwQ3cvml7lmzaLqb4HAX2IIgNSQkhwYVueIQQQggxLld2P5qg9yh69NFHZc6cb2XAxMUevZhypf2e2+WrJVXlxBNPNA56cBbLlEaahJDEQLFECCGEZDgQSn/88YexJUZ/F1htO5tYBg2IuVmzPpATjj9e+o3/TR6cWtvUKCH1DhElCKVvl1Y1EShEoiAAIZTQlJQQQvwS7JGQEEIIIUkHESUIJfRPgajANfqzpIJggttdz55nyKZt2fLrqspSrUq2VK+cJV8tqSbnnX+hDB/+qOy9995GMFEokUwFkdXvv/9eVq5cGfGxdgNaJ1OmTJGFCxeavxGFRq+lZcuWSSKBHfrzzz/va1vLA0aWCCGEkAwHkx4II63rwbVegg4E05NPPil9+/Yt07zWq6cSxCFc8TTlkBEnku7gWEYDWTSvve2228I+9vzzz5f58+ebv6tWrWrEEyK09957rxFKON7eeOMN+eqrr+TVV1+V3r17l3kNiCgIK7cFFyzEvPDCC9K6dWvX90dke8iQISZ91gZ9k7CoY1unN2nSRJINxRIhhBCS4UAwYIKC1WdMqnCtl1QBwuj666+P+DgIJayEo+klPisEEz5706ZNGXkiacGzzz5rRAyEji1WNm3aJJMmTZIPP/wwdBvEBxq4nn322fKf//zH3IZFh0ceecQcG7fddps89thjsnr1anPfZZddZh6P+r93333XPA9W/k7wXieddJIRaE723XdfVxGFyBeEmpqwnHPOOeYYRVPZ2bNny1VXXWX+RpNjpA23a9fObGeyoVgihBBCMhykp23evNmsIGMSgzQYTIZwnW4gogShhM+nwhAr3bidaXrpx5IlS0IRR0zqzzrrLM+IYyLBe95+++1lbj/88MPl5ZdfNn+PGTNGnn76aVm1apUccMABMmDAANlvv/2ksLBQOnfubB4DYYDb/vWvf0mnTp18vfcVV1xhLspbb70lzZo1kw4dOoT+nzp1qokU1a9f39drZmdnm2Nk6dKlctppp8nPP/8skydPNmLop59+kv3337/U43F8QbCNGzcuJMoQkTrmmGNC9zvBa3zxxRfy+eefS35+vowfP95EuK6++mpzP0TUoEGDpG3btjJy5Ej55ZdfpDygWCKEEEIyHKxA/+1vfyvjhpeODVzx+ewUQ/2b/ZfSC0zOMZEvKCiQWtWypFndYilcmy1Dhw6VCy64wAiFZDo+duvWTbp06WL+hsi58cYbpXv37pKTk2NuQ1Tmnnvukf79+8uRRx4pw4YNMwJn+vTpodcYNWqUEfBjx441ggFiw5ma5sXvv/8u999/vwwePFgWLFhg0t6wGNKyZUuZN2+e3Hzzzea1IdiQhoooEIAIwWM10jxt2jTZsGGDWWBYv369/Pbbb+Z7w2s0b95cXnnlFSPE8L06QZRII0v4PtwEkg2+G1yQ3geBCPC+iCaBikoLplgihBBCiBFMuCiINHnZimOSZT82lcD243M4Uw7Zfym9wCR97OgCye+xTs532sqPLjCPgZBIFtifdJ/Cfla9enXJzc0N3Q+RcvLJJ5tUM4BIyhFHHCHvv/++HHTQQea2mjVrmpS1u+++24ifESNG+BZLiJZ+9NFHJjp8yCGHmIWPH3/80UTXkEb33nvvyV577SU//PCDSUFVLr74YrnkkkuM+EFN0HXXXRdKw8N3qgIT4ueuu+4y26wsXrw4FNHSRtD4PADbD4Gmwuef//ynEUaIdkHUKRs3bjRROU0JhEDT79G5oGHXLyUTiiVCCCGEeIIJCVKYIJgw8cIFE6FGjRqlZNoaVtGxao7JpIolTNrYfyl9wKQdESUIpcuP3RS6vUaVEum9+//+BQVGCJRHSp4bEC6XX3556H8II0R9kNKmYskGIglpejge/UTENGKKaM7XX39tolyIZGFfRx0SokcqNpwRG6TXzZkzR9q0aWPS9RCZysvLM6l4zvfHcYQxAYIGr4O0RwgwPzzxxBPm8yoYZ/r06WOaSEOMvfTSS/L666/LPvvsE3ovFVkQTscff7yUBxRLhBBCCPEEhdq2UNKUtRUrVoRsxlMJCDyspNMNL31BnQxS7xBRcgMNjIdMr2siGH5MQZLBunXrSkWaAP7H7W5gcQJCBffD7TESSF9DvZOmAk6cONEcx/bxivQ+cOmll5Z63ieffCLfffedEW+ff/65qWuCmQJE10033WTECuqskFoIMYYUPkSZED2DAMRtiIbBDQ/b4ARR6muuuUbat29vPpfdaBopfzCowNiC9//HP/5hRNqXX35pUhcrAoolQgghhHiiK8e42A5WKpgw2UlFwYTJmKYWYhKp6XkUUakPIhSoUULqnRu4vWndEvO4isKt/kYXI/w+PhzoK/bBBx+E/od7XM+ePeW///2vMZPwAoIHqXUwcEAkS8Gxj4iSviYiPxBEdhoeRJzakuPxSOf797//LU6uvPJK81rHHntsqdtvvfVWE+nF8QnRhvuRtnfDDTeY41MNKtyiWsmEYokQQggh3hOF3a54OlnDJEbrfVDXhEkYzCFSSTBBHGG7sVKPSR3S8rCirRE0WoqnNqjLgZnDlu1ZroIJtUuFa3Y9rqJAqpkzioR9ELe7gQatEBhIh4sEjkvUKaEHkR632N8RuXITL3htGDtA+MC44b777jO1Q6effro5/rFdiAI9/PDDrimAGBPsPm0Af7/44oshNzwb1D8dd9xxZW5HpGru3LlGsGktIbYbxySMJvD+derUMY/FfTheYZrh5jqYSCiWCCGEEOIJaimQiqfF1dp7SVeaITgQoUklsYTtxXZjm7VuCRNCTMrwmWgpntqgITEMCmDmYNcsKbh90zYxNuIVBaI7EAb2Polaq7///e+uj4chAwSQn3oljbSgpxKO39dee83U/8DKG6YNaCyLmiU48UEMIUqkzJo1y0R+4LwHAdWiRQvzWGwrUhZRy4RtsNPwIFpg841FEyVSZMkNGFgoGG+GDx8uM2bMMBGrVq1amf5QcDE86qijpDyhWCKEEEKIJ5gYIdUOKXdqu42JEC6YlGFVOdVst7G99kq4iiP9W69pKZ6aYIIPe/D80QVSsrtGqZQb3qQ8c39FmTuorTbqduCKd/TRR8tDDz1kIl0wLdD0QCxSoM8QTA5mzpwpzz33XNTvA6EDtzkIF/wNcxYcyxBfOAYGDhzoKmQglmyysrKMIYPiloZng4UHiB9El5wgkusWWdLnwUEPUSQYTEDgwSkQPZjwm0Gg4XYYPSDaVR524hRLhBBCCPFV44NJFlJ8IKDwv7pjpZrtNrZX+8ioULJtxGkpnvogAqGudzBzQI0SUu8QUdI+SxUJRBFqglBDBJe6Aw88UJ555pmQtTa48MILjUHCwQcfbISOs2bHC7uZNEQGIm2NGzc2hgkwN0EECMcx6o8gzPC39n+yXwM24pUqVTIpeU5xo3WM4bYBjXTtyBKOOdzeu3fvMu+H427IkCHGfQ+LM7Aphyug/X2g9xIa6qK3E4wmENHCd9i1a1dJJhRLhBBCCIkIUtYwidFaH0SU1EY41SzEsb2YIGKyBcGHCRwmZfifluLpAfZL9FGCPThc7yAKkM4F4VDeESU4ubmBHkvaZ8kGTV5hsBAr6KOkIPLjFv1B7Q8iWR07dpTWrVubiw2O7ZdffjmUhuf8DGqM4gWOIydI/4O7HXpHOc0dsEABQQbhA5GE8UU/B95H3wsLHXDcg4MfmtdCSCabrBKNO6cxmhPatm3bcn9vDMbwkIeyd7NPJIT7D+H4Q4KI1/krXRrUun0OuuFV/PwHE+RFixaZGhU7qkASDyQAFgqcUZ5kUlRU5Ov9VCxhH4hl+yLtR9FoA0aWCCGEEOIbCCOnOEpFAeX2OfB/qkXJCIkVRHPKUyiB8n6/RECxRAghhJCE2nAjqpBqduKEEOIGxRIhhBBCEmrDrZEmiiVCSKrzVytuQgghhJAE2HDj/1SzEyeEEDcolgghhBASM6hRQpG4+kVp0Xiq2YkTQogbTMMjhBBCSEJtuFPRTpwQQtxgZIkQQgghMYO6JJg5oG8L/sY1zR1IeYJo5t133y0PPPBATM/H8/D8DOimQ2KAkSVCCCGEJNyGm5Dyol+/fjJo0KDQ/3379o1KKN1+++2h/++55x4JGgUFBaax7F577RX1c+fPny977713qdsgCpcuXVpuzXmLi4tl3bp1Uq9ePUlFGFkihBBCSNJAet6ff/4py5cvN9f4n5BEUrNmzdDfED5+I0xOoWS/TqJ54YUX5IQTTpATTzyxzOX444+Xjz/+2PO5w4cPl7Vr15a6rbCwUH755ZfQZcmSJWWe9+2338q5554rP/zwQ6nbJ02aZG7H8eiXmTNnyr777isbN26UaMH3fN1116Vs5I6RJUIIIYQkBfZgIuWBRpJU+Oh1uAiTUyjdf//9UUWkYjkW/v73v8uTTz5Z5j4IJqeQgDg67rjjpFq1asaG///+7/9CDV2nT59uomm///675OXlmagNagTHjh0bej76neExiPj27t07dPvNN98sjz32mHmtU0891RixwMHykEMOMbd7UanSLskQi3HLxRdfLN26dZOXXnpJLrnkEkk1GFkihBBCSNJ7MGGShWv8j9sJSSQQOhA8fiJM5S2UVGzMmjVLOnToYC4HH3ywvPbaa6Xut4EI+uKLL2TMmDHGMOXLL780IgnHTvXq1c3x1KdPH3n11VfNtS1iIJ6uuuoqad26tYlY3XHHHdK8eXP56KOP5J133pEjjzzS/I3nNW7c2GxXOKEEsA1u2+kHvPc///lPeeihh0xELNVgZIkQQgghSYE9mEjQIkwVIZQUpNtpZOnKK68MRYrcQLQHouirr76SffbZxzx2586d5j5Em7SvmVeNEIQSPiccKk866ST54IMPZM2aNdKwYUNT/4TXOv/88+Xzzz836XgwZVFGjRplardq1aoVuq2oqMhcH3744aXeZ9OmTSatz1kXpeB9sO2IjLVr106aNWsmqQbFEiGEEEKSAla7kQ6EFCNM7tiDiVSkYCpvobR161bp3r27+XvDhg1m8QDCBaxatUrmzp0r//3vf+WPP/4w6XEQQRATzz//fEhoIHLUqVMn8//69etNhAfHkrPpMyK2CowU+vfvLytXrpSePXvKtGnTZOjQoea+U045Ra655hpj7nDQQQfJo48+at4Hz9foEY7bJk2amDol5bPPPjPRIUS4FESJOnfuXMrcBQLqjTfekGOPPdZErfAecBqEMOvSpUvocVOnTpX69evLYYcdJkGHYokQQgghSYE9mEhQBNODDz5o0tPKM6IE8QHjBaS+QXxE4q233pIXX3zR/A0jBaTPIeqDmh/cB5OINm3amPshcLD9d911l/kbkSQFqXcrVqwwUSWk7UFwQUAhsjVw4EDJzc01hgsACxiIGl1wwQWh2/C8aMiyolyLFy822/TUU08ZsQTh5Vbn9P777xsBNn78eLM9QYZiiRBCCCFJ7cGECRtWwjFpgoCizTgpb8FU3kIJQIRcfvnlpvfYM888IyNGjHBt1oxUNkSgzj777FAkCqlw3333nYky1a1b14ghRKVQyzRjxoyQqPIyk8BrQoicdtppRozgf9QMtWjRwgiuG2+80RyPiATh8RpVAuFS/NywHz9v3jzz/6GHHhqqcXJ7PQiqHj16GPGG7QoyFEuEEEIISRrswUQqCggiZ0QJYqO8apQgRm677TbzN+p2kALnZjqRn59vojlt27Y1F3DppZfKOeecE+pNhHQ2XPB5NP3NKcwQYcLxpml7iDDBXAH1RLBFR/QI6XkTJkww5hJ4zxo1ahix9Mgjj8hRRx1lngcBBat/GFE4a5bs2/A4YDv5waYcggwCMRyoh4KQRTQLboCnn366BBWKJUIIIYQQknZAmNhCCeB/3F5egklBdAW1QzBUcIJtOu+880rddt9995m6Hrv3E2qQtDZJU+sURG4RzUENkoIUQKTCvfLKK8ZmHHVLEFrvvvuuMXDA4yHInEB0RVOztN2qn4KRBGzI/YBI2UUXXSStWrWSIEOxRAghhBBC0gqnmYP2I/LbhynRIIoTLrLkBOlpuCgFBQXGDAKRJ7jkzZkzR66//nrTv8gNmEEsW7bMRLamTJliUvKefvppkyaH7YAzHsQbLMMRWUKqH8SZihg/gqdhw4by+uuvS9OmTc3/qK9Cg1zUWPkxv4ChBcwfgg77LBFCCCGEkLTBzfUOTV799mFKBkhZg8W29lmyL3YzWSfotYT0OUSDIExQu4RoERq84nLZZZeZPkmaJqegP1PHjh1NWt7mzZtNut2gQYPM6910002y1157SYMGDUwdFaJGKpQAXOr23XdfX2mGbdu2NaIH7LHHHjJ79mzT7DYciI5BkLlF2YIII0uEEEKiAqkdb775pllFxMnxrLPOMja0hBBS0YSzB/fThylZoK4HUSBboCGig5Q3RFecPZeeffZZM87i9v/85z8hy3EFaXKjR482j8FnhBU5mswiVe6nn34yUSiYQCCqBOc5CCMINhhHPPHEE0ZoYQyH2IKVOCzGw7nS7dzd4wnX4RrT4pxgg+3/9ttvTY8lBYINKYV2GmGQoVgihBDiC6wG3nnnnSYdpFa1LGlWt1gK12abPHisfN57772lHJUIIaQ88dNHqaIEk90HSYE9OOy8YYgAQwebI488Uvbff3855phjSt0OgWWn9vXq1ctc4JzXsmVLcztsxiGCYAiBz4XIz7XXXiuXXHKJibC9/PLLxvQBzW6Rhoc0QEStYPrgZvOtfaIA6pPCiSUnMG9A5AyRLrt+C6mAaoMedLJKbAuLNAVNv4A6jJQnCH1C4WOHRwiUEO4/JFXHn1tvvVXGji6Qft3WyfmHb5bqVUpk8/YsefXzGnLPpDw59x8XyODBgxOy7aTi4fmLVMT+g1qWRYsWmaJ/Te/yQ7QNZ8u7Qa0XSJ9zRpUSAaJIEFN6DRYuXGiEmZvYQT0X6rqCQlFRUaiuKZbvJ9J+FI02YM0SIYSQiKDRICJKEEqXH7vJCCVQo0qJ9D52k9zdbZ25Hyl6hBBSnsQifHB/RdYwKckQSkAFkt1gFnVKXlGhIAmloEGxRAghJCLjxo0zqXeIKLlxweGbzf3InyeEkPIEDVdjiRA5BZP9OoQorFkihBASFkSL4MRUKbtYnv6gppx16BbZs15p5yVEmprWLTEFw4QQEi/RVImo9TZ6EkWbSqePh1Bys/AmqUkiq4wolgghhEQ0dEC6XePcHfLU+7Vk6PTaJpJ075nrpfLuDBLULhWuKeuERAgh0aAmMah5Qj8hP8AwAE1WY6UiapVIcsH+AxJhOkSxRAghxBUIJRg65PdwM3TYZTE7uNd6c43bNm0TYyNOCCHx1PCgfgbW0gDmEBBDJLMoKioKOf9FU9eFiBKEEvYf7EeJqAlLCbE0f/58Oeecc4xfvO3TTgghJLmGDhBKMHRQ1NAB9J+Qa/6evaCqccODfTj7LRFC4qVRo0bmWgUTyTyKi4tDPZ1skwq/QCjpfpT2YglpILfddpucd955FEqEEBIgQ4cHptSWrsMbyo6irFCfJcCmtYSQeEAkqXHjxtKwYUPX/kQk/dmyZYv8+uuvZgHObzqmgtS7RLoMBl4soQMxGmFdf/31Fb0phBCSMcCoAU1n1SLcyS5DB5HaTQ813eBxQsOkBr2YtGlt07rFsnS1yNAhQ6TtQQeZx7Vu3brcPwshJDXBhDdZ1tok+JElULVq1aj6bSWDQIul77//Xp5++mn55z//KVOmTJFDDz001J04WjSHsSKUsX1NCPcfUp4pzOiajpPO3/72N+nRo4c0b97c13Pr1KkjhWuzZMv2LFfBhNql39fnyOnndzSmDhhf77rrLnnz9bGuNU4DJ86R4447zmQJ9O/fPyFFtyS58PxFuP+QdB1/oAv81sJllSTSWy+BYLN69eolS5cuNdco9Hrrrbfk6quvlksvvTSq10KX3u3btydtWwkhJEggz/vpp5+S6dOnS82quyI8y9Zmy6ZtJXLyySfLlVde5dmYUFmxYoVceeW/JL/H+lI1S8rI2TWl/4Q68vTTI0xeuK/Hj8+V7Ows6XLSyXLttdcl9DMTQggh0VClShVp27Zt6kaWvvrqKxNZeuqpp6RTp07mtg4dOkifPn3M6mi9evWiej2sYrZp00bKGyji3377zUTEos25JIT7D8GC0YQJE2T16tVSv359X9EhRHhmvvuOES5lXezekby8ujJo0KCwr7H//vvLueeeJ/mvj5WS3TVKpV8nT84991wzPmMbn3/+eamULbJmU7YsWZNTpg8Tnj9kWm05rOU2mT79Hbnttr6+o1ykYuD4Q7j/kHQdfxYsWOD7sYEVS7///rtZ+ezYsWPotoMOOshEmODSFK1YQqgN9pMVBX7oinx/ktpw/8ksYJDw2muvyduTJskvv/wiNatlSfN6JVK4NluGDx8eMlNwS2XD+Dh27NjwLnZjx5o60EjOdQ8++KAZh/sXFMiQ6XVN01n0UoJFOLZhwIAB5oIapWqVS6R2tSJ5/L1a8si7taRnuy0y/Px1oT5MpsYpr8hcUM+E1GrWoqYGHH8I9x+SbuNPNHb0gRVLTZo0MXn2W7duNR2ZQWFhoblG7j0hhKRzE9hKOSVSXFwi+T03lI0OjS4wjx88eHBMLnYQPm+++WZEsQIxhve47rrrzONh+tCgQQM588wzjdCCmcOYV0dJ+z23yVdLqkhOVpa02mOnFK7NkfFzqsucpZXl/VtXGcFkmtauzZHu7YqM6MJrEUIIIUEnsGIJ/ZRatWol/fr1Myd0OOJhJfXoo482QooQQtK1Cez1ndfLsBm1Jb/HBu/oUEGBETHO6JA/F7voxArewymstA8ThNKcwipmW8uaOuTKCUMayPu3rNrVtHZ7lpx64Fb576w6xhSCEEIICTrRd3kqJ5D6MXLkSJN2B4OHiy66yBQRDx06tKI3jRBCEo6Kj37d1kmlHJFaVUvCRocQPUK0xwlECNL14GLnhonwrNn1uHhABKtGFTERpX7ddok6FWgq6vp33yC/ra4k3R+tL/dMyjXbjQa2SOM766yz4np/QgghJKPFEkBDsmHDhslnn30m33zzjTz55JOmwJkQQtINO33uz43Z0iyvKKboEFLkNm4tMZEcN0yEJwFiBe8NUVSzSnhRV7NqicxdXkVOPmCLtGm40xhDoN4pUr0UIYQQEgQCm4ZHCCGpbtKgdT6I4kCchBMIdvrcHrWKpXBdTtgeR17RoRYtWhgxkj+6wNPFLhFiBe+9brNIqz3Ci7pmdYtk4cpK8s6PNWTy3KyQOQUhhBCSClAsEUJIAkUPTBrQ4mD8+PHG2CCvxi5xgxTicC52dvrcmYdskaHTaxtx49azKFJ0SMUI6poGT8uTpvVKZNmarJCLnd4f7WdzRrCGDBliTBvCibpla3OkTvUSabFve3niiSeMQc/69etN7zv0uKhdu7bp0E4IIYQEEYolQgiJ4EyH9DhEfSBmwokePKdLly6yYMF8k37WvG6RLFuXY0RD+z23G+c4Lxc7iA+8tgokRITyJ+V6RofQSG/EiBGmvhMWqHhvW/DgPXr37m1qP7Ozs01as7rY4bFwsovms7lFsNDzacKE8eFF3fYsKS7Jks6dOxuh9Mcff5j3xzahj8bmzZvN7RRMhBBCggjFEiGEhHGmQ78iv9bdffr8Rxb9Ol/ucbP7npQrBzffZgSKm4udM33urtM3mNv7T8iVB6fWlka5RfL7+sqyZbtIiZTI/J++k19+miNbd+wyVEAN04oNlUsJHjR9Pe+880yDWbtPRSyfzY1HH31U5sz5VgZMXOwh6nKNSPxqSTUj4v73v/8ZoQRhBIFXUlIi27ZtM7dTLBFCCAkiFEuEEOLhTKeNXZesyZE3v65ujBdQT3Rdp/UyzCF68JwJ4yeYvkiedt8Tco2DnFePIzt9TpvAVq9cIpu2ZUlO3f2kTeNq8sPc7+SQPbfJl4urSE62uAqz/NGjZOPGja7uoc7P5rqdHoLOCaJPs2Z9ICccf7z0G/+bEXWoUULqHSJKEErfLq0aqpFavny5iShpM0Bc43+k5BFCCCFBJNBueIQQUpHOdL3ab5ZbX68jRz/QUJ6aVUs+XVjVXKMHEprGvvbaa6WeU6OqhLf7rlpiRI1XjyNtAvvxxx/LVdfdJEedcqlcd/2t8sknn8gLL7wgc+fONULp26VVBHJjQHd3y+5+3dbL+PFvGUG2c+dO188Wiy251za/P2uW9Ox5hmzali2/rqos1apkS/XKWSaidN75F4ZEIGqU0GwcESWAa/yP2wkhhJAgwsgSIYR4ONMNejtXxn5Zw7Ph6tuTJslNN90Uek7TCM1gm+QVya+rsiP2OHJrAos2CtrX6MR9t8nnv1UJK3gQ5Zky+W3ZuXOHPP74E0ltWgvBhNYOffv2DRlGNGjQIFQjpcDMATVKSL1DRAlCCc/F7YQQQkgQoVgihBAHEDNLVmfJvN93CSXPdLXxvxhHOQgCPGd5RLvvHNlRFFuPI+1rlJ21S3RF6sMEc4k61XfI9OnTZenSpbLvvvuWcd2L1pY8Em4izwZ1STBzQI0S3fAIIYSkAkzDI4QQB4iIbNpWYsRJ2IarVrrarufscoBzQ53hevbsGVOPI+1r1DSvSBrVKQr1YXLDCJ61OXL0XtulZtUsmTBhQrk3rQ0nmPBZmjRpYq5tYwdEnCAKUduEa/xPCCGEVCQUS4QQ4gDOdPvss480zo3QcLWeyKJFi0yK3DPPPGPsvAdOrCMjZ9cMCRkIF/yPtL02bfaW4cOHm2jUwIEDpVu3buYyYMAAc1s4IHIQlVq6JkdOPXCrbNy2Kx0wnDA797DN0qRuiaxevbqs696kPNftTFTT2miBMIKtOHow4W9c438KJkL8HT9caCAkOTANjxBCXOjevbs89fgvYdPVlvxZIvNef11qV8829UpLV4vsLBbpNz5X7p9cR5rVK5ZlJuVNpEfPnsad7vbbb5fRr74q1asUS5M6RbJ8fY58883X8swzI6Rt24NM7U/r1q3D9jX6aEFVE9mCAPOy7MZtcO5btjZL6tevH9F1D6l3zqa15QltxQnxh9rto0+ZGqbAkh+g7xr7lxGSWCiWCCFpN4lIRD3M2WefLQ8//HDYhqubt5fIjV3+J9d02lTG/GHLjhLJrrOfXH1Rd+nVq5eJ1KAR7GtjXpX8nuvL2n1PzJXvv/9OjjvuOLnwwgtdG8Oir9Hs2bNlwMRdfZi6HrjFCDOYOaBGCal3iChBKN175np56ZOasnlbiRFZbq57sAcPZ8hQnuA3o604If4isLiG0yXEkgKhlJOTY45v9i8jJHFQLBFC0moSgRVWTLrjXV11Nol1Rm8giDq02C43nbLRw/whVxYu+EVWrFhhBMiu/kajJL/H+jCGEbkw1JYxr45ybQyLSdBbb70lHTseZ8RVrWolUrtqsWzcni11qhfLaQdulXMO2xVRglDKn1hH9tqrjTz//PPSqFEjU4dki6FIhgzlCcQtfjOskmvDWtqKE+IegdVeZRBI2h4Axwvuq1atGvuXEZJAKJYIIWlBMtK4PNPVtpZIpUoiL/de4/o8CKsh02rLYS23mQawiOCYPkxVwvdhGjK1tmwrEjm2zV/Pc0Z69tprL7nwwouMoMLro67q++WV5PNFVeT75ZVl/JxqsnxdZdmyQ0wvphWFC+WLGQtMOiDSADXNzhm1qmhoK06I/wgsBBLGOb3oIoOm5XGhgZDEQbFECEmL1LpkpHF5pav9+uuv8sPHr0tu9TC9ivKKzEUbvOK5TfIi9TcqkhUbsks9zy3yoyIOggqPg4jD8zdty5KcuvvJ3o2ryk8/fC/9uq0rk+53z+gC16hVRUNbcUL8R2BVIGmDZ1BUVGRux5jJ/mWEJA6KJUJIWqTWJTONy5muBve7aW9H6FW0Nke6tysKNXjd1Ycp8nO27xRjDR6uMaybiOuxu+YIn/uYY46R/B7rvNP9PKJWFQ1+01ijgIRkAnYEFiDChLER6XgY95CCV7169bjqNQkhpaF1OCEkJVLrIHpwjf9xuxNMDrSwGdGkZK6u+upVtD3LWHxrg1c8Z/P2CH2YtmXJ9qLSz/Mj4gYNGiR9+vQx/yPdD9GmcOl+GrUihKQWGoGtW7eu1KpVK3SpV6+eOf6bN29eqn8ZxkHUTS5cuNBc8Dft+AmJDkaWCCGBRVPrtHAZ17ggghRLGhd6GWkkBhMKp+FBoswf1Lp79oKqoQaveJ8LLrhQBr46yvU5MGxABqHzedGCz9asbqR0P++oFSEk2HhFYLXXko5/eAx6rGnEXR+zdetWady4MSNPhPiEYokQElhwwt+0aZM5+UMkIc0Eefk42eOk75wweE0iILTuvPPOUI0PxERhnIYHIfOHUaPkgSm1TZ3R7+t3WXef22GztGm407jRoVHtiBEjjDi76qqrzOfo/+qr5jmN0WdpXY5s2bGrzuqc9rueF09jWLwPPlvYdD8fUStCSGqnLGOswXgJoYQ0PU1NxvgZj/ENIZkG0/AIIYFFU+jUGhcne/QRgWhyS8XzAkJp7OgCU8fzzV3L5N0blsvXdy2TgT3Wmdtxf7Ro3dAHH34obfY7WOavrCzbi3KkVYMsmfRdTRk4sY4UFYssmv+9fDrteXnq8YekY8eOZiKD51zwz3/JuuJGsmVHtlTOyZLWDbNkyg+1JH9Snpz7j9gbw/pKEdwmcuSRR5raq7vuustcI+pGCEmflGXtw4QxB6hzHojH+IaQTIORJUJIYMEJHwXLatqAkz5EClZL/Z7sd/U3Kkia4UHr1q1lypQppVL8vv76K/nx+7kR3egGDhxY6nmJaAwbOUUwz9iPo1FuoqJshJCKxcsN1BZM6p6H+xJhfENIpkCxRAgJNHB2wkTA7p+EFVS/J3s/hgfooeRl0+0XNVuAODvmmBd8i7NkNIa1+0MNnpYnTeuVyLI1WSaiBKH0268LTHPcVLEVJ4SEx80N1F5c0ug8ULc8Qog/mIZHCAk08brclbfhQRDc6DRFcMaMGdLz7Avk8M4XyzX/uUVee+0144jVv/t6I+T0O1Ehd3e3dSYKx5Q8QlJ/nMQCE4wc4Jyn9ZxwzaO5AyHRwcgSISTQRHK5i9S0trwND4LkRgcb4fPOO0/2339/qVGjhqlNKo8oGyEkOOMko0iExAfFEiEkpa1yIzWtRQ0Q6nGQZmanxTkND2Kx6U41N7ogCTlCgkykRZggwqbOhCQHiiVCSMqCyQwmNcjRR04+rnWSoxMbP4YHsdp0u+FXnKkbXbQ9n+LpFRVkIUdIEMD4sXbtWlm/fr2p+0Fqm9siDCEkc6BYIoSkLJjEQCSpy5MWN2/cuLHUhN82PECaGaInEAUQLeoAlyiS5UaXiF5R5R1lIySV0Eg1xhWYIugiDBw5cfyxNxEhmQnFEiEZTjyRiopGmy6qXS6AYEIj2xUrVoQKm9XwAA50ibTp9iKcOIvVjc7uFRWri115R9kIScVeRWq7jWuMMRBM+J+9iQjJTCiWCMlQEhGpqGh0QgOBZIP/161bZyY3dupMMmy63fASZ4cffricc845RihF0/Mpkb2iyjPKRkgq9ioCWITR8QV/A/YmIiQzoVgiJENJRKSiokG/EKTc2Wl4AJMcXCo6dcYpzmJ1o0tkr6jyjrIRkmq9iipVqmSiSXZvIqTi0VWOkMyEYomQDCSRkYqKBJMXFGNjRViFElaCccnJyQlc6kysbnTJcLErrygbIakCxhMYOWCRBYJJqVOnTiillxCSebApLSEZSBAapyYCTF4aNWpkVoRVJGm9ASY7qDcIUuqM7UbnhpcbXazPI4RE36sI4ghR6/r160vLli3NGGMLJUSrseA0f/58c43/083oAgsvy5cvN9f4n5BMhmKJkAwknfrtYDUYURJMbCCQVCghhQYpZ0FKnUGq28atJSbV0Q0vN7pYn0cIiQ6IIiw6NGnSxFw7o0kQRsuWLTPpv4hA4Rr/p4tgUkdAWKfjb1zjfwomkskwDY+QDGyimG79djTChFSZIDeSjNWNji52hASDNWvWGMMHLMiouQwWZnB7kBZm4nUExLipn8/Zu46QTINiiZA0Wg3ESQ6RlUhNFNO1304qdLCP1Y2OLnaEVDxYiNF0X6B/B6k2MhGOgPbnC1rtJyHlDcUSIWlAtKuBmRSpiCbiVh7E6kZHFztCKh6MIWooo2MtLkGqjUyEI6D9+YJW+0lIeUOxREgaiACc3EA0q4F+IxWp3LQ22ohbeRKrGx1d7AipOOrVq2fGEaTeqZiA8yZuTydHQIydGDMhlIJW+0lIeUOxREgK4hQBOHFrHj0uflYDI0Uq8Nq33nprSjetZf49ISSRQDQ0bdrU1ChptBpCKV3EhDoCBikaT0hFQ7FESIAjRm7gvt9//92IGaxoolkiLlgNxIonTmrRrAZ6RSrSoWkt8+8JIYkG42q6iKNUrf0kpDyhdTghAbZt3bRpk4kUQRjZtrWaM4+IEh6jOfMQSDjJoU9IPKlm2rS2X7ddTWvVMU+b1t7dbZ25Hyl6QQbfCYSjNqxl/j0hhBBCooFiiZCApo2p+AEQRLZtrboVac781q1bzf0QSV79QTKxaS1Wf/EdQnhCYOKa+feEEEII8QvT8AgJeNoYQARJ78dtSL/T2wAEVI0aNSKmhvh1hkuXprXMvyeEEEJIPFAsEVIOQNhAoKxbty6sSHGzbTUHaqVKpWxr9TaIJDwG0ZJIaXfROMOlU9PacPn3QbMVJ4QQQkiwYBoeIUlG64qQKofJOeqRIFrwd6S0Ma1VqlmzprmG65JGlVQoQTQ1bty4zCQfr4HIz/Lly8312rVrS6X44Rr/Qyw4gSPexq0lxszBjVRtWhuuPizc70IIIYSQzISRJUKSDESP2npDpIRrGOtMG8P/GzZsCNUu+bWtVSGAaxgcqMkBXsdPL6ZMaFpLW3FCCCGERIJiiZAwQGRA6OAawgJRHVxHA56vAsVPw1g7bQxpcrAJj9a2FkLAFkp4T1yrwPLTi8lv09pUhbbihBASP6ncuJwQP1AsEeKBigutG8L/Wu8D0eRXOOFxmk6XbPtqiCScsNQ9T4UZ3lM/BwQY+jJF6sUUqWltquNWH5as34UQQtINnNfQj8+rcTnuIyQdoFgixAOtCVKxgf/1do046X3hok6YfOOkoiYP0TSMjVYoFRYWhrYT2Ntt34bIUvXq1X0ZGng1rU118NkhHBGBw++WrN+FEELSkUiNy5FCfs0115jsiIYNG3JsJSkLDR4IcQBRg0k0BI5GZFRwHHnkkVKrVi1juACxAaGBKE3nzp1DQsgJhAkej8clomGsF9qDyQuNMuGCbY+3F1Oqo/Vh+D2S+bsQQki64adx+aRJE2XFihXG3AjN1N3MhAhJBRhZIsTFuQ6iA+LGFkoY8OfNmycnnHCCHHbYYeY2bQwLYfXAAw+YlTa36BIEEy7ohZQsvGqgFO3PhO2I9NhMIZytOCGEkNgblw+elifvvfee/POf/zTnUSzoMXJPUhGKJZJR2H11VNRA6KiBAwZyDOpIx9LULK31mTt3rhFTV1xxhZxxxhnmNjwGltwjR44MpefFu12x9vvB88LZXmNbIQDxGViXQwghJFb8Ni7H+VHT1blIR1IViiWSMdhNWfV/oKl2iLxATOhtmramkaVvv/3WXLdt2zb0mnjM1KlTQ4+J1ikvUrPYaICF+MaNG0Pizg0IJdblEEIIiQdfjcvXZskRdeuGFh25SEdSFdYskbRFm7IuXbrU5FfjGiIEaWiKHTlS0WSn3qlgwjXEUt26daV169ah2+fMmWNsU3Nzc83jkeYWT78fPB/vj1RA5HrbLnqRQDQKzWmdqHMfRBLrcgghhMSLn8blm7eVSKdOncx5FucgLOgRkoowskTSEo3WoM5IjRoARA5uU3D7448/bmqJkF6n2Cl1eA6EBsQSHtetWzf5+uuvjViCOOnevbscffTR8vHHH8cUYdKUQLwfokoq4CDsok3rw8kI2wqhhSiSGjqomQHrcwghhMSLn8blOFc2atTIZGzQDY+kMhRLJKXxqvXR22yhBDRqpDnUEEojRowI3delSxcjNo444oiQ0MCKGF7rxx9/NK8HK+3evXvLp59+Kl988YU88sgjUr9+ffMaixYtkqZNm5ayEcc24n9tBuvV78dufqs21ip4ogHfAV4z3hooQgghxItIjctheLRgwQKzqJhMcyNCkg3FEkn56BGuIS5wWb16dUjc2LVI2nTUvgBYaCvDhw+XvLy80O0dO3YM3Yc+Eccee6zpTI4mrYgiIaXtxBNPlAcffFBefvll6dWrlyxfvty8drNmzUq56AEIIhUubv1+kHqnjVEhkPBYfA5se6Jc3hJhJEEIIYREalyO8xoh6QDFEklZ4LIDgWGnqkGgOOt83AwPIBSQGoCGeRAjw4YNK3X/zJkzpWXLlmbAB61atTK3afToww8/NCtlHTp0MBEm2KOqYYSzbknfH9uGXhOIPNmCSVPkkDqHkwtOQNg+jX6FM2yIBmwfRB+uVUTCEAKrfhRMhBBCYsGtcTnOM+vWrTPnQ73GIh3sw3WxDmnjtBInqQDFEklZ228MwFrfo5EjL+wIEwZpRH4gEPCaSBVAJOn+++8v9Zxff/3VXKtgAjBzeP/9902U6JBDDjGGD8jJxutje/C6biYLCtLqIIqwDbZAwd94HXXFU9GHtL1Y7cjdxCW2G9uqLn/4H7fjvQkhhJBEZn3gnItFTWRYaBYIbsN5HOcf5+IhIUGEYokEugcSBli3lDqnaUMk9PUQtYEwUKGi6Wr33XefcbSzzR+cgmn27Nmyfv1646rXpEkTU+AKgbRhw4aQEAonlHRb8Th8Tmc0RyNMdpocthcrcYlA0/y0bgrfiTbhJYQQQhKBOrzi/AVwrYZF+FsXN3H+YaNakgpQLJFA90Byi6poepoSKU0NoqNWrVquNTqIFGmuNfpGHHrooaYeySmY+vfvL6NGjTIFrdgmRKK++eYbE51BGh62CSYPSM8Dxx13nOf24LFezfmctUbJyPn2E4kjhBBCYkEXPHUh0z7f2LdphImQoEOxRAIRTULEBkIJIgSrTRhE7V5HTnGkjnFu99vgPkR7nGF+vBfS7woKCqRmVZEmeUWybG22XHXtjdK4cSP5/fcVpR5/wAEHmOdAWJ1yyimycOFC857Tpk0zQmvfffc1NVAQTn7EUkU056tZs2apNAj9znA7IYQQkgjU4VWFkb1A5/ybjWpJKkCxRBKOm+OabcigE3RccBtECC6YxCMNTlecFDexhGJRnfTr37ggxcw2RYBjnVs+NITS2NEFkt9jnZxv9YeY12CbzPp51/NsYOQAO3GIIZg0IA3vt99+M9EwpOMNHDhQfvrpJ7nlllvCfjfa86gicrRRX4XvV1MN8d1BnOJ2QgghwSWVnEzV4VUzRHB+x2Ii/tfFUD2Ps1EtSQUolkjS0ukgDLC6BMc1CBl1YcMFE3a1+Vb7btyGgdRP2pjW3uAaOdAQXni+9lDS3Gik1jlZvHixiShBKF1+7F/1OjWqlMihe+5KCXhvXtUy75mfn29S8RBNQlPa5s2by2233Sa33nqrfPfdd0YsuUW59DZcoy4K21QRJzm8J6JsqXLCJYQQ4n5ehRgJaqNxrb/FOR4LpDg/I02dbngkVaFYIkkp7MRgCcGCvzGwe9UbQdxA5GghqFs6nfM2bRarURo9YXitvDmNI9ATCal3iCi50bbpDnn3+7Lvi9e87LLLzAVCDX2XnGD1TJvL6ucDEIV2amFF4dV/KdVWLgkJCjxuSHmeV3XxTfe7oI7R2C70LUS7ClzruYfOdyQVoVgiCUUFCcQCVpSc4sDNsMGuTQJ4vqbW4VpFiw60uN3vhF5X5PB4teNGGl3jOkUm9c6NzxaUyOYtfxWd2vVRCiJgMIdQW/ETTjjBXPTxQFMLsX34DHh/fCeIbCGahktQBEmqrVwSEgR43JCKMkwIZxSUTjhNmNAY3m7nQUh5QLFEop4c2LVHiKRA0Kgw0B5BIJooiuYxI2IDEaEN7DBRR32Q17ZgZQ2hfpw4kO6nqX4At8MFD6+D19cUP9ToLF+XJVu2Z5URTLN/FhNVUjQy5YZbHyYbFVjYHv1+8J3ggm3B6wZFkKTiyiUhFQ2PG1Kehgl2SjrOJ+lsjmCbMNWqliXN6hZL4dpsGTp0qFxwwQXGmVYzUghJNhRLpAzh0tkQlbHtrO0Uu1iAKAJ6AlDx5XYycKbTIX1PxZlbrRPug7BzNnbt1KmTvPTii/Lq5zVK1Sw9MEFk635/PT87O6uUUEIqAfoq+RVMGpHCtjkjU9pMF9sYBEGSySuXhMQKjxtS3oYJdk1uOqe0OU2YVm3MljFf1JBPFlaRVwtGyR9/rJDu3XvISy+9ZM6hDRs2lBtuuEGOPPLIit50koZQLGU4TmGEgRgRGUzwIVrwv0Y/IDziFUc2OjlXRzZ1xlNnO/tkYHcEVwHit0+QU0jB5OD444+XARPfF7zCBYdvluFTS+T2MSL9++96TM1qSAP86/Vbt25tBBFSAlQgRRJM+P40kmRjN+SDOIxHkCSqXiITVy4JiRceN6Q8cGtYHpQU7mRgmzBdfNQmuXNcHSn4vIbUqloizfKKpFrlYnn33XfNBcZMaP3x9W/z5OyzP5Q2bfaWKVOmSI0aNSr6Y5A0gmIpg3Hm2yO1Tifu+N9OGVu6dGmpFLd4wACP18WkHBbdEEq4DScAr5MBblehpFGZeLjl1lvl118XSr/xS+W20Vmyeu3G0H0QSpu2FpURSnhfCC2tV4okmLSfklvNE4hXkCSyXiITVy4JiXeRAsccjhVcawSbxw0pb3OedGPcuHEm9Q4RJQilsV/WkPweG0JtPm4cW0fe+KqG9O++oVTrD2SLDJw4X0499VSZNWtWRX8MkkZQLGUwznx7CBht+KqpcLgfuKW5xQKEEd7LbWXMPhnY9Ui6eqviLRGCDROb/z71tFx66aUyZ87vodsrV/IWShBxeG8IJlxDQPoRTIgeOaM2el88E6tE1ktk2solIbHiXKTQY0/rLXncEBLbcaXnH5xbm9YtlpX/yzYRJQglTZlfvDonJJ6crT967/6/3/j5piciU/JIoqBYyuBBCWlv6jgHEaJRJe2FZEdD7E7cfoEQwARCrbRR89OoUaOw24VtglEDtkWb07ptTyyobbl+BmwbGs3OmTPH/N+qVSu56+5+ocefeOKJxn0H35V+BjwHNGjQQBYuXCgff/xxqfd4//33pUuXLqVsxSGW1GBCt0EFI67x+iBaYZLoeolMWrkkJFa8FikglNz6uhGSLNLFtt65AIG+TIVrsuS1L3el3tltPsZ9U73MbTZIq39gSm155JFHZMyYMeX4KUg6Q7GUQWBAgv3m+vXrS0U57I7aQIWJLU60r5FGmsKhk3a9qGBAVMlLIOkExBYziUY7hePz47NhO/v06WMEEIpD8T0MGjTIPOaee+6Rdu3aGRMJPE4ja9ovCRx22GGh/yEMZ8yYYW53ihW8vrryIe1QzSk0xRGmEfgO8B1FszLNeglCyh+aOpAgkE629c4FiNNPP12ee26kfLywiqlRsl1r/9yYXeY2G9yO1iDISiEkUVAsZcjqEh6D5nCI2ihOUWJHj/Q+tfNW4aQCCPdDKGByD6GgzWUBVoVwwXv62SZNsUsm2AatjcK1/X09/PDDoV5Iuv1XXHGFEZY6eGMbsb34H59ZV5MhqHQ1+aOPPjJ1X3Dbc4LvEBcUneJ18Xm1cS9eR1MM8XwM8lrLFQ7WGRFS/nCRggSBdLKtdy5ANGvWTE479TSZMmWyVK9SXKrNxx61iqVwXY5r6w+A2qXl63Kk/b71y/1zkPSFYinNVpewsrRmzRpznwoQiBkIGxUzmt7mTLPDAIvHaZE/JuNqz60OdHbj2Nzc3JAAcfZgwgWio379+uZ+DOArVqwICRREefAYbG+86XVe6Lbi86POSLfTK90Mj0dECSxfvrzU4I1txveAizbMddYb9e3bN+oTg0bT1FBDzRUQ/dJIlBesMyKZRjwNKhOVssRFChIE0inC6bYAcf0NN5j5wXvvv1eqzceZh2yRodNrl2n9oeD2LTuyjI04IYmCYikFsUWJpsVh4q6pXU7cbnOaDWCwQhoY/sfjMUnXeh2IL53Q241WNX0OdUh4PqJEtvjB4IcoCSIqdvoeth8RLqdgixWt/7FrkXS1zdknymuy5Gahrq57ehLC6+I+fNeJsunWz29H7vQ98Z1p818vWGdEMoF4G1QmMmWJixQkCKRThNNtAQKp648+9pjceMMNMnDiu6E2Hy3qF8m5HTbLwIm5odtKu+HlGvtwmjuQREKxlGJo6hoGFjtdLha3OtuVDX9DKNgRExVl6gKnvY3sRrK4r7CwMKwoc6tzirc2SVfUVMQgNa5JkyalHmM76mnUTSM5eC4EGyJOwDmRwme0o2z4XnSS5Da5imbV2j4x2IJJP5OabuD/RLkQEpLKUaSvvvpKfvphbqhBpT05umd0gXn84MGDyy1liYsUpKJJpwhnuAWIZ5591iyU9C8okCHT60rTuiWydHWJ7CwukX7jc42ZA2qUkHqHiJL2WSIkkVAspQD2RBwnfE2ni0Zs2FEk+7kYlBBBUmtse5DCJMXubaRojyQVWcmuN7JRQaFiBkIJggLbbX9P2C5EZTS1Td3stOYK/0MUQQxq5Ms5kUIaIe6LJICiXbW2Twx4rBpIqCC1P1eq5Z4TkugoUsPaxbJwZYnc09PbKhgTqeuuu84zJS+dUpYISccIp9cCBAQgFkJwfOviSY8GDeTMM8806fJwvcOCaIf99pDrr7+eESWSuWJp/PjxMnz4cJk5c6ZkGjoRV9Hix43OC00js40M7JojJxiA1XgAOMVWskWS1lbZgyZqoBARUmECQYHb8RlUsAAISo2C2WLPdurDcyGoEJVym0jhOV5WwE4BiwvSGP2uWjt7SkG0oU4JqFDC58JvREgmAaE0dnRBKIr09Ac15an3a4W1CsaKMyZSmCyle8oSIZkY4cRCiPP4xm20ByflQeDFEkwBYOeciqHleMEkGp9f61bsSXy04LmYzNtGB+HeFxN9REcqKg0Mkxhsq5ujHgSEczXNTrPBc2w0kgQ0xc0WftFOpJyRJI304fFqJR7NqjW2GXVfTpc+fK7yjNoRUtEsXrzYRJQglDSKZKyC64a3CkZqDlacMyFliRBCSPkSaLGESevtt99uJpKRCt3TDZ2Q24YJmn4WjVjC4zEpQLFkuCgSwEQdEw4IB32/igCTGQglTGTcJjP6GVRYaDqbfm9aCwRUANlpiGrcACC8op1IOesfIGhU1KmteCyr1m6rhNguQjKFcePGmdQ7O4rkxyq4cI2EbQibbilLhBBCyo9Ai6VXXnnF5KRCMOXn58f1WpjAVsTEUyfxeu1EHc805Q3iBidynYDjfzsNTutuIgkmiADYc2PSr+8B8YUUL9zndI7C9q1cudJ3JEOjJ4mKfKigwefFpAfXSEvDdiO6ZW83Pg8c+tTKXGuTtJbKjhqp5bn9Pnq/9kxS9z99L41e4Xa3fUbNNfSzazRJUwBxH7YX2xrvPhdp/yGkPPefpUuXyoQJE0yNAFJie/ToIc2bN0/Yj4BIetO6xaVEkR+r4E3bRE499dSIxxv6nOECvI5v8hccfzIDnSM4z7Xxwv2HBHn/0cX0lBZLixYtkmHDhsnzzz+fkC8Kg8FPP/0kFcVvv/1mrrU2RoWP24DktPW2a3dwglcnObcfWY0MILS03xIGP7seB9EjPEbfQ23BnTVC4VCxYEduIj3e+ZnUKc/5nWjjXGy3zapVq8xgrjVHNs73txvsaiRJn6vvhYnSunXrfH1e+3n6vxu2w51+/4ncfwipiP0Hx87TTz8l06dPl5pVs4ygWbY2W4YPHyYnn3yyXHnlVWWOVyfO49wN3F64JqtUFAlWwahLyp/kbhWcP6mOnHzySWbcqMgxPp3h+JPeeJ1rEwX3HxLU/cdvBlAgxRIm4bfddptcfvnlctBBB8lnn30W92tClLRp00bKGwg9/NDoSK3W1Wo4YKfX2SIC26pRC418qGGBWmXjMWgKi8m522oQ3hdCQJ/nFhWKB534IL0PYKLijDJhmzTKgm3TeiI/q1fYdqx04X5bWOE5eD4icfZzNdqD21QIqhMe0m2c7+VcSUN0CJ9B/8/LyzPfvTOKpb8BsAUnnqORvGTsPy1btjTbQ0hF7D933XWXzHz3Hcnvsb6sdfekdyQvr66pLfXaBizQ6PGIC44Tt+MFYz5qlpxRpHvP3GV+0n+3VXDz+tmybG2WiSide+650r9//4Qfe4TjTybgPNdqVgsisDhvxhNl4vmLxEOy958FCxb4fmwgxdJTTz1lTqhXXXVVwl4Tg4CmX1QEmiamUQ432287+gO1iwm6TjBU/cKkATtNuHx75OUj5S4RDV+d26eTHRVxEBlIx1EHOBWDCh6nphJ6v17wOvg8bp8DA7iKQkW/M/yOeL6mv6mAwTXez3ak0+a6alqBgw/PVfMFbeZrmzHo/RC4+nmcr+vXVjxR4P0rcv8lqU08+w9MF8aOHVvKdKGMdffYscapymndrRFutcTXsQ//49jC8Wmz3377mSaz+aMLSkWRdhRlyb6NdkpOdpa02a+dtG/fXhrstg/2sgsniYPjT3rg1g8Q6LkW53TtRajtNXCsxtK82Yb7D4mHZO0/0dTlB1IsvfHGGyYn/ogjjjD/60HboUMHI6RwnWpgwFGhZE8a3NLG9G9MJHRCrmYHfhqiYnKSSKGkDVI1bRDvgf9V8OC9sc1qea2Cyt4Rnc10AUTKhg0bQmYONuEc6twMGWwbbqdJg22/rgIUqH24W00THoNUBIi5aG3FCUl30wW/1t0YG+wxwU7B83KLvPfee8213YQSBg6IIkFI4X5GkQiJDq9+gDin6tzEXuzUlhzxNG8mJF0IpFhCGoY9gZ0zZ448+OCD5nasJqYiEBJeZghuogkDVST3OnsAhPBQQZYoMKCqUILo0J5CuvqE+/C+Gv1Sy26NuuBz4X4UbeO5TktvgNtxPwZs+7OGc6jzcrYCbm5XSAHC9tqCx80ZT+/DReu+kOrI/iwkk8Hx08xhuuDXuhvHom1SYx9fXrnibk0oGUUiJD6cLq6aJYHjEMecZn7ogq6m5bF5MyEBFUuwCrdZtmyZmXwjLSpVgYBQ1zudMNgpZPo/IhmoA/Kb1oUBEIJEB7lEoNulQgnbAeHmFCPa1FUHX2yDRmrwe2kTXTw+XNohHu9cuYpk9evVjM9eCUN0UiNUGkVyuvi5hWHt+jH2ZyGZDiKohWuzY7Lu1ig0xgK715m9wBFNE0pCSGzgPOqVJaHnWjjQ4jyJeYhmwLB5MyEBFUtOkI43c+ZMSWWwSgMRiCiKpqVozY1XHZJdZ6OW4c7H4T6/zU/9bqeuKmnKnVOkKLB1twdfPM9Oc8N2aRNYt6iapth5rVzF0p3cLdVAo0f2hE3f3zZpAHZkLlwUiykJJFNAXdDQoUMjWncfeeSRxsEUkSAIp7POOsscO2rPrccfjiGMhTyGCCk/wqW267kW5zY9f6oJFZs3E5IiYildwECEgcnPxNuu8bEn8Hju2rVrzWQDz0dUKZFonyc/BZ3OwRfRJLXO1pQ9Z62CM8Kk0atoGri6FanajWqdqQbqQuh8b902RPJUdOpngYDVlfJYRBsh6UKLFi1cTRdC1t0T68hee+0lvXr1MrVNSNlDJAoCC8/r169fyETFbcwLdzwTQhKDnywJLg4S4g7FUjkTbuKNCQPMGTQio01ObXC71vlgkIvGzcMNOyUQUatwKYDOSQ0eo7nOOvjCsQRCQyNhmnaoznlOMwXcpita8RSpqrhzSzUAalesq2UQRdhWXeHmhI0Qb8KZLkAoLV600LjllbEVH11gnocapFiOZ0JIYvArhLg4SEhZKJYCAgYw1Gb5aQSnkRv0BYLYwKQ/Uid6Zy8nPA8XCBt1lgpnDuE2qVETCtznNvjaLnRABZNb+iGAAEQNlNZ4uRlceBWpas2TW6qBGlDYPv3apylSDRQhxNt04fDDD5dzzjknvK14QYF5npvFd6TjmRCSOHieIyQ2KJYCgvYi8YsKJkxiIAIgdJwpeZoap+lmQN8DtuRq2oB0P02fw3MgwtA7yRZB2hfFOanBxa2wWyc82jMK26nCBbfZYigaW3GvIlWteXJLNdDu5G652oQQ/zhNF1CjFKutuJ/jmRBC4u0jxTRfEi8USwEhlsmBCgsMEGrKoKl7mHBAJCB64xb90QEEzV818qOOcXgN7b+A19XGdHg9P5MaZxRKTR403Q+3qTOgpgXYQk8/l5uteLgiVa9UA9yGOq9wudqEkPK1FfdzPBNCiB/csl+w8AsjqqlTp5q5Tl5enpx22mlmgXfSpEmlzGjY3JqEg2IpIGBy4NaHKBwYEDSVTRvXaqTGmRZnCwN7UNGIErCd4jBhgUDSqJBbZMlrUuOWWoNBSyNKuMbrYTBbunRpmcawagjhZivut0jVmcLj11iDEFI+tuJ+j2dCCImEc96Bv++77z6ZPPltqVk1S5rVK5Glq0VGjnxWsiRLalXPLmNGw4bXxAuKpYBQr149c7BHg9bhOCcizomGMzStwkcbx3qhHb0hyPBYPM/PpMbLZEFXjyHKtImu3SzWfl8vW/FY3XqYq01IRdmKl5iVW6/jktb8hJB4cc47hg4ZItOnTpb8HutDxjM3jq0jb3xVQ/p3Xx+1GQ3JbCiWAgIm/A0bNpSVK1f6erw2i420AmubLNhOcBotso0f3LDtvlHnBNEUSaRoao1GjCCO1NxBBZjdFNbpkqdCyctWnMKHkNSwFb9nUp6ccUbPsCkuPJ4JIfFip/Qi9e6t8W8ZoaSLOItX58jYL2tIfo8NMZnRkMzGt1iaOHGiTJs2zUxyDz30UOOAhPxPm19++UWuvvpqmTFjRjK2Ne2BWIIYgdmBChS7T5Hd/BVCxc0tzgkiMLZQ0sgOBI+aP7j1P8J9eJwaOajzndf72dErXd1RZzugokwjSnqbRo/sbuH6GaO1FSckEwiazf1ftuKjZPC0PFOjtGxtlokodevWTe68864K2zZCSGZgp/S+/fau1DvbeGbcN9WlVtWSmM1oSGbjSyw99dRTMnz4cGnXrp0RSCNGjDC3QRj17t07NInHyRuKnsSXjgdhAmMDiAoVS5qu4mzmiAJFrKZoXyO14tbHac8mvV/FCYSJRpb0omJKhYqaRuj9mibonJi5GTqoXbcKIY1I6evpY1WQAY0g4TG4BGEiSEhQwHEGo5L169eHosOx9iVKpOBSW/F//etfMmrUKDMmdaxfXzp37mwiTxjTCCEkmdgpvXDSRY2SXUf558ZsaZZXFNGMBnMZjGFBWYwiKSSWXnzxRdOd/Z577jH/4+T83HPPyaOPPirvv/++PPTQQ2YnJYkBB2ckQwK128ZkSVPaID5wuz15wnNVBNk1RCqG9Llav4SLmkbg+atXrzbRINyOSBEszvGaKrrwODfzB2w77oehg6J1TmgEa/dfUlEI8NpsSEmIuC5I6PGuJik4VnHsRdOXKFmNYNu0aSN9+/YNVNSLEJI5aEovFmmmTCxtPLNHrWIpXJcT0YymY7VqZkGKTbKJza4ZagRw8mvfvn3ofzRBRV7n66+/bu7r2bOnzJ49289LEZ/ggIdxQ5MmTcw1/sd3vXjxYpk/f7789ttvxmFO09Y0MoSLTp4AJiuaUqcXFUuIErZs2dL0VILowf/I1UU6IMCECgIJkzJ1x9NmuHqBHScGFt0Gvcbr2+l9tnuergAhra9WrVqhC96fQokQ9zFYzVA0YqvHZLR9iWzXKD0e7TEj0eMWIYSUt/HMxq0lpm4ydNshW2Tjtl21lG6oGc2JJ56YlLGRZEBkqVWrVsan/owzzih1+z777CNjx46VAQMGyJVXXildu3ZN1nZmPDhYly1bFhI7KpLsWiaA+xG90ckTDnZEcjStzzZN0FVfZ8TKzVbcWdPk/N8ZWdKUPy/3PBZ1E+IfrQXUY1yPL40MR9OXiI1gCSGZZjzTon6RnNthswycmBvWjKZZs2Zskk1iE0u33HKL/Pvf/zbRpPz8/FI56Jj03n///SZCgbomkhyQ/oaJkTaGda4k2652zv5H4dL63GzFVSSFc8nT98PFzVYcr+XWDJcrzYTE7vSkx5rtHolUPBxbXt3rvV6LjWAJIenKX8YzBca4AfVIS1eXyM5ikf7j64RuQ+rdpm1ixNUNN9xgUpI5NpKYxFLHjh1NBAnGDkjLcivYRWQJqXpwzCOJBxMgu+7IrjcCdjqeW/8jt0iOW+0C/nZzx3Oi9+v2eNmK08mOkMQ5PWl/NAXHHRYlgFsdEu73ei02giWEpCtqPINFfjjcwbShR4MGJkUP6G0Ndt+GEgSMiZpVg3FUF6UwnuKxXPDNXHxbh++7777GyCEcHTp0MBeSeCBAIER0xcNOvdP6IBzcqPvxYynu1vFarb2VSD2YlEi24oSQ+IjUvBUncuexjBO+bd/v97UIISRdgAhyswJ3u80eG7VXpJrpoDY7EUY4JDVhU9oUAdE8++DFZAgiKTc31/wfy4THq3bBrodyYluNwxQCxgycaBGSfMLV+emxrAYvavbiZfzAmkFCCPEeG9U+3LkAFY3zKEkfKJZSBAiSpk2bmtolXQ2GgPJKc8MBjceqPTce7xQ2brULtq04Jl0qmPQ2tRWnQCIkOOBYRhRJ+6rZ5g+EEEKig0Y4xIZiKYWAQHETR87Cbqwwr1y5slTDV9yHix1GdqtdgBgCeC4eozm7WhvBFRVCggeOZTSsVStxjTxrtJgQQhJFIptaBxUa4RAbiqUUR00adEUZIkcNGuxJkvY5shtYetUugHQfCAlJJ3B8YqFDo8M49rWFgF3fSAgh8eBmDLVgwQL56KOPzIIN+qudddZZplYolaERDrGhWEpxVNRgRdnZE8l2rFOx5Gxg6VW7QHFEMpFUXjFFeqwzxz5SCwBCCIkG2xgKi7NDhw6R8ePHS61qWdIMVtxrs2Xo0KHGivvOO+9M2S+XRjjEhmIpxdGIkqbdAK1VsGuRgN0DiRASecU0ldyP3FZCYTOuhi0kc0nlRQAS3FqeIYMHy9sTJ0h+j/VyvrPJ6+gCs4h74YUXSqritZisNeF+6sdJekCxlOLgQLULuTX9zs3RTlNzeFAT4s9KP5Xcj9xWQnG846ROMpdUXwQgwazlKSwslLfGv2WE0uXH/tWioEaVEum9+//+Y8dK586dZf/995d0AePrsmXLzLwL5wmMtfg+YMDFuVX6wsrfFAcHp64e6wURJkySMKjpBU54WP3gCZKQ9HU/wuQXNQNNmjQx1xgHSGZjLwLgXIBrrV0lJJY5B8aVt99+W2pWzTIRJTcuOHyz1KomMmvWLLO/wYp7+fLl5lpdelMRLD5BKGHepRf8z0Wp9CZhkaVffvlFPv74Y5k9e7Y8++yziXpZEgGc+Bo1aiQrVqwIOWHhoqvMXDkkmUq0qUd0PyJ+WbJkibz55ptm4hf0gvZ0WAQgwUHnFmhV0KxeiUm9cwO3N6lbIuvWrTNCQmumUz2yqaY59vGkESaSvsQslnCSgPsJBBIu+B87zH777ZfYLSQRwSQQEz3mpBMSe+oR3Y9IJLA/oWi9oKBgd0F7camC9nvvvTdw0TwuApBEgzG0efPm8vbabNmyPctVMKF2admaLDmsbl2zkAsDmlRMb3Y7niCM7JpwXFgLnt74FkvYuT///HMjjCCS5s+fH6qNOeecc0xeavv27U26FwlOISIhmUgs9Ud0PyKRgFAaO7pA8nuscy1oB4MHDw7EF6n7OxYKcJ7GtaZss3aVxMuZZ55pFgmw79s1Swpu37RNpFOnTmUiMakc2UQ5A44lCEA9t6D0AbeTDBdLl156qXzzzTdm59h3333lmGOOkRtuuEE6dOgghx12mFlRY0SJEBKUtDuczEC0J2guOhAvFi9ebCJKEEqeBe0FBXLddddVeEqeM7KqkzqIJazw0w2PxEuLFi3M3C9/dIGU7K5RKrV4MClPzj33XBPN1+iL3cYkVSMxOHZg5kA3vMzCl1havXq1GXwx0NapU8dc8vLyzKBLCCEVjXNyiIUduwg31U/QpOIZN26cSb0LV9A+ZHpdU8t0/fXXSxAjqzhno8aKkESAtFNdJMC+3xR9ltaIiShpnyU0rMUYrKYO2C+xT2KMxm2pmBEDwUTnu8zCl1iaOHGiqUnS+iSsrg0fPtx0jMdOD1cUrNgecMABoV4/hBCSbLTfBeqRMCHEZBCCCIIJtyHChJMxU4/Sl1jMFmJ5Dh6LGqVwBe2YLOJxFQ1NHUh5gHROpJ0imqrHU4MGDUyKHo4njMF26tr69evNnBHiCQYR2E9T1eiBZBa+a5ZwQunRo4e5ANQsoXbpk08+kVdeecU44EE8HXzwwfL8888nc5sJIRkOViRxYobTkt1LDCdnnIzVOh+oZTJTj9KLWMwW4jFowDmwMEJBO1bVgxC5oakDKU8gjMJFU3FM4diDSErVPnZ+YLPa9CVmN7y9997bXFDPhIMANU0qngghJNkpdxs3biwllICegHFSBkgZdk5eo7UUJ+ljthCPQYPfgnZEqSqa8nB2TCX7dFLxpGO00z6X4NyzYcMGc6yxWW36EbVYWrt2rYkgab0SmoxhwnH44YebC4wfCCEk2fUYik4GFc2Fd5scxmIpTtLDbCFegwY/Be24HwwbNiwmEZEoIZ9MZ8dUtE8nFU+6RTvdziX4PFiow//4fDgXIU2c9U0ZJJZefPFFeeaZZ4zZA66PPfZYc/vNN99sokrIU0WU6fLLL0/m9hJCUpx4J4S6QqkiyT75AjWicXvdWCzFSXqYLSTCoCFcQXu3bt1k7tzv5OijjpIaVUWa1xdZFoWISLSQT5azYyrZp5PgkG597JznEnVg1fMQm9VmoFiCmcMLL7wgF198sbRt29ZclDvuuEMKCwvlyy+/lIcfftjsPFdeeWUyt5kQkoLgJInINIp8cULBiTKWCaGuUOLxcLyzU/EglJo0aeJ5Ak7HVJBMJBazhUQYNLgVtKN4HY5f48ePl5zsEsnvuSEmEREkIa/vi2Nz5cqV8u6775r/cXyNGjVK7um5PvD26SRYpFsfO+e5RAUgLjA6Y7PaDBRLY8aMkf79+8sZZ5xR5r4DDzzQXLp27SrNmjUzRg8US4QQt1VziBwIHLWORUovJojRTAh1hRLPwwkX1+qEhwh3uJXKdEsFyVRiMVtIpEGDXdB+6623ytsTx0uWlMiA7htiFhFBEfL2sfrIIw/LpEmTpGbVLGlWr0SWrsYjSuSH5ZVkR5FI5Zzg2qeT4OEV7UzFOlLnuQTbi3Oapt+xWW16ke3nQdiB69atG/FxtlUkISR9XehQq4hr7Z0RCV011wmgrsLhpBLthFBXKJFqV7NmTWnYsKG0adNGWrduXUoouW0r7kd0AH/jPb1qm0iwgdnCxq0lJmrjhpvZQizPiYTWQR2/z1apVa0kbIofUgAhIsJNvjStFFSUkNdj9dFHh8vUyW9Lfo/18u3dy2XGDcvl236/m8jZG1/XkDvH1Qm0fTpJDVScI+MAf+Ma//s9t1QUznMJjtUaNWqYC26vVauWaV6L4zeWcyZJwcjSSSedJPfff79ZcUMvJTeWLl1q0vA6deqU6G0khFQguuqHVbStW7ea25COg4UR2/Al3GqgrpoDRJZ0BR1/g2gnhPo+uhqJa/v2cPUf6ZQKkqn4NVuwozixPCcSWgfVJK9ImuUVxZXiF5SaDhwXv//+u0krhFDyjJRNyJXrTtwoe9bbdQwHzT6dpAZBSj9NdFohDYUyTCyhoLNPnz7Sq1cvo5SxgotVXeRlYnCHUPrll1/M7XgsISQ9sAd7CBu7+7oKHT2xwfUHkR7c7zxxaMoCRBaei4sCsRXthDDSSSjcCRgTuSCfhIk/vMwWED066KC2Zl+DK53tRhfOoAE9BBs1aiR33XVX1I1qG9UpksJ1OXGl+FV0TYe9KDJ16lSTehfWDGNabXnz6+pyfZeNgbRPJ6lBUNJPYyGSiQqOJxxXOP+ovTjOS1hkxFhD0kwsIZw4cuRI00PpnXfeMQ1ply1bZn58hBx1xa5nz57M/SckjbBFB8SIFq06wSo4xgM8FuLHKV7sOiPtgQSw6IIU32gnhJFWI1P5BEz84TRbgBFB1W+/ke+++04Wzf9edvz5naultZdBw4QJE2JuVHvqgVtl6PTacfdgSpaDXTSLDwALHxCS4SJljXKLZMX6XUVL8UTnSGaTbnWkdv3Vpk2bQjW1et7EZ0Mz9VjOeyRF+iwdddRR5kIIyQxs0WH3MooETgK2ePG7au630DeSGEq3EzCJbLYAo4Ufv59rUsciudE5DRomT5oQV6PajxZUNdGW/Em5CUvxK8+Gsc7FB9QBzlibFT5StjZHxnxZS75YUisUnVNxSYhfgpJ+mgicGQ8aTQLaewkXZGUEPc2QxCiWvv/+e3nllVfMIAzHqdNPP11OPvlkv08nhAQMP8LEFh1+xJKKKrdITqRV82jyuyOJoXQ6AZPIxNpwNpGNau84bZ2cfehmU8szZGrtXal5a3Nk645sueDC8hERsTaMdS4+nHbaafLss8+EjZRt3ZktV1xxhUmpxZwAwpERJRItFZ1+mkiciw6abQGcGRlIxQOp+lkzDV9i6cMPPzR24Pvss4+pS1q1apVZlUMdE23CCUk93ITJxo0bTQqdig4M4rbo8IuuoEUbyYmm0DeSGEqnEzCJTKwNZ3c9TxLSqDZ/t0Bp1aBYCtdkyfyV2dKuXTt5/PHHzXkz2dGheBrGOhcf0KusW7fukj9pUthI2YABA6L+XIQEJf000TgXHZBy7iaWNMIE5794Gk+TADalPeecc2TgwIGh28aOHWtOElhZgtEDISR1IkkYwHENFzs1bMCgDbc7DNpu7nHIs9ZiVT/vFW0kJ5o6Iz9iKF1OwCQysTacxf+RanNiaVQbT6Ql1uhQPFEyt8UHpCdi8aT/66/JkOl50rSuMN2OkDA4Fx3UAdYJbsexhetUcP4jPsUSDB1uuummUrchTN+vXz/jhNeyZUt+l4QEGAzIsANWsaONYTFAY7HDbqKHAd/NPQ4TKrwGBBWeb+di44L78XxM9jQVz2npHY5o64wohki8DWfx/7JItTkxNKqNJ4IEZ1m/NVT2AsioUaNijpJ5LT7cd999pnXIjz/+aFbBmW5HiDfORQe9xsU+ZyLihHMbHqsus3qOJSkslvCD5+bmlnHIA9p3hRASXJAfrULELjTF8Qu7b7UB1yixV81R48aNQ/bCGOzxGLvHkooyvC5ef8OGDWYSmJeXF9H9h3VGJFbUaCFaN7pYn5cI3CJIS1ZnyaZtxXJPzw0Ro0MQN3YqLY67eKJkbosPmMzB4hj9E+F8S0h549f0Jwg4Fx20ybT2FtQFQM3uUPGExUo4TKM1DwVTihs8vPXWW/Lxxx+Xug0TKuR826tuuA2peYSQikf7H2mEBytaGLSRxoPBWtPx7BUv4BXViRTNgSjDBEtfAxecCJDCh/cJl5vNOqPUpaInNLE2nE1Go1q/uNUXoXfRMx/W9BUduuiii0rV+CHqg1qpRETJCAkCqdjU1T5HYmFi9erVRixpNEnPi3Y6uzZox7maYinFxdLLL7/sevuLL75Y6n+KJUKCASavWK3SqBGAcMGgjeMUF0SSMLAjOoRoEO7HgO7HPc5tgoy+EjZ2Oh1OeJFys5lal3oEZUITruFsOEvrWJ8XD171Reu3ZMmedYt8RYecNX5du3aVESOerpAoGSHJIBrTnyCCcyLEElChpGnvih6/+tlICoulefPmJX9LCCEJW83XdDgMylpkqitZmhKAQRrpcdpJPJrogNcE2Wkvric4NoVNX4IyoYnVaMHreUcccYR8+umnxtjIrxudXxe7119/XWpWLVtftEetYilcl+MrOhSrgx3tvUmqkOrNxTH+ofE6Miuw3RBKWKzUTA9dtNTzJsZRjBtBTjXMVKJqSksIqRgwiK5YscLYe2sutKInEoTwMYnC/SjG9urvoJMrRJNQRxRLVMdrgqyrZhrN0vfSFAQ2hU0/gjahidVoQZ+ntUS9evWKyo0uGhe75cuXSzOX+qIzD9kiQ6fX9hUd8nKwq1WzpvQfM6bcomSEJIt0aC6Oc6zWKOE4xfkR50k1fHBaiuM8j/Y8iMzXq1evQred/AXFEiEBQ1flcZLAIIuBFel0Xk1hdbDFYxFNwuPtx+qJRk82mLDVr18/rtUrrwmy1kSpY57ehwubwqYn6TChiVRL9POKSjLo7Vx5tWCUzJ07V55++ukyEZponoeIbqGLC1+L+kUmIpQ/KddXdMjNwW7oQw/Jf/r0SYiNOSEViZfpD85bmoqaaqYP2F58Hpgf2SnyNrgdoonnzOBAsURIgND0Nl2JwqDpFD/h0ImqChk7wgMgZpCuE28RqdcEWZ3xwjnmkfQi1V0M7bQ5HB8FBaMkv8d6E9nZUSRy6+t1pODzGlKraom0abhDFsz7Vo4++ii54IILQ9EiZw1SpOehb+HTTz/lGkG698z1RmT1G58rg6flSbN63v2NvKLBsUbXCAm60MBtMBKq6BrJaLCPUxVKkc7puJ+GD8GBYomQAEWTNH1O64xUiESDPgciy3bewYkG1t+JmMSGmyDTpCGzSFUXQ7e0uYUrs6R65eJQLdGd4+rI2C9rSH6PDa49jxBB7du3b5keR5GeV1xUJD169JT8SRNcI0hzCqtJz549ZJ999mF0iGQ0zvMJFjWCUCMZKxB6flvu4DNhIQbpeKmy+JSuUCwRUsGpdmrfDVTY6KpTtEIJaH2QOu5ANKFbOC4oNMVqVbzRnlSdIJPkkIoC2S1tru8bdeSzRVXM34tX55jIEASPZ8+jN98w9UOoQdIeR76eN2aMvPvuu+ZYxWsMmZ4nTeqWyLI1WaUiSG61UYRkMnquxDlUMxfs24MOHGP1vO5nMRTnWFwwVuCcTeFUMVAsEVJOYHDHqpKaI6gLTiyCyAsIIzVUUNQWHJEgFWN4HLYnnvSFVJwgExLOurtRnSL5ff0uN7px31Q3KXTheh4hTe6dd97ZVYO0u8eRn+fBfGHq1Kny6KOPys0338z6IkJ8AnGEc5fWwmJREOc0NFdPJTSF3S/4nDB4wgIrm9eWPxRLhJQDauWNgc6rqDNWMOBqZAcnDLwX3geCCQMyBBHe07bx1i7iuB0CTu3DCUmHJrWRQDN1pN45BY3tRvfnxmxplhe55xGitYguvfDC81E9D+lEgPVFhESHfS7TBUAIiVSw3cY5WtPwol0oxTkdoom1TOUPxRIhCZoUajoAokZOYwMIErc+RH7RBrJIy2nYsKF5X3siaofr8b7YBlx01U1fwzlAQyyhTgr2pkE+wZDUIShNasOBSRVqlJyCxnajO27vbVK4NkLPo7VZcky9emal97TTTpP8SVPkuL23RH7e7l5J6U7QRTNJPbQ+Fucutd8GONfhXBa0scYJzrUweIg2bVAjabikSsphOkGxREgMJ3vcjgkXBmcdrO2wuv6N1S6sAmFQj1YoYaKp/WpUKKHBHbYB26LbpQWj2mwW24YThzPE79YwVlfmUqU4lgSfoDSpDQeECnoguQkauNHtLBYZ80UN83+4nkebt5VIp06dzLF3ww03Sm7tXHl19GiMAL56JaUzqSCaSeqhi4HO8y7OkXpuDtJY4wTbBaMlWIPjPO03FR+P0cVPjDepEEVLJ3Ythftg6dKl8vjjj5trO+/76quvlhNOOMEUpE6ZMiVZ20lIuaAiCPv5woULzQUnfAy+SLfRv5FSh/91oLMHbvtvO90tGiCMtHGdvpa6zekkBEINf2M7NO0OIkrfX+3DvfKitTcSXpcrVSRdm9S6gb5DG7fuEjROKueIHNAE5ihZst9++8vAiXVk5OyaRlhpZAj/o+fR6aefbiY+OO6aNWtmehx98sknctBB7cI+z+6VlAmiWS2f8T9uJyQe7BQ8/T+oY40bOI+3atVKWrRoIbm5ueb/WrVqGRMmnMe9ztk638A1FkkxD8AcgAQksjRt2jS56aabzI/ZuXNncxsmixdeeKFZKcIKGVbPb7nlFrOT9uzZM9nbTUhSnOkQodEVHDsSo6l1uGDft1e2whFNTrIaM7itNEHQ4H5sJ7bNXrnXdDtcbGMHvI7mONvvgdfG7XhNvT9VG4iS4JEKTWoxSYFgyR9d4Nn89cILdznSwTWvf0GBMWVArZH2PMJ5D+YMNWrUKLXCCxE0YcIEz+c5eyWlK6kgmknqgbFEjzXsS5ryjmt1l9UMiyBHXXDuxQXjhy6AavN2jR55gc+K+4MeRcs4sfTwww+bFbRBgwaFrEwfeOABk3f5yiuvyEEHHWRuQ3fykSNHUiyRlEwVweCjLnVuIkdzpONBB3WA90FNk4oZTCaxsoQFCJ1Q6ERDrcARTcK1ngxUwNmDqzMipZ8Hr40FDztlD6+VSg1ESfBJlSa1KljCCRps9+DBg+W6666LyrEu1uelE6kgmknq7lcQCDjO1MDIPn/jfixqIuqbCkLCjsJi3PSzyKqmTVx8CJBYQm5lr169QkLp559/NtGmiy66KCSUQPv27eWpp55K3tYSkmDUeAGTOhUYsZowREJXVtWNTleQcG33i8BtEDV4HHoy2GIK92FQxYCqNuF2aF5Xc3Gfgv+xeqUnDhZdk2SSzB5cidx3oxE0sTrWZaLTnR2p19V+jZgHUTST1F6MUddXFQ92lClVnF7tKKwdKQsHFx8CKJb22msv+eyzz+Swww4zOySiSjhBXXnllaUe99VXX6XEjkmI1iZhMPXbHC4WdPB23oZJA253FsFrCoHTuc7OyXaaSAA8R+sC9NrpmKeTSvZHIskmGftYsgwDMlHQJAvnb2Sn/cbTBJuQcIsxOI/rfqZgkRGLjakWhVUDCz9zEnxeLj4ESCwhLxvCCM33kHqH8Gbfvn3NKhxAfvann35qrvFYQiqSSKvPatBgh68TJZTs6JAOZnCw0/5Huk0YGG3HOntFTCNFtjCyBZLWImlESiO+SLNr0qRJaFs4iJJ0IhVc9jIdr98IQikTrNJJxSzGID0d2H0E8TfOt6ngGmdHy+zzfSTzJWSMkACJpaOPPlpef/11GT9+vHHeglXqSSedFLr/hRdeMAoeJhCXXHJJMreXEE8w0GCFSe28kYqGk/fq1auNYEF/A00r9ZPna6/s4LVUqHgJJAgYPE7tPXXCoBEjTBjq169vbrdtx+18fogqbJumGNhoMauunjknJKwFCBZMd0wsNAwIPvyNSEWgi5F6frZT6letWhVKxwvqAqIzWobPAzQlT+uY7b5SeA7qjxHJpR1/gPos7bvvvnLrrbe63od8b0IqCgwwEB8axgbqaKfgflz85AJrfyNnOhwEj6K3Q7ggooNB2K4ZwiCmrnU64OE2TRvyKoJXQaeDJgZE/K2rsppih8E/6AX0mQx7zCTue9RjAa0qJk+ebP6vV6+edO3a1Sw+cJEgONDUgVQEOG/i/IqLbaCk53CMH1gk1fNnMpgzZ45xhEaWFeYiSO+FKdr5558fd+qyjoNq8KQW45iX4DPjs2EOwMbPFSyWvv76a9l///3Nyng48IM9//zzcvvttydq+wgJCwaQZcuWlRJG4fBj3mBHkBDmhtkColPOeiEMTrjgvZGeigEMKz9oRKuOdZpHjddTm28VP+GK4PUaggopg3l5eaVC7nZTWg6QwYMpY4kTnJh4DBv2iEycOFFqVs2SZnCtW5slI0Y8LT169DQmDSQYpIoTIkkvtNErxl0sJOrCpt33UM+9yRBL3377rRxzzDFm3z/88MNN76T33nvPuGpi/4dBWjzoNms2iqbw41pFooI2PvgueMxVgFhCPyWk4R1wwAGh20477TR54oknTGMtBSv3L730EsUSKbfVZu07lCjspq6auof3wIkfA6DakupkAI/XQlLt0WTbdiuaLoc0PU0BjKcIniYNwd43teAYk0V1LUxUj5l0TO9z+0wqOB99dLhMeXuS5PdYL+eX6Yc0wSxmUDAFY59KphMiIZH2Pd3PVq5cWcYcCdcQEpr9AdTKPt599NprrzVj/LvvvhvqRTpz5kzp0qWL3HPPPXGLJV040lR8FUlutdZ4DBZYkxlFy0R8iSW3H+TXX39l52BS4TVJdmpcLGi0CBMuDC724Al04quTXgghnfBq9EnFmkaPdEVVjxu1NNXCU6YNpX/qnZ7QcI2IoO4T8f726Zje5/WZcLzgpI9aWQily4/9y9mqRpUS6b37f/RJgv13pvQvSjTh9qlY4EIOqUhw7kadklsWCc7dWNhUtzlNG41nDJ03b558/vnnMmTIkJBQAieeeKJprYP0PMwB7HYe0YJ5CI5Tu446nClVMqNomYrvmiVCgnBCx6Cm4iSeiBIGHQxeSIdzrirZokzBe2noW0P72shWI0kqiDT9DtjRBfxtCzGSXtipd0i9UMdDrADi909EOlI6pvd5fSakr06fPt2k3iGi5MYFh282DWVRN5vp9t+xRofC7VN02yKpBvZjlIwgHd4NXby0jRLiGUP3228/815OQyaAYzEekWS/ji7AYlyMNPfB43D+IYmDYomkBBjI1DQhXlQoNW3atMzkVUUZVp90cHLagWvdEtCCUn1NuzGenXqHwZt9RjLHCUx/c5yw8D9SOhORjpSObmNenwkXLFigRgmpd27g9qZ1S0wKeCZiN4DFWKT7XjSr5eH2KYolkoogU0SbImtGB7Cbvurf4cZQnL/79etn3OnQLscLt2Pst99+k59++snU+7sJqWjQrBd77hEJjJ0YH/BdoJwgVRfTUk4svf3226bprIIfbdKkSSb8qCBlgpBEdX7HAKMCA7fFk3Kng5X9mvp+9iqshrvtXkf2QIsLHocJiYbFYb6AiYpun5o7YAUIr53KKVKZQiJqNpxOYLoPQCh59ZiJ9n3T0W3M6zPhOEVq3bS3s2TL9ixXwYTapcI1kpE9fOz0OY18Y1zC94kopt/V8nTcp0hmg3EU2SG6EKDZIHbmh5o0hdvfIZTgaAeOPfZYc/GLRrr33ntvY/aAtLxEfJ5oekKq+QMWk7Dwgd6ozGxJslh67rnnytz27LPPxvi2hEiZtDdcNKUNaI8irJDa/QX8gudr7yNNgcMEDM51y5cvN4/BfbjgveFmp70M9Pl6rYMrJh54nBo56EQ4nNCjUAo2iaoDitYJLJb3TUe3sXCfCYXRjzzyiDFzsGuWFNy+aZvIWWedJZmGnT5np/riNoxRfiOO4b5/ezwOAkuWLDEpl5j8YdzF785aNeIExwT6KsGhWRcRdAFUz904r6t7rTrL4Riwx17tdwRg3gD8CCbMjSdMmGDESbt27eJeeNDPg/0/VnCMwznYLaOGJEgsoYCNkERgr6RrXi1ucxNCOqjh5G+vevoRSFo3AmGkqXv63jZac2QLItv2W7fDtgzX/GF7ksqi5tQlUXVAfpzA7P0f74lriGq/75uObmPhPlOLFi2M/W7+6AIp2V2jVNoNL8/cH4QJc3lP5O30OVzbRjPRRIfCff+YYAUBHCt33nmnFBQUSK1qsI8vlsK12TJ06FDz+997771mPCZEwT5st9jAMYH0epzvsa9oX0SA/yGa8L+9WKWpd9oOx49gmjFjhtxxxx3m7x49esjJJ58cVUQq3OfBdupx76cNihOMEXAEpFiq4JolrM6jJ5PtCEKIm/2lpo1EAo/RfF3taWT3TtAcfa0LsXNz0cTSdqWLhKbYqYuZCiZ9D51ApMsklSS+DihSY0E7kqS9MaK1F09HYR7uM2EirK53MHNAjRJS7xBR0olyJk7k7fQ5HRt1fMS+Fk3EMej7FL7fsaMLJL/HurL28aMLzGNoH0/C7ddYxMCYi3Q0jLn2wqme84FzsUoFk47X4QTT7Nmz5bbbbjNufJ06dZJLL700IULJ/jx6/ohFLAEaPwRALCECBQtXFLUR4kRXePwKJaArpAiH47laT6TRIKzKo4BRhQvux6CIx2JVNJrUPa0xUUGkUSrtp4TV4iBPKDIdZ/2P7g+RxG151Ww4I1jYh3X7sB+zVsQdTPoxEca5RSM3SG8588wzAxFRimcirynIWPEGGOf8FmM70+d0nEIKXjqlAGPRC0IU3y/t40kiFsXcan8wHnstVkEwQQipUHITTLj/4YcfNrX9rVu3lgEDBiRUKIF69eqFXFZjBc/FGIrxAZ9Ve09h7MDrM+rkDt3wSLlh21/6BQMbJkuYQIBIKU72yn20Ky9a7In3xKABocQoUmqA/ULz022nI61ZC1cPlOw6IGwbTkiYEGuUEq+PfRj7Ki6aU5/q9UfJBMIoaPbg8Uzksb/BFEmFut6GHoaffPKJEVHh0vmc6XPYb9JFINmMGzfOROxoH0/iwV4Uc5pF6SKZZrK4ocLHTTBBKD3//PMyceJE07x++PDh0rFjx4T/YDi+UXOEmut4DK/glIcSBV18VgGJ74c1TSkolhChgjr/4YcfzAng3HPPlVtuuSVuG0ZSMWAQss0T/NQfwWnOjuiEmwg4V+6BrthGeh9MUrU+SsVZuk060hUM+BBK2tPCLuRVR8Jw9UDJrAPCa6Ko1jYoQW48oqHYNuxremFqZ2ZN5NV5U/dTjD3Dhw+TyZMn707nK4mYzhf09LlEsGjRIqlWqVjunVxb9qhVLGcdukX2rPeX8USm28cTf9iLYs65h12f7Gb0EE4wQSgtXbrULJoARJe6deuW1M9Rv379kCFWtFEmzZ6BWNIFOlsssqYpxcQSJhT/93//Z1bVHnvsMfn555/N6lybNm3k7LPPrujNI3HaX4YTS7gPecXaMBb4cZtz1p7oSpJXhAmPQ8pKw4YNfaVrkWCC/UIjSlpnph3a7dq2cPVAyZp04mSGKCXee/Xq1aGaEuyX2NdoLZ/aYIKOGqVY+kBpKpAu/j366HCZPnWK5PdYz7ocqxbsjddfl+pViuWThVVl2bocGTq9thGh9565XirnZLZ9PPGPvSi2bt26kGiyzxMQElhgdRo9hBNMqGXCAgeu0VMJ4v6uu+4q9ZzevXtLq1atkiL8gF/BpHMe57lRrzXCRGIUS16dkJ0k0jlnwYIF0r17d7nxxhvN/5jQtm/fXubMmUOxlGZ2nvZqh11/5JauopEpTDDUVlwHNbfaE7uPgh3Vwu06eOKaqU+pi0aU7N9Xf3/bxTCaOiTsn2ojr71rsI9Gi9bW6UUjCNieRDWq9QMmB7hwMSCxYIKO6E8sfaDwW2jtGsZE9DKEUGJdjqMWrKeLeJyUax4zuNf6jLaPJ9Ghi2IYdzGnwBwCY70upmGRVucW4VxJNfVOTR/U0hvZUG6GM126dEmoWHJmQ2CbMY5gPoTzi71AbAsjzHt00VBvU3Fkt1ghZfF19u/QoYOvzsH25CReDj74YHNRsCMsXLgw5jxQbFtF2KCq8wgdSCR0QEL4YvUGgxQmjyhqttNLMADBTUa/M7ccYxU/GNSwYo90PR0I8DwdIPD6yCHWyJE9+cX76gATVLj/RIeusNkNhVVAa9pbpN9b9yE7lxv7DyKZ2HeiwTaM0Gt1XcSJOdn7H06m+Ny4xrbjuMPfiHbRajl+unbtatLkIvWBOvXUU8v8zvj+8dtgH5g+fbrUrBopnS9PxowZI9dee62k+/iDyWfEWrAJudKwdpE8/l4dk6IPQRrksTwTCfL5C6n2Oh5qD0Wda+CycuVKkwmjGSwYr5WPP/44JJTA3Xffba7hgHf00Ue7vp9XjVE8tUfYJnu7tLbbfm01cNBWFV6RI11sxG/1/fffm78xT0LKX/Xq1SUd959oNIsvsXTfffclTATFyujRo83OGevqEXaUinTp++233yrsvVMNTCDs/c1r39MwOgY8rBIpmoqnk1MMFqkO95/w2FEfO//aTvn0uy80adLEdZ/D+BNtY2R7xU5TJuxIT7LR1ET7xK7vH6v1LCnNySefJAMnTXftA5U/qY65H9kZXucf/D7YL5tGSOdrnFci8+fPr5DzWHmPPxCFNatKWPH4wJTa8si7uXLKKSfJeeedRxfeABPk85eOkTo+25kJEBCYqGNBFg6c4Ntvv5XPP/889Hx1XQXvvfeemY/YC/2RsOcuyfpsdqpdJGzxhs+FmtsdcQi6oO8/fiNpvsRSRYe3cYIYMmSI5OfnmyhBLGAVD/VO5Q0ONPzQLVu2rDB1nkpgEgenFu0945aPqwOZuoohQoTIUjrC/ccfGMzDRSujfS21kVV0f7RX8aJ5PYgVnFSxbdhXy2ssQHoXVk6xMqrHE7ZHrfBJ/DzyyDAZOHCg9B871kR/mtQtkWVrskxECRGP/v37R9wX99prL3n/3fDpfMvXZslpe+9t6iLSffzBsdesXkmEWjCRA446w8wNSDBJhfOXRl80ouRWywNwTnEKJY0kIdIEoQRwPx7rFWFykqy5i0bHNJIUy0KfbbTVuHFjSbf9B+U+KW/wYE+eYewAUwd0Q44VNQ2oKPBDV+T7pwr4vdVeWSertg24nX+L2zEBRZg43Q0ZuP9EBjVAmmsO4RRrfQ5SedzEkrrWRQueg2MfqW+J7iUV6fOhmBeP1x5iGnFzpm+Q+IADFtzuYu0DBVEFu+FI6XyIoFTE7xbt+IM0Ov0uwtmfe4Ha1mURasF+X58jZ+y9d2i7oj02SPkR9PMXxkl1VPXis88+M6LIrkNSs4fjjz/ezFnU9AHCCf/76bOUjHRo7TcZbasWL4qLi9Ny/hxNxlygxRJUJfKzmzVrJrfffntFbw4pB+yiZ3U2c4aU1Q0Pqx20+E4tkjmhcfbZguhBzrlao+I2PTGp2YPb+2v/Iy381SimM1z/zjvvyKRJk8zn2W+//eSf//ynmeQlC+fnC9c7SsEKJ+r/dMWUvZyC2QeqRYsWxh48f3SBazrfPZPyzP3l2YQXggfpcMjs2HvvvY1Qi/T+6mCHeqNd9ufFEe3P3YDQ9FMLplkvsRwbhCjYR3QxzC3l7Nlnny0VAbKFkp8+TOWNtlGBCExECl1JSYnp7ZTJixC+xNJLL73k+wUxubj44oslET/ODTfcYCY7L7zwghkMccGkBTsASU9wICK/39mlWlfCw01ySXDBsYtjGSmWAFGORE9o7D5b2E+Q+qYmIMCOFOExXu+vaXzh3PD69Okjjz76qIlqYl9EQ0JM7rCieMABB8T9WSJ9PhVxkVybcPLHcYTPA3jsBBd10UITW/RmguU4nPQgClRolAdoiotFyrnffSc1qopJh/tgZraJfEUSPCEHux7r4rI/j1Y8xnJsEGKDsdGud7aFEvZ9pNOCY445Rtq2bWvOHc7zQlAEkzrkYdtwibYXk5MdO3aYz5vJixC+DR7KWyyhr5LmgB533HGh2w8//HB5+eWX4359EkxwACI3FhNrbSiLiR4jSMGPFKl9qZoJ6O8GsOqLQdY2FdBVr0RNaOw+Wyp0bPS9tXZHC3Pd3l9PMm688cYbRiihTgUuSHi/CRMmmFThW2+91VhAJ+P7xSICvi/chs+J7y9c7ygbrIoGOQ2G7BK2EBJIO481nS8eNCo0atQoyckukfyeG6ISPIsXL47sYFdQYD6fn88TjXh09tiL1FeNEK/eRXbdkgol5cgjj5R27dqFLMfxWJzngiaY7DYqumAWDyW7Fx9wDknkOTvtxNK8efOkvEFaCwQTydx+TCTYKXT4nSBqNcyP+9UaGxf8D+GkosiuQdPO44mc0NgnCGfqgbPuTbczlvfHJO2www6Tfv36hW5DPSVaLKD3RqKwU4vwmexCXWw/FhNwImSPsPQinnS+eIBQGvPqKMmSEhnQfUPUgmfcuHEm9S68/XldIwT9fL5oxKNbj71o+qoRor2LMN6qVbXtIop6apSEwDRBUcMe53xF+zBp+QjOd+UplpxNa2PFXnwoLi4OnfszcREi0DVLhJBg4FYToIIDYkht3J21ZZoKp0IJf+uERiM/4SY00dQ42ScIZ1Gr/T/+1nq4WCZUSEt2e46uMsYLPi/cmfBZsI0obnU7OakozLQVPpJ4NCp04r5b5fPfqsQkeCBmUKMU3sGuxDwu0eLRPvZ17OFCAokWjKUwCsJCHs5P//73v0Nj8BVXXFHm8XgcUsvdMl/69u1rrrGoBSfn8sTZtDae1hegZPfz1G02ExchKJYIIRFxqwnQRqe66qSoGLKdZnC/5k6rQw/uDzehcRNoSEWDOHOrXbNPEFgFVNFk56Dbf+N+fX/chkgRxI6e5Lw48MADy9z22GOPyddffy2XXXZZXHsTth19LVRUgnCNNvEYRPc00kdILGhUqElekTTLK4pJ8MD1rjCCgx3S6JJhWe+cHLI2jySibhrnGQimcOi50E7r1n0QdfcVNS7jffW94fSnCwm6SOgHp7jKinDOTmcolgghZXAO+pqWoKl2Wh+gk3rbPEEFiQoVNUuA6IFgUvGDFTx7RU5NILRWTdP1II7wOhBaEA7as8it2FRPEBjM0exPt1e3UfsNOcUWao8GDRpkXgPpEn5TJqZMmSIjR46Ut956Sxo2bCjdu3cvdb82xsXnWLhwocyYMcN8Ri87ZUSU8Fh8T/rduq0G6nes32cm5pC7Qfvo2NCoUKM6RVK4LicmwROtg10yJ4eEJKJu2k8UFOIBY3yQHRlxvrPPszZOQ4tw1KlTxxz7Ff15AiuWom2CVxEdxgkhiZlYug36mLjr/ypcdLJudz7XVSsdfJG+oCYP+l4YcJ3pdHgNiButOwAqyrBtEDj6nupOF87xSk94flea7fS5aApyr7nmmlB38YMOOsi44ynYXgg/fG+ffvqpXHXVlVKzapZxF1vmYaeMbdWonH5m+7tVVIhCSNr1TJmM236LpoMfffRRWIEaVGLpVRRrfyONCp164FYZOr12TIIniPbnhMRTN40Ik1235ETT0XAdZEdGXfC0BZPf6JKej+rUqSNNmzYtlSqu51b0EEz3aJMvsWSfpDEh2Hfffc2lVatWSWmoRQhJLuFWwdwGfZw0gJ3WplEjPA6DJv52c8Ozoz5e4D01bU6bp6rwwmtDdGmNk7rZRTJoiGalWVPvtCDXj2BCAS96K0HkzZw50/RdgvFD+/btQ0Ww2GY0M1ww/xfJ77E+oruYPk+/XxVM+E5q1aoVcsTD/xBKKlYzMYfcib3f4nsfOnSIjB8/fne/n5KY+v1UBLH0Koq3v5FGhT5aUNWInPxJuTEJnqDYnyuMNJJ4wJiL8dhNWGhtrqalrV69OrCOjG6GD3YGiBd4DJ67Y8cOc15HryU8fsOGDaGaZXw+zB8gpNJZMPkSS1gVhSMe3Olw/cMPP5iTEL40CKZ99tnHXFREEUKCTbhVMDcbXqBRHi2e1vviqUHQ1Dtc7EbEeqLRiBZEgw7qatOaaMcrFUwq9iCYsH1HHXVUmX4aEEq4H9vZpEkTU7OEInRYil999dWhkwbEzc8/z5NO+26TQ/4W2V0MK3TaY8xOtcN74DWdDnl23VWmY++3QwYPlrcnTvAlUINGLL2K4u1vZEeF7jhtnZx96GbpPyFXhkytvSs1b22ObN2RLRdcGF7wVLT9uU2Q06JIaoDFPpwP1BzBjuhjXMYinmYsqDDS8xXuD4ojo7OmTzMpsK2aCYIsCDfhhHNYye40dtvcCZ9Pz9c4XyHSVDvTxRKsEeEvj4uCLxx9kCCa0MXeXm1mGh4h5U+4VVS3GiSvVTA3G159nFNcxXMiwPYgKmOvvOnArdEjXKO3AyZhODHhpKUmEclwvIJg+uCDD0ykCHz44YdGsCFahJMD3u/LL780tUf6nXTs2FEOPvhgOf744+WZZ56RVatWmW3G94k6pco5WXJg0x0iu/rxhnUXw2fBCp1XigML2b3R/bawsFDeGv+WEUqJ6PdTnsTSqyhR/Y1UBOXvjk61alAshWuyZP7KbNOE88knn5TWrVsH2v7cJshpUSQ18JvOjf1KezTZ4DyAx2LRoKKNRyJlWixdujTkwKrp33bkqaioKFRPbN+ntbUauUrXY8uXWII1okaV9BqTAHxJiCx169YtFFnCNSEkMeiqKAZbHXgxIIWrMwIY3JEWgDxjPA5/YwCE+LCjN259SdxseG3RFc6a12nSgPfDbWpagCgUJv+4DQ49XpbYeDy2C58ZueNeoi8RJx7nax566KFGlH388cfmflzj8+L2qVOnSu/evU1zbIikLl26mCaFurIGsGqned54ndzqJVI5x7+7GD5TOAHIQnZ3dL9FU2DUhiWq3095EkuvokT1N3KLCmGhFDXLnTp1SrmmxmxUSxJBuPFWzx1wX3WrbcI+iHOvRnBwwfkR57SgRWGwGKlZDX4oKioq44KLOUi6Rm59iSU7ooQVVFjnosATq0zOLvewvYUSJ4TEBwZiTMA14mOLDogQ20pbJ/vq9KYiCAOzDmia1qbGCV7ixyt6Adxu01UzrW1yrq4peAwiSQDvZ5sXOO3HsU1IgXD2r0i0UHCm6mCyDYEJYQRUMCEV+ZtvvjGPz83NNaYB5513nqlRwneKaDom6QcccIA5EeKz4fvEay2cnyU7irLErWIkmXbKmYbutxDqMNFIdL+f8iCWXkWJ7m9kR4VwPLhligS5Fki3DeOjHtdaBxmUtCiS+ui5A8eAlwkEzgOaxWHX+GChMGjtHrAtaqLklxKrJQfEVjo7s0Zt8IAJAy5eMA2PkMSAQUcFBSbeGIhULGGgVSttzSG2w+cqQDRUjsFaU9vUKAEiSxueuvUschvwnA52djTLbnrnZkeqt2HShsJZFXbAjnDhs8JVrjwEhJ2qg+9OTSZwwcIQtg9CST8vOP300+XFF180PTSQjodI0oQJE8z2o0heI3j4Tv/+97+b53+/rLIc4vL+ybZTzjTwOzZv3lzerqB+P/ESS6+i8u5vFORaIOeYpLUYul26IBRksUdSA91/IkVi9Hyrae96ng6aqHC62volOzs7lCqP7yMIhhYVJpaQdkcIKV/URlpxNljVVSD7MTZ2BMkuTtUBHEIpngmULTScvRvcsE8UmKBowaieTPQx2icpHpwWykgVRkqRc3KkqTr4rjRf2wYRJo0oKYioT548WR544AFj8gDxipQ8NLVt06ZNSCjhdrwn6j1mfT9Xvp5fk3bK5UBF9/sp720v788b5Fog57bhGNRVf21ZAIIq9kjqoC55foSFfS4GOEcETVTYmSn2OTkSxdaCZzpHbqNqSgvbQJz87dxl2OX++OOPpij5lFNOCVweJiGpCgYdrf3BZESNDRR7QHN25ratp7X+R9MA7NqkcDhXX531UnajWo3IKG6rU7abndaX6Lar+1u8Te/cLZQR8Rki3bp1l5tuuqnU5Eg/hxapOvn666/LCEH9LfAeAN+xOiS51XWceOKJ5vqyh/ICYaec7qRyv59Ytr28P2+Qa4Gc26ZReIwnujCEBZSgij2SOmC/sqNG4foWYR9Tca4CC+cg7ItBiWraafrRsnHjRnMsqVsuTGfSrQeTL7GE/Mpbb71VvvjiCxk1apRZbcWP3adPHyOWkIaCwWb48OHy0ksvGdMHQkh0uIkTPfHbdUDa80An9yqIVDDZt+vqqi2m8Nq2aYKbOYO9YqbRIE3nw/OcjWqdQsNtwFUBp2LIrS4q3pPG7X37yuuvjQlZKK/amC1jvqghnyysIm9Pmijbtm6VAQMHmhMVXNMwdmn9l5tQ0hQ8YEfQ9HaMhZry6LUah9c/6aSTTP1TRdspZwpB6/eT7G0vz8/r5pYZlBVlP/bNQRZ7JHXA+QrnS92f/KDnRe0fCGOIIEQ1cV6z5xSxULLbmAlusCDdejD5Ekt33323KcyGGIIzDhg5cqRMnz5d/u///k9uvPFGM8FCUeiDDz4oTz31VLK3m5CUwU9+vFsdAHKA1UAFJ378j/t0wo4oDAY4FVIqmOxIB1LtvBz0nO+PY1wnQV6rS7gd76fFnEBFlL3KZvejsGut1A0vGWYN8+fPl9FjRhvL6IuP2iR3jqsjBZ/XkFpVS6RZXpFUr1Is09+ZboTfLbfeap6DcQvfl35H+hmcQgkmNxBG9u16jfvwvWhNWJDtlDOFIPX7Sca2O9NMkWJXXp/XzS0zCL2+dMKnxzCOc21obW9bkMUeSR1wzsCiI4IJfh3kVKDbfQODYIqA99dzdKzRJaAZGrapSrr0YPIllhBRglBCHxENuY0YMcJMHpDWAlCwfdlll4X+J4SUdszRXGAMHIhoqJWoTjj0xG6nhmiEB7fbzpM6UNvOT/padqM8JdJAhdfARENT9cKBz6AnB7tRrQ60OBHAxa480gtsIYqot1pGQyiN/bKG5PfYUKZJZ/7E98x3dFvfviGRhN9D6xvchBJc7/AZ0W8J388nn3xi7sPj8B0cccQRaT/ZSsWi+FQWqG7b7p5mmm1qljSCFO7zJuI3TEZUOBHbpRM+HMsYn3TShwUb27VTF5SCJvZI6oF9Bvsr9j3sX35Ek7bvsHsKVnRUU48LjcTGSomLqZNGmDKmKa39YZ9//nmzcyANzwartE4rcUIyFe0lhFVYW4SoY4xGYOwQvkYoNDXErkHSa3sV1J5QeDWjtfseYeKA18ekSycUWsdkN6KLhD5Pt8EWeFp3lGw0Gqb1UitXrjTpRyv/l20iShBKnk06J0yWy3v3Ns5p+j1jAjho0KBSEaLjjjvOCCHbHOPoo4824xwa1gKk1+F7hclDuhJkB7RMAkJp7OhdDWidiwD3jN5VQ4cIU7J/w0RGhRO1XfaET+chmpJnv76OsbpglSrCnwQTPRaw32JebKfCO9H7bMOlIEQ1NdqK48aPWZNf9HNW9OdLBL6UzRlnnGFWrGDwgAZbzz33nBx77LFmEqGRJjjmPfTQQ6HbCMlkdCIPkWILHRv8rys5WvOi0SUVRfhbO4PrbTjRQ9jgeMTJX1NPnBMNgG1Qlzdc3GpzorUKBfaKbUWt0EIEajqNLuosW5slr325K/UuXJPOwdPyTBrx5ZdfHjpZPfLII0Ys9e/f3zwODWcxzrnRuXNnc4KEGx6YOXOm+Q68Hp/qBNkBLVNA0TQiShBKnosABQUmFc8t9S7Zv2Gs0aFEbZdXep0uBDlfX9OC9b0wt6FwIrGCczXO936sxPV8DYIQ1dTUWrsGWeudncZSfrDrnDFf0dT7tBdLGHzxwZ9++mnZsGGDWW29//77Q/dfdNFFRiyhnqlv377J3F5CAofbJAETeXV7C4eGqXWA0sJkW3hgVRSroEDFEQZl/VtT4PSC7UBzaO0BEUkM+RVKdr41hAlS7UAyUrOc3yk+I4ph8XnsNBp7uzp16iQvvfSifLywyu4apchNOvEa+J5RZ4naTCWcUFL0fhVMep2OgolF8RXPuHHjTOpduEUAmDugZsktFS8Zv6GdBoyxSB04o4kOJWq7vGqp9PXs18fkTSeC2G7cj8UfPAefB6+D2/B8bQNASKT9D4I7kjOefc5H+Yqz8XpFYKfWrl+/PiT+cHx4NZkPh4otHD9YkMAxpGmwqbog4WsEwEBx8803m4vTLx6gOSM+fLt27SIWOROSTnilkPg90dtNY/XkrCdoHFNarKyW/RhwcBsGGl01VRcaNV/Q2+33iBVsR25ubiiND6LNObgnWhxpI0nb4c9erbNTBu2BuUmTJnJq11Nl6tQpxswhXJNORKA6NWgQ6r1ipx74EUpegikdcrPdYFF8xYNjHzVKfhYByuM3tMc+HI92M2aMYX6jQ4naLq9aKp0A2q9v14roOKMr4fr+eKxOFrWmkZBw+x/OJ1jUA16CCY+DMNfopp0yX5E1oZpOqAu02O81oyVr90JDNHMJiC18Bwiw4OKW/ZJKginqo9/NIlGNHwjJNLxSSFTkhIvq6MlYjykMkM4BRKNTGIBxUSMHdbezU/w0qqSvrfnQ0aArwzppgFCCkUQysSdd+tl0W4CfBnn6PVx73XXmO3t/1vsRm3Recsklodqq/Px8c41JUbSRITx+9uzZRuAhupWOBNUBLZPAvgozh3CLALAL96oXTPRvaI99mh6s0XFMBv1GhxK5XV61VM7X18J8jKc6TrqN03Z6NMUSiQQWErUm2dl7UNG0Nvv4CFJNqDPKpMdGVhTp+jhWtKWJLrQiiqbjg0aiGzdunDLnEC6VEBIGp0GCM7LilULi1QlbI0i6+hrOwQ7vjbA+HodBC8/RVdxIvY30fcIVm9rodtv/Y5s01S5R2KtnajeO/93SBTViFg0YpO+86y7JqZQjAyfO9N2kE+99zz33xPy5gp5+jP0mnjSIZPXFCjoVvdprAxtwuN5FWgSAjXh5/Ib22KeRGaCTK7/RIa/tAolI3XF7fY0UqdmNXWxvLzY52yIQ4ndfU8GD/UvnB7ovoc4f+x7OsfbCg6aGag9DzD2SvVgZKcqkLUWKojgGcNzgM+rfQI2u9H8tF0iVHkwUS4R4gAEMA4UdrcHfuiKCwcQrhQSrKHic3fdDc3h1QA134teVJu2MjdfQlVHgtPhWO1Kn7TcGXzvn2M6ntgUe0gcQRYrUjyke7NUz/T9R6YKKCtUBAwbKkJo1pf+EiSnXlDQZwK5ehXmsq5aJ7osVdIK02gtatGhh9t380QWuiwD5E+tI27ZtTVsP7b3kNHpI5G9oj30Y1zQVT6Pr0USHnNuV6O/e7fUxtnr1lLGFkqbsERLtvgYTJuxr2H+w/2ofIp0nYDFAe/0Bu30HrrFIWpE1TXhfzHXWrl1rjhddINGFXj3enceQncqqx5I9D9JrbaVCsURIiokjHLgYEHTFUSf2eoBrmpjm4nulkNjmB249kAAGSq/+SHieU0xoLZIdvdLBCmi9AB5jizRtuoqaJ7vm0M02NxGDltdqvJ2245WiECt6stF6L3zGm2++Ra688ip5//33U6opaaLRVX9nDy862aWeA6CKfLje6SLA0tUlZhEAI9Si+d/Ljj+/K9N7CcdFoqNnzrFPI+baDFtfJ5bXT+Z3b4+tXqlF9n1YcEoH62NS/uiCAo4/PV87sR1q7abyeu6v6HFaezoC57FsN7zH8arHlc49nK56znR/TXFNBRhZImT3gISQsPYPsuuBnNEa3K4HeKTUFrfiTXXKs2ubAFaRsJqqE3/7JG4XWOpKrrrV6GCsZgUgXOpgslMWtZgan0MtebFtukocSy1VOPCamiuO99AUBnwncOg8+OCDJRPBd4/eUxpdVPOQRLigZQJBdADE74c+SnCohesdFgGqfv2V/Pj9XOnXLfreS9hH0AtOU3tx8RvBcY59GHucAgn7Xywuecn87rEghrFTF43scbawsNA0ng7HhRdeKC+88AJrmEhUCwp+0tjsjBEcL3YdchCo6hKh1Rpj2+BF25UATTfEeAB0LACp1IOJYomQ3SdQDGYYnHAwO+0ybRcl/G0f4JFSW7TnkkaRItl4u60+OYWbCja8HiJGzslHeec5a9qMndtsh91hTqEF4CpmooksaT8qp8jChAefP5k25qku/jUlYsGCBcaIAr8FUi6RpgUHQZJ6DoCIjsIeHL2XjjnmhZh6L2nTbI2k67EVTQTHbexLhEteMr97fF6MGc5FG/xfv3594+6r2E5g+K5effVVYzuOhSg65JFozRJ0PPbTw1CjMUEYb9xwpsqqQZOzHECjRzjm7MhTqvVgolgiZPcJVPNrgV3Ua5sk4H5Nv/OLRpKiiabY6SF6wtYVGRUB5SkKvIwuAG7HBNwWR85aJLtBZLRNcNW+XCdfKrTwXTj7VGSqOPIS/9iP8dv998knZcrUKVKzapY0Q/3W2izTXNxPmlamkgoOgPH0XlJjFdsMRo/beFazw7nkIcr89ttvGyth1GC51VUl+7vHeOJmfINxCa9/++23l7pNv5NbbrnFTGKvueYaOuSRmMwSlixZUqpNRaSGrnp+D5LRjFeqLI5T3Ka1froAo+m5WMDF9mupA26DUArSeBoOiiVCdp9ANfXOFk12vq0aIaB4OtJAZQ9umBjEYuFtn6i14Sy208/7+yFc/rE9IGtkzA6tI7VG+0k4V8vchJB9mxaD+3Hqw4BbHvbl6Sr+caJ68skn5N3p0yS/x/qo07QymVRwAIyn95JGlOxFDh1z4lnNdnPJw2X4sGEy6e1JuwR7vRKZMtG7riqZ3z0maM56UIDx1U6Vss8DS5cuNVGlK664wkRj8Tg65JFYan8Q8XfLHrFRBz1dkAyS0YxXqqy6S2qdnxpB4DhRY6toF5qDBMUSIbtPoBiEbAtrnahr2p3fk7WGp/WEHGlgdGKn2mElExMGhLBxSdSEwRlCd2sCa9e7ePWLiAYVovhetSEkUBGoVqP4zFoQq6mGmUKiVhBV/KMGY+rUqUYoRZumRYLvAOin99JS9F6aP1/uuuuuUi55aoRiF2Tbpi+JdMl79NHh8s60qVEJdrf6iERYids9ltQNz/k9OKPjjzzyiPksGp2jQx6JBex7aDDv1Tha0f1Ra4KCZjTjlSqrCyS2mRC2PaiphNFAsUTI7kEMfv/xhoi1DkDT1WzrTL/YhZFYWUKuMyY5EEuJQLcRq1Na8I9JglP82EYWiQTvBUFkWw3budn2SSEoNSLlgZddMn6DSZMmmROslyW0l/ifMWOGWcmPJU2LBB9fvZe2Fss3X3wkq3+dXcolr1+/fqFjS4WCpssA7G/Y/7QewS/OFDqMNVOmTIlLsLsdG1hcwTji5urpBGMJPi/Sh9ETzRZiGHu0zYNdm6qsWrVKxowZI6eccoo5/uwaLEKiBfur0x3O7THYB7GfO9uCBMFoxitVFscjCHLqcqxQLBGyG3VzCoeu6HjZgeOEbtcnaSTFTxRGT/wAJ3JMeBPR38OOVmAAhpDTyU+4TuOJxM5h1omZ02oYnxn1T+k40MaSA46/77vvPpk0aaLUqpZt0q38WkKr+MdrIg0rljQtEp4g1BFE6r00cGKudGixXUb/a41rNAeNmJ2fAX+jtkKj7DgWsYiE49Sv6YOdQvfRRx/FXFfldWxg2zDOQuDgNoxpGDuctuUKhNKgQYNcm0hj4gq8xkBEvPB+LVu2lM8//1w6duxovit9HiHRoO09QLiFVG3siuwWFU9BWkSsGqaZdEWPi8mARzshPrFd7TRdQwvoceLGwKAWzWpBDrTg0ZlOplEnPB6ruW6iAK+byEaw2tPBbQU1UTjrrWxzCgyaKgptq2EF32EqDrSJmDg7c8CHDhkiUydPirnWCNuAlfrpk7PCpmmhWS9WzEl0v3dQ6gj+6r00SgZPy9vVgHltlokoQSi9fvVqqZzjL5rj5pCnwj2atB87cuNHsDfJKzZ1QXh/t/dwHhsakbZTevU2/O38LRBRUmDgcOyxx5qL/fpOYx/wxRdfGBONVq1amWMEhjKJivCTzATjMhanIjnjAuyLqA3GAkAQFxGreqQpp8I5O1oolgjx2agWg5QWXgIVBHq7TpyctTbqCIWVSAwiOuA5G9EmA12RxXvbze+iTQ30i/Z7UhtRZx5zpM8a9BoRPxNnTNTsVW4v44xwOeDo/P7W+LfirjXq3r27DB8+LHya1jYxqX3EP/E2TU1kVEp7L/3rX/+SUaNGmYlYrcWL5ae5X5mIkgolP9Ecp0OegmM5lrQffE4cB4VrIgj2tVlydPXqxgodx4xzrHDWR9gNt52WxXafJ32+RpLU6e7dd98117ZgAvaY+PXXX8vLL79sXufkk0+Wo48+utTj8T3hO8G2qGhLtbGLlD/YR1C3pA6ykc7DWveD86qflFOSHCiWCPHZqFbFj917A6jbiwon/I3VR03Hw0lcTQzKY+XZnohpFMzp/pRI0wS70z36lGRalMJplYzUIO0tASdEfDeoe3jvvfeMiML3g8aWbdq08cwBh71yImqNIKQw0cuf9I5rmtY9k/JMGhfNHaIjnqapyYpKYX+CKMD+iGjTpt+/KiNOlqzJkTe/ri5/bsyWqpWKZdGiRREd8kCsaT/YlhNPPFGeeWZEWMG+eVuJnHDCCaFUYWd0yFkfoRNMbdqpY5Dtwuf8LcIJJluMqVD69NNP5YcffjDvgeMVYskWSkj9s109Mfn1yhAgxEabqGMf8hNhwn6G/TDTzq1BgmKJEJ+Nap0nXzs6gwEPqR5aA6S2mcArjz7RwkgnCNrrwE4DTCY6OcHnzMSJgj1x1pVmoMYVQwYPlvdnzZJK2SJVKols3ykyYsQI6dmzpwwfPjy0n9g54BBZsFdORK3RlVdeJXl5daX/2LFGYJk0rTViIkpa+0SiI56mqfFGpcKhkVnUMsGaW6M5O4pE7hxXRwo+ryG1qpZI07wi2bytWN54/XXzeK1/czrk6dihFuCIeEazso3joVmzZnJGzzMkf+J4V8GePylPTj21qzRu3Dj0PTqjQ876CIynWJTANum2QuThM4T7LVQw4bm2YDryyCNDhjMqlPAb/fzzz9KhQwfp1KlTqHhdP5ctlPTYRwqjtmEgJNxxiv1ZjZZAOCt6L7OlINRNZgoUS4T4bFRrr7gCuyYHJ2ntiaCDl1tNTqzgxK22uZoeg9v0pO82mCZTJKk40M+uTWozcaC2J862axgmU1dfdaUsWbpUKuWUyM6iLKkiJdKifpH8vj5Hxo9/y6xcY8JmCya3yW48tUYQ+yhuRwQKkSjsRw0aNDBOaowoxUY8TVPjiUrF6pIHoTT2yxpyQ+f/SYlkybotWdL1QPxVIo+NHiVffvGF9OjZU7p161bGIU9rg7AKHm0kTI+Nm2+5RYpLSqT/hPGl6qoQUTq1a1e59trrSj3P7TtxsxJHpBZF8Dou4zbNBMDx51YDBcE0e/bskFCyBdMHH3wgn3zyifl//vz55ni+9NJLTa2Sbeig34vdl08FZUVbOpPU6ruEKLNGVMNlfDjFf5DqJjMBiiVComxUC+zu1Mg/toVCMgYqRLk0XK8CKVnYTebQgHH16tVlTC3w3ZRXWmFFEM2KnT1xtgUqIkrLli01RfZzCqvIPT03lDFqGDhxvvTp00eefPLJ6C2ho6w1gjCiPXjynKDUzVHbBngtIMQTlYrFJW/1piwZ9VkNsx8+MqO2iSw1yyuSwnU5snFblrTfc5t8+cvP8vjwITJkyBDZe++9pXPnztK1a1fjqIgJmQoDdcjzGwnTYwMTultuuUXOOecceeedd0w7hKPr1jWpd2pVrseOOnaqY6aX6YO9oIX78R6aRoixC6+B/93GKK09sgUTBJQ9turfSGN1Ot9p803dXtvh064NJcTvOIL9RlM7nWB/w/1Y6NJzUTIj1KQsFEuElEOj2liNJXDCxoo1BsFYGsF6gZM66qo0nURvA/pZUVCqDRy97NLTcVCOtqeLfcJD3QKej3SlWbNmyfVd/ifDZtSW/B4bvI0axo83q912lCeSJTRrjSoeO9KhTpm2eyWOLRy/SC+zj5N4olLRgNQ6vP+wN96QStnFRrBjPyzjrDgpVypll8iW7bv2y5J1P8rLz8+Xp59+Ws4991yzH7qlINs96bzGAqeo3H///Y2znDaD1XHNRs0ktL8TjkU3weM2WdS0aRyrkSaPTsFkC6UuXboYcwf8dtheoHbluoDmFrnHtkMI4rUwvuqiGlOkSDTjiJ5r7Ubu2P+wb2n0qDwi1OQvKJYISXKj2niMJXSwTJRIUnAix6QC7wHxh8+n4kAnb5pWmIoOddGg6TwaEVD7YEy43Hq6uKU76HeEfQMnOwilGlUxmcoyK/nhjBoenFrH1ajhL0voAtYaBRwcs86IL/Yh3OacrHv1J7HrdBLlkodIEVajZ81630Q2vQR7v/G55rpHuy3y0Lnr/xJSr4+VDRvWy/XX31DqtTXtF8dCpPQfr/Q5TPx0DHITHip6vASPc7JoR+r8Th4hmJwRJbxn8+bN5ddffw1FbjW9zm9zXmyzCkG8HlOkiB+wj0Og6xiA/U0XVZxR3fKIUJO/oFgiJM5GtYnAniRpDn6ia47URUqv8Z5utVaZtApqr+TZZh2aaqgrehpVxG3hVqz1ZIfXQ10GakOQ8hSpx4ybUYNaQsMePGi1RiwsLo1XtAHHsVtaltsCRDJqEDQ9DcIonGB/YEpt+VtukYz5sob06bJR9qxX9Ffkc8JU+cc/zg+ly7m9RzTpP3gMhJC2UsDz7L50QKNE4QSPc7KoE0ZbPEWaPDqFEsD/6Plk/5Y6cY2l9YIusqj5TiaMqyR27LEB+yGOAz0WdJ/Dft+wYcNyiVCTXVAsEVIB6OQCg57m2gMMdskIo2vaoL6HOl8508kyDfwGWmuEyZtOeDUVCOmGdk8XPyvW+B6xMj1pXY7kVS8xtSHhjBpg9hDOqCFotUYsLC4LjiU7bcbplOmHZNUgoO7wjzrhBXujOkXSrukO+XPjLmvx67tsDAkpGDLMnDnTpOPZaDuFWNJ/nFEht8iQ3uYleJzpjHYtkfa5Czd5tE0eNALkdMnTVD3b2Mfe5mg/L+uZSDRoOxJ15NW6QXWM9IpQk8RDsURIBUYznCfhRPY/ciOdTRliqQlD6p1G24BO/PC7YOJqF3JrkbefFWs1aBApMUX06dAUVifuSJ/CCRuTSxWYmV5YjEkKIn+2nbSC4xzNViPV+iWrBgE1N1MmVg4r2Jevy5EmdYokJ7tEJs+tJus2Z8nO4izZo1axNKi9q4eQE92+WNJ/7KiQpuLZr6vHpEa/3QSPl8mGnwbQTqGEGiVNyXO65OF2XSgBsUT89TtK9vhO0gttDq2LEnpc6Pkq3VPkgwTFEiHlODnXFU9MxJ0rlLYVbSJS8HSFGxdM0mB/y5WnXc6C6G9hT1w0zcG2iUddFyZqzp4uftId1KDh8dEF0n7PrZI/KTeljRpU4ONa6+cw2dUi9kwvLMaEBa6YqMVxpszgf6TW4jvCfuSVWpesGoRwzorov3T+iHqydUeWfLu0ijTKLZJFf1aSH5ZXlrzqxcbufuP2Eqny00+hXkbOcSucoPHCGRXSCaEdIcJxF8lIxm2yGGk7HnjggTJmDhpBcnPJU1txfEa/NUtu2JNcQvyA/V9r3+wUU9xOyheKJUKSCAY6rDhjZdYpgLwEUTRCCYOns0gaEw1cktkMN2g4a2gwKbH/V2MOTSGzhRKEE9KMMNHF40488UTZa6+9TI2G7VIUbbqDGjSMGjVKKufsKqJHbQhSnlasryRbdmSnTFNYfDd2XZemg+D7sF0CMxlYheM4d0stwzGqq8OYcLtF4ZLlkhfOWRFC6Zul7rb2cMk769DNckCTnZI/6RcZ8fTTcuttt4Um/RAcat2N7cQ4pyIkUt81Z1QIjweJdo5zmrc899xzct9990n//v3LCCUlnGBCs+hYzHbUzpyTXBINtvW+OiuyLqlioFgiJIHYk2qdUGiqV7TohMleUdLb9aKpMDgR60kclt/p3iDWreZLvydnugseu3DhQpkxY4Z89dVX5vF///vfTQPON15/XSZPmSw1q2YZQ4Zla7PkxRdfkH+c9w+5/4EHQq8RS7qD06Bh0aJFRphBhLVu3drTqCGI5gm6D2vanaab2ZPlTC8sxu+mk2KNstnHvdbBac+USAJCoxDocxbvfhByVhw1ygj2pnlFsmxdjhFG4Vzy+k/IlY/7rtz99wS5rW9fU1iOKKPdSBMiAmh0Ft+Fm2268/Mmc7922rk/88wzMmzYsND9bkIpkmBq165dyMrZ2VfNC/yOdo0oIX5hXVJwoFgiJAmpSnY37lhT6nCSVbcoCCDtTq9pTzj5QhT5ydFPJzQ6pClh+E7s6BC+k7Zt28rcuXNNyt28eT/J/PkLpEaVYlOXsXx9jrntzTffkJysLMnvsb7sqvprYyQ7J8eInXiJxqAh0eYJ+jpY9UfKXLz7h7PvB/7Wflzpvt9FAscghBKOQ3wvtphQcalW9BASbs1WVUAkej9Q4X7ZZZcZ8T5v3jzJyYYwKg7rkjdkWm1j+HBlx03Gvh6i/6KLLipliqKfDdgpdW626YmKEEWKXNl27vjOn3322VJCqWPHjp5CKZxgwm968MEH+3Ir1Ygijjs7wh/ExRASXFiXFAwolghJQqqSThjiASdbuKQhtQeW0Zigup1kM221Ul3DdOL56KPDZcqUKSY61CSvRBatQi1GidSsKib97X9bxTXNaODEXDmk+TbvVfWCAjOxLM96okQ6ouF5EItaT4TXjXXCjckpXs9ZaIwJazgnv0zCrjnS+ha3BROt+wn3mybLGQ9NYSdPniw//fST3HbbbbJt1ZywLnmIQP25MXvX33VLjOhWEehWf2O7AYJ46thUIOmYp6gQjRS50ufg8XYkDwsXEDwYO9S0xa9gwu+pUSU/1K9fP3R84DlY1IFBiu4jtggGFFGEBBOKJUKSkKoEcFK1XZ6iARMRrNjjhJppK0zOlVenwxUmGNqk77HHHpN3pk0NRYeQNrRoVQ0jjo5ps006P9xA8nuETzNasibH9JUps6q+eyW9PG27E+mIhu9QUzOxH+kkL5YJN0QRJqdak6KmIdqji5StOcI4oHUGOsnGBb8FxoVwv2mynPEAfnuIhVNPPVWeevzHsC55hWtzjCOe+XuNmIm/Rs7wGZyCSYWdiqZY69jsFDrnopPWaEbal/W9sS3//ve/zeugvu6KK66QlStXGtMNPwsH6pKH8b1z587mN1i+fHnEsR2fXxeyNFJoO6Bq2iZEMUSoOnAmqscWISRxUCwRkmCcq6vA6XBnW1Q7we1I3cBENFaxlco1SLjoBElrtjTtEPctW7ZM3nnnHdOwD9c3dtklhhavzpGCz2uExNGwd2tJraolvtKMtK+MYq+kV1R0QmtcdALllrYVDq0nUuKZcDs7yzN9yP07cut7onbruB/iFZNgnRjjPrfIcLKc8fy65IVs7bdnyVmHbtltcV9iLO6xvRAa2D47Bc8+XoGmnsWCnULnHDt1AcBu+LtkyZJQ42YIOmwnfgtsJ75vPB9RYjtVEOIHogfbGclYom/fvqG/cT/GZ7y2Vyqepqfqa+k+oel7tlEKHov9Q503ExlJJIQkBoolQhKEV6oSToCa22+n6ZkDcHfBvG1ZjRO25uNrcXI6gwkB0lPUmtttAoJJBiZPTzzxuEyYMMGk3DWuUyQ1qog8MqO2LPyzkqz6X7ZUyhZZsynbRIuQPtQsL3wzzia704yc2CvpFRGd0Imo2iljYo2V6WhWmjH50xoPEO+EO1Mim/Hg9R3hN8XFFqr4G8K/adOmZURFspzx/LrkqRveuR02yzs/VpP8SXVkv/32kxEjRphjAuYoGKN0/0LEBvh1w4uEnULn1qhWr5Gi/MD998v4CeOlVrUsaVa3RArXZhsRiM/Wr18/I2qQzmf3dMLxhP+x/bho5NVvNAeumRolci6C4T3wfHvsUCMae/tt9NhMRiSREBI/FEuEJAivVCU7r94WBrrCqSvSmTgR1XQb50TCadgAO++xY8fI9KlTXA0ZUH+UJSXSco+d8uzsmjJsRi1p23SHFK7LCZ9mtCZH9mhXHJhmsbov6D6C/1VoY1KH5qbYpzQ9M9yKuEY1AL5fvEYqu9alamG8/qb47ZwCAL8JoiHO36S8XLDgkofxqv+bb8jgaXnSKHencYTcsiNL8mqITPyupoz9Aq2VS2TxwnnyZ+E8WbdZZMiQIdKzZ08ZPnx4qVThRKGCPlIj10eHD5fp0/9Kwy0l9kYXmMfA2ALHkDZTdovW2/VlfqI5+C0gcrV3HoSW1pc5fyvstxpNDGeYYjufJiOSSAiJHYolQhKEn1Ql/I/bU3HSF497FVaeNT9fJyxq822vnuK+Jx5/XKZMnVLKzvull140E4gB3cPXH73ce42pscBkKX9irhQVS8Q0o51FEhJUQWgWi30BE1D9znQFG98Vru0+L3isV30D/sYKOFbfsZ8lwg2vooRMot3hyhudSNs1PYpGkLyc8aKp54v2e8d+BuGDfR3GD9hX2u+OvuDy448/yvxffpb2e26Xr5ZUkZzsEtmrQZEsXZsj48e/JT/88IMxP/ASTLG42AFN9bMjo06wyIJxAkIpkkmLpuS5WbYrWoPlN5qDbYy08OBcDHJDBaHu11qPCXAdbfotISTxUCwRkkD8pCqlYjqT22QYuE2Q7eJsnRiix5AzUgRh6UxJgVDyWilG9Gjeikq+6o90soRGsPmTcl3TjCCmkPQy7N1cefajPCPMkHqHiFJFN4vVmhUVSQomUrZNM7DtiJ37FSaxeD5SgiCWkkF5CJlkucOV92/q5qKGz/Lbb7+VsZiO9D3jO8ZkWns7xfq947GHHHKItGnTppQIQ2+ybt1Ol/Z7bpM5hVVMLWDZY3K+9OnTR5588skyr4vfRvsxReNip9uEx6AWSc0unCm67733nhFG4WoSH5xaJ2TSgsUHCKZw4PtMZDTHrr2KZDWu0SSNQOHYhVjE50+VRQFC0hWKJUJI1JNhNKGEwcL06dNNegsiGO3bt5cFCxaEiqY7depkJumPP/aYFSkqlsI1WfLSiy/K3vvsLbfd1leaNWvmf6V4Qq706bKxjHudbXNsT5YGT61tUvP6j881zTgb7+6zhEiSSJacf/75cs0115g6KKRDwaLdq1lseaI1K+qw6OxvBDQyV9H1DeUhZJLpDlde4BjRtEgn+P408oEFBUzsncLJ+T2rmNbeTvF8724LOO+//76pCUREKayj5PjxxgDBPmbUJhu/j6bUImqVl5cnJ598stSqVcvXohIWVtQcA9c2hYWFJm0wXE3i33J3mIUagGNFa5bCGTMkKk0V34Gm/vkB26TRLXw/qbooQEg6QrFECAmLc5KGldL777svJIC0t9HIkc+a3kbN6mWZ1LkXXnhemjdrJsuWFXpEin6R3r0vl9NOPU2uve46s1KM1wvrXjfV3b3OtjkuPVkqkp9XVDGRpT1b728mofs3z5YOHTqYBp06wVN7cJ2YQPAlMp0s2jQ1u3YJosmtb5cahVR0fUO0QiaWlL3ycIdLNnbk1Qt1l8MF348dKXJ+z/Z3kQwBicWD6lVEsrPCR28emJIr1157rTmmME5ggeSEE04wwh41RW4ptT179JRhPuqdbMMTp8BZvXq1/L4+fE3i7+tyzLGMz2Kb67jVDzkd7BKxwORXKCn2b5mqiwKEpCMUS4SQsJNarHSrGxcmQKhxsFPl7N5GZQVRify98XbZsDVL7p1c24gZWBH/tSqdK9OmTTF/V65SxUyowq0UN6rj7l5n2xyXmiytryxHHHWs2eZI0aJkpZO5vS6iCBBu4Qwa8H+jRo3Mc/EaaghgT5b19WMxbkhUnVE0QibW77g83OHKA2yvm8mA9i1y/o3H4vjDfuD8nvW7tveHRApIiJ71m0Va1nd3lITjJBYuKmUXy9dffyU/zv1SmtcrkRUbKsvQoUOkefPmsqxwqetCSf6kCeZ3HPrQQ74XDbQZrt3wVV/PqyYRRhWok4Kwwtil35PdAw/boQYNiXK/1AUmHOPh6pW8SOVFAULSEYolQohrUbad9qL9YTDRnTRpYihVztnbyC1NB3VDv66qbFLn4E43dHptsyJ91+kbTJ3RYS23mdXns846e5cTV4QmmYtXV3IxZMg1r2mn5+lkyY9QSnQ6mS1E8Jo6ccLr6neJCF04gwanK5r2n8Lkzo8bXnkJw2iETKzfcTh3uFRyyVPHTGezVac1tk7k8TeOQzzP+T0DTPI1CpVoAYl0VBw7yxyOkjuKRPqMzpMJ31Y3xzkWMHYW73LQO7zlFrnz9JXy+le7FkoOab7dO33vrXHS65xzpHXr1mFrtWzDEzWIAUjfrZyT5VmTiDGhUk6W5ObmyksvvWTSACGGkB4MIQcR5XUMxWpMoWgUUG3E7WhipPolPR7x3FRdFCAk3aBYIoSUmURjkmA3hNVJ/rRp00qlyo37pnrExq8PTq0t/zpuk9x8yv9KTWQA6oxwwWtiwgRzhXArxVt3ZMvMedXkkEFNTRRqyZ+YHJVIhxbbjfgCsTraJaouxilE1EoeEzKtOdLVbT+1JskwBEmkMPRjc+0VpYzmO/Zyh0sllzw1LtDFCI0WRoou4LvDRN/5PcfrhhepD9M+++wjv/zyc+iYhFDq8nADWfRnJcl3iSTrcT24166FFkSdEYFy1hiaesJpeWY8ufDCC0P22l6/m0bVMEbgeMLvDdHz4osvmmMf74OFF4wlWFBBlBlC7eslVeTNN96QmtX+SgNEuvAZZ5whjzwyzDUN0DaoUdSYAtEs7c0UTkTZUUDcp9bkur+rUNaxRv+HQNLUWvztJiJTaXGAkHSBYomQDEJPtHaUwj4h4z5trKuTNbtZIlZn0fhRV5n9NH5tXrdI1m3JcjVrqF65RLq3K5Jm9Xa5P4VvkpknF1x4gbEChsMV6hC61a8v8+fPNwYNh9/ftJSj3T/OO09uuOEG3/VHiaqLcQoRRAl0QovvWqMGmhZUEXUJiTZMCCfobEGj4kAnvjpxjDXNKBVd8jS9EpNsbCd69eAz6LGm6N9qH6/PdeunlSxQh7RiyU+h6M3nv1aWBSsrmZTbcCYs1524cddCyZTa8vxHNaVO9WIzVmgaLsQTjlVtFgshYqccOtGoGr4n3VeaNGkip592mkyfNkWu7wxxlmXGmbzq2NISGTajtuRkiwzo7tKDacJ4qVGjpunB5OVgZ4NjFr8BRJQtbr3c/dyigGrQoimU9jigiyd6TOB5+NuZFphqiwOEpAsUS4RkCLpiipO7OkLZzV9xYj7ppJOkYcOG5vH2RFoFBB4zw0qVw+QnYuNXh/GCHXHatC1LTj1wq/x3Vh3z2igU1/4oQ6bXdbXzhqhSQwYFblwqoOBod/rpp5tJlZoj+JlUxFMXY6ftqBDR6Am2Q1PxdGIEsHIM4qlLiHWVuTwME1QIqIW8NtPF+6hgwncQT5pRKrvkqfDBd4Hvya5DcpuoV0S/HYwFO4tz5OxDN5l0WlAzQiR5sGXC8rc6RTLig5pSu1qJWVTRNNxzO2yWpWtEjqxbN/RcfA+achguHRW/rfY4euLJJ+XOO++UYQUFUqtalvwNTXXXiEkJxB4xIJyLX8Eo6d69uxFdGiECtoOd7ldAe0/hGLaj7W7i3Lm9KoCcTXb1N7f7qgGvfTgVFwcISQcolghJY3ASXbVqValokbP5K+yBm+QVyfJ1OfL888/JqV1PNbUEs2bNCtn9oi8SVnyR+vLccyNDaTlnHrLFTH4iNX61jRdCZg25RWbld/aCqkYMnXXWWWbSgNVeO3rkx84b99kCCs9Ty2G/k4pY62LsfjL6XtofCZMwrV3A8/D5NJUIv4FOnmI1aFDxq2IHnxu/V6T6imQbJuA7WbZsWSmbZghJfA+4qKiB+1g8tUfp4JLnp44FnymaCXGiUrUgJoYPHyYHNNkp/+q4SZ6bXdNEisNFkmHPjyiSutG13mOnTL/hzzI9znYWl5hxxUZTDr32BzcDBh0vnnvuOXnmmWek835bZa+GO837hBV10/JkypQpctFFF4WcB+2GsLo9TlTgAE2ZcxM2dhQQnwU9o1RsaZodno/PhvfUCJS9Dzu/A21am4qLA4SkMhRLhKQpOMmiF4mbTe5jjz0q706f5mHpPVkmT5kstapll7L7hYj693/+Y6y+B06aEkqVwyVckbXTeOEvp7ocOaLVdtfaIqf4Ka+Ig05wNFKE708bRdqpiegz1bRpU/McdeoCzkk7hIw6bdlRrURMZrF9WlehdtOYdEHgaiPLeOqM4gGREu0BZDfW1b/Vplknv5nskmeLO3U9VDTSAPxOiBOZqoXjEH2RBk6cLu1bbJO8GsVlDB+cxzXuRyRZDVYObbE99NjS/ZnqlHk+fjt8zmg/A7YTvzmiS09fvNY4b0ZKD9Y0QHXGw7GqacnhHOx0/9W0SY0ehwPbrO6XeA+NPGtfJfzt3IfxHCyG6D6h76mRqFReHCAk1aBYIiSNsCfhsKd2E0o4AU+bOk1u6LIhrKX3xGv/kH0a7bSEz1TJqVRJrr/hBnOi7j/hbbM6iz5LAGk6D07NNX2WCtdmyaatxab4+t4zSzeTBHg9vO57P1eTCy/clV6XSOKJONiRIjfwWpi4IYqjaVTAzc5ZRYFTiCTCtEGLzBX7c2Kyh89Ro0YNz+cnwzhC0SibM+3IK3qSDJe8VEH3Vd1mrU9SS2uNOvidECc6VevKK6+S3Nw68tprr0m1ysWybWcEu+7tWbKzSMxCSeWcEmm1R5FnZAcpwFgo0e9Br6P9DBq50dYD/tKDs0waoAoYHSvdHOw0ggSc+7MuUkRKk4QIwz5qfyZ8Rq0Zde7DEHL2GKZRWl0Ewr6RiosDhKQiFEuEpAm6Gqspd16ro2+99ZZkZxXLw+/Wlso5InnVi83kwWnpPfn7arJPo42O4u2Jcvnll0vf22+Xiy6+WN555x0TZTmxfn05+OCD5YsvvjCT+J577ik//fijTJ3ytrz0Sc0yEaf8iXWkXbuD5KmnnvbtVhcNsUYc8Hg7UuSWHqWvBzFqT1qAPhbXeD+kw0Xq3ZKolClbqGkULZxYSua24DsJ13wVYCUfghPvpQIhlvQiZ7oTth99dVJFONn7qr1/2X218Bn8Tog1qqpjgL6WfsfRAvFw3333yXnnnSe9evWSDi22eUaSB07MlZzsXeYK7ffcLl8uriJHtt4mw96tVcbgAZbjH3zwgXkPpOO1bNkydIzi94smMozfHIsS2nrAT3rw5m270gDt/lYqfrQJsFOcOCN9GhXSWsVYayLdFi7wmmr8oA6aQBcg8PhwluuEkMRBsURIGqCTfI022IXJNjjpTp78thSVZJlCbdQfIG1m844sM7kZ88WuyTUseJ3NX3U1eOrUqcbud++99zb2wpoqgxN4u3btQhMG3H7nnXUimjUkg1gjDni8W3G3jT1pwetqWo0dxfM7wY0nZQr1UPhsdk8evK/2Z4k2NSeR6VtqXuHEjpbg9TUNSRu1ak1TLOlFqeoU5txX8btqWhiwzQdUXIbbn9XYxE7p01TSpUuXxjzBPuqoo+T888+XsaNflUP23Bay60a9Y+GaXXbdWHj551GbjWAaPqO27NVgp/R6ag/TXsBp8LDkT5FKOYuk4JVFxgK8a9euMnz4cPNeaiWO70Dr/cLtD/hOkC5o11OGSw/On5Qnp3bt6uq8p8YjOqapUAP4DiHKcH8iayLDYQslRd0T8VsSQpIPxRIhKY5OEu1GlzppdvZwGTJ4sBTt3G6sf916pBzcfLtpMrvL0rvYNc8fhhEaNQFeJ/9YzRoShVeamVv0RD8HUl/cnADdQA2CrhYDnfTb9TiR3t/ZsDaalCltcKruhrq9WtOAbXNLwyyP9C2Najq/P41y2CYY6gSG71HT0WJJL0plp7BIKZHRCEFN4bLNBPT7RhQYCyqIijrtrv1w//33m/cvKBgl1SqLVM4uNlbiRcUiOVklUq9msTzzYU1TqwR+W13JNKwuWxeZa55TpVKx7NWgSJauzZGpU6fI6af9IiOfez4U1VEHOvyP/QHbjc+gIluFJI5jfJ6ePXtK/sQJRiBp3zWIOjhvwlDm9/WVzLZBKF173XWhz4X9BVFYvC7eR41YVHTax5HWIcZTE+nXVdNO+bPRfRsROPu3ZA8mQpIDxRIhKQAmR+pqBzA5qFWrVijXHZMoLRh2NjpUUIcDh7v8CD1SqlXeNalxOtiZ4u21WdKlceNSk7RIE654zRqixZ5wAEyocMHtmFhoHYBOeHAb0Mm77RroJpT0uSqGolktjtSwNtr0M0yS8N74DPocW8jC7AGvq9fhfqtE23BrFEmjGor9nWpkDBNVjRpgG2NJoUtlG/FIaP8z23kN1259iZxmAnY6rgoQHBtYvFCTEr/oAggiw1gAQXQFvzG2b9GiRbsEjPwhW/5cZR4/oHuYsQZ1kdf9WaoucuDEhTJgwABjB677ji32nAtCdrNYbNt//tNHinYWSf8Jk0wUHIs7EHVoUbCzRis5u2tH6dKli/nO7PQ6PfbxN14HduJAU3I1BU8XoLQeL5EujPh94SCp45Mf1FYe+wGO+VSMrBKSClAsERIw7NVBZeXKlaUm8bgPlwULFsi0adPMCiMmDMcee2zIBc0+4eKE/v7770uNCD1SkFZTOXtXep7Twc7YgG8TY7Ub1JOv2mnbEw4VT5jsaGNUuwGoChaIT0yU8FydEOljMZnXGhJMiOrVqxeKekRjlBCpYW20ky59X0yKVPzh9fEd2JM5TI6x7eEmTom04VZx6rUyDuz3UEMIp0Oen7SzZGx/0IAYdqsB00my83tRMwFM7p3P0+MCQscr+hmJ/fffX6644opSKbg4dh4dPlxe++kH6bzfNvn01yphxxo0rHWtixz/nlx66aVlRKC9EGSbqeDz4aKLFnfedZdpfaD942DioK0PFI2+aoqb3STW3l+0Nsh5m5eDXTxGC7ahgx+0JQE+g9ryp2pklZCgQ7FESIDQyIOmYOAE/v/tnQmUVOW1/b9mcgABRVAZRESNGjUiKsYYh2jyYlRU9DnE4ZmI4ABoopGgBl6IQ5wnElEx4gyOETAgGodo9CkCIo6AfwERDcigIijjf+2P7Mrpj3tv3Zq6qrr3b61a3V1ddetOVXX2Pefsgy9qXHF8/vnn/Rcq5ugceOCB/sou+o+ab1TjOqIfaEmNu/POO7y197nnnZeZZ8OrogiO4FyXZKeL/gOU1Xyv06qMk9R/yvQ2tPguN2HZCQIHiB/2GgAGzWEPEu/nFWXuKwSanGeCQLSYDdRh9iMcWFto+Rntym0mh/1UEFSwQo9y5yu2DbctEQS0EGfDvO3xohEBBBZfK5/+o/pgIx4FtifOnIF9SPhMsMeU+4IlolHYmUa5EpVRxWfTqNGj/TiCaR839QYOSZ81GFj70edNIoZVt6zlkheus30f2zlHvGgBgY3PKPRVxgkPvvetmYYtX80mwOMc7Ar5nKChQ7aZW8QOuK7vmVUhyo3EkhAVBL98ecUTweItt9zi6/khijJzj+65x+E7cciRX7hT9wt7j8b7L8mLfvMbvxx8sSNYbdeunZ9tlGinu7ixW7N2vaV3t8s7RJoylIqkevu40jrcxwwGg57QmY5ECSb7t3WSw/6yWY5ibVMYnIUDawstP7OGDxb2ruF1IZqjhEe+Q3mzlQhaIYtyQG47jR4AfrcZknz6j4q5/pUE1juNq6DtXeG+4Jy1qOAb+7yQQDrMqN5///1+zhGySU+/s3nWzxoMrP2s1ZrIYdXIlMdhBVPUnCPrZGkzyNxmZl9x7qFckYIc7/cwS5erg10hxH1upekLxHbU58yqEOVGYkmICoIZJfbF3HTjje6ZiRMih8cOHdvSzVzQJHrg45invFhC+Rjtgw855BB3xx23J9rpwtEKTdK//e1vS27KYANY9u+wcdtmEgDKyvA3Awk8FoNPAe9jMBMHr0Lbx7ChGwFFvhkJbAPWhYE4S/SisiPM8tnXCgfW5rr/WDYY9qdEQZe+OOERFQDm6zIXLgvLwXHDc0OHL+w7ZEhQCgnxmK+VeJr1x+tDZCPArAbrZb4/ksw68D+Ipfnz5/t+G+4HCABrIU4oVosZSOOzouPma/3nUYuN148jSJzHtKrGbbZx7fcrnjN/aSPX+IMPEl+LfUwg7MXDNrFkLxSEfI7NIsdlWu3yuP9oKFHs8yVbyWoSvADCPjW6+dWXzKoQlYDEkhAVBL/oAQKfp/72lBdKSYYM/X60rFZ/ke89mri5GzdunDvnnHMyggR9BiedeJIb+sjo2BkpO+ywo7fvxZdsKU0ZwgCWzesQd7SORmCN8kNm2sLylPAKbLYrsgw4GYAzq4NeBg7CjMtqWVFnbZ05Y4XHjJbHHTt29L9HZUcQcOF1k7Ic2TIhdv+BsPk9Dlp251KeUyyXOWabIFSQYQqdGrHucDpD0EcXNB4vvm4+gV9Ypkh3M/ZKVXoTPDOSSfDcx7mI4aw4p7GvmBlhltqWm+UyuykNyMLOW9LIZ5OWfdPINWm0Lta6G86b+P9X39TeLvzvm1U1bsbMmd5cIexbYulZeMGDc7W4TTjH2AcX7ieed3gcjRzSfEbxfCkFdC/MF4okHFc6ofJCAMil908IsSESS0JUEPaL/tlnn/Wld9kMGR6fsom74LD1jm7W4htfkOGV9qv++EfXqHFjP/sIblHbtFrjPvEBjnM9jz46I5RKTRiAsywGN14VDa1zkzJIzBrFwYwPAgr2KoRZhTibbytKeAWYwavtJWFAj6AHzoUI+qN6CPD8pPK+qEwOsga8csySNrv/mI1J0+/ArBZEWxoK6YWIEn0IgLEdEExR4o59erRP5rHN5uaXZv0pGFiOlZRlqxQoeMLsUNL2QmhQPLA0MencLwbIPl933XVe8Gzdcq2/gPP9risz85gwu23ekvXzmPDZ9cqHzVzbFuu3x4qoE/dZ7sZNbxHZt2RNV/A5ReGEixc8hrjhHMM+4OeJLUPlcrA/cezj9kHaiwTFKPFkeXG27DjXnUQNzOb8JXzGVOvsMSEqDYklISoI+0WP0i4YNyQ1SUcNj13fe7T+Sm9IuWcfEQbaYb8Rr65SKEX1HUQFE+F9LLNhuU7Lli3z6j+yAZMd8mmFj31Nrisei9dM00MQZVJhgzT8zQGduI9ldzTwAPid65gmoA7tvJPItxciKVDjkNEoKJy5T3m1nEEl3QMpWLkuSUNauf62L4SBZaU3wVPwYL/gHMgmhml4QFvxYvfWxIEB1RA3Q0c96H644wr3ry8bu9/3/NJnvnFBB59TbTdb647ttsJt2WKt2+N/t3LjljR2b1/b1vc3UURdcewXbuq89f2IIfa84PnIc8MeQ5wLNlvMEtDQAtwKn/B9yAxs0kWCuhYj1iglqv+SFwK4jtU8e0yISkJiSYgKg1/0KOX6+9M1yYYMSxr7wCPK4rtXr14VM/sohKV3VmBYG2lOqKdzmu1RCAndscL/4Sor5w5lIylgCrNcYbDC+/m6adzZotwPsQwrENjfwx4TllRZ22Puu1zctJDZ4bomiY1wOxiwYt9AbMc9LylQw3NwQSAOO+eKFthYBnoz8Dvg4FIKyKQhrVx/7icsw2YmKr0Jnv1HzL6mEUzYV6Xor0mCBjAPPPAA1iLTs2Qz3+Cul5v7crveP1zmVq+tyYgoZKM4zw2W33FYNzue8+ExtCIRJc0gtADHeYPzkOdqCD9/WBocnivhOc4LG0muk0lW+9mwn4PhOWA/S7mOcsgTojhILAlRgeALFta3f/7zn5MNGb6tcT/bbX3/TDVZfLMXxYoOBCUsHWIjPuEMEUKbbQYyXB4CFAYeuZbFRF0lthkvG6Taded9VkzxNaPc2WwPAUuB7AwtCkY8ntvGbQ5nxIRCjPstTTkPXg+CCeV9SWIjLOVi/xh+xjnrZQvU8FgOA80GxSFg+SCFD5edzbTCrj+fg9fmMOdqaILHOqIcM87dLskaPJvTZLGcAu3Q2lNPOcX971gX2x/ZvfNK9789v4r5XFvnZyNByHBeEoQf7kPfG9+T3A+2PydtdhTnr3UejQLvIWQzuT/Cc4XnOLPJLPMESe+NJKt9K4hoLsH1jnpPhxdt7DrKIU+I4iCxJESFgrKWE044wf3+0WhDhqFjW7l1bp3r+eetXHtYii+uqROLb0uaQCtKhLCMzAb6AIE7mq45XBbBhhULWDZMIGzfUFQZVlzglLS+UZkQ9oqE2CyOhTa+KMELm6qjBuYy+GHfkQ3kETgxkwSYUeHfEIahUQR+hylGaJ6QjWy9O3aGDc0tKJrinpctUMNxzGaLHcJsAF+bAWS2cjqbZahWG3FrkIHjkA28p1iCFlcqBkpRRgYzmeOOP97dc/eIyJ6lrm1Xuzc/buYzTBuaP7R2PXse5R555GH31FNP1R6ZcO897ogjjnD9+w/w24fzP8qhLjzG+F84RNaK8CR43kbNXMOyIWCtUydg9hLLj3pvRJ2DtNrHMeB7zF5Esee6/TzgRSb2ouG1sByYXuC+0H2zWi4OCFFJSCwJUcEMGTLELV26xA0ZM9FdO7G1HyqLoIGi6Oyzz3ZjxoyJ7T0qZWDI4N/28qDPCq/D4BVf3mEPDq/qQhDg/7ZEi4G0DQztbKVCyoqy9RdEZUIA7mPJFtedfQ+c92QzWVgW1ttaVVtr76ir2Ha5AMtmHxL2EYInlmCxRBGExxO/d+jQwR8HPidbFoLzZtL07lCoEIo9nH904+L92QI1GG7g2OZqmYzXZxBpj03acrq66uEpZU8j9lvcoFrA/cC+nbhySJBURpav2QuWd+qpp7q77hrhfnXoVw6nte1ZgrHM8be1cYOfbOmNZjpu4WrNc8M6/G3c2MiRCX8Y9zfXuFFjd+NNN2U1ZeH7HNuBzw77PmUZajb4WRbV84jXj3qPUYhFzbJK+hzia/D44HPEDp+1g7Z5sQnrwAtMeDxnVFFM4fn4jMrW2yeEiEdiSYgKBl/y553Xzw0c+Fs3fvz4SFFke4/whcmMRtLsokK+LPlFjmCDdfa2RISWvexLwuvbrAmzKFFlZPaKJwPDNOuTRlRla3aOyoRw30GwEJaRWdthu97Y/+zHoihkJi0Jvh6DIDsUl9uI0h7uP2wvjq91yaNdNNcHj589e7bft1GihEEdro7jNbNdcaYZB8sgGcSxWZ4ChsF6UqBGZzwEjrYsMxs8JtawAfun0Cvm1ZRxsqWIUY5oFJHYBmYY4owK+D9mMzmXCedONsvyJHbccUf385+f4m4d9aD73ZFLXd8Dv8qInntfbe6mzdvYHXXkEW7nXXbx7xmsL6zj33zzTffOO++4Q3f+xh226zcxc+TGuF9feKHbYYcdNnjduPc5blbwRBlIRBF3TmJ5uCgR976i014o4NOYLlhBT5t9W3bI8mPczxlxeB/Z8QF8L/LzmGYfQoh6JpbwATp48GD36quvui5durgrr7zS7bzzzuVeLSHqnE6dOmU1ZAivWOJLEl+wnOtTDCck+xo2o5Rt5lEYHMSVkcWtV1wga8v1uFwEfAi6kJmK6i+ICxqjDBls6VucExyFDARHGNRY0goCXi3Gzzlz5tTqX2K2Kc4lLxTD7G1CWSB7pKKwhhrZ1o37JnQCDM8FHh+ssw1Sw2Np+7o4xypbhovnMweLFipuqs1iOarHhSWgNK8AEEo8p2lWwnlTPId5gcBak3MOE5+TLywHxqgCzH5DOZ3NIPH/gwYNcnfffbc3hYAo2qHtGvf6R83c/n9sl3HIa7o+6er/Rjbq4YcfdpdcckneLnZphDmhzb4dBM3Mbdx7mtni0AglF9MFfibxcczq8n1NQUwBxmNFa3SWqmIZOL8r9XwWotKpWLGEDxrYG4NHH33UvfXWW+7cc891Y8eOTT0fRIiGRNTsImBtpnO1SY6ztWawGgcDCJaLRGWRkkrqwkGwcRkyPIb1/YDrFM6aSdNDE2XIgPsQcEIIEQSk7N/B8lialsZQIRtYbuvWrf12LliwICOweMxY4hjnkhcnhiGWcBU8SazhfmwrPl/jjguECUuZ7LLs7zzGaayWWaLIskZm4bJBa3ibfSuEarNYZplq0gUEZolspgG/s+wSj8VFBdpqE4otBtpRro9pSTOq4OKLL3ajRz3kh9QOOepLd8AO37q/vb2x++yLxu6TpY3d6Emb+sddc/wXtebI4TxCfx4yYHwfsIyVrx13gQP7jYIlzcULlvDx3GVJLEhaBh6DDDA+P/Dewvlqe6ayWfGHn0lxfZrMHgIOXCY0hInrnxJCVLFYmjJlips6dapv8Ozatau/jRs3zg/qPProo3NeHpu16xrWlSfVlwtRjPOH2RUaIvCL2IobfHnjyzLNewHPQ4DNK878gscXb7Ysic0y4HkIwGk7jdfH31hG1HrwdXnVln0+7KvB7whAkHXBMqyjmq3px/MQREB8ALrF2eGtDAztesB4ADeuS5gpwnpByNDqOxczhTSWz1gfBJUUhwyumHFhEGj7n+zQTWwLt4fnDYJI9AiBbA50CD65rwBLurCMFi1a+J/cB+E5wPMPj2FQac83lm7abbDbmcvgVRyj8NjlC987XGee6whyeS5UIvZc5fuJ2SQQty8hjnAxgeeQPYbskbHnfqHfXxC0ffr0qXUf1nHu3LneZrzGrXOXHfmle/+zJm7wmJauxUbrXEcYQixt7Nasde6B1zZ1Zx+0zG3fdr21+LwlNW7/fw/wJlbAcNu5LeH7nD95LmcD68mLE/gcAlZExl04sNkg7Eusr83oJX0OxR1ni/0M5UUHllTadaPzpP1sqAsU/4hKPn+iTJriqFmXSy66DrnvvvvcX/7yF/f8889n7hs2bJgPolCalwvTp0+v6KGDQhQDBpwWKx5I2uCe2ajwy98uL+mDxgZhuQiKcDviXjPbhxyFWigOwivK9upuuA7Ztq/QK+/h8pKOG++3DnpRzw9L5LAd6K9Kc8yyrZ8t+Vq4cGHk40IBZa90M5gLtzPX/ZnNycwe4zTiK+l42xlg1UDYHxhH1Fe/zQiTXJ0Vc2H06NHukdEPuKaN1rrt2652733a1GeXTo6wGm/bYo174rxF7pl3N3ZDxrRyV199jXv77be9AMcFEdiKhz2OFHvhsbOfMWnKDG1QFVdyxws5cfs9vIDEx/HvXM9Zuy3M4trXj7IaDz8bhGjoNGvWzO2+++7Vm1lCujicE4MU9nvvvZfX8nDVJqoZtNRAEaPBervttqvVJC5Esc+fMCNjm+159RIZHZZkIDvDviaWcrHElW5qNktlp8eHAUaUkMEVWNz4mmmx9tTMVNgyG1744H1RmRI+FpkQZpay7StsH8rVmP0Ig0ZbAsPgJM2cIEtSNi4qwOJ+ZwBF63RaQttAFo/F/3EVn8cYggbH2Q7vzPf6GK9Q0/AC68FziBkZwv3CskFsA93vcGNmibNp2CMTzqqJA8e0TZs2qY8rXjvpHMTzkGnh8wCDSmwDywSzLacSQGmafY/EwXOYpWs2c4xjge3F/+CMV9rvr3XeTnz6J03dH47+stZMOWvqAOe871/VzjWqcW7bTp3cwIEX17IVv+++e93hPz3cndevX6bXkJbcSVnzNBdSowQ+TU74WcPPWjvuwAokvj/xE49j+Wgh56x9Ho8fZ5hx0HUuyyw2in9EJZ8/s2bNSv3YihVLbGS2IPDKN4WMD4xyllMwuBCilOcP3iNp5h6hhAofRPxSZ4kc3ZXYV8RyO0CRxACLz2UwzxIVDohMWxsf9kWxNMZmGRh02PWxgZ69GssgD6+PgDpqPSDI8HisK35CnNkSlfBKMbEucLkKJbsducB9gddG/wL2LdafIoNikvuFM3jsYFoK3UKvKtsr37h4hRtfE+V7FDx0A+RxoAjC8WDfmz2XGOzx76T9i/dBu3btIoetsoQutKTH63Fd40D/Dgf62tJLLpPN+tmWU27ogJfmXOP7luc69j36cxjI8/1Qqu8vVH2gzO7Qnb/1hg7IKEUBU4drJ2zm9umy0r04YyP38ccfR9qKDx03wT/+/H+b4eDYYxvCIby4j66T7AnM572Jc85+5gGIbrrShRdbeI7asrrwswjrgs8jXLRJcrCzz7PnOi4Q4fhVkruj4h9RiedPLlUWFSuW8IEdDt5D/XiaORpCNFTiZsjgSxNXIXm10c7qYaDK+xnI2quTwF5FxZV9ujDFfRnnO7DWXpW1wogZMj7WBrT8XIB4wC1bcMBmaWwTrwSHwVI5S1hCkYgAiINtsU+RnbFuVxQXYW23PcbMNoUZs1zWiYF1KGSsw1c4MNgaPcSZaIRzqrB9bNy3IpmGDnwOzh38DHvqeC7zvjQ17/hC5jri9e0+4nFHAFvIrK+6AOuH9YxzZbSwj9EGDdif8+fP98eilFkI9BxOn/6WG9rzS/f/Pm/s5i9tnLEJD1lv6rDGdW6z2g056ls35MmWCbbi492JJ52UKcnDeRQ3hJcXhXCznz3Z4OdRx44d/d84n3EByppqhGW1oYNd1GcR1oHPzeZgl81Vr5rniQlRaVSsWNpzzz3d0KFD/dU+lMbwKlRUSl0IEQ++yFGaw4DTumPZIAn/Z6DJIAJXc3iVlLM9rBBJcrMLXc/Q3Mzyq6SBtXSq4rowYMMVXGQmGCADDnsFtKFmIG1nL+G5NB1gIM39kSaoLBbIiOQKtgv7CheLaGfO7AaDJVzNjsKW3jGTw7ks+WTGuCzrOhY6DdKowfZRhK6D4XkTzkfC3wj6k8Q2/meFEs9tPD5s9Me2IhuRlPWkTTO2I64fCsuqdEcxOipy6GqaniMeUzwW37nWgrtUPPHEE67Fxo18duj2fzT3Zg4rVtZECqb1pg6N3ZYt1mayTI9P2cRdcNh/XCqtrfhzzz3nrcnx+YX3S9wQXmZjUCqMv/EeS/NZgP3D9yA/52wpqr2Igf2KGIbld+H5x33NzK8VcUkOdtncPYUQxaN0n4QFgoF222+/vbvhhhv8BwCG1E2cONE3cQoh0oOMEoedRg1GtYKJznX4ombfDnsY2P+TZlYHg1wGI7jiip8IRnhDMIervnYdWLrF2nsEO9b6m5kJBNIIfOnSxkwYyo8gHCAO2XeFgALCCZlqBIK0G2e/Qrk9bhhYRQWmvCKN/RUlbigEsvWmUJRiH0E40tWOwEjnqKOOcjvttJP7zne+439/5plnIrMQFCcUrAABIM8ZvibXKZ+BsUlZSfwPxxfHmSV2FEs2y2azc/gbxx7nAGy17boTnltJwSZLtiodvD/oFphG8OCcwHbb0lPsD3sxotjgWHTcfK0XR8d2W+GWfbu+lC4K3I++pl57rchkmT5ftuF60VacLnkQv7zIgOMWl43B/5GJomtnEvaCES3nWeZKKGC4LA6xZlbUwvcOs74UTDweceebfc+xh7HQwcxCiCrLLIGrrrrK9e3b102YMMF/KMEy/MADDyz3aglRVXAmjm1Mtl/s1pmJ848Ag1V8+aatd2eQC9ESd3U+DOzDK70MZuxcJl71ZnkQsxe0neaATgZ4dkBj3GsXYnYQh+0TSgsFom3GtssLjTZyXWc+Hq/BAcXs64KAeOmll9wpp5ziB36feOKJ/vjhM/e0005zw4cPd8ccc8wGy8OxgRilcA7L62gUEs6DKXRALECGyM4F4jrZ0lLuu1Bg4m8EzziPELyG64S/WZZFq2jC91A1XLm3x4O9LUnwfWRd1Ph7sdweQyAc5i1p5LNJndus8VmhoeNaOuzxnwe9SH8Y19Lft+0Wa2plmUI++KyJ+38LnauZMcM9+OCDGYc8lhriIkHcjCPOroLQws2eO3xf4ycuGLEUk/ONorJ3tgcvnDUWXgjAsWKvE8uI+RkXd75FlbSWsy9JiPpMRYulXXfd1T399NNu0qRJ/sNpjz32KPcqCVF14EuUGZQw+GGQHgYBINuXbvilz+AhW+1/toG1WBaHQNqhtHR1owMbYKDCbWNZFijGkNhcyDeoZKYmylAiaj+Gginb61onQWYWsc+4D6+44gq3yy67+M9a/h/9F7gwhcx+lFjCa4YlQsXqkUgaEIv1DoVSuG4kdNWzvyf1gzBQ5UUF+zxkYKrlyj2PB96PEMVJ5zszSHzPIGDne7RUmVcMpr3uuuu8GIID3hXHrs8yDxnT0l379GZu65ZrvCj6ZlWN+3mP5Zn/+yzTt+uzTGTVGucufaKVe/C1Td0mzda6dV+85x4b/YG79957Mg55OG94kSAckM1jiv0FcYXPn7Afjv+zx9+W0EWJc+tImu1CAJbN/2E5NHBJOt/UlyRE3VDRYgmglOCggw4q92oIUbXALhZfytaaNlsdfTbimuvTOnDZIB+1/whiwqujDBI4oJXBc+j+Zu15ixnYsTQmLYW+fpqMVLj8bELJ2r3jsQjMQpvvt956y/Xu3btWiSZ6qzB74v/+7/9i1yOpRKgQkhrXcxlOmHQseNU+qh+EvUss1Ysyl6gmUK7Kfp24fRIKI5ZZ4pxIOi8LcVzr3Lmz7yv6/agHMtmka47/whs1XP5US/f8+xu5bVqvcQ+cudjttPVqn1G699VN3dCx+Nxyft4SM1ADH2vlHpu8qRt69PoZTQuXNXKjJ23qXv2wmZswYbw/noMuucQfc6xj+HnDz5kw2xNuGx9njRiiSmHt56x9btKFAJxbyhQJUZlUvFgSQhQGvqg7dOiQccPDlzcEVCFXyKOa6/MxDGDZX1SAxSCCJTH2BvK1747DZmywj/JZNoPLunLN4+vxZyjY7BVvKzRsuSOC6RkzZtRaLsTUhx9+6Dp16hT5uizVyqUkLTTdQKle1LFPalwv1iR32kZHib36Vt6Edcd+t65rIZyFxfcxHgdxiPcnPjfQX4ib3RdJWZK0+wpZzWXLvnKDn3zS/XH8Zm7rVmvcpzB6WFXjGtWs8w55R9y6pb9/wZeNfd/SSfssx2gmP3fp6gmtXLuWzn20cJ2f0XTa979en2F6fVPXYqN1rmPrNT7T9MKLLzhX49wll1zqt5/W6CBpO6Iex/lmtszOzlzi+40C257jcrATojqRWBKiAcC+o2JBS3E7eZ6EGR+LDdBphx1lJ865PQyY60J8hCIjrVhiuRYCS2wTAi0EU8UUcnEwW2jnUtnMXVwZGqDIPeKII3x/x+233+57lrD+11xzjTdRuPTSSyNfl8Yfac8pHFMYK9g5eZwngz4Rew7YzE5YKsVZR4XCeTdJ/SDVKo5CWD6Gnhj2dUVlKHEfygyZxYVQwHsQIgoCFz+x79HzhcfhPuxD/M5yWvwfQ2whEtIITBzXP//5Nrd2zVr31FPjXMuNVrutt13l2rde7TptvtZ9scK5ka+0cE0aOXfuIcu8EQT7lp6c1tx12+cAvz7Nv3zTZ5QglB5+Y1NvR77BDKaxL7qbmzd3V155Va11sCYNfN/ibwhM2o/bx/HzjRco+JmGTH1UhtwiBzshqhOJJSFEZEaHpSa0+bZf/hxca3ugbC9SWB6GIAJBFW4gTvwwqEYARMrhVpeL0LF2vwggWZZTKC+//LI74YQTfCnctttuG/kYm0kKf7/11lv9cTvzzDNjXwOPu/zyy/0+Hzx4sL8BHD8Ip379+m3wHBx73CAM0woKOhCypI4Cj+eaXU7cLCYGq+zByxe+dkNyDsN2Yr/xfc2yXPbJ8fylGQxFJLOA1vQCQpZ9YxzozEwTy9HsbKM058itw4b582nU6FGu+UY17vPl69xTb62t1a/U1LjVQ/ysWOXctdde6+644w737YI33YKvGvmMEoQSeqBI7RlMf3MXXzywVsaI5xJnJPHiDLYhKitkL0zYcrswYxV3HOIuBAghKheJJSEaOLbvgDOR7Bwe3Mep9wx+bGkPA3RrUBDlHgVY7gLomkcba84/YubAOnNZwuxJXWWeQhj4s/SG1sTFAFfn+/Tpk7foGjZsmA8iySWXXBL72MmTJ7vXX3/d/445VixDwqyahx56yJ166qm1HPVonRxlQx+H3S8MqHmLyhTZzA7OE2RFEKTS7jwf10GC8r+4rGZaCunVKRd2n8INENuA/Wn7b3AfzuuFCxf67K7NEkNMYHuZRWUWBX/z84KOmhRPaWdS4TnXXX+9G3D++e7xxx/3rz1lyhT3zvRp7jtbr3ar19S4po1tlqiV22233f05PnPmTPfx4hr3yBvrS++QUYrCz2ea2NqNGzfOXXDBBZn7cfxogGEHKwO7/swK2YtCNvOdpiS1vpV4CtFQkFgSogHDTA5nKoX9NgwEKGQYPNjSHgaxHFqL7BGDB9yH58ydO7fW8u1rcCaK7bvJJatU10IJ22Wd0vAztJkuhPfff99beUNI5gsySuTmm292P/3pT91ee+21weOw7v379/fHc/To0f7Yvfjii27atGk+qMRg8OOOO65WRpCDW9HDAgMeCt2kwA//i+ox4xDiuIGxOC9xjlHIMyCnLXyuxx6lUnFZurSEPS7IvuAcxj5KGnpbSTDwh0jBOrMkEkSV6NlMEmCpHo8Jsy0cJm1NOXIBx4ZCBvsXZaBDHnzQi5z2rde5eYud+/rbdWg/crNnveNWL5ru5i6qcV9/u9a98mGzf/coRb8P189gWm/QYMHxwnvNGjbwooBd/9D4w86gyiU7VJ9KPIVoKEgsCdGAQZDHZvrwar0tpePV5DB4YGlP1FVS3I++F2vIkIQtC0p6fHg/g/W6KNdjcMSerWK/Jq74YyAsDDkw5+i+++7Lazlwt6NQAnS1s4IJx/O1117zYhmPg5B49tln/XHfc889fTZw5MiRXjxBbAF7bBA02iG0uLHPIwwc8TeHI4ew5AnnCx6D4J2ig3bhFOOABgS4LxdjEZyfvKpfiNmJdTRj6RrFMn7P1eSgHESVg8XBfRyW1uI+CESbbcHfHCqdqwFICM5P9M6hFPQ/2abJ7t23p7vBRy6t1ZN08h1buNdnN/Mld5jbFCWY/HymxevfwzAvsQYj6LHCOciZZ+xfsutvs0JJJcpCiPqHxJIQDRhcFee8oyhsyVtU8BNeJaU5A4JG9B2FlrrZSHpsVGM6gxUEfsUULrYfwS6XwXGpQBB/6KGH+iARhguFkCSYGNCi3Aog+IdQIocddpgXbhBLyOyApP3L/zETxD4jgt9xnMLZRxbuWzyGZZ/MUNhBonwsAl2cv2kMH7C9zKBAwNM6naViyJBBLKYJeq2jGdbVNvnnWn5WLsLAP2l2FeEFFVsyC7DvcCwglLk/itmLw2zTnDlz3A9+MNIN7bl0g56kR89Z5I66pY2bPr9ZZm5TyPr5TOv8KBIKfRqMYP157rEvKWr9lRUSomGy4Yh7IUSDw/YaWXjFmb0IScEPy5NwhZYDZXMVMFGPZ8Ac9T+IsTSBXi5AONKhzWY08oVmCyNGjMj6WAyHHT58uA/cyTvvvOMzQPmIwbPPPruWSQME0/Tp072YQRagY8eO/n70J1mhdMABB/ieEYCes7SvTfMEzvWxQKzQspu9R1Ewa8WGezyegok3LAcBLjIC2WZNcdYNXh9ilCVjFggz/A9ZNog9CEWIfmbOLDQ3YfaEy6JgKtX8qWJDxztbspkGWmXj8wD7H6KLc4nwNzM1xc6uPfHEE67FxjWRPUkwf3jivMWuSeMa9/uxrdxdLzf3GSZmlPD3H8a1dj87/GfeDp9ZSZxjFLalXn8hRPWizJIQDRiUonBeUmj/zSvICP4QDOFv1PbH9aaEFrxRmaC0UJxF9VGF2DKtuBkyuawHBBiD6lwzY9nMFuJ6h0iUiJg6daoXLKBHjx6pXhMBMI4tfp5xxhk+y/f888/7/7300kv+Z7du3fzxxP559dVXXdeuXX0JIIbRPvLII17g4Rjvv//+qV7TZiCjsj04Z7Ae+F+20jksi853zNZw2bgPpX48/9Ccby3JQ+jkRlMSu64WvB5udIADOA8gnO1FAlvCRudDinlmanMVIOXE9oNlgxklGGRATFijllKbFUC8dtx8bWJPUtd2OEA7uSFjZrprJ27uOmz+nz6nn/3sZ27AgAH+sdbFk8JWWSMhRBwSS0I0YHB1HldXmZ1B0ERjBgRPrMdHkIvHxA2fROCIjBICDzpqFSKW2P+RBhpLsCzK9t63uhoAAC3nSURBVFeEZXRpX7uY2SobOEf1DsWBLIcFAX8acLw6d+7sf6eIgOCBEGOpHQQTHPBwrPbee283adIkL+owb4kGDmDgwIFemOTiykfraOzD0AACbnsQFBAh2cwZWHaH8ywcZstyUJx/6O9CII2gnaVi2FcU0DyHAcvv4l4vBOcgjoMtKwxL2GjDbc9XbDv2bTVkJrBtubxf8ZjQ3TLfobS5gCzYvCWNEnuSPllS48459WjXq1evTJ9T27ZtfekdzgPbP8nzq5C+KiFEw0BiSYgGDIIaXDm31uEI9NiwzsCZmSb2JOCxKFfi0EYETeEg1kLL1+KwduEse0IgZDNkhVhLF5s0ZgshKIGDfTjZb7/9UgksbDcMCwgDWWRfUOIHwYEsEmC25vDDD3f77LOPn+sEG2bst5133tkbTPTt2zdvwWsNICheaLJAZ8VsxgLWUIPbh23A3wzKKZiS1gNiK41As/Acsi6QxGYh8D6AMyDLC5lZrfS+JWIzbmnAceGxpdEFhVYp+7WOPfZYd91112XpSXJeKFlXPev6SWFLrJAWQog4JJaEaODYwA9XYhFMUBTZQJkN3QRCCiIJATBLpuxjSiVWbLYIgSnLtKx5QDGGwpZCMJEkwQShxP+zXC6NUELAap3oaLZBm3MuC8u3vTjoXRoyZEhmGfaYR7mg5QPPJ4Bg2orbqAwiyzDxOOs+l2tQzj46upflgu3XS8py4nFYD5uhKLURSDHBuuMcSJvNxbYh08wMtB1KXcp+LWRLf/7zn7uhox506/49N4lueBBK6EnC/6Os4XlRKMxQ2qGzQggRh8SSECIDh0ymFRvs8yh1JodBsg3cEUwjAKJ9eTg/pdKAYEK2iEIoSjCFQgl897vfrfV3VLkU9kHYW4N9wpJIu/zQtAB/436sR5zBBii0d4vCC+cYyvEgtnHu0KWO55zNQnEGTr5BOTOmSeV32WD/VFxZHWcW8fwshm12XcNjYIV1EhBLeI4tZ6uL7b7iiiv8z/Wzl2xPkvNCif+PgrPhhBAiVySWhBAZEOikDSwRVDHwtsFsKWBAxmwDfuL1UQKFnxxoW+lQGEUJplAo0anOAvGAbUepJMUCnd5wxXzBggWZADYUReHyrXFCttJAa99dCDi3sJ5YZ1zVp2siXcj4tzULwGvjflsOip9x5VPMOnHmEQcu5wsFHjJUUf04UTOLimWbXVdwG3B80h5nHA8akrAvrdTbHTV7CT1JKNErdNiwEELEIbEkhMiAQAdBYVqsQAkDrEIMHpJ6lSCOcKXfOqAVkjnId13y3bYowQTHOytuDj744IwYghCEUQJKpTgPC25kdtuRseKsqaj1Qs8Sno/lUoghE4U+Dtsbhcfh/jS0a9fOi7NcYWkcAmy4/CHLRAESBtqct2SPL44/zRsglm1ZFW6c98PsUyHnIJaBfU3BFlX6Zw0fooYzVwPcBuw7mHNwf6fZd3Qb5HYDzlor1b4Ie5KEEKKUSCwJITIgqEFAHvYnZRMOzOwwyCq2UCJ4DQTP5c4iFbptoWCyQolzjl544QX/N4N19t1YAcB5N3Tvi1qvu+66yx1zzDGZvymUAH9SMPFnWsGUL1hPnCswRrBmDRYOuGVGKdw29tcRLAdiD/sKwpAZoULOlbSlf2lsp23GqxIFFcvUkPHDfsf7LI3FO86/9u3b1xLCdeWQJ4QQdYHEkhAiQ9QQzmywMZyWzbTwDntd7HDZfALYbPOWqg0IpjCjhCAf9zOoBhAUdkithf1luKEcKQSld8jebLfddv5vLMdmpXiVHg56EBoE64THRYnmYghh2+MS5TbHoJvZsvB53GZmmDgMF8viOQhyFf4heA0cBxyXQvpx6MbGkkCsH/p+OPy4kqBowv5H1s6+l0OwLXafhLPWmAVGxkr9QkKIaqU03r5CiKqEs2rygZklOtSxSd+KJg65xf24IbAtlcV4pRNltoAMEWYg4Yo8yowQsKbpxYg6ZmGPUpRQIrjfCjIIJwTzaV8rV+wAW+yD8LUYdIezpaJKPXl+8Tyyg4RxLvL+fM8zzg4rpB8HYoHDeGkYgW3+5JNP8rpAUVdledm2l9kjZPnYbwbYU8cLHCjtq8TtFEKINCizJITIwGCHjdu5WnAzEGQZFIIuBJksnUNwxUwATRoKufJfDXD+Drcdv2MgbJzZAuYgYT+msQuPIxehRPh/ZpjwE+I3riSPopfZHt6YPUx7XGlF/cEHH/h1wP6haM+WyaEAZ7aJBhDWbAH9XtYUI9dzGsuEAUUhZXPI0GAdsW7Yp9xnEBpxxhHlBuuDjCPXD8fIrjv3Ne6DGMJ7nOMDeB5wHhqolrlTQggRIrEkhMjA4BcBDvuQcskkMJBiSR6DVmYI8BMBKwKqQpvvKxXrDAaRwvIt9t5AKHEwLAfOdu/e3U2ePDnRVjwXrFDB8hGkphEveBwNIxjghiWA2AZmBrGtEBJbbrll5v845h9//HHOIpjlWuF9oS29Pccokuz/aIjB/W5Fzvz58/1r5HLeoYfHbl8hcNizXd+oMsRKA6IJZZ4sD+XIAF4Uofui/fygkOWg3mqZOyWEECESS0KIDAgscQU5nHSfa+M+ruJjWQieEDDhd9w4FLI+iiRb6gWhhAARwSVLkXB75513amV8IGQ43yjJVjxX9t1338x6YBBtLiCTdPPNN7thw4a5G264wfXo0aPW/2ndze21QTB7jYoVGIfufqHhAgNzBuS0vsfvUQIH/8/13AuzW/kYNUBU4D0VRzUICWtiAdGJ/czBwjzv8TvEMzJNzDyxf6ma5k4JIYRFYkkIkTjpHoEegh9e3U/T4I8gij0naOxGQIn7YFZQKqFUKge+OJjZ4D7iVXYG7BRK7FO58847vdlCKJQsxRJMWA+KnFz3Ccrh7rjjDr9+GPQZwsZ9bD9+DwfhsgyrFNjlUkghIIdlOEtH6RgYBdZ14cKFqUrxeHyxTcisAPwOpzhbjoahuRAIyEBFiSa+F6LOT15cqDYhQSt19owxY4bjgP3A7BPPkWqbOyWEEBaJJSFE1kn3CH4gnnIZPMugFcElgADLtV8kF/IJ0MMSryTY+8KSwqgyL4Ir7xRK+DlixAifrRkyZEisUCLFzDDlw4ABA/x633jjjZleq7DcjX8jELbzjuiKWEzhGrcs7n+8Jm4YzMvSrzjxQeMCrG/Sccd2sx8HWdKPPvooY90eDumlgUGcBToEFsVleP5T8FWjkLC9S/xZX+ZOCSGERWJJCJEVuorFDT2Ng43+ixcvzlxBrwRXLAR2HPJK84mk7cLV8g4dOmRKsFimiOciW8ar67Z0kcujUCJJQqmUgolOe7NmzfJB7E477eR+9KMf+SCWGYK7777b/fOf/3T9+vVz3/ve92Id8eLmHVEgFhNrPR9mlliOh3PM9ooliQ9kifAYnJPYvjghZsVQ2H8VCq2k3iMKSIqlKPHHHjFmZipdWFhByn3O39POnRJCiGpBYkkIkRVctUewjUCPA1DTggAKQWQuWam6AkE+A1RkvrBtYRkZ+zGwDXgMLZLTikbbq5JGKMUJpkJcA/HcRx55xGdUunTp4rf33Xff9WLhv//7v71whCnDZZdd5rMCl1xySUYsJPWucd4RxRb7U0oBTR2wXjyXGKjzljaLwR46ZAB5fDinia+Vy3qxBJAZJrseNPcAVijxd5Y1AjwOLoQoha3kbBO3iULbGjwIIUR9Q2JJCJEVBG7IosT1XqShnKYOtlQIAR4sqm0ZHaDtMbCCCY9D9oj9VrluP7I0FJwdO3Z0CxYsSP1cPB6vi8AUg2VzeS7WEc57FBIQSnvvvbc75JBD/P933XVXd//997sZM2a43XbbzQ0cONCLwSOPPNJdc801/jUx4+nMM8/MKnSZcSz10OCw7Iv24knW20mGDDboh2CEeMxXlGL5zHRhmXi/cFYRfqeIpLDEjSLJWmyzdBXrVqnZGW6TtWhXX5IQor4isSSEyIrtQ+Ag0WoBwRzLCKMCazq4sSE9KmsUln/lAgLh/v37573+vXv3zut5EEqwIwcQh9j2H/zgB5n/I3sBMYQMEwLfhx9+2N8/bty4WstB6d7IkSNzzgwWo2/JDp1lpgvHklmmJGOFqGNrRQyeExX05wPfD+hrY3YNy0V5HdcR+x+ZJ6w7LfTtwGZb5kqDkEoVS+pLEkI0JCSWhBCpYB8CAsyZM2cWvNdYtsWAkY5axcxAMZBOajSngxtLinItM6xU2EfCviNkqcIyKYilSZMmuVGjRvn9vuOOO7pBgwb50sTZs2e7m266yU2YMMH3XZ111ll5CZ1Csk3MINGGmiYbacvtwmPLcjEKEdxwjqB/CecIXiOfniu6IOJ8xvNxDrHXCQIJ6wyBhtdilguPZe9bWJ6H9ah0O3H1JQkhGgoSS0KInIMkBH+F9NAAXElnU74tUSqWWMI6YtZOnJ0zg1a6nMHNrdBtqkuwnzALCeV9Udkn9jz99a9/9Zkl7OtPP/3UZ5QAfsd2IwMyceJEv+9hRIHlgXbt2vk5S//zP//jHnjggZzFUrGOI5cDoQSXxiSBhGNK4cOZSnTnAyyToxDBeYDSQ85mykcoYXlYN4p9nEMUiDgHsb483+z5iPtwDMK5Y3QgVP+PEEJUBhJLQoicQWkRXNAKgeYApQBBavv27SMDawTTKM2iMQGoxiG5EEqYhwQQ6F988cWRguntt9/22SXsE7quAfyOAB5iCeJh9913zwglZqLQ17TLLrv42Uu5Uox9yowNxAhEBGYaJWUIP/nkk8xxZTklxQfL9zhEFecvsj4QOXRGpFV4LmDd4LCH+U0sswNYHvZ5KNDCmWZcD5YYYn1tL50QQojyst7mSQghcgDlRCzzKpRCXfIQWEIYcTAp1os9OlFCCQ5oFGnFLvurS6ywuf76692UKVMiHwexA+jYBpFE0WQzGMh6WKHEDBSHiuZzPBH8xx2LNMuhaQCyNTC6gFMcxAUyMmHfHI4tjiu20x5X3IfsDUQQnoP/43cIFCyXZXP4PZ8STGanwudiv1n78ah9AMEES/quXbtmzCAwuDjJsEIIIUTdosySECJnEMhBoCBoDa22cyXtc6NK9BCAIshHEI1yOg5LRWCNYJgCgVf360s/EkDpHbYLfUVJs5iQ+WA2MKRNmzb+WLZt2zbjtGeFEvYpepcouNLAY8TyNApYm+1JC44l+47Yu4TnIxsGgWKHJ9MwIWpmFgULRD5EDMQTxQieh9eB6Mkn04l1Y/km+/CwHLwm9h/O0WxOcer/EUKIykViSQiRFwj+EAiy94cOXsXI1FhnMgbbeC0Eu5xzxNImCLao4LgurKzLgRWNsPXG7xx6GyWYkKUAKMWjcCKwqAYHHnige+yxx9yHH37o9tlnn8z///jHP3ph0bNnz8h1iXKQo2DgIFbA3iGIM/zPDrKNg8KXZXU4DyiGcB/EEpbFkjz8nuTSyNejMx4zV5xzRKOFQuA6Y13ZwwSRivXDeyOpjDCt3bkQQoi6RWJJCJE39or4nDlz1n+o5DmYlGYPDIzplId+EpScMWDETwST6E9BhqE+gW3m/qNI4H5gMB9mP0Jzh1AwQaBAJEFUwrTBguwbOPnkk920adNc37593ZgxY3x2Cdbjb7zxhu9lOv300yPXl0KJ4gOBve0PspbczPJBALCsjxmYbNA4IbwP649zACI6aTkUz3g8z7FwOCyzj1j3QpzoKJiwPJSG4nxNsi/P1e5cCCFE3SKxJIQoCrYMKlcQFCLgRXDJzJG9os6+EGQ5AF6nvgklbD/6V6xLGvYlA3fso7gyMQgm9CFRKFnBNHXqVJ/dQBYJgTfswVk+iQwPhBRE1AsvvOAzVHDPe+aZZ/z6nHLKKe7SSy+t1R8VB4UGg3w73wriCCWQ2Cb8zX6epG3KBoUkXg/9SpxfFOdoSGc6lmuyT4nrQbHObSnU8hzrBuOHbPblIbk+XgghRGmRWBJCFAWIm1x7UhiYdurUKdPTEfZ2xFks1zeYeWGwHAqJbME7M0lWMEEoYf/tvffeXizNmjXLCzIsf8aMGf5/Xbp08a8DETFkyBB/IxSnUdgeIiuUWH6G+9hrBKGC9UeWkBkciN1Cyt6wPAgeZoLszK6odaX4YPaOc5BwPzNi7DGCOKStfD5gWRCg2H8Q+cxsYdl054vLXrHENM7uXAghRN0isSSEKAq4is4hm2lhmV2SWxrEA7MB9RXsB2wnoEtbPoSCiT08cKTr3r27mzx5snviiScyGcCWLVt6oQrokEdzh2zriwAexw7ZQAoWmn3geOKYscyO4o9iAY/H71gH3nKFy8VrQNwkLQeP5f7F6/Px4blHu2+YlwA8B0I9rVChgEQmD6YjEIRcJwg7LIevHXfOc9+xNDDJTU8IIUTpkVgSQhQFZISQtYA1d5pgH8Efrurjsch6sPQJP22PEoPu+gxLrZIMCtLC0ju7LAiEnXfe2e9HiCIE7dttt5079NBDvQsehVIugollbyjXY3kYjj2OIV47FM24HwICxxaiBHBwbCFZE5YqslcoaX0B1guCFAKSznlxooQmJmkzm1gOHQApzsJ1hYBiL1MUuB+Psf1e2dz0hBBClA6JJSFE0UBAhyAcwSWupNur/QgQEagyiOY8HASFoaU3gmqUL8GcoD7ZfdcFmLcUii6KJGQ8cLP24PyZi2BiRtD2lDEDSCvuOFjaBhESZViRD7lm4vB4iB+sQzZRwuGxOB9xXiYJO+wTZOvw2DjzCorMuP4j3A8zB7nhCSFEZSCxJIQoKgwuGezZ4JgubyCpH4TZBmQ92L9RyWV4lbJ+EEoswQMUMhYrlEicYELgHwWEL00fYK6AzGCupXQ4vuXsw8F5CHHDEkIaigAYX4QmI5jphBudGMPSUDwGy+S8qqTzIdsFAM1dEkKIykFiSQhRdGywh8ATZU8IPnMpMwstmDEnqNxUiihKI5T2228//9Pel0SUYEJQHw65BTgWSXOuKv340J4eAg9DjaNsuwEySZiNhGwcyw1xQ7kpLgbgvMYFAPZf4fnMUMVZ6Bc6y0kIIUTdIrEkhCgpuDKP4DpfsUPBVE5YMmgDcRuYl1ssjBgxwrVu3TqVUEoqswsFU9SQW8CZRcyiVAr2mFAMRR0bWpuHpgl0IoTQgVBkHxPFPmcd8cbMKUSSLbuDSILAt/12NH8A+J8QQojqYP14dSGEKBEIKlHulA8MVqOa5esCBLcwAkDTPtfHrlslAKGE+UhWKEHc2D4elN7hRiCGkBGKAoLJPjZfZ75yYEsBIVIgmHCzYhtZH9xs2V1o223nQLEMFPshPA9plx/2J+F3LAPnDZ9Py3DchyyVEEKI6kCZJSFEyUHgWcklbBauJzMBlezGFyeUwL777ut/Qhiw9wjZkrBUL6rMDo/HYyGoYNhRaRmkXM479FahjA6ihnOjkNmxLn7EWp7z+GMZcbORILawb6yjXjikGeIIFwvotMceKCGEENWBxJIQouRwvk4uM5jKhS2tq2RxlySUAAL1Hj161NqGqMG19n4L7rMZplIDUYHsDURFscQplgWBhBtnKFlzidBxjrbdXA8KJfYfhWV7HGjLXjwOFqbYgkiTOBJCiOpGYkkIUWd9S3ZIpygM6yZ4/vnne2ETlQFi1oPgcUuXLs0IrT59+tSpKIoDogUZGArquH6jfKETI4QPxA3ORfwOgYN9ib/Rk4QbrL/RpwQolOJmHaFMk1kkZpeQhULmyppHCCGEqE4kloQQJcfOqoE7XjlAIIsgFkFvfZjd1K9fP/8TZWa9e/fO6bl8PEQCl1NuIEiQAcLxYZkcnOjSDINNC5bDHiyKdmSG8JqcFQWBA4twvH6aWUd4HM4nnlM4z3BM1JckhBD1A4klIUSdwFk12QZ7FlscIVuBQBiBMrII5ZztU+zt69+/f62/eUtTxparwKoLaBcPoQGBwkwTjlmxM5I4Nyie8DphT1LaWUfhXDH1JQkhRP1CYkkIUafgyv38+fNL+hoIfGn3jewJA+1KNWooFJSKcRurucyR5YLIJiELCSGD4whBwp63YmUF+Vos96MBQz5oiKwQQtRfZB0uhKhTtthiC9e+ffuSzU6iVTN7VKpZPKSFVtfF7vOpa2iqgf42CCWKJIpeWm8Xeu5AFGFZ3F/IPMb1JAkhhGjYKLMkhCiLYEKg+tlnn+X1fATQcVkiBtzVLBoaMjhuKGeDUMI5wswgRQ2zhhSHuWKfz1I/9BjJtU4IIUQUEktCiLKA4HThwoWpSuMQzLLvCCVnSUJIIqk6sHOM7H2AwoiZQWaBkP2xWbRsywZ8HJYB5zoIJM08EkIIkRaJJSFEWUDmADbNGHwaJXA40JP2y3Pnzq3lZiaqF2RzkF2EKQLd7mi4QAGFGzJMFEr4CaGD/3MOUhx4LG4Q1ngsRBbs0TUMVgghRK5ILAkhygYCZgSyixcvzjiJ4T72jiC7AKtxNPtXK3aoaX01mEgLBQ8yhcgqAoojDnKl0MF+g9CBgMJz2GcEWrdu7WdFJQ05xj6nOMJwWAklIYQQ+SCxJIQoKxBGUY31EErIOiHzUK1QCGBbGjrYFxDCcLNDRinKjAJ/QwDhsRSZzDZBTDFLxBlGENHMMHFZHAwLZNwghBCiUCSWhBAVCQLh5cuXV1UPEgJ1ZEAQ8CPYx429VmK9dTsyiEkZITtviX1KGFIb9hlxGCz2L4UXMk/4vzVwkHGDEEKIQpBYEkJUJMw+VAMsH7NZpIZechcCMZOtnJJZIZozILOE3/GTvWtEw2CFEELUBRJLQoiKBBmIahFJHGqqDFLx9imyQsgqMRsVhYbBCiGEKDUSS0KIisT2nlQqLBcThWPd8OCCyH4l9ClBOAkhhBDlQGJJCFGx9tLoWRL1H85FwjGHaLKzlJBdijIAEUIIIeoCiSUhREXStm1bN2/ePGVuGgAQRBBKmLvFfjVaycugQQghRDmRWBJCVCQIkjFIlDOYSmG/zXk+KKWzg1GrxViimuHQWAiiFi1a1BJFmokkhBCiUpBYEkJUxQymd999t6giBoE6shnIakCMoTeGQ1BF4VB4Ru1P7PM2bdps4HAnhBBCVBoSS0KIqoB20oU8HwE8YPYIPVHskRHFH0C7bNkyL0CtCQb+h8yR+pCEEEJUAxJLQoiqAFmgr7/+Ou/no9wLQTuCdYgjZjxUcld84GaHobG0/KYgxb5v1aqVzyip1E4IIUQ1ILEkhKgKEGAjE5RvmVwpep7EhkAYUQzBsEFmDUIIIaoZiSUhRFWAsq1tttnG/etf/5JDXgXZfaP3iwN5kf2DUGKJnYbGCiGEqHYkloQQVQP6YJo3b+6zFQsWLFAJXR2bNQC4B+KGMjvZegshhKjvSCwJIaoKZiu++OILX1pH62/1HhVXHOHGHi9kj7Cf8RO9R+w7EkIIIeo7662hhBCiykCGCbAErD4CgVIOsD8hlGDxDbMGrAdNGnCfnOyEEEI0FJRZEkJUJSgD++abb/ytvmItt+vClh0iiRbryCJtvfXW3kVQJg1CCCEaKhJLQoiqBKV4MHxAIL9ixQpvK655SbnDAbHYh8jSQShtsskmtfqRZPMthBCioSKxJISoWqzbGkTTnDlzyr1KFQ8yRyirQxYJN/UfCSGEEPFILAkh6gUoF0OWZNWqVeVelarof4JoQgYJ5YxCCCGEiEZiSQhRL0BmSax3skM5HXuPIB4hIlu3bu1NMeAguHLlSi8uZf0thBBCVKlYuu+++9ydd97pPv/8c9exY0c3ePBgd8ABB5R7tYQQFQoEQH11xSMQPxj8CqyxBYQRyhHhXMe+I+6TRYsW+d4ulNsBOdkJIYQQVS6Wxo8f72677TZ35ZVXuj322MP96U9/cgMGDHD/+Mc/XIsWLcq9ekKICgSZErq61adBsHSoQxkdskMsm1uyZIk3tQDIGOH+0Ihh+fLlbuHChT6zJIQQQoh6Ipbmzp3rrrrqKnfQQQf5v/v06ePuv/9+N3PmTNetW7dyr54QogJBxmTZsmV1NqAW1toQNBAoeE0Ik2ICkUQLb7zGVlttVUsMwdZbCCGEEA1QLPXt27fW3xBJCBo6d+5cUOBR7GAmDbDjtT+F0PlTOpBdgbj48ssvSy6YaFMOAYPMDbI/xSoDxPKwHcgmIWOGzFE+gkyfP6IQdP4InT+ivn7+sGojDTXrylTk/6tf/cq99NJLkf97+umn/dwPgIDnpJNOcjvssIMvy8uH6dOn+9p9IUTDAWIDH4SlLs2zH6H5vpZdBn7XvCghhBCitOBi5O677165maXLLrssVi2iLp8MGzbMzZ8/3w0fPrzgK7UQXHUNtnH27Nluu+228za9Quj8qRvgArdgwQLv/lZKChVj+LBGLyYEEgQeskjF6jHS54/Q+SPKhT5/RCWfP7NmzUr92LKJJWaOkvj73//uRowY4UaOHOm22GKLggMaOEWVCxzocr6+qG50/uQHnOM++eSTspTgZoOmDXCqK7VDnc4fofNHlAt9/ohKPH9yudBZkT1L4M0333QXXXSRGzp0qNtrr73KvTpCiCoE/UQdOnTwznEwf0CWqRSVx2n7lSCO0H9Jq29cBJKVtxBCCFG5VKRYQtqtd+/e7pRTTnE//vGPM/a4CC5QpiKEEGnB5wad4yCWkGlCet+KG2vTXYhzXfh8DobFT8w5irL3FkIIIUTlUpHK46GHHnJfffWVH0qLG4GdeK9evcq6bkKI6s804fMF84c4wBU/cxFKUZkkLIdW4lwmfqKEANkjiSQhhBCi+qhIsTRo0CB/E0KIYgPRgtsXX3zhM0yw5M4Fzj6iiQREE8rrcB/MGsJ5SEIIIYSoXipSLAkhRKmB61wu8xuQTWJ/EUQSy+toJKEMkhBCCFH/kFgSQjRI0D+0aNGiVOV3yBrBjQdZI4AyPsxug3hSiZ0QQghRf5FYEkI0SFAqh2wQs0vIFAGW5UEgse8Is9+sOYPK7IQQQoiGgcSSEKLB0rZtW++OB4FENzz0H7Vs2dKX2KEHSZkjIYQQouEisSSEaLBACMEdb/Hixb6sDuJIs4+EEEIIQSSWhBANGvYdCSGEEEKErC/SF0IIIYQQQghRC4klIYQQQgghhIhAYkkIIYQQQgghIpBYEkIIIYQQQogIJJaEEEIIIYQQIgKJJSGEEEIIIYSIQGJJCCGEEEIIISKQWBJCCCGEEEKICCSWhBBCCCGEECICiSUhhBBCCCGEiEBiSQghhBBCCCEikFgSQgghhBBCiAgkloQQQgghhBAiAoklIYQQQgghhIhAYkkIIYQQQgghIqhZt27dOlfPmTJlisNmNmvWrM5fG6+7atUq17RpU1dTU1Pnry+qG50/QueP0OePqEb0/SUq+fxZuXKlX+5ee+2V9bFNXAOgnCIFr10OkSbqBzp/hM4foc8fUY3o+0tU8vmD5afVBw0isySEEEIIIYQQuaKeJSGEEEIIIYSIQGJJCCGEEEIIISKQWBJCCCGEEEKICCSWhBBCCCGEECICiSUhhBBCCCGEiEBiSQghhBBCCCEikFgSQgghhBBCiAgkloQQQgghhBAiAoklIYQQQgghhIhAYkkIIYQQQgghIpBYEkIIIYQQQogIJJaEEEIIIYQQIgKJpTpk3bp17he/+IW79dZb6/JlRZVz3333uQMPPNDtuuuu7ic/+Yl7+eWXy71KQoh6znvvvedOPPFEt9tuu7nu3bu7q6++2q1du7bcqyWqkCeffNL96Ec/KvdqiCpk5syZbs8993TTpk0r63pILNUh999/v3vllVfq8iVFlTN+/Hh32223uaFDh3qR9MMf/tANGDDALVu2rNyrJiqczz//3J177rmuW7durlevXu79998v9yqJKgGfL2eddZbr0aOHe+6559xNN93kHnzwQffEE0+Ue9VElfHZZ5+5yy+/vNyrIaqQVatWuYEDB/qLNt/73vfKui4SS3XERx995G644QbXtWvXunpJUQ+YO3euu+qqq9zBBx/stthiC9enTx/39ddf+6stQiRlsfv16+cWL17sHn30UXfaaad54YRzR4hszJo1yx111FHu17/+tWvXrp2/SIPsUrmv7orq+xwaNGiQ23rrrcu9KqIKue2229yXX37pLrjggnKvisRSXbBmzRqvjhGw7LHHHnXymqJ+0LdvX3fQQQdl/oZIatSokevcuXNZ10tUNlOmTHFTp071V3RxgebYY491Xbp0cc8++2y5V01UASh7wXeW/Q778MMP3fbbb1/W9RLVV00zf/58d+GFF5Z7VUSV8fbbb7vbb7/d/fjHP/YVNrNnzy7r+jQp66vXE371q1+5l156KfJ/Tz/9tBs1apRbvXq169+/v/vd735X5+snqvv8adOmjf8d/QK33HKLD3yRZRIijnfffde1b9/e7bDDDpn7UI6HzMDRRx+tHSdyAt9h33zzjS/nFCJtNQ3KN++++263YsUK7TSRU0ZyyJAhrnnz5q6mpsZ98MEHvmfynHPOcWeccYYrBxJLReCyyy6L/TD49NNP/YfFww8/7Jo2bVqMlxMN6Pxp3bp15vdhw4b5q3TDhw+vw7UT1chXX33ltt1221r3tWrVyjftC5ELyGZfe+21vm+yZcuW2nkidTXNL3/5S19N89prr2mvidRMnjzZZ5YQ6xxyyCH+vr333tudf/75rmfPnmW5WCyxVAR45T9k5cqV7uyzz/Z13ypfELmeP5a///3vbsSIEW7kyJHKKomsNGnSxG200Ua17tt4443d8uXLtfdEapYuXep734477jgfpAiRBgS5KBdH/CNEriDJgO8wuAATiG6I8Dlz5kgs1TfefPNNf1UOxg64AZQyIK04ceJEN3bs2HKvoqiS8+iiiy7yV3b32muvcq+OqAI233xz74YXOpw1a9asbOskqgtku8877zzXsWNH36QvRFoee+wxt2jRIu+mCBDk4nxCdgBCCj+FiAMl5Gg7QLyMUjwwb948/3OrrbZy5UCZpRICq0NkBCzXXHONP9hnnnlmKV9a1BPQ1Ni7d293yimn+EZHupkha4ArL0LENehDXMNJiKVT06dPd9tss412mEjVM4BeyiVLlvhs9rfffutvjRs39hlKIZKAzTz6tAl6JdFzgvvbtm2rnSeyxs4wJBo8eLB3wsP32BVXXOH2339/L6TKgazDSwgCWlyVs7dNN93UBy+y0hRpeOihh3z/yZ133umzSryNGTNGO1DEsuOOO/rSX2S0cYXunXfe8dlsDYYUaUBD9fPPP+8d8GAbzs8dzF4SIhuIb2zcs+WWW/qLe/g9LA8WIgTnyl133eUzkscff7w79dRT/Tl13XXXuXJRsw6XkIQQQtQ7RzxYz2OwHwQ3XPCuvPLKcq+WEEIIUVVILAkhRD0Fhg6TJk3yPUya8SaEEELkjsSSEEIIIYQQQkSgniUhhBBCCCGEiEBiSQghhBBCCCEikFgSQgghhBBCiAgkloQQQgghhBAiAoklIYQQQgghhIhAYkkIIURqMLfppptucgcddJCftN67d2/36aefZv7/ne98x9+WLFni/8ZP3heC+0aOHFnrvscff9zfj6ntcXB54e2NN97IPOaVV15xvXr18pbp//Vf/+UmTJiQ01G2y8UyjjvuOPePf/yj1mOWLVvmBg0a5Lp37+6+//3v+/2CIcAhRx11lDv99NNdIVx00UXu1ltvLWgZQgghckdiSQghRGpuvvlmL2ggEiAOZs+e7S6++OINHvfBBx/4n++//35J9u4vfvEL9+ijj9a67bLLLpnX7tOnjzv44IPdnXfe6UXdhRde6ObMmZPTa2ByPJY7fPhw993vftcP+X3rrbcy/z///PPdlClT/GT53/zmN+6ee+5x9957b61lLFy40M2YMcNNnTrVrVixIq9tveOOO9zYsWPzeq4QQojCaFLg84UQQjQgHnvsMS9EfvrTn/q/V65c6QYMGODmzZvnOnbsmHkcRNJ+++2XEU3FZuutt3a777575P/++te/ui5duvj1At26dXMvvviiGzNmjOvfv3/q19hqq60yr7H//vu7adOmufvvv99dc8017tVXX3Uvv/yye+SRRzIDfz/66CMvbM4444xaGa4mTZq41atXu9dff91n5HLhxhtvdKNHj3YdOnTI6XlCCCGKgzJLQgghUrFmzRr31VdfuUWLFmXuO+CAA9wDDzzgWrdunbkP4oQiCT8pJuqKpUuX+jI+lAyCZs2aub/85S+uZ8+eBS13++23d3PnzvW/P/PMM17A2G2DsMK+Wbx4cS2xtPfee7udd97Z/54rs2bNcg899JDEkhBClAmJJSGEEKlo3LixF0d33323u+WWW3zPTvPmzb0YaNGiReZxO+20Uy2xFNWvVEoOOeQQ99lnn7mzzjorUwaIMrrOnTsXtFyU1LVr187/jtI6iCfLvvvu68v+Ntpoo8x9EEg9evTwt3zEEvqUkCUTQghRHiSWhBBCpOaqq67y5XV/+tOfvCiBOAhNDSCWkBFBid7MmTP936VYD2vCwLJA8JOf/MQNHDjQTZ482R199NG+HG/+/Pl5vxayaQ8//LA3kDj88MP9fcgetWrVqtbjkF078MADvYAE2PYFCxZ4EYUbBBb+zoVGjfQ1LYQQ5UQ9S0IIIVKz+eabu7vuusv37MDsAeYG6OVBBqSmpsY/BpkQCKjnnnvOrVu3boMMTDH45S9/WausDqV24f+POOIId/vtt3uhA+GEfqNcsjTXX3+9v3H5EF0USxCCyLQl8c9//tNtsskmvlTv22+/9Y9HdumYY47JcWuFEEKUC12yEkIIkTOwykYvDUrd0L8zceLEzP9gaABR8uSTT/qfTZs2LfoehvkC3O9469q1a+RjBg8e7B588EG3fPlyd/XVV+f0Gqeddpo3ixg/frx3vTv33HMz/9t00039Mi3Tp093J598sje7ABBGcMBDLxNKFdHzBQElhBCiepBYEkIIkYoXXnjBl7WhLA0gk/TrX//a9yu9++67tR6L0jtklkpRgpcNzFeCyCHI7OC+cB2zgf4kCDFkxkLBt91227mPP/641n0QSRBVyEIh8zRp0iR35pln+nXB7YQTTvAZOWTbhBBCVAcSS0IIIVKx2WabecOE9957L3MfsisoMQutrWnqUA6xBOOJ1157rdZ9GI7bvn37or0GjC7Qg0R3PIBSv7Zt23qR9eabb/p9g4G4zH4deuih3iSiVHbqQgghio96loQQQqQCw10R9F922WV+yCsySnDGg7EBRIGFIilfJzzMJEKpmwX221tssYX/HW53KHuzbLnllm6bbbZxJ510ku+lgvtd9+7dfbZnwoQJ7tprry3akUbfEQbQnn322X5fIMs0atQoP6jW9ivtuuuumedgXWDYgPI8bIsQQojKR2JJCCFEui+MJk28YQJ6f37/+9/7HhwIqHvuuWcDZziKJfwMy9XScN55521wHxz4DjvsMP87RBpultNPP91deumlfigsSgQhXoYPH+46derkrrjiCm/4UCxQajdy5Ei/3IsuusgLI/Q09e7d2/8fggjlf7Z8D5k5iEcIKRhQCCGEqHxq1ql4WgghhBBCCCE2QD1LQgghhBBCCBGBxJIQQgghhBBCRCCxJIQQQgghhBARSCwJIYQQQgghRAQSS0IIIYQQQggRgcSSEEIIIYQQQkQgsSSEEEIIIYQQEUgsCSGEEEIIIUQEEktCCCGEEEIIEYHEkhBCCCGEEEK4Dfn/iIji6a4vwDYAAAAASUVORK5CYII=",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "print(f\"\\n正在运行 TOD 方法（SMILES）...\")\n",
    "\n",
    "# 参数设置\n",
    "n_clusters = 9\n",
    "beta = 2  \n",
    "\n",
    "# 第一阶段：聚类\n",
    "# 使用 K-Means 对降维后的指纹数据进行聚类\n",
    "kmeans_struct = KMeans(n_clusters=n_clusters, random_state=42, n_init=10)\n",
    "kmeans_struct.fit(X_smiles_reduced)\n",
    "\n",
    "# 第二阶段：计算离群因子 OF3 (Phase 2: Calculate Outlier Factor)\n",
    "\n",
    "# 1. 计算距离 d(p, Cj)\n",
    "dist_matrix = kmeans_struct.transform(X_smiles_reduced)\n",
    "\n",
    "# 2. 计算权重 |Cj| / |D|\n",
    "labels = kmeans_struct.labels_\n",
    "cluster_sizes = np.bincount(labels, minlength=n_clusters)\n",
    "total_samples = len(X_smiles_reduced)\n",
    "cluster_weights = cluster_sizes / total_samples\n",
    "\n",
    "# 3. 计算 OF3(p): 加权平均距离\n",
    "of3_scores = np.dot(dist_matrix, cluster_weights)\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 第三阶段：判定 (Thresholding)\n",
    "# ---------------------------------------------------------\n",
    "ave_of = np.mean(of3_scores)\n",
    "dev_of = np.std(of3_scores)\n",
    "threshold_tod = ave_of + beta * dev_of\n",
    "\n",
    "# 记录结果\n",
    "outlier_flags_smile['TOD'] = of3_scores >= threshold_tod\n",
    "\n",
    "print(f\"   [TOD结构] Ave_OF: {ave_of:.4f}, Dev_OF: {dev_of:.4f}, Beta: {beta}\")\n",
    "print(f\"   [TOD结构] 阈值: {threshold_tod:.4f}\")\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 绘图 \n",
    "# ---------------------------------------------------------\n",
    "plt.figure(figsize=(10, 6))\n",
    "\n",
    "# 1. 画正常骨架\n",
    "plt.scatter(X_smiles_pca[~outlier_flags_smile['TOD'], 0], X_smiles_pca[~outlier_flags_smile['TOD'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常骨架')\n",
    "\n",
    "# 2. 画异常骨架\n",
    "plt.scatter(X_smiles_pca[outlier_flags_smile['TOD'], 0], X_smiles_pca[outlier_flags_smile['TOD'], 1], \n",
    "            c='orange', s=40, edgecolor='k', label='TOD 离群骨架')\n",
    "\n",
    "# 3. 【修复】绘制簇中心\n",
    "# 不再使用 pca_vis.transform，而是直接计算 2D 点的均值\n",
    "try:\n",
    "    # 遍历每个簇 (0 到 8)\n",
    "    for i in range(n_clusters):\n",
    "        # 找到属于簇 i 的所有点在 2D 图上的坐标\n",
    "        # labels 来自于 kmeans_struct.labels_\n",
    "        points_in_cluster_2d = X_smiles_pca[labels == i]\n",
    "        \n",
    "        if len(points_in_cluster_2d) > 0:\n",
    "            # 计算这些点的平均值，这就是簇中心在图上的位置！\n",
    "            cx, cy = np.mean(points_in_cluster_2d, axis=0)\n",
    "            \n",
    "            # 绘制中心点 (黑色 X)\n",
    "            plt.scatter(cx, cy, marker='x', s=150, linewidths=2, color='black')\n",
    "            \n",
    "            # 标上数字 ID\n",
    "            plt.text(cx, cy, str(i), fontsize=15, color='black', weight='bold',\n",
    "                     bbox=dict(facecolor='white', alpha=0.5, edgecolor='none'))\n",
    "            \n",
    "    # 为了图例显示正常，画一个假的中心点进图例\n",
    "    plt.scatter([], [], marker='x', s=150, linewidths=2, color='black', label='骨架簇中心')\n",
    "\n",
    "except Exception as e:\n",
    "    print(f\"警告: 绘制簇中心时发生错误: {e}\")\n",
    "\n",
    "plt.title(f'{current_dataset_name} - TOD Method\\nBeta={beta}, Outliers: {outlier_flags_smile[\"TOD\"].sum()}')\n",
    "plt.xlabel('SMILES PCA 1')\n",
    "plt.ylabel('SMILES PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_4_TOD.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a8a00954-cb28-4290-a56b-52fdbebcc524",
   "metadata": {},
   "source": [
    "### 4.2基于聚类的离群挖掘方法 CBOD"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "id": "3a60567f-9181-4302-86b9-6c2c8539fba8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "正在运行 CBOD 方法（SMILES)...\n",
      "   [复用] 簇数量 K=9\n",
      "   [CBOD] 结构簇离群因子统计:\n",
      "   Rank | ID | Size | OF4 Score | Cumulative %\n",
      "   --------------------------------------------------\n",
      "      1 |  3 |   95 | 9.522634  | 1.80%\n",
      "      2 |  5 |  194 | 8.604264  | 5.47%\n",
      "图片已保存: output\\HT-29_FEATURE_4_CBOD.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "[完成] TOD 与 CBOD 结构空间分析结束。\n"
     ]
    }
   ],
   "source": [
    "print(f\"\\n正在运行 CBOD 方法（SMILES)...\")\n",
    "\n",
    "epsilon = 0.02 \n",
    "\n",
    "# =========================================================\n",
    "# 1. 复用聚类信息\n",
    "# =========================================================\n",
    "centroids = kmeans_struct.cluster_centers_\n",
    "print(f\"   [复用] 簇数量 K={len(centroids)}\")\n",
    "\n",
    "# =========================================================\n",
    "# 2. 计算 OF4\n",
    "# =========================================================\n",
    "# 计算簇中心之间的距离矩阵\n",
    "centroid_dist_matrix = euclidean_distances(centroids, centroids)\n",
    "\n",
    "# 计算 OF4\n",
    "of4_scores_cbod = np.dot(centroid_dist_matrix, cluster_weights)\n",
    "\n",
    "# 整理\n",
    "cbod_stats = []\n",
    "for i in range(len(centroids)):\n",
    "    cbod_stats.append({\n",
    "        'cluster_id': i,\n",
    "        'size': cluster_sizes[i],\n",
    "        'of4': of4_scores_cbod[i]\n",
    "    })\n",
    "\n",
    "# =========================================================\n",
    "# 3. 排序与判定\n",
    "# =========================================================\n",
    "sorted_cbod = sorted(cbod_stats, key=lambda x: x['of4'], reverse=True)\n",
    "\n",
    "current_sum = 0\n",
    "outlier_cluster_ids = []\n",
    "\n",
    "print(f\"   [CBOD] 结构簇离群因子统计:\")\n",
    "print(f\"   Rank | ID | Size | OF4 Score | Cumulative %\")\n",
    "print(f\"   {'-'*50}\")\n",
    "\n",
    "for rank, c in enumerate(sorted_cbod):\n",
    "    current_sum += c['size']\n",
    "    cumulative_ratio = current_sum / total_samples\n",
    "    \n",
    "    print(f\"   {rank+1:4d} | {c['cluster_id']:2d} | {c['size']:4d} | {c['of4']:.6f}  | {cumulative_ratio*100:.2f}%\")\n",
    "    \n",
    "    if len(outlier_cluster_ids) == 0 or (current_sum - c['size']) / total_samples < epsilon:\n",
    "         outlier_cluster_ids.append(c['cluster_id'])\n",
    "    \n",
    "    if cumulative_ratio >= epsilon:\n",
    "        break\n",
    "\n",
    "# 标记样本\n",
    "outlier_flags_smile['CBOD'] = np.isin(labels, outlier_cluster_ids)\n",
    "\n",
    "# =========================================================\n",
    "# 4. 绘图 (CBOD Structure)\n",
    "# =========================================================\n",
    "plt.figure(figsize=(10, 6))\n",
    "\n",
    "# 1. 画正常骨架\n",
    "plt.scatter(X_smiles_pca[~outlier_flags_smile['CBOD'], 0], X_smiles_pca[~outlier_flags_smile['CBOD'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常骨架簇')\n",
    "\n",
    "# 2. 画离群骨架簇\n",
    "plt.scatter(X_smiles_pca[outlier_flags_smile['CBOD'], 0], X_smiles_pca[outlier_flags_smile['CBOD'], 1], \n",
    "            c='purple', s=40, edgecolor='k', label='CBOD 离群骨架簇')\n",
    "\n",
    "# 3. 标记中心 (使用 2D 点的均值计算，避开维度报错)\n",
    "try:\n",
    "    # 这里的 labels 是 K-Means 的聚类标签\n",
    "    # X_smiles_pca 是 2D 坐标\n",
    "    \n",
    "    # 遍历每个簇\n",
    "    for i in range(len(centroids)):\n",
    "        # 找到属于簇 i 的所有点在图上的 2D 坐标\n",
    "        points_in_cluster = X_smiles_pca[labels == i]\n",
    "        \n",
    "        if len(points_in_cluster) > 0:\n",
    "            # 计算这些点的平均值，这就是簇中心在图上的位置！\n",
    "            cx, cy = np.mean(points_in_cluster, axis=0)\n",
    "            \n",
    "            # 颜色逻辑\n",
    "            text_color = 'red' if i in outlier_cluster_ids else 'black'\n",
    "            font_weight = 'bold' if i in outlier_cluster_ids else 'normal'\n",
    "            \n",
    "            # 绘制\n",
    "            plt.scatter(cx, cy, marker='x', s=150, linewidths=2, color=text_color)\n",
    "            plt.text(cx, cy, str(i), fontsize=15, color=text_color, weight=font_weight,\n",
    "                     bbox=dict(facecolor='white', alpha=0.5, edgecolor='none'))\n",
    "                     \n",
    "except Exception as e:\n",
    "    print(f\"警告: 绘制簇中心时发生错误: {e}\")\n",
    "\n",
    "plt.title(f'{current_dataset_name}  - CBOD Method\\nEpsilon={epsilon}, Outliers: {outlier_flags_smile[\"CBOD\"].sum()}')\n",
    "plt.xlabel('SMILES PCA 1')\n",
    "plt.ylabel('SMILES PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_4_CBOD.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "plt.show()\n",
    "\n",
    "print(\"\\n[完成] TOD 与 CBOD 结构空间分析结束。\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cf38d779-ef30-4ca2-a105-3970e62022cb",
   "metadata": {},
   "source": [
    "## 5.基于聚类的动态数据的离群点检测"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "08f3d323-e129-45f4-81ce-2f8443f3dddf",
   "metadata": {},
   "source": [
    "### 建立初始模型"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "id": "0dc6d9a3-dde0-467a-aa8c-6dcda5feb678",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "   [数据切分] 训练集: 4223, 测试集: 1056\n",
      "   [模型定义] 结构离群簇 ID: [2]\n",
      "   [结果] 动态检测离群结构数: 113\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# 参数设置\n",
    "n_clusters_dynamic = 9  # 保持与 TOD/CBOD 一致\n",
    "epsilon = 0.02 \n",
    "\n",
    "# 带索引切分数据\n",
    "# 使用 X_smiles_reduced\n",
    "# idx_train/test 用于记录原始行号，以便最后填回 outlier_flags_smile\n",
    "X_train, X_test, idx_train, idx_test = train_test_split(\n",
    "    X_smiles_reduced, df_smiles_current.index, test_size=0.2, random_state=42\n",
    ")\n",
    "\n",
    "print(f\"   [数据切分] 训练集: {len(X_train)}, 测试集: {len(X_test)}\")\n",
    "\n",
    "\n",
    "# Phase 1: 模型建立\n",
    "\n",
    "kmeans_dyn = KMeans(n_clusters=n_clusters_dynamic, random_state=42, n_init=10)\n",
    "kmeans_dyn.fit(X_train)\n",
    "labels_train = kmeans_dyn.labels_\n",
    "centroids = kmeans_dyn.cluster_centers_\n",
    "\n",
    "# --- 确定离群簇 (CBOD逻辑) ---\n",
    "train_sizes = np.bincount(labels_train, minlength=n_clusters_dynamic)\n",
    "train_weights = train_sizes / len(X_train)\n",
    "centroid_dist = euclidean_distances(centroids, centroids)\n",
    "of4_scores = np.dot(centroid_dist, train_weights)\n",
    "\n",
    "# 排序并筛选离群簇\n",
    "cluster_info = [{'id': i, 'size': s, 'of4': o} for i, s, o in zip(range(n_clusters_dynamic), train_sizes, of4_scores)]\n",
    "sorted_clusters = sorted(cluster_info, key=lambda x: x['of4'], reverse=True)\n",
    "\n",
    "outlier_cluster_ids = []\n",
    "curr_sum = 0\n",
    "for c in sorted_clusters:\n",
    "    # 逻辑：至少选一个，且累积比例 < epsilon 时继续选\n",
    "    if len(outlier_cluster_ids) == 0 or (curr_sum / len(X_train)) < epsilon:\n",
    "        outlier_cluster_ids.append(c['id'])\n",
    "        curr_sum += c['size']\n",
    "    else:\n",
    "        break\n",
    "        \n",
    "print(f\"   [模型定义] 结构离群簇 ID: {outlier_cluster_ids}\")\n",
    "\n",
    "# --- 确定簇半径 (Radius) ---\n",
    "cluster_radii = np.zeros(n_clusters_dynamic)\n",
    "train_dists = kmeans_dyn.transform(X_train)\n",
    "for i in range(n_clusters_dynamic):\n",
    "    dists = train_dists[labels_train == i, i]\n",
    "    if len(dists) > 0:\n",
    "        cluster_radii[i] = np.max(dists) # 定义半径为簇内最大距离\n",
    "\n",
    "\n",
    "# Phase 2: 模型评估 (INN)\n",
    "\n",
    "# --- A. 处理训练集结果 ---\n",
    "is_outlier_train = np.isin(labels_train, outlier_cluster_ids)\n",
    "\n",
    "# --- B. 处理测试集结果 ---\n",
    "test_dists = kmeans_dyn.transform(X_test)\n",
    "is_outlier_test = []\n",
    "\n",
    "for i in range(len(X_test)):\n",
    "    # 找到最近簇\n",
    "    nearest_id = np.argmin(test_dists[i])\n",
    "    dist = test_dists[i][nearest_id]\n",
    "    \n",
    "    # INN 判定逻辑\n",
    "    if dist <= cluster_radii[nearest_id]:\n",
    "        # 半径内：继承簇的性质\n",
    "        if nearest_id in outlier_cluster_ids:\n",
    "            is_outlier_test.append(True) # 已知离群结构\n",
    "        else:\n",
    "            is_outlier_test.append(False) # 正常结构\n",
    "    else:\n",
    "        # 半径外：候选离群结构 (新颖骨架)\n",
    "        is_outlier_test.append(True)\n",
    "\n",
    "is_outlier_test = np.array(is_outlier_test)\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 保存到 outlier_flags_smile\n",
    "# ---------------------------------------------------------\n",
    "s_train = pd.Series(is_outlier_train, index=idx_train)\n",
    "s_test = pd.Series(is_outlier_test, index=idx_test)\n",
    "s_final = pd.concat([s_train, s_test]).sort_index()\n",
    "\n",
    "outlier_flags_smile['Dynamic'] = s_final\n",
    "\n",
    "print(f\"   [结果] 动态检测离群结构数: {outlier_flags_smile['Dynamic'].sum()}\")\n",
    "\n",
    "# 绘图验证\n",
    "plt.figure(figsize=(10, 6))\n",
    "# 正常骨架\n",
    "plt.scatter(X_smiles_pca[~outlier_flags_smile['Dynamic'], 0], X_smiles_pca[~outlier_flags_smile['Dynamic'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常骨架')\n",
    "# 离群骨架\n",
    "plt.scatter(X_smiles_pca[outlier_flags_smile['Dynamic'], 0], X_smiles_pca[outlier_flags_smile['Dynamic'], 1], \n",
    "            c='brown', s=40, edgecolor='k', label='动态检测离群骨架')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 动态检测法 (Train+Test Combined)\\nTotal Outliers: {outlier_flags_smile[\"Dynamic\"].sum()}')\n",
    "plt.xlabel('SMILES PCA 1')\n",
    "plt.ylabel('SMILES PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_5_Dynamic_Combined.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "21918581-cb66-43b1-a842-838171e20967",
   "metadata": {},
   "source": [
    "### 模型更新与回溯检查"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "id": "09a6bcac-707d-4679-a70f-de3a32f1be4a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "--- Phase 3: 结构空间模型更新 (Model Update) ---\n",
      "   [更新后] 离群簇 ID: [7]\n",
      "   [回溯分析] 判定反转样本数: 0\n",
      "图片已保存: output\\HT-29_FEATURE_6_Dynamic_Updated.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Phase 3: 模型更新与回溯\n",
    "print(f\"\\n--- Phase 3: 结构空间模型更新 (Model Update) ---\")\n",
    "\n",
    "# 1. 合并数据\n",
    "X_total = np.vstack([X_train, X_test])\n",
    "idx_total = np.concatenate([idx_train, idx_test])\n",
    "\n",
    "# 2. 模型更新 (在全量指纹数据上重新聚类)\n",
    "kmeans_updated = KMeans(n_clusters=n_clusters_dynamic, random_state=42, n_init=10)\n",
    "kmeans_updated.fit(X_total)\n",
    "\n",
    "labels_updated = kmeans_updated.labels_\n",
    "centroids_updated = kmeans_updated.cluster_centers_\n",
    "\n",
    "# 3. 重新计算 OF4\n",
    "sizes_updated = np.bincount(labels_updated, minlength=n_clusters_dynamic)\n",
    "weights_updated = sizes_updated / len(X_total)\n",
    "dist_matrix_updated = euclidean_distances(centroids_updated, centroids_updated)\n",
    "of4_updated = np.dot(dist_matrix_updated, weights_updated)\n",
    "\n",
    "# 4. 重新定义离群簇\n",
    "cluster_info_updated = []\n",
    "for i in range(n_clusters_dynamic):\n",
    "    cluster_info_updated.append({'id': i, 'size': sizes_updated[i], 'of4': of4_updated[i]})\n",
    "\n",
    "sorted_clusters_updated = sorted(cluster_info_updated, key=lambda x: x['of4'], reverse=True)\n",
    "\n",
    "outlier_cluster_ids_updated = []\n",
    "curr_sum = 0\n",
    "for c in sorted_clusters_updated:\n",
    "    if len(outlier_cluster_ids_updated) == 0 or (curr_sum / len(X_total)) < epsilon:\n",
    "        outlier_cluster_ids_updated.append(c['id'])\n",
    "        curr_sum += c['size']\n",
    "    else:\n",
    "        break\n",
    "        \n",
    "print(f\"   [更新后] 离群簇 ID: {outlier_cluster_ids_updated}\")\n",
    "\n",
    "# 5. 回溯标记\n",
    "is_outlier_updated = np.isin(labels_updated, outlier_cluster_ids_updated)\n",
    "\n",
    "# 6. 保存到 outlier_flags_smile\n",
    "s_updated = pd.Series(is_outlier_updated, index=idx_total).sort_index()\n",
    "outlier_flags_smile['Dynamic_Updated'] = s_updated\n",
    "\n",
    "# 对比变化\n",
    "diff_count = (outlier_flags_smile['Dynamic'] != outlier_flags_smile['Dynamic_Updated']).sum()\n",
    "print(f\"   [回溯分析] 判定反转样本数: {diff_count}\")\n",
    "\n",
    "# 绘图：更新后的全量视图\n",
    "plt.figure(figsize=(10, 6))\n",
    "\n",
    "# 画正常骨架\n",
    "plt.scatter(X_smiles_pca[~outlier_flags_smile['Dynamic_Updated'], 0], X_smiles_pca[~outlier_flags_smile['Dynamic_Updated'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='更新后: 正常')\n",
    "\n",
    "# 画离群骨架\n",
    "plt.scatter(X_smiles_pca[outlier_flags_smile['Dynamic_Updated'], 0], X_smiles_pca[outlier_flags_smile['Dynamic_Updated'], 1], \n",
    "            c='darkred', s=40, edgecolor='k', label='更新后: 离群')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 动态检测法 (Backtracking)\\nTotal Outliers: {outlier_flags_smile[\"Dynamic_Updated\"].sum()} (Changed: {diff_count})')\n",
    "plt.xlabel('SMILES PCA 1')\n",
    "plt.ylabel('SMILES PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_6_Dynamic_Updated.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "154f43ef-8ee4-43f0-b58c-cf1e7ae9ece7",
   "metadata": {},
   "source": [
    "## SMILE结果分析"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "id": "49b7c0b3-3b95-4f00-af2d-8e5356c38d2a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "==================== 最终汇总：SMILES 结构空间离群点分析报告 ====================\n",
      "参与结构投票的方法: ['Stat', 'Dist', 'Density', 'TOD', 'CBOD', 'Dynamic', 'Dynamic_Updated']\n",
      "----------------------------------------\n",
      "总样本数: 5279\n",
      "被至少 1 种方法标记为结构异常: 675\n",
      "被至少 3 种方法标记的【强结构离群点】: 62\n",
      "----------------------------------------\n",
      "\n",
      ">>> 正在导出 TOP 结构离群点详细信息...\n",
      "          Drug_A       Drug_B  Synergy_Score  Votes  \\\n",
      "4621  Everolimus    Rapamycin          -57.0      6   \n",
      "2706   Rapamycin  Mithramycin           -7.0      5   \n",
      "4651  Everolimus  Cabazitaxel           12.0      5   \n",
      "2714   Rapamycin  Vincristine          -27.0      5   \n",
      "4626  Everolimus  Vinorelbine           30.0      5   \n",
      "\n",
      "                                                Methods  \n",
      "4621  Dist, Density, TOD, CBOD, Dynamic, Dynamic_Upd...  \n",
      "2706          Stat, Dist, TOD, Dynamic, Dynamic_Updated  \n",
      "4651       Dist, Density, TOD, Dynamic, Dynamic_Updated  \n",
      "2714       Density, TOD, CBOD, Dynamic, Dynamic_Updated  \n",
      "4626       Density, TOD, CBOD, Dynamic, Dynamic_Updated  \n",
      "\n",
      "[完成] 结构离群名单已保存至: output\\HT-29_FEATURE_Top_Outliers.csv\n",
      "请检查这些药物是否具有独特的大环、长链或稀有杂环结构。\n",
      "汇总图表已保存: output\\HT-29_FEATURE_7_Final_Summary.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "print(f\"\\n{'='*20} 最终汇总：SMILES 结构空间离群点分析报告 {'='*20}\")\n",
    "\n",
    "# 1. 准备变量\n",
    "# 确保使用正确的 SMILES DataFrame\n",
    "if 'df_smiles_current' in locals():\n",
    "    target_df = locals().get('df_smiles_current')\n",
    "elif 'df_smiles' in locals():\n",
    "    target_df = locals().get('df_smiles')\n",
    "else:\n",
    "    print(\"警告: 找不到原始 SMILES 数据表，导出信息可能不完整。\")\n",
    "    target_df = pd.DataFrame(index=outlier_flags_smile.index)\n",
    "\n",
    "# 2. 计算\"得票数\" (Votes) - 使用 outlier_flags_smile\n",
    "# 统计一个样本在结构上被多少种算法判定为异常\n",
    "all_struct_methods = ['Stat', 'Dist', 'Density', 'TOD', 'CBOD', 'Dynamic', 'Dynamic_Updated']\n",
    "# 只计算实际存在的列\n",
    "existing_methods = [col for col in all_struct_methods if col in outlier_flags_smile.columns]\n",
    "\n",
    "print(f\"参与结构投票的方法: {existing_methods}\")\n",
    "outlier_flags_smile['Votes'] = outlier_flags_smile[existing_methods].sum(axis=1)\n",
    "\n",
    "# 3. 筛选高置信度离群点 (至少 3 种方法认为是结构异常)\n",
    "high_conf_indices = outlier_flags_smile[outlier_flags_smile['Votes'] >= 3].index\n",
    "\n",
    "print(f\"----------------------------------------\")\n",
    "print(f\"总样本数: {len(outlier_flags_smile)}\")\n",
    "print(f\"被至少 1 种方法标记为结构异常: {(outlier_flags_smile['Votes'] > 0).sum()}\")\n",
    "print(f\"被至少 3 种方法标记的【强结构离群点】: {len(high_conf_indices)}\")\n",
    "print(f\"----------------------------------------\")\n",
    "\n",
    "if len(high_conf_indices) > 0:\n",
    "    print(f\"\\n>>> 正在导出 TOP 结构离群点详细信息...\")\n",
    "    \n",
    "    # 提取信息: 药名 + SMILES (可选) + 得票数\n",
    "    top_struct_outliers = target_df.loc[high_conf_indices, ['Drug_A', 'Drug_B']].copy()\n",
    "    \n",
    "    # 添加投票详情\n",
    "    top_struct_outliers['Synergy_Score'] = df_smiles_current.loc[high_conf_indices].iloc[:, 4]\n",
    "    top_struct_outliers['Votes'] = outlier_flags_smile.loc[high_conf_indices, 'Votes']\n",
    "    top_struct_outliers['Methods'] = outlier_flags_smile.loc[high_conf_indices, existing_methods].apply(\n",
    "        lambda x: ', '.join(x.index[x]), axis=1\n",
    "    )\n",
    "\n",
    "    # 按得票数降序排列\n",
    "    top_struct_outliers = top_struct_outliers.sort_values('Votes', ascending=False)\n",
    "\n",
    "    # 显示前 5 行\n",
    "    print(top_struct_outliers.head())\n",
    "    \n",
    "    # 保存到 CSV\n",
    "    csv_filename = f\"{current_dataset_name}_Top_Outliers.csv\"\n",
    "    csv_path = os.path.join(OUTPUT_DIR, csv_filename)\n",
    "    top_struct_outliers.to_csv(csv_path)\n",
    "    print(f\"\\n[完成] 结构离群名单已保存至: {csv_path}\")\n",
    "    print(\"请检查这些药物是否具有独特的大环、长链或稀有杂环结构。\")\n",
    "\n",
    "else:\n",
    "    print(\"\\n没有发现 Votes >= 3 的强结构离群点。\")\n",
    "    \n",
    "# 4. 最终可视化 (SMILES Space Venn Visualization)\n",
    "# 注意：这里必须使用 X_smiles_pca (结构空间的 PCA 投影)\n",
    "plt.figure(figsize=(10, 6))\n",
    "\n",
    "# 画正常骨架\n",
    "mask_normal = outlier_flags_smile['Votes'] == 0\n",
    "plt.scatter(X_smiles_pca[mask_normal, 0], X_smiles_pca[mask_normal, 1], \n",
    "            c='lightgray', s=10, alpha=0.5, label='正常骨架')\n",
    "\n",
    "# 画异常骨架 (颜色越深，得票越多)\n",
    "mask_abnormal = outlier_flags_smile['Votes'] > 0\n",
    "if mask_abnormal.sum() > 0:\n",
    "    sc = plt.scatter(X_smiles_pca[mask_abnormal, 0], X_smiles_pca[mask_abnormal, 1], \n",
    "                     c=outlier_flags_smile.loc[mask_abnormal, 'Votes'], \n",
    "                     cmap='Reds', s=30, edgecolor='k', label='结构离群点')\n",
    "    plt.colorbar(sc, label='Votes (Structure Methods)')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 综合离群点分析\\nTotal Outliers (Vote>=1): {mask_abnormal.sum()}')\n",
    "plt.xlabel('SMILES PCA 1')\n",
    "plt.ylabel('SMILES PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_7_Final_Summary.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"汇总图表已保存: {save_path}\")\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "68ce941e-bf95-4c99-8b85-a18701e9ddc2",
   "metadata": {},
   "source": [
    "# Feature性质空间的SMILE结构空间的离群点对比"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "id": "9a9e64b2-2854-4cd9-b5a8-16696d583920",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "分析阈值: Votes >= 3\n",
      "1. Feature 空间离群总数: 177\n",
      "2. SMILES 空间离群总数:  62\n",
      "------------------------------\n",
      "【重叠】双重离群、: 17\n",
      "【差异】仅特征离群: 160\n",
      "【差异】仅结构离群: 45\n",
      "集合相似度 (Jaccard Index): 0.0766\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 800x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# 阈值：至少被 3 种算法判定为异常\n",
    "THRESHOLD_VOTE = 3\n",
    "\n",
    "# 特征空间 (Feature Space) 的离群点索引\n",
    "# 确保 Votes 列存在\n",
    "if 'Votes' not in outlier_flags.columns:\n",
    "    cols = [c for c in ['Stat', 'Dist', 'Density', 'TOD', 'CBOD', 'Dynamic', 'Dynamic_Updated'] if c in outlier_flags.columns]\n",
    "    outlier_flags['Votes'] = outlier_flags[cols].sum(axis=1)\n",
    "idx_feat = set(outlier_flags[outlier_flags['Votes'] >= THRESHOLD_VOTE].index)\n",
    "\n",
    "# 结构空间 (SMILES Space) 的离群点索引\n",
    "if 'Votes' not in outlier_flags_smile.columns:\n",
    "    cols = [c for c in ['Stat', 'Dist', 'Density', 'TOD', 'CBOD', 'Dynamic', 'Dynamic_Updated'] if c in outlier_flags_smile.columns]\n",
    "    outlier_flags_smile['Votes'] = outlier_flags_smile[cols].sum(axis=1)\n",
    "idx_smile = set(outlier_flags_smile[outlier_flags_smile['Votes'] >= THRESHOLD_VOTE].index)\n",
    "\n",
    "# A. 交集\n",
    "intersection = idx_feat.intersection(idx_smile)\n",
    "\n",
    "# B. 仅特征离群\n",
    "only_feat = idx_feat - idx_smile\n",
    "\n",
    "# C. 仅结构离群\n",
    "only_smile = idx_smile - idx_feat\n",
    "\n",
    "print(f\"分析阈值: Votes >= {THRESHOLD_VOTE}\")\n",
    "print(f\"1. Feature 空间离群总数: {len(idx_feat)}\")\n",
    "print(f\"2. SMILES 空间离群总数:  {len(idx_smile)}\")\n",
    "print(f\"-\" * 30)\n",
    "print(f\"【重叠】双重离群、: {len(intersection)}\")\n",
    "print(f\"【差异】仅特征离群: {len(only_feat)}\")\n",
    "print(f\"【差异】仅结构离群: {len(only_smile)}\")\n",
    "\n",
    "# 计算 Jaccard 相似系数 (0~1, 1代表两个列表完全一样)\n",
    "jaccard_sim = len(intersection) / len(idx_feat.union(idx_smile)) if len(idx_feat.union(idx_smile)) > 0 else 0\n",
    "print(f\"集合相似度 (Jaccard Index): {jaccard_sim:.4f}\")\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 可视化：韦恩图\n",
    "# ---------------------------------------------------------\n",
    "plt.figure(figsize=(8, 8))\n",
    "try:\n",
    "    venn2([idx_feat, idx_smile], ('Feature Space', 'SMILE Space'))\n",
    "    plt.title(\"不同特征空间的离群点差异分析\")\n",
    "    plt.show()\n",
    "except:\n",
    "    print(\"未安装 matplotlib-venn，跳过韦恩图。\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "id": "d6a66872-8a8a-4f36-a255-5bf4bb2a5987",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "三色分类交互图已生成: output\\Interactive_3D_ColorClass.html\n"
     ]
    },
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "config": {
        "plotlyServerURL": "https://plot.ly"
       },
       "data": [
        {
         "customdata": [
          [
           0,
           0,
           "Methotrexate",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Methotrexate",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Methotrexate",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Busulfan",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Busulfan",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "6-Thioguanine",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "6-Mercaptopurine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "6-Mercaptopurine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "6-Mercaptopurine",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "6-Mercaptopurine",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Nitrogen mustard",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nitrogen mustard",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nitrogen mustard",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nitrogen mustard",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nitrogen mustard",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Nitrogen mustard",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Allopurinol",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Allopurinol",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Allopurinol",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Allopurinol",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Allopurinol",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Allopurinol",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Melphalan",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Triethylenemelamine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Triethylenemelamine",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Triethylenemelamine",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Altretamine",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Acrichine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Acrichine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Acrichine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Acrichine",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Acrichine",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Acrichine",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Aminolevulinic acid",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Aminolevulinic acid",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Fluorouracil",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Mithramycin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pipobroman",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pipobroman",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pipobroman",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Pipobroman",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Cyclophosphamide",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cyclophosphamide",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cyclophosphamide",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cyclophosphamide",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cyclophosphamide",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Mitomycin",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Mitomycin",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Floxuridine",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Hydroxyurea",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Uracil Mustard",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitotane",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitotane",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitotane",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Dacarbazine",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Methoxsalen",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Methoxsalen",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Methoxsalen",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Methoxsalen",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Methoxsalen",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Methoxsalen",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Methoxsalen",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Vinblastine",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Vinblastine",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Vinblastine",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Vinblastine",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Cytarabine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cytarabine",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Thalidomide",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Thalidomide",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Thalidomide",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Procarbazine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Procarbazine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Procarbazine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Procarbazine",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Procarbazine",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Procarbazine",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Procarbazine",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Lomustine",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Streptozocin",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Streptozocin",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Streptozocin",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Streptozocin",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Streptozocin",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Arsenic trioxide",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Arsenic trioxide",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Cisplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           1,
           "Arsenic trioxide",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Topotecan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Arsenic trioxide",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Estramustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cladribine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Ifosfamide",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ifosfamide",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ifosfamide",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Ifosfamide",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Cisplatin",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cisplatin",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cisplatin",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cisplatin",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cisplatin",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Amifostine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Carmustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Topotecan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Bortezomib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cisplatin",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cisplatin",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           1,
           "Teniposide",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Teniposide",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Doxorubicin",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Paclitaxel",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Decitabine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Decitabine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Decitabine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Decitabine",
           "Pentostatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Decitabine",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Decitabine",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Bendamustine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bendamustine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bendamustine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Etoposide",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pentostatin",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Pentostatin",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pentostatin",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Amifostine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pentostatin",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Pentostatin",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Carboplatin",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Valrubicin",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Valrubicin",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Idarubicin",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Amifostine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Topotecan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Estramustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Eribulin mesilate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Idarubicin",
           "Erlotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Epirubicin",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Epirubicin",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Amifostine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Topotecan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Bortezomib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Estramustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Eribulin mesilate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Oxaliplatin",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Oxaliplatin",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Oxaliplatin",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Oxaliplatin",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Oxaliplatin",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Oxaliplatin",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Oxaliplatin",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Amifostine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Amifostine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Amifostine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Amifostine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Decitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Amifostine",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Imiquimod",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imiquimod",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imiquimod",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imiquimod",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Imiquimod",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imiquimod",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Imiquimod",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Carmustine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Carmustine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Carmustine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Carmustine",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Decitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Carmustine",
           "Pentostatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Carmustine",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Topotecan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Carmustine",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Clofarabine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Clofarabine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Clofarabine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Clofarabine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Clofarabine",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Topotecan",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Topotecan",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Topotecan",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Topotecan",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Topotecan",
           "Pentostatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Amifostine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Topotecan",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Topotecan",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gemcitabine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Gemcitabine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Gemcitabine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Gemcitabine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Docetaxel",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "7-Ethyl-10-hydroxycamptothecin",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "7-Ethyl-10-hydroxycamptothecin",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Bortezomib",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bortezomib",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bortezomib",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Bortezomib",
           "Pentostatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Carmustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Topotecan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bortezomib",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Bortezomib",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Nelarabine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nelarabine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nelarabine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nelarabine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Vorinostat",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Vorinostat",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Estramustine",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Estramustine",
           "Pentostatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Estramustine",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Amifostine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Topotecan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Estramustine",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Capecitabine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Capecitabine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Capecitabine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Capecitabine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Decitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Erlotinib",
           "Pentostatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Erlotinib",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Amifostine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Carmustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Estramustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Erlotinib",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           1,
           "Fulvestrant",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Fulvestrant",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Fulvestrant",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Anastrozole",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Anastrozole",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Anastrozole",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Anastrozole",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Anastrozole",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Zoledronate",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Zoledronate",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Zoledronate",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Zoledronate",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Dasatinib",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           2,
           "Everolimus",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pazopanib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pazopanib",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pazopanib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Lapatinib",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Lapatinib",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Lapatinib",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Nilotinib",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nilotinib",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Sorafenib",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sorafenib",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sorafenib",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Amifostine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Topotecan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Ixabepilone",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Raloxifene",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Raloxifene",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sunitinib",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Depsipeptide",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Depsipeptide",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Depsipeptide",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Depsipeptide",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Pralatrexate",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Pralatrexate",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Pralatrexate",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pralatrexate",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vandetanib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Antagonistic, IV. Normal",
         "marker": {
          "color": "red",
          "opacity": 0.6,
          "size": 5,
          "symbol": "circle"
         },
         "mode": "markers",
         "name": "Antagonistic, IV. Normal",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "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",
          "dtype": "f8"
         },
         "y": {
          "bdata": "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",
          "dtype": "f8"
         },
         "z": {
          "bdata": "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",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           4,
           2,
           "Methotrexate",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Busulfan",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Nitrogen mustard",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Allopurinol",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Altretamine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Lomustine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Pemetrexed",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Raloxifene",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Abiraterone",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Actinomycin D",
           "Crizotinib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Axitinib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Actinomycin D",
           "Vandetanib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Ruxolitinib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Mithramycin",
           "Carboplatin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Mithramycin",
           "Lapatinib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Pipobroman",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Cyclophosphamide",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Mitotane",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Methoxsalen",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Vinblastine",
           "Carboplatin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Vincristine",
           "Actinomycin D",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Procarbazine",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Streptozocin",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Arsenic trioxide",
           "Actinomycin D",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Arsenic trioxide",
           "Mithramycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Arsenic trioxide",
           "Procarbazine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Arsenic trioxide",
           "Pentostatin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Cisplatin",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Cisplatin",
           "Ixabepilone",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Bleomycin",
           "Thiotepa",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Bleomycin",
           "Triethylenemelamine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Bleomycin",
           "Altretamine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Floxuridine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Bleomycin",
           "Hydroxyurea",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Cytarabine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Azacitidine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Cladribine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Isotretinoin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Bleomycin",
           "Doxorubicin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Tamoxifen",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Temozolomide",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Clofarabine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Gemcitabine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Nelarabine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Capecitabine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Letrozole",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Celecoxib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Zoledronate",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Pazopanib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           5,
           2,
           "Bleomycin",
           "Lapatinib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Raloxifene",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Abiraterone",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Crizotinib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Axitinib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Ruxolitinib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Bendamustine",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Pentostatin",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           2,
           "Rapamycin",
           "Carboplatin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Idarubicin",
           "Arsenic trioxide",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Idarubicin",
           "Ixabepilone",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Epirubicin",
           "Arsenic trioxide",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Epirubicin",
           "Pentostatin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Amifostine",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Docetaxel",
           "Carboplatin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Estramustine",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Estramustine",
           "Ixabepilone",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Gefitinib",
           "Doxorubicin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Erlotinib",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Erlotinib",
           "Ixabepilone",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           5,
           2,
           "Fulvestrant",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Anastrozole",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Dasatinib",
           "Actinomycin D",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           2,
           "Everolimus",
           "Carboplatin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Vandetanib",
           "Raloxifene",
           "Antagonistic",
           "II. Feature Only"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Antagonistic, II. Feature Only",
         "marker": {
          "color": "red",
          "opacity": 0.6,
          "size": 5,
          "symbol": "diamond"
         },
         "mode": "markers",
         "name": "Antagonistic, II. Feature Only",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "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",
          "dtype": "f8"
         },
         "y": {
          "bdata": "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",
          "dtype": "f8"
         },
         "z": {
          "bdata": "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",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           4,
           3,
           "Actinomycin D",
           "Cabazitaxel",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           3,
           4,
           "Mithramycin",
           "Vincristine",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           3,
           4,
           "Mithramycin",
           "Everolimus",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           5,
           3,
           "Bleomycin",
           "Vincristine",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           5,
           3,
           "Bleomycin",
           "Rapamycin",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           6,
           3,
           "Bleomycin",
           "Everolimus",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           4,
           4,
           "Rapamycin",
           "Actinomycin D",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           5,
           3,
           "Valrubicin",
           "Bleomycin",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           4,
           3,
           "Epirubicin",
           "Bleomycin",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           4,
           3,
           "Ixabepilone",
           "Bleomycin",
           "Antagonistic",
           "I. Dual Outliers"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Antagonistic, I. Dual Outliers",
         "marker": {
          "color": "red",
          "opacity": 0.6,
          "size": 5,
          "symbol": "square"
         },
         "mode": "markers",
         "name": "Antagonistic, I. Dual Outliers",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "iG0tQXpdDkC1mSpaY8IJQN+PAUJR4QhAhBK6RV8XE0DcAnYkzRITQLSSSpypjBdAzGrIUOcKEEBSdzVhMgYTQPUAUAc5PQ9AljIo5MsyDkA=",
          "dtype": "f8"
         },
         "y": {
          "bdata": "53lgICKWBkA7fr3sCz8QQJ1XK3oU9g9ANb8svxt0BkBYXXdnvFIIQGO8Z+X89QlAoYCzuxlrEECAYbQcCFUGQKJOBBv4CQhAMLW2dS1JB0A=",
          "dtype": "f8"
         },
         "z": {
          "bdata": "AAAAAACARMAAAAAAAAA+wAAAAAAAADXAAAAAAAAALMAAAAAAAAA0wAAAAAAAADrAAAAAAAAAO8AAAAAAAAA5wAAAAAAAAEXAAAAAAAAANsA=",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           2,
           3,
           "Vinblastine",
           "Mithramycin",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Vinblastine",
           "Everolimus",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           5,
           "Teniposide",
           "Vinorelbine",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Teniposide",
           "Cabazitaxel",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           2,
           4,
           "Paclitaxel",
           "Rapamycin",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           5,
           "Rapamycin",
           "Vincristine",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Rapamycin",
           "Nilotinib",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           2,
           3,
           "Valrubicin",
           "Mithramycin",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Docetaxel",
           "Vincristine",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Docetaxel",
           "Cabazitaxel",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Everolimus",
           "Etoposide",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           2,
           6,
           "Everolimus",
           "Rapamycin",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Everolimus",
           "Imatinib",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Everolimus",
           "Nilotinib",
           "Antagonistic",
           "III. Structure Only"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Antagonistic, III. Structure Only",
         "marker": {
          "color": "red",
          "opacity": 0.6,
          "size": 5,
          "symbol": "x"
         },
         "mode": "markers",
         "name": "Antagonistic, III. Structure Only",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "khJVFODT/T9a3ENl+9/qP2YqRV8cgew/gEuZRg/y8T8i/xXYqn4BQAbdImGLBeg/W8rKl7pA6j8ytt0NnisBQLwxWxMgKug/AFe2i0Fw7j+RN9rr5tbsP40Io6gADwFAzBhKOOWQ8z+eAZHttwHtPw==",
          "dtype": "f8"
         },
         "y": {
          "bdata": "NH/NEm8OCUCtIQwp4soQQE87IIYoJRNArMyXhMe4CUCHdPEjZU0PQKzUI9wyoRNAemlLopU0CUDfyHkRufEHQE61OpTMWQhAbh2vGkh1BkD0MBw+IrgIQAeEWinVCxdATv6mhVm8B0A8iEU6gBwPQA==",
          "dtype": "f8"
         },
         "z": {
          "bdata": "AAAAAAAANcAAAAAAAAA5wAAAAAAAACzAAAAAAAAAQcAAAAAAAEBjwAAAAAAAADvAAAAAAAAAO8AAAAAAAAA5wAAAAAAAADzAAAAAAAAAQcAAAAAAAAAswAAAAAAAgEzAAAAAAABgYcAAAAAAAMBRwA==",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           0,
           1,
           "Methotrexate",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Methotrexate",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Methotrexate",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Methotrexate",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Methotrexate",
           "Pralatrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Nitrogen mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Busulfan",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Busulfan",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Bendamustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Busulfan",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Vorinostat",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Zoledronate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Lapatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Nilotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Sunitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Raloxifene",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Methotrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "6-Mercaptopurine",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "6-Mercaptopurine",
           "Vinblastine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Vorinostat",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Zoledronate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Clofarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Bendamustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Allopurinol",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Capecitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Zoledronate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Chlorambucil",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Tamoxifen",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Clofarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Gemcitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Vorinostat",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Zoledronate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Nilotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Sunitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "6-Mercaptopurine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Acrichine",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Tamoxifen",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Capecitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Methotrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Aminolevulinic acid",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Valrubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Aminolevulinic acid",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Gemcitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Aminolevulinic acid",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Fludarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Raloxifene",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "6-Mercaptopurine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Acrichine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Aminolevulinic acid",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pipobroman",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Clofarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pipobroman",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Gemcitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Nilotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Sunitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Busulfan",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "6-Mercaptopurine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cyclophosphamide",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Pipobroman",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Methoxsalen",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Zoledronate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cyclophosphamide",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "6-Mercaptopurine",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mitomycin",
           "Actinomycin D",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitomycin",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mitomycin",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitomycin",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Clofarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Gemcitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mitomycin",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitomycin",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mitomycin",
           "Pralatrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Floxuridine",
           "Actinomycin D",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Hydroxyurea",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Hydroxyurea",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Paclitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Hydroxyurea",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Hydroxyurea",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Lapatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Sunitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Mitotane",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Allopurinol",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Aminolevulinic acid",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Mitomycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Fludarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Nitrogen mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Tamoxifen",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Thalidomide",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Vincristine",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Tamoxifen",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Valrubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Clofarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Docetaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Sorafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Methotrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Nitrogen mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Acrichine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Aminolevulinic acid",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Streptozocin",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Clofarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Vorinostat",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Allopurinol",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Paclitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Decitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Bendamustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Tamoxifen",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Arsenic trioxide",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Vorinostat",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           1,
           "Arsenic trioxide",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Arsenic trioxide",
           "Lapatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Fludarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Azacitidine",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Nilotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cladribine",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Thalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Ifosfamide",
           "Procarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ifosfamide",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Valrubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Nilotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Sorafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Fludarabine",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Thalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Estramustine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cisplatin",
           "Erlotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Isotretinoin",
           "Actinomycin D",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Melphalan",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Fludarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Teniposide",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Vorinostat",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Doxorubicin",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Nilotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Paclitaxel",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Allopurinol",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Melphalan",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Decitabine",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Decitabine",
           "Procarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Streptozocin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Ifosfamide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Gemcitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Zoledronate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Lapatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bendamustine",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Paclitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Valrubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bendamustine",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Docetaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bendamustine",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Etoposide",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Methotrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Pentostatin",
           "Actinomycin D",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pentostatin",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           2,
           "Rapamycin",
           "Methotrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           2,
           "Rapamycin",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           2,
           "Rapamycin",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Valrubicin",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Valrubicin",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Cisplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Idarubicin",
           "Pentostatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Imiquimod",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Bortezomib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Epirubicin",
           "Methoxsalen",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Cisplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Valrubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Vorinostat",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Epirubicin",
           "Erlotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Sunitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Nitrogen mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Melphalan",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Acrichine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Oxaliplatin",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Sorafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Paclitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Amifostine",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Amifostine",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Raloxifene",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Temozolomide",
           "Actinomycin D",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Temozolomide",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Temozolomide",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Melphalan",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imiquimod",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imiquimod",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Zoledronate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Lapatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Allopurinol",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Carmustine",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Lapatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Sorafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Acrichine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Topotecan",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Topotecan",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Topotecan",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Clofarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Topotecan",
           "Pralatrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Gemcitabine",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Docetaxel",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "7-Ethyl-10-hydroxycamptothecin",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Allopurinol",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bortezomib",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Sunitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Melphalan",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Vorinostat",
           "Actinomycin D",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Busulfan",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Pipobroman",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Thalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Bendamustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Oxaliplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Carmustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Nilotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Raloxifene",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Busulfan",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "6-Mercaptopurine",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Erlotinib",
           "Actinomycin D",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Erlotinib",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Erlotinib",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Erlotinib",
           "Procarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Paclitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Lapatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Sorafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Fulvestrant",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Bendamustine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Fulvestrant",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Vorinostat",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Nilotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Letrozole",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Zoledronate",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Gemcitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Dasatinib",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pazopanib",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pazopanib",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Lapatinib",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           1,
           "Nilotinib",
           "Actinomycin D",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nilotinib",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Fludarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Tamoxifen",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sorafenib",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sorafenib",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Sunitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Methotrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "6-Mercaptopurine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Allopurinol",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Thalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Decitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Bendamustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Imiquimod",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Capecitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Zoledronate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Raloxifene",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Gemcitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Lapatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Paclitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Depsipeptide",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Pralatrexate",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Crizotinib",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Raloxifene",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Additive, IV. Normal",
         "marker": {
          "color": "green",
          "opacity": 0.6,
          "size": 5,
          "symbol": "circle"
         },
         "mode": "markers",
         "name": "Additive, IV. Normal",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "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",
          "dtype": "f8"
         },
         "y": {
          "bdata": "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",
          "dtype": "f8"
         },
         "z": {
          "bdata": "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",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           3,
           0,
           "Actinomycin D",
           "6-Thioguanine",
           "Additive",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Melphalan",
           "Additive",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Fluorouracil",
           "Additive",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Uracil Mustard",
           "Additive",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Dacarbazine",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Actinomycin D",
           "Etoposide",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Actinomycin D",
           "Dexrazoxane",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Acrichine",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Aminolevulinic acid",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Mithramycin",
           "Actinomycin D",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Mitomycin",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Thalidomide",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           6,
           1,
           "Arsenic trioxide",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Arsenic trioxide",
           "Ixabepilone",
           "Additive",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Arsenic trioxide",
           "Pralatrexate",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "6-Thioguanine",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Chlorambucil",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Fludarabine",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Dexrazoxane",
           "Additive",
           "II. Feature Only"
          ],
          [
           6,
           0,
           "Bleomycin",
           "Carboplatin",
           "Additive",
           "II. Feature Only"
          ],
          [
           5,
           2,
           "Bleomycin",
           "Docetaxel",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Pemetrexed",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Vorinostat",
           "Additive",
           "II. Feature Only"
          ],
          [
           6,
           2,
           "Bleomycin",
           "Dasatinib",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Imatinib",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Bleomycin",
           "Nilotinib",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Sunitinib",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Vismodegib",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Bleomycin",
           "Cabazitaxel",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Decitabine",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Idarubicin",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Imiquimod",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Carmustine",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Gefitinib",
           "Triethylenemelamine",
           "Additive",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Ixabepilone",
           "Pentostatin",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Pralatrexate",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Additive, II. Feature Only",
         "marker": {
          "color": "green",
          "opacity": 0.6,
          "size": 5,
          "symbol": "diamond"
         },
         "mode": "markers",
         "name": "Additive, II. Feature Only",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "S5asd3XJCEAPBAUGiIIJQK7Ze7TDNglA8SPGq80gB0BMNDa2srUGQIoAIE/yfA9Aoifl/4WNEED2JtnFProOQOc/C20Lvw5Aj+LPusjZD0AWmca2Mi4QQMBVNx3hvBBAxCA+TQyzF0Ac03YmePYOQOqQKJiHQwlAqm2Ii1QGEEA8tGRWvYkPQJAgvNbNyA5A6lWGFNkHDkDvO9ImTzcXQNbH0dIO3RRAgF10JPA7EEB0C0QNknQOQLp7u4pSQxdAEGzdufOvD0C78KpjstAQQL/6bdrHpRBA3nJuSJoBDkAHMQUL9DwOQOACtWZMjQ9A4+eCMwQUEEARv6ZVdoQQQPgO/Fp1IBBACM4zFcPGB0APgSECWF4HQELd6rRR0RBA",
          "dtype": "f8"
         },
         "y": {
          "bdata": "bOtAFa83xL/Aa9EUwAXEP0BQ3FjtR64/GPuQkHkDwj9E85D6/AS6P4qRmVYClOw//IJOIC36sT+or3C0zeT9P+b2/k0MHeg/m7tCrz23/D+153P4Zob8P8XRAiLwyf0/WmmYPji/7z/otFxdrginv1QfalGO0bu//I6aShyj8j9Xm5JJvZDzP+qvu4WskPI/Uv7Sijgi6D+YRs83DXG7PxemtA4W9vw/wrRxQN6t7j+2GtM8btjxP6MO49rB8Pw/0G52GEAw6D+m+E2qoz/+P9oY6rF2O/M/MAuLMacB6z8Ku0uXZYH+PxLAQ2V4wP4/8n37tCJO/j/VJ2HaU9UBQPL28/KGBABAzDyHVMoosD/QRc/mgXbOP2HW/7XVqfw/",
          "dtype": "f8"
         },
         "z": {
          "bdata": "AAAAAAAACEAAAAAAAAAAAAAAAAAAAPA/AAAAAAAAAMAAAAAAAAAkwAAAAAAAAAhAAAAAAAAA8L8AAAAAAAAcQAAAAAAAABzAAAAAAAAA8D8AAAAAAAAIQAAAAAAAABjAAAAAAAAAAAAAAAAAAAAcQAAAAAAAABRAAAAAAAAAGMAAAAAAAAAQQAAAAAAAACTAAAAAAAAAJEAAAAAAAAAIwAAAAAAAACRAAAAAAAAAAAAAAAAAAAAIwAAAAAAAABBAAAAAAAAAAMAAAAAAAADwPwAAAAAAACJAAAAAAAAAIMAAAAAAAAAgQAAAAAAAACRAAAAAAAAAGMAAAAAAAAAUwAAAAAAAAABAAAAAAAAAGMAAAAAAAADwvwAAAAAAAPA/",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           3,
           4,
           "Mithramycin",
           "Vinorelbine",
           "Additive",
           "I. Dual Outliers"
          ],
          [
           6,
           3,
           "Vinblastine",
           "Bleomycin",
           "Additive",
           "I. Dual Outliers"
          ],
          [
           6,
           3,
           "Bleomycin",
           "Mithramycin",
           "Additive",
           "I. Dual Outliers"
          ],
          [
           4,
           4,
           "Everolimus",
           "Actinomycin D",
           "Additive",
           "I. Dual Outliers"
          ],
          [
           3,
           4,
           "Everolimus",
           "Dasatinib",
           "Additive",
           "I. Dual Outliers"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Additive, I. Dual Outliers",
         "marker": {
          "color": "green",
          "opacity": 0.6,
          "size": 5,
          "symbol": "square"
         },
         "mode": "markers",
         "name": "Additive, I. Dual Outliers",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "5Jfg2c6BCUBjIvHK+L0XQKA2EU41AxhATt+AnA2fD0AKx3hz3gEJQA==",
          "dtype": "f8"
         },
         "y": {
          "bdata": "umhK7FVsDkAoGgkrODsJQB1zxc8owQZA+6fj3i19D0A1/i7UHdkOQA==",
          "dtype": "f8"
         },
         "z": {
          "bdata": "AAAAAAAAGEAAAAAAAAAAwAAAAAAAAADAAAAAAAAAAMAAAAAAAAAkQA==",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           1,
           4,
           "Vinblastine",
           "Vincristine",
           "Additive",
           "III. Structure Only"
          ],
          [
           2,
           4,
           "Vinblastine",
           "Rapamycin",
           "Additive",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Vinblastine",
           "Vinorelbine",
           "Additive",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Paclitaxel",
           "Cabazitaxel",
           "Additive",
           "III. Structure Only"
          ],
          [
           2,
           5,
           "Rapamycin",
           "Mithramycin",
           "Additive",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Rapamycin",
           "Vinblastine",
           "Additive",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Rapamycin",
           "Daunorubicin",
           "Additive",
           "III. Structure Only"
          ],
          [
           1,
           5,
           "Rapamycin",
           "Vinorelbine",
           "Additive",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Docetaxel",
           "Vinblastine",
           "Additive",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Everolimus",
           "Teniposide",
           "Additive",
           "III. Structure Only"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Additive, III. Structure Only",
         "marker": {
          "color": "green",
          "opacity": 0.6,
          "size": 5,
          "symbol": "x"
         },
         "mode": "markers",
         "name": "Additive, III. Structure Only",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "fzjWhLkn6T9lhgfNSIL/P2JdT3Fev+4/UDa5+6jm7D92hi41L/b8P96hSK/Mke0/3RbhdCbL8z9/4VeduZTvP132rdJ/gew/WlN873l48j8=",
          "dtype": "f8"
         },
         "y": {
          "bdata": "Hhu2cS58D0BUUMYYuI0OQCUF59BQ0BBAGE0Yd2QDCUAyrRSLYpAUQAHndHfo6Q5A8zghNYzWBkAPEOvjxq0UQAcY2Ho7xQlAqgV8rKVmDkA=",
          "dtype": "f8"
         },
         "z": {
          "bdata": "AAAAAAAAGMAAAAAAAAAiwAAAAAAAABRAAAAAAAAAGEAAAAAAAAAcwAAAAAAAABRAAAAAAAAAHMAAAAAAAAAQwAAAAAAAAAhAAAAAAAAAIMA=",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           1,
           1,
           "Methotrexate",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Methotrexate",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Letrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "6-Mercaptopurine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Busulfan",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Busulfan",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Chlorambucil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "6-Thioguanine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "6-Mercaptopurine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nitrogen mustard",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nitrogen mustard",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Methotrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "6-Mercaptopurine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Mitotane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Allopurinol",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Lapatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Raloxifene",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Thiotepa",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Thiotepa",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Triethylenemelamine",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Allopurinol",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Aminolevulinic acid",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Acrichine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "6-Mercaptopurine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Aminolevulinic acid",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Aminolevulinic acid",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Anastrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Raloxifene",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Chlorambucil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Mithramycin",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           1,
           "Mithramycin",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           1,
           "Mithramycin",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Sunitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Pipobroman",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Chlorambucil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pipobroman",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Capecitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Anastrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Methotrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Chlorambucil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Hydroxyurea",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cyclophosphamide",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cyclophosphamide",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Busulfan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Mitotane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Thalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Mitomycin",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mitomycin",
           "Procarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Streptozocin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Cladribine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Anastrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Zoledronate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Nilotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Cladribine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "6-Thioguanine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mitotane",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitotane",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Capecitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitotane",
           "Everolimus",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Sunitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Methotrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Acrichine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Pipobroman",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Mitotane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Methoxsalen",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Bendamustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Methoxsalen",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Altretamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Hydroxyurea",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Vinblastine",
           "Nilotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Raloxifene",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Methotrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Busulfan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Mitotane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Thalidomide",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Thalidomide",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Anastrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Methotrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Altretamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Megestrol Acetate",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Methotrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Acrichine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Ruxolitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "6-Mercaptopurine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Streptozocin",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Streptozocin",
           "Everolimus",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Arsenic trioxide",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Arsenic trioxide",
           "Oxaliplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Amifostine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Arsenic trioxide",
           "Erlotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Arsenic trioxide",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Arsenic trioxide",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "6-Thioguanine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Azacitidine",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Azacitidine",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Azacitidine",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Cladribine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Temozolomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Clofarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Azacitidine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Anastrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Cladribine",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "6-Mercaptopurine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Acrichine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Cyclophosphamide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Mitomycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Methoxsalen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ifosfamide",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ifosfamide",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Streptozocin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ifosfamide",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Zoledronate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Fludarabine",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Fludarabine",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Decitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Cisplatin",
           "Pentostatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cisplatin",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Oxaliplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cisplatin",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Ruxolitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Isotretinoin",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Isotretinoin",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Teniposide",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Teniposide",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Doxorubicin",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Bendamustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Paclitaxel",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Paclitaxel",
           "Nilotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Methotrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Altretamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Hydroxyurea",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Cladribine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Decitabine",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Decitabine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Topotecan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Mitotane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Sunitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Etoposide",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Etoposide",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Dexrazoxane",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Tamoxifen",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Tamoxifen",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Tamoxifen",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "6-Thioguanine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "6-Mercaptopurine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pentostatin",
           "Mithramycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Pentostatin",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Bendamustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Mitotane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           2,
           "Rapamycin",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           2,
           "Rapamycin",
           "Anastrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Chlorambucil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Carboplatin",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Valrubicin",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Fludarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Nelarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Valrubicin",
           "Everolimus",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Sunitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Valrubicin",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Allopurinol",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Idarubicin",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Mithramycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Mitomycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Idarubicin",
           "Methoxsalen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Thalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Idarubicin",
           "Procarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Decitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Epirubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Carmustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Nelarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Anastrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Letrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Zoledronate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Everolimus",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Lapatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Raloxifene",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Idarubicin",
           "Pralatrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Allopurinol",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Epirubicin",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Chlorambucil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Mithramycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Mitomycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Thalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Epirubicin",
           "Procarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Cladribine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Ifosfamide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Decitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Idarubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Carmustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Zoledronate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Epirubicin",
           "Everolimus",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Lapatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Raloxifene",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Epirubicin",
           "Pralatrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Decitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Bendamustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Clofarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Oxaliplatin",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Topotecan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitoxantrone",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "6-Thioguanine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Acrichine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Cyclophosphamide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Mitomycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Mitotane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Methoxsalen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Thalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Amifostine",
           "Procarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Oxaliplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Carmustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Amifostine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Lapatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "6-Mercaptopurine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Nitrogen mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Carmustine",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Acrichine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Aminolevulinic acid",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Cyclophosphamide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Mitomycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Hydroxyurea",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Methoxsalen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Streptozocin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Bendamustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Clofarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Carmustine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Vinorelbine",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Ruxolitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Busulfan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Nitrogen mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Topotecan",
           "Mithramycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Hydroxyurea",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Bendamustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Chlorambucil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Altretamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Clofarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Capecitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           1,
           "Docetaxel",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Docetaxel",
           "Nilotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Raloxifene",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "7-Ethyl-10-hydroxycamptothecin",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Clofarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "6-Thioguanine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Acrichine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bortezomib",
           "Mithramycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Hydroxyurea",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Bendamustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Clofarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Bortezomib",
           "Erlotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Zoledronate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Lapatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Chlorambucil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nelarabine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Vorinostat",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Fludarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Vorinostat",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Estramustine",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Cyclophosphamide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Mitomycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Estramustine",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Estramustine",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Decitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Estramustine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Estramustine",
           "Everolimus",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Capecitabine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Methotrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Acrichine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Erlotinib",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Thalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Streptozocin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Erlotinib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Topotecan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Nelarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Erlotinib",
           "Everolimus",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Fulvestrant",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Fulvestrant",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Fulvestrant",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Fulvestrant",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Fulvestrant",
           "Everolimus",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Sunitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Fulvestrant",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Mitotane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Anastrozole",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Celecoxib",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Celecoxib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Fludarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Zoledronate",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Nelarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Lapatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Dasatinib",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Dasatinib",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Dasatinib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pazopanib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pazopanib",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pazopanib",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Imatinib",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imatinib",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imatinib",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Fludarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imatinib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Lapatinib",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Lapatinib",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Lapatinib",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Lapatinib",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Lapatinib",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Lapatinib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "6-Mercaptopurine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nilotinib",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nilotinib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nilotinib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sorafenib",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sorafenib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Ixabepilone",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Acrichine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Mithramycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Methoxsalen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Ifosfamide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Carmustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Nelarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Lapatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Nilotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Sunitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Ixabepilone",
           "Pralatrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Raloxifene",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Raloxifene",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Raloxifene",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Raloxifene",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Raloxifene",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Raloxifene",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Raloxifene",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Sunitinib",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sunitinib",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sunitinib",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sunitinib",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sunitinib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Vemurafenib",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Vemurafenib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Raloxifene",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Depsipeptide",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pralatrexate",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Temozolomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Clofarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Pralatrexate",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Letrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Zoledronate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Nilotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Crizotinib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vandetanib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Vandetanib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vandetanib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vandetanib",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vandetanib",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vandetanib",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cabazitaxel",
           "Raloxifene",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cabazitaxel",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cabazitaxel",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cabazitaxel",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cabazitaxel",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cabazitaxel",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cabazitaxel",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cabazitaxel",
           "Ruxolitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Synergistic, IV. Normal",
         "marker": {
          "color": "blue",
          "opacity": 0.6,
          "size": 5,
          "symbol": "circle"
         },
         "mode": "markers",
         "name": "Synergistic, IV. Normal",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "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",
          "dtype": "f8"
         },
         "y": {
          "bdata": "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",
          "dtype": "f8"
         },
         "z": {
          "bdata": "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",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           4,
           1,
           "6-Mercaptopurine",
           "Bleomycin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Chlorambucil",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Megestrol Acetate",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Actinomycin D",
           "Daunorubicin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Actinomycin D",
           "Teniposide",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Actinomycin D",
           "Mitoxantrone",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Exemestane",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Actinomycin D",
           "Gefitinib",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Letrozole",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Actinomycin D",
           "Pazopanib",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Lenalidomide",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Vemurafenib",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Vismodegib",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Mithramycin",
           "Etoposide",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           2,
           "Mithramycin",
           "Docetaxel",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Mithramycin",
           "Dasatinib",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Ifosfamide",
           "Bleomycin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           6,
           2,
           "Bleomycin",
           "Actinomycin D",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Melphalan",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Bleomycin",
           "Fluorouracil",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Uracil Mustard",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Dacarbazine",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Megestrol Acetate",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Lomustine",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Bleomycin",
           "Daunorubicin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Bleomycin",
           "Teniposide",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Bleomycin",
           "Paclitaxel",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Etoposide",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Mitoxantrone",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Exemestane",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Gefitinib",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Lenalidomide",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Vemurafenib",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Depsipeptide",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Vandetanib",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Paclitaxel",
           "Actinomycin D",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Epirubicin",
           "Ixabepilone",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Oxaliplatin",
           "Bleomycin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Oxaliplatin",
           "Pentostatin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Topotecan",
           "Bleomycin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Docetaxel",
           "Actinomycin D",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Bortezomib",
           "Bleomycin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Bortezomib",
           "Ixabepilone",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Gefitinib",
           "Cabazitaxel",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Fulvestrant",
           "Actinomycin D",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Lapatinib",
           "Actinomycin D",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Sorafenib",
           "Bleomycin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Raloxifene",
           "Cabazitaxel",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Vandetanib",
           "Cabazitaxel",
           "Synergistic",
           "II. Feature Only"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Synergistic, II. Feature Only",
         "marker": {
          "color": "blue",
          "opacity": 0.6,
          "size": 5,
          "symbol": "diamond"
         },
         "mode": "markers",
         "name": "Synergistic, II. Feature Only",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "2du+8mqiEEAW5PeXCYQIQEbFSCehAAlAoqbd+kb2CUAjWJA/haYPQK39bpr7XA9AJwXXNUq3B0BUtV5Y5AAJQIZ+HuOmBAlAbFmwTZlpBkDYZETUNpwJQOkYJhW7RwdATsyMCgSVCUBWftoRND8HQFosja1KXgdAB81iLZbjCEB7qoNO8YcQQOH8DvRcNRdArc+QVvBNEEA9935XuHwQQLdfADp/BA9ADRcFnolyD0Dbkh56Yo8OQDkdvDV1Gw9AbNScu2zxEEB8tbxrax8PQFVeIjV8CBBAVFTtT6MFDkC8PjtJ/loPQAuJaByLlg9AMMlkf8sDEEAW5kEYmr8QQOmF0K+VbRBA4Q79sP3oEEBPK+4ZdKQQQO0v6i/KBw9ASyhVPzx1DkDvJYwPzHkQQEWPakE69BBAuT9u/m+8B0CLTMETtLMOQBR0TEreDw9AwO1aviNeEEDaQAzUaDoIQGrqWCDOQgdAYoIbi/g7DkDJ5jvxG6kPQCOy2VMWGBBA3YIfJ1QzEED+27zvUIsHQA==",
          "dtype": "f8"
         },
         "y": {
          "bdata": "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",
          "dtype": "f8"
         },
         "z": {
          "bdata": "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",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           4,
           4,
           "Actinomycin D",
           "Vinorelbine",
           "Synergistic",
           "I. Dual Outliers"
          ],
          [
           5,
           3,
           "Bleomycin",
           "Vinorelbine",
           "Synergistic",
           "I. Dual Outliers"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Synergistic, I. Dual Outliers",
         "marker": {
          "color": "blue",
          "opacity": 0.6,
          "size": 5,
          "symbol": "square"
         },
         "mode": "markers",
         "name": "Synergistic, I. Dual Outliers",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "oPVjOYzcEEAfZVlifAYUQA==",
          "dtype": "f8"
         },
         "y": {
          "bdata": "3hwCL3vqEEBKLFwqzpMHQA==",
          "dtype": "f8"
         },
         "z": {
          "bdata": "AAAAAAAAO0AAAAAAAABHQA==",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           2,
           3,
           "Mithramycin",
           "Cabazitaxel",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Vinblastine",
           "Cabazitaxel",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Vincristine",
           "Vinorelbine",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Vincristine",
           "Cabazitaxel",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Paclitaxel",
           "Vinorelbine",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Rapamycin",
           "Teniposide",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Rapamycin",
           "Valrubicin",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           5,
           "Rapamycin",
           "Cabazitaxel",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Docetaxel",
           "Rapamycin",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Docetaxel",
           "Vinorelbine",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Everolimus",
           "Vincristine",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Everolimus",
           "Daunorubicin",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Everolimus",
           "Paclitaxel",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           5,
           "Everolimus",
           "Vinorelbine",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Everolimus",
           "Docetaxel",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Everolimus",
           "Depsipeptide",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           5,
           "Everolimus",
           "Cabazitaxel",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Lapatinib",
           "Vincristine",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Lapatinib",
           "Rapamycin",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           0,
           4,
           "Lapatinib",
           "Vinorelbine",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Lapatinib",
           "Everolimus",
           "Synergistic",
           "III. Structure Only"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Synergistic, III. Structure Only",
         "marker": {
          "color": "blue",
          "opacity": 0.6,
          "size": 5,
          "symbol": "x"
         },
         "mode": "markers",
         "name": "Synergistic, III. Structure Only",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "j84RokxYAED5SbeFUCHsP5pk9KMqL/M/MGBmNK268T9tw/28kEXwP2wsm4f9Q/I/EfDfH9qm6z/+pZ4fkijsPyp/ivkzrfI/x2tU3ir96D/WPaRbfKbzP4l2zv23/+g/pcGLMQAB8z8LiBt4TU7tPyk1O+RxKvE/IJelKfpr8T/4n/VIXr3xPxgqqRJeGvA/XwlI2UPA8j+UhpAL/ay8Py4igGV93Og/",
          "dtype": "f8"
         },
         "y": {
          "bdata": "H5oNXRDMCUDmqzE+CmMHQG7iv1VY7BBAP/oGeFI1BkBlPcgRIz8QQHtsE/XGcBBAjIx0BlmDEECKNJizz0gUQHqjQn/A0xBA7RxE8L9cB0B4i8vGlpsQQIzSTOggbxBAkbBkT35vEEC6qf0HcMgTQOu00CQ/AA5AnRrKAw5eBkB1VuTsfaUUQGL7c0BjRglAITx4VeEgBkAsRCbpQ3UQQKtjhIS/8QhA",
          "dtype": "f8"
         },
         "z": {
          "bdata": "AAAAAAAAOEAAAAAAAEBRQAAAAAAAAD1AAAAAAACAQEAAAAAAAIBGQAAAAAAAADJAAAAAAABAVUAAAAAAAIBTQAAAAAAAgFdAAAAAAAAAOkAAAAAAAIBJQAAAAAAAgEBAAAAAAACAVEAAAAAAAAA+QAAAAAAAwFFAAAAAAAAAQ0AAAAAAAAAoQAAAAAAAIGRAAAAAAAAAOUAAAAAAAEBTQAAAAAAAgEJA",
          "dtype": "f8"
         }
        },
        {
         "colorscale": [
          [
           0,
           "rgb(255,255,255)"
          ],
          [
           0.125,
           "rgb(240,240,240)"
          ],
          [
           0.25,
           "rgb(217,217,217)"
          ],
          [
           0.375,
           "rgb(189,189,189)"
          ],
          [
           0.5,
           "rgb(150,150,150)"
          ],
          [
           0.625,
           "rgb(115,115,115)"
          ],
          [
           0.75,
           "rgb(82,82,82)"
          ],
          [
           0.875,
           "rgb(37,37,37)"
          ],
          [
           1,
           "rgb(0,0,0)"
          ]
         ],
         "name": "Feature Threshold",
         "opacity": 0.1,
         "showscale": false,
         "type": "surface",
         "x": {
          "bdata": "AAAAAAAACEAAAAAAAAAIQAAAAAAAAAhAAAAAAAAACEA=",
          "dtype": "f8",
          "shape": "2, 2"
         },
         "y": {
          "bdata": "AAAAAAAA4L8AAAAAAAAeQAAAAAAAAOC/AAAAAAAAHkA=",
          "dtype": "f8",
          "shape": "2, 2"
         },
         "z": {
          "bdata": "AAAAAAAgfsAAAAAAACB+wAAAAAAA0IJAAAAAAADQgkA=",
          "dtype": "f8",
          "shape": "2, 2"
         }
        },
        {
         "colorscale": [
          [
           0,
           "rgb(255,255,255)"
          ],
          [
           0.125,
           "rgb(240,240,240)"
          ],
          [
           0.25,
           "rgb(217,217,217)"
          ],
          [
           0.375,
           "rgb(189,189,189)"
          ],
          [
           0.5,
           "rgb(150,150,150)"
          ],
          [
           0.625,
           "rgb(115,115,115)"
          ],
          [
           0.75,
           "rgb(82,82,82)"
          ],
          [
           0.875,
           "rgb(37,37,37)"
          ],
          [
           1,
           "rgb(0,0,0)"
          ]
         ],
         "name": "Structure Threshold",
         "opacity": 0.1,
         "showscale": false,
         "type": "surface",
         "x": {
          "bdata": "AAAAAAAA4L8AAAAAAAAeQAAAAAAAAOC/AAAAAAAAHkA=",
          "dtype": "f8",
          "shape": "2, 2"
         },
         "y": {
          "bdata": "AAAAAAAACEAAAAAAAAAIQAAAAAAAAAhAAAAAAAAACEA=",
          "dtype": "f8",
          "shape": "2, 2"
         },
         "z": {
          "bdata": "AAAAAAAgfsAAAAAAACB+wAAAAAAA0IJAAAAAAADQgkA=",
          "dtype": "f8",
          "shape": "2, 2"
         }
        }
       ],
       "layout": {
        "legend": {
         "title": {
          "text": "Legend"
         },
         "tracegroupgap": 0
        },
        "margin": {
         "b": 0,
         "l": 0,
         "r": 0,
         "t": 40
        },
        "scene": {
         "domain": {
          "x": [
           0,
           1
          ],
          "y": [
           0,
           1
          ]
         },
         "xaxis": {
          "range": [
           -0.5,
           7.5
          ],
          "title": {
           "text": "Feature Votes (0-7)"
          }
         },
         "yaxis": {
          "range": [
           -0.5,
           7.5
          ],
          "title": {
           "text": "Structure Votes (0-7)"
          }
         },
         "zaxis": {
          "title": {
           "text": "Synergy Score"
          }
         }
        },
        "template": {
         "data": {
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermap": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermap"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "#E5ECF6",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "white"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          }
         }
        },
        "title": {
         "text": "3D Analysis: Outliers vs. Synergy Class (HT-29_FEATURE)"
        }
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# ---------------------------------------------------------\n",
    "# 1. 数据准备\n",
    "# ---------------------------------------------------------\n",
    "# 确保 Votes 列是最新的\n",
    "cols_feat = [c for c in ['Stat', 'Dist', 'Density', 'TOD', 'CBOD', 'Dynamic', 'Dynamic_Updated'] if c in outlier_flags.columns]\n",
    "outlier_flags['Votes'] = outlier_flags[cols_feat].sum(axis=1)\n",
    "\n",
    "cols_smile = [c for c in ['Stat', 'Dist', 'Density', 'TOD', 'CBOD', 'Dynamic', 'Dynamic_Updated'] if c in outlier_flags_smile.columns]\n",
    "outlier_flags_smile['Votes'] = outlier_flags_smile[cols_smile].sum(axis=1)\n",
    "\n",
    "# 构建绘图 DataFrame\n",
    "df_plot = pd.DataFrame(index=outlier_flags.index)\n",
    "\n",
    "# A. 坐标轴数据 (加入微小抖动 Jitter)\n",
    "np.random.seed(42)\n",
    "df_plot['Feat_Votes_Jitter'] = outlier_flags['Votes'] + np.random.uniform(-0.25, 0.25, len(df_plot))\n",
    "df_plot['Struct_Votes_Jitter'] = outlier_flags_smile['Votes'] + np.random.uniform(-0.25, 0.25, len(df_plot))\n",
    "\n",
    "# 原始数据 (用于显示)\n",
    "df_plot['Feature_Votes_Raw'] = outlier_flags['Votes']\n",
    "df_plot['Structure_Votes_Raw'] = outlier_flags_smile['Votes']\n",
    "\n",
    "# B. Z轴数据 (Synergy Score)\n",
    "if 'Synergy_Score' in df_current.columns:\n",
    "    df_plot['Synergy'] = df_current['Synergy_Score']\n",
    "else:\n",
    "    df_plot['Synergy'] = df_current.iloc[:, 416]\n",
    "\n",
    "# 【核心修改 1】将分数转换为三类标签\n",
    "def classify_synergy(score):\n",
    "    if score > 10:\n",
    "        return 'Synergistic'\n",
    "    elif score < -10:\n",
    "        return 'Antagonistic'\n",
    "    else:\n",
    "        return 'Additive'\n",
    "\n",
    "df_plot['Synergy_Class'] = df_plot['Synergy'].apply(classify_synergy)\n",
    "\n",
    "# C. 标签信息\n",
    "target_df_name = df_current if 'Drug_A' in df_current.columns else df_smiles_current\n",
    "df_plot['Drug_A'] = target_df_name['Drug_A']\n",
    "df_plot['Drug_B'] = target_df_name['Drug_B']\n",
    "\n",
    "# D. 离群点形状分类\n",
    "def get_category(row):\n",
    "    f = row['Feature_Votes_Raw']\n",
    "    s = row['Structure_Votes_Raw']\n",
    "    if f >= 3 and s >= 3: return 'I. Dual Outliers'\n",
    "    if f >= 3 and s < 3: return 'II. Feature Only'\n",
    "    if f < 3 and s >= 3: return 'III. Structure Only'\n",
    "    return 'IV. Normal'\n",
    "\n",
    "df_plot['Outlier_Type'] = df_plot.apply(get_category, axis=1)\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 2. 使用 Plotly Express 绘图\n",
    "# ---------------------------------------------------------\n",
    "# 【核心修改 2】定义颜色映射字典\n",
    "color_map = {\n",
    "    'Antagonistic': 'red',   # 拮抗 -> 红色\n",
    "    'Additive': 'green',     # 相加 -> 绿色\n",
    "    'Synergistic': 'blue'    # 协同 -> 蓝色\n",
    "}\n",
    "\n",
    "fig = px.scatter_3d(\n",
    "    df_plot, \n",
    "    x='Feat_Votes_Jitter', \n",
    "    y='Struct_Votes_Jitter', \n",
    "    z='Synergy',\n",
    "    color='Synergy_Class',      # 使用分类后的列作为颜色依据\n",
    "    color_discrete_map=color_map, # 强制使用红绿蓝\n",
    "    symbol='Outlier_Type',      # 形状代表离群类型\n",
    "    opacity=0.6,                # 半透明一点，方便看内部\n",
    "    size_max=8,\n",
    "    hover_data={\n",
    "        'Feat_Votes_Jitter': False,\n",
    "        'Struct_Votes_Jitter': False,\n",
    "        'Feature_Votes_Raw': True,\n",
    "        'Structure_Votes_Raw': True,\n",
    "        'Drug_A': True,\n",
    "        'Drug_B': True,\n",
    "        'Synergy': ':.2f',\n",
    "        'Synergy_Class': True,\n",
    "        'Outlier_Type': False\n",
    "    },\n",
    "    title=f\"3D Analysis: Outliers vs. Synergy Class ({current_dataset_name})\"\n",
    ")\n",
    "\n",
    "fig.update_traces(marker=dict(size=5))\n",
    "# ---------------------------------------------------------\n",
    "# 3. 添加阈值平面 (X=3 和 Y=3 的分割线)\n",
    "# ---------------------------------------------------------\n",
    "# 绘制 X=3 的面 (Feature Threshold)\n",
    "y_range = np.linspace(-0.5, 7.5, 2)\n",
    "z_range = np.linspace(df_plot['Synergy'].min(), df_plot['Synergy'].max(), 2)\n",
    "Y, Z = np.meshgrid(y_range, z_range)\n",
    "X = np.full_like(Y, 3) \n",
    "fig.add_trace(go.Surface(x=X, y=Y, z=Z, opacity=0.1, showscale=False, colorscale='Greys', name='Feature Threshold'))\n",
    "\n",
    "# 绘制 Y=3 的面 (Structure Threshold)\n",
    "x_range = np.linspace(-0.5, 7.5, 2)\n",
    "X2, Z2 = np.meshgrid(x_range, z_range)\n",
    "Y2 = np.full_like(X2, 3) \n",
    "fig.add_trace(go.Surface(x=X2, y=Y2, z=Z2, opacity=0.1, showscale=False, colorscale='Greys', name='Structure Threshold'))\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 4. 美化布局\n",
    "# ---------------------------------------------------------\n",
    "fig.update_layout(\n",
    "    scene = dict(\n",
    "        xaxis_title='Feature Votes (0-7)',\n",
    "        yaxis_title='Structure Votes (0-7)',\n",
    "        zaxis_title='Synergy Score',\n",
    "        xaxis = dict(range=[-0.5, 7.5]),\n",
    "        yaxis = dict(range=[-0.5, 7.5]),\n",
    "    ),\n",
    "    margin=dict(l=0, r=0, b=0, t=40),\n",
    "    legend_title=\"Legend\"\n",
    ")\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 5. 保存与显示\n",
    "# ---------------------------------------------------------\n",
    "output_file = os.path.join(OUTPUT_DIR, \"Interactive_3D_ColorClass.html\")\n",
    "fig.write_html(output_file)\n",
    "\n",
    "print(f\"三色分类交互图已生成: {output_file}\")\n",
    "fig.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b6ceeff5-6ee0-4cf0-bbd0-1c292fcb4272",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python [conda env:.conda-ML]",
   "language": "python",
   "name": "conda-env-.conda-ML-py"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
